data_1gkg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gkg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 121.139 0.495 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.46 126.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.453 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -99.49 141.84 31.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.161 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 93.7 m -80.0 33.02 0.27 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.792 0.33 . . . . 0.0 110.809 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 962' ' ' SER . 60.5 tttp 60.8 136.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.546 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 42.8 m -63.94 124.55 85.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.167 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.58 ' HG2' HG13 ' A' ' 974' ' ' VAL . 37.0 Cg_endo -66.06 109.73 1.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.217 1.945 . . . . 0.0 111.958 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.41 129.93 16.6 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.642 2.228 . . . . 0.0 111.805 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -51.33 104.9 0.46 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 2.6 Cg_exo -76.6 -152.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.734 2.289 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.63 HG13 HG21 ' A' 1019 ' ' ILE . 2.2 p -50.47 83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.156 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 3.4 t30 68.68 -34.9 0.28 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.598 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.4 116.4 7.48 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.253 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.27 140.17 31.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.584 0.23 . . . . 0.0 111.162 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.581 HG23 HD11 ' A' ' 986' ' ' ILE . 2.8 p -89.94 147.69 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.208 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.495 ' O ' HG13 ' A' ' 977' ' ' ILE . 18.8 m170 -111.94 82.53 1.64 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.875 ' HA ' HG23 ' A' ' 986' ' ' ILE . 4.3 p -69.04 85.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 975' ' ' HIS . 50.5 mt -75.37 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.25 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.455 ' HG1' ' H ' ' A' ' 979' ' ' ASP . 35.9 p -55.9 -72.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.658 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 3.4 m-20 -157.42 -133.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.87 -21.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.648 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 25.3 mt-30 -72.52 176.42 5.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.447 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' 1004 ' ' CYS . 71.4 t -44.35 144.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.938 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.66 -30.43 1.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.439 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.658 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 34.6 m -68.47 153.53 43.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' 1002 ' ' ALA . 53.0 ttt-85 -138.32 150.02 46.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.906 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.875 HG23 ' HA ' ' A' ' 976' ' ' VAL . 36.4 pt -142.8 -169.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 68.3 p -148.49 130.63 15.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.551 ' CE2' HG22 ' A' ' 974' ' ' VAL . 0.5 OUTLIER -98.31 154.95 17.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.076 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 989' ' ' SER . . . . . 0.572 ' HA ' HD13 ' A' ' 996' ' ' LEU . 94.1 p -161.23 128.1 4.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 111.851 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.58 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 85.1 m -82.92 51.15 1.86 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.944 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.476 HG21 HD22 ' A' ' 971' ' ' ASN . 14.9 t 38.22 -149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.262 0.553 . . . . 0.0 111.907 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 19.4 m -95.65 141.21 29.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.46 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.47 82.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.161 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 990' ' ' CYS . 50.4 m80 -152.83 135.03 14.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.92 0.36 . . . . 0.0 110.846 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.69 ' HB2' HD12 ' A' 1023 ' ' ILE . 38.4 ttt85 -81.94 121.45 26.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' 1000 ' ' SER . 2.9 tt -76.2 128.86 35.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.456 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -102.22 146.87 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.484 ' N ' HG21 ' A' ' 997' ' ' ILE . . . 82.13 -118.86 4.71 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.503 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -149.65 129.54 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.164 0.482 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.727 ' HB3' HD12 ' A' ' 996' ' ' LEU . 80.0 p -69.9 -43.99 70.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.423 ' O ' HG22 ' A' 1015 ' ' THR . 95.7 p -77.85 136.08 38.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.64 149.62 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.454 . . . . 0.0 111.433 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -134.0 131.63 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 50.3 t -70.43 96.88 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' 1012 ' ' HIS . 27.5 pt -90.43 -175.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' 1011 ' ' ALA . 9.6 tp -158.42 120.41 3.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 43.8 m -81.77 -48.65 11.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.495 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.88 -48.21 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.96 -49.83 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 91.6 m -151.19 149.95 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.304 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.547 ' HB2' ' SG ' ' A' ' 963' ' ' CYS . . . -75.16 140.48 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.528 ' O ' HG12 ' A' 1005 ' ' ILE . 90.5 m-70 -149.39 145.88 27.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 71.7 m95 -71.27 132.66 45.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.735 0.303 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.482 ' HB3' HG22 ' A' 1005 ' ' ILE . 80.8 p -52.46 -29.07 22.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.423 HG22 ' O ' ' A' 1001 ' ' SER . 72.9 p -87.76 -134.62 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -166.95 150.13 6.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.731 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -40.62 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.17 . . . . 0.0 112.503 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.44 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 29.8 Cg_exo -63.1 135.64 52.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.907 2.405 . . . . 0.0 112.028 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.697 HG23 ' H ' ' A' 1020 ' ' CYS . 5.0 mt -95.75 -170.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.006 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.697 ' H ' HG23 ' A' 1019 ' ' ILE . 67.6 m -152.31 98.02 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.473 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.562 ' H ' HD11 ' A' ' 997' ' ' ILE . 3.4 tp-100 -82.53 131.51 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.684 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' 1022 ' ' ARG . 11.8 tpt180 -65.9 127.93 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.61 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.69 HD12 ' HB2' ' A' ' 995' ' ' ARG . 44.3 mm -63.25 106.63 0.94 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.504 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' 1022 ' ' ARG . 3.5 Cg_exo -76.12 136.37 18.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.7 2.267 . . . . 0.0 112.881 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.767 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 29.8 p -124.73 133.94 53.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.03 -154.45 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.733 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.54 147.97 87.54 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 120.66 0.266 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.701 ' HD3' ' HE2' ' A' 1044 ' ' PHE . 78.6 Cg_endo -75.86 142.97 25.94 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.533 2.155 . . . . 0.0 111.6 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.717 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.0 Cg_exo -51.67 106.29 0.13 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 121.997 1.798 . . . . 0.0 111.508 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 90.3 m -77.46 126.81 31.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.665 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.593 HD12 ' HD2' ' A' 1052 ' ' TYR . 18.0 pt -90.41 136.53 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.893 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -52.0 138.38 25.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.774 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.545 ' HA ' ' ND2' ' A' 1055 ' ' ASN . 4.4 m120 75.14 -36.18 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -72.23 132.86 19.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.814 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -81.64 -159.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.148 0.499 . . . . 0.0 111.335 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.628 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -155.99 133.18 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.587 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.489 HG13 ' HB ' ' A' 1051 ' ' THR . 39.4 pt -142.04 -148.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.963 0.411 . . . . 0.0 111.484 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' 1050 ' ' VAL . 8.2 t 78.21 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.861 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 28.7 p -66.46 -43.3 85.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.755 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' 1044 ' ' PHE . 4.5 m120 -52.21 140.18 21.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.254 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.628 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 86.3 mtm180 -155.16 -47.17 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -162.99 -43.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -71.67 58.26 0.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.461 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.701 ' HE2' ' HD3' ' A' 1028 ' ' PRO . 2.3 m-85 -76.68 132.21 39.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 55.4 m170 -130.71 -56.29 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.16 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' 1023 ' ' ILE . 78.0 t80 170.79 150.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.443 0.464 . . . . 0.0 110.386 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.558 ' N ' ' HB2' ' A' 1074 ' ' CYS . . . 76.46 -31.12 1.42 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.681 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.408 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 49.4 m -45.85 131.26 9.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1049 ' ' VAL . . . . . . . . . . . . . 6.8 p -102.2 146.45 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.542 HG22 ' CD1' ' A' 1036 ' ' PHE . 7.3 p -133.39 135.15 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.489 ' HB ' HG13 ' A' 1037 ' ' ILE . 44.1 m -98.63 122.57 42.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.593 ' HD2' HD12 ' A' 1031 ' ' ILE . 3.6 m-85 -85.64 167.11 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' 1053 ' ' ARG . 28.9 mtt85 -159.59 -149.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.972 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.787 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 8.5 t -163.57 157.68 19.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 110.531 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.69 ' O ' ' HG ' ' A' 1056 ' ' LEU . 77.2 m-20 -55.13 153.47 6.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.513 . . . . 0.0 112.316 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' 1055 ' ' ASN . 1.4 mt -154.97 43.25 0.47 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.937 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 72.48 -59.48 1.59 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.387 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 43.3 t 174.38 -18.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 0.0 110.681 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -155.27 55.47 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.28 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . 72.49 129.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.285 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.514 ' H ' HD21 ' A' 1056 ' ' LEU . 39.6 ttm180 -178.15 145.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.577 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.643 ' O ' HG11 ' A' 1063 ' ' VAL . 40.5 ttmt -65.25 81.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.856 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.643 HG11 ' O ' ' A' 1062 ' ' LYS . 9.6 m -151.82 88.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.516 0.674 . . . . 0.0 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.877 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 72.5 m-85 70.79 141.86 0.05 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.511 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1065 ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.7 mt-10 -142.39 142.33 32.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.103 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' 1070 ' ' PRO . 1.4 tt -68.57 137.71 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.295 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.644 ' N ' HD22 ' A' 1066 ' ' LEU . 7.3 p -139.49 127.43 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.663 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.55 138.56 1.4 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.395 -0.821 . . . . 0.0 114.056 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.777 ' O ' ' HG3' ' A' 1089 ' ' PRO . 32.9 tt0 36.75 59.21 3.64 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.193 0.597 . . . . 0.0 112.457 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.66 ' HA ' HD12 ' A' 1066 ' ' LEU . 32.9 Cg_endo -63.21 6.58 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.231 1.954 . . . . 0.0 112.612 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' 1069 ' ' GLU . 81.0 p -156.17 147.12 22.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.308 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.499 HD12 ' OH ' ' A' 1052 ' ' TYR . 44.7 pt -142.22 179.73 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -160.06 154.68 24.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.447 . . . . 0.0 111.828 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' 1047 ' ' GLY . 65.8 m -62.6 146.23 52.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.907 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.0 t -155.76 -158.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.055 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.6 p -151.48 143.37 23.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.49 ' N ' HD21 ' A' 1077 ' ' ASN . 0.0 OUTLIER -164.82 29.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.6 t70 176.38 52.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.258 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.25 -129.08 0.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.503 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.703 ' HG2' ' H ' ' A' 1081 ' ' VAL . 6.7 tt0 -67.59 -139.85 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.703 ' H ' ' HG2' ' A' 1080 ' ' GLN . 27.2 t 72.99 -43.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 122.541 0.336 . . . . 0.0 111.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 67.85 64.51 3.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.658 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.433 HD13 ' HB ' ' A' 1081 ' ' VAL . 3.4 mp -81.89 135.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 110.555 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.466 ' CZ3' HG13 ' A' 1050 ' ' VAL . 26.0 m95 -78.14 -160.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 77.6 p -81.58 -65.03 1.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 144.14 5.53 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.696 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.717 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 98.5 Cg_endo -83.71 49.9 3.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.097 2.531 . . . . 0.0 112.034 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.495 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -64.33 -41.62 61.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.777 ' HG3' ' O ' ' A' 1069 ' ' GLU . 86.6 Cg_exo -45.78 137.78 12.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.507 2.138 . . . . 0.0 113.051 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.577 ' O ' HG13 ' A' 1067 ' ' VAL . 38.3 tt0 -150.32 143.08 24.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.877 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 73.9 m -84.32 137.18 33.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 31.0 pt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.097 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.419 ' HG3' ' CD1' ' A' 1006 ' ' LEU . 46.6 mmtm 62.1 145.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.987 0.423 . . . . 0.0 111.422 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 82.1 p -157.97 136.01 10.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.5 m -79.95 164.45 23.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.317 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.84 126.77 28.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 4.2 t -76.77 114.09 35.81 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.498 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.877 ' HG2' HG12 ' A' ' 974' ' ' VAL . 86.5 Cg_endo -85.48 111.06 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.485 2.123 . . . . 0.0 112.142 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 19.6 Cg_endo -58.88 -39.55 80.24 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.282 1.988 . . . . 0.0 110.951 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 62.9 t0 179.25 119.14 0.21 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.443 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 974' ' ' VAL . 35.5 Cg_endo -64.84 -150.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 112.613 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.742 HG21 ' H ' ' A' ' 971' ' ' ASN . 9.6 p -53.13 -136.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.559 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.742 ' H ' HG21 ' A' ' 970' ' ' VAL . 4.7 m120 -65.33 -33.39 75.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.066 0.46 . . . . 0.0 110.583 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -69.08 -147.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.803 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 85.5 mtp -156.35 142.51 18.2 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.327 0.251 . . . . 0.0 110.408 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.877 HG12 ' HG2' ' A' ' 966' ' ' PRO . 1.1 p -92.18 144.94 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.004 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.41 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 23.1 m170 -121.22 112.38 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.601 HG12 HG22 ' A' ' 980' ' ' ILE . 90.5 t -64.72 -41.49 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.773 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 20.2 mt 64.88 -98.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.144 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 12.6 p -80.73 -52.85 7.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.528 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 980' ' ' ILE . 21.1 m-20 -169.3 -157.69 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.235 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.601 HG22 HG12 ' A' ' 976' ' ' VAL . 20.1 pt -155.91 10.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.837 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.675 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 74.3 mt-30 -73.2 -45.72 54.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.624 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 7.5 p 167.38 151.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 79.43 -40.32 2.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.361 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 14.4 t -69.83 141.99 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.39 . . . . 0.0 111.049 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -110.96 118.29 35.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.118 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' A' ' 976' ' ' VAL . 36.7 pt -91.28 138.46 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.203 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 82.6 p -103.51 132.18 49.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.544 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 4.7 m-85 -101.41 152.62 20.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.7 m -154.21 126.05 7.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.594 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 991' ' ' THR . 37.3 t -98.64 178.68 4.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.422 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 61.2 p -65.11 -158.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.216 0.532 . . . . 0.0 111.84 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 46.0 m -86.04 -68.02 0.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.001 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.435 ' HA2' ' CE1' ' A' 1046 ' ' TYR . . . -81.02 42.29 2.7 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.424 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.577 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 41.6 m80 -149.48 125.35 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 0.0 110.726 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.57 ' HB3' ' NE2' ' A' 1080 ' ' GLN . 52.2 ttt-85 -95.14 121.63 36.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.741 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 1.4 tt -76.21 137.34 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.655 ' N ' HD21 ' A' ' 996' ' ' LEU . 1.8 mp -101.29 149.81 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.017 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.79 34.68 38.01 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.691 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 58.96 130.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.223 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 988' ' ' TYR . 49.8 m -83.05 41.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 68.8 m -162.18 148.39 13.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.569 ' HA ' HG22 ' A' 1015 ' ' THR . . . -159.22 128.06 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -103.25 125.67 50.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.763 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.487 ' O ' HG21 ' A' ' 982' ' ' VAL . 44.6 t -68.4 84.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 49.7 pt -87.3 -162.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.737 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' 1007 ' ' SER . 5.2 tt -158.36 125.81 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.346 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.456 ' N ' HD22 ' A' 1006 ' ' LEU . 45.3 m -78.39 -55.88 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.415 ' N ' HD22 ' A' 1006 ' ' LEU . . . 169.55 42.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.727 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 21.7 p30 -177.9 -36.95 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.26 149.58 29.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.443 ' HB2' ' SG ' ' A' 1004 ' ' CYS . . . -75.26 132.95 41.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.129 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -149.43 145.81 27.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.488 ' CH2' HG22 ' A' ' 986' ' ' ILE . 52.3 m95 -70.82 122.83 20.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.328 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.6 p -52.48 -25.69 10.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.708 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' 1002 ' ' ALA . 50.5 p -87.72 -144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.53 ' HB2' ' NZ ' ' A' 1016 ' ' LYS . 10.7 mtmp? -151.57 161.27 30.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.281 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 78.6 Cg_exo -40.95 124.69 2.08 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.61 2.206 . . . . 0.0 112.692 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.544 ' HG3' ' CE2' ' A' ' 988' ' ' TYR . 90.7 Cg_endo -80.67 145.59 16.32 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.143 2.562 . . . . 0.0 113.376 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.502 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 7.2 tt -148.84 113.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.99 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 9.7 t -86.44 121.16 28.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.124 0.488 . . . . 0.0 111.382 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -85.55 136.61 33.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.616 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' 1024 ' ' PRO . 57.8 mtt85 -75.93 127.75 33.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.177 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.739 HG12 ' HG3' ' A' 1080 ' ' GLN . 84.9 mt -76.73 108.54 6.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.282 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.924 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 66.7 Cg_endo -74.0 121.54 7.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.384 2.056 . . . . 0.0 111.384 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.518 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 16.8 m -89.16 28.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1026 ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' 1044 ' ' PHE . . . 37.22 -158.83 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.668 -0.697 . . . . 0.0 114.273 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.592 HD11 ' N ' ' A' 1027 ' ' LEU . 7.7 mp -74.01 145.78 84.09 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 122.599 0.36 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.512 ' HB3' ' CD1' ' A' 1072 ' ' ILE . 23.1 Cg_exo -63.43 144.8 91.57 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.731 2.287 . . . . 0.0 111.375 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.751 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 5.9 Cg_endo -47.86 113.9 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.243 1.962 . . . . 0.0 111.396 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1030 ' ' THR . . . . . 0.471 ' O ' HG21 ' A' 1031 ' ' ILE . 64.0 p -77.78 141.36 39.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.304 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.586 HG22 ' HB2' ' A' 1088 ' ' ALA . 25.6 pt -147.82 121.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.64 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.08 135.63 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.123 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 1032 ' ' ALA . 76.4 m-20 75.01 -38.36 0.38 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.516 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' 1032 ' ' ALA . . . -69.98 76.97 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.724 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.81 126.26 29.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' 1038 ' ' SER . 17.8 p90 -93.26 147.3 23.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.98 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.529 HG21 ' N ' ' A' 1038 ' ' SER . 49.8 mm -87.37 159.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.822 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.529 ' N ' HG21 ' A' 1037 ' ' ILE . 23.1 t 75.39 144.65 0.08 Allowed 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' 1041 ' ' ARG . 17.0 p -66.13 -57.02 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.486 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 61.28 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' 1039 ' ' THR . 49.8 mtt85 40.27 -128.36 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.29 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' 1043 ' ' ASN . 8.2 pt-20 -77.15 -145.75 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' 1042 ' ' GLU . 62.9 m-20 34.85 36.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.212 0.529 . . . . 0.0 110.61 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.463 ' CZ ' ' HA3' ' A' 1026 ' ' GLY . 1.2 p90 -89.02 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.048 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.924 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 21.0 p-80 -165.36 -164.59 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.174 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.499 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 22.1 t80 -59.24 153.76 17.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 111.56 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 68.77 10.52 61.24 Favored Glycine 0 C--N 1.33 0.222 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.296 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.509 ' OG ' ' HB2' ' A' 1025 ' ' CYS . 74.4 p -48.39 134.32 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.179 0.49 . . . . 0.0 109.929 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' 1073 ' ' TYR . 38.3 t -146.72 142.86 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.427 HG21 ' CG1' ' A' 1072 ' ' ILE . 28.4 m -152.64 134.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.192 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.47 HG22 ' OG ' ' A' 1071 ' ' SER . 91.2 m -92.9 124.72 37.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.695 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.491 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 8.2 m-85 -73.72 154.67 39.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.473 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' 1053 ' ' ARG . 38.0 ttt85 -148.3 0.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.463 ' HB3' ' CD1' ' A' 1064 ' ' PHE . 59.0 m 64.12 152.27 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 111.079 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' 1057 ' ' GLY . 48.5 t30 -62.62 -49.19 76.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' 1061 ' ' ARG . 0.4 OUTLIER -71.31 39.23 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.613 ' HA3' HG12 ' A' 1063 ' ' VAL . . . -89.02 -24.17 32.93 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.1 p -151.91 121.14 6.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.324 -0.938 . . . . 0.0 109.52 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' 1058 ' ' SER . 38.5 mmt180 81.71 44.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.32 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.645 ' C ' HD21 ' A' 1056 ' ' LEU . . . 179.99 -44.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.66 ' O ' HD21 ' A' 1056 ' ' LEU . 51.4 mmt-85 64.5 177.59 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 122.499 0.32 . . . . 0.0 111.826 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' 1061 ' ' ARG . 16.0 tptm 75.85 -41.7 0.44 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.367 0.603 . . . . 0.0 109.619 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.613 HG12 ' HA3' ' A' 1057 ' ' GLY . 0.0 OUTLIER 47.64 40.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.346 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.536 ' HE1' ' H ' ' A' 1056 ' ' LEU . 0.1 OUTLIER 42.84 -138.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -150.19 121.07 7.62 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.342 0.591 . . . . 0.0 110.47 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.532 HD13 ' HB2' ' A' 1089 ' ' PRO . 55.0 tp -68.5 145.58 53.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.167 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 65.1 t -138.2 131.75 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.889 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.38 -143.67 22.91 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.413 ' OE2' HG21 ' A' 1072 ' ' ILE . 22.5 pt-20 -68.49 126.94 93.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.447 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 2.7 Cg_endo -83.3 -10.21 10.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.104 2.536 . . . . 0.0 111.759 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.47 ' OG ' HG22 ' A' 1051 ' ' THR . 49.4 m -153.5 127.41 8.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.093 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.512 ' CD1' ' HB3' ' A' 1028 ' ' PRO . 19.4 pt -89.5 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.3 0.572 . . . . 0.0 111.905 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' 1049 ' ' VAL . 24.8 p90 -145.06 128.94 17.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.679 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 13.5 t -63.68 164.15 10.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.113 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.0 t -155.78 -27.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.484 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 56.1 m 65.48 146.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.921 0.391 . . . . 0.0 111.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.713 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -164.98 -34.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.713 ' H ' HD21 ' A' 1077 ' ' ASN . 9.5 t70 -60.28 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.62 0.248 . . . . 0.0 110.863 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -162.95 -42.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.761 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.739 ' HG3' HG12 ' A' 1023 ' ' ILE . 52.4 tt0 -175.0 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.23 0.538 . . . . 0.0 110.321 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 20.5 t -83.33 -117.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.678 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . -165.78 50.85 0.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.776 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' 1083 ' ' ILE . 2.0 mp -81.95 126.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.679 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.8 m95 -85.37 -151.23 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' 1073 ' ' TYR . 80.2 p -95.39 -27.63 15.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.111 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.426 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . -166.43 152.66 21.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.612 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 10.7 Cg_exo -73.48 47.35 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 112.883 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.751 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 65.36 141.89 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.859 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.532 ' HB2' HD13 ' A' 1066 ' ' LEU . 58.6 Cg_endo -69.89 -146.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.726 2.284 . . . . 0.0 112.113 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.412 ' H ' ' HB2' ' A' 1089 ' ' PRO . 3.3 mm100 -150.65 128.71 11.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 91.9 m -96.69 70.54 2.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.459 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.25 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.724 0.297 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 0.8 OUTLIER 61.63 122.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.628 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 31.0 t -157.95 131.96 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.934 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 2.9 p -79.84 142.22 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.68 126.36 27.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 0.0 110.665 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.72 ' HB ' HD12 ' A' ' 980' ' ' ILE . 9.1 t -67.89 131.91 92.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.111 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.74 108.83 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.349 2.033 . . . . 0.0 111.649 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 965' ' ' THR . 88.9 Cg_exo -48.02 -46.76 21.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.537 2.158 . . . . 0.0 111.644 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 968' ' ' ASP . 2.1 p30 179.28 111.73 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.223 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 24.2 Cg_exo -62.55 152.9 74.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.668 2.245 . . . . 0.0 111.971 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' 1019 ' ' ILE . 60.0 t -48.02 100.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 75.3 m-20 74.44 -50.74 0.68 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.597 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -73.44 141.34 29.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.908 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.4 mtp -89.28 138.12 31.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.42 ' C ' ' HD2' ' A' ' 975' ' ' HIS . 4.9 p -83.5 151.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.397 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 987' ' ' THR . 21.8 m170 -119.07 76.17 1.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.812 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.518 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 48.5 t -75.21 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 977' ' ' ILE . 66.8 mt -75.27 -75.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.825 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 33.2 p -56.42 -88.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.572 ' OD1' ' HB2' ' A' ' 981' ' ' GLN . 2.8 p30 -168.7 151.42 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.72 HD12 ' HB ' ' A' ' 965' ' ' THR . 5.1 pt -83.93 27.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.337 0.589 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.572 ' HB2' ' OD1' ' A' ' 979' ' ' ASP . 27.2 mt-30 -90.37 151.73 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.07 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' 1004 ' ' CYS . 74.8 t -44.26 146.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.734 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 83.26 -39.85 2.8 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 114.258 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.2 m -68.45 175.72 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.612 0.706 . . . . 0.0 111.143 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.463 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 4.7 tmm_? -156.6 128.72 7.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.194 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 34.3 pt -97.28 -163.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 975' ' ' HIS . 54.7 p -149.23 130.13 14.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.937 0.398 . . . . 0.0 112.028 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.1 m-85 -99.18 147.82 24.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.376 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -151.13 132.15 14.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.536 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 85.8 m -81.93 -125.93 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 992' ' ' THR . 1.8 t -165.01 176.15 8.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.306 0.574 . . . . 0.0 111.375 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.474 ' N ' ' OG1' ' A' ' 991' ' ' THR . 22.1 m -48.54 131.02 17.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.643 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.19 84.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.459 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.01 122.44 7.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.943 0.371 . . . . 0.0 110.706 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.6 ' NH2' ' HA ' ' A' 1080 ' ' GLN . 38.0 ttm180 -82.24 114.54 20.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.581 HD13 ' N ' ' A' ' 997' ' ' ILE . 7.6 tp -76.27 127.81 33.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.24 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.678 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.8 mp -98.75 140.78 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.482 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.2 174.34 40.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.068 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.507 ' C ' ' H ' ' A' 1001 ' ' SER . 86.6 m-70 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 0.0 111.357 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.3 p -75.4 31.3 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.838 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 999' ' ' HIS . 63.0 m -162.12 152.18 16.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.048 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.83 ' HB2' ' HB3' ' A' 1013 ' ' TRP . . . -150.8 129.03 11.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.63 122.96 33.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.097 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 14.9 t -70.13 80.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' 1014 ' ' SER . 40.7 pt -87.33 -142.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.516 ' HG ' ' C ' ' A' 1010 ' ' THR . 5.1 tt -158.39 121.62 3.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.878 0.37 . . . . 0.0 110.566 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 53.0 m -92.03 47.03 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.811 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.482 ' N ' HD21 ' A' 1006 ' ' LEU . . . 75.35 -57.63 2.85 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.092 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.18 -60.08 3.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.855 0.327 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.516 ' C ' ' HG ' ' A' 1006 ' ' LEU . 15.2 t -151.27 -172.51 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.611 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.26 136.89 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 111.003 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -149.44 151.72 34.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.836 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.83 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 61.2 m95 -72.41 127.45 32.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.545 ' HA ' HD12 ' A' 1005 ' ' ILE . 46.9 t -52.46 -27.7 17.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.972 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 999' ' ' HIS . 82.5 p -105.8 142.28 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 111.95 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -57.08 149.2 47.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.276 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.84 108.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.247 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.443 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 34.1 Cg_exo -59.3 148.73 85.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.897 2.398 . . . . 0.0 112.163 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.678 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 9.1 tt -148.82 135.71 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.433 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 50.1 m -86.49 159.42 19.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.912 0.387 . . . . 0.0 110.64 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.42 ' HB3' HD12 ' A' ' 997' ' ' ILE . 7.0 tt0 -153.5 117.69 4.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.595 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -64.21 127.66 32.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.194 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' 1045 ' ' HIS . 76.0 mt -71.05 126.69 92.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.39 126.49 19.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.563 2.175 . . . . 0.0 112.776 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.725 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 71.6 m -97.21 135.05 39.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -84.74 151.72 26.65 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.49 HD21 ' N ' ' A' 1027 ' ' LEU . 1.4 mm? -39.44 137.15 1.06 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 117.168 0.484 . . . . 0.0 111.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.51 ' O ' HG21 ' A' 1030 ' ' THR . 29.7 Cg_endo -63.68 145.24 91.04 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.677 2.251 . . . . 0.0 112.12 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.588 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.4 Cg_exo -54.61 91.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.295 1.997 . . . . 0.0 111.376 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1030 ' ' THR . . . . . 0.51 HG21 ' O ' ' A' 1028 ' ' PRO . 53.2 p -77.47 118.78 20.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.66 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.666 HD12 ' HB2' ' A' 1089 ' ' PRO . 18.4 pt -84.95 119.89 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.46 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -43.55 141.53 1.41 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 78.08 -38.78 0.26 Allowed 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.506 0.504 . . . . 0.0 111.001 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.766 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -69.78 120.11 9.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.428 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' 1052 ' ' TYR . 1.4 m-20 -83.06 173.46 11.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.667 ' HA ' ' O ' ' A' 1051 ' ' THR . 43.9 p90 -151.43 133.64 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.169 0.509 . . . . 0.0 111.728 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.639 HD13 ' HD2' ' A' 1053 ' ' ARG . 29.5 mt -108.54 45.34 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.501 ' HB3' HG11 ' A' 1050 ' ' VAL . 81.6 p -71.2 -140.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.701 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' 1041 ' ' ARG . 88.7 m -161.16 -29.53 0.05 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.599 ' HB3' ' OG ' ' A' 1048 ' ' SER . 21.8 p30 -53.35 -39.05 63.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' 1039 ' ' THR . 37.9 mmt180 59.02 -111.43 0.55 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.231 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.12 -131.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.51 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.1 p30 -56.26 145.6 26.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' 1027 ' ' LEU . 29.6 p90 -159.79 129.23 5.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.75 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' O ' ' A' 1023 ' ' ILE . 48.9 m-70 -76.6 -41.54 45.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.508 ' HH ' ' HA ' ' A' 1075 ' ' THR . 60.1 t80 176.03 157.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.551 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' 1048 ' ' SER . . . 76.54 96.67 0.17 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.284 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.599 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 45.7 t 174.26 153.68 0.11 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' 1073 ' ' TYR . 3.6 m -137.81 159.42 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.258 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' 1038 ' ' SER . 18.1 m -133.37 134.67 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' 1036 ' ' PHE . 86.7 m -104.77 119.05 38.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' 1035 ' ' ASP . 7.7 m-85 -80.56 160.07 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.639 ' HD2' HD13 ' A' 1037 ' ' ILE . 79.6 mtp180 -142.71 -41.6 0.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.766 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 40.1 t 70.73 122.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.818 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.624 ' HB2' ' HB2' ' A' 1064 ' ' PHE . 3.5 m120 17.57 -123.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.533 ' HA ' HG21 ' A' 1063 ' ' VAL . 79.6 mt 69.5 123.49 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.69 -62.79 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.612 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.468 ' C ' ' HD2' ' A' 1059 ' ' ARG . 38.2 t -90.06 44.02 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.569 ' HD2' ' N ' ' A' 1059 ' ' ARG . 0.0 OUTLIER 39.45 44.98 1.21 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.071 -179.121 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.59 -29.13 0.12 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.098 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -45.75 146.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.605 0.241 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.554 ' HB3' ' NZ ' ' A' 1062 ' ' LYS . 6.3 ttpm? -65.37 80.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.986 0.422 . . . . 0.0 111.59 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' 1056 ' ' LEU . 3.2 m -155.17 90.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.624 ' HB2' ' HB2' ' A' 1055 ' ' ASN . 0.5 OUTLIER 68.75 144.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.566 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -146.18 143.36 29.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 112.338 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' 1070 ' ' PRO . 34.6 tp -68.55 151.7 46.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.969 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.864 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 76.9 t -138.22 136.25 44.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.061 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.1 -148.09 32.6 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.131 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.1 pt-20 -63.45 128.6 92.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.522 ' HB3' HD22 ' A' 1066 ' ' LEU . 79.4 Cg_endo -94.74 11.16 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.974 2.449 . . . . 0.0 113.23 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' 1050 ' ' VAL . 80.2 p -157.02 145.86 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1072 ' ' ILE . . . . . . . . . . . . . 42.9 pt -140.95 174.29 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.631 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.663 ' HB3' HG11 ' A' 1049 ' ' VAL . 1.6 p90 -160.04 148.13 16.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.486 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.902 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 44.6 t -65.37 137.37 57.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.508 ' HA ' ' HH ' ' A' 1046 ' ' TYR . 8.0 t -154.98 11.05 0.35 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' 1075 ' ' THR . 99.7 p 55.74 151.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.603 ' ND2' ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -168.34 40.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' 1081 ' ' VAL . 54.3 t0 -178.57 -18.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' 1080 ' ' GLN . 33.1 m-20 70.42 134.63 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.6 ' HA ' ' NH2' ' A' ' 995' ' ' ARG . 72.7 mt-30 76.2 21.96 1.4 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 109.211 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' 1078 ' ' ASP . 2.6 m -163.3 109.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.075 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.725 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . -74.31 63.89 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.581 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.603 ' HB ' ' ND2' ' A' 1077 ' ' ASN . 64.4 mt -81.92 138.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.902 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.5 m95 -70.98 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.002 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.0 t -80.61 -65.75 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.999 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.6 145.44 6.08 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.343 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.588 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 92.3 Cg_endo -81.71 51.12 3.73 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.116 2.544 . . . . 0.0 112.787 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.469 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -66.28 -43.94 56.29 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.666 ' HB2' HD12 ' A' 1031 ' ' ILE . 87.1 Cg_exo -43.56 137.74 5.75 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.438 2.092 . . . . 0.0 112.699 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.864 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.4 mm100 -129.77 127.96 41.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 36.5 t -93.45 72.41 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.266 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.61 0.243 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.544 ' HD2' HD22 ' A' 1006 ' ' LEU . 27.1 mttm -77.62 146.86 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.684 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.507 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 80.4 p -157.98 143.29 16.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 95.5 m -80.01 146.83 31.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.256 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.83 139.43 58.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 111.337 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 62.9 m -68.28 128.12 93.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.981 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 974' ' ' VAL . 11.0 Cg_exo -70.05 127.38 14.29 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 111.211 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 968' ' ' ASP . 18.3 Cg_endo -60.08 -60.09 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.114 1.876 . . . . 0.0 111.708 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 967' ' ' PRO . 42.1 p-10 175.73 115.18 0.12 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.979 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.756 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 18.3 Cg_exo -66.22 134.92 38.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.489 2.126 . . . . 0.0 111.727 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.551 HG12 ' HB ' ' A' 1019 ' ' ILE . 0.8 OUTLIER -49.11 125.47 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.039 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.547 HD21 ' HB2' ' A' 1020 ' ' CYS . 73.4 m-20 75.29 -58.32 0.57 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.225 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -80.04 -161.54 23.89 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.756 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 40.6 tpp -160.47 135.16 7.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.613 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.508 HG23 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -81.76 150.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.321 . . . . 0.0 110.779 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -117.31 99.5 7.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.498 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.442 ' HA ' HG23 ' A' ' 986' ' ' ILE . 7.2 p -75.03 86.19 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.704 0.764 . . . . 0.0 109.693 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.22 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.505 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 984' ' ' SER . 41.2 p -79.86 79.27 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 111.044 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.1 -142.38 0.75 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.054 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 3.6 pt -155.84 23.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 75.5 mt-30 -85.6 169.97 13.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.675 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' 1004 ' ' CYS . 92.3 t -44.33 145.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.368 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.506 ' HA3' ' OE2' ' A' 1003 ' ' GLU . . . 78.97 -44.45 2.59 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.927 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 978' ' ' THR . 92.8 p -68.36 123.64 21.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.463 0.631 . . . . 0.0 111.047 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.743 ' HD3' ' HB2' ' A' 1001 ' ' SER . 33.8 ttm180 -102.71 135.82 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.846 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.442 HG23 ' HA ' ' A' ' 976' ' ' VAL . 16.3 pt -95.52 -170.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.954 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 55.7 p -148.29 123.9 10.44 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.565 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 4.9 m-85 -97.24 154.15 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.539 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 20.8 m -157.64 126.29 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.662 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 85.0 m -85.16 147.83 26.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.518 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.37 163.36 5.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.587 0.708 . . . . 0.0 112.154 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.4 m -55.79 138.25 48.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.476 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 71.52 40.1 60.06 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.836 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -151.07 138.53 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.494 0.188 . . . . 0.0 110.545 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 995' ' ' ARG . 37.3 ttt85 -82.02 127.13 32.77 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.218 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.662 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 3.5 tt -76.22 118.72 19.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 111.38 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' 1021 ' ' GLN . 30.4 mm -94.2 140.87 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.93 177.19 32.09 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.105 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.545 ' O ' ' HG3' ' A' 1018 ' ' PRO . 22.7 m170 -75.03 127.27 32.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.299 . . . . 0.0 111.172 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.622 ' HB3' HD12 ' A' ' 996' ' ' LEU . 83.4 p -79.02 26.36 0.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.044 0.45 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.743 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.1 p -162.16 140.44 8.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.09 128.45 7.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.506 ' OE2' ' HA3' ' A' ' 983' ' ' GLY . 85.6 tt0 -89.99 130.83 36.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.443 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 51.3 t -67.16 128.54 36.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' 1011 ' ' ALA . 31.2 pt -134.8 -142.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.573 HD11 ' C ' ' A' 1006 ' ' LEU . 0.3 OUTLIER -144.08 120.45 10.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 -179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.494 ' N ' HD11 ' A' 1006 ' ' LEU . 46.0 t -85.93 -47.89 9.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.414 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 177.28 -50.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.111 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 42.3 t30 -79.79 -51.41 9.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.737 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 11.8 t -151.28 -161.95 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.507 ' HB2' ' SG ' ' A' 1004 ' ' CYS . . . -75.31 140.78 43.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.463 ' HD2' ' HB3' ' A' 1007 ' ' SER . 90.2 m-70 -149.49 144.58 26.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 68.6 m95 -67.0 135.21 53.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.883 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 82.4 p -52.49 -22.2 4.58 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.675 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.423 HG22 ' ND1' ' A' ' 999' ' ' HIS . 70.8 p -131.44 139.86 49.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.876 0.369 . . . . 0.0 111.918 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.502 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -52.16 145.47 18.45 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.826 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.57 103.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.396 2.064 . . . . 0.0 111.806 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.565 ' HG2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_endo -62.42 150.79 86.09 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 111.998 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.624 HG13 ' HB ' ' A' ' 997' ' ' ILE . 41.3 pt -125.77 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.547 ' HB2' HD21 ' A' ' 971' ' ' ASN . 22.0 m -146.75 121.32 9.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.642 ' HB2' HD13 ' A' ' 997' ' ' ILE . 64.8 tp60 -83.48 128.36 34.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -81.55 117.89 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.121 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' 1045 ' ' HIS . 75.7 mt -70.94 112.4 13.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.82 127.1 8.46 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.543 2.162 . . . . 0.0 112.139 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' A' 1044 ' ' PHE . 62.8 m -88.43 -145.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 0.0 111.564 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1026 ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' 1044 ' ' PHE . . . -161.08 154.81 25.87 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.629 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.569 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 45.8 mt -42.51 137.93 2.22 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-O 120.81 0.338 . . . . 0.0 111.529 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.58 ' HD3' ' ND2' ' A' 1040 ' ' ASN . 13.1 Cg_endo -56.31 146.68 71.26 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.777 2.318 . . . . 0.0 111.743 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.673 ' HD2' HD13 ' A' 1072 ' ' ILE . 89.0 Cg_exo -47.41 108.66 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.155 1.903 . . . . 0.0 111.606 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 82.1 p -77.59 116.54 18.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.868 HG23 ' HD2' ' A' 1089 ' ' PRO . 11.6 pt -100.28 29.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.449 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 55.2 120.95 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.415 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 61.7 m-80 69.64 12.41 8.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.745 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.62 134.51 38.34 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.998 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.81 -37.25 79.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.719 ' HD1' HG22 ' A' 1050 ' ' VAL . 0.8 OUTLIER 61.34 108.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.831 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.723 ' HB ' ' HB ' ' A' 1051 ' ' THR . 7.9 mt -111.34 -176.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.715 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.536 ' HG ' ' H ' ' A' 1039 ' ' THR . 15.7 t 69.71 -129.51 0.08 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.168 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.536 ' H ' ' HG ' ' A' 1038 ' ' SER . 25.3 p -145.03 140.26 28.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 111.739 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.58 ' ND2' ' HD3' ' A' 1028 ' ' PRO . 23.9 t-20 -169.79 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' 1041 ' ' ARG . 42.1 mtp85 52.03 -142.18 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.7 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -79.06 -45.2 20.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.0 p30 -65.93 141.56 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' 1025 ' ' CYS . 0.5 OUTLIER -163.21 40.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.837 0.351 . . . . 0.0 111.212 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 23.9 m80 -53.49 -40.27 65.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' 1045 ' ' HIS . 43.9 t80 173.61 159.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.695 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.99 -24.99 3.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.136 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 69.1 m -47.61 139.78 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.638 HG22 ' HB3' ' A' 1073 ' ' TYR . 14.4 p -138.19 157.65 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.719 HG22 ' HD1' ' A' 1036 ' ' PHE . 3.3 p -154.02 135.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.723 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 92.3 m -100.96 123.65 45.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.708 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.488 ' HE2' HG22 ' A' 1031 ' ' ILE . 3.7 m-85 -83.7 144.52 29.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.008 0.433 . . . . 0.0 111.355 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' 1066 ' ' LEU . 42.8 ttm-85 -157.42 -25.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.791 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1054 ' ' CYS . . . . . . . . . . . . . 16.2 m 64.86 145.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.059 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 3.4 m120 -62.85 129.77 41.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.288 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.81 ' HG ' ' HA3' ' A' 1060 ' ' GLY . 1.9 mm? -70.33 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.639 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.426 ' H ' ' HB3' ' A' 1056 ' ' LEU . . . -152.05 29.41 0.9 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 23.8 p 177.44 -51.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.74 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' 1059 ' ' ARG . 19.3 tpt85 -169.61 -49.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.81 ' HA3' ' HG ' ' A' 1056 ' ' LEU . . . -172.72 29.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.985 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.497 ' O ' HG21 ' A' 1063 ' ' VAL . 40.1 mtp85 -80.35 169.5 17.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.752 0.31 . . . . 0.0 111.09 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.32 83.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.592 ' O ' ' HB2' ' A' 1064 ' ' PHE . 3.3 m -155.05 99.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.506 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.9 m-30 79.49 62.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.088 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -86.56 130.01 34.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.61 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' 1070 ' ' PRO . 3.2 tm? -68.53 138.66 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.266 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' 1066 ' ' LEU . 11.6 t -151.91 156.68 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.456 ' H ' HG11 ' A' 1067 ' ' VAL . . . 79.79 -27.76 2.56 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.989 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' 1089 ' ' PRO . 16.5 tp10 -167.82 103.7 0.57 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.994 0.397 . . . . 0.0 111.323 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.72 ' HA ' HD13 ' A' 1066 ' ' LEU . 95.7 Cg_endo -87.5 -28.94 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.0 2.467 . . . . 0.0 114.642 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 48.9 m -152.95 137.19 16.52 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.673 HD13 ' HD2' ' A' 1029 ' ' PRO . 28.6 pt -140.94 166.23 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.641 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.638 ' HB3' HG22 ' A' 1049 ' ' VAL . 2.9 p90 -157.17 145.73 19.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.963 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 52.3 t -63.84 148.54 49.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.497 . . . . 0.0 111.413 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.7 t -140.89 150.56 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.114 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 54.5 m -74.54 123.34 24.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' 1077 ' ' ASN . 0.0 OUTLIER 179.31 -165.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.742 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.401 ' O ' HG21 ' A' 1081 ' ' VAL . 8.3 t0 44.35 46.64 7.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.454 ' OD1' ' HG2' ' A' 1080 ' ' GLN . 9.9 t0 72.97 -59.4 0.57 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.178 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.454 ' HG2' ' OD1' ' A' 1079 ' ' ASP . 18.0 pt20 179.61 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' 1078 ' ' ASP . 42.6 t -86.32 -38.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 82.58 55.41 3.02 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.484 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.506 HG12 ' ND2' ' A' 1077 ' ' ASN . 33.8 pt -81.96 137.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.688 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.471 ' CH2' ' HB3' ' A' 1028 ' ' PRO . 11.9 m95 -70.58 146.52 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.641 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 80.1 p -56.54 -9.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.423 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.423 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . -166.42 135.94 3.92 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.36 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.423 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 15.0 Cg_exo -69.44 -153.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.057 2.504 . . . . 0.0 113.038 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' 1031 ' ' ILE . . . -77.16 138.5 64.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.432 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.868 ' HD2' HG23 ' A' 1031 ' ' ILE . 2.3 Cg_endo -80.47 -136.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.491 2.794 . . . . 0.0 111.898 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.504 ' H ' ' HB2' ' A' 1089 ' ' PRO . 62.5 tp60 -152.41 119.84 5.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.757 0.313 . . . . 0.0 110.889 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.506 ' SG ' HD13 ' A' 1031 ' ' ILE . 88.8 m -103.11 128.75 49.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.523 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.367 -179.323 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.854 0.359 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 981' ' ' GLN . 47.6 mmtm 63.26 138.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 56.9 p -157.96 140.51 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 98.6 m -79.85 134.05 36.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -64.96 142.02 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.004 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.7 m -50.8 121.09 14.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.69 132.31 51.36 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.392 2.062 . . . . 0.0 112.416 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.72 140.64 62.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.425 2.083 . . . . 0.0 111.355 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.6 m-20 -48.57 117.65 6.24 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 110.719 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.56 ' HG2' ' N ' ' A' ' 973' ' ' MET . 18.8 Cg_endo -58.9 149.2 80.24 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.801 2.334 . . . . 0.0 112.524 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 79.4 t -42.8 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.1 m-20 73.42 -42.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.727 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.595 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -69.1 -156.34 1.09 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.079 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.57 ' HG3' ' HE2' ' A' ' 975' ' ' HIS . 22.5 ptp -159.25 138.89 11.61 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.631 0.253 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.926 ' HA ' ' HB3' ' A' ' 988' ' ' TYR . 0.7 OUTLIER -87.33 145.53 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.398 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.57 ' HE2' ' HG3' ' A' ' 973' ' ' MET . 19.0 m170 -119.13 106.78 12.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 68.9 t -69.71 94.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 987' ' ' THR . 39.3 mt -75.24 -90.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.367 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.585 ' HG1' ' H ' ' A' ' 985' ' ' ARG . 37.2 p -62.11 -68.62 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.354 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 27.4 t70 -166.89 -138.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.064 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.499 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 10.9 pt -155.81 53.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 961' ' ' LYS . 8.4 tt0 -152.65 158.04 41.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.719 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' 1004 ' ' CYS . 56.5 t -28.29 123.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.31 0.381 . . . . 0.0 111.334 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.58 2.6 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.682 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 981' ' ' GLN . 88.0 p -157.1 127.23 6.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.818 0.342 . . . . 0.0 110.96 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.585 ' H ' ' HG1' ' A' ' 978' ' ' THR . 58.6 mtt85 -101.54 149.57 23.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.7 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' 1002 ' ' ALA . 38.9 pt -142.78 168.85 13.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.075 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.443 HG21 HD13 ' A' ' 977' ' ' ILE . 66.5 p -146.12 147.38 31.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.834 0.349 . . . . 0.0 111.867 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.926 ' HB3' ' HA ' ' A' ' 974' ' ' VAL . 6.5 p90 -145.9 159.29 43.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.8 p -155.23 143.48 20.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.931 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.595 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 36.8 t -82.01 -179.56 7.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.452 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 38.1 p -60.24 155.06 18.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 112.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.475 HG21 ' N ' ' A' ' 993' ' ' GLY . 52.2 m -54.82 139.59 39.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.476 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.475 ' N ' HG21 ' A' ' 992' ' ' THR . . . 82.93 -32.41 2.97 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.204 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -82.43 148.67 28.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.776 ' HG2' ' H ' ' A' ' 996' ' ' LEU . 49.2 ttt-85 -81.97 -172.25 3.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.024 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.776 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 5.5 tt -161.77 128.07 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.857 ' HB ' HG12 ' A' 1019 ' ' ILE . 1.7 mp -86.62 144.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.967 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.6 165.18 36.38 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.506 ' C ' ' H ' ' A' 1001 ' ' SER . 89.5 m-70 -71.38 137.03 48.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.625 0.213 . . . . 0.0 110.762 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 78.7 p -72.14 39.47 0.07 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.948 0.404 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 999' ' ' HIS . 36.4 t -160.06 171.44 19.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.98 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' 1013 ' ' TRP . . . -165.27 134.02 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.4 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -114.05 128.25 56.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.434 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 48.9 t -73.2 85.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 14.7 pt -91.52 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.168 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' 1007 ' ' SER . 0.5 OUTLIER -92.46 128.34 38.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.709 0.29 . . . . 0.0 110.544 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.648 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 46.5 t -162.52 136.75 6.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 66.0 40.37 95.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.381 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.16 21.64 6.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.622 0.249 . . . . 0.0 111.564 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 87.9 m -152.36 133.59 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.818 0.342 . . . . 0.0 111.181 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.32 134.1 41.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.648 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.1 p80 -153.8 150.86 28.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.765 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.511 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 31.8 m95 -68.14 120.59 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.776 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.8 t -52.38 -22.58 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.707 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' 1002 ' ' ALA . 46.6 p -87.0 132.43 33.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -66.05 156.43 84.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.62 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -46.82 118.32 2.62 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.236 1.958 . . . . 0.0 112.019 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 988' ' ' TYR . 64.4 Cg_endo -84.62 160.42 12.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.162 2.574 . . . . 0.0 113.169 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.857 HG12 ' HB ' ' A' ' 997' ' ' ILE . 35.2 pt -144.53 -157.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 49.4 t -143.36 171.18 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.309 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.46 ' HA ' ' OE1' ' A' 1021 ' ' GLN . 1.0 OUTLIER -153.51 130.76 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.036 0.446 . . . . 0.0 111.113 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.592 ' HD3' ' HB3' ' A' 1045 ' ' HIS . 77.7 ttt180 -64.37 -17.54 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.527 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 995' ' ' ARG . 61.4 mt 64.21 89.33 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.934 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.62 126.26 21.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.611 2.207 . . . . 0.0 112.931 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 56.1 m -88.43 -145.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.055 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -163.91 155.57 27.01 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.432 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' 1044 ' ' PHE . 8.8 mp -40.92 139.41 1.21 Allowed Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.578 ' HD3' HD22 ' A' 1040 ' ' ASN . 59.6 Cg_endo -71.67 145.37 46.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.882 2.388 . . . . 0.0 112.054 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' 1087 ' ' PRO . 24.0 Cg_endo -61.47 117.19 3.98 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.206 1.938 . . . . 0.0 111.933 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 83.5 m -82.47 121.05 26.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 24.8 pt -86.66 135.55 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.352 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -51.79 138.61 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' 1032 ' ' ALA . 75.3 m-80 75.03 -40.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.172 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -79.16 116.71 4.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' 1053 ' ' ARG . 57.4 m-20 -68.81 -150.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 110.685 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.528 ' CD1' HG22 ' A' 1050 ' ' VAL . 0.0 OUTLIER -156.0 137.15 13.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.285 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' 1051 ' ' THR . 34.5 pt -128.87 -161.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.566 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.53 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 66.4 m 63.66 159.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.857 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 99.9 m -56.48 130.55 45.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.306 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.578 HD22 ' HD3' ' A' 1028 ' ' PRO . 17.0 t-20 -177.18 -121.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' 1040 ' ' ASN . 21.9 mmt85 75.35 -49.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.606 0.362 . . . . 0.0 111.211 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' 1043 ' ' ASN . 13.5 pt-20 -162.95 -141.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.411 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' 1042 ' ' GLU . 2.9 m120 33.56 43.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.193 0.52 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' 1027 ' ' LEU . 0.3 OUTLIER -77.89 43.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.882 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.592 ' HB3' ' HD3' ' A' 1022 ' ' ARG . 58.3 m-70 -53.3 -52.49 58.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.554 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 32.2 t80 171.9 160.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.392 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 77.51 -20.97 3.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.061 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' 1046 ' ' TYR . 55.3 m -47.66 142.2 4.74 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.896 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.56 HG21 ' N ' ' A' 1050 ' ' VAL . 11.3 p -137.79 155.43 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.338 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.56 ' N ' HG21 ' A' 1049 ' ' VAL . 9.4 p -149.03 139.27 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.334 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.514 ' O ' HG12 ' A' 1037 ' ' ILE . 96.6 m -102.55 128.99 48.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -73.5 139.95 46.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.526 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' 1035 ' ' ASP . 79.3 ttt180 -146.54 133.07 19.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.03 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.571 ' O ' HD21 ' A' 1056 ' ' LEU . 75.5 m -76.45 158.1 31.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 111.834 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.515 ' HA ' ' OD2' ' A' 1035 ' ' ASP . 24.4 t-20 -65.6 -22.92 66.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.957 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.605 ' HB3' ' O ' ' A' 1061 ' ' ARG . 4.1 mm? 46.21 43.77 11.53 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-O 120.786 0.326 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 72.81 -53.94 1.68 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' 1059 ' ' ARG . 36.3 t -178.83 126.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' 1059 ' ' ARG . 3.0 mmp_? 72.37 -60.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.124 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.44 29.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.086 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.605 ' O ' ' HB3' ' A' 1056 ' ' LEU . 42.1 ttt85 -66.17 132.13 47.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -65.24 109.28 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.515 0.674 . . . . 0.0 111.992 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.685 HG11 ' H ' ' A' 1064 ' ' PHE . 3.0 p -157.47 -45.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.156 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.685 ' H ' HG11 ' A' 1063 ' ' VAL . 3.1 m-85 -86.11 155.57 20.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.344 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -146.28 121.34 10.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' 1070 ' ' PRO . 30.9 tp -71.9 142.97 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.466 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' 1089 ' ' PRO . 63.7 t -138.33 138.16 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.427 ' N ' HG11 ' A' 1067 ' ' VAL . . . 84.51 -145.65 22.1 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.8 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1069 ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -62.42 110.41 3.32 Favored Pre-proline 0 C--O 1.225 -0.186 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.688 ' HB3' HD22 ' A' 1066 ' ' LEU . 74.3 Cg_endo -87.8 -45.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.547 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 83.4 p -94.54 146.86 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 112.009 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.811 HG13 ' HB2' ' A' 1085 ' ' SER . 7.0 tt -149.67 158.39 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.688 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.521 ' N ' HG12 ' A' 1072 ' ' ILE . 0.1 OUTLIER -159.7 171.97 18.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.688 0.28 . . . . 0.0 111.19 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.54 ' O ' HG21 ' A' 1075 ' ' THR . 43.4 t -62.16 -44.22 97.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.243 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.54 HG21 ' O ' ' A' 1074 ' ' CYS . 12.4 t 44.16 21.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.668 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.592 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 99.5 p 55.63 141.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.342 0.591 . . . . 0.0 112.483 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.983 ' HA ' HG12 ' A' 1083 ' ' ILE . 0.7 OUTLIER -67.05 -98.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.782 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.61 3.03 0.08 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.277 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 7.3 t0 -163.14 -51.01 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.509 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' 1080 ' ' GLN . 1.8 pm0 -174.84 50.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.435 ' HB ' ' CB ' ' A' 1077 ' ' ASN . 45.9 t -134.31 -37.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.954 -0.466 . . . . 0.0 111.867 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' 1076 ' ' SER . . . 73.8 64.79 2.37 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.983 HG12 ' HA ' ' A' 1077 ' ' ASN . 20.2 pt -81.98 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.557 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 11.1 m95 -72.43 162.91 28.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.218 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.811 ' HB2' HG13 ' A' 1072 ' ' ILE . 57.6 m -43.58 -41.76 4.73 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 107.43 145.94 12.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.664 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' 1029 ' ' PRO . 68.5 Cg_exo -50.77 149.28 14.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.152 2.568 . . . . 0.0 112.845 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.731 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -171.77 -47.57 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.3 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.731 ' HD2' ' H ' ' A' 1088 ' ' ALA . 20.1 Cg_endo -59.65 149.88 79.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.634 2.223 . . . . 0.0 112.725 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -147.7 149.85 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.757 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 56.4 m -93.73 142.3 27.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.092 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.444 HD12 HG23 ' A' 1067 ' ' VAL . 33.4 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.943 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . 0.634 ' C ' ' HD2' ' A' ' 961' ' ' LYS . . . . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.689 0.28 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.634 ' HD2' ' C ' ' A' ' 960' ' ' ALA . 3.1 mptp? -146.55 155.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 98.6 p -152.99 129.12 10.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.39 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 964' ' ' LYS . 1.6 p -79.92 30.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.254 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.757 ' HE2' ' HA ' ' A' ' 964' ' ' LYS . 10.0 mmpt? 54.5 138.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.478 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 6.9 t -63.14 121.46 69.35 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.45 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 986' ' ' ILE . 17.3 Cg_exo -67.25 107.25 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.475 2.117 . . . . 0.0 112.307 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 965' ' ' THR . 28.7 Cg_endo -63.39 136.2 53.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.211 1.941 . . . . 0.0 110.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.8 107.97 0.82 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.765 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 970' ' ' VAL . 73.2 Cg_endo -73.11 -133.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.936 2.424 . . . . 0.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.731 HG12 ' H ' ' A' 1020 ' ' CYS . 8.5 p -51.95 -148.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.914 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.598 ' H ' ' CG2' ' A' ' 970' ' ' VAL . 5.1 m120 -65.46 -28.44 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.767 -0.583 . . . . 0.0 110.469 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.748 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -72.33 126.6 11.59 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.234 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 988' ' ' TYR . 65.9 mtt -94.42 143.95 25.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.552 HG22 ' CZ ' ' A' ' 988' ' ' TYR . 4.5 p -92.88 148.36 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 O-C-N 123.361 0.413 . . . . 0.0 111.6 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.16 109.12 16.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.022 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.716 HG12 HG22 ' A' ' 980' ' ' ILE . 72.6 t -65.38 -48.01 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 22.9 mt 64.69 -98.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.602 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.483 ' HG1' ' H ' ' A' ' 979' ' ' ASP . 38.7 p -62.25 -65.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.507 ' O ' HG11 ' A' ' 976' ' ' VAL . 51.7 p-10 -173.33 -148.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.568 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.716 HG22 HG12 ' A' ' 976' ' ' VAL . 21.1 pt -155.95 25.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.2 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 962' ' ' SER . 85.7 mt-30 -78.81 -57.62 3.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.942 0.401 . . . . 0.0 111.272 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.621 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 7.7 p 167.77 156.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 79.06 -35.87 1.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.669 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.443 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 80.7 p -68.5 -160.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.12 0.486 . . . . 0.0 111.444 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 986' ' ' ILE . 45.4 ttm-85 -156.66 160.64 39.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.085 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.511 ' N ' ' HG2' ' A' ' 985' ' ' ARG . 47.0 pt -142.75 155.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.117 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' 1001 ' ' SER . 82.2 p -142.25 134.32 27.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.552 ' CZ ' HG22 ' A' ' 974' ' ' VAL . 4.0 m-85 -83.23 -161.87 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 73.6 m -148.18 -40.47 0.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.748 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 29.1 t 69.42 137.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.835 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -60.27 145.84 45.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.735 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 74.9 m -51.58 134.64 29.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.361 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 74.03 37.54 49.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.247 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.586 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 33.4 m80 -146.96 125.29 12.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.36 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.437 ' HB2' HD13 ' A' 1023 ' ' ILE . 38.2 ttt85 -82.0 96.82 7.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 1.002 HD23 ' HB3' ' A' 1000 ' ' SER . 3.6 pp -63.62 140.42 58.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.614 ' HB ' HG13 ' A' 1019 ' ' ILE . 50.4 mm -107.96 154.69 9.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.22 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.563 ' N ' HG21 ' A' ' 997' ' ' ILE . . . 76.92 14.63 82.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.071 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 63.68 134.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1000 ' ' SER . . . . . 1.002 ' HB3' HD23 ' A' ' 996' ' ' LEU . 77.8 p -87.76 46.78 1.42 Allowed 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -162.14 146.8 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.711 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.496 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -165.19 125.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.717 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.403 ' HB2' ' NH1' ' A' ' 985' ' ' ARG . 89.2 tt0 -87.65 130.96 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 43.4 t -74.13 86.57 1.88 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.888 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.604 HD11 ' N ' ' A' 1006 ' ' LEU . 2.4 pp -87.28 -146.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.604 ' N ' HD11 ' A' 1005 ' ' ILE . 4.6 tt -158.46 129.37 6.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.1 t -80.25 -59.63 2.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.306 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.27 42.8 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.589 ' H ' HD22 ' A' 1006 ' ' LEU . 16.5 p-10 -176.25 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.377 . . . . 0.0 110.395 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.566 ' O ' ' HG ' ' A' 1006 ' ' LEU . 11.8 t -151.29 175.99 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.537 ' HB2' ' SG ' ' A' 1004 ' ' CYS . . . -74.8 145.71 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.125 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.515 ' O ' HD13 ' A' 1005 ' ' ILE . 88.3 m-70 -149.44 145.61 27.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.438 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.438 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 92.9 m95 -76.42 125.41 29.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.362 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.2 p -53.69 -19.91 4.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.092 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 30.3 p -131.26 135.84 47.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 112.265 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.433 ' HB3' ' HD2' ' A' 1017 ' ' PRO . 14.7 mmmm -69.81 161.96 71.29 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.891 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 80.2 Cg_exo -45.43 132.31 12.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.735 2.29 . . . . 0.0 112.686 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 88.9 Cg_endo -80.51 170.56 15.74 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.997 2.465 . . . . 0.0 113.143 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.614 HG13 ' HB ' ' A' ' 997' ' ' ILE . 25.4 pt -148.83 121.53 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.811 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.731 ' H ' HG12 ' A' ' 970' ' ' VAL . 88.9 m -86.16 118.26 25.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 112.118 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -82.41 126.01 31.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.915 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.546 ' O ' ' HB2' ' A' 1046 ' ' TYR . 40.9 ttt85 -67.2 -9.37 39.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.256 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.437 HD13 ' HB2' ' A' ' 995' ' ' ARG . 45.9 mt 54.01 56.77 12.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.428 . . . . 0.0 110.445 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.504 ' CB ' ' HA ' ' A' 1045 ' ' HIS . 58.0 Cg_endo -71.6 138.28 31.89 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.273 . . . . 0.0 113.019 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.417 ' HB2' ' H ' ' A' 1026 ' ' GLY . 3.8 p -88.42 -136.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.317 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1026 ' ' GLY . . . . . 0.51 ' HA3' ' CE1' ' A' 1044 ' ' PHE . . . -148.4 -151.35 5.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.809 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.464 HD22 ' HE2' ' A' 1044 ' ' PHE . 70.6 mt -64.73 132.84 95.55 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-O 120.711 0.291 . . . . 0.0 111.567 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.478 ' HB2' ' HH ' ' A' 1052 ' ' TYR . 27.5 Cg_endo -61.58 149.81 88.18 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 111.092 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.772 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 95.9 Cg_exo -45.47 119.59 2.74 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.287 1.992 . . . . 0.0 112.283 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 81.3 p -81.81 139.9 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.958 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' 1031 ' ' ILE . 45.6 pt -148.45 120.6 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.433 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -73.56 14.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.111 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' 1031 ' ' ILE . 3.5 m120 -80.36 -31.83 37.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.22 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.659 ' HA3' ' ND2' ' A' 1055 ' ' ASN . . . -163.14 -125.2 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.302 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' 1034 ' ' GLY . 53.3 m-20 -156.66 -151.7 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.633 ' HB2' HG11 ' A' 1050 ' ' VAL . 45.9 p90 -155.96 129.65 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 111.945 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.414 HD12 HG22 ' A' 1037 ' ' ILE . 55.9 mt -88.28 78.2 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.986 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' 1039 ' ' THR . 39.6 t -167.39 154.0 8.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 111.492 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' 1041 ' ' ARG . 60.7 m -55.8 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' 1041 ' ' ARG . 7.0 m120 52.91 -125.1 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' 1039 ' ' THR . 76.0 mtp180 74.92 -47.34 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.662 0.385 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' 1044 ' ' PHE . 3.9 tm-20 -162.89 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.68 0.276 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -71.63 38.09 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.665 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.567 ' HD1' ' H ' ' A' 1045 ' ' HIS . 0.3 OUTLIER -76.7 -46.82 24.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.567 ' H ' ' HD1' ' A' 1044 ' ' PHE . 24.2 m-70 40.62 -147.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.18 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.723 ' O ' ' HB3' ' A' 1074 ' ' CYS . 14.8 t80 -63.45 -49.18 74.68 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -96.1 121.6 7.01 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.891 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 47.2 t 178.6 122.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.64 0.734 . . . . 0.0 111.344 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.567 HG21 ' N ' ' A' 1050 ' ' VAL . 11.2 p -102.3 157.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.546 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' 1036 ' ' PHE . 87.4 t -146.81 117.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.951 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' 1036 ' ' PHE . 96.2 m -99.55 109.94 22.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.909 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.478 ' HH ' ' HB2' ' A' 1028 ' ' PRO . 31.4 m-85 -80.98 124.66 29.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.976 0.417 . . . . 0.0 111.684 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' 1054 ' ' CYS . 18.2 tpt85 -97.07 -137.02 0.26 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.643 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.486 ' H ' ' HG3' ' A' 1053 ' ' ARG . 99.1 m -161.43 156.23 23.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 110.512 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.659 ' ND2' ' HA3' ' A' 1034 ' ' GLY . 5.2 m120 -65.85 62.1 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.631 ' HB3' ' HA3' ' A' 1060 ' ' GLY . 3.6 mm? -70.33 135.72 49.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 110.731 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' 1058 ' ' SER . . . -82.74 131.75 10.6 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.864 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' 1057 ' ' GLY . 55.1 m 74.91 -49.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.502 0.321 . . . . 0.0 111.731 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -167.75 -51.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.863 0.363 . . . . 0.0 111.543 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . -172.62 37.8 0.15 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.298 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -66.17 165.82 13.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' 1063 ' ' VAL . 39.5 ttmt -65.38 78.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.277 0.561 . . . . 0.0 111.025 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' 1064 ' ' PHE . 7.9 m -155.08 95.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.559 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.1 m-85 75.77 139.58 0.07 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.026 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 143.63 31.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.66 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' 1070 ' ' PRO . 47.5 tp -68.47 142.36 55.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.564 ' O ' ' HB2' ' A' 1089 ' ' PRO . 77.7 t -149.05 132.5 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.867 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 77.42 145.31 2.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.373 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.726 ' HG2' ' HB3' ' A' 1089 ' ' PRO . 16.3 pt-20 18.12 67.83 0.22 Allowed Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 112.689 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.813 ' HB3' HD22 ' A' 1066 ' ' LEU . 13.9 Cg_endo -56.18 -11.56 6.15 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.539 2.159 . . . . 0.0 111.907 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' 1050 ' ' VAL . 79.6 p -156.23 152.05 27.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.452 HG22 HD11 ' A' 1072 ' ' ILE . 26.3 pt -140.96 -166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.821 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.564 ' CE1' ' HB3' ' A' 1085 ' ' SER . 0.6 OUTLIER -160.09 158.14 29.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.958 0.409 . . . . 0.0 111.359 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.723 ' HB3' ' O ' ' A' 1046 ' ' TYR . 51.5 t -64.63 -42.6 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.97 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.536 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 14.7 t 45.95 -161.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.231 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.801 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 81.2 p -165.38 139.49 4.76 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.579 0.228 . . . . 0.0 111.381 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.872 HD22 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -177.01 -39.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.784 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.744 ' H ' HD21 ' A' 1077 ' ' ASN . 38.7 t70 -82.97 47.22 1.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.196 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.433 ' O ' HG22 ' A' 1023 ' ' ILE . 1.6 m-20 61.34 -130.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.529 ' C ' HG21 ' A' 1081 ' ' VAL . 12.0 mp0 -76.96 49.92 0.69 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.648 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.724 HG13 HG21 ' A' 1083 ' ' ILE . 18.4 t -145.9 -46.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' 1076 ' ' SER . . . 77.67 -45.84 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.24 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.872 HG12 HD22 ' A' 1077 ' ' ASN . 6.6 pt 52.58 135.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.449 0.642 . . . . 0.0 111.752 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 42.0 m95 -71.92 147.21 47.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.46 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.564 ' HB3' ' CE1' ' A' 1073 ' ' TYR . 80.2 p -48.02 -23.88 0.93 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.795 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . -166.49 140.52 6.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.783 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 12.8 Cg_exo -72.44 47.85 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.528 2.818 . . . . 0.0 113.079 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.772 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 64.44 138.99 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.023 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.726 ' HB3' ' HG2' ' A' 1069 ' ' GLU . 97.4 Cg_endo -81.73 -140.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.963 2.442 . . . . 0.0 112.2 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.477 ' H ' ' HB2' ' A' 1089 ' ' PRO . 39.8 tt0 -152.46 153.59 33.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.859 ' O ' HG12 ' A' 1092 ' ' ILE . 90.4 m -80.76 -146.82 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.859 HG12 ' O ' ' A' 1091 ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . 0.404 ' HB1' ' H ' ' A' ' 961' ' ' LYS . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.651 0.262 . . . . 0.0 111.458 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.593 ' HG2' HD23 ' A' 1006 ' ' LEU . 17.2 tppt? 65.51 151.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 78.3 p -149.78 149.82 31.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.928 0.394 . . . . 0.0 111.497 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 89.1 m -79.93 147.61 31.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.335 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -63.75 138.2 58.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.898 0.38 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 62.2 m -51.94 125.19 30.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.065 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.662 ' HG2' HG13 ' A' ' 974' ' ' VAL . 56.6 Cg_endo -70.86 127.53 13.84 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.325 2.016 . . . . 0.0 111.824 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.85 139.01 50.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.289 1.992 . . . . 0.0 111.564 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -43.81 115.3 2.01 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 110.847 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.606 ' HG3' ' HD2' ' A' ' 988' ' ' TYR . 45.7 Cg_endo -67.45 149.5 80.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.792 2.328 . . . . 0.0 112.301 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' 1020 ' ' CYS . 0.6 OUTLIER -44.86 102.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.206 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.51 ' OD1' HG21 ' A' ' 970' ' ' VAL . 4.8 m120 74.2 -37.28 0.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -68.86 -172.82 8.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.57 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 64.6 mtm -154.56 135.12 13.46 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 110.916 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.662 HG13 ' HG2' ' A' ' 966' ' ' PRO . 6.3 p -92.93 149.55 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.424 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 15.4 m170 -119.09 113.76 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 980' ' ' ILE . 78.5 t -60.89 -51.64 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.152 0.501 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 33.6 mt 74.93 -33.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.195 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.5 p -138.0 -64.95 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.487 ' HB3' HE21 ' A' ' 981' ' ' GLN . 38.7 t70 -172.47 2.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.633 HG22 HG23 ' A' ' 976' ' ' VAL . 49.8 pt 52.81 72.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.431 0.634 . . . . 0.0 110.893 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' 1004 ' ' CYS . 22.6 pt20 -152.34 174.74 13.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.128 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' 1004 ' ' CYS . 48.4 t -43.38 138.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.337 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 80.54 -44.87 2.99 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.998 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.575 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 53.4 m -68.43 123.21 20.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.976 0.388 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 74.9 ttt180 -101.43 121.12 41.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . . . . . . . . . 31.7 pt -93.46 160.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.411 HG21 ' HA ' ' A' 1001 ' ' SER . 78.0 p -143.99 132.38 22.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 111.911 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.606 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 3.7 m-85 -84.85 -168.11 2.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 11.1 t -161.59 -47.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.195 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.795 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 3.2 t 70.05 -137.64 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.33 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 158.28 4.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.641 0.734 . . . . 0.0 112.43 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 28.5 m -53.99 114.77 1.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.755 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 147.24 -28.15 1.53 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HA ' HG12 ' A' 1023 ' ' ILE . 7.2 m80 -139.07 143.0 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.571 ' H ' HD12 ' A' 1023 ' ' ILE . 22.8 ptt-85 -80.02 127.34 32.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.143 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.636 HD22 ' HB2' ' A' 1018 ' ' PRO . 3.3 tt -76.13 129.86 37.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.7 mp -104.33 146.68 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.119 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 74.75 169.9 24.28 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.78 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -75.01 125.71 29.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.455 ' O ' ' HD1' ' A' ' 988' ' ' TYR . 79.3 p -64.88 -44.05 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.437 ' HB3' ' NE ' ' A' ' 985' ' ' ARG . 50.5 m -82.72 142.95 31.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.409 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -161.66 116.4 1.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 37.5 tt0 -85.93 132.51 34.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 43.0 t -69.71 93.52 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.32 -178.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.593 HD23 ' HG2' ' A' ' 961' ' ' LYS . 9.9 tp -158.44 125.5 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.5 t -85.42 -48.91 8.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.278 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 171.84 -48.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.659 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.6 t30 -70.99 -55.19 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.817 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.407 HG21 ' N ' ' A' 1011 ' ' ALA . 87.9 m -151.21 149.05 28.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.492 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.407 ' N ' HG21 ' A' 1010 ' ' THR . . . -75.28 143.96 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -150.71 149.98 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.464 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 52.1 m95 -68.78 132.53 46.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.713 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 78.5 p -52.36 -24.74 8.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.976 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 75.3 p -131.43 141.17 49.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -56.88 155.45 15.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 17.0 Cg_endo -57.71 118.11 4.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.36 2.04 . . . . 0.0 112.037 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.636 ' HB2' HD22 ' A' ' 996' ' ' LEU . 21.6 Cg_endo -61.48 159.15 32.96 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.545 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 26.4 pt -143.9 127.97 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.622 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.599 ' N ' HG12 ' A' ' 970' ' ' VAL . 50.5 m -88.0 112.79 22.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.052 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 995' ' ' ARG . 93.0 mm-40 -86.38 145.02 27.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.955 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.591 ' NH2' ' HB3' ' A' 1046 ' ' TYR . 25.8 tpt85 -63.92 128.12 34.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.237 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 994' ' ' HIS . 48.5 mm -65.34 128.25 93.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -96.97 139.3 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.738 2.959 . . . . 0.0 113.488 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.743 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 98.0 m -112.94 135.14 54.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.208 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.95 -152.35 4.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.789 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 48.8 mt -83.08 146.17 51.0 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.619 0.247 . . . . 0.0 111.059 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.16 149.8 90.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.324 2.016 . . . . 0.0 111.127 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.753 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 2.5 Cg_endo -46.18 119.66 3.16 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.573 2.182 . . . . 0.0 111.862 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 71.8 p -77.43 145.22 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.44 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.538 ' O ' HG21 ' A' 1031 ' ' ILE . 10.3 tt -149.89 114.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.801 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -56.59 144.57 31.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.491 ' HB3' HD21 ' A' 1055 ' ' ASN . 5.0 m120 75.21 -35.95 0.3 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.501 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.867 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -64.62 178.12 8.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.532 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -156.58 127.32 6.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.633 ' HB2' HG22 ' A' 1050 ' ' VAL . 3.7 p90 -84.34 144.57 28.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 0.0 110.664 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.449 HD11 ' O ' ' A' 1036 ' ' PHE . 42.2 mm -133.66 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.655 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.42 ' HG ' ' H ' ' A' 1039 ' ' THR . 11.3 t -167.8 -161.18 0.37 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.974 0.416 . . . . 0.0 111.289 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.42 ' H ' ' HG ' ' A' 1038 ' ' SER . 68.9 p -75.16 -13.4 60.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.279 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.533 ' OD1' ' HB ' ' A' 1050 ' ' VAL . 3.7 m120 -47.42 136.39 9.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.4 ' HB3' ' OE1' ' A' 1042 ' ' GLU . 25.3 mmm180 -154.18 -82.73 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.611 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.5 OUTLIER -163.01 145.16 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' 1042 ' ' GLU . 3.5 m120 70.27 58.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.893 0.377 . . . . 0.0 110.419 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' 1025 ' ' CYS . 2.5 m-85 -76.73 132.46 39.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' 1046 ' ' TYR . 20.4 m80 -90.32 -65.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.619 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.679 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.0 t80 171.91 44.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.548 0.69 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.45 89.2 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.73 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' 1047 ' ' GLY . 77.6 p 172.38 141.66 0.03 OUTLIER 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 111.515 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.585 HG11 ' HB3' ' A' 1073 ' ' TYR . 12.3 m -107.2 -173.53 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.431 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' 1036 ' ' PHE . 7.3 p -153.93 129.57 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.981 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 50.1 m -116.83 110.66 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.772 ' HB2' HD23 ' A' 1066 ' ' LEU . 2.2 m-85 -70.58 158.03 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -149.75 -13.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.867 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 65.1 m 66.16 166.02 0.2 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.491 HD21 ' HB3' ' A' 1033 ' ' ASN . 19.1 p30 -55.68 -44.64 77.52 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.599 ' HB3' ' HA3' ' A' 1060 ' ' GLY . 2.8 mm? 38.69 33.32 0.07 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 68.89 -52.63 0.53 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.906 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.574 ' C ' ' HD2' ' A' 1059 ' ' ARG . 70.8 m -161.53 -28.62 0.05 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.321 0.56 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.574 ' HD2' ' C ' ' A' 1058 ' ' SER . 5.6 mpt_? -150.06 -50.58 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.526 0.203 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.599 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . -174.75 37.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.892 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.492 ' O ' HD11 ' A' 1056 ' ' LEU . 70.1 mtt-85 -70.96 163.15 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' 1062 ' ' LYS . 39.9 ttpt -67.85 70.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.17 0.51 . . . . 0.0 110.934 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' 1064 ' ' PHE . 6.7 m -155.07 89.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.747 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.501 ' O ' HD12 ' A' 1056 ' ' LEU . 77.4 m-85 75.55 145.5 0.08 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.951 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -145.09 143.7 30.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.649 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.772 HD23 ' HB2' ' A' 1052 ' ' TYR . 61.7 tp -68.57 135.54 51.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.0 111.314 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' 1089 ' ' PRO . 61.5 t -138.25 123.03 22.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.114 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 71.82 161.3 4.9 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.285 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' 1069 ' ' GLU . 83.4 tt0 30.37 62.47 0.95 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.593 ' HA ' HD22 ' A' 1066 ' ' LEU . 57.3 Cg_endo -72.68 -24.59 18.25 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.993 1.795 . . . . 0.0 112.302 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' 1050 ' ' VAL . 42.7 m -156.25 137.67 13.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 111.567 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' 1049 ' ' VAL . 44.6 pt -145.43 -169.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.585 ' HB3' HG11 ' A' 1049 ' ' VAL . 0.6 OUTLIER -162.14 156.89 22.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.051 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.7 t -62.24 148.31 45.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.384 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 6.5 t -146.04 -7.89 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.743 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.487 ' HB3' ' HA3' ' A' 1082 ' ' GLY . 89.3 p 47.81 54.74 9.49 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.773 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -55.14 -46.23 75.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.739 ' HB2' HG23 ' A' 1081 ' ' VAL . 22.9 m-20 -75.71 -3.1 32.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.301 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.619 ' OD1' ' HG3' ' A' 1080 ' ' GLN . 9.8 t70 65.4 134.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.376 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.619 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 27.6 mt-30 56.87 43.3 25.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' 1078 ' ' ASP . 24.5 m -148.6 -35.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.253 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 63.98 41.15 98.73 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.084 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.633 ' HB ' HD22 ' A' 1077 ' ' ASN . 73.7 mt -85.73 136.5 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.837 0.351 . . . . 0.0 111.345 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' 1084 ' ' TRP . 8.1 m95 -76.15 141.12 41.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.704 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 78.9 p -59.78 -61.73 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.898 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.616 ' O ' ' HG3' ' A' 1029 ' ' PRO . . . -71.09 126.67 13.72 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.843 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -88.9 46.34 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.945 2.43 . . . . 0.0 112.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.753 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 62.37 130.89 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' 1069 ' ' GLU . 86.3 Cg_endo -78.43 -137.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.821 2.347 . . . . 0.0 112.85 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.417 ' H ' ' HB2' ' A' 1089 ' ' PRO . 40.3 tt0 -152.37 140.14 19.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.012 0.435 . . . . 0.0 111.587 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 66.8 m -100.75 130.72 46.82 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.772 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.409 HG22 HE21 ' A' 1090 ' ' GLN . 21.5 pt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.053 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.556 ' N ' HG22 ' A' ' 982' ' ' VAL . 17.1 tppt? -84.9 132.62 34.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.968 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.9 p -82.08 133.31 35.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.016 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 98.9 m -80.52 36.26 0.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.022 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 962' ' ' SER . 58.7 tptt 63.38 133.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 56.5 m -70.9 116.99 51.87 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.321 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.771 ' HG2' HG13 ' A' ' 974' ' ' VAL . 61.2 Cg_endo -72.99 120.68 6.76 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.243 1.962 . . . . 0.0 112.168 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 23.5 Cg_exo -63.98 -61.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.232 1.955 . . . . 0.0 111.299 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 170.65 96.93 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.262 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.596 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 58.0 Cg_exo -53.79 179.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.759 2.306 . . . . 0.0 112.668 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 972' ' ' GLY . 92.9 t -48.92 90.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.796 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.801 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 75.0 m-20 71.22 -26.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.262 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -68.52 114.2 5.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.415 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.566 ' H ' ' HA ' ' A' ' 990' ' ' CYS . 77.3 mmm -80.84 124.06 28.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.771 HG13 ' HG2' ' A' ' 966' ' ' PRO . 0.3 OUTLIER -92.38 138.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.45 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.414 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 23.3 m170 -122.65 108.96 13.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.4 98.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.097 0.475 . . . . 0.0 109.832 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.19 -93.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.197 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -68.96 -58.4 4.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 0.0 110.182 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.574 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 54.6 m-20 -164.62 -133.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.191 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.58 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 5.0 pt -155.63 -16.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.254 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.968 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 68.1 mt-30 -73.53 177.36 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.621 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.556 HG22 ' N ' ' A' ' 961' ' ' LYS . 99.9 t -44.28 144.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.528 ' N ' HG11 ' A' ' 982' ' ' VAL . . . 77.25 -38.24 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.295 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.574 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 49.2 m -68.51 148.1 51.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.845 0.323 . . . . 0.0 110.373 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' 1002 ' ' ALA . 5.3 tmm_? -138.44 127.6 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 111.336 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.675 HD11 HG23 ' A' ' 974' ' ' VAL . 17.4 pt -96.97 -176.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.095 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' 1001 ' ' SER . 50.5 p -150.14 127.96 11.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.004 0.43 . . . . 0.0 111.605 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' 1000 ' ' SER . 1.4 m-85 -85.18 -176.58 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 69.2 m -161.47 -34.41 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.676 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.566 ' HA ' ' H ' ' A' ' 973' ' ' MET . 43.0 t 68.36 167.14 0.26 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 81.1 p -60.15 -170.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 51.6 m -88.8 129.55 35.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.155 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 72.25 39.56 57.38 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.788 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -146.87 133.24 19.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.414 HH11 ' HG3' ' A' ' 995' ' ' ARG . 35.2 ttt85 -98.68 113.74 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.0 111.283 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.998 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 4.1 pp -76.14 138.39 40.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.498 . . . . 0.0 111.467 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.633 ' O ' ' HB2' ' A' 1018 ' ' PRO . 1.7 mp -95.6 153.18 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.632 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.37 23.45 58.63 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.354 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 80.2 m-70 65.58 141.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.744 ' HB3' HD23 ' A' ' 996' ' ' LEU . 86.9 p -86.26 50.3 1.96 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.726 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 23.0 t -161.81 165.96 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.484 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' 1015 ' ' THR . . . -165.2 129.56 2.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -104.94 124.6 49.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.031 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 49.1 t -74.6 123.7 25.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 13.0 pt -136.99 150.92 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.658 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 961' ' ' LYS . 0.4 OUTLIER -98.89 121.82 41.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.009 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 50.7 m -78.54 -55.5 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.36 37.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.127 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.55 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 0.0 110.33 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.512 HG21 ' N ' ' A' 1011 ' ' ALA . 53.2 m -151.26 149.9 29.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.923 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 963' ' ' CYS . . . -75.1 141.4 43.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.92 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.4 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.5 m-70 -149.45 140.19 22.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.58 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 66.9 m95 -71.81 127.13 31.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.794 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.0 p -52.49 -28.8 21.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.673 ' O ' ' HG2' ' A' 1016 ' ' LYS . 48.2 p -90.64 -24.85 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' 1015 ' ' THR . 15.0 pttp 59.9 152.62 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 123.657 0.598 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.29 105.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.481 2.121 . . . . 0.0 112.157 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.633 ' HB2' ' O ' ' A' ' 997' ' ' ILE . 94.3 Cg_endo -80.14 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' 1018 ' ' PRO . 35.4 pt -148.94 -169.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.44 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.998 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 15.8 t -153.98 110.82 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.626 ' HG3' ' H ' ' A' 1023 ' ' ILE . 3.2 tp-100 -77.66 134.13 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -76.49 6.36 5.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.452 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.666 HG22 ' HA ' ' A' 1080 ' ' GLN . 57.2 mt 53.29 76.55 0.52 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.665 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' 1045 ' ' HIS . 31.3 Cg_exo -59.39 116.83 3.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.242 1.961 . . . . 0.0 111.759 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 10.0 p -91.11 34.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.829 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 43.97 -142.37 2.61 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.062 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' 1042 ' ' GLU . 72.2 mt -106.49 136.35 19.39 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-O 120.619 0.247 . . . . 0.0 111.381 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.405 ' HB3' ' CH2' ' A' 1084 ' ' TRP . 35.3 Cg_endo -64.34 143.32 82.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.588 2.192 . . . . 0.0 111.714 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.86 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 49.4 Cg_exo -55.3 108.88 0.34 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.255 1.97 . . . . 0.0 112.046 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 54.9 m -93.4 124.68 37.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.583 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 62.7 mt -85.26 139.32 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.369 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -56.53 -55.39 34.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.245 0.545 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -80.23 -36.45 34.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.933 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.877 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -72.78 121.83 8.04 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.614 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -83.4 -151.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.403 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 9.3 p90 -155.93 138.97 15.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.545 HD13 ' HD2' ' A' 1053 ' ' ARG . 46.3 mt -122.5 67.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 74.5 m -157.18 -140.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.347 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 11.1 m -119.58 38.63 3.83 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 110.978 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.715 HD22 ' HB ' ' A' 1050 ' ' VAL . 5.1 m120 -80.89 121.32 25.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -156.42 43.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' 1043 ' ' ASN . 37.7 tt0 62.94 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' 1042 ' ' GLU . 73.4 m-80 78.64 52.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' 1045 ' ' HIS . 5.1 m-85 -76.74 -56.75 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.137 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' 1046 ' ' TYR . 21.9 m80 72.62 -44.44 0.59 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.699 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 43.3 t80 171.73 148.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.958 0.409 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 73.6 97.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.754 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' 1047 ' ' GLY . 81.4 p 173.45 156.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 110.979 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' 1072 ' ' ILE . 3.5 p -137.78 155.44 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.967 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.715 ' HB ' HD22 ' A' 1040 ' ' ASN . 13.5 p -143.52 127.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 89.4 m -104.46 120.21 40.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.224 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.544 ' HH ' HD12 ' A' 1072 ' ' ILE . 13.1 m-85 -83.84 148.01 27.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.642 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.545 ' HD2' HD13 ' A' 1037 ' ' ILE . 44.9 ttt85 -142.77 -27.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.017 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.877 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 11.7 t 67.66 154.99 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -51.19 -93.45 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.601 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.752 HD22 ' HB2' ' A' 1064 ' ' PHE . 5.7 mt 61.71 -166.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.226 0.536 . . . . 0.0 111.843 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.544 ' N ' ' N ' ' A' 1061 ' ' ARG . . . 54.28 -121.38 19.52 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.206 -0.906 . . . . 0.0 114.136 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 75.1 p -45.59 -66.43 0.4 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.26 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -87.21 35.62 0.71 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' 1056 ' ' LEU . . . -174.68 -117.68 0.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.563 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.544 ' N ' ' N ' ' A' 1057 ' ' GLY . 11.2 tpt180 85.32 108.22 0.05 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.547 0.739 . . . . 0.0 110.103 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.517 ' O ' ' HG2' ' A' 1062 ' ' LYS . 63.9 tttp 44.65 36.16 1.67 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 122.093 0.949 . . . . 0.0 109.609 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' 1060 ' ' GLY . 31.1 m -104.37 -12.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.591 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.752 ' HB2' HD22 ' A' 1056 ' ' LEU . 70.3 m-85 -156.09 162.99 40.19 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.921 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1065 ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' 1091 ' ' CYS . 44.7 mt-10 -142.4 131.27 22.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.016 0.436 . . . . 0.0 110.826 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 31.0 tp -68.48 147.21 52.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.646 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 58.4 t -138.34 135.46 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.21 -148.03 26.44 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.302 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' 1069 ' ' GLU . 7.0 pm0 -72.1 120.67 81.57 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.452 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 62.7 Cg_endo -75.84 -25.73 10.31 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.747 2.298 . . . . 0.0 112.395 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 54.3 m -137.57 153.95 49.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.739 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.544 HD12 ' HH ' ' A' 1052 ' ' TYR . 36.1 pt -143.01 -169.07 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.098 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' 1085 ' ' SER . 0.4 OUTLIER -160.01 158.26 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.284 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.699 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 10.2 t -62.16 -51.92 65.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.458 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.448 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 15.3 t 45.59 -172.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.974 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.3 p -165.47 143.73 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.681 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.695 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -162.82 -45.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.737 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.695 ' H ' HD21 ' A' 1077 ' ' ASN . 40.3 t0 -81.12 -146.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.499 ' H ' ' CG ' ' A' 1078 ' ' ASP . 36.3 m-20 -82.04 -137.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.666 ' HA ' HG22 ' A' 1023 ' ' ILE . 73.8 mt-30 -81.0 26.16 0.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.549 HG13 HG21 ' A' 1083 ' ' ILE . 17.7 t -77.58 -44.25 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.298 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 59.66 63.22 5.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.191 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.549 HG21 HG13 ' A' 1081 ' ' VAL . 34.4 pt -81.93 129.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.462 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.405 ' CH2' ' HB3' ' A' 1028 ' ' PRO . 20.0 m95 -76.53 163.88 26.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.1 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.491 ' HB2' ' CE1' ' A' 1073 ' ' TYR . 43.8 t -48.62 -32.86 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.641 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.51 147.58 12.26 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.033 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.771 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 73.9 Cg_endo -75.38 49.42 2.36 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.988 2.459 . . . . 0.0 112.78 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.86 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 63.73 133.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.742 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.434 ' HB2' HD13 ' A' 1066 ' ' LEU . 56.1 Cg_endo -71.65 -149.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.116 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -151.93 117.93 5.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.724 0.297 . . . . 0.0 111.442 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' 1065 ' ' GLU . 28.1 p -103.11 88.39 3.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.248 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.404 ' HA ' ' HD1' ' A' 1064 ' ' PHE . 27.8 pt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.82 0.343 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.668 ' HG3' HD13 ' A' 1006 ' ' LEU . 71.9 mmtt -79.38 148.78 31.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.1 p -157.86 127.25 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.253 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.449 ' N ' ' HB2' ' A' 1011 ' ' ALA . 3.7 p -79.86 142.69 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.755 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.82 141.07 58.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.386 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.449 HG21 ' HD2' ' A' ' 966' ' ' PRO . 62.4 m -64.8 130.49 94.82 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.449 ' HD2' HG21 ' A' ' 965' ' ' THR . 31.5 Cg_exo -59.35 120.51 8.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.188 1.925 . . . . 0.0 111.634 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 46.1 Cg_exo -55.97 -50.24 12.98 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.167 1.911 . . . . 0.0 111.659 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 59.2 t0 174.03 106.96 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.92 155.16 19.09 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.366 2.044 . . . . 0.0 111.232 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.688 ' HB ' ' HA ' ' A' 1019 ' ' ILE . 80.4 t -46.55 106.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.79 0.329 . . . . 0.0 111.445 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.669 HD21 ' HB2' ' A' 1020 ' ' CYS . 73.7 m-20 74.72 -53.98 0.67 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.078 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -79.5 138.34 20.22 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.274 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.423 ' HB3' ' HE1' ' A' ' 973' ' ' MET . 86.7 mmm -81.87 -156.65 0.16 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 110.812 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 988' ' ' TYR . 3.3 p -159.29 148.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.441 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.448 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 17.1 m170 -120.15 109.84 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 986' ' ' ILE . 43.3 t -65.33 105.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.645 HG13 HG22 ' A' ' 987' ' ' THR . 44.7 mm -75.23 -94.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.753 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.7 p -67.93 -65.99 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.476 ' OD1' HG12 ' A' ' 980' ' ' ILE . 46.7 t0 -165.71 -132.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.63 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.476 HG12 ' OD1' ' A' ' 979' ' ' ASP . 1.6 pt -155.95 14.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.355 0.597 . . . . 0.0 110.33 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.4 171.24 10.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.353 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.542 HG23 HD23 ' A' 1006 ' ' LEU . 61.9 t -47.51 141.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.646 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.38 -46.95 2.6 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.489 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 151.28 47.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.262 0.531 . . . . 0.0 110.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.842 ' HB3' ' HA ' ' A' 1003 ' ' GLU . 0.0 OUTLIER -138.43 -168.53 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.679 HG23 ' HA ' ' A' ' 976' ' ' VAL . 23.6 pt -148.55 -160.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.97 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.645 HG22 HG13 ' A' ' 977' ' ' ILE . 68.5 p -142.03 124.55 15.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 112.028 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.519 ' HA ' HG21 ' A' ' 974' ' ' VAL . 1.3 m-85 -98.89 150.94 21.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.319 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 19.3 m -150.25 138.95 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.261 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.669 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 42.4 t -81.97 154.39 25.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.285 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 11.0 t -64.87 -139.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.392 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 993' ' ' GLY . 12.8 t -60.94 -142.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.045 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 992' ' ' THR . . . -63.42 75.35 0.04 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 113.971 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.622 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 37.6 m80 -145.94 140.81 27.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.497 HH22 ' HB3' ' A' 1079 ' ' ASP . 41.3 ttm-85 -81.96 118.98 23.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.996 0.427 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.674 HD12 ' HB3' ' A' 1018 ' ' PRO . 5.9 tp -76.2 126.09 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.964 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.649 ' N ' HD13 ' A' ' 996' ' ' LEU . 1.8 mp -107.83 150.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.794 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.614 ' N ' HG21 ' A' ' 997' ' ' ILE . . . 76.58 54.58 4.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.677 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.56 -143.85 0.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.196 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m -160.81 27.27 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.031 0.443 . . . . 0.0 110.152 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 65.9 p -162.17 162.51 28.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.223 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.731 ' HB2' ' HB3' ' A' 1013 ' ' TRP . . . -153.79 130.65 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.837 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.842 ' HA ' ' HB3' ' A' ' 985' ' ' ARG . 21.1 pt-20 -101.74 129.6 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.946 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' 1011 ' ' ALA . 5.9 t -72.17 128.54 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.334 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.403 HD12 ' OG ' ' A' 1014 ' ' SER . 37.5 pt -145.55 169.36 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.103 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.668 HD13 ' HG3' ' A' ' 961' ' ' LYS . 4.0 mm? -81.57 146.43 30.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.938 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.616 ' HB2' ' HD2' ' A' 1012 ' ' HIS . 71.2 m -159.8 59.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 104.99 51.39 0.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.166 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 58.87 24.97 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 110.399 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 71.4 m -151.32 139.21 19.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.679 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.47 ' HB3' ' SG ' ' A' 1004 ' ' CYS . . . -75.33 136.7 40.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.959 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.616 ' HD2' ' HB2' ' A' 1007 ' ' SER . 92.1 m-70 -149.47 141.32 23.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.731 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 70.6 m95 -67.75 123.6 20.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.127 0.489 . . . . 0.0 110.854 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.403 ' OG ' HD12 ' A' 1005 ' ' ILE . 20.7 m -52.39 -24.44 7.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.947 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 55.2 p -103.65 142.02 35.05 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 61.5 pttt -62.61 149.74 88.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.868 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 120.99 9.16 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.304 2.003 . . . . 0.0 111.7 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.674 ' HB3' HD12 ' A' ' 996' ' ' LEU . 32.7 Cg_exo -59.18 145.29 98.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.829 2.353 . . . . 0.0 112.903 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.688 ' HA ' ' HB ' ' A' ' 970' ' ' VAL . 40.3 pt -140.05 130.4 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.669 ' HB2' HD21 ' A' ' 971' ' ' ASN . 74.2 m -86.35 108.93 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.181 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -81.62 130.49 35.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.524 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -71.65 120.14 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' 1080 ' ' GLN . 77.4 mt -67.24 110.97 6.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.741 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.06 125.22 17.51 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.898 2.399 . . . . 0.0 113.424 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.596 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 66.9 m -95.94 133.11 40.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.087 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -79.87 -154.0 8.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.394 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' 1027 ' ' LEU . 0.3 OUTLIER -67.45 138.99 94.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.788 0.328 . . . . 0.0 111.321 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.721 ' HB2' ' HH ' ' A' 1052 ' ' TYR . 51.1 Cg_endo -68.64 148.73 72.75 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.774 2.316 . . . . 0.0 112.048 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.71 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 34.7 Cg_exo -59.15 111.18 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.081 1.854 . . . . 0.0 111.476 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 26.9 p -77.52 122.46 25.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.641 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.502 HG23 HD11 ' A' 1031 ' ' ILE . 18.4 pt -88.59 29.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.851 0.358 . . . . 0.0 111.855 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' 1034 ' ' GLY . . . 52.87 125.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.495 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' 1032 ' ' ALA . 77.1 m-20 71.43 -26.6 0.17 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.234 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -69.54 124.73 16.09 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.717 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' 1053 ' ' ARG . 1.5 m-20 -76.46 -159.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.657 0.265 . . . . 0.0 110.368 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' 1051 ' ' THR . 45.6 p90 -155.99 137.8 14.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 20.3 mm -128.77 37.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.74 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 78.2 p -69.24 145.48 53.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.615 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 38.2 m -59.42 -38.37 80.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.647 HD21 ' HB3' ' A' 1048 ' ' SER . 23.4 p30 -72.19 -155.44 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.597 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' 1040 ' ' ASN . 18.3 mmt85 -162.2 -54.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.701 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' 1043 ' ' ASN . 42.0 tt0 -162.89 148.73 12.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' 1042 ' ' GLU . 75.4 m-20 78.12 65.2 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.59 134.92 39.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.308 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' 1046 ' ' TYR . 13.1 m80 -96.93 -51.52 4.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.546 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 69.7 t80 171.06 144.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.412 0.445 . . . . 0.0 110.55 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 76.5 -14.54 6.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.221 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.647 ' HB3' HD21 ' A' 1040 ' ' ASN . 65.5 m -47.36 136.15 9.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.033 0.444 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' 1072 ' ' ILE . 88.7 t -102.19 146.88 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.224 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.74 ' HA ' ' HB3' ' A' 1038 ' ' SER . 30.8 m -142.57 126.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.398 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' 1036 ' ' PHE . 59.1 m -100.49 108.69 20.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.721 ' HH ' ' HB2' ' A' 1028 ' ' PRO . 21.0 m-85 -77.08 163.13 26.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.307 0.575 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.742 ' HB2' ' HB2' ' A' 1035 ' ' ASP . 75.6 mtp180 -142.76 -138.96 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.655 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.486 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 48.7 t -163.7 145.42 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 111.686 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.1 68.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.243 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.6 ' N ' HD21 ' A' 1056 ' ' LEU . 3.7 mm? -72.22 41.91 0.09 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 53.37 -106.15 0.39 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.525 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.544 ' HB2' ' HD3' ' A' 1061 ' ' ARG . 66.8 m -67.37 -48.28 67.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.432 ' HG2' HH11 ' A' 1059 ' ' ARG . 11.6 tpt180 -165.83 -49.85 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.044 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' A' 1056 ' ' LEU . . . -164.38 39.91 0.31 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.752 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.656 ' HD2' ' N ' ' A' 1061 ' ' ARG . 0.7 OUTLIER -83.14 172.76 12.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 110.769 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 58.5 tttm -65.48 79.91 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' 1064 ' ' PHE . 6.9 m -155.14 92.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.637 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.643 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 0.8 OUTLIER 74.27 141.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.695 -178.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1065 ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.8 mt-10 -137.27 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.064 0.459 . . . . 0.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' 1070 ' ' PRO . 38.7 tp -68.44 152.09 45.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.156 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' 1089 ' ' PRO . 65.1 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 77.51 -168.37 54.39 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' 1069 ' ' GLU . 15.2 pm0 -72.05 126.85 91.13 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.702 ' HB3' HD23 ' A' 1066 ' ' LEU . 96.8 Cg_endo -82.17 -36.95 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.38 2.053 . . . . 0.0 111.87 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.8 p -83.81 140.87 31.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.179 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.466 HD12 ' CE1' ' A' 1052 ' ' TYR . 36.3 pt -147.78 -171.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.899 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.3 p90 -162.26 143.87 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.699 0.285 . . . . 0.0 111.386 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.937 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 52.1 t -66.51 154.15 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.075 0.464 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.48 HG21 ' O ' ' A' 1083 ' ' ILE . 10.2 t -147.59 -144.62 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.106 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.405 ' HG ' HD11 ' A' 1023 ' ' ILE . 47.5 t -155.76 137.77 14.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.018 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.506 ' N ' HD21 ' A' 1077 ' ' ASN . 0.0 OUTLIER -166.58 31.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.757 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.7 t70 175.84 50.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.255 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.497 ' HB3' HH22 ' A' ' 995' ' ' ARG . 1.5 m-20 61.88 -125.24 0.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.607 ' HA ' HG22 ' A' 1023 ' ' ILE . 25.3 pt20 -66.01 -140.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.51 0.195 . . . . 0.0 110.71 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.498 HG21 ' HG3' ' A' 1080 ' ' GLN . 25.9 t 74.22 -45.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.992 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 66.36 62.61 4.5 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.48 ' O ' HG21 ' A' 1075 ' ' THR . 74.3 mt -80.19 130.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 110.972 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.937 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 26.1 m95 -72.6 177.09 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.0 t -55.52 -64.2 0.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.684 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.57 131.66 1.6 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.628 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.71 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 93.7 Cg_endo -79.72 48.64 2.92 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.828 2.352 . . . . 0.0 111.698 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.684 ' N ' ' HD2' ' A' 1089 ' ' PRO . . . -62.57 -47.34 88.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.34 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' 1088 ' ' ALA . 4.9 Cg_endo -48.45 137.12 25.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.432 2.088 . . . . 0.0 112.112 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.89 132.99 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 15.2 t -102.49 137.79 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.415 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' 1091 ' ' CYS . 8.1 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.353 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.645 0.26 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 982' ' ' VAL . 1.0 OUTLIER 55.86 47.11 20.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.439 . . . . 0.0 111.436 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 964' ' ' LYS . 81.4 p -89.95 132.2 35.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 73.0 m -79.93 39.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.798 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.4 OUTLIER 60.58 116.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.595 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 51.0 m -59.84 112.81 5.89 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.081 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.621 ' HB2' HG23 ' A' ' 974' ' ' VAL . 27.2 Cg_exo -62.0 113.05 1.7 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.11 1.873 . . . . 0.0 111.761 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 968' ' ' ASP . 26.5 Cg_endo -62.39 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.203 1.935 . . . . 0.0 111.277 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 967' ' ' PRO . 2.5 p30 176.19 119.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.811 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 37.4 Cg_endo -66.92 149.34 83.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.339 2.026 . . . . 0.0 111.267 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 98.6 t -40.65 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.826 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.551 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 75.6 m-20 75.27 -51.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.662 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -68.56 -172.37 7.33 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.88 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.811 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 67.3 mtm -156.7 136.29 12.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.675 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.783 ' HB ' HD13 ' A' ' 986' ' ' ILE . 2.6 m -85.27 149.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.469 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 32.8 m170 -114.93 104.0 11.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.501 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 59.5 t -70.43 92.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.043 0.449 . . . . 0.0 110.333 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.18 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.881 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 38.0 p -71.53 -68.83 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.343 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 18.6 t70 -165.67 -153.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.353 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.493 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 11.4 pt -155.94 11.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.618 0.247 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.669 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 25.7 mt-30 -87.22 30.81 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.669 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 67.4 t 100.61 143.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.553 0.741 . . . . 0.0 111.762 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.575 ' N ' HG11 ' A' ' 982' ' ' VAL . . . 75.87 -46.22 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.626 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.496 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 57.9 m -68.41 150.79 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.538 ' H ' ' HD2' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -138.4 135.87 35.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.228 0.537 . . . . 0.0 111.113 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.783 HD13 ' HB ' ' A' ' 974' ' ' VAL . 20.1 pt -91.06 -163.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.226 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 45.5 p -146.38 123.72 11.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.004 0.43 . . . . 0.0 111.561 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.62 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.6 OUTLIER -91.86 151.12 20.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.565 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.8 p -155.18 125.7 6.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 61.3 m -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 992' ' ' THR . 62.5 p 27.94 -143.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.054 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 991' ' ' THR . 7.3 t -117.32 -24.72 7.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.396 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -135.5 45.49 1.1 Allowed Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.111 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.413 ' HB2' ' OG1' ' A' ' 991' ' ' THR . 27.5 m80 -139.91 144.92 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.693 0.283 . . . . 0.0 110.589 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.563 ' NH2' ' HA ' ' A' 1079 ' ' ASP . 43.7 ttm-85 -81.97 125.97 31.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.617 HD11 ' HG ' ' A' 1000 ' ' SER . 7.0 tt -76.24 123.14 25.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.658 ' HB ' HG13 ' A' 1019 ' ' ILE . 51.7 mm -86.64 148.42 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.402 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.519 ' HA3' ' HZ2' ' A' 1016 ' ' LYS . . . 82.79 -107.04 2.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.832 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' A' 1001 ' ' SER . 91.2 m-70 -149.76 133.02 16.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 15.6 m -78.43 27.41 0.2 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.522 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 999' ' ' HIS . 81.4 p -162.22 145.77 11.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.451 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.98 132.27 10.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.411 . . . . 0.0 111.435 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -104.95 133.53 49.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.197 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 53.1 t -73.46 129.39 37.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' 1012 ' ' HIS . 38.1 pt -130.49 -167.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.802 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.95 127.06 17.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.895 0.379 . . . . 0.0 110.79 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.703 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 56.5 p -81.75 -59.4 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.856 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.52 35.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -37.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 110.361 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 27.6 m -149.98 142.73 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 963' ' ' CYS . . . -75.31 141.18 43.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.226 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.703 ' HE2' ' HB3' ' A' 1007 ' ' SER . 10.9 p80 -149.68 147.19 27.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.3 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 84.2 m95 -67.19 129.61 40.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 111.021 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.4 p -52.37 -27.16 14.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.865 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 75.9 p -107.99 138.35 44.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.583 ' HD3' ' H ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -58.23 152.38 42.3 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.5 103.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.381 2.054 . . . . 0.0 112.532 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.1 154.35 72.7 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.993 2.462 . . . . 0.0 111.767 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.658 HG13 ' HB ' ' A' ' 997' ' ' ILE . 37.1 pt -135.84 -147.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.403 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 971' ' ' ASN . 23.0 m -143.06 -178.78 6.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -166.86 126.54 1.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -74.3 120.71 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.35 119.51 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.213 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.06 122.45 7.64 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.188 1.926 . . . . 0.0 111.758 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 28.8 m -88.41 134.93 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.591 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 161.79 52.24 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.051 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' 1044 ' ' PHE . 10.4 mt -49.75 138.83 17.01 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 117.018 0.409 . . . . 0.0 111.895 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.584 ' HG3' HG22 ' A' 1050 ' ' VAL . 59.2 Cg_endo -70.85 150.31 61.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.893 2.396 . . . . 0.0 111.516 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.512 ' HG2' ' O ' ' A' 1087 ' ' PRO . 83.4 Cg_exo -47.01 126.12 10.89 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.415 2.077 . . . . 0.0 111.985 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.0 p -77.53 126.56 31.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.709 HD11 ' HD2' ' A' 1052 ' ' TYR . 6.7 tt -88.59 111.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -67.11 141.77 57.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 68.84 26.93 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.308 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -175.34 135.06 2.9 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.28 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -74.17 -155.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.564 ' HB2' ' CG1' ' A' 1050 ' ' VAL . 49.0 p90 -156.0 131.89 9.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 111.251 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.546 HG13 ' CZ ' ' A' 1053 ' ' ARG . 47.9 mm -91.3 99.97 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.835 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 44.3 t -171.12 146.58 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.911 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 90.9 m -58.94 -33.61 70.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.485 ' H ' ' HG ' ' A' 1038 ' ' SER . 44.7 t30 -56.53 128.39 35.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -151.69 -31.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.635 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -147.16 -51.73 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.163 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -71.57 135.71 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.585 ' HD2' HD22 ' A' 1027 ' ' LEU . 0.1 OUTLIER -162.21 55.09 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 12.2 m80 -63.5 -47.9 79.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.196 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' 1045 ' ' HIS . 74.0 t80 172.37 161.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.53 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.9 -24.11 3.47 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 49.7 m -47.59 143.87 3.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 110.92 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -142.47 123.53 11.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.782 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.835 ' HA ' ' HB2' ' A' 1038 ' ' SER . 98.1 t -106.55 129.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.042 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.7 m -99.43 125.05 45.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.709 ' HD2' HD11 ' A' 1031 ' ' ILE . 4.6 m-85 -72.24 146.79 47.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.546 ' CZ ' HG13 ' A' 1037 ' ' ILE . 38.3 ttm180 -146.11 -29.24 0.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.75 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 47.7 t 65.44 160.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.464 ' N ' ' HA3' ' A' 1034 ' ' GLY . 75.1 m-20 -62.13 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.584 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.75 ' HB3' ' HA3' ' A' 1060 ' ' GLY . 23.0 mt -154.94 27.0 0.43 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.285 0.564 . . . . 0.0 110.65 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.454 ' HA2' HG22 ' A' 1063 ' ' VAL . . . 53.71 -113.15 2.89 Favored Glycine 0 C--N 1.317 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.859 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 49.3 m -51.44 -50.48 59.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.508 ' O ' HD11 ' A' 1056 ' ' LEU . 25.9 tpt180 -167.7 -53.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.352 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.75 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . -176.89 38.2 0.09 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.942 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' 1061 ' ' ARG . 34.6 ttm180 -93.86 33.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' 1062 ' ' LYS . 26.2 ttpp 41.09 52.19 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.172 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.527 HG21 ' N ' ' A' 1064 ' ' PHE . 16.1 m -85.02 -39.27 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.253 0.549 . . . . 0.0 110.728 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.582 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 2.9 m-85 -85.96 147.76 26.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.066 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -134.44 128.91 34.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 111.658 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.716 HD22 ' N ' ' A' 1067 ' ' VAL . 4.5 tt -68.6 140.31 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.309 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.716 ' N ' HD22 ' A' 1066 ' ' LEU . 78.5 t -135.49 109.51 10.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 111.142 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.561 ' O ' ' HG3' ' A' 1089 ' ' PRO . . . 76.98 156.55 7.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.754 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.653 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 38.2 tt0 30.37 77.39 0.32 Allowed Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.632 ' HA ' HD12 ' A' 1066 ' ' LEU . 90.0 Cg_endo -86.66 7.39 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.588 2.192 . . . . 0.0 112.473 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 53.1 m -156.23 150.01 24.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.387 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.533 ' O ' HG21 ' A' 1049 ' ' VAL . 15.5 pt -148.0 150.15 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.591 ' HB3' HG21 ' A' 1049 ' ' VAL . 2.8 p90 -160.12 145.67 15.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.601 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.907 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 42.0 t -66.28 144.12 56.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.7 t -144.07 -7.55 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' 1082 ' ' GLY . 57.8 m 66.11 136.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.308 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.47 HD22 ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -172.18 43.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.867 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -170.07 -122.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.453 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.563 ' HA ' ' NH2' ' A' ' 995' ' ' ARG . 9.5 t70 -163.09 121.48 2.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.771 0.319 . . . . 0.0 110.757 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.473 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 86.7 mt-30 55.88 42.35 28.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' 1079 ' ' ASP . 21.1 t -147.59 -38.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 110.46 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 76.73 -68.96 2.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.753 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.47 ' HB ' HD22 ' A' 1077 ' ' ASN . 75.5 mt 60.57 130.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.981 0.419 . . . . 0.0 111.202 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.907 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.6 m95 -74.58 -153.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -62.96 -46.84 85.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . 178.66 -149.05 8.69 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.906 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' 1029 ' ' PRO . 10.4 Cg_exo -71.57 -127.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.387 2.725 . . . . 0.0 112.74 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.481 ' H ' ' HB2' ' A' 1087 ' ' PRO . . . -159.33 138.84 8.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 58.5 Cg_endo -68.36 -138.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.505 2.803 . . . . 0.0 113.105 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.464 ' H ' ' HB2' ' A' 1089 ' ' PRO . 40.5 tt0 -152.4 143.51 23.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.177 0.513 . . . . 0.0 111.734 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 42.6 t -103.13 139.38 38.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.48 HG12 HG22 ' A' 1067 ' ' VAL . 11.9 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.127 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.803 0.335 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -77.51 140.97 39.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 83.6 p -155.41 139.85 16.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.464 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.0 m -80.0 140.85 36.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.268 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.93 148.66 49.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.008 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 41.8 m -39.71 119.66 1.37 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.537 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.653 ' HG2' HG13 ' A' ' 974' ' ' VAL . 11.2 Cg_endo -55.03 127.2 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.358 2.039 . . . . 0.0 111.725 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.14 125.14 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.038 1.825 . . . . 0.0 111.37 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.483 ' OD2' ' HE2' ' A' ' 973' ' ' MET . 1.5 m-20 -50.06 120.03 11.17 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.457 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.544 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 77.2 Cg_exo -50.51 140.34 35.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.479 2.119 . . . . 0.0 112.247 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.743 HG22 ' HA ' ' A' 1019 ' ' ILE . 66.9 t -47.03 110.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.508 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.2 m-20 75.66 -45.91 0.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -72.62 -156.02 3.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.896 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.544 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 94.9 mmm -158.85 143.3 15.69 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.51 0.324 . . . . 0.0 110.418 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.653 HG13 ' HG2' ' A' ' 966' ' ' PRO . 0.5 OUTLIER -91.61 144.73 8.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.387 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -117.06 107.96 15.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.736 0.303 . . . . 0.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.717 ' HA ' HG23 ' A' ' 986' ' ' ILE . 57.3 t -66.42 119.59 11.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.731 HG13 ' HA ' ' A' ' 986' ' ' ILE . 31.3 mt -84.43 -89.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.802 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 30.9 p -75.25 -69.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.452 ' O ' HG21 ' A' ' 980' ' ' ILE . 2.6 m-20 -153.13 -147.57 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.95 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 979' ' ' ASP . 12.1 pt -155.95 25.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.705 0.288 . . . . 0.0 111.21 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.681 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 71.3 mt-30 -87.26 -55.75 3.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.474 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.596 HG21 ' C ' ' A' ' 981' ' ' GLN . 13.1 t -173.42 140.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 124.142 0.901 . . . . 0.0 109.469 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.24 -20.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.888 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.437 ' HB2' ' H ' ' A' ' 979' ' ' ASP . 81.1 p -68.34 129.15 39.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.452 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 48.3 ttm-85 -97.47 156.74 16.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.731 ' HA ' HG13 ' A' ' 977' ' ' ILE . 28.2 pt -143.16 136.22 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.455 HG21 HD13 ' A' ' 977' ' ' ILE . 59.4 p -91.0 126.24 36.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.06 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.898 ' HB2' ' HA ' ' A' 1000 ' ' SER . 2.4 m-85 -96.48 146.93 24.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 15.3 t -145.53 169.34 18.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.827 ' HB2' HD11 ' A' ' 996' ' ' LEU . 4.7 t -158.11 107.07 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.483 ' HB ' ' H ' ' A' ' 992' ' ' THR . 35.6 p 34.73 -150.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.971 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.483 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.4 t -117.91 -37.09 3.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.819 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.525 ' HA2' ' CZ ' ' A' 1046 ' ' TYR . . . -118.05 48.9 0.9 Allowed Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.275 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -144.71 131.81 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.621 HH21 ' HA ' ' A' 1079 ' ' ASP . 39.1 ttm-85 -82.04 109.88 16.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.703 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.827 HD11 ' HB2' ' A' ' 990' ' ' CYS . 6.6 tt -76.44 113.69 14.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.564 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' 1019 ' ' ILE . 2.0 mp -90.11 91.41 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.922 0.868 . . . . 0.0 110.663 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -161.05 -113.71 0.32 Allowed Glycine 0 C--N 1.315 -0.621 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.023 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -154.19 -10.43 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.898 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 19.4 m 57.58 18.52 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.432 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.6 p -162.18 144.39 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -162.97 153.67 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.779 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.436 ' N ' ' OE1' ' A' 1003 ' ' GLU . 11.2 pm0 -135.04 135.46 41.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.724 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 31.6 t -71.41 88.65 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.304 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.43 HD11 HG22 ' A' 1005 ' ' ILE . 37.8 pt -87.33 -167.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.487 ' C ' HD21 ' A' 1006 ' ' LEU . 4.0 tt -158.38 121.89 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.474 ' N ' HD21 ' A' 1006 ' ' LEU . 44.3 t -77.51 -48.04 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.74 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.441 ' N ' HD21 ' A' 1006 ' ' LEU . . . 175.83 -45.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.793 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.32 -48.86 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.2 153.3 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.924 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.32 141.33 43.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.113 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.1 p80 -154.92 147.87 24.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.698 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 41.2 m95 -70.76 126.87 30.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 110.531 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 t -52.43 -25.54 10.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.788 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 30.9 p -95.5 138.81 32.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.589 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 24.0 pttm -79.16 163.8 57.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.354 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.589 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 11.2 Cg_endo -54.28 120.0 7.28 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.086 1.858 . . . . 0.0 111.405 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.662 ' HB2' HD22 ' A' ' 996' ' ' LEU . 72.3 Cg_endo -76.66 136.22 16.92 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.769 2.313 . . . . 0.0 113.521 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.743 ' HA ' HG22 ' A' ' 970' ' ' VAL . 30.0 pt -116.37 124.07 72.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.648 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 84.6 m -91.12 121.46 32.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.615 ' HG2' HD12 ' A' ' 997' ' ' ILE . 96.9 mm-40 -86.52 129.92 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.166 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.561 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.01 129.68 40.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.677 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.1 mm -73.93 107.64 3.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.21 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 92.4 Cg_endo -81.4 123.57 4.43 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.297 1.998 . . . . 0.0 112.477 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.595 ' O ' ' HB2' ' A' 1044 ' ' PHE . 73.3 m -88.64 132.97 34.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.202 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -82.93 -154.61 16.4 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.064 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.742 HD21 ' N ' ' A' 1027 ' ' LEU . 1.7 mm? -72.75 144.9 86.34 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 120.711 0.291 . . . . 0.0 111.519 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.642 ' HG3' HD22 ' A' 1040 ' ' ASN . 27.1 Cg_endo -61.45 166.65 11.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.879 2.386 . . . . 0.0 112.284 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.731 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 81.9 Cg_exo -47.98 -24.35 5.2 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.757 2.305 . . . . 0.0 112.449 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 46.4 p 56.91 144.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.733 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.485 HD11 ' O ' ' A' 1089 ' ' PRO . 2.9 pt -152.88 117.97 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -70.11 67.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.148 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' 1034 ' ' GLY . 15.0 p30 -174.25 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.609 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -79.25 -177.18 49.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.367 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' 1053 ' ' ARG . 3.2 m-20 -156.47 132.65 9.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 5.1 p90 -84.02 152.71 24.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.425 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 39.1 mm -127.71 66.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.328 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.406 ' O ' ' HE1' ' A' 1036 ' ' PHE . 9.6 t -171.08 -141.52 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' 1040 ' ' ASN . 39.7 m -67.57 -103.92 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.685 ' HB2' HG13 ' A' 1050 ' ' VAL . 24.2 t-20 50.1 118.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' 1040 ' ' ASN . 22.0 mmt180 -164.57 -69.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.242 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -156.62 -51.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.188 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.427 HD21 ' N ' ' A' 1043 ' ' ASN . 2.5 m120 -72.87 61.58 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.75 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.595 ' HB2' ' O ' ' A' 1025 ' ' CYS . 73.1 m-85 -76.72 -58.08 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.314 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.697 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 7.2 m80 55.54 -172.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.525 ' CZ ' ' HA2' ' A' ' 993' ' ' GLY . 34.4 t80 -56.9 142.78 40.11 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.48 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.445 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.47 124.34 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' 1073 ' ' TYR . 38.2 m 178.37 144.55 0.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.374 0.67 . . . . 0.0 110.041 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' 1072 ' ' ILE . 11.2 p -155.83 145.32 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' 1040 ' ' ASN . 27.3 m -149.54 141.88 17.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.638 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.5 m -88.68 124.46 34.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.327 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.555 ' HB2' ' HA ' ' A' 1070 ' ' PRO . 11.3 m-85 -85.26 147.95 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.722 0.772 . . . . 0.0 112.789 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' 1035 ' ' ASP . 43.1 ttt85 -148.71 129.75 14.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.29 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 12.8 t -76.44 153.54 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.675 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -49.19 -70.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.02 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.8 HD21 ' HA3' ' A' 1060 ' ' GLY . 4.3 mt 62.37 164.99 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.8 42.25 2.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.394 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.575 ' O ' ' HD2' ' A' 1059 ' ' ARG . 84.0 p 49.73 29.12 2.99 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.349 . . . . 0.0 111.391 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' 1058 ' ' SER . 0.7 OUTLIER -152.77 -37.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.8 ' HA3' HD21 ' A' 1056 ' ' LEU . . . 98.08 46.36 2.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.702 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' 1061 ' ' ARG . 13.5 tpp85 -76.93 40.2 0.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' 1062 ' ' LYS . 24.7 ttmm 44.17 35.04 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.528 0.68 . . . . 0.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 11.3 m -95.9 -10.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.452 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.69 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 88.3 m-85 -153.93 141.48 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.606 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -142.16 119.14 11.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.01 0.433 . . . . 0.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.898 HD12 ' HB3' ' A' 1070 ' ' PRO . 5.5 tt -73.42 130.16 39.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.651 ' N ' HD21 ' A' 1066 ' ' LEU . 7.5 p -156.64 73.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.038 0.923 . . . . 0.0 110.88 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' 1089 ' ' PRO . . . -172.64 23.05 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.218 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.727 ' HB3' ' O ' ' A' 1068 ' ' GLY . 7.8 tt0 81.99 104.4 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.898 ' HB3' HD12 ' A' 1066 ' ' LEU . 89.0 Cg_endo -82.96 31.64 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.912 2.408 . . . . 0.0 113.229 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.9 p -158.86 134.65 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.561 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' 1049 ' ' VAL . 42.2 pt -140.89 152.31 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.06 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' 1048 ' ' SER . 9.9 p90 -146.77 137.08 23.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.421 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.628 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 41.7 t -75.18 148.01 39.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.229 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.51 ' O ' HG21 ' A' 1075 ' ' THR . 5.2 t -155.07 130.32 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.631 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.424 ' HB3' HG22 ' A' 1023 ' ' ILE . 80.9 p -75.66 153.72 37.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.327 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.64 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -165.34 -22.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.64 ' H ' HD21 ' A' 1077 ' ' ASN . 57.9 m-20 -116.46 -128.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.216 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.621 ' HA ' HH21 ' A' ' 995' ' ' ARG . 54.5 m-20 -76.78 -150.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -85.53 29.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.044 0.45 . . . . 0.0 110.495 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.603 HG13 HG21 ' A' 1083 ' ' ILE . 32.4 t -79.97 -35.45 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.489 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' 1083 ' ' ILE . . . 85.09 -48.98 4.15 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.729 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.603 HG21 HG13 ' A' 1081 ' ' VAL . 0.1 OUTLIER 39.38 118.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.628 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 22.2 m95 -72.23 138.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.507 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 79.8 p -64.46 -54.31 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' 1072 ' ' ILE . . . -72.07 125.51 11.02 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.285 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.13 41.13 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.579 2.186 . . . . 0.0 112.953 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 60.46 134.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.489 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.832 ' HA ' ' HA2' ' A' 1068 ' ' GLY . 40.4 Cg_endo -68.13 156.74 64.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.226 2.617 . . . . 0.0 113.71 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.552 HE21 HG22 ' A' 1092 ' ' ILE . 60.9 tp60 -104.69 114.73 29.12 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.797 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 48.1 t -97.29 132.15 43.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.327 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.552 HG22 HE21 ' A' 1090 ' ' GLN . 7.0 pt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.422 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.868 0.366 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 961' ' ' LYS . 2.6 mppt? -77.63 137.35 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.927 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 86.5 p -82.09 136.29 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' 1012 ' ' HIS . 87.8 m -79.96 34.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 962' ' ' SER . 86.3 tttt 62.73 139.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.71 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.4 m -61.61 124.75 82.55 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.336 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.05 118.29 5.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.6 2.2 . . . . 0.0 112.561 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 135.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 111.271 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -48.39 104.28 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.19 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 54.7 Cg_endo -69.15 -151.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.607 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' 1020 ' ' CYS . 45.5 t -52.76 73.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.812 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 969' ' ' PRO . 75.5 m-20 72.57 -35.85 0.34 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.558 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.44 130.35 26.18 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.923 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.1 mtp -92.27 145.5 24.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.47 HG23 HD11 ' A' ' 986' ' ' ILE . 3.1 p -84.88 151.15 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -114.02 99.33 7.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.674 ' HA ' HG23 ' A' ' 986' ' ' ILE . 39.2 t -75.31 85.65 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 987' ' ' THR . 46.1 mt -74.75 -92.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.778 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 23.3 p -61.84 -65.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.582 ' O ' HG21 ' A' ' 980' ' ' ILE . 3.6 m-20 -159.16 -136.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.578 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 979' ' ' ASP . 6.5 pt -154.31 -19.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.06 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.927 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 25.2 mt-30 -73.01 175.8 6.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.654 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' 1004 ' ' CYS . 64.2 t -44.29 147.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.832 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.86 -36.82 1.89 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.354 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.47 ' HG ' ' N ' ' A' ' 985' ' ' ARG . 43.1 t -68.38 158.86 32.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 0.0 111.092 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.647 ' HE ' ' HB2' ' A' 1003 ' ' GLU . 39.4 ttm180 -145.16 120.75 10.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.8 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.674 HG23 ' HA ' ' A' ' 976' ' ' VAL . 18.8 pt -97.16 -168.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.351 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 986' ' ' ILE . 73.7 p -153.09 124.09 7.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.5 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 2.0 m-85 -94.76 154.47 17.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.184 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 72.5 p -152.91 127.47 9.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.111 0.482 . . . . 0.0 111.13 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' A' ' 996' ' ' LEU . 73.3 m -82.94 148.13 27.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.052 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 26.1 p -62.06 157.65 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.182 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 60.7 m -48.68 138.29 11.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.583 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 95.9 -41.86 2.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.572 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -82.41 133.46 35.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.979 0.389 . . . . 0.0 111.286 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' 1021 ' ' GLN . 40.5 ttt85 -82.25 120.65 25.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.583 HD22 ' HB3' ' A' 1000 ' ' SER . 7.3 tp -65.97 124.47 22.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.177 0.513 . . . . 0.0 111.804 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.789 ' HB ' HG21 ' A' 1019 ' ' ILE . 46.7 mm -107.83 145.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.919 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.45 169.92 30.29 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.525 ' HD2' HG23 ' A' 1015 ' ' THR . 88.5 m-70 -74.98 125.56 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 0.0 111.587 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.583 ' HB3' HD22 ' A' ' 996' ' ' LEU . 81.6 p -68.18 -46.8 69.69 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.066 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.408 ' N ' ' HG ' ' A' 1000 ' ' SER . 80.6 p -77.93 139.77 39.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.215 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.64 127.62 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.282 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.647 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 43.4 tt0 -98.02 132.09 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.709 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 52.9 t -66.7 94.54 0.3 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' 1014 ' ' SER . 22.2 pt -90.07 -155.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.872 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.684 HD21 ' HA ' ' A' 1011 ' ' ALA . 2.0 tm? -149.96 124.21 9.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.599 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.502 ' N ' HD11 ' A' 1006 ' ' LEU . 46.1 t -80.53 -48.4 12.82 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.403 ' N ' HD11 ' A' 1006 ' ' LEU . . . -161.44 -54.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.305 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -123.53 -52.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.1 m -88.9 144.34 26.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.29 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.684 ' HA ' HD21 ' A' 1006 ' ' LEU . . . -75.24 145.02 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.044 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.478 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 93.3 m-70 -149.17 140.69 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.448 ' CH2' HD12 ' A' ' 986' ' ' ILE . 82.5 m95 -68.12 135.68 52.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.671 ' HA ' HD12 ' A' 1005 ' ' ILE . 46.1 m -52.34 -24.68 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.184 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.525 HG23 ' HD2' ' A' ' 999' ' ' HIS . 53.4 p -132.94 137.59 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 111.817 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -56.51 150.1 36.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.06 117.99 2.16 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.342 2.028 . . . . 0.0 112.521 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.5 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 72.5 Cg_exo -51.06 138.35 43.91 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.693 2.262 . . . . 0.0 112.063 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.789 HG21 ' HB ' ' A' ' 997' ' ' ILE . 0.0 OUTLIER -110.08 139.7 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.41 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.644 ' HB2' HG13 ' A' ' 970' ' ' VAL . 63.0 m -97.68 128.91 44.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.816 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 995' ' ' ARG . 3.1 tp-100 -82.17 125.52 31.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.314 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' 1022 ' ' ARG . 11.4 tpt180 -67.71 -26.36 66.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.487 HG21 ' HA ' ' A' 1080 ' ' GLN . 49.7 mt 58.24 61.53 5.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.245 0.545 . . . . 0.0 109.678 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.641 ' HA ' ' N ' ' A' 1046 ' ' TYR . 38.1 Cg_endo -65.68 138.49 54.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.13 2.553 . . . . 0.0 114.008 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.482 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 38.5 m -88.43 141.23 28.71 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.744 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.19 -153.36 4.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.143 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.462 ' HA ' HD21 ' A' 1027 ' ' LEU . 26.9 mt -71.95 155.51 91.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.113 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.629 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 31.2 Cg_exo -58.01 154.48 38.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.265 . . . . 0.0 111.879 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.546 ' HD2' ' OH ' ' A' 1052 ' ' TYR . 55.3 Cg_exo -51.13 -17.3 3.55 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.435 2.09 . . . . 0.0 112.274 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 73.8 p 49.08 94.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.663 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' 1031 ' ' ILE . 29.5 pt -84.1 104.3 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . 43.03 -139.36 0.21 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -79.64 41.74 0.5 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.44 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -64.68 -141.43 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.361 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' 1036 ' ' PHE . 19.6 t70 -168.03 -159.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.32 . . . . 0.0 110.795 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.544 ' H ' ' CG ' ' A' 1035 ' ' ASP . 1.4 t80 -156.0 125.82 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.221 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.465 HD13 ' C ' ' A' 1036 ' ' PHE . 4.3 mp -143.98 70.46 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.148 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.578 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 40.4 t -159.63 -119.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' 1040 ' ' ASN . 65.3 p -140.5 111.73 7.19 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.832 0.348 . . . . 0.0 111.917 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.506 ' HB2' ' CE2' ' A' 1044 ' ' PHE . 19.7 p30 165.31 130.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.062 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' 1043 ' ' ASN . 84.0 mtm180 -153.17 117.25 4.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.745 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.563 ' N ' ' HE1' ' A' 1044 ' ' PHE . 0.5 OUTLIER 53.1 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.551 179.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' 1041 ' ' ARG . 72.1 m-20 -70.37 65.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.13 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.629 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 1.9 m-85 -76.79 135.69 38.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.335 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.515 ' HA ' ' CB ' ' A' 1024 ' ' PRO . 52.0 m-70 -141.91 -165.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.553 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.641 ' N ' ' HA ' ' A' 1024 ' ' PRO . 10.5 t80 -58.02 139.25 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.414 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 64.87 111.18 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.453 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' 1073 ' ' TYR . 79.6 p 176.54 128.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.265 0.555 . . . . 0.0 110.521 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.795 HG21 ' HB3' ' A' 1073 ' ' TYR . 97.4 t -102.16 147.04 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.965 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.578 ' HA ' ' HB3' ' A' 1038 ' ' SER . 12.3 p -138.46 126.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.927 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.439 HG21 ' O ' ' A' 1070 ' ' PRO . 87.9 m -101.04 117.32 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 111.559 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.546 ' OH ' ' HD2' ' A' 1029 ' ' PRO . 4.8 m-85 -83.94 134.71 34.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.186 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.46 ' HB2' HD12 ' A' 1037 ' ' ILE . 50.9 mtp85 -148.19 25.02 1.02 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.812 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.558 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 57.9 m 58.78 150.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' 1056 ' ' LEU . 13.5 t-20 -68.29 39.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.576 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' 1062 ' ' LYS . 0.4 OUTLIER 27.59 50.56 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.685 ' HA3' ' HE1' ' A' 1064 ' ' PHE . . . 73.7 -40.02 0.95 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.269 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 47.0 t -169.87 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.906 0.353 . . . . 0.0 111.274 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.636 ' HD3' ' N ' ' A' 1059 ' ' ARG . 0.0 OUTLIER -163.0 -28.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.451 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' 1061 ' ' ARG . . . -151.02 149.39 21.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.837 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.47 ' N ' ' HB3' ' A' 1056 ' ' LEU . 44.5 ttm-85 71.61 116.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' 1056 ' ' LEU . 40.1 ttmt -72.99 146.0 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.469 HG21 ' CD1' ' A' 1064 ' ' PHE . 28.5 m -143.87 -22.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.733 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 4.7 m-85 -73.82 -26.36 60.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.72 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1065 ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' 1062 ' ' LYS . 58.5 mm-40 61.39 111.66 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.751 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.801 HD23 ' H ' ' A' 1067 ' ' VAL . 3.2 tm? -71.23 149.48 46.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.323 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.801 ' H ' HD23 ' A' 1066 ' ' LEU . 21.3 t -129.56 138.57 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.95 -153.94 42.55 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.536 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.515 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.0 pt-20 -72.11 113.46 20.69 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-O 120.504 0.192 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.707 ' HB3' HD13 ' A' 1066 ' ' LEU . 93.2 Cg_endo -84.67 24.41 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.274 1.982 . . . . 0.0 112.929 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' 1050 ' ' VAL . 40.4 t -158.87 142.11 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 111.678 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.522 ' O ' HG11 ' A' 1049 ' ' VAL . 42.2 pt -141.92 -177.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.482 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.795 ' HB3' HG21 ' A' 1049 ' ' VAL . 2.3 p90 -160.21 151.09 18.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 32.3 t -62.14 149.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.611 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.538 HG23 ' HA ' ' A' 1085 ' ' SER . 7.4 t -149.01 -27.44 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.646 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 58.3 m 58.78 54.3 5.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.703 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -63.84 -43.04 97.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.173 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.703 ' H ' HD21 ' A' 1077 ' ' ASN . 33.2 m-20 -74.15 -82.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.395 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.504 ' OD1' HG21 ' A' 1081 ' ' VAL . 2.2 p30 -163.18 -135.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.026 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.487 ' HA ' HG21 ' A' 1023 ' ' ILE . 64.5 mt-30 -68.34 12.17 0.14 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.504 HG21 ' OD1' ' A' 1079 ' ' ASP . 14.0 t -68.04 -43.56 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.311 0.577 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . 82.57 42.06 8.65 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.471 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 62.7 mt -82.02 142.3 13.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.668 0.271 . . . . 0.0 110.295 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.516 ' CZ3' HG13 ' A' 1050 ' ' VAL . 28.4 m95 -70.5 -163.97 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.358 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.538 ' HA ' HG23 ' A' 1075 ' ' THR . 81.6 p -65.02 -63.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 177.86 127.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.224 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.41 140.62 70.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.518 2.145 . . . . 0.0 111.537 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.68 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -165.69 -50.88 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.611 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.68 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.4 Cg_endo -52.36 145.55 35.71 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.395 2.063 . . . . 0.0 111.76 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -152.37 136.8 16.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.662 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 94.7 m -91.9 123.15 35.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.015 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.454 HG23 HD11 ' A' 1092 ' ' ILE . 7.6 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.662 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.889 0.376 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.669 ' HA ' ' HE3' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -77.58 134.01 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.113 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.545 ' OG ' ' HG2' ' A' ' 981' ' ' GLN . 25.1 m -154.4 135.0 13.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 92.8 m -79.92 136.62 36.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -63.78 138.68 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.477 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 7.1 t -57.44 122.65 56.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.842 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.805 ' HG2' HG12 ' A' ' 974' ' ' VAL . 42.4 Cg_endo -66.95 107.62 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.384 2.056 . . . . 0.0 111.98 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 965' ' ' THR . 26.4 Cg_exo -61.69 134.6 51.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.549 2.166 . . . . 0.0 111.694 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -53.26 106.97 0.73 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.777 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 97.4 Cg_endo -82.34 -150.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.534 2.156 . . . . 0.0 112.903 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' 1020 ' ' CYS . 1.4 p -48.94 83.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.52 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 969' ' ' PRO . 76.6 m-20 69.83 -28.37 0.17 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.703 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -68.4 147.27 46.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.444 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 63.4 mtm -143.19 131.8 22.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 110.413 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.805 HG12 ' HG2' ' A' ' 966' ' ' PRO . 3.3 p -87.4 154.03 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.366 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.405 ' H ' HG21 ' A' ' 974' ' ' VAL . 14.5 m170 -114.7 100.02 7.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.774 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.487 ' HA ' HG23 ' A' ' 986' ' ' ILE . 35.6 t -65.73 106.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.6 mt -75.27 -94.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 22.0 p -72.44 -56.35 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 0.0 110.144 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -165.75 -131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.563 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.511 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 1.8 pt -153.59 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.017 0.437 . . . . 0.0 111.113 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.545 ' HG2' ' OG ' ' A' ' 962' ' ' SER . 19.8 mt-30 -87.33 -176.44 5.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.69 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 983' ' ' GLY . 97.8 t -48.57 139.99 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.251 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.44 ' N ' HG11 ' A' ' 982' ' ' VAL . . . 77.35 -34.17 1.55 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 981' ' ' GLN . 92.1 p -67.92 130.31 42.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.899 0.849 . . . . 0.0 111.127 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.691 ' HG2' ' HB3' ' A' 1003 ' ' GLU . 99.1 mtt180 -101.58 163.63 12.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 974' ' ' VAL . 26.0 pt -150.68 139.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.083 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' 1000 ' ' SER . 81.1 p -102.95 122.25 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -92.33 155.51 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.263 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 989' ' ' SER . . . . . 0.62 ' HA ' HD13 ' A' ' 996' ' ' LEU . 16.6 m -160.3 122.6 3.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.38 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.703 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 94.4 m -82.25 68.16 8.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 992' ' ' THR . 33.7 p 45.95 -155.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.479 . . . . 0.0 111.864 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.4 ' H ' ' HB ' ' A' ' 991' ' ' THR . 13.6 t -97.4 -45.39 6.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.211 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -93.17 43.73 2.53 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.419 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.493 ' CE1' ' HB2' ' A' 1022 ' ' ARG . 56.1 m-70 -157.53 135.21 10.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.66 ' HG3' ' HG3' ' A' 1080 ' ' GLN . 77.7 ttt180 -82.19 129.68 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.692 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 4.0 tt -75.01 100.18 4.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.443 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.597 ' HB ' ' O ' ' A' 1019 ' ' ILE . 26.6 mm -87.35 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.126 0.965 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.49 ' H ' HD21 ' A' ' 996' ' ' LEU . . . -156.52 -118.55 0.58 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.291 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -153.08 109.92 3.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -57.2 -54.64 44.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.174 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.5 p -77.86 137.23 38.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.485 ' HB1' ' HE1' ' A' ' 988' ' ' TYR . . . -157.94 150.06 22.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.691 ' HB3' ' HG2' ' A' ' 985' ' ' ARG . 10.1 pt-20 -135.11 132.02 37.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 44.2 t -66.68 93.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.766 HG22 ' HB2' ' A' 1014 ' ' SER . 40.8 pt -87.33 -168.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 11.0 tp -158.36 120.94 3.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 25.4 m -81.51 -55.17 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.085 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 164.57 47.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -175.61 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.08 0.467 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 82.3 m -151.35 146.7 26.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.018 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -72.94 135.92 45.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.437 . . . . 0.0 110.77 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.45 145.05 26.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.703 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.511 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 58.9 m95 -69.68 128.2 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.766 ' HB2' HG22 ' A' 1005 ' ' ILE . 48.0 t -52.47 -26.2 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.257 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 64.2 p -86.93 130.87 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.776 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.72 155.63 81.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.874 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -41.42 112.44 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.154 1.902 . . . . 0.0 111.905 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.438 ' HG3' ' CD2' ' A' ' 988' ' ' TYR . 51.0 Cg_endo -69.9 129.1 16.88 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.928 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.597 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 8.1 tt -116.62 147.24 20.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.558 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.631 ' H ' HG12 ' A' ' 970' ' ' VAL . 72.1 m -106.88 156.83 18.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.15 124.1 6.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.985 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.705 ' HD3' ' HB3' ' A' 1046 ' ' TYR . 40.6 ttm180 -59.43 132.71 54.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.851 HD12 ' HA ' ' A' 1080 ' ' GLN . 68.1 mt -73.15 122.4 87.54 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.426 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' 1045 ' ' HIS . 96.2 Cg_endo -84.95 130.79 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.861 2.374 . . . . 0.0 112.532 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.498 ' HB3' ' NE1' ' A' 1084 ' ' TRP . 22.5 m -88.39 32.33 0.78 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.525 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1026 ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' 1044 ' ' PHE . . . 40.18 -130.69 2.77 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.287 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.772 HD11 ' HD2' ' A' 1028 ' ' PRO . 24.1 tp -121.94 126.56 26.3 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.772 ' HD2' HD11 ' A' 1027 ' ' LEU . 26.2 Cg_endo -61.42 156.26 47.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.824 2.349 . . . . 0.0 112.42 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.792 ' HG3' ' HA ' ' A' 1087 ' ' PRO . 19.2 Cg_endo -58.67 126.1 20.25 Favored 'Trans proline' 0 CA--C 1.518 -0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 112.036 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1030 ' ' THR . . . . . 0.49 HG21 ' N ' ' A' 1031 ' ' ILE . 17.9 m -93.27 151.19 19.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.016 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.704 HG13 ' O ' ' A' 1034 ' ' GLY . 11.1 pt -142.57 134.58 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.261 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -67.86 163.99 20.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' 1032 ' ' ALA . 6.6 m120 76.8 -41.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.452 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.915 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -168.28 136.54 4.14 Favored Glycine 0 CA--C 1.507 -0.455 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.444 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.452 ' HB3' HG13 ' A' 1031 ' ' ILE . 2.8 p30 -171.17 142.71 1.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.069 0.462 . . . . 0.0 112.034 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 12.3 t80 60.4 115.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.349 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.799 HD11 ' HD3' ' A' 1053 ' ' ARG . 38.2 mt -152.09 60.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.143 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.74 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 22.9 t -163.78 -137.09 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.032 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' 1040 ' ' ASN . 85.9 m -111.64 128.09 55.95 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' 1039 ' ' THR . 26.4 t-20 174.87 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.451 HH11 ' HG3' ' A' 1041 ' ' ARG . 52.7 mtt85 58.84 67.67 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.239 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.689 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 47.9 mt-10 58.87 -169.85 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.534 ' HB3' ' HD1' ' A' 1045 ' ' HIS . 2.6 m120 76.62 -70.3 0.14 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.969 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' 1042 ' ' GLU . 7.6 m-85 52.66 47.27 25.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.97 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.585 ' O ' ' HA ' ' A' 1024 ' ' PRO . 27.3 m80 -62.63 -51.5 67.05 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.039 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.775 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 62.4 t80 173.24 139.07 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 72.29 92.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.414 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.4 p 172.15 130.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' 1072 ' ' ILE . 11.3 p -102.25 156.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.997 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.74 ' HA ' ' HB3' ' A' 1038 ' ' SER . 18.8 m -149.15 130.13 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 40.2 m -89.93 110.42 21.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.545 ' HH ' ' HB2' ' A' 1028 ' ' PRO . 15.8 m-85 -85.22 135.79 33.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.453 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.799 ' HD3' HD11 ' A' 1037 ' ' ILE . 41.2 mtp85 -146.28 -143.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.235 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.915 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 32.6 t -163.66 135.3 4.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -65.81 97.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.483 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.713 ' HG ' ' HA3' ' A' 1060 ' ' GLY . 0.0 OUTLIER -80.76 43.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.784 179.054 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.637 ' HA2' HG22 ' A' 1063 ' ' VAL . . . 79.1 -62.48 4.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.296 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' 1059 ' ' ARG . 69.2 m -167.29 93.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.242 0.521 . . . . 0.0 111.686 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.589 ' C ' HD22 ' A' 1056 ' ' LEU . 39.5 mmt-85 72.54 -42.24 0.53 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.713 ' HA3' ' HG ' ' A' 1056 ' ' LEU . . . 174.57 39.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.531 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' 1061 ' ' ARG . 35.9 ttm180 -83.96 32.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' 1063 ' ' VAL . 23.4 ttmm 42.47 83.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.607 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.637 HG22 ' HA2' ' A' 1057 ' ' GLY . 6.0 t -149.99 89.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.605 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 29.8 m-85 71.21 90.35 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -90.74 136.26 33.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.901 HD22 ' HB3' ' A' 1070 ' ' PRO . 47.5 tp -68.35 155.96 38.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.607 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' 1089 ' ' PRO . 72.5 t -142.62 139.82 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.926 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 86.0 -158.91 32.26 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.417 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.7 pt-20 -64.08 111.15 4.84 Favored Pre-proline 0 CA--C 1.528 0.107 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.901 ' HB3' HD22 ' A' 1066 ' ' LEU . 94.8 Cg_endo -90.79 23.07 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.885 2.39 . . . . 0.0 113.152 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.4 p -157.64 143.79 17.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.514 ' O ' HG21 ' A' 1049 ' ' VAL . 44.2 pt -148.16 171.12 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.137 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.5 p90 -161.67 145.3 12.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 4.2 t -66.04 144.98 56.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.907 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.4 t -144.41 -151.41 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.231 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.452 ' OG ' HD11 ' A' 1023 ' ' ILE . 44.9 t -161.29 131.34 4.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.016 0.436 . . . . 0.0 111.563 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.524 HD22 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER 178.96 -146.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.115 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 63.3 t0 52.48 -87.63 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' 1077 ' ' ASN . 11.6 p-10 -163.13 51.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.151 0.501 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.851 ' HA ' HD12 ' A' 1023 ' ' ILE . 3.5 mm100 65.42 41.24 4.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 25.4 t -94.05 -40.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' 1025 ' ' CYS . . . 86.28 47.15 5.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.238 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.524 HG12 HD22 ' A' 1077 ' ' ASN . 35.6 pt -81.97 135.1 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.581 ' HZ2' ' HB3' ' A' 1044 ' ' PHE . 26.3 m95 -70.64 147.27 49.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.1 t -40.36 -36.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.581 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.94 150.05 16.43 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.442 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.792 ' HA ' ' HG3' ' A' 1029 ' ' PRO . 31.5 Cg_endo -63.01 157.54 48.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.884 2.389 . . . . 0.0 112.336 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . -62.62 144.91 95.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.109 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.547 ' HB2' ' O ' ' A' 1067 ' ' VAL . 56.5 Cg_endo -68.0 -144.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.784 2.322 . . . . 0.0 112.271 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' 1089 ' ' PRO . 0.1 OUTLIER -152.41 136.33 16.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.064 0.459 . . . . 0.0 111.702 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 50.7 t -98.37 132.97 43.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' 1091 ' ' CYS . 26.2 pt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.117 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.581 0.229 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? 66.3 149.19 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.959 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.5 p -156.44 129.8 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.285 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' 1011 ' ' ALA . 2.0 p -84.63 35.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.893 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 963' ' ' CYS . 58.0 tptt 56.63 129.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.709 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 85.6 m -61.56 122.4 70.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.73 110.24 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.287 1.991 . . . . 0.0 112.519 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.85 139.55 24.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.559 2.173 . . . . 0.0 111.47 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 11.7 p-10 -49.42 107.25 0.74 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 971' ' ' ASN . 6.3 Cg_exo -78.87 -146.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.064 2.509 . . . . 0.0 111.938 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' 1020 ' ' CYS . 64.4 t -49.1 81.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.434 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 969' ' ' PRO . 22.0 p30 42.72 27.77 0.11 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.148 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.599 ' HA3' ' SG ' ' A' ' 990' ' ' CYS . . . -83.01 -161.11 30.23 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.858 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 45.4 ttm -159.17 114.55 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.418 HG23 HD11 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.9 144.22 9.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.284 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -119.75 91.72 3.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.148 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.764 ' HA ' HG23 ' A' ' 986' ' ' ILE . 64.0 t -66.47 103.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.179 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.2 mt -84.14 -92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 41.2 p -84.14 62.84 7.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 111.819 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.92 -153.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.706 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.423 HG22 HG12 ' A' ' 976' ' ' VAL . 21.5 pt -155.81 26.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.945 0.403 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.65 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 22.6 pt20 -87.34 28.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.061 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.65 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 70.8 t 100.43 142.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 111.34 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 70.71 -7.46 5.2 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.234 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 982' ' ' VAL . 34.9 m -68.33 160.05 30.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.273 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -143.13 109.4 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.227 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.764 HG23 ' HA ' ' A' ' 976' ' ' VAL . 27.2 pt -96.77 -174.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 986' ' ' ILE . 65.9 p -149.43 131.3 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.691 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.4 m-85 -96.23 165.08 12.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.0 p -149.75 -40.56 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 111.408 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.599 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 12.8 t 71.26 177.99 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.893 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 971' ' ' ASN . 22.2 p -62.98 -161.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.321 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 11.8 t -94.7 -44.94 7.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.145 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.407 ' HA2' ' OH ' ' A' 1046 ' ' TYR . . . -94.62 39.05 2.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.411 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.619 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 45.3 m80 -149.08 132.76 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.952 0.376 . . . . 0.0 110.681 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.499 ' HG2' HD12 ' A' ' 997' ' ' ILE . 79.1 ttt180 -82.01 123.4 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' 1000 ' ' SER . 8.4 tp -71.25 132.16 44.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' 1021 ' ' GLN . 17.6 mm -132.13 62.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.628 0.728 . . . . 0.0 110.792 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.596 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . -154.27 33.51 0.71 Allowed Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.122 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 59.11 4.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.691 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 81.7 p 43.65 31.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.07 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 83.2 p -162.23 151.12 15.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.528 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.731 ' HA ' HG22 ' A' 1015 ' ' THR . . . -158.04 128.94 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.335 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.81 127.22 47.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.812 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -77.48 82.29 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.611 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.688 HD12 ' HB3' ' A' 1014 ' ' SER . 46.3 pt -87.21 -152.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' 1008 ' ' GLY . 3.0 tm? -141.9 121.12 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.593 ' HB2' ' HD2' ' A' 1012 ' ' HIS . 45.5 m -93.42 -39.14 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.486 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.528 ' N ' HD12 ' A' 1006 ' ' LEU . . . -169.05 -126.27 0.84 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.084 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -68.38 8.2 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.224 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' 1008 ' ' GLY . 99.3 m -151.87 145.28 24.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 963' ' ' CYS . . . -75.31 147.95 39.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.593 ' HD2' ' HB2' ' A' 1007 ' ' SER . 92.3 m-70 -149.43 149.92 31.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 111.539 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.476 ' CE3' ' HB1' ' A' 1002 ' ' ALA . 60.8 m95 -81.11 117.25 21.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.197 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.688 ' HB3' HD12 ' A' 1005 ' ' ILE . 80.1 p -53.35 -25.52 15.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' 1002 ' ' ALA . 82.2 p -86.93 141.81 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -65.72 150.1 96.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.371 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.31 115.32 2.11 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.124 1.883 . . . . 0.0 111.883 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.608 ' HG2' ' CE2' ' A' ' 988' ' ' TYR . 31.1 Cg_exo -61.12 140.5 89.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.913 2.409 . . . . 0.0 112.873 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.626 HG21 ' HB ' ' A' ' 997' ' ' ILE . 5.2 tt -129.78 136.48 58.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.725 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 64.6 m -97.25 126.08 42.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.541 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.661 ' HG2' HG13 ' A' ' 997' ' ' ILE . 99.1 mm-40 -75.77 124.34 27.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.81 -12.49 59.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' 1080 ' ' GLN . 53.5 mt 56.28 70.82 1.34 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 109.939 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' 1045 ' ' HIS . 9.4 Cg_endo -51.44 132.47 40.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.117 2.545 . . . . 0.0 113.519 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.682 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 3.0 m -86.43 -146.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1026 ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -153.24 -155.44 7.15 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.19 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.569 HD22 ' HE2' ' A' 1044 ' ' PHE . 75.4 mt -68.36 143.88 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.714 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' 1027 ' ' LEU . 20.5 Cg_exo -64.72 147.55 89.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 111.472 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.818 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 83.7 Cg_exo -47.34 113.38 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 112.213 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 68.5 p -77.6 140.45 39.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' 1032 ' ' ALA . 29.2 pt -151.32 31.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.559 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 52.04 117.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.376 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' 1032 ' ' ALA . 75.6 m-20 74.74 -25.97 0.2 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.362 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' 1032 ' ' ALA . . . -70.7 68.77 0.76 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.702 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.75 -150.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.133 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.478 ' HB3' HG12 ' A' 1050 ' ' VAL . 12.3 p90 -155.99 141.6 17.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.559 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 42.6 mm -92.62 63.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.055 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 69.2 m -159.98 -159.13 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 111.707 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 64.9 m -83.59 -92.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.553 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.603 ' OD1' ' HB3' ' A' 1048 ' ' SER . 73.3 m-80 54.06 -138.89 1.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 61.88 109.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' 1043 ' ' ASN . 16.6 pt-20 38.42 41.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.842 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' 1042 ' ' GLU . 72.3 m-80 -167.74 116.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.569 ' HE2' HD22 ' A' 1027 ' ' LEU . 0.8 OUTLIER -163.39 143.66 8.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' 1024 ' ' PRO . 16.9 m-70 -140.82 -58.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.449 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.706 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 48.3 t80 175.22 47.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.43 -25.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.032 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.603 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 63.3 m -47.62 147.69 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.262 0.554 . . . . 0.0 111.962 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.604 HG23 ' HB3' ' A' 1073 ' ' TYR . 69.2 t -137.62 145.98 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.124 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' 1072 ' ' ILE . 3.4 t -133.38 120.38 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.026 0.441 . . . . 0.0 112.183 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 76.7 m -100.23 119.44 38.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.196 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.546 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 26.5 m-85 -74.5 145.54 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.442 0.639 . . . . 0.0 112.431 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -150.99 -30.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.03 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1054 ' ' CYS . . . . . . . . . . . . . 9.6 t 70.31 142.68 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.115 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.44 ' O ' ' HE2' ' A' 1064 ' ' PHE . 12.6 t-20 -65.06 129.02 38.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.855 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.799 ' N ' HD21 ' A' 1056 ' ' LEU . 1.8 mm? -73.48 43.26 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.835 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 56.27 48.17 76.87 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' 1059 ' ' ARG . 45.6 t 58.02 39.23 26.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' 1058 ' ' SER . 23.9 mmm180 -157.54 -128.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.871 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -149.76 -26.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -57.74 147.6 27.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -65.2 133.02 50.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.973 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 10.8 p -155.07 27.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.446 0.641 . . . . 0.0 111.137 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.44 ' HE2' ' O ' ' A' 1055 ' ' ASN . 0.4 OUTLIER -168.77 -175.3 2.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.672 -179.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1065 ' ' GLU . . . . . 0.538 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 72.4 mt-10 -150.11 122.39 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 110.592 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 53.7 tp -68.56 119.67 13.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 85.0 t -101.62 86.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 62.1 -163.08 26.38 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.961 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' 1089 ' ' PRO . 29.9 tp10 30.25 58.43 0.89 Allowed Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.491 0.716 . . . . 0.0 112.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 83.4 Cg_endo -80.75 2.76 8.3 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.473 2.115 . . . . 0.0 113.186 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 51.1 m -156.27 144.69 19.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.557 HG13 ' HB ' ' A' 1050 ' ' VAL . 19.5 pt -146.39 157.25 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.604 ' HB3' HG23 ' A' 1049 ' ' VAL . 0.3 OUTLIER -160.1 147.91 16.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 50.8 t -62.18 133.17 54.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.083 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 8.2 t -144.51 -20.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' 1078 ' ' ASP . 57.9 m 58.82 59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.528 HD22 HD11 ' A' 1083 ' ' ILE . 0.0 OUTLIER -72.96 31.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.708 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' 1076 ' ' SER . 64.3 t0 179.43 53.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' 1076 ' ' SER . 59.3 m-20 62.15 -127.65 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.196 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.527 ' HA ' HG22 ' A' 1023 ' ' ILE . 0.0 OUTLIER -66.19 -140.17 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 121.369 -0.133 . . . . 0.0 111.194 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.5 ' H ' ' HB2' ' A' 1080 ' ' GLN . 33.4 t 75.74 -44.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.682 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 78.26 46.86 8.71 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.762 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.528 HD11 HD22 ' A' 1077 ' ' ASN . 69.1 mt -82.0 130.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.829 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 15.3 m95 -72.87 -150.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.054 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 48.2 t -74.19 -41.68 61.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -178.06 153.24 12.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.506 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' 1069 ' ' GLU . 89.2 Cg_exo -46.41 153.82 1.05 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . -62.54 143.61 96.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.872 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.546 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 51.9 Cg_endo -67.72 -143.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.96 2.44 . . . . 0.0 112.181 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.695 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.5 mm100 -135.46 125.0 25.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.975 0.417 . . . . 0.0 111.74 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 43.0 t -85.78 66.91 9.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.593 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.538 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 34.6 pt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.559 0.218 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.671 ' HG3' ' HB3' ' A' 1011 ' ' ALA . 0.0 OUTLIER 61.88 145.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 50.3 m -153.74 132.48 12.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.054 0.454 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.496 ' HB3' ' HB1' ' A' 1011 ' ' ALA . 14.5 p -79.89 140.54 36.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.647 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 1.1 tpmt? -63.73 146.29 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.267 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.567 ' H ' ' HE2' ' A' ' 964' ' ' LYS . 93.0 m -46.39 128.31 7.86 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.348 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.564 ' HG3' HD12 ' A' ' 986' ' ' ILE . 38.7 Cg_endo -66.65 130.94 24.64 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.18 1.92 . . . . 0.0 111.601 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.47 124.63 12.35 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.977 1.785 . . . . 0.0 111.428 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -47.32 122.95 8.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.671 ' HB3' ' HB2' ' A' 1018 ' ' PRO . 6.6 Cg_endo -50.43 153.46 7.39 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 112.22 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.769 ' HB ' ' H ' ' A' 1020 ' ' CYS . 23.3 t -41.96 117.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.633 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.551 ' ND2' HG11 ' A' ' 970' ' ' VAL . 23.8 p30 41.91 46.3 3.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.938 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.598 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -159.11 133.7 3.48 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.736 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.448 ' HB3' ' HE1' ' A' ' 973' ' ' MET . 22.3 ptp -97.66 150.37 21.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.977 0.418 . . . . 0.0 111.849 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 19.3 m -92.88 -157.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.632 ' HB2' ' HG1' ' A' ' 987' ' ' THR . 97.9 m-70 -157.8 100.58 1.76 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.28 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.89 111.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.032 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.73 HD12 HG22 ' A' ' 987' ' ' THR . 35.5 mt -84.93 -81.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.06 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 23.6 p -67.98 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.912 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.617 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.4 m-20 -163.26 17.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.587 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 979' ' ' ASP . 20.1 pt 52.1 28.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.269 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.34 160.08 18.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.386 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' 1004 ' ' CYS . 86.3 t -44.44 142.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.174 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.96 -33.8 1.93 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.134 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.593 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 49.4 m -68.48 177.38 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.878 0.339 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' 1002 ' ' ALA . 48.2 ttp85 -156.78 132.2 9.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.118 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.647 ' O ' HG21 ' A' ' 987' ' ' THR . 36.6 pt -96.56 -159.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.73 HG22 HD12 ' A' ' 977' ' ' ILE . 40.6 p -152.17 128.38 10.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.631 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.833 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.1 OUTLIER -93.92 167.01 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 989' ' ' SER . . . . . 0.425 ' HG ' ' HE2' ' A' ' 975' ' ' HIS . 52.7 p -145.46 -43.39 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.598 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 36.3 t 74.05 164.88 0.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.061 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 992' ' ' THR . 11.3 t -60.77 -141.22 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.406 0.622 . . . . 0.0 112.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.527 HG21 ' HD1' ' A' ' 994' ' ' HIS . 13.4 t -61.24 -137.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.82 -178.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 992' ' ' THR . . . -70.6 30.39 0.48 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.537 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 17.1 m80 -83.34 129.14 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.473 0.637 . . . . 0.0 109.976 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.63 HH22 ' HB3' ' A' 1079 ' ' ASP . 33.1 ttm180 -81.9 91.59 6.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.832 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 2.4 pp -61.51 137.53 58.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.371 0.605 . . . . 0.0 110.71 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.491 HG21 ' N ' ' A' ' 998' ' ' GLY . 41.2 mm -100.13 160.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.785 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.4 12.49 81.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.709 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 84.3 m-70 71.02 138.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.833 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 83.5 p -80.53 41.15 0.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.808 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 13.1 t -162.13 159.67 26.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' 1015 ' ' THR . . . -165.19 132.51 3.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -100.05 126.24 46.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.656 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 49.9 t -74.84 81.66 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' 1014 ' ' SER . 46.1 pt -87.3 -157.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 5.4 tt -158.43 124.36 4.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 50.1 m -77.56 -54.1 6.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.218 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.84 43.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.652 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 48.6 t30 -177.86 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.564 HG21 ' N ' ' A' 1011 ' ' ALA . 59.1 m -151.22 154.59 37.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.201 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 961' ' ' LYS . . . -74.42 135.81 42.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.253 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.41 146.39 27.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' 1002 ' ' ALA . 21.7 m95 -76.17 118.03 18.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.787 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.573 ' HB3' HD12 ' A' 1005 ' ' ILE . 90.4 p -52.95 -21.35 4.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.126 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' 1002 ' ' ALA . 37.9 p -86.93 134.29 33.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.046 0.45 . . . . 0.0 111.771 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.19 152.36 88.32 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.3 125.56 7.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.671 ' HB2' ' HB3' ' A' ' 969' ' ' PRO . 96.7 Cg_endo -77.33 149.87 28.2 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.012 2.474 . . . . 0.0 113.459 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' 1019 ' ' ILE . 32.7 pt -148.79 121.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.863 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.832 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 82.9 m -81.8 127.15 32.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.304 0.573 . . . . 0.0 112.196 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -84.33 129.48 34.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.145 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.671 ' NH1' ' HB3' ' A' 1046 ' ' TYR . 21.3 tpt85 -67.65 -10.29 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.582 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.443 HG12 HE22 ' A' 1080 ' ' GLN . 56.6 mt 51.74 64.59 7.56 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.607 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' 1045 ' ' HIS . 52.0 Cg_exo -53.72 124.12 15.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.542 2.161 . . . . 0.0 112.81 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.854 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 33.0 m -88.47 153.41 21.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.14 140.47 25.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.44 ' HA ' ' HZ ' ' A' 1044 ' ' PHE . 68.5 mt -41.57 142.01 1.09 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.977 0.389 . . . . 0.0 111.243 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.458 ' HB3' ' CH2' ' A' 1084 ' ' TRP . 17.9 Cg_endo -57.68 140.21 92.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.083 1.855 . . . . 0.0 110.455 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.441 ' HD2' HD13 ' A' 1072 ' ' ILE . 99.5 Cg_exo -38.03 127.95 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.142 1.895 . . . . 0.0 111.493 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 70.2 p -76.62 137.35 39.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.529 HD13 ' HB2' ' A' 1091 ' ' CYS . 5.8 tt -147.46 107.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.574 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -64.43 143.41 57.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.173 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.638 ' HA ' ' ND2' ' A' 1055 ' ' ASN . 4.7 m120 76.76 -40.92 0.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.394 0.434 . . . . 0.0 111.264 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -74.76 72.64 1.52 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.672 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -68.81 133.44 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 111.076 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.575 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 22.4 p90 -84.01 150.68 25.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.246 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 33.4 mm -110.32 58.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.478 ' H ' ' HD1' ' A' 1036 ' ' PHE . 68.6 m -162.89 -154.54 0.3 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.082 0.467 . . . . 0.0 111.869 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' 1038 ' ' SER . 41.7 p -86.1 -129.85 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.192 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.479 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 4.7 m120 59.65 44.91 13.76 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.481 ' HG2' HH11 ' A' 1041 ' ' ARG . 62.2 mtt-85 -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.543 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 63.29 37.28 11.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.594 HD21 ' N ' ' A' 1043 ' ' ASN . 0.0 OUTLIER -179.5 128.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.923 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' 1025 ' ' CYS . 5.5 p90 -163.27 -41.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.625 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' 1046 ' ' TYR . 90.1 m-70 72.65 -36.58 0.36 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.671 ' HB3' ' NH1' ' A' 1022 ' ' ARG . 25.1 t80 170.63 148.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.446 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.59 94.36 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.827 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' 1047 ' ' GLY . 29.2 m 178.0 143.56 0.1 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.938 0.495 . . . . 0.0 109.966 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' 1073 ' ' TYR . 12.3 p -138.21 161.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.289 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' 1036 ' ' PHE . 29.5 m -146.42 137.08 18.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 34.9 m -102.21 120.24 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.977 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.688 ' HB2' HD23 ' A' 1066 ' ' LEU . 2.9 m-85 -72.83 156.23 39.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' 1054 ' ' CYS . 78.4 ttt180 -154.53 -30.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.59 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.606 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 54.4 m 68.59 146.35 0.05 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.077 0.465 . . . . 0.0 111.046 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.69 ' O ' ' HG ' ' A' 1056 ' ' LEU . 75.9 m-20 -54.7 162.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.983 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' 1055 ' ' ASN . 3.3 mt -154.98 162.32 41.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.82 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.484 ' H ' ' HB3' ' A' 1061 ' ' ARG . . . -82.09 41.79 2.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.562 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 12.8 t 57.27 18.96 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -167.66 46.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.281 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 53.39 33.56 46.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.317 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' 1057 ' ' GLY . 78.4 ttt180 -71.41 142.2 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 110.978 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.33 102.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.042 0.449 . . . . 0.0 110.413 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.673 ' CG1' ' HA ' ' A' 1056 ' ' LEU . 3.4 p -155.7 87.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.806 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.604 ' HD1' HG23 ' A' 1063 ' ' VAL . 80.5 m-85 70.84 139.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.757 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -134.26 134.91 42.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.883 0.373 . . . . 0.0 111.659 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' 1052 ' ' TYR . 17.0 tp -68.54 149.55 49.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 60.0 t -150.19 147.24 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.27 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.546 ' N ' HG11 ' A' 1067 ' ' VAL . . . 90.43 -50.13 3.25 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.512 ' HG3' ' HG3' ' A' 1089 ' ' PRO . 22.0 pt-20 -167.89 130.94 1.35 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 117.72 0.76 . . . . 0.0 112.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.682 ' HA ' HD23 ' A' 1066 ' ' LEU . 94.9 Cg_endo -98.53 8.83 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.512 2.808 . . . . 0.0 113.698 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 60.3 m -156.9 142.75 17.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.575 ' O ' HG21 ' A' 1049 ' ' VAL . 19.6 pt -149.37 147.13 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.996 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.594 ' HB3' ' HB ' ' A' 1049 ' ' VAL . 1.9 p90 -153.47 149.32 27.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.5 t -65.06 150.7 47.65 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.0 t -140.1 -25.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.529 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 43.5 t 59.06 51.13 7.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.738 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.807 ' ND2' ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -67.32 -59.05 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.473 -179.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.807 ' H ' ' ND2' ' A' 1077 ' ' ASN . 1.6 m-20 -81.52 58.8 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 111.087 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.63 ' HB3' HH22 ' A' ' 995' ' ' ARG . 1.5 m-20 63.85 -132.07 0.38 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.071 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.443 HE22 HG12 ' A' 1023 ' ' ILE . 3.0 mm100 -64.33 -144.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.561 0.22 . . . . 0.0 110.525 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.47 HG13 ' CG1' ' A' 1083 ' ' ILE . 21.8 t 72.59 -36.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 66.28 55.42 18.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.758 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.725 ' HB ' HD22 ' A' 1077 ' ' ASN . 74.4 mt -81.95 132.93 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.479 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 10.0 m95 -84.17 165.31 18.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.19 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 86.9 p -53.77 -31.72 49.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.526 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.65 148.97 14.15 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.3 -154.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.742 2.295 . . . . 0.0 112.689 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' 1089 ' ' PRO . . . -77.03 136.83 65.79 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.142 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.512 ' HG3' ' HG3' ' A' 1069 ' ' GLU . 3.1 Cg_exo -74.99 -134.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.237 2.624 . . . . 0.0 111.205 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.657 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -145.12 115.9 7.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.529 ' HB2' HD13 ' A' 1031 ' ' ILE . 22.0 t -97.37 63.98 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.099 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.299 -179.083 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.736 0.303 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.481 ' HB2' HG13 ' A' ' 982' ' ' VAL . 47.4 mmtm 66.36 131.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.746 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.782 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 79.6 p -157.96 141.4 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.758 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 85.3 m -80.2 32.31 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 962' ' ' SER . 57.6 tptt 60.95 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.304 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.9 m -56.73 130.32 77.72 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.293 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.554 ' HB2' HG13 ' A' ' 974' ' ' VAL . 31.9 Cg_exo -58.57 120.88 9.04 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.4 Cg_endo -76.69 66.75 7.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.838 2.359 . . . . 0.0 111.949 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 967' ' ' PRO . 17.6 m-20 22.38 83.33 0.12 Allowed Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.675 0.609 . . . . 0.0 111.56 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.56 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 83.6 Cg_exo -42.69 148.67 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.139 2.56 . . . . 0.0 112.761 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.692 HG22 HG23 ' A' 1019 ' ' ILE . 76.8 t -46.98 122.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.226 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.815 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 2.2 m120 71.92 -70.51 0.16 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.736 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 989' ' ' SER . . . -75.65 128.73 9.87 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.798 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 973' ' ' MET . 1.8 mpt? -84.35 155.7 22.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.645 0.26 . . . . 0.0 110.332 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 966' ' ' PRO . 1.3 p -89.93 148.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.721 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -117.49 96.55 5.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.374 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.671 HG12 HG22 ' A' ' 980' ' ' ILE . 60.8 t -71.17 81.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.339 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.862 HD13 HG22 ' A' ' 987' ' ' THR . 48.8 mt -75.29 -78.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.371 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.7 p -68.41 -77.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.56 ' HB2' ' HG ' ' A' ' 984' ' ' SER . 52.2 m-20 -165.7 149.57 8.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.072 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.671 HG22 HG12 ' A' ' 976' ' ' VAL . 16.8 pt -84.11 -20.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.176 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.782 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 26.3 mt-30 -72.46 157.91 36.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.459 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' A' ' 961' ' ' LYS . 9.0 p -44.24 144.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.191 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.84 43.97 21.12 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.166 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.56 ' HG ' ' HB2' ' A' ' 979' ' ' ASP . 66.9 m -168.36 129.73 1.34 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 32.0 ttm-85 -101.61 128.38 47.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.897 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 987' ' ' THR . 29.3 pt -97.15 -164.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.229 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.862 HG22 HD13 ' A' ' 977' ' ' ILE . 66.7 p -150.29 127.96 11.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.569 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.56 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 2.8 m-85 -99.49 163.14 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.538 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 989' ' ' SER . . . . . 0.595 ' O ' ' HA2' ' A' ' 972' ' ' GLY . 22.7 t -145.53 -156.92 0.75 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.004 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.471 ' H ' ' HG ' ' A' ' 989' ' ' SER . 23.4 m -158.06 157.89 33.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.592 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 992' ' ' THR . 17.9 p -68.64 -151.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.772 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.494 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.0 t -85.4 132.58 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.07 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.78 91.62 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.765 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.568 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 13.8 m80 -142.12 129.46 21.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 111.508 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.634 HH11 HD12 ' A' ' 997' ' ' ILE . 6.6 ptm180 -95.91 135.86 37.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.407 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' 1000 ' ' SER . 4.6 tt -76.18 132.18 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.936 0.398 . . . . 0.0 111.653 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.857 ' HB ' HG13 ' A' 1019 ' ' ILE . 44.2 mm -97.85 144.04 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.331 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.79 43.81 Favored Glycine 0 C--N 1.328 0.116 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.1 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.13 132.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.658 ' HA ' HD12 ' A' ' 996' ' ' LEU . 79.6 p -90.85 38.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.0 p -162.15 145.7 11.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.487 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -158.41 130.98 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.182 0.515 . . . . 0.0 111.396 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 86.8 tt0 -105.0 132.49 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.528 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -70.93 127.08 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.103 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.81 152.24 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.632 HD12 ' H ' ' A' 1007 ' ' SER . 0.2 OUTLIER -85.62 141.04 30.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.431 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.632 ' H ' HD12 ' A' 1006 ' ' LEU . 48.0 t -155.17 131.54 10.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 65.66 -82.4 0.08 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.316 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -157.77 16.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.004 0.43 . . . . 0.0 110.331 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.473 HG21 ' N ' ' A' 1011 ' ' ALA . 99.5 m -151.84 142.37 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.095 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.503 ' HB2' ' SG ' ' A' ' 963' ' ' CYS . . . -75.22 141.86 43.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.449 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.0 m-70 -149.57 141.63 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.563 ' HB2' ' HA ' ' A' 1016 ' ' LYS . 89.5 m95 -66.65 132.65 48.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.3 t -52.48 -21.53 3.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 71.7 p -131.47 -14.19 3.31 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.514 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.691 ' HB3' ' HZ3' ' A' 1016 ' ' LYS . 2.0 mmmp? 66.69 148.33 0.11 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.632 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.509 ' HD2' ' HZ1' ' A' 1016 ' ' LYS . 79.7 Cg_exo -45.21 104.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.56 2.173 . . . . 0.0 112.283 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.621 ' HB2' HD22 ' A' ' 996' ' ' LEU . 12.6 Cg_exo -71.34 -144.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.127 2.551 . . . . 0.0 112.957 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.857 HG13 ' HB ' ' A' ' 997' ' ' ILE . 21.4 pt -149.75 -159.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.201 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.815 ' HB3' ' HB2' ' A' ' 971' ' ' ASN . 8.6 t -153.59 111.7 3.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.979 0.418 . . . . 0.0 110.465 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.408 ' HB2' ' CG1' ' A' ' 997' ' ' ILE . 3.1 tp-100 -81.62 132.93 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.152 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.754 ' HE ' ' HB3' ' A' 1045 ' ' HIS . 17.1 ttp-105 -66.84 128.48 36.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.331 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' 1046 ' ' TYR . 33.1 mm -53.76 107.71 0.93 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.31 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' 1045 ' ' HIS . 86.4 Cg_endo -86.93 126.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.733 2.289 . . . . 0.0 113.953 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' 1044 ' ' PHE . 26.2 p -108.17 127.85 54.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.922 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.36 -154.77 7.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.5 HD23 ' HE1' ' A' 1044 ' ' PHE . 1.9 mm? -62.44 155.27 68.46 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 122.245 0.218 . . . . 0.0 111.139 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.494 ' HD2' HD11 ' A' 1027 ' ' LEU . 9.2 Cg_endo -50.35 140.8 33.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.683 2.255 . . . . 0.0 111.627 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' 1030 ' ' THR . 33.8 Cg_exo -57.73 -9.1 5.05 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.606 2.204 . . . . 0.0 112.86 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1030 ' ' THR . . . . . 0.409 ' O ' ' O ' ' A' 1029 ' ' PRO . 13.5 t 47.08 176.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.469 HG22 HD11 ' A' 1031 ' ' ILE . 28.3 pt -152.08 30.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.605 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 54.64 123.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.403 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' 1032 ' ' ALA . 74.6 m-80 74.87 -36.84 0.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -76.09 121.05 6.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.38 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.535 ' CG ' ' HA ' ' A' 1055 ' ' ASN . 61.0 m-20 -75.4 -159.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.582 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.836 ' HB2' HG22 ' A' 1050 ' ' VAL . 21.4 p90 -156.03 142.13 18.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.358 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 43.4 mm -123.68 109.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.691 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 97.6 p -171.07 151.5 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 88.4 m -60.58 -39.41 87.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.617 HD21 ' HE2' ' A' 1044 ' ' PHE . 1.9 p-10 -61.54 143.56 55.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.348 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.36 -36.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.01 -44.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.031 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -73.39 59.11 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.617 ' HE2' HD21 ' A' 1040 ' ' ASN . 64.1 m-85 -76.66 -57.11 4.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.747 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.754 ' HB3' ' HE ' ' A' 1022 ' ' ARG . 64.4 m170 66.9 -67.66 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.885 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' 1045 ' ' HIS . 33.8 t80 173.96 35.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.536 0.684 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.48 ' O ' ' OG ' ' A' 1048 ' ' SER . . . -160.48 98.81 0.17 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.135 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.564 ' HG ' ' HB3' ' A' 1040 ' ' ASN . 26.2 m 177.35 153.39 0.25 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.366 0.603 . . . . 0.0 111.054 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' 1050 ' ' VAL . 76.5 t -137.82 144.12 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.166 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.836 HG22 ' HB2' ' A' 1036 ' ' PHE . 15.0 p -135.86 147.87 28.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' 1070 ' ' PRO . 88.2 m -118.54 125.88 50.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.757 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.586 ' HB2' HD23 ' A' 1066 ' ' LEU . 9.5 m-85 -78.45 149.37 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.003 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' 1053 ' ' ARG . 35.7 ttt85 -152.9 25.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.56 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 64.6 m 57.69 153.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.535 ' HA ' ' CG ' ' A' 1035 ' ' ASP . 28.3 t-20 -65.91 -57.27 8.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.41 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.537 HD11 ' O ' ' A' 1059 ' ' ARG . 2.9 mt 66.17 159.61 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.479 ' HA2' ' NH2' ' A' 1061 ' ' ARG . . . -81.92 -33.9 25.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.175 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.7 p -153.86 62.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.745 0.272 . . . . 0.0 111.171 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.537 ' O ' HD11 ' A' 1056 ' ' LEU . 35.1 mmt180 77.83 -40.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.819 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.432 ' HA3' ' CD2' ' A' 1056 ' ' LEU . . . 178.62 127.82 1.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.731 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.647 ' HG3' HG12 ' A' 1063 ' ' VAL . 40.3 ptt180 -172.74 41.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 0.0 110.634 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt 44.32 71.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.56 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.647 HG12 ' HG3' ' A' 1061 ' ' ARG . 23.9 m -142.68 -7.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.78 0.8 . . . . 0.0 110.116 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.695 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 70.6 m-85 -155.73 140.79 17.38 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.682 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -143.33 121.22 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 0.0 111.291 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.955 HD22 ' HB3' ' A' 1070 ' ' PRO . 36.3 tp -71.86 153.96 41.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.808 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' 1089 ' ' PRO . 85.2 t -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.237 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 83.17 -157.7 35.41 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.723 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.539 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.9 pt-20 -64.41 118.77 50.48 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-O 120.769 0.318 . . . . 0.0 111.474 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.955 ' HB3' HD22 ' A' 1066 ' ' LEU . 56.8 Cg_endo -96.26 27.21 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.092 2.528 . . . . 0.0 113.564 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' 1050 ' ' VAL . 58.6 m -156.18 142.06 18.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 112.036 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1072 ' ' ILE . . . . . . . . . . . . . 31.2 pt -144.93 174.78 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.766 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.27 148.0 24.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.996 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 60.4 m -63.26 125.25 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.347 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' A' 1085 ' ' SER . 11.4 t -157.84 145.78 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.516 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 79.3 p -74.6 149.13 40.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.35 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.774 HD22 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -164.55 -42.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.773 ' H ' HD21 ' A' 1077 ' ' ASN . 38.1 t70 -83.05 -80.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.978 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.12 -130.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.311 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -59.58 -34.44 72.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 110.808 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.433 HG11 HG21 ' A' 1083 ' ' ILE . 2.6 t -59.02 -53.2 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.15 0.5 . . . . 0.0 110.989 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' 1083 ' ' ILE . . . 77.55 -44.51 2.25 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.63 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.774 HG12 HD22 ' A' 1077 ' ' ASN . 17.1 pt 46.28 -163.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.445 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 36.2 m95 -85.26 -163.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.908 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' 1075 ' ' THR . 76.7 p -67.48 -65.1 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.984 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . 178.21 131.84 1.62 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.596 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 16.5 Cg_exo -68.52 143.05 55.81 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.698 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -168.02 -49.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.698 ' HD2' ' H ' ' A' 1088 ' ' ALA . 11.9 Cg_endo -55.65 148.91 51.82 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.333 2.022 . . . . 0.0 112.149 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.453 ' HA ' HD13 ' A' 1031 ' ' ILE . 37.7 tt0 -152.36 133.47 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 41.5 t -92.63 141.3 28.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.104 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.618 ' HD2' HD23 ' A' 1006 ' ' LEU . 28.5 mttm -77.6 142.09 39.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 77.9 p -157.28 141.07 15.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.059 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 71.4 m -79.93 134.02 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.594 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.75 140.57 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 97.4 m -53.52 120.31 21.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.143 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 42.9 Cg_exo -57.94 112.6 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.342 2.028 . . . . 0.0 112.656 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.68 134.38 32.55 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.575 2.183 . . . . 0.0 111.013 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -48.48 106.81 0.65 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.903 0.382 . . . . 0.0 111.216 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 72.9 Cg_endo -75.33 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.591 2.194 . . . . 0.0 112.295 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' 1020 ' ' CYS . 95.6 t -49.01 85.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 969' ' ' PRO . 71.2 m-80 44.68 63.8 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.896 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.822 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -157.04 124.97 1.5 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.783 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 37.8 ttp -97.75 134.49 40.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.698 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 3.9 p -93.69 151.32 3.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.401 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 15.9 m170 -116.79 106.82 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.376 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.488 ' HA ' HG21 ' A' ' 986' ' ' ILE . 22.0 t -65.44 113.3 2.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.672 HG12 ' HA ' ' A' ' 986' ' ' ILE . 46.5 mm -80.38 -91.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.312 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.467 HG21 HG23 ' A' ' 977' ' ' ILE . 41.3 p -80.68 -58.63 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.834 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.551 ' HB2' ' HG ' ' A' ' 984' ' ' SER . 30.0 m-20 -164.58 -154.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.657 HG21 ' HH2' ' A' 1013 ' ' TRP . 14.2 pt -155.89 25.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.737 0.303 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.589 ' C ' HG21 ' A' ' 982' ' ' VAL . 87.1 mt-30 -87.33 -56.26 3.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.351 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.589 HG21 ' C ' ' A' ' 981' ' ' GLN . 21.6 t -173.1 141.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.24 1.016 . . . . 0.0 109.412 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.42 -34.82 0.97 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.573 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.551 ' HG ' ' HB2' ' A' ' 979' ' ' ASP . 50.3 m -68.41 126.85 30.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.403 ' HD2' ' C ' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -101.39 -179.63 4.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.391 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.672 ' HA ' HG12 ' A' ' 977' ' ' ILE . 20.3 pt -154.01 171.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.616 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' 1001 ' ' SER . 77.8 p -141.71 129.56 21.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.317 . . . . 0.0 111.47 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.4 m-85 -83.27 -164.46 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 75.5 p -153.83 -46.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.397 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.822 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 42.7 t 71.96 150.76 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.868 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -62.42 152.0 35.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.811 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 54.4 m -58.06 137.51 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.482 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 75.63 35.5 46.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.267 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 30.6 m80 -147.0 132.49 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.639 ' NH1' HG12 ' A' ' 997' ' ' ILE . 50.8 ttt-85 -81.58 117.47 21.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.43 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 988' ' ' TYR . 5.7 tt -76.05 111.83 11.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.457 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.689 ' HB ' HG13 ' A' 1019 ' ' ILE . 18.3 mt -99.47 59.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.528 0.68 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.734 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . -154.32 20.3 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.787 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 57.07 17.58 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.604 0.24 . . . . 0.0 111.122 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.614 ' H ' HD23 ' A' ' 996' ' ' LEU . 83.2 p 36.99 39.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 18.0 t -162.14 161.86 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.482 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -165.28 126.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' 1013 ' ' TRP . 43.5 tt0 -105.0 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.1 t -73.19 81.3 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' 1014 ' ' SER . 44.3 pt -86.87 -172.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.359 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.618 HD23 ' HD2' ' A' ' 961' ' ' LYS . 10.8 tp -158.36 124.42 4.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.47 . . . . 0.0 111.919 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 45.7 t -83.67 -45.56 13.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.153 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.478 ' H ' HD13 ' A' 1006 ' ' LEU . . . 167.77 -45.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.752 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.23 -52.41 10.09 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.606 HG21 ' N ' ' A' 1011 ' ' ALA . 86.9 m -151.26 149.16 29.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.606 ' N ' HG21 ' A' 1010 ' ' THR . . . -74.72 140.75 44.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.1 p80 -153.08 151.91 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.657 ' HH2' HG21 ' A' ' 980' ' ' ILE . 53.4 m95 -72.08 120.04 17.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.958 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.458 ' HB3' HD11 ' A' 1005 ' ' ILE . 80.1 p -52.5 -25.32 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 44.6 p -86.9 133.8 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 111.954 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 25.3 pttm -62.7 152.42 81.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.681 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 74.9 Cg_exo -47.55 118.09 2.75 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.323 2.015 . . . . 0.0 111.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.734 ' HB3' ' HA2' ' A' ' 998' ' ' GLY . 15.9 Cg_exo -69.43 139.94 42.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.015 2.477 . . . . 0.0 112.987 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.689 HG13 ' HB ' ' A' ' 997' ' ' ILE . 16.7 pt -134.28 126.26 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.921 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 92.5 m -86.43 95.67 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 111.211 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -77.02 138.43 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.191 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.457 ' HE ' ' HD2' ' A' 1045 ' ' HIS . 39.3 ttt85 -54.76 127.61 29.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.695 ' O ' ' HB2' ' A' 1046 ' ' TYR . 47.1 mm -56.02 110.38 2.27 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.683 ' HG2' ' HB2' ' A' 1080 ' ' GLN . 93.6 Cg_endo -81.17 133.09 8.61 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.511 2.141 . . . . 0.0 113.374 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 8.1 p -113.02 143.81 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.896 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.06 -148.63 2.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.095 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' 1027 ' ' LEU . 10.1 mt -70.02 148.82 96.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' 1029 ' ' PRO . 16.4 Cg_exo -66.5 137.07 45.28 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 110.499 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' 1028 ' ' PRO . 49.9 Cg_exo -34.11 135.28 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.667 2.244 . . . . 0.0 111.782 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 77.2 p -76.54 139.39 40.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' 1089 ' ' PRO . 7.8 tt -142.67 117.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.321 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -44.7 131.42 6.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.529 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.475 ' OD1' ' HB2' ' A' 1091 ' ' CYS . 22.5 p30 42.58 30.12 0.2 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.482 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.441 ' HA2' HG21 ' A' 1031 ' ' ILE . . . -79.16 160.8 46.59 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.526 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.721 ' HB2' ' HA ' ' A' 1055 ' ' ASN . 31.3 t0 -156.56 156.62 33.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.697 ' HA ' ' O ' ' A' 1051 ' ' THR . 23.4 p90 -155.88 145.37 20.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 111.91 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.568 HD13 ' HD2' ' A' 1053 ' ' ARG . 29.5 mt -109.23 111.27 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.775 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 57.1 m -171.12 -140.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.441 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 11.6 t -117.79 -27.87 6.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -45.56 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.951 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 54.39 -126.69 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -77.03 -40.73 45.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.136 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -67.5 148.45 51.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.31 152.91 15.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.307 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' 1046 ' ' TYR . 15.7 p-80 -155.08 -62.07 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.809 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.695 ' HB2' ' O ' ' A' 1023 ' ' ILE . 6.2 t80 169.11 40.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.594 0.235 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.46 -43.87 0.02 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.568 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 66.7 m -47.58 128.51 12.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 112.001 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' 1072 ' ' ILE . 7.7 p -97.17 175.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.558 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.571 HG11 ' O ' ' A' 1049 ' ' VAL . 30.9 m -151.41 131.77 4.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.172 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.697 ' O ' ' HA ' ' A' 1036 ' ' PHE . 42.4 m -104.33 102.64 12.32 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.433 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' 1035 ' ' ASP . 2.5 m-85 -70.57 135.08 48.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 111.254 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.568 ' HD2' HD13 ' A' 1037 ' ' ILE . 3.1 ptp85 -159.63 34.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.388 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.558 ' HB3' ' CD1' ' A' 1064 ' ' PHE . 77.5 m 62.03 149.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.188 0.518 . . . . 0.0 111.809 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.721 ' HA ' ' HB2' ' A' 1035 ' ' ASP . 47.3 t30 -63.45 -35.38 80.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.279 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.954 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 21.7 mt -70.31 -157.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 58.68 39.8 93.96 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.607 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 11.6 p -175.04 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 110.552 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -155.88 45.58 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.839 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.722 ' HA2' HD22 ' A' 1056 ' ' LEU . . . -172.19 -41.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.834 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.655 ' O ' ' HB3' ' A' 1062 ' ' LYS . 20.8 tpp180 67.6 158.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.461 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.655 ' HB3' ' O ' ' A' 1061 ' ' ARG . 20.2 tptm 94.97 -35.97 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.014 0.821 . . . . 0.0 110.077 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.954 ' HA ' ' HB2' ' A' 1056 ' ' LEU . 0.1 OUTLIER 43.1 32.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.537 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' 1091 ' ' CYS . 0.1 OUTLIER 36.93 -135.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1065 ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' 1092 ' ' ILE . 98.7 mt-10 -150.14 105.71 3.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.205 0.526 . . . . 0.0 110.814 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' 1070 ' ' PRO . 43.6 tp -70.51 149.73 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.112 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' 1089 ' ' PRO . 97.2 t -139.18 137.51 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.325 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.13 -158.79 35.0 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.561 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' 1089 ' ' PRO . 18.6 pt-20 -69.03 125.97 92.4 Favored Pre-proline 0 C--O 1.227 -0.117 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.76 ' HB3' HD22 ' A' 1066 ' ' LEU . 84.7 Cg_endo -96.16 26.15 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.114 2.542 . . . . 0.0 112.869 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.584 ' O ' HG21 ' A' 1072 ' ' ILE . 78.8 p -157.4 143.59 17.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.684 ' O ' HG21 ' A' 1049 ' ' VAL . 13.4 pt -155.19 171.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.881 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.8 p90 -137.46 144.07 42.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 0.0 111.315 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.57 ' HA ' ' CE2' ' A' 1084 ' ' TRP . 0.9 OUTLIER -62.19 121.37 12.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.55 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.433 HG23 ' HA ' ' A' 1084 ' ' TRP . 11.8 t -157.72 140.68 15.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.719 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' 1082 ' ' GLY . 69.7 m -89.77 -154.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.716 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER 179.22 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.409 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.716 ' H ' HD21 ' A' 1077 ' ' ASN . 29.5 m-20 -80.67 -54.92 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -163.24 -46.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.009 0.433 . . . . 0.0 111.635 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.683 ' HB2' ' HG2' ' A' 1024 ' ' PRO . 17.0 pt20 -175.3 32.81 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' 1082 ' ' GLY . 2.5 p -88.93 -104.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.612 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.75 ' H ' HG12 ' A' 1081 ' ' VAL . . . -153.24 -115.15 0.58 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.705 HD12 HD22 ' A' 1077 ' ' ASN . 4.2 mp 56.02 82.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.57 ' CE2' ' HA ' ' A' 1074 ' ' CYS . 15.4 m0 -70.66 -153.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.707 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' 1084 ' ' TRP . 47.9 t -56.42 -57.01 14.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 131.8 1.63 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.478 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.5 130.67 9.05 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 111.184 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.736 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -169.92 -46.74 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.736 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.7 Cg_endo -52.02 132.82 44.4 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.195 1.93 . . . . 0.0 112.54 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.627 ' NE2' HG22 ' A' 1092 ' ' ILE . 0.0 OUTLIER -153.21 138.51 17.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.427 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 74.5 m -103.04 135.32 44.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.627 HG22 ' NE2' ' A' 1090 ' ' GLN . 13.5 pt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.381 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.85 0.357 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.738 ' HD2' ' H ' ' A' 1011 ' ' ALA . 4.4 tppp? -77.46 140.85 39.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.794 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 67.2 p -157.99 144.84 17.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 76.8 m -79.9 31.7 0.26 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.82 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 59.47 142.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.841 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 966' ' ' PRO . 54.8 m -52.15 122.13 22.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.571 ' HG3' HD11 ' A' ' 986' ' ' ILE . 10.1 Cg_endo -53.53 115.52 2.36 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.495 2.13 . . . . 0.0 112.168 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.51 127.71 19.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.502 2.134 . . . . 0.0 111.559 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.18 109.74 2.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.864 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.641 ' HG3' ' HG2' ' A' 1018 ' ' PRO . 26.4 Cg_exo -61.94 147.25 95.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 111.571 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.575 HG23 HG13 ' A' 1019 ' ' ILE . 35.9 m -47.43 127.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 990' ' ' CYS . 75.4 m-20 51.23 46.35 26.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.718 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -171.53 124.1 1.08 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.198 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.73 144.53 27.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.696 0.284 . . . . 0.0 111.53 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.57 HG13 ' HG2' ' A' ' 966' ' ' PRO . 1.4 p -89.57 147.13 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.041 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.448 ' O ' HG13 ' A' ' 977' ' ' ILE . 17.7 m170 -115.43 95.27 5.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 979' ' ' ASP . 73.7 t -67.56 89.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.643 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 975' ' ' HIS . 42.5 mt -75.13 -90.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.512 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.412 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.8 p -59.65 -63.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.378 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.541 ' HB3' ' H ' ' A' ' 980' ' ' ILE . 25.4 m-20 -165.68 -137.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.24 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.541 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 8.3 pt -152.51 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.518 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.794 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 22.4 mt-30 -72.35 164.42 26.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.595 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' 1004 ' ' CYS . 3.5 p -43.99 135.84 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.887 0.375 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.19 54.74 4.29 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.795 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.412 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 94.4 p -164.52 130.37 2.87 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.617 ' NE ' ' HB2' ' A' 1003 ' ' GLU . 35.9 mmt180 -94.11 149.63 21.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.586 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 966' ' ' PRO . 48.7 pt -142.83 141.38 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -106.37 123.97 48.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.372 . . . . 0.0 111.951 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.7 ' HB2' HD12 ' A' ' 996' ' ' LEU . 1.3 m-85 -86.66 172.04 10.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.7 t -145.47 -174.24 4.34 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.081 0.467 . . . . 0.0 111.852 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.545 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 92.2 m -158.12 159.67 36.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 41.3 p -67.72 -160.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 111.378 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 43.7 m -82.53 130.26 35.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.694 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 68.44 45.39 68.69 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.538 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -148.08 123.13 10.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.489 ' HG3' HE22 ' A' 1080 ' ' GLN . 78.7 ttt180 -84.98 129.05 34.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.354 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 988' ' ' TYR . 3.7 tt -74.66 130.79 40.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.52 ' N ' HD21 ' A' ' 996' ' ' LEU . 49.6 mm -99.87 144.61 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.878 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.426 ' HA2' ' HE3' ' A' 1016 ' ' LYS . . . 77.26 36.23 35.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.872 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 59.4 131.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.401 ' HB3' HD11 ' A' ' 996' ' ' LEU . 79.1 p -84.59 36.4 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 986' ' ' ILE . 80.9 p -162.09 145.89 12.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.07 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -161.07 141.51 11.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.145 0.497 . . . . 0.0 112.162 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.617 ' HB2' ' NE ' ' A' ' 985' ' ' ARG . 89.0 tt0 -104.78 134.43 47.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.953 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 54.0 t -74.62 98.2 3.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 26.7 pt -90.73 -166.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.073 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.496 HD11 ' H ' ' A' 1008 ' ' GLY . 0.4 OUTLIER -141.08 121.78 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.147 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 37.8 t -90.38 41.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.496 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.496 ' H ' HD11 ' A' 1006 ' ' LEU . . . 50.92 39.84 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.599 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.65 -46.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.094 0.474 . . . . 0.0 110.571 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 67.8 m -151.24 147.85 27.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.738 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.19 134.78 41.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.522 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 88.9 m-70 -149.46 141.71 24.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.455 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 78.3 m95 -68.9 125.56 27.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.351 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 32.7 m -52.62 -25.36 10.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.899 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.473 HG22 ' O ' ' A' 1001 ' ' SER . 72.9 p -87.95 143.11 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' 1017 ' ' PRO . 0.0 OUTLIER -68.3 162.13 63.55 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.089 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.485 ' O ' ' HD2' ' A' 1016 ' ' LYS . 99.2 Cg_exo -43.18 116.57 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.519 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.641 ' HG2' ' HG3' ' A' ' 969' ' ' PRO . 56.1 Cg_endo -69.49 138.22 38.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.881 2.387 . . . . 0.0 112.728 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.575 HG13 HG23 ' A' ' 970' ' ' VAL . 12.1 tt -148.81 133.27 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 79.2 m -86.38 113.33 22.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 111.575 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -78.79 129.05 34.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.926 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -71.16 122.4 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.841 HG22 ' HB2' ' A' 1077 ' ' ASN . 37.7 mt -52.55 121.62 22.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.413 ' O ' ' HA2' ' A' 1082 ' ' GLY . 84.9 Cg_endo -81.64 125.25 4.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.872 2.382 . . . . 0.0 111.03 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.667 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 0.5 OUTLIER -97.06 25.29 5.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 36.67 -143.96 0.13 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.328 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.542 HD22 ' CE2' ' A' 1044 ' ' PHE . 22.3 mt -93.27 141.84 24.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.592 0.235 . . . . 0.0 111.225 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.771 ' HG3' HD22 ' A' 1040 ' ' ASN . 56.6 Cg_endo -68.8 156.93 63.84 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.493 2.129 . . . . 0.0 111.307 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.632 ' HB2' ' HH ' ' A' 1052 ' ' TYR . 82.8 Cg_exo -42.7 126.29 4.17 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.526 2.151 . . . . 0.0 112.273 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 66.6 p -77.41 98.27 5.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.545 HD11 ' HD2' ' A' 1052 ' ' TYR . 7.4 tt -86.41 106.73 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.563 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -76.22 148.01 37.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.968 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.8 m120 73.7 28.35 1.64 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.524 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.648 ' HA3' ' N ' ' A' 1055 ' ' ASN . . . -160.86 -46.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.78 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' 1034 ' ' GLY . 57.8 m-20 71.44 147.38 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.611 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' 1040 ' ' ASN . 14.4 p90 -84.0 145.59 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.098 0.475 . . . . 0.0 112.017 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' 1038 ' ' SER . 58.8 mt -90.72 164.01 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' 1037 ' ' ILE . 75.1 m 72.57 166.43 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.598 0.237 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' 1040 ' ' ASN . 57.5 p -49.54 -64.93 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.771 HD22 ' HG3' ' A' 1028 ' ' PRO . 18.7 t-20 33.46 49.09 0.21 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.031 0.444 . . . . 0.0 110.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -86.4 -60.71 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -147.5 -42.76 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 1.1 m120 -71.48 123.29 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.581 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.542 ' CE2' HD22 ' A' 1027 ' ' LEU . 86.3 m-85 -148.56 -46.88 0.15 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.633 ' C ' ' H ' ' A' 1047 ' ' GLY . 23.8 m80 58.1 -111.66 0.59 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' 1074 ' ' CYS . 10.0 t80 -64.31 27.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.059 0.456 . . . . 0.0 110.556 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' 1045 ' ' HIS . . . 76.51 -84.85 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.519 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' 1047 ' ' GLY . 34.2 t 115.72 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.885 0.874 . . . . 0.0 109.669 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.521 HG21 ' H ' ' A' 1050 ' ' VAL . 13.2 p -156.4 153.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.434 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.522 ' HB ' HD21 ' A' 1040 ' ' ASN . 5.0 p -153.81 129.08 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.945 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 71.7 m -86.74 120.62 28.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.128 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.632 ' HH ' ' HB2' ' A' 1029 ' ' PRO . 3.1 m-85 -80.28 139.44 36.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -147.63 142.84 27.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.546 ' O ' HD13 ' A' 1056 ' ' LEU . 40.9 m -77.97 149.93 34.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.525 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.648 ' N ' ' HA3' ' A' 1034 ' ' GLY . 44.5 t30 -56.31 -51.74 67.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.642 ' HA ' HG11 ' A' 1063 ' ' VAL . 1.7 mt 49.47 34.79 7.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.718 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.16 0.37 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.307 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' 1059 ' ' ARG . 85.8 p -68.35 -54.14 19.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' 1058 ' ' SER . 24.9 mmm180 -159.52 -47.02 0.05 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.697 0.284 . . . . 0.0 111.278 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.548 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . -167.14 50.58 0.25 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.43 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' 1062 ' ' LYS . 0.0 OUTLIER -77.06 47.7 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.403 0.281 . . . . 0.0 110.491 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' 1061 ' ' ARG . 61.9 tttp 38.45 61.98 1.07 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' 1056 ' ' LEU . 3.3 p -147.26 87.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.207 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.722 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 1.5 m-30 88.26 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.189 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -147.94 145.61 28.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.458 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.861 HD21 ' N ' ' A' 1067 ' ' VAL . 3.8 tt -68.58 142.1 55.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.391 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.861 ' N ' HD21 ' A' 1066 ' ' LEU . 56.3 t -133.48 111.37 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.475 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' 1089 ' ' PRO . . . 77.03 133.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.355 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.729 ' O ' ' HG3' ' A' 1089 ' ' PRO . 5.2 tp10 46.0 107.94 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 111.833 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.804 ' HA ' HD12 ' A' 1066 ' ' LEU . 68.8 Cg_endo -87.18 -28.15 0.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.48 2.12 . . . . 0.0 113.106 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 87.6 p -151.2 129.97 12.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.545 HD13 ' HD2' ' A' 1029 ' ' PRO . 45.6 pt -106.86 175.84 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.436 0.636 . . . . 0.0 112.514 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.13 144.62 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.04 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.722 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 34.9 t -67.43 125.31 25.73 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.736 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.428 HG21 ' N ' ' A' 1076 ' ' SER . 3.3 t -92.05 -40.98 10.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.221 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.428 ' N ' HG21 ' A' 1075 ' ' THR . 10.9 p -166.49 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 0.0 111.421 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.841 ' HB2' HG22 ' A' 1023 ' ' ILE . 0.8 OUTLIER -170.97 143.33 1.98 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.385 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.708 ' H ' HD21 ' A' 1077 ' ' ASN . 61.7 t0 -57.52 -48.37 79.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.929 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -150.4 -55.65 0.16 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.489 HE22 ' HG3' ' A' ' 995' ' ' ARG . 13.3 mm-40 -148.21 -26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.494 ' O ' HG21 ' A' 1023 ' ' ILE . 21.8 t -68.89 -110.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . -165.81 136.13 4.03 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.068 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' 1077 ' ' ASN . 8.1 tp -145.91 132.94 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.722 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 20.8 m95 -83.98 -155.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 67.2 m -79.75 -57.5 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.701 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.59 134.11 2.04 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.047 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.422 ' HB3' ' CG ' ' A' 1029 ' ' PRO . 87.8 Cg_endo -79.71 48.93 3.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.858 2.372 . . . . 0.0 112.017 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -69.92 -41.0 14.18 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.729 ' HG3' ' O ' ' A' 1069 ' ' GLU . 78.3 Cg_exo -48.96 120.42 5.43 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.759 1.639 . . . . 0.0 112.552 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.515 HE21 HG21 ' A' 1092 ' ' ILE . 58.6 tp60 -134.04 116.38 15.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.106 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.722 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 49.9 t -87.26 117.02 25.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.128 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.515 HG21 HE21 ' A' 1090 ' ' GLN . 10.2 pt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.213 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.961 0.41 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 962' ' ' SER . 45.4 mmtm -77.6 -127.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.746 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.96 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 47.3 t 74.19 139.76 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.224 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.53 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 79.0 m -79.98 37.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.008 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 962' ' ' SER . 22.9 tptm 61.27 134.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.34 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 95.1 m -59.69 114.34 9.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 24.1 Cg_exo -63.82 118.49 5.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.372 2.048 . . . . 0.0 112.08 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.56 132.37 15.96 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.396 2.064 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 30.4 m-20 -55.65 110.02 2.0 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.771 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.457 ' HD2' ' HA2' ' A' ' 972' ' ' GLY . 5.5 Cg_exo -79.84 -146.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.053 2.502 . . . . 0.0 111.923 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' 1019 ' ' ILE . 1.6 p -48.95 93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.456 ' HB3' HG22 ' A' ' 991' ' ' THR . 76.6 m-20 49.28 22.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.393 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -83.05 159.31 37.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.6 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.528 ' N ' ' HA ' ' A' ' 990' ' ' CYS . 11.4 tpt -157.45 110.67 2.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 9.0 p -87.98 145.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.993 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.4 ' N ' ' CD2' ' A' ' 975' ' ' HIS . 11.8 m170 -106.58 97.45 7.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.823 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.691 ' HA ' HG23 ' A' ' 986' ' ' ILE . 16.3 t -65.29 96.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 977' ' ' ILE . 37.4 mt -75.24 -92.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.264 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.0 p -68.84 -73.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 110.359 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -161.2 151.04 17.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 980' ' ' ILE . 11.5 pt -84.18 3.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.363 0.601 . . . . 0.0 109.793 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.96 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 88.6 mt-30 -82.03 157.08 24.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.945 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.618 HG21 ' N ' ' A' ' 983' ' ' GLY . 7.2 p -44.35 150.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.644 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.618 ' N ' HG21 ' A' ' 982' ' ' VAL . . . 81.02 -44.19 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.712 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.515 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 54.4 m -74.14 -170.1 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.83 0.315 . . . . 0.0 111.035 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' 1003 ' ' GLU . 79.6 mtp180 -151.51 169.53 21.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.295 0.569 . . . . 0.0 111.991 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.691 HG23 ' HA ' ' A' ' 976' ' ' VAL . 37.6 pt -150.01 139.05 15.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.499 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' 1001 ' ' SER . 48.7 p -107.36 122.67 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 5.4 m-85 -83.28 160.1 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.995 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 75.1 m -161.5 -6.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.74 ' SG ' ' HG ' ' A' ' 996' ' ' LEU . 65.8 m 62.29 -158.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.07 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 971' ' ' ASN . 34.2 p -75.08 -142.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.604 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.483 HG21 ' HD1' ' A' ' 994' ' ' HIS . 9.8 t -62.4 -127.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.537 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -72.57 43.75 0.93 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 114.501 0.56 . . . . 0.0 114.501 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.483 ' HD1' HG21 ' A' ' 992' ' ' THR . 18.4 m80 -93.96 139.6 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.201 0.5 . . . . 0.0 110.646 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -81.99 117.22 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.738 0.304 . . . . 0.0 110.553 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' 1000 ' ' SER . 1.7 tt -76.16 133.28 40.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.647 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.948 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -105.16 155.1 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.406 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 79.41 -75.81 2.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.818 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.474 ' O ' HD23 ' A' ' 996' ' ' LEU . 35.0 p80 -165.28 139.13 4.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.772 ' HA ' HD12 ' A' ' 996' ' ' LEU . 21.7 m -100.15 22.04 11.98 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 83.8 p -162.27 148.16 13.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.903 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.49 134.4 13.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 111.547 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 985' ' ' ARG . 87.7 tt0 -101.62 128.78 47.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.05 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -79.38 125.69 29.86 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.535 HD11 ' N ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -138.26 153.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 0.0 110.286 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.58 124.2 29.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.473 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.473 ' HG ' ' N ' ' A' 1008 ' ' GLY . 81.2 p -86.63 -125.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.09 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' 1007 ' ' SER . . . -65.08 -54.89 24.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.154 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -153.35 20.79 0.56 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.447 HG21 ' N ' ' A' 1011 ' ' ALA . 95.4 m -151.37 147.45 26.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.53 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.3 136.39 40.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.591 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.513 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 82.9 m-70 -149.14 142.78 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.733 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.5 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 83.2 m95 -71.66 136.2 47.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.985 0.421 . . . . 0.0 111.428 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 74.8 p -52.44 -24.46 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.839 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 25.2 p -132.38 130.57 40.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.45 . . . . 0.0 111.858 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.532 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -57.95 158.9 11.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.629 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -41.56 126.49 3.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.123 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.695 ' HB2' HD22 ' A' ' 996' ' ' LEU . 64.2 Cg_endo -72.57 -156.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.511 2.141 . . . . 0.0 112.217 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.948 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 11.3 mt -143.04 -179.26 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.783 ' H ' HG21 ' A' 1019 ' ' ILE . 21.1 m -145.81 79.06 1.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.377 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.695 ' H ' HD12 ' A' ' 997' ' ' ILE . 3.0 tp-100 -71.6 138.57 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.008 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.643 ' HB3' ' HB3' ' A' 1046 ' ' TYR . 9.5 mpt_? -72.33 126.61 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.998 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.2 mt -67.32 113.25 12.88 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.638 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' 1045 ' ' HIS . 30.1 Cg_endo -63.69 114.37 2.54 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.758 2.305 . . . . 0.0 113.679 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.57 ' O ' ' HB2' ' A' 1044 ' ' PHE . 9.1 p -95.67 135.97 36.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.208 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.13 -150.59 3.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.104 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.87 139.03 97.26 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.12 168.33 19.4 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.024 2.483 . . . . 0.0 111.291 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 65.5 Cg_exo -50.86 110.3 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.873 1.716 . . . . 0.0 111.529 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.6 p -77.42 141.02 39.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.269 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.567 HG13 ' HA2' ' A' 1034 ' ' GLY . 24.1 pt -149.68 124.33 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.446 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.96 139.38 10.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-20 75.1 -28.41 0.19 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.344 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.567 ' HA2' HG13 ' A' 1031 ' ' ILE . . . -64.62 160.07 41.39 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' A' 1036 ' ' PHE . 71.5 m-20 -153.78 -156.53 0.69 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.717 ' HB2' HG22 ' A' 1050 ' ' VAL . 36.7 p90 -155.95 142.33 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 112.298 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.402 HD12 ' HD2' ' A' 1053 ' ' ARG . 53.9 mt -111.26 57.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.054 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 60.1 m -157.76 -163.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 22.6 m -96.91 49.15 1.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.265 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.613 HD22 ' HB ' ' A' 1050 ' ' VAL . 5.3 m120 -62.93 -52.26 63.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.765 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 56.81 -137.27 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -149.23 50.38 0.96 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -168.42 60.99 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.164 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' 1025 ' ' CYS . 5.3 m-85 -76.77 129.99 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.744 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' 1046 ' ' TYR . 20.8 m80 -98.42 -58.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.643 ' HB3' ' HB3' ' A' 1022 ' ' ARG . 42.3 t80 172.17 31.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.71 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.46 98.09 0.16 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.79 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.8 p 175.72 134.41 0.05 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.535 0.683 . . . . 0.0 111.391 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.529 HG21 ' N ' ' A' 1050 ' ' VAL . 12.7 p -102.17 155.52 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.448 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.717 HG22 ' HB2' ' A' 1036 ' ' PHE . 6.4 p -133.47 126.47 52.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.012 0.435 . . . . 0.0 111.05 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 33.2 m -106.69 109.84 21.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.524 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 10.3 m-85 -71.92 147.65 46.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.726 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' 1054 ' ' CYS . 14.0 ptm180 -142.8 -14.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.201 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' 1053 ' ' ARG . 66.1 m 71.29 146.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.104 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' 1033 ' ' ASN . 28.7 t30 -62.64 -133.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 111.665 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.73 HD12 ' HA3' ' A' 1060 ' ' GLY . 8.6 mt -155.04 133.57 11.93 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.96 31.43 3.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.184 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.642 ' O ' ' HG2' ' A' 1059 ' ' ARG . 68.0 m -169.36 -70.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.783 0.292 . . . . 0.0 111.615 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' 1058 ' ' SER . 31.8 mmt-85 -167.21 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.65 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.73 ' HA3' HD12 ' A' 1056 ' ' LEU . . . -153.29 -32.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.444 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' 1061 ' ' ARG . 41.4 ttt85 -55.43 120.53 7.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.93 133.73 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.469 HG21 ' N ' ' A' 1064 ' ' PHE . 32.5 m -147.0 -29.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 111.302 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.514 ' HD2' ' HB3' ' A' 1091 ' ' CYS . 15.6 m-85 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1065 ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' 1092 ' ' ILE . 34.6 mt-10 -98.52 126.43 44.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.718 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.586 HD12 ' HB3' ' A' 1070 ' ' PRO . 3.6 tt -68.81 143.47 54.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.517 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.755 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 96.2 t -135.1 117.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 88.77 -142.82 17.28 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.658 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1069 ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -62.52 122.87 76.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.018 0.437 . . . . 0.0 112.17 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.586 ' HB3' HD12 ' A' 1066 ' ' LEU . 87.0 Cg_endo -85.33 -17.46 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.812 2.341 . . . . 0.0 112.175 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 77.9 p -156.37 155.66 32.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.502 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' 1049 ' ' VAL . 34.8 pt -150.29 -162.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.656 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -160.28 150.06 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 2.4 t -62.39 141.03 58.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.698 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 12.8 t -145.73 -146.89 0.2 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' 1082 ' ' GLY . 46.9 t -165.46 147.92 7.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.886 0.374 . . . . 0.0 111.46 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.696 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -163.97 -33.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.696 ' H ' HD21 ' A' 1077 ' ' ASN . 5.0 t0 -73.78 -139.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.49 -39.87 11.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -162.91 -16.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 50.5 t -58.74 -28.9 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.501 . . . . 0.0 110.776 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 81.13 -63.06 4.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.901 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.517 ' HB ' HD22 ' A' 1077 ' ' ASN . 75.4 mt 60.69 130.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.106 0.479 . . . . 0.0 111.847 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 18.1 m95 -80.19 138.2 36.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.587 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 71.5 p -55.47 -61.73 2.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -71.38 121.85 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.643 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.39 39.87 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.087 2.525 . . . . 0.0 112.012 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.809 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 61.98 135.02 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.504 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.524 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 36.3 Cg_endo -64.9 -138.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.657 2.238 . . . . 0.0 112.399 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.755 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -151.84 128.09 10.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.514 ' HB3' ' HD2' ' A' 1064 ' ' PHE . 98.8 m -102.74 104.06 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.361 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' 1065 ' ' GLU . 17.8 pt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.304 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.995 0.426 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.594 ' HB2' ' HZ2' ' A' ' 961' ' ' LYS . 0.0 OUTLIER 64.39 143.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 81.2 p -157.99 146.73 19.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.97 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.02 152.23 29.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 0.0 OUTLIER -63.87 133.57 53.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.598 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.438 ' O ' HG21 ' A' ' 965' ' ' THR . 6.5 t -73.73 125.73 90.2 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.857 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.62 ' HG2' HG12 ' A' ' 974' ' ' VAL . 93.5 Cg_endo -79.73 113.14 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.296 1.997 . . . . 0.0 111.219 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 95.5 Cg_exo -42.2 -48.96 6.25 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.435 2.09 . . . . 0.0 112.051 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 174.5 126.95 0.11 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.339 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.654 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 50.2 Cg_exo -54.04 150.91 29.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.686 HG22 HG13 ' A' 1019 ' ' ILE . 93.6 t -46.65 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.507 ' ND2' HG11 ' A' ' 970' ' ' VAL . 73.4 m-20 75.28 -43.42 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.829 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -69.13 -145.09 0.17 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.094 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.654 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 25.8 ptm -159.22 139.83 12.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.738 0.304 . . . . 0.0 110.668 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.62 HG12 ' HG2' ' A' ' 966' ' ' PRO . 9.9 p -92.08 142.68 12.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.225 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -106.88 93.97 4.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 979' ' ' ASP . 84.3 t -65.35 -44.73 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.393 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.0 mt 61.06 -100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.4 p -67.35 -60.4 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.617 ' O ' HG11 ' A' ' 976' ' ' VAL . 39.5 t0 -172.53 -141.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.493 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 9.0 pt -152.83 20.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 110.815 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 70.5 mt-30 -87.32 -157.59 0.4 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.517 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 983' ' ' GLY . 94.2 t -46.57 140.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.751 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 984' ' ' SER . . . 74.11 -79.46 0.89 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.06 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' 1003 ' ' GLU . 95.8 p 21.15 106.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.391 0.676 . . . . 0.0 112.802 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -98.77 77.16 2.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . . . . . . . . . 41.0 pt -80.37 137.45 21.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.509 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -108.62 130.51 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.486 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 6.6 m-85 -98.21 147.21 24.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.514 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.5 p -152.48 128.26 10.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.8 t -86.87 -133.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.41 163.82 15.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.415 0.626 . . . . 0.0 111.593 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 25.4 m -53.8 123.57 12.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 131.87 -31.53 3.05 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.232 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -139.73 142.2 36.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.094 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -82.03 121.1 26.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' 1018 ' ' PRO . 4.4 tp -67.63 123.6 20.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.579 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.773 ' HB ' HG21 ' A' 1019 ' ' ILE . 43.3 mm -94.65 149.55 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.193 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 75.91 177.67 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.222 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.475 ' C ' ' H ' ' A' 1001 ' ' SER . 95.6 m-70 -74.98 131.68 40.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 0.0 111.006 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.457 ' OG ' HD22 ' A' ' 996' ' ' LEU . 10.0 m -75.21 28.82 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.992 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 999' ' ' HIS . 82.2 p -162.13 151.19 15.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.11 122.74 6.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 111.847 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 984' ' ' SER . 10.4 pt-20 -107.07 135.86 47.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.231 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.408 ' SG ' ' CZ3' ' A' 1013 ' ' TRP . 19.3 m -70.55 126.78 30.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.085 0.469 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.505 HD11 ' N ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -136.74 147.47 27.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.523 178.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.55 127.02 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.709 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 46.4 t -90.09 -42.03 11.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -163.34 -36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.321 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.449 ' O ' ' HE2' ' A' ' 961' ' ' LYS . 77.0 m-20 -150.61 -49.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 111.175 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 89.4 m -97.49 137.82 35.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 111.626 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.558 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.21 140.26 43.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.752 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.709 ' HE2' ' HB2' ' A' 1007 ' ' SER . 9.3 p80 -149.52 153.29 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.408 ' CZ3' ' SG ' ' A' 1004 ' ' CYS . 74.8 m95 -67.95 131.61 45.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.432 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.419 ' HA ' HD13 ' A' 1005 ' ' ILE . 46.8 t -52.43 -22.28 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.235 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.4 HG22 ' CD2' ' A' ' 999' ' ' HIS . 81.7 p -136.64 142.09 43.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.021 0.439 . . . . 0.0 112.148 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.581 ' HD2' ' H ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -54.94 148.66 26.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.789 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.86 120.42 7.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.447 2.098 . . . . 0.0 112.462 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.666 ' HB3' HD12 ' A' ' 996' ' ' LEU . 50.6 Cg_exo -54.95 152.21 30.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.773 HG21 ' HB ' ' A' ' 997' ' ' ILE . 3.6 tt -143.08 131.7 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.586 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.509 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 49.7 m -86.39 113.11 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 111.267 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -84.55 129.15 34.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.928 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.5 ' HD2' ' CD2' ' A' 1045 ' ' HIS . 20.0 ptt-85 -72.8 134.78 45.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.525 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.61 HG21 ' HD2' ' A' 1024 ' ' PRO . 63.7 mt -100.72 131.07 24.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.315 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.61 ' HD2' HG21 ' A' 1023 ' ' ILE . 65.4 Cg_endo -74.0 115.06 4.19 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.2 1.933 . . . . 0.0 111.715 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.602 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 44.0 t -89.75 148.96 22.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.347 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 149.64 37.88 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.545 HD21 ' HZ ' ' A' 1044 ' ' PHE . 0.1 OUTLIER -52.52 141.4 34.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 117.048 0.424 . . . . 0.0 111.417 -179.159 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.11 145.01 99.13 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.547 2.164 . . . . 0.0 111.229 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.95 134.24 14.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.314 2.009 . . . . 0.0 112.128 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 73.3 p -77.5 126.17 30.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' 1034 ' ' GLY . 6.0 tt -89.56 113.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.445 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -60.86 141.17 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.932 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.6 m-20 57.55 35.37 25.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.966 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' 1031 ' ' ILE . . . -168.33 131.8 2.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.605 ' HB2' ' HD3' ' A' 1053 ' ' ARG . 35.8 m-20 -76.57 -148.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 110.82 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.409 ' H ' ' HB3' ' A' 1035 ' ' ASP . 36.3 p90 -155.88 141.22 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.656 HD13 HG23 ' A' 1051 ' ' THR . 59.5 mt -87.99 154.98 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.406 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' 1037 ' ' ILE . 73.6 m 73.79 138.33 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.265 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' 1040 ' ' ASN . 70.7 p -50.27 -61.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.978 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' 1039 ' ' THR . 55.1 t30 33.1 44.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.099 0.476 . . . . 0.0 111.091 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -76.26 -161.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.956 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.08 67.86 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.672 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.2 p30 -169.72 23.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.862 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.57 ' O ' ' HD1' ' A' 1044 ' ' PHE . 0.1 OUTLIER -92.44 132.26 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.511 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' 1047 ' ' GLY . 5.6 m80 -84.26 -114.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1046 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -56.41 71.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.963 0.347 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.833 ' HA2' ' HB3' ' A' 1074 ' ' CYS . . . 43.5 -107.31 0.12 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.686 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' 1047 ' ' GLY . 95.6 p 135.06 -142.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.371 1.068 . . . . 0.0 109.806 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' 1073 ' ' TYR . 71.8 t -148.96 141.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.701 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 30.2 m -140.84 137.21 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.656 HG23 HD13 ' A' 1037 ' ' ILE . 72.6 m -92.5 125.41 37.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.077 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.593 ' HB2' HD23 ' A' 1066 ' ' LEU . 4.0 m-85 -72.0 156.33 39.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.666 HH22 HD12 ' A' 1056 ' ' LEU . 7.4 ptm180 -145.6 -145.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.112 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.649 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 62.0 m -155.1 145.54 22.08 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.95 0.405 . . . . 0.0 111.707 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -55.16 150.64 10.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.373 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.822 ' H ' HD21 ' A' 1056 ' ' LEU . 1.6 mm? -70.4 -149.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -143.6 -29.28 0.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 54.8 m -144.58 -31.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 31.9 tpt85 -167.66 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' 1056 ' ' LEU . . . -165.68 39.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.828 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.773 ' HG2' ' H ' ' A' 1062 ' ' LYS . 27.0 ttm180 -81.26 -147.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.773 ' H ' ' HG2' ' A' 1061 ' ' ARG . 87.5 tttt -173.49 67.42 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.594 HG21 ' N ' ' A' 1064 ' ' PHE . 18.2 m -84.92 -38.37 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.223 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' 1054 ' ' CYS . 56.3 m-85 -72.71 147.54 45.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.114 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.98 120.48 32.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' 1052 ' ' TYR . 53.3 tp -68.46 144.26 54.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' 1089 ' ' PRO . 57.9 t -138.3 123.87 24.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 71.57 156.94 2.65 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.779 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' 1069 ' ' GLU . 41.4 tt0 30.32 65.81 0.85 Allowed Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.588 ' HB3' HD22 ' A' 1066 ' ' LEU . 88.1 Cg_endo -79.99 7.01 4.88 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.072 1.848 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 40.1 t -156.47 149.73 24.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.56 HG12 ' HE1' ' A' 1052 ' ' TYR . 25.2 pt -140.91 165.22 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.275 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.624 ' HB3' HG23 ' A' 1049 ' ' VAL . 9.9 p90 -151.58 138.72 19.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.386 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.833 ' HB3' ' HA2' ' A' 1047 ' ' GLY . 41.2 t -76.84 133.43 39.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.468 HG21 ' N ' ' A' 1076 ' ' SER . 5.2 t -90.01 -35.05 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.468 ' N ' HG21 ' A' 1075 ' ' THR . 73.4 m 61.84 135.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.82 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' 1077 ' ' ASN . 0.1 OUTLIER -175.25 -137.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.298 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' 1079 ' ' ASP . 27.6 t70 53.1 -138.53 1.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.459 ' H ' ' CG ' ' A' 1078 ' ' ASP . 1.6 m-20 -92.44 -49.22 6.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.983 0.42 . . . . 0.0 110.446 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.466 ' HA ' HG22 ' A' 1023 ' ' ILE . 3.2 pt20 -179.86 31.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.432 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 41.3 t -87.21 -45.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 67.51 124.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.217 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.424 HD11 HG22 ' A' 1083 ' ' ILE . 0.2 OUTLIER -153.96 137.32 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.622 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.0 m95 -70.68 126.94 30.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' 1075 ' ' THR . 44.8 t -70.96 -39.56 72.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . -62.28 122.77 29.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.166 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' A' 1088 ' ' ALA . 17.9 Cg_exo -67.15 -121.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.298 2.665 . . . . 0.0 112.093 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.458 ' H ' ' HB2' ' A' 1087 ' ' PRO . . . -160.85 129.34 2.97 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.571 ' HB2' ' O ' ' A' 1067 ' ' VAL . 73.3 Cg_endo -74.76 -141.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.885 2.39 . . . . 0.0 113.486 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.537 HE21 HG22 ' A' 1092 ' ' ILE . 57.1 tp60 -152.39 127.28 9.61 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.439 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 44.6 t -103.11 123.49 46.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.537 HG22 HE21 ' A' 1090 ' ' GLN . 11.8 pt . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 961' ' ' LYS . 0.4 OUTLIER 61.32 125.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.398 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.3 p -157.97 135.21 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.521 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 980' ' ' ILE . 2.9 p -84.71 148.65 26.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.171 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -63.64 140.16 58.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 -179.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 73.9 m -60.72 126.07 84.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.378 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 19.7 Cg_exo -66.87 121.5 8.71 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.47 2.113 . . . . 0.0 112.329 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 133.92 26.84 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.412 2.075 . . . . 0.0 111.676 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.26 109.4 1.41 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.769 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 971' ' ' ASN . 68.7 Cg_endo -87.83 -153.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 112.605 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' 1021 ' ' GLN . 2.2 p -49.42 88.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.32 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 969' ' ' PRO . 74.3 m-20 45.28 34.21 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.157 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.729 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -76.3 -56.88 4.15 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.786 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.611 ' HB2' ' HB2' ' A' ' 989' ' ' SER . 60.8 mtt 61.04 96.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 987' ' ' THR . 0.3 OUTLIER -92.99 143.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.374 179.278 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.407 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 26.0 m170 -122.07 111.61 17.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.442 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.473 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 69.6 t -67.45 99.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.94 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 986' ' ' ILE . 41.8 mm -75.23 -90.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.685 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.0 p -65.59 -60.43 2.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.211 0.529 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.502 ' O ' HG21 ' A' ' 980' ' ' ILE . 7.5 t0 -167.49 -128.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.982 178.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.502 HG21 ' O ' ' A' ' 979' ' ' ASP . 5.2 pt -154.76 -21.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.742 0.306 . . . . 0.0 110.313 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' 1004 ' ' CYS . 23.5 pt20 -72.43 -164.29 0.14 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' 1006 ' ' LEU . 40.4 t -47.27 137.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 64.81 12.41 53.58 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.416 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' 1003 ' ' GLU . 87.7 p -77.0 171.06 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.199 0.5 . . . . 0.0 110.684 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.73 ' HD3' ' N ' ' A' ' 986' ' ' ILE . 0.0 OUTLIER -151.14 138.23 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.967 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.73 ' N ' ' HD3' ' A' ' 985' ' ' ARG . 28.2 pt -142.7 173.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 111.538 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' 1000 ' ' SER . 69.6 p -136.98 124.8 22.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.603 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.6 m-85 -87.17 47.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.922 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 989' ' ' SER . . . . . 0.671 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 66.9 m 30.03 -77.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.674 ' SG ' HD23 ' A' ' 996' ' ' LEU . 33.8 m 67.02 70.65 0.38 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 1.2 t -60.16 154.54 19.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.53 HG22 ' HD1' ' A' ' 994' ' ' HIS . 11.0 t 38.94 -156.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 113.626 -1.625 . . . . 0.0 113.39 178.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.565 ' O ' HD13 ' A' 1023 ' ' ILE . . . -80.29 50.23 3.95 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.199 -0.455 . . . . 0.0 113.829 -178.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.53 ' HD1' HG22 ' A' ' 992' ' ' THR . 2.5 m80 -82.67 149.8 27.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.85 0.325 . . . . 0.0 110.907 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.742 ' HB2' HG12 ' A' 1023 ' ' ILE . 79.5 ttt180 -80.26 93.2 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.874 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.699 HD23 ' HB3' ' A' 1000 ' ' SER . 4.7 tp -76.05 124.6 27.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.65 ' HB ' HG13 ' A' 1019 ' ' ILE . 1.8 mp -98.15 137.55 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.128 178.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.46 ' O ' ' CD2' ' A' ' 999' ' ' HIS . . . 76.76 -118.66 5.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.481 -178.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.496 ' C ' ' H ' ' A' 1001 ' ' SER . 19.0 m170 -149.36 130.95 14.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.085 0.443 . . . . 0.0 111.278 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.699 ' HB3' HD23 ' A' ' 996' ' ' LEU . 88.1 p -79.95 34.0 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.351 0.596 . . . . 0.0 109.817 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.533 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 79.6 p -162.2 138.56 7.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.888 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.519 ' HB3' ' OG1' ' A' 1015 ' ' THR . . . -160.45 141.63 12.14 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 984' ' ' SER . 21.5 pt-20 -105.06 132.86 50.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 8.3 t -71.3 84.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -179.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' 1014 ' ' SER . 18.8 pt -87.27 158.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.711 HD22 HG23 ' A' ' 982' ' ' VAL . 3.3 mm? -95.31 136.18 35.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.67 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.631 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 48.0 t -162.43 131.02 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.18 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 58.44 39.02 92.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.86 36.31 27.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.676 0.274 . . . . 0.0 111.464 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.1 m -151.25 129.83 12.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.578 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 961' ' ' LYS . . . -75.64 136.79 40.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.098 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.631 ' HE2' ' HB3' ' A' 1007 ' ' SER . 7.6 p80 -163.06 156.51 19.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.942 0.401 . . . . 0.0 111.105 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.498 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 29.6 m95 -74.35 118.28 17.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.517 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.526 ' HB3' HD12 ' A' 1005 ' ' ILE . 79.7 p -52.41 -22.37 4.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.239 -178.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.519 ' OG1' ' HB3' ' A' 1002 ' ' ALA . 53.7 p -105.05 20.92 18.0 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.508 ' O ' ' HD3' ' A' 1018 ' ' PRO . 21.7 ptmt 47.49 165.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.46 107.15 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.121 1.88 . . . . 0.0 111.903 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' 1016 ' ' LYS . 90.5 Cg_endo -82.37 168.14 14.99 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.786 2.324 . . . . 0.0 112.352 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.666 ' HB ' HG13 ' A' ' 970' ' ' VAL . 18.1 pt -148.85 118.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.408 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.729 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 1.9 m -86.39 73.24 10.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.998 ' HA ' HG23 ' A' ' 970' ' ' VAL . 3.5 pt20 -71.73 -166.91 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.691 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.449 ' O ' ' HD3' ' A' 1024 ' ' PRO . 38.4 ptt180 -96.94 136.18 37.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' 1076 ' ' SER . 53.6 mt -79.19 106.32 4.34 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.502 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.478 ' HB3' ' HA ' ' A' 1045 ' ' HIS . 45.6 Cg_endo -67.43 135.48 36.64 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.825 179.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.684 ' HB3' ' H ' ' A' 1075 ' ' THR . 3.4 p -87.62 144.03 26.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.739 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.15 174.32 53.34 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.074 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 14.4 mt -53.49 150.03 13.53 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.906 0.353 . . . . 0.0 111.142 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.503 ' HB3' HD13 ' A' 1072 ' ' ILE . 19.0 Cg_endo -59.74 174.75 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.956 ' HD3' ' HA ' ' A' 1085 ' ' SER . 56.6 Cg_endo -68.56 -0.78 6.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.933 2.422 . . . . 0.0 112.62 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1030 ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' 1029 ' ' PRO . 70.8 p 55.71 145.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.946 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 13.8 tt -151.1 112.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.364 0.602 . . . . 0.0 111.425 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -66.88 155.73 37.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.76 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' 1032 ' ' ALA . 69.1 m-20 75.53 -40.57 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.685 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.497 ' HA3' ' CA ' ' A' 1054 ' ' CYS . . . -70.69 -157.13 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.953 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.593 ' HB2' ' HB3' ' A' 1053 ' ' ARG . 55.3 m-20 -160.01 135.91 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.547 ' HD1' HG22 ' A' 1050 ' ' VAL . 0.1 OUTLIER -84.03 148.36 26.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.435 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' 1051 ' ' THR . 67.7 mt -121.78 148.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.36 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.496 ' N ' HG21 ' A' 1037 ' ' ILE . 11.7 t 75.93 -136.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.727 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 45.7 p -100.82 130.79 46.89 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.461 HD21 ' HB ' ' A' 1050 ' ' VAL . 22.2 t-20 -179.71 68.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.249 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.481 ' N ' ' HE1' ' A' 1044 ' ' PHE . 32.0 ptt180 -170.38 105.6 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' 1041 ' ' ARG . 56.8 mt-10 69.24 -51.86 0.6 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.453 HD21 ' N ' ' A' 1043 ' ' ASN . 0.0 OUTLIER -71.48 52.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.043 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.481 ' HE1' ' N ' ' A' 1041 ' ' ARG . 6.6 m-85 -88.5 148.93 23.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.732 0.777 . . . . 0.0 112.692 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.582 ' O ' ' SG ' ' A' 1074 ' ' CYS . 14.3 p-80 -166.88 179.03 5.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.264 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.495 ' HE1' HG13 ' A' 1081 ' ' VAL . 4.1 t80 -65.44 31.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' 1045 ' ' HIS . . . -161.19 104.4 0.24 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.379 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' 1074 ' ' CYS . 79.7 p 177.48 145.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.552 0.691 . . . . 0.0 111.585 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1049 ' ' VAL . . . . . . . . . . . . . 6.6 p -137.79 146.23 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.594 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.547 HG22 ' HD1' ' A' 1036 ' ' PHE . 7.6 p -137.71 133.5 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.968 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.544 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 91.3 m -102.48 134.22 46.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.401 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.837 ' HB2' HD13 ' A' 1066 ' ' LEU . 0.4 OUTLIER -70.56 -167.15 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.174 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' 1035 ' ' ASP . 6.0 tpm_? -159.62 -41.39 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.497 ' CA ' ' HA3' ' A' 1034 ' ' GLY . 88.2 m 68.4 121.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.815 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.602 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 19.0 t-20 21.66 -118.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.615 0.572 . . . . 0.0 112.068 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.668 ' HB3' ' O ' ' A' 1059 ' ' ARG . 93.4 mt 62.18 117.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.106 0.479 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -100.66 129.56 9.94 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.572 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 15.7 t 72.73 -47.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.428 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.668 ' O ' ' HB3' ' A' 1056 ' ' LEU . 8.6 ttt85 -162.61 -135.51 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.244 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.49 ' H ' ' HG2' ' A' 1059 ' ' ARG . . . -88.62 46.6 3.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.202 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' 1061 ' ' ARG . 17.9 mmt85 -62.24 157.41 19.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.621 0.248 . . . . 0.0 111.197 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.57 71.7 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.994 0.426 . . . . 0.0 110.847 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' 1064 ' ' PHE . 4.0 m -154.51 86.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.602 ' HB2' ' HB3' ' A' 1055 ' ' ASN . 0.4 OUTLIER 70.1 143.42 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.69 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 1065 ' ' GLU . . . . . 0.444 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 49.4 mt-10 -141.98 139.53 32.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.837 HD13 ' HB2' ' A' 1052 ' ' TYR . 2.2 tt -68.38 133.06 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.064 0.459 . . . . 0.0 111.397 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.819 ' HB ' HE21 ' A' 1090 ' ' GLN . 47.1 t -138.24 129.73 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 93.89 -133.06 11.47 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.681 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.744 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 37.0 tt0 -57.11 106.06 0.62 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 117.153 0.476 . . . . 0.0 111.131 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.423 ' HA ' HD12 ' A' 1066 ' ' LEU . 81.7 Cg_endo -96.24 -12.19 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.098 2.532 . . . . 0.0 113.968 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.432 ' HG ' ' HA ' ' A' 1051 ' ' THR . 52.8 m -156.16 167.45 30.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.412 0.625 . . . . 0.0 112.268 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.503 HD13 ' HB3' ' A' 1028 ' ' PRO . 18.4 pt -141.22 157.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.637 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -117.7 149.71 40.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' 1045 ' ' HIS . 37.2 t -61.61 159.19 13.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.188 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.915 HG23 ' H ' ' A' 1084 ' ' TRP . 15.0 t -157.59 -150.61 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1076 ' ' SER . . . . . 1.139 ' HB2' ' HB ' ' A' 1081 ' ' VAL . 47.2 t -89.79 -107.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 112.339 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.773 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -174.62 -30.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.317 -177.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.773 ' H ' HD21 ' A' 1077 ' ' ASN . 54.4 t0 177.47 -9.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.353 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.92 -141.05 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.951 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.7 -52.47 51.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 1.139 ' HB ' ' HB2' ' A' 1076 ' ' SER . 19.7 t -56.98 -24.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' 1076 ' ' SER . . . 80.75 -140.19 21.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.215 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.844 ' HA ' HG22 ' A' 1075 ' ' THR . 0.0 OUTLIER -149.75 138.16 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.472 0.653 . . . . 0.0 112.639 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.915 ' H ' HG23 ' A' 1075 ' ' THR . 0.2 OUTLIER -77.38 -114.76 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.567 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 1085 ' ' SER . . . . . 0.956 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 30.6 t 69.52 59.14 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' 1088 ' ' ALA . . . -59.22 124.36 36.34 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.688 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' 1088 ' ' ALA . 23.9 Cg_exo -64.54 22.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.329 2.019 . . . . 0.0 113.749 -178.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' 1086 ' ' GLY . . . 53.88 139.22 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 113.112 178.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 84.7 Cg_endo -76.11 -122.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.762 2.308 . . . . 0.0 110.725 178.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.819 HE21 ' HB ' ' A' 1067 ' ' VAL . 1.8 pm0 -152.41 143.48 23.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.939 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 3.6 m -103.13 133.91 47.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.479 HG12 HG22 ' A' 1067 ' ' VAL . 23.4 pt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.112 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.677 0.275 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' A' 1010 ' ' THR . 55.3 tptt -77.61 150.01 34.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.396 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 64.1 p -157.42 154.74 29.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 90.0 m -79.31 159.6 27.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.094 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -63.88 132.96 52.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 0.0 111.039 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.582 ' HG1' HD13 ' A' ' 980' ' ' ILE . 59.9 m -73.14 112.87 17.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.038 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.459 ' HB2' HG13 ' A' ' 974' ' ' VAL . 30.8 Cg_exo -61.84 123.46 12.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.242 1.961 . . . . 0.0 111.963 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.83 -50.78 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.263 1.975 . . . . 0.0 111.497 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 179.26 115.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.679 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 32.2 Cg_endo -66.03 144.73 77.1 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.462 2.108 . . . . 0.0 111.969 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' 1019 ' ' ILE . 0.2 OUTLIER -44.97 116.92 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.888 179.879 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' A' 1020 ' ' CYS . 14.8 t30 70.94 -50.31 0.68 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -77.93 -152.53 5.71 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.392 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.64 ' HG3' ' HE2' ' A' ' 975' ' ' HIS . 24.0 ptm -159.2 133.36 7.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 988' ' ' TYR . 3.3 p -81.91 146.76 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.64 ' HE2' ' HG3' ' A' ' 973' ' ' MET . 22.2 m170 -123.54 105.24 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 980' ' ' ILE . 52.1 t -65.31 -65.74 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 47.9 mt 75.31 -51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.255 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 45.6 p -86.62 -80.91 0.23 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.002 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.59 ' O ' HG12 ' A' ' 980' ' ' ILE . 9.2 t70 -173.35 -18.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.404 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.655 HG21 HG11 ' A' ' 976' ' ' VAL . 28.6 pt 54.97 72.46 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.21 0.604 . . . . 0.0 111.419 -178.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 24.3 mt-30 -152.63 38.89 0.54 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.667 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 76.6 t 101.06 133.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.924 0.889 . . . . 0.0 112.096 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 71.79 -29.93 0.62 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.361 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.582 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 79.9 p -68.45 124.01 22.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.448 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 5.1 tmm_? -101.64 118.85 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.558 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.612 HG23 ' HA ' ' A' ' 976' ' ' VAL . 28.7 pt -95.42 -169.0 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.312 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' 1001 ' ' SER . 35.2 p -153.01 128.71 10.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.0 m-85 -93.95 149.8 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.024 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.0 m -157.35 133.43 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.659 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 9.1 m -82.02 -131.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 110.693 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.417 ' O ' ' ND1' ' A' ' 994' ' ' HIS . 1.2 t -165.02 159.24 17.74 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.796 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 992' ' ' THR . 50.8 m 37.66 54.12 1.47 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.972 0.891 . . . . 0.0 110.266 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 994' ' ' HIS . . . 78.85 -99.53 1.66 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.957 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.553 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 24.9 m80 54.85 140.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.892 0.477 . . . . 0.0 111.53 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -89.86 106.5 18.51 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.229 -0.294 . . . . 0.0 111.018 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.542 ' C ' HD21 ' A' ' 996' ' ' LEU . 1.7 tt -76.15 121.23 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' 1019 ' ' ILE . 38.6 mm -89.16 153.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.832 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.77 -112.54 3.53 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.732 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' 1001 ' ' SER . 92.1 m-70 -149.72 133.75 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 111.402 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 81.2 p -80.61 30.25 0.3 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 61.3 m -162.14 151.24 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.646 ' HB2' ' HB3' ' A' 1013 ' ' TRP . . . -157.59 127.49 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.577 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -103.57 126.8 50.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.598 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' 1011 ' ' ALA . 41.9 t -73.56 126.52 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.537 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 20.8 pt -147.41 155.32 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.696 HD12 ' HG2' ' A' ' 961' ' ' LYS . 3.8 mm? -92.36 146.33 23.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.292 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.727 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 44.7 t -162.44 -58.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -94.2 47.4 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.129 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.422 ' N ' HD21 ' A' 1009 ' ' ASN . 2.6 m120 60.49 13.84 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.037 0.446 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.77 ' HA ' ' HE2' ' A' ' 961' ' ' LYS . 89.2 m -151.25 146.21 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.519 ' HB3' ' SG ' ' A' 1004 ' ' CYS . . . -75.29 134.14 41.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.96 0.409 . . . . 0.0 110.714 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.727 ' HE2' ' HB3' ' A' 1007 ' ' SER . 8.1 p80 -152.18 146.34 25.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.402 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.646 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 57.0 m95 -70.13 124.85 25.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.7 t -52.52 -25.44 10.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 77.1 p -92.2 137.82 32.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.065 0.459 . . . . 0.0 112.046 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.636 ' HB3' ' NZ ' ' A' 1016 ' ' LYS . 0.2 OUTLIER -62.19 152.5 78.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.272 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -43.9 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.54 147.77 92.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.052 2.502 . . . . 0.0 112.413 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.763 HG13 HG13 ' A' ' 970' ' ' VAL . 5.5 tt -148.01 122.8 2.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 994' ' ' HIS . 4.4 t -86.36 113.66 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.121 0.486 . . . . 0.0 111.411 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -84.75 130.1 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.971 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.528 HH12 ' HG3' ' A' 1024 ' ' PRO . 0.0 OUTLIER -82.07 124.25 29.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.319 179.319 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.651 HG22 ' HA ' ' A' 1080 ' ' GLN . 64.1 mt -71.8 112.71 15.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.412 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.528 ' HG3' HH12 ' A' 1022 ' ' ARG . 34.4 Cg_exo -61.6 133.21 44.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.831 2.354 . . . . 0.0 113.063 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.728 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 92.4 m -98.39 -150.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.451 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1026 ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -163.84 156.23 27.98 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.659 HD11 ' H ' ' A' 1027 ' ' LEU . 8.7 mp -40.3 132.17 1.63 Allowed Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.161 0.481 . . . . 0.0 111.459 -179.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.469 ' HB2' HD12 ' A' 1072 ' ' ILE . 54.4 Cg_endo -69.8 155.44 65.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.0 102.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.088 1.859 . . . . 0.0 111.363 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.3 p -77.39 118.35 19.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.661 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' 1089 ' ' PRO . 10.4 pt -93.63 116.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.474 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -49.54 141.0 9.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.722 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' 1054 ' ' CYS . 5.1 m120 74.91 -13.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.58 -140.62 0.02 OUTLIER Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.273 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.598 ' HB3' ' H ' ' A' 1053 ' ' ARG . 30.4 t70 -168.9 -168.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.561 -0.376 . . . . 0.0 110.842 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.547 ' H ' ' CG ' ' A' 1035 ' ' ASP . 1.2 t80 -155.99 127.52 7.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.749 HD11 ' HD2' ' A' 1053 ' ' ARG . 52.5 mt -147.78 77.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.791 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.586 ' HG ' ' H ' ' A' 1051 ' ' THR . 68.8 m -160.32 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.003 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 7.0 m -136.99 41.67 2.47 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.593 ' ND2' ' HB ' ' A' 1050 ' ' VAL . 5.0 m120 -72.01 -99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.762 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 60.85 48.46 6.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.653 ' HG2' ' H ' ' A' 1043 ' ' ASN . 66.9 tt0 62.95 -136.37 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.653 ' H ' ' HG2' ' A' 1042 ' ' GLU . 23.2 p30 34.23 44.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' 1042 ' ' GLU . 88.4 m-85 -77.48 147.88 35.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.401 . . . . 0.0 111.533 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' 1046 ' ' TYR . 79.3 m-70 -147.13 -49.79 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.48 179.25 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.638 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 53.9 t80 171.87 149.03 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.303 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 78.71 -17.63 6.64 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.888 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 58.8 m -47.72 144.55 3.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.85 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' 1072 ' ' ILE . 12.8 p -137.79 148.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.273 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.593 ' HB ' ' ND2' ' A' 1040 ' ' ASN . 2.5 p -143.13 136.11 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.253 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.586 ' H ' ' HG ' ' A' 1038 ' ' SER . 87.8 m -106.54 111.97 24.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.449 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.551 ' HE1' HG12 ' A' 1072 ' ' ILE . 11.4 m-85 -85.25 142.18 29.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.749 ' HD2' HD11 ' A' 1037 ' ' ILE . 99.9 mtt180 -156.44 30.76 0.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' 1033 ' ' ASN . 71.3 m 59.13 143.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 0.0 111.739 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 8.9 m120 -65.86 97.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.665 ' H ' HD21 ' A' 1056 ' ' LEU . 3.2 mm? -70.37 177.23 3.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.593 178.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.74 -28.49 38.38 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 52.5 m -160.07 -29.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.69 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 33.9 tpt85 -163.83 -45.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.526 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.52 ' HA3' ' HG ' ' A' 1056 ' ' LEU . . . 178.61 43.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.775 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -77.3 46.76 0.52 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.633 0.254 . . . . 0.0 111.625 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.7 tttt 44.61 81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.173 0.511 . . . . 0.0 111.703 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' 1056 ' ' LEU . 3.3 m -155.13 95.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.465 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.684 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 65.8 m-85 72.82 136.44 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.437 -178.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -141.09 130.04 23.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.308 0.575 . . . . 0.0 111.693 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.832 HD22 ' HA ' ' A' 1070 ' ' PRO . 35.5 tp -68.47 158.87 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.557 HG22 HG12 ' A' 1092 ' ' ILE . 75.4 t -139.39 143.82 30.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.527 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1068 ' ' GLY . . . . . 0.421 ' N ' HG11 ' A' 1067 ' ' VAL . . . 79.72 -144.56 26.66 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.12 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' 1089 ' ' PRO . 79.4 tt0 -60.41 127.81 87.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.817 0.309 . . . . 0.0 110.623 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.832 ' HA ' HD22 ' A' 1066 ' ' LEU . 26.0 Cg_endo -92.3 -54.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.813 2.342 . . . . 0.0 112.802 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 41.7 t -98.85 152.86 19.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.579 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.571 ' O ' HG22 ' A' 1049 ' ' VAL . 31.5 pt -141.42 162.06 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.258 179.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 6.3 p90 -151.02 141.14 22.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.417 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.917 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 46.9 t -65.11 152.41 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.233 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.447 ' C ' ' HE1' ' A' 1046 ' ' TYR . 13.1 t -140.09 -147.41 0.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.021 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.6 t -153.28 145.79 24.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.972 0.415 . . . . 0.0 111.537 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.687 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -162.7 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.064 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.687 ' H ' HD21 ' A' 1077 ' ' ASN . 1.2 m-20 -77.22 -147.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.568 0.223 . . . . 0.0 110.626 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1079 ' ' ASP . . . . . 0.422 ' H ' ' HB3' ' A' 1078 ' ' ASP . 29.4 p-10 -83.61 -45.38 13.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.286 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.651 ' HA ' HG22 ' A' 1023 ' ' ILE . 3.0 pt20 -178.22 30.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.737 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.575 ' HB ' HD13 ' A' 1083 ' ' ILE . 43.7 t -77.25 -34.84 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 85.37 61.37 1.73 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.994 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.575 HD13 ' HB ' ' A' 1081 ' ' VAL . 2.1 mp -81.99 135.11 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.917 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 14.4 m95 -72.57 -173.93 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.978 0.418 . . . . 0.0 112.003 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.3 t -59.51 -71.24 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.149 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 137.43 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.308 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.93 136.23 34.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.672 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -167.6 -44.99 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' A' 1088 ' ' ALA . 63.3 Cg_exo -48.23 137.98 23.38 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.122 1.881 . . . . 0.0 112.138 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.442 ' HB2' HE21 ' A' 1090 ' ' GLN . 0.3 OUTLIER -149.7 134.57 17.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 0.0 111.619 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 29.1 t -90.67 132.54 35.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.557 HG12 HG22 ' A' 1067 ' ' VAL . 39.2 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.074 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.933 0.397 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.874 ' HD2' ' H ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -79.18 132.02 36.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.878 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.756 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -92.44 135.57 33.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' 1012 ' ' HIS . 80.9 m -81.1 26.42 0.44 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.037 0.446 . . . . 0.0 110.652 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 962' ' ' SER . 59.6 tttm 61.12 136.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.573 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.741 ' HA ' HG22 ' A' ' 980' ' ' ILE . 4.7 t -58.06 129.11 82.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.148 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.85 ' HG2' HG13 ' A' ' 974' ' ' VAL . 55.7 Cg_endo -69.72 107.2 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.115 1.877 . . . . 0.0 112.197 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 10.4 Cg_endo -53.47 143.68 54.26 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.546 2.164 . . . . 0.0 111.078 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -40.4 113.33 0.95 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.171 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.792 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 24.2 Cg_exo -64.03 148.24 91.54 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.044 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' 1020 ' ' CYS . 0.2 OUTLIER -43.92 114.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.458 179.853 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 7.7 t30 71.01 -57.45 0.6 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.096 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.594 ' HA2' ' SG ' ' A' ' 990' ' ' CYS . . . -70.06 -162.47 3.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.978 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.792 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 88.5 mtp -158.15 140.12 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.85 HG13 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -83.66 148.85 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.592 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -109.81 87.15 2.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.997 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.473 ' HA ' HG23 ' A' ' 986' ' ' ILE . 58.4 t -65.45 109.85 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 29.3 mm -75.14 -83.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.909 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.4 p -81.42 -61.04 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.266 0.555 . . . . 0.0 109.979 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -165.94 -130.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.558 179.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.741 HG22 ' HA ' ' A' ' 965' ' ' THR . 0.2 OUTLIER -144.97 10.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 111.109 178.871 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.756 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 26.0 mt-30 -85.68 171.76 11.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.988 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.1 t -44.31 143.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.2 -31.25 1.83 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.276 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 36.2 m -68.4 124.02 22.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.028 0.414 . . . . 0.0 110.928 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.781 ' HD2' ' N ' ' A' ' 986' ' ' ILE . 5.5 tmm_? -101.63 152.2 21.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.562 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.781 ' N ' ' HD2' ' A' ' 985' ' ' ARG . 38.3 pt -142.25 138.41 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 80.8 p -107.53 125.68 51.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.672 ' HB2' ' HA ' ' A' 1000 ' ' SER . 5.2 m-85 -92.08 149.24 21.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.761 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.9 m -159.93 121.3 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.075 0.464 . . . . 0.0 111.335 179.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.594 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 85.0 m -99.91 155.15 17.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 35.9 p -61.6 161.16 10.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.089 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.1 m -57.45 145.68 32.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.695 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.59 -45.62 1.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.184 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.566 ' CD2' ' HA ' ' A' 1022 ' ' ARG . 7.5 m80 -82.45 136.06 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.758 0.313 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 995' ' ' ARG . 44.0 ttm-85 -82.03 130.47 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.619 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.696 ' HA ' ' SG ' ' A' 1020 ' ' CYS . 0.9 OUTLIER -76.11 126.91 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.058 0.456 . . . . 0.0 111.59 -179.474 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.717 HD12 ' HG2' ' A' 1021 ' ' GLN . 1.7 mp -107.14 148.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.443 178.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.44 -119.35 4.84 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.021 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.447 ' C ' ' H ' ' A' 1001 ' ' SER . 92.0 m-70 -149.67 133.53 16.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.132 0.466 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.672 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.2 p -78.44 30.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.2 p -162.19 140.07 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.356 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.434 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -164.13 131.12 3.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.603 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -104.94 137.52 42.57 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.487 ' O ' HG21 ' A' 1005 ' ' ILE . 53.4 t -71.1 131.69 43.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.487 HG21 ' O ' ' A' 1004 ' ' CYS . 45.9 pt -148.04 -165.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 111.285 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.04 163.42 12.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.643 ' HB3' ' HD2' ' A' 1012 ' ' HIS . 47.4 t -162.51 -116.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -49.96 -43.86 40.58 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.779 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.9 t30 -167.73 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 110.981 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 7.7 t -96.48 -162.52 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.227 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.45 ' HB1' ' C ' ' A' ' 962' ' ' SER . . . -80.05 139.11 37.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.996 0.426 . . . . 0.0 110.925 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.643 ' HD2' ' HB3' ' A' 1007 ' ' SER . 94.5 m-70 -149.4 140.03 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.412 ' HZ2' ' HB ' ' A' ' 980' ' ' ILE . 89.3 m95 -66.71 133.6 50.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.069 0.461 . . . . 0.0 110.956 -178.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' 1005 ' ' ILE . 87.7 p -52.33 -23.97 6.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.883 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 81.0 p -121.4 140.37 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 111.695 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -54.26 151.73 12.84 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.083 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.02 105.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.321 2.014 . . . . 0.0 112.028 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.15 143.72 96.35 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.603 2.202 . . . . 0.0 111.942 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 997' ' ' ILE . 36.5 pt -138.67 -171.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 89.9 m -153.78 131.4 11.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.506 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.717 ' HG2' HD12 ' A' ' 997' ' ' ILE . 98.2 mm-40 -80.32 132.31 35.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.566 ' HA ' ' CD2' ' A' ' 994' ' ' HIS . 15.7 ptp180 -67.98 -25.17 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.813 ' HA ' HE22 ' A' 1080 ' ' GLN . 46.4 mt 59.96 73.11 0.68 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.833 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 78.1 Cg_exo -49.8 126.98 17.78 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.362 2.041 . . . . 0.0 112.447 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 23.8 t -88.49 147.18 24.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.661 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.07 142.66 28.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.64 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 28.4 tp -54.73 131.41 65.37 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.887 ' HB3' HD12 ' A' 1072 ' ' ILE . 67.0 Cg_exo -52.6 153.77 13.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.195 2.597 . . . . 0.0 112.821 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.692 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 37.4 Cg_exo -58.98 127.83 25.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.353 2.035 . . . . 0.0 111.664 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.5 p -77.47 142.24 39.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.206 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 29.7 pt -140.37 123.07 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.417 178.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.42 141.74 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.278 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 75.63 -37.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.765 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -65.04 121.13 20.77 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.4 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' 1036 ' ' PHE . 35.5 t0 -82.23 -158.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.832 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -157.18 142.67 17.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 111.339 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.865 HD12 ' HD3' ' A' 1053 ' ' ARG . 6.9 mt -149.69 -138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.851 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.527 ' H ' ' CG2' ' A' 1037 ' ' ILE . 58.2 m 71.81 -163.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 7.9 t -73.66 -46.63 45.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.689 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.559 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 73.0 m-80 -54.06 151.13 7.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.18 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.832 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 83.1 mtm180 -143.02 -48.57 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.256 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.1 OUTLIER -162.94 145.24 10.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.48 179.656 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' 1042 ' ' GLU . 2.7 m120 82.13 -46.59 0.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.515 ' HD2' ' HZ2' ' A' 1084 ' ' TRP . 1.1 m-85 54.82 57.07 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.738 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.714 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 50.6 m170 -52.52 -44.65 65.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.454 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.595 ' HB2' ' O ' ' A' 1045 ' ' HIS . 9.7 t80 166.89 70.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.999 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1047 ' ' GLY . . . . . 0.483 ' O ' ' OG ' ' A' 1048 ' ' SER . . . -77.59 -77.02 0.85 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.935 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1048 ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' 1047 ' ' GLY . 4.3 m 167.71 -53.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.818 HG23 ' HB3' ' A' 1073 ' ' TYR . 20.4 t -147.56 153.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.635 ' N ' HG11 ' A' 1049 ' ' VAL . 10.4 p -135.65 120.22 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.3 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' A' 1071 ' ' SER . 91.4 m -93.85 126.37 39.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.391 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.633 ' O ' ' HG2' ' A' 1053 ' ' ARG . 13.2 m-85 -82.42 -41.29 20.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.865 ' HD3' HD12 ' A' 1037 ' ' ILE . 17.2 ptt180 66.5 -34.04 0.2 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.165 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.645 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 83.9 m 66.95 135.53 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.693 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 2.2 m120 21.58 -105.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.698 HD11 ' O ' ' A' 1061 ' ' ARG . 0.2 OUTLIER -154.9 139.36 16.83 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.96 0.409 . . . . 0.0 111.032 -179.225 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' 1061 ' ' ARG . . . -88.92 -48.44 3.86 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.205 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 66.7 m -102.3 -57.39 2.07 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' 1061 ' ' ARG . 27.2 mtt85 -76.98 117.41 18.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.405 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 74.49 -37.7 1.01 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.77 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.698 ' O ' HD11 ' A' 1056 ' ' LEU . 0.0 OUTLIER 62.3 -139.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.483 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.545 ' H ' ' CD ' ' A' 1061 ' ' ARG . 59.6 tttm 69.02 25.2 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.514 0.673 . . . . 0.0 110.053 -178.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.693 ' HA ' ' HB2' ' A' 1055 ' ' ASN . 11.7 p -84.86 23.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.787 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' 1064 ' ' PHE . 0.2 OUTLIER 39.24 -131.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.086 0.47 . . . . 0.0 109.932 179.459 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -132.1 123.79 27.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.919 178.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1066 ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 48.3 tp -68.85 129.04 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 111.678 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' 1090 ' ' GLN . 62.0 t -106.35 121.45 58.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.986 179.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.42 -147.58 34.48 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.548 179.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' 1069 ' ' GLU . 0.3 OUTLIER -69.01 131.3 90.89 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.509 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 54.1 Cg_endo -70.77 -32.84 13.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 111.777 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' 1051 ' ' THR . 80.4 p -142.58 132.01 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.363 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.887 HD12 ' HB3' ' A' 1028 ' ' PRO . 18.4 pt -87.81 -167.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.167 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.818 ' HB3' HG23 ' A' 1049 ' ' VAL . 7.9 p90 -158.89 137.37 10.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 0.0 112.072 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 49.0 t -76.7 164.0 26.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.915 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1075 ' ' THR . . . . . 0.408 ' O ' ' OG ' ' A' 1076 ' ' SER . 6.5 t -155.04 -33.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1076 ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' 1075 ' ' THR . 89.8 p 58.97 148.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.303 0.377 . . . . 0.0 110.904 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.706 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -164.81 -30.1 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.706 ' H ' HD21 ' A' 1077 ' ' ASN . 62.2 t0 -55.42 -87.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.708 0.29 . . . . 0.0 111.14 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -163.2 -38.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.813 HE22 ' HA ' ' A' 1023 ' ' ILE . 72.2 tp60 -166.22 51.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.701 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 15.6 t -130.38 -48.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.568 -178.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.524 ' O ' HG21 ' A' 1083 ' ' ILE . . . 66.28 125.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.989 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' 1082 ' ' GLY . 0.2 OUTLIER -150.42 137.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.025 0.44 . . . . 0.0 111.141 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.559 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 18.4 m95 -70.53 135.83 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.196 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 46.8 t -65.93 -50.93 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.622 ' HA2' HG23 ' A' 1072 ' ' ILE . . . -65.99 125.88 28.21 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.705 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.96 41.52 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.6 2.2 . . . . 0.0 112.817 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 58.71 138.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.319 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' 1090 ' ' GLN . 84.6 Cg_endo -80.39 -150.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.748 2.299 . . . . 0.0 112.237 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.779 ' HG2' HG12 ' A' 1092 ' ' ILE . 35.0 tt0 -152.36 134.07 14.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.272 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 37.0 m -91.96 78.6 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.795 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1092 ' ' ILE . . . . . 0.779 HG12 ' HG2' ' A' 1090 ' ' GLN . 46.0 pt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.442 179.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 960' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 982' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.064 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.451 ' HG2' HD22 ' A' 1006 ' ' LEU . 4.3 mptp? 61.63 159.07 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.407 0.623 . . . . 0.0 112.153 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.438 ' C ' ' HB3' ' A' 1011 ' ' ALA . 49.6 m -157.94 138.96 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.678 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.428 ' O ' ' NE1' ' A' 1013 ' ' TRP . 73.8 m -79.93 38.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 111.608 -179.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 55.6 tptt 63.68 130.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.467 ' OG1' HD13 ' A' ' 980' ' ' ILE . 88.8 m -74.43 130.04 82.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.733 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.676 ' HG2' HG13 ' A' ' 974' ' ' VAL . 68.8 Cg_endo -101.34 72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.912 3.075 . . . . 0.0 113.38 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 968' ' ' ASP . 57.1 Cg_endo -70.02 125.9 12.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.985 1.79 . . . . 0.0 111.731 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 967' ' ' PRO . 59.0 m-20 16.5 62.8 0.18 Allowed Pre-proline 0 N--CA 1.467 0.378 0 O-C-N 123.759 0.662 . . . . 0.0 112.167 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 39.2 Cg_exo -58.83 -143.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.002 2.468 . . . . 0.0 113.185 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.902 HG13 ' HA ' ' A' 1019 ' ' ILE . 4.0 p -49.05 85.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.819 -179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 969' ' ' PRO . 6.7 p-10 38.95 48.73 1.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.979 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.625 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -162.44 128.57 1.9 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.805 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.424 ' HB2' ' HE1' ' A' ' 973' ' ' MET . 22.2 ptm -88.77 135.92 33.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 111.548 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.676 HG13 ' HG2' ' A' ' 966' ' ' PRO . 4.1 p -91.56 146.85 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.459 ' HE2' ' HG ' ' A' ' 989' ' ' SER . 12.6 m170 -107.59 96.71 6.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.24 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.751 ' HA ' HG23 ' A' ' 986' ' ' ILE . 14.0 m -65.37 113.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.298 0.57 . . . . 0.0 110.801 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 985' ' ' ARG . 38.8 mt -79.92 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.315 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.1 p -149.33 54.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.572 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.57 -154.32 0.37 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.942 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.467 HD13 ' OG1' ' A' ' 965' ' ' THR . 6.1 pt -155.91 95.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.117 0.484 . . . . 0.0 111.463 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.65 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 24.0 mt-30 -152.62 28.98 0.54 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.55 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.65 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 66.0 t 102.13 135.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 124.239 0.962 . . . . 0.0 111.099 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.34 -29.75 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.862 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 982' ' ' VAL . 49.7 m -68.4 132.93 47.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 111.058 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 38.2 ttm180 -101.71 147.42 26.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.751 HG23 ' HA ' ' A' ' 976' ' ' VAL . 39.7 pt -143.14 134.08 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.17 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' 1001 ' ' SER . 80.3 p -100.72 122.96 44.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.058 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.607 ' HH ' ' HG3' ' A' ' 966' ' ' PRO . 3.8 m-85 -88.36 120.47 29.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 989' ' ' SER . . . . . 0.459 ' HG ' ' HE2' ' A' ' 975' ' ' HIS . 80.9 p -88.82 -54.09 4.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.577 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 13.0 t 69.54 142.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -178.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.1 p -60.25 146.75 42.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.284 0.564 . . . . 0.0 111.849 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.1 t -52.99 -26.65 15.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.38 41.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.52 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -139.87 139.99 36.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.245 0.522 . . . . 0.0 111.413 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' 1080 ' ' GLN . 57.0 ttt-85 -81.97 125.62 30.98 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.029 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.67 HD21 ' N ' ' A' ' 997' ' ' ILE . 0.7 OUTLIER -72.78 140.37 47.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.226 0.536 . . . . 0.0 111.605 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.911 ' HB ' HG21 ' A' 1019 ' ' ILE . 45.6 mm -107.92 148.53 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.501 ' N ' HG21 ' A' ' 997' ' ' ILE . . . 77.1 41.49 21.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.674 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' 1001 ' ' SER . 89.8 m-70 62.46 136.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 112.122 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 82.7 p -79.16 36.36 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.439 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.728 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 46.2 m -158.58 160.61 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.471 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.556 ' HB3' ' OG1' ' A' 1015 ' ' THR . . . -159.81 128.8 5.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.392 . . . . 0.0 111.892 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -104.99 125.16 50.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.116 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.613 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 31.1 t -68.8 129.3 39.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.731 0.3 . . . . 0.0 110.753 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' 1014 ' ' SER . 15.0 pt -138.51 152.52 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.451 HD22 ' HG2' ' A' ' 961' ' ' LYS . 0.3 OUTLIER -95.47 120.38 35.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.0 t -80.9 -45.17 17.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.363 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -166.09 -34.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.079 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -148.84 -49.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.15 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 86.8 m -99.75 135.87 40.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 179.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.438 ' HB3' ' C ' ' A' ' 962' ' ' SER . . . -75.36 143.05 43.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.268 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.417 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 90.7 m-70 -149.45 142.94 25.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.428 ' NE1' ' O ' ' A' ' 963' ' ' CYS . 79.3 m95 -68.14 116.71 9.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.105 0.478 . . . . 0.0 110.642 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.632 ' HB2' HD11 ' A' 1005 ' ' ILE . 47.2 t -52.42 -22.35 4.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.243 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' 1002 ' ' ALA . 81.1 p -90.1 16.34 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.827 ' HE3' ' HA ' ' A' 1016 ' ' LYS . 0.0 OUTLIER 58.58 159.27 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.275 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.39 127.31 25.45 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.25 1.967 . . . . 0.0 112.104 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.486 ' HG3' ' CE2' ' A' ' 988' ' ' TYR . 67.2 Cg_endo -73.09 148.55 44.84 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.797 2.332 . . . . 0.0 112.371 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.911 HG21 ' HB ' ' A' ' 997' ' ' ILE . 6.4 tt -148.81 125.31 2.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.592 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 61.7 m -85.45 101.28 12.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.493 . . . . 0.0 112.006 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.401 ' HB3' HD13 ' A' ' 997' ' ' ILE . 7.6 tt0 -79.7 140.06 37.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.112 178.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.459 ' HG2' HH11 ' A' 1022 ' ' ARG . 11.5 tpt180 -50.03 135.8 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.377 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' 1046 ' ' TYR . 26.6 mm -55.59 119.29 23.82 Favored Pre-proline 0 C--O 1.226 -0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.368 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -92.37 138.5 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.184 2.589 . . . . 0.0 112.877 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1025 ' ' CYS . . . . . 0.659 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 71.8 m -112.93 30.08 7.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.752 0.311 . . . . 0.0 111.622 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 42.84 -138.03 3.26 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.776 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1027 ' ' LEU . . . . . 0.539 ' HB3' ' HD2' ' A' 1028 ' ' PRO . 19.9 mt -108.74 164.96 13.56 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1028 ' ' PRO . . . . . 0.625 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 37.9 Cg_endo -66.0 152.22 81.91 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.72 2.28 . . . . 0.0 112.3 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1029 ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' 1030 ' ' THR . 86.1 Cg_exo -47.44 -29.2 9.69 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.626 2.217 . . . . 0.0 112.935 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1030 ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' 1029 ' ' PRO . 20.1 m 64.71 147.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1031 ' ' ILE . . . . . 0.511 HG23 ' CD2' ' A' 1052 ' ' TYR . 13.2 tt -152.47 125.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1032 ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -65.75 135.62 55.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.518 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1033 ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' 1032 ' ' ALA . 4.4 m120 74.81 -38.19 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.574 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1034 ' ' GLY . . . . . 0.804 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -64.66 121.6 22.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.699 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1035 ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' 1036 ' ' PHE . 9.6 t70 -74.46 163.34 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1036 ' ' PHE . . . . . 0.468 ' HB2' ' CG2' ' A' 1050 ' ' VAL . 29.9 p90 -144.31 136.35 26.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.204 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1037 ' ' ILE . . . . . 0.574 ' CG2' ' H ' ' A' 1038 ' ' SER . 5.7 mt -87.91 -160.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1038 ' ' SER . . . . . 0.574 ' H ' ' CG2' ' A' 1037 ' ' ILE . 57.0 m 55.26 -133.04 1.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1039 ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' 1041 ' ' ARG . 41.1 p -152.96 70.1 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1040 ' ' ASN . . . . . 0.648 HD22 ' HB ' ' A' 1050 ' ' VAL . 5.8 m120 -78.29 44.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.499 0.666 . . . . 0.0 109.69 178.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1041 ' ' ARG . . . . . 0.463 ' H ' ' C ' ' A' 1039 ' ' THR . 32.6 ptt180 -82.5 -43.93 16.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.209 -178.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1042 ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' 1043 ' ' ASN . 74.3 tt0 -162.92 -126.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.922 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1043 ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' 1044 ' ' PHE . 3.1 m120 37.48 -125.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.212 0.205 . . . . 0.0 111.136 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1044 ' ' PHE . . . . . 0.625 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 5.3 m-30 69.52 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.969 0.414 . . . . 0.0 111.589 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1045 ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' 1023 ' ' ILE . 70.6 m-70 -149.42 -49.48 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.704 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1046 ' ' TYR . . . . . 0.659 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.5 t80 176.32 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.743 0.782 . . . . 0.0 110.343 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.48 -18.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.049 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 70.0 p -47.6 145.53 2.61 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.877 -0.662 . . . . 0.0 112.78 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1049 ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' 1072 ' ' ILE . 14.7 p -145.59 155.26 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.457 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1050 ' ' VAL . . . . . 0.648 ' HB ' HD22 ' A' 1040 ' ' ASN . 5.9 p -153.97 130.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.981 0.419 . . . . 0.0 112.041 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1051 ' ' THR . . . . . 0.533 ' O ' HG13 ' A' 1037 ' ' ILE . 85.8 m -103.43 116.55 32.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1052 ' ' TYR . . . . . 0.582 ' HE1' HG12 ' A' 1072 ' ' ILE . 7.4 m-85 -74.92 151.37 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1053 ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' 1053 ' ' ARG . 50.1 ttt-85 -142.75 -13.89 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.948 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1054 ' ' CYS . . . . . 0.804 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 91.9 m 69.88 152.19 0.1 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.895 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1055 ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' 1033 ' ' ASN . 27.9 t-20 -50.34 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.577 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1056 ' ' LEU . . . . . 0.703 ' HA ' HG22 ' A' 1063 ' ' VAL . 15.8 mt 61.02 -148.27 0.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.591 0.71 . . . . 0.0 111.393 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1057 ' ' GLY . . . . . 0.464 ' C ' ' N ' ' A' 1059 ' ' ARG . . . 71.84 -34.49 0.61 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.903 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1058 ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' 1059 ' ' ARG . 53.2 m -47.67 -26.99 1.71 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1059 ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' 1057 ' ' GLY . 39.3 mmm-85 -157.07 -1.24 0.11 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.488 -1.687 . . . . 0.0 108.656 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1060 ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' 1061 ' ' ARG . . . 48.31 30.46 7.97 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1061 ' ' ARG . . . . . 0.639 ' H ' HG23 ' A' 1063 ' ' VAL . 4.8 tmm_? 178.65 134.98 0.08 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.064 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1062 ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' 1061 ' ' ARG . 39.5 ttpt 54.64 42.34 31.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.904 0.859 . . . . 0.0 109.37 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1063 ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' 1056 ' ' LEU . 14.8 m -140.59 57.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.466 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1064 ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 71.3 m-85 83.9 95.59 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.081 -178.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -89.85 151.15 21.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.185 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1066 ' ' LEU . . . . . . . . . . . . . 27.6 tp -68.56 142.67 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.484 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1067 ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 58.9 t -139.0 133.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.29 -139.12 21.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.956 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1069 ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' 1069 ' ' GLU . 1.1 pm0 -66.4 125.6 90.66 Favored Pre-proline 0 N--CA 1.453 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 111.837 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1070 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1069 ' ' GLU . 3.3 Cg_endo -83.8 -26.94 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.142 2.562 . . . . 0.0 112.134 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1071 ' ' SER . . . . . 0.522 ' HG ' HG21 ' A' 1051 ' ' THR . 49.1 m -144.09 147.84 34.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1072 ' ' ILE . . . . . 0.582 HG12 ' HE1' ' A' 1052 ' ' TYR . 26.6 pt -143.61 160.65 16.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.336 0.588 . . . . 0.0 111.761 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1073 ' ' TYR . . . . . 0.465 ' HB3' HG21 ' A' 1049 ' ' VAL . 0.6 OUTLIER -160.19 148.61 16.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.504 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A 1074 ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 48.3 t -65.66 145.33 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 9.9 t -157.7 23.13 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.767 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 99.2 p 52.59 176.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.575 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1077 ' ' ASN . . . . . 0.694 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -174.1 -40.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.508 179.903 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A 1078 ' ' ASP . . . . . 0.732 ' HB3' HG22 ' A' 1081 ' ' VAL . 7.9 t70 -84.04 -75.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.841 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.14 -41.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1080 ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 995' ' ' ARG . 3.0 pm0 -162.87 29.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1081 ' ' VAL . . . . . 0.732 HG22 ' HB3' ' A' 1078 ' ' ASP . 21.9 t -83.92 -37.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1082 ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 78.85 45.82 8.93 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.165 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1083 ' ' ILE . . . . . 0.43 HG23 HD11 ' A' 1083 ' ' ILE . 67.7 mt -81.98 136.04 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.008 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1084 ' ' TRP . . . . . 0.596 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.4 m95 -70.54 146.76 49.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.862 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 85.2 p -44.93 -37.25 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.885 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1086 ' ' GLY . . . . . 0.438 ' O ' HD11 ' A' 1072 ' ' ILE . . . -166.63 141.07 6.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.907 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1087 ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 34.0 Cg_exo -57.79 177.29 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.928 2.419 . . . . 0.0 112.758 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1088 ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' 1031 ' ' ILE . . . -63.63 141.34 97.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.618 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1089 ' ' PRO . . . . . 0.471 ' HA ' ' OE2' ' A' 1069 ' ' GLU . 37.6 Cg_endo -66.72 -141.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.916 2.411 . . . . 0.0 112.586 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1090 ' ' GLN . . . . . 0.657 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -145.37 132.65 20.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.019 0.437 . . . . 0.0 111.206 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1091 ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 95.9 m -99.53 72.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.197 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 35.9 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.044 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.44 -46.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -172.22 123.76 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.824 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -172.75 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.369 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.46 126.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.453 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -99.49 141.84 31.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.161 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 93.7 m -80.0 33.02 0.27 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.792 0.33 . . . . 0.0 110.809 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 962' ' ' SER . 60.5 tttp 60.8 136.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.546 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 42.8 m -63.94 124.55 85.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.167 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.58 ' HG2' HG13 ' A' ' 974' ' ' VAL . 37.0 Cg_endo -66.06 109.73 1.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.217 1.945 . . . . 0.0 111.958 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.41 129.93 16.6 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.642 2.228 . . . . 0.0 111.805 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -51.33 104.9 0.46 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 2.6 Cg_exo -76.6 -152.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.734 2.289 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.63 HG13 HG21 ' A' 1019 ' ' ILE . 2.2 p -50.47 83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.156 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 3.4 t30 68.68 -34.9 0.28 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.598 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.4 116.4 7.48 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.253 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.27 140.17 31.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.584 0.23 . . . . 0.0 111.162 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.581 HG23 HD11 ' A' ' 986' ' ' ILE . 2.8 p -89.94 147.69 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.208 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.495 ' O ' HG13 ' A' ' 977' ' ' ILE . 18.8 m170 -111.94 82.53 1.64 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.875 ' HA ' HG23 ' A' ' 986' ' ' ILE . 4.3 p -69.04 85.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 975' ' ' HIS . 50.5 mt -75.37 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.25 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.455 ' HG1' ' H ' ' A' ' 979' ' ' ASP . 35.9 p -55.9 -72.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.658 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 3.4 m-20 -157.42 -133.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.87 -21.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.648 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 25.3 mt-30 -72.52 176.42 5.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.447 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' 1004 ' ' CYS . 71.4 t -44.35 144.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.938 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.66 -30.43 1.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.439 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.658 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 34.6 m -68.47 153.53 43.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' 1002 ' ' ALA . 53.0 ttt-85 -138.32 150.02 46.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.906 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.875 HG23 ' HA ' ' A' ' 976' ' ' VAL . 36.4 pt -142.8 -169.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 68.3 p -148.49 130.63 15.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.551 ' CE2' HG22 ' A' ' 974' ' ' VAL . 0.5 OUTLIER -98.31 154.95 17.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.076 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 989' ' ' SER . . . . . 0.572 ' HA ' HD13 ' A' ' 996' ' ' LEU . 94.1 p -161.23 128.1 4.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 111.851 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.58 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 85.1 m -82.92 51.15 1.86 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.944 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.476 HG21 HD22 ' A' ' 971' ' ' ASN . 14.9 t 38.22 -149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.262 0.553 . . . . 0.0 111.907 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 19.4 m -95.65 141.21 29.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.46 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.47 82.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.161 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 990' ' ' CYS . 50.4 m80 -152.83 135.03 14.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.92 0.36 . . . . 0.0 110.846 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.69 ' HB2' HD12 ' A' 1023 ' ' ILE . 38.4 ttt85 -81.94 121.45 26.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' 1000 ' ' SER . 2.9 tt -76.2 128.86 35.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.456 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -102.22 146.87 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.484 ' N ' HG21 ' A' ' 997' ' ' ILE . . . 82.13 -118.86 4.71 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.503 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -149.65 129.54 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.164 0.482 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.727 ' HB3' HD12 ' A' ' 996' ' ' LEU . 80.0 p -69.9 -43.99 70.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.423 ' O ' HG22 ' A' 1015 ' ' THR . 95.7 p -77.85 136.08 38.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.64 149.62 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.454 . . . . 0.0 111.433 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -134.0 131.63 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 50.3 t -70.43 96.88 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' 1012 ' ' HIS . 27.5 pt -90.43 -175.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' 1011 ' ' ALA . 9.6 tp -158.42 120.41 3.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 43.8 m -81.77 -48.65 11.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.495 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.88 -48.21 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.96 -49.83 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 91.6 m -151.19 149.95 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.304 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.547 ' HB2' ' SG ' ' A' ' 963' ' ' CYS . . . -75.16 140.48 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.528 ' O ' HG12 ' A' 1005 ' ' ILE . 90.5 m-70 -149.39 145.88 27.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 71.7 m95 -71.27 132.66 45.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.735 0.303 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.482 ' HB3' HG22 ' A' 1005 ' ' ILE . 80.8 p -52.46 -29.07 22.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.423 HG22 ' O ' ' A' 1001 ' ' SER . 72.9 p -87.76 -134.62 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -166.95 150.13 6.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.731 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -40.62 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.17 . . . . 0.0 112.503 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.44 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 29.8 Cg_exo -63.1 135.64 52.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.907 2.405 . . . . 0.0 112.028 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.697 HG23 ' H ' ' A' 1020 ' ' CYS . 5.0 mt -95.75 -170.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.006 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.697 ' H ' HG23 ' A' 1019 ' ' ILE . 67.6 m -152.31 98.02 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.473 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.562 ' H ' HD11 ' A' ' 997' ' ' ILE . 3.4 tp-100 -82.53 131.51 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.684 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' 1022 ' ' ARG . 11.8 tpt180 -65.9 127.93 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.61 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.69 HD12 ' HB2' ' A' ' 995' ' ' ARG . 44.3 mm -63.25 106.63 0.94 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.504 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' 1022 ' ' ARG . 3.5 Cg_exo -76.12 136.37 18.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.7 2.267 . . . . 0.0 112.881 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.767 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 29.8 p -124.73 133.94 53.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.03 -154.45 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.733 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.54 147.97 87.54 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 120.66 0.266 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.701 ' HD3' ' HE2' ' A' 1044 ' ' PHE . 78.6 Cg_endo -75.86 142.97 25.94 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.533 2.155 . . . . 0.0 111.6 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.717 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.0 Cg_exo -51.67 106.29 0.13 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 121.997 1.798 . . . . 0.0 111.508 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 90.3 m -77.46 126.81 31.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.665 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.593 HD12 ' HD2' ' A' 1052 ' ' TYR . 18.0 pt -90.41 136.53 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.893 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -52.0 138.38 25.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.774 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.545 ' HA ' ' ND2' ' A' 1055 ' ' ASN . 4.4 m120 75.14 -36.18 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -72.23 132.86 19.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.814 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -81.64 -159.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.148 0.499 . . . . 0.0 111.335 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.628 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -155.99 133.18 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.587 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.489 HG13 ' HB ' ' A' 1051 ' ' THR . 39.4 pt -142.04 -148.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.963 0.411 . . . . 0.0 111.484 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' 1050 ' ' VAL . 8.2 t 78.21 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.861 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 28.7 p -66.46 -43.3 85.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.755 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' 1044 ' ' PHE . 4.5 m120 -52.21 140.18 21.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.254 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.628 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 86.3 mtm180 -155.16 -47.17 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -162.99 -43.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -71.67 58.26 0.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.461 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.701 ' HE2' ' HD3' ' A' 1028 ' ' PRO . 2.3 m-85 -76.68 132.21 39.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 55.4 m170 -130.71 -56.29 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.16 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' 1023 ' ' ILE . 78.0 t80 170.79 150.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.443 0.464 . . . . 0.0 110.386 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.558 ' N ' ' HB2' ' A' 1074 ' ' CYS . . . 76.46 -31.12 1.42 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.681 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.408 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 49.4 m -45.85 131.26 9.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1049 ' ' VAL . . . . . . . . . . . . . 6.8 p -102.2 146.45 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.542 HG22 ' CD1' ' A' 1036 ' ' PHE . 7.3 p -133.39 135.15 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.489 ' HB ' HG13 ' A' 1037 ' ' ILE . 44.1 m -98.63 122.57 42.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.593 ' HD2' HD12 ' A' 1031 ' ' ILE . 3.6 m-85 -85.64 167.11 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' 1053 ' ' ARG . 28.9 mtt85 -159.59 -149.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.972 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.787 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 8.5 t -163.57 157.68 19.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 110.531 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.69 ' O ' ' HG ' ' A' 1056 ' ' LEU . 77.2 m-20 -55.13 153.47 6.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.513 . . . . 0.0 112.316 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' 1055 ' ' ASN . 1.4 mt -154.97 43.25 0.47 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.937 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 72.48 -59.48 1.59 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.387 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 43.3 t 174.38 -18.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 0.0 110.681 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -155.27 55.47 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.28 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . 72.49 129.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.285 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.514 ' H ' HD21 ' A' 1056 ' ' LEU . 39.6 ttm180 -178.15 145.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.577 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.643 ' O ' HG11 ' A' 1063 ' ' VAL . 40.5 ttmt -65.25 81.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.856 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.643 HG11 ' O ' ' A' 1062 ' ' LYS . 9.6 m -151.82 88.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.516 0.674 . . . . 0.0 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.877 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 72.5 m-85 70.79 141.86 0.05 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.511 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1065 ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.7 mt-10 -142.39 142.33 32.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.103 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' 1070 ' ' PRO . 1.4 tt -68.57 137.71 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.295 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.644 ' N ' HD22 ' A' 1066 ' ' LEU . 7.3 p -139.49 127.43 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.663 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.55 138.56 1.4 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.395 -0.821 . . . . 0.0 114.056 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.777 ' O ' ' HG3' ' A' 1089 ' ' PRO . 32.9 tt0 36.75 59.21 3.64 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.193 0.597 . . . . 0.0 112.457 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.66 ' HA ' HD12 ' A' 1066 ' ' LEU . 32.9 Cg_endo -63.21 6.58 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.231 1.954 . . . . 0.0 112.612 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' 1069 ' ' GLU . 81.0 p -156.17 147.12 22.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.308 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.499 HD12 ' OH ' ' A' 1052 ' ' TYR . 44.7 pt -142.22 179.73 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -160.06 154.68 24.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.447 . . . . 0.0 111.828 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' 1047 ' ' GLY . 65.8 m -62.6 146.23 52.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.907 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.0 t -155.76 -158.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.055 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.6 p -151.48 143.37 23.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.49 ' N ' HD21 ' A' 1077 ' ' ASN . 0.0 OUTLIER -164.82 29.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.6 t70 176.38 52.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.258 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.25 -129.08 0.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.503 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.703 ' HG2' ' H ' ' A' 1081 ' ' VAL . 6.7 tt0 -67.59 -139.85 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.703 ' H ' ' HG2' ' A' 1080 ' ' GLN . 27.2 t 72.99 -43.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 122.541 0.336 . . . . 0.0 111.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 67.85 64.51 3.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.658 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.433 HD13 ' HB ' ' A' 1081 ' ' VAL . 3.4 mp -81.89 135.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 110.555 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.466 ' CZ3' HG13 ' A' 1050 ' ' VAL . 26.0 m95 -78.14 -160.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 77.6 p -81.58 -65.03 1.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 144.14 5.53 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.696 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.717 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 98.5 Cg_endo -83.71 49.9 3.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.097 2.531 . . . . 0.0 112.034 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.495 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -64.33 -41.62 61.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.777 ' HG3' ' O ' ' A' 1069 ' ' GLU . 86.6 Cg_exo -45.78 137.78 12.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.507 2.138 . . . . 0.0 113.051 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.577 ' O ' HG13 ' A' 1067 ' ' VAL . 38.3 tt0 -150.32 143.08 24.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.877 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 73.9 m -84.32 137.18 33.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 31.0 pt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.097 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . 0.41 ' HB1' ' OG ' ' A' ' 962' ' ' SER . . . -171.61 -44.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.82 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 63.78 123.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.796 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 43.39 38.23 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.851 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.419 ' HG3' ' CD1' ' A' 1006 ' ' LEU . 46.6 mmtm 62.1 145.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.987 0.423 . . . . 0.0 111.422 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 82.1 p -157.97 136.01 10.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.5 m -79.95 164.45 23.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.317 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.84 126.77 28.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 4.2 t -76.77 114.09 35.81 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.498 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.877 ' HG2' HG12 ' A' ' 974' ' ' VAL . 86.5 Cg_endo -85.48 111.06 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.485 2.123 . . . . 0.0 112.142 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 19.6 Cg_endo -58.88 -39.55 80.24 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.282 1.988 . . . . 0.0 110.951 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 62.9 t0 179.25 119.14 0.21 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.443 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 974' ' ' VAL . 35.5 Cg_endo -64.84 -150.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 112.613 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.742 HG21 ' H ' ' A' ' 971' ' ' ASN . 9.6 p -53.13 -136.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.559 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.742 ' H ' HG21 ' A' ' 970' ' ' VAL . 4.7 m120 -65.33 -33.39 75.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.066 0.46 . . . . 0.0 110.583 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -69.08 -147.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.803 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 85.5 mtp -156.35 142.51 18.2 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.327 0.251 . . . . 0.0 110.408 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.877 HG12 ' HG2' ' A' ' 966' ' ' PRO . 1.1 p -92.18 144.94 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.004 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.41 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 23.1 m170 -121.22 112.38 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.601 HG12 HG22 ' A' ' 980' ' ' ILE . 90.5 t -64.72 -41.49 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.773 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 20.2 mt 64.88 -98.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.144 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 12.6 p -80.73 -52.85 7.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.528 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 980' ' ' ILE . 21.1 m-20 -169.3 -157.69 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.235 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.601 HG22 HG12 ' A' ' 976' ' ' VAL . 20.1 pt -155.91 10.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.837 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.675 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 74.3 mt-30 -73.2 -45.72 54.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.624 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 7.5 p 167.38 151.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 79.43 -40.32 2.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.361 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 14.4 t -69.83 141.99 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.39 . . . . 0.0 111.049 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -110.96 118.29 35.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.118 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' A' ' 976' ' ' VAL . 36.7 pt -91.28 138.46 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.203 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 82.6 p -103.51 132.18 49.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.544 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 4.7 m-85 -101.41 152.62 20.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.7 m -154.21 126.05 7.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.594 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 991' ' ' THR . 37.3 t -98.64 178.68 4.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.422 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 61.2 p -65.11 -158.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.216 0.532 . . . . 0.0 111.84 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 46.0 m -86.04 -68.02 0.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.001 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.435 ' HA2' ' CE1' ' A' 1046 ' ' TYR . . . -81.02 42.29 2.7 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.424 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.577 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 41.6 m80 -149.48 125.35 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 0.0 110.726 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.57 ' HB3' ' NE2' ' A' 1080 ' ' GLN . 52.2 ttt-85 -95.14 121.63 36.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.741 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 1.4 tt -76.21 137.34 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.655 ' N ' HD21 ' A' ' 996' ' ' LEU . 1.8 mp -101.29 149.81 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.017 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.79 34.68 38.01 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.691 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 58.96 130.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.223 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 988' ' ' TYR . 49.8 m -83.05 41.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 68.8 m -162.18 148.39 13.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.569 ' HA ' HG22 ' A' 1015 ' ' THR . . . -159.22 128.06 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -103.25 125.67 50.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.763 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.487 ' O ' HG21 ' A' ' 982' ' ' VAL . 44.6 t -68.4 84.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 49.7 pt -87.3 -162.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.737 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' 1007 ' ' SER . 5.2 tt -158.36 125.81 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.346 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.456 ' N ' HD22 ' A' 1006 ' ' LEU . 45.3 m -78.39 -55.88 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.415 ' N ' HD22 ' A' 1006 ' ' LEU . . . 169.55 42.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.727 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 21.7 p30 -177.9 -36.95 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.26 149.58 29.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.443 ' HB2' ' SG ' ' A' 1004 ' ' CYS . . . -75.26 132.95 41.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.129 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -149.43 145.81 27.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.488 ' CH2' HG22 ' A' ' 986' ' ' ILE . 52.3 m95 -70.82 122.83 20.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.328 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.6 p -52.48 -25.69 10.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.708 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' 1002 ' ' ALA . 50.5 p -87.72 -144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.53 ' HB2' ' NZ ' ' A' 1016 ' ' LYS . 10.7 mtmp? -151.57 161.27 30.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.281 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 78.6 Cg_exo -40.95 124.69 2.08 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.61 2.206 . . . . 0.0 112.692 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.544 ' HG3' ' CE2' ' A' ' 988' ' ' TYR . 90.7 Cg_endo -80.67 145.59 16.32 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.143 2.562 . . . . 0.0 113.376 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.502 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 7.2 tt -148.84 113.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.99 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 9.7 t -86.44 121.16 28.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.124 0.488 . . . . 0.0 111.382 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -85.55 136.61 33.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.616 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' 1024 ' ' PRO . 57.8 mtt85 -75.93 127.75 33.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.177 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.739 HG12 ' HG3' ' A' 1080 ' ' GLN . 84.9 mt -76.73 108.54 6.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.282 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.924 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 66.7 Cg_endo -74.0 121.54 7.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.384 2.056 . . . . 0.0 111.384 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.518 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 16.8 m -89.16 28.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1026 ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' 1044 ' ' PHE . . . 37.22 -158.83 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.668 -0.697 . . . . 0.0 114.273 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.592 HD11 ' N ' ' A' 1027 ' ' LEU . 7.7 mp -74.01 145.78 84.09 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 122.599 0.36 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.512 ' HB3' ' CD1' ' A' 1072 ' ' ILE . 23.1 Cg_exo -63.43 144.8 91.57 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.731 2.287 . . . . 0.0 111.375 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.751 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 5.9 Cg_endo -47.86 113.9 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.243 1.962 . . . . 0.0 111.396 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1030 ' ' THR . . . . . 0.471 ' O ' HG21 ' A' 1031 ' ' ILE . 64.0 p -77.78 141.36 39.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.304 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.586 HG22 ' HB2' ' A' 1088 ' ' ALA . 25.6 pt -147.82 121.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.64 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.08 135.63 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.123 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 1032 ' ' ALA . 76.4 m-20 75.01 -38.36 0.38 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.516 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' 1032 ' ' ALA . . . -69.98 76.97 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.724 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.81 126.26 29.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' 1038 ' ' SER . 17.8 p90 -93.26 147.3 23.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.98 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.529 HG21 ' N ' ' A' 1038 ' ' SER . 49.8 mm -87.37 159.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.822 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.529 ' N ' HG21 ' A' 1037 ' ' ILE . 23.1 t 75.39 144.65 0.08 Allowed 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' 1041 ' ' ARG . 17.0 p -66.13 -57.02 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.486 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 61.28 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' 1039 ' ' THR . 49.8 mtt85 40.27 -128.36 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.29 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' 1043 ' ' ASN . 8.2 pt-20 -77.15 -145.75 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' 1042 ' ' GLU . 62.9 m-20 34.85 36.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.212 0.529 . . . . 0.0 110.61 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.463 ' CZ ' ' HA3' ' A' 1026 ' ' GLY . 1.2 p90 -89.02 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.048 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.924 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 21.0 p-80 -165.36 -164.59 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.174 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.499 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 22.1 t80 -59.24 153.76 17.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 111.56 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 68.77 10.52 61.24 Favored Glycine 0 C--N 1.33 0.222 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.296 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.509 ' OG ' ' HB2' ' A' 1025 ' ' CYS . 74.4 p -48.39 134.32 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.179 0.49 . . . . 0.0 109.929 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' 1073 ' ' TYR . 38.3 t -146.72 142.86 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.427 HG21 ' CG1' ' A' 1072 ' ' ILE . 28.4 m -152.64 134.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.192 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.47 HG22 ' OG ' ' A' 1071 ' ' SER . 91.2 m -92.9 124.72 37.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.695 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.491 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 8.2 m-85 -73.72 154.67 39.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.473 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' 1053 ' ' ARG . 38.0 ttt85 -148.3 0.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.463 ' HB3' ' CD1' ' A' 1064 ' ' PHE . 59.0 m 64.12 152.27 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 111.079 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' 1057 ' ' GLY . 48.5 t30 -62.62 -49.19 76.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' 1061 ' ' ARG . 0.4 OUTLIER -71.31 39.23 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.613 ' HA3' HG12 ' A' 1063 ' ' VAL . . . -89.02 -24.17 32.93 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.1 p -151.91 121.14 6.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.324 -0.938 . . . . 0.0 109.52 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' 1058 ' ' SER . 38.5 mmt180 81.71 44.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.32 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.645 ' C ' HD21 ' A' 1056 ' ' LEU . . . 179.99 -44.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.66 ' O ' HD21 ' A' 1056 ' ' LEU . 51.4 mmt-85 64.5 177.59 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 122.499 0.32 . . . . 0.0 111.826 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' 1061 ' ' ARG . 16.0 tptm 75.85 -41.7 0.44 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.367 0.603 . . . . 0.0 109.619 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.613 HG12 ' HA3' ' A' 1057 ' ' GLY . 0.0 OUTLIER 47.64 40.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.346 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.536 ' HE1' ' H ' ' A' 1056 ' ' LEU . 0.1 OUTLIER 42.84 -138.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -150.19 121.07 7.62 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.342 0.591 . . . . 0.0 110.47 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.532 HD13 ' HB2' ' A' 1089 ' ' PRO . 55.0 tp -68.5 145.58 53.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.167 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 65.1 t -138.2 131.75 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.889 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.38 -143.67 22.91 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.413 ' OE2' HG21 ' A' 1072 ' ' ILE . 22.5 pt-20 -68.49 126.94 93.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.447 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 2.7 Cg_endo -83.3 -10.21 10.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.104 2.536 . . . . 0.0 111.759 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.47 ' OG ' HG22 ' A' 1051 ' ' THR . 49.4 m -153.5 127.41 8.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.093 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.512 ' CD1' ' HB3' ' A' 1028 ' ' PRO . 19.4 pt -89.5 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.3 0.572 . . . . 0.0 111.905 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' 1049 ' ' VAL . 24.8 p90 -145.06 128.94 17.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.679 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 13.5 t -63.68 164.15 10.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.113 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.0 t -155.78 -27.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.484 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 56.1 m 65.48 146.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.921 0.391 . . . . 0.0 111.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.713 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -164.98 -34.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.713 ' H ' HD21 ' A' 1077 ' ' ASN . 9.5 t70 -60.28 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.62 0.248 . . . . 0.0 110.863 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -162.95 -42.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.761 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.739 ' HG3' HG12 ' A' 1023 ' ' ILE . 52.4 tt0 -175.0 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.23 0.538 . . . . 0.0 110.321 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 20.5 t -83.33 -117.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.678 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . -165.78 50.85 0.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.776 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' 1083 ' ' ILE . 2.0 mp -81.95 126.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.679 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.8 m95 -85.37 -151.23 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' 1073 ' ' TYR . 80.2 p -95.39 -27.63 15.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.111 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.426 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . -166.43 152.66 21.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.612 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 10.7 Cg_exo -73.48 47.35 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 112.883 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.751 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 65.36 141.89 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.859 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.532 ' HB2' HD13 ' A' 1066 ' ' LEU . 58.6 Cg_endo -69.89 -146.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.726 2.284 . . . . 0.0 112.113 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.412 ' H ' ' HB2' ' A' 1089 ' ' PRO . 3.3 mm100 -150.65 128.71 11.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 91.9 m -96.69 70.54 2.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.459 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.25 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . 0.586 ' H1 ' ' HB3' ' A' ' 960' ' ' ALA . 93.1 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.64 0.257 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.14 132.56 52.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.027 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 86.5 tt0 53.96 45.13 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 110.412 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . 0.586 ' HB3' ' H1 ' ' A' ' 957' ' ' GLU . . . -78.46 38.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.262 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 0.8 OUTLIER 61.63 122.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.628 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 31.0 t -157.95 131.96 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.934 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 2.9 p -79.84 142.22 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.68 126.36 27.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 0.0 110.665 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.72 ' HB ' HD12 ' A' ' 980' ' ' ILE . 9.1 t -67.89 131.91 92.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.111 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.74 108.83 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.349 2.033 . . . . 0.0 111.649 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 965' ' ' THR . 88.9 Cg_exo -48.02 -46.76 21.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.537 2.158 . . . . 0.0 111.644 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 968' ' ' ASP . 2.1 p30 179.28 111.73 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.223 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 24.2 Cg_exo -62.55 152.9 74.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.668 2.245 . . . . 0.0 111.971 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' 1019 ' ' ILE . 60.0 t -48.02 100.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 75.3 m-20 74.44 -50.74 0.68 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.597 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -73.44 141.34 29.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.908 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.4 mtp -89.28 138.12 31.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.42 ' C ' ' HD2' ' A' ' 975' ' ' HIS . 4.9 p -83.5 151.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.397 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 987' ' ' THR . 21.8 m170 -119.07 76.17 1.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.812 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.518 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 48.5 t -75.21 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 977' ' ' ILE . 66.8 mt -75.27 -75.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.825 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 33.2 p -56.42 -88.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.572 ' OD1' ' HB2' ' A' ' 981' ' ' GLN . 2.8 p30 -168.7 151.42 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.72 HD12 ' HB ' ' A' ' 965' ' ' THR . 5.1 pt -83.93 27.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.337 0.589 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.572 ' HB2' ' OD1' ' A' ' 979' ' ' ASP . 27.2 mt-30 -90.37 151.73 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.07 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' 1004 ' ' CYS . 74.8 t -44.26 146.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.734 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 83.26 -39.85 2.8 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 114.258 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.2 m -68.45 175.72 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.612 0.706 . . . . 0.0 111.143 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.463 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 4.7 tmm_? -156.6 128.72 7.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.194 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 34.3 pt -97.28 -163.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 975' ' ' HIS . 54.7 p -149.23 130.13 14.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.937 0.398 . . . . 0.0 112.028 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.1 m-85 -99.18 147.82 24.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.376 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -151.13 132.15 14.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.536 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 85.8 m -81.93 -125.93 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 992' ' ' THR . 1.8 t -165.01 176.15 8.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.306 0.574 . . . . 0.0 111.375 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.474 ' N ' ' OG1' ' A' ' 991' ' ' THR . 22.1 m -48.54 131.02 17.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.643 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.19 84.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.459 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.01 122.44 7.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.943 0.371 . . . . 0.0 110.706 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.6 ' NH2' ' HA ' ' A' 1080 ' ' GLN . 38.0 ttm180 -82.24 114.54 20.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.581 HD13 ' N ' ' A' ' 997' ' ' ILE . 7.6 tp -76.27 127.81 33.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.24 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.678 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.8 mp -98.75 140.78 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.482 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.2 174.34 40.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.068 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.507 ' C ' ' H ' ' A' 1001 ' ' SER . 86.6 m-70 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 0.0 111.357 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.3 p -75.4 31.3 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.838 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 999' ' ' HIS . 63.0 m -162.12 152.18 16.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.048 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.83 ' HB2' ' HB3' ' A' 1013 ' ' TRP . . . -150.8 129.03 11.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.63 122.96 33.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.097 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 14.9 t -70.13 80.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' 1014 ' ' SER . 40.7 pt -87.33 -142.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.516 ' HG ' ' C ' ' A' 1010 ' ' THR . 5.1 tt -158.39 121.62 3.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.878 0.37 . . . . 0.0 110.566 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 53.0 m -92.03 47.03 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.811 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.482 ' N ' HD21 ' A' 1006 ' ' LEU . . . 75.35 -57.63 2.85 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.092 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.18 -60.08 3.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.855 0.327 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.516 ' C ' ' HG ' ' A' 1006 ' ' LEU . 15.2 t -151.27 -172.51 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.611 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.26 136.89 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 111.003 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -149.44 151.72 34.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.836 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.83 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 61.2 m95 -72.41 127.45 32.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.545 ' HA ' HD12 ' A' 1005 ' ' ILE . 46.9 t -52.46 -27.7 17.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.972 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 999' ' ' HIS . 82.5 p -105.8 142.28 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 111.95 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -57.08 149.2 47.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.276 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.84 108.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.247 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.443 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 34.1 Cg_exo -59.3 148.73 85.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.897 2.398 . . . . 0.0 112.163 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.678 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 9.1 tt -148.82 135.71 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.433 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 50.1 m -86.49 159.42 19.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.912 0.387 . . . . 0.0 110.64 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.42 ' HB3' HD12 ' A' ' 997' ' ' ILE . 7.0 tt0 -153.5 117.69 4.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.595 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -64.21 127.66 32.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.194 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' 1045 ' ' HIS . 76.0 mt -71.05 126.69 92.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.39 126.49 19.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.563 2.175 . . . . 0.0 112.776 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.725 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 71.6 m -97.21 135.05 39.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -84.74 151.72 26.65 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.49 HD21 ' N ' ' A' 1027 ' ' LEU . 1.4 mm? -39.44 137.15 1.06 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 117.168 0.484 . . . . 0.0 111.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.51 ' O ' HG21 ' A' 1030 ' ' THR . 29.7 Cg_endo -63.68 145.24 91.04 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.677 2.251 . . . . 0.0 112.12 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.588 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.4 Cg_exo -54.61 91.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.295 1.997 . . . . 0.0 111.376 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1030 ' ' THR . . . . . 0.51 HG21 ' O ' ' A' 1028 ' ' PRO . 53.2 p -77.47 118.78 20.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.66 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.666 HD12 ' HB2' ' A' 1089 ' ' PRO . 18.4 pt -84.95 119.89 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.46 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -43.55 141.53 1.41 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 78.08 -38.78 0.26 Allowed 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.506 0.504 . . . . 0.0 111.001 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.766 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -69.78 120.11 9.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.428 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' 1052 ' ' TYR . 1.4 m-20 -83.06 173.46 11.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.667 ' HA ' ' O ' ' A' 1051 ' ' THR . 43.9 p90 -151.43 133.64 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.169 0.509 . . . . 0.0 111.728 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.639 HD13 ' HD2' ' A' 1053 ' ' ARG . 29.5 mt -108.54 45.34 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.501 ' HB3' HG11 ' A' 1050 ' ' VAL . 81.6 p -71.2 -140.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.701 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' 1041 ' ' ARG . 88.7 m -161.16 -29.53 0.05 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.599 ' HB3' ' OG ' ' A' 1048 ' ' SER . 21.8 p30 -53.35 -39.05 63.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' 1039 ' ' THR . 37.9 mmt180 59.02 -111.43 0.55 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.231 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.12 -131.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.51 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.1 p30 -56.26 145.6 26.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' 1027 ' ' LEU . 29.6 p90 -159.79 129.23 5.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.75 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' O ' ' A' 1023 ' ' ILE . 48.9 m-70 -76.6 -41.54 45.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.508 ' HH ' ' HA ' ' A' 1075 ' ' THR . 60.1 t80 176.03 157.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.551 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' 1048 ' ' SER . . . 76.54 96.67 0.17 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.284 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.599 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 45.7 t 174.26 153.68 0.11 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' 1073 ' ' TYR . 3.6 m -137.81 159.42 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.258 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' 1038 ' ' SER . 18.1 m -133.37 134.67 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' 1036 ' ' PHE . 86.7 m -104.77 119.05 38.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' 1035 ' ' ASP . 7.7 m-85 -80.56 160.07 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.639 ' HD2' HD13 ' A' 1037 ' ' ILE . 79.6 mtp180 -142.71 -41.6 0.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.766 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 40.1 t 70.73 122.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.818 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.624 ' HB2' ' HB2' ' A' 1064 ' ' PHE . 3.5 m120 17.57 -123.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.533 ' HA ' HG21 ' A' 1063 ' ' VAL . 79.6 mt 69.5 123.49 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.69 -62.79 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.612 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.468 ' C ' ' HD2' ' A' 1059 ' ' ARG . 38.2 t -90.06 44.02 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.569 ' HD2' ' N ' ' A' 1059 ' ' ARG . 0.0 OUTLIER 39.45 44.98 1.21 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.071 -179.121 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.59 -29.13 0.12 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.098 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -45.75 146.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.605 0.241 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.554 ' HB3' ' NZ ' ' A' 1062 ' ' LYS . 6.3 ttpm? -65.37 80.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.986 0.422 . . . . 0.0 111.59 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' 1056 ' ' LEU . 3.2 m -155.17 90.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.624 ' HB2' ' HB2' ' A' 1055 ' ' ASN . 0.5 OUTLIER 68.75 144.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.566 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -146.18 143.36 29.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 112.338 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' 1070 ' ' PRO . 34.6 tp -68.55 151.7 46.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.969 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.864 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 76.9 t -138.22 136.25 44.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.061 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.1 -148.09 32.6 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.131 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.1 pt-20 -63.45 128.6 92.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.522 ' HB3' HD22 ' A' 1066 ' ' LEU . 79.4 Cg_endo -94.74 11.16 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.974 2.449 . . . . 0.0 113.23 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' 1050 ' ' VAL . 80.2 p -157.02 145.86 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1072 ' ' ILE . . . . . . . . . . . . . 42.9 pt -140.95 174.29 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.631 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.663 ' HB3' HG11 ' A' 1049 ' ' VAL . 1.6 p90 -160.04 148.13 16.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.486 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.902 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 44.6 t -65.37 137.37 57.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.508 ' HA ' ' HH ' ' A' 1046 ' ' TYR . 8.0 t -154.98 11.05 0.35 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' 1075 ' ' THR . 99.7 p 55.74 151.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.603 ' ND2' ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -168.34 40.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' 1081 ' ' VAL . 54.3 t0 -178.57 -18.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' 1080 ' ' GLN . 33.1 m-20 70.42 134.63 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.6 ' HA ' ' NH2' ' A' ' 995' ' ' ARG . 72.7 mt-30 76.2 21.96 1.4 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 109.211 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' 1078 ' ' ASP . 2.6 m -163.3 109.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.075 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.725 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . -74.31 63.89 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.581 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.603 ' HB ' ' ND2' ' A' 1077 ' ' ASN . 64.4 mt -81.92 138.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.902 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.5 m95 -70.98 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.002 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.0 t -80.61 -65.75 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.999 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.6 145.44 6.08 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.343 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.588 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 92.3 Cg_endo -81.71 51.12 3.73 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.116 2.544 . . . . 0.0 112.787 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.469 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -66.28 -43.94 56.29 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.666 ' HB2' HD12 ' A' 1031 ' ' ILE . 87.1 Cg_exo -43.56 137.74 5.75 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.438 2.092 . . . . 0.0 112.699 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.864 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.4 mm100 -129.77 127.96 41.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 36.5 t -93.45 72.41 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.266 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 957' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.265 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 59.03 -138.78 0.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -171.37 47.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.938 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.12 51.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.593 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.544 ' HD2' HD22 ' A' 1006 ' ' LEU . 27.1 mttm -77.62 146.86 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.684 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.507 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 80.4 p -157.98 143.29 16.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 95.5 m -80.01 146.83 31.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.256 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.83 139.43 58.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 111.337 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 62.9 m -68.28 128.12 93.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.981 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 974' ' ' VAL . 11.0 Cg_exo -70.05 127.38 14.29 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 111.211 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 968' ' ' ASP . 18.3 Cg_endo -60.08 -60.09 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.114 1.876 . . . . 0.0 111.708 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 967' ' ' PRO . 42.1 p-10 175.73 115.18 0.12 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.979 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.756 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 18.3 Cg_exo -66.22 134.92 38.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.489 2.126 . . . . 0.0 111.727 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.551 HG12 ' HB ' ' A' 1019 ' ' ILE . 0.8 OUTLIER -49.11 125.47 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.039 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.547 HD21 ' HB2' ' A' 1020 ' ' CYS . 73.4 m-20 75.29 -58.32 0.57 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.225 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -80.04 -161.54 23.89 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.756 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 40.6 tpp -160.47 135.16 7.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.613 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.508 HG23 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -81.76 150.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.321 . . . . 0.0 110.779 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -117.31 99.5 7.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.498 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.442 ' HA ' HG23 ' A' ' 986' ' ' ILE . 7.2 p -75.03 86.19 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.704 0.764 . . . . 0.0 109.693 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.22 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.505 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 984' ' ' SER . 41.2 p -79.86 79.27 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 111.044 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.1 -142.38 0.75 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.054 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 3.6 pt -155.84 23.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 75.5 mt-30 -85.6 169.97 13.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.675 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' 1004 ' ' CYS . 92.3 t -44.33 145.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.368 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.506 ' HA3' ' OE2' ' A' 1003 ' ' GLU . . . 78.97 -44.45 2.59 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.927 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 978' ' ' THR . 92.8 p -68.36 123.64 21.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.463 0.631 . . . . 0.0 111.047 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.743 ' HD3' ' HB2' ' A' 1001 ' ' SER . 33.8 ttm180 -102.71 135.82 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.846 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.442 HG23 ' HA ' ' A' ' 976' ' ' VAL . 16.3 pt -95.52 -170.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.954 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 55.7 p -148.29 123.9 10.44 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.565 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 4.9 m-85 -97.24 154.15 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.539 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 20.8 m -157.64 126.29 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.662 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 85.0 m -85.16 147.83 26.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.518 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.37 163.36 5.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.587 0.708 . . . . 0.0 112.154 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.4 m -55.79 138.25 48.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.476 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 71.52 40.1 60.06 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.836 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -151.07 138.53 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.494 0.188 . . . . 0.0 110.545 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 995' ' ' ARG . 37.3 ttt85 -82.02 127.13 32.77 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.218 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.662 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 3.5 tt -76.22 118.72 19.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 111.38 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' 1021 ' ' GLN . 30.4 mm -94.2 140.87 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.93 177.19 32.09 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.105 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.545 ' O ' ' HG3' ' A' 1018 ' ' PRO . 22.7 m170 -75.03 127.27 32.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.299 . . . . 0.0 111.172 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.622 ' HB3' HD12 ' A' ' 996' ' ' LEU . 83.4 p -79.02 26.36 0.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.044 0.45 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.743 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.1 p -162.16 140.44 8.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.09 128.45 7.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.506 ' OE2' ' HA3' ' A' ' 983' ' ' GLY . 85.6 tt0 -89.99 130.83 36.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.443 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 51.3 t -67.16 128.54 36.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' 1011 ' ' ALA . 31.2 pt -134.8 -142.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.573 HD11 ' C ' ' A' 1006 ' ' LEU . 0.3 OUTLIER -144.08 120.45 10.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 -179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.494 ' N ' HD11 ' A' 1006 ' ' LEU . 46.0 t -85.93 -47.89 9.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.414 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 177.28 -50.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.111 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 42.3 t30 -79.79 -51.41 9.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.737 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 11.8 t -151.28 -161.95 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.507 ' HB2' ' SG ' ' A' 1004 ' ' CYS . . . -75.31 140.78 43.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.463 ' HD2' ' HB3' ' A' 1007 ' ' SER . 90.2 m-70 -149.49 144.58 26.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 68.6 m95 -67.0 135.21 53.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.883 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 82.4 p -52.49 -22.2 4.58 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.675 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.423 HG22 ' ND1' ' A' ' 999' ' ' HIS . 70.8 p -131.44 139.86 49.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.876 0.369 . . . . 0.0 111.918 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.502 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -52.16 145.47 18.45 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.826 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.57 103.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.396 2.064 . . . . 0.0 111.806 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.565 ' HG2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_endo -62.42 150.79 86.09 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 111.998 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.624 HG13 ' HB ' ' A' ' 997' ' ' ILE . 41.3 pt -125.77 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.547 ' HB2' HD21 ' A' ' 971' ' ' ASN . 22.0 m -146.75 121.32 9.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.642 ' HB2' HD13 ' A' ' 997' ' ' ILE . 64.8 tp60 -83.48 128.36 34.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -81.55 117.89 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.121 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' 1045 ' ' HIS . 75.7 mt -70.94 112.4 13.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.82 127.1 8.46 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.543 2.162 . . . . 0.0 112.139 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' A' 1044 ' ' PHE . 62.8 m -88.43 -145.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 0.0 111.564 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1026 ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' 1044 ' ' PHE . . . -161.08 154.81 25.87 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.629 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.569 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 45.8 mt -42.51 137.93 2.22 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-O 120.81 0.338 . . . . 0.0 111.529 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.58 ' HD3' ' ND2' ' A' 1040 ' ' ASN . 13.1 Cg_endo -56.31 146.68 71.26 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.777 2.318 . . . . 0.0 111.743 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.673 ' HD2' HD13 ' A' 1072 ' ' ILE . 89.0 Cg_exo -47.41 108.66 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.155 1.903 . . . . 0.0 111.606 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 82.1 p -77.59 116.54 18.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.868 HG23 ' HD2' ' A' 1089 ' ' PRO . 11.6 pt -100.28 29.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.449 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 55.2 120.95 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.415 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 61.7 m-80 69.64 12.41 8.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.745 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.62 134.51 38.34 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.998 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.81 -37.25 79.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.719 ' HD1' HG22 ' A' 1050 ' ' VAL . 0.8 OUTLIER 61.34 108.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.831 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.723 ' HB ' ' HB ' ' A' 1051 ' ' THR . 7.9 mt -111.34 -176.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.715 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.536 ' HG ' ' H ' ' A' 1039 ' ' THR . 15.7 t 69.71 -129.51 0.08 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.168 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.536 ' H ' ' HG ' ' A' 1038 ' ' SER . 25.3 p -145.03 140.26 28.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 111.739 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.58 ' ND2' ' HD3' ' A' 1028 ' ' PRO . 23.9 t-20 -169.79 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' 1041 ' ' ARG . 42.1 mtp85 52.03 -142.18 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.7 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -79.06 -45.2 20.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.0 p30 -65.93 141.56 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' 1025 ' ' CYS . 0.5 OUTLIER -163.21 40.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.837 0.351 . . . . 0.0 111.212 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 23.9 m80 -53.49 -40.27 65.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' 1045 ' ' HIS . 43.9 t80 173.61 159.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.695 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.99 -24.99 3.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.136 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 69.1 m -47.61 139.78 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.638 HG22 ' HB3' ' A' 1073 ' ' TYR . 14.4 p -138.19 157.65 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.719 HG22 ' HD1' ' A' 1036 ' ' PHE . 3.3 p -154.02 135.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.723 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 92.3 m -100.96 123.65 45.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.708 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.488 ' HE2' HG22 ' A' 1031 ' ' ILE . 3.7 m-85 -83.7 144.52 29.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.008 0.433 . . . . 0.0 111.355 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' 1066 ' ' LEU . 42.8 ttm-85 -157.42 -25.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.791 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1054 ' ' CYS . . . . . . . . . . . . . 16.2 m 64.86 145.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.059 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 3.4 m120 -62.85 129.77 41.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.288 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.81 ' HG ' ' HA3' ' A' 1060 ' ' GLY . 1.9 mm? -70.33 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.639 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.426 ' H ' ' HB3' ' A' 1056 ' ' LEU . . . -152.05 29.41 0.9 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 23.8 p 177.44 -51.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.74 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' 1059 ' ' ARG . 19.3 tpt85 -169.61 -49.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.81 ' HA3' ' HG ' ' A' 1056 ' ' LEU . . . -172.72 29.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.985 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.497 ' O ' HG21 ' A' 1063 ' ' VAL . 40.1 mtp85 -80.35 169.5 17.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.752 0.31 . . . . 0.0 111.09 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.32 83.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.592 ' O ' ' HB2' ' A' 1064 ' ' PHE . 3.3 m -155.05 99.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.506 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.9 m-30 79.49 62.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.088 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -86.56 130.01 34.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.61 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' 1070 ' ' PRO . 3.2 tm? -68.53 138.66 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.266 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' 1066 ' ' LEU . 11.6 t -151.91 156.68 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.456 ' H ' HG11 ' A' 1067 ' ' VAL . . . 79.79 -27.76 2.56 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.989 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' 1089 ' ' PRO . 16.5 tp10 -167.82 103.7 0.57 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.994 0.397 . . . . 0.0 111.323 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.72 ' HA ' HD13 ' A' 1066 ' ' LEU . 95.7 Cg_endo -87.5 -28.94 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.0 2.467 . . . . 0.0 114.642 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 48.9 m -152.95 137.19 16.52 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.673 HD13 ' HD2' ' A' 1029 ' ' PRO . 28.6 pt -140.94 166.23 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.641 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.638 ' HB3' HG22 ' A' 1049 ' ' VAL . 2.9 p90 -157.17 145.73 19.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.963 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 52.3 t -63.84 148.54 49.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.497 . . . . 0.0 111.413 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.7 t -140.89 150.56 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.114 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 54.5 m -74.54 123.34 24.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' 1077 ' ' ASN . 0.0 OUTLIER 179.31 -165.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.742 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.401 ' O ' HG21 ' A' 1081 ' ' VAL . 8.3 t0 44.35 46.64 7.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.454 ' OD1' ' HG2' ' A' 1080 ' ' GLN . 9.9 t0 72.97 -59.4 0.57 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.178 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.454 ' HG2' ' OD1' ' A' 1079 ' ' ASP . 18.0 pt20 179.61 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' 1078 ' ' ASP . 42.6 t -86.32 -38.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 82.58 55.41 3.02 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.484 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.506 HG12 ' ND2' ' A' 1077 ' ' ASN . 33.8 pt -81.96 137.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.688 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.471 ' CH2' ' HB3' ' A' 1028 ' ' PRO . 11.9 m95 -70.58 146.52 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.641 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 80.1 p -56.54 -9.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.423 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.423 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . -166.42 135.94 3.92 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.36 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.423 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 15.0 Cg_exo -69.44 -153.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.057 2.504 . . . . 0.0 113.038 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' 1031 ' ' ILE . . . -77.16 138.5 64.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.432 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.868 ' HD2' HG23 ' A' 1031 ' ' ILE . 2.3 Cg_endo -80.47 -136.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.491 2.794 . . . . 0.0 111.898 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.504 ' H ' ' HB2' ' A' 1089 ' ' PRO . 62.5 tp60 -152.41 119.84 5.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.757 0.313 . . . . 0.0 110.889 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.506 ' SG ' HD13 ' A' 1031 ' ' ILE . 88.8 m -103.11 128.75 49.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.523 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.367 -179.323 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.828 0.347 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 56.4 45.47 22.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.464 ' HG3' ' NZ ' ' A' ' 961' ' ' LYS . 39.4 tt0 55.91 47.34 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.516 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -68.0 -48.86 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 981' ' ' GLN . 47.6 mmtm 63.26 138.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 56.9 p -157.96 140.51 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 98.6 m -79.85 134.05 36.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -64.96 142.02 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.004 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.7 m -50.8 121.09 14.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.69 132.31 51.36 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.392 2.062 . . . . 0.0 112.416 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.72 140.64 62.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.425 2.083 . . . . 0.0 111.355 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.6 m-20 -48.57 117.65 6.24 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 110.719 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.56 ' HG2' ' N ' ' A' ' 973' ' ' MET . 18.8 Cg_endo -58.9 149.2 80.24 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.801 2.334 . . . . 0.0 112.524 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 79.4 t -42.8 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.1 m-20 73.42 -42.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.727 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.595 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -69.1 -156.34 1.09 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.079 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.57 ' HG3' ' HE2' ' A' ' 975' ' ' HIS . 22.5 ptp -159.25 138.89 11.61 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.631 0.253 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.926 ' HA ' ' HB3' ' A' ' 988' ' ' TYR . 0.7 OUTLIER -87.33 145.53 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.398 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.57 ' HE2' ' HG3' ' A' ' 973' ' ' MET . 19.0 m170 -119.13 106.78 12.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 68.9 t -69.71 94.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 987' ' ' THR . 39.3 mt -75.24 -90.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.367 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.585 ' HG1' ' H ' ' A' ' 985' ' ' ARG . 37.2 p -62.11 -68.62 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.354 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 27.4 t70 -166.89 -138.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.064 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.499 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 10.9 pt -155.81 53.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 961' ' ' LYS . 8.4 tt0 -152.65 158.04 41.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.719 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' 1004 ' ' CYS . 56.5 t -28.29 123.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.31 0.381 . . . . 0.0 111.334 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.58 2.6 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.682 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 981' ' ' GLN . 88.0 p -157.1 127.23 6.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.818 0.342 . . . . 0.0 110.96 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.585 ' H ' ' HG1' ' A' ' 978' ' ' THR . 58.6 mtt85 -101.54 149.57 23.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.7 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' 1002 ' ' ALA . 38.9 pt -142.78 168.85 13.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.075 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.443 HG21 HD13 ' A' ' 977' ' ' ILE . 66.5 p -146.12 147.38 31.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.834 0.349 . . . . 0.0 111.867 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.926 ' HB3' ' HA ' ' A' ' 974' ' ' VAL . 6.5 p90 -145.9 159.29 43.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.8 p -155.23 143.48 20.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.931 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.595 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 36.8 t -82.01 -179.56 7.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.452 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 38.1 p -60.24 155.06 18.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 112.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.475 HG21 ' N ' ' A' ' 993' ' ' GLY . 52.2 m -54.82 139.59 39.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.476 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.475 ' N ' HG21 ' A' ' 992' ' ' THR . . . 82.93 -32.41 2.97 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.204 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -82.43 148.67 28.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.776 ' HG2' ' H ' ' A' ' 996' ' ' LEU . 49.2 ttt-85 -81.97 -172.25 3.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.024 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.776 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 5.5 tt -161.77 128.07 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.857 ' HB ' HG12 ' A' 1019 ' ' ILE . 1.7 mp -86.62 144.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.967 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.6 165.18 36.38 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.506 ' C ' ' H ' ' A' 1001 ' ' SER . 89.5 m-70 -71.38 137.03 48.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.625 0.213 . . . . 0.0 110.762 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 78.7 p -72.14 39.47 0.07 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.948 0.404 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 999' ' ' HIS . 36.4 t -160.06 171.44 19.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.98 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' 1013 ' ' TRP . . . -165.27 134.02 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.4 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -114.05 128.25 56.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.434 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 48.9 t -73.2 85.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 14.7 pt -91.52 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.168 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' 1007 ' ' SER . 0.5 OUTLIER -92.46 128.34 38.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.709 0.29 . . . . 0.0 110.544 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.648 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 46.5 t -162.52 136.75 6.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 66.0 40.37 95.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.381 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.16 21.64 6.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.622 0.249 . . . . 0.0 111.564 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 87.9 m -152.36 133.59 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.818 0.342 . . . . 0.0 111.181 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.32 134.1 41.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.648 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.1 p80 -153.8 150.86 28.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.765 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.511 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 31.8 m95 -68.14 120.59 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.776 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.8 t -52.38 -22.58 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.707 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' 1002 ' ' ALA . 46.6 p -87.0 132.43 33.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -66.05 156.43 84.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.62 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -46.82 118.32 2.62 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.236 1.958 . . . . 0.0 112.019 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 988' ' ' TYR . 64.4 Cg_endo -84.62 160.42 12.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.162 2.574 . . . . 0.0 113.169 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.857 HG12 ' HB ' ' A' ' 997' ' ' ILE . 35.2 pt -144.53 -157.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 49.4 t -143.36 171.18 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.309 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.46 ' HA ' ' OE1' ' A' 1021 ' ' GLN . 1.0 OUTLIER -153.51 130.76 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.036 0.446 . . . . 0.0 111.113 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.592 ' HD3' ' HB3' ' A' 1045 ' ' HIS . 77.7 ttt180 -64.37 -17.54 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.527 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 995' ' ' ARG . 61.4 mt 64.21 89.33 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.934 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.62 126.26 21.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.611 2.207 . . . . 0.0 112.931 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 56.1 m -88.43 -145.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.055 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -163.91 155.57 27.01 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.432 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' 1044 ' ' PHE . 8.8 mp -40.92 139.41 1.21 Allowed Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.578 ' HD3' HD22 ' A' 1040 ' ' ASN . 59.6 Cg_endo -71.67 145.37 46.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.882 2.388 . . . . 0.0 112.054 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' 1087 ' ' PRO . 24.0 Cg_endo -61.47 117.19 3.98 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.206 1.938 . . . . 0.0 111.933 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 83.5 m -82.47 121.05 26.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 24.8 pt -86.66 135.55 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.352 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -51.79 138.61 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' 1032 ' ' ALA . 75.3 m-80 75.03 -40.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.172 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -79.16 116.71 4.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' 1053 ' ' ARG . 57.4 m-20 -68.81 -150.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 110.685 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.528 ' CD1' HG22 ' A' 1050 ' ' VAL . 0.0 OUTLIER -156.0 137.15 13.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.285 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' 1051 ' ' THR . 34.5 pt -128.87 -161.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.566 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.53 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 66.4 m 63.66 159.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.857 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 99.9 m -56.48 130.55 45.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.306 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.578 HD22 ' HD3' ' A' 1028 ' ' PRO . 17.0 t-20 -177.18 -121.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' 1040 ' ' ASN . 21.9 mmt85 75.35 -49.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.606 0.362 . . . . 0.0 111.211 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' 1043 ' ' ASN . 13.5 pt-20 -162.95 -141.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.411 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' 1042 ' ' GLU . 2.9 m120 33.56 43.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.193 0.52 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' 1027 ' ' LEU . 0.3 OUTLIER -77.89 43.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.882 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.592 ' HB3' ' HD3' ' A' 1022 ' ' ARG . 58.3 m-70 -53.3 -52.49 58.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.554 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 32.2 t80 171.9 160.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.392 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 77.51 -20.97 3.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.061 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' 1046 ' ' TYR . 55.3 m -47.66 142.2 4.74 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.896 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.56 HG21 ' N ' ' A' 1050 ' ' VAL . 11.3 p -137.79 155.43 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.338 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.56 ' N ' HG21 ' A' 1049 ' ' VAL . 9.4 p -149.03 139.27 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.334 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.514 ' O ' HG12 ' A' 1037 ' ' ILE . 96.6 m -102.55 128.99 48.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -73.5 139.95 46.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.526 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' 1035 ' ' ASP . 79.3 ttt180 -146.54 133.07 19.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.03 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.571 ' O ' HD21 ' A' 1056 ' ' LEU . 75.5 m -76.45 158.1 31.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 111.834 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.515 ' HA ' ' OD2' ' A' 1035 ' ' ASP . 24.4 t-20 -65.6 -22.92 66.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.957 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.605 ' HB3' ' O ' ' A' 1061 ' ' ARG . 4.1 mm? 46.21 43.77 11.53 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-O 120.786 0.326 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 72.81 -53.94 1.68 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' 1059 ' ' ARG . 36.3 t -178.83 126.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' 1059 ' ' ARG . 3.0 mmp_? 72.37 -60.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.124 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.44 29.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.086 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.605 ' O ' ' HB3' ' A' 1056 ' ' LEU . 42.1 ttt85 -66.17 132.13 47.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -65.24 109.28 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.515 0.674 . . . . 0.0 111.992 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.685 HG11 ' H ' ' A' 1064 ' ' PHE . 3.0 p -157.47 -45.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.156 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.685 ' H ' HG11 ' A' 1063 ' ' VAL . 3.1 m-85 -86.11 155.57 20.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.344 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -146.28 121.34 10.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' 1070 ' ' PRO . 30.9 tp -71.9 142.97 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.466 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' 1089 ' ' PRO . 63.7 t -138.33 138.16 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.427 ' N ' HG11 ' A' 1067 ' ' VAL . . . 84.51 -145.65 22.1 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.8 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1069 ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -62.42 110.41 3.32 Favored Pre-proline 0 C--O 1.225 -0.186 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.688 ' HB3' HD22 ' A' 1066 ' ' LEU . 74.3 Cg_endo -87.8 -45.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.547 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 83.4 p -94.54 146.86 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 112.009 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.811 HG13 ' HB2' ' A' 1085 ' ' SER . 7.0 tt -149.67 158.39 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.688 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.521 ' N ' HG12 ' A' 1072 ' ' ILE . 0.1 OUTLIER -159.7 171.97 18.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.688 0.28 . . . . 0.0 111.19 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.54 ' O ' HG21 ' A' 1075 ' ' THR . 43.4 t -62.16 -44.22 97.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.243 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.54 HG21 ' O ' ' A' 1074 ' ' CYS . 12.4 t 44.16 21.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.668 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.592 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 99.5 p 55.63 141.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.342 0.591 . . . . 0.0 112.483 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.983 ' HA ' HG12 ' A' 1083 ' ' ILE . 0.7 OUTLIER -67.05 -98.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.782 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.61 3.03 0.08 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.277 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 7.3 t0 -163.14 -51.01 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.509 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' 1080 ' ' GLN . 1.8 pm0 -174.84 50.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.435 ' HB ' ' CB ' ' A' 1077 ' ' ASN . 45.9 t -134.31 -37.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.954 -0.466 . . . . 0.0 111.867 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' 1076 ' ' SER . . . 73.8 64.79 2.37 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.983 HG12 ' HA ' ' A' 1077 ' ' ASN . 20.2 pt -81.98 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.557 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 11.1 m95 -72.43 162.91 28.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.218 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.811 ' HB2' HG13 ' A' 1072 ' ' ILE . 57.6 m -43.58 -41.76 4.73 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 107.43 145.94 12.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.664 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' 1029 ' ' PRO . 68.5 Cg_exo -50.77 149.28 14.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.152 2.568 . . . . 0.0 112.845 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.731 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -171.77 -47.57 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.3 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.731 ' HD2' ' H ' ' A' 1088 ' ' ALA . 20.1 Cg_endo -59.65 149.88 79.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.634 2.223 . . . . 0.0 112.725 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -147.7 149.85 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.757 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 56.4 m -93.73 142.3 27.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.092 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.444 HD12 HG23 ' A' 1067 ' ' VAL . 33.4 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.943 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -61.27 135.95 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -171.0 143.13 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.651 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . 0.634 ' C ' ' HD2' ' A' ' 961' ' ' LYS . . . 55.92 -109.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.634 ' HD2' ' C ' ' A' ' 960' ' ' ALA . 3.1 mptp? -146.55 155.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 98.6 p -152.99 129.12 10.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.39 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 964' ' ' LYS . 1.6 p -79.92 30.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.254 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.757 ' HE2' ' HA ' ' A' ' 964' ' ' LYS . 10.0 mmpt? 54.5 138.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.478 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 6.9 t -63.14 121.46 69.35 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.45 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 986' ' ' ILE . 17.3 Cg_exo -67.25 107.25 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.475 2.117 . . . . 0.0 112.307 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 965' ' ' THR . 28.7 Cg_endo -63.39 136.2 53.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.211 1.941 . . . . 0.0 110.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.8 107.97 0.82 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.765 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 970' ' ' VAL . 73.2 Cg_endo -73.11 -133.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.936 2.424 . . . . 0.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.731 HG12 ' H ' ' A' 1020 ' ' CYS . 8.5 p -51.95 -148.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.914 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.598 ' H ' ' CG2' ' A' ' 970' ' ' VAL . 5.1 m120 -65.46 -28.44 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.767 -0.583 . . . . 0.0 110.469 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.748 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -72.33 126.6 11.59 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.234 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 988' ' ' TYR . 65.9 mtt -94.42 143.95 25.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.552 HG22 ' CZ ' ' A' ' 988' ' ' TYR . 4.5 p -92.88 148.36 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 O-C-N 123.361 0.413 . . . . 0.0 111.6 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.16 109.12 16.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.022 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.716 HG12 HG22 ' A' ' 980' ' ' ILE . 72.6 t -65.38 -48.01 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 22.9 mt 64.69 -98.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.602 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.483 ' HG1' ' H ' ' A' ' 979' ' ' ASP . 38.7 p -62.25 -65.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.507 ' O ' HG11 ' A' ' 976' ' ' VAL . 51.7 p-10 -173.33 -148.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.568 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.716 HG22 HG12 ' A' ' 976' ' ' VAL . 21.1 pt -155.95 25.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.2 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 962' ' ' SER . 85.7 mt-30 -78.81 -57.62 3.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.942 0.401 . . . . 0.0 111.272 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.621 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 7.7 p 167.77 156.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 79.06 -35.87 1.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.669 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.443 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 80.7 p -68.5 -160.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.12 0.486 . . . . 0.0 111.444 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 986' ' ' ILE . 45.4 ttm-85 -156.66 160.64 39.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.085 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.511 ' N ' ' HG2' ' A' ' 985' ' ' ARG . 47.0 pt -142.75 155.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.117 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' 1001 ' ' SER . 82.2 p -142.25 134.32 27.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.552 ' CZ ' HG22 ' A' ' 974' ' ' VAL . 4.0 m-85 -83.23 -161.87 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 73.6 m -148.18 -40.47 0.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.748 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 29.1 t 69.42 137.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.835 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -60.27 145.84 45.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.735 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 74.9 m -51.58 134.64 29.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.361 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 74.03 37.54 49.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.247 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.586 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 33.4 m80 -146.96 125.29 12.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.36 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.437 ' HB2' HD13 ' A' 1023 ' ' ILE . 38.2 ttt85 -82.0 96.82 7.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 1.002 HD23 ' HB3' ' A' 1000 ' ' SER . 3.6 pp -63.62 140.42 58.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.614 ' HB ' HG13 ' A' 1019 ' ' ILE . 50.4 mm -107.96 154.69 9.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.22 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.563 ' N ' HG21 ' A' ' 997' ' ' ILE . . . 76.92 14.63 82.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.071 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 63.68 134.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1000 ' ' SER . . . . . 1.002 ' HB3' HD23 ' A' ' 996' ' ' LEU . 77.8 p -87.76 46.78 1.42 Allowed 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -162.14 146.8 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.711 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.496 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -165.19 125.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.717 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.403 ' HB2' ' NH1' ' A' ' 985' ' ' ARG . 89.2 tt0 -87.65 130.96 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 43.4 t -74.13 86.57 1.88 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.888 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.604 HD11 ' N ' ' A' 1006 ' ' LEU . 2.4 pp -87.28 -146.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.604 ' N ' HD11 ' A' 1005 ' ' ILE . 4.6 tt -158.46 129.37 6.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.1 t -80.25 -59.63 2.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.306 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.27 42.8 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.589 ' H ' HD22 ' A' 1006 ' ' LEU . 16.5 p-10 -176.25 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.377 . . . . 0.0 110.395 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.566 ' O ' ' HG ' ' A' 1006 ' ' LEU . 11.8 t -151.29 175.99 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.537 ' HB2' ' SG ' ' A' 1004 ' ' CYS . . . -74.8 145.71 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.125 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.515 ' O ' HD13 ' A' 1005 ' ' ILE . 88.3 m-70 -149.44 145.61 27.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.438 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.438 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 92.9 m95 -76.42 125.41 29.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.362 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.2 p -53.69 -19.91 4.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.092 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 30.3 p -131.26 135.84 47.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 112.265 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.433 ' HB3' ' HD2' ' A' 1017 ' ' PRO . 14.7 mmmm -69.81 161.96 71.29 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.891 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 80.2 Cg_exo -45.43 132.31 12.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.735 2.29 . . . . 0.0 112.686 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 88.9 Cg_endo -80.51 170.56 15.74 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.997 2.465 . . . . 0.0 113.143 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.614 HG13 ' HB ' ' A' ' 997' ' ' ILE . 25.4 pt -148.83 121.53 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.811 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.731 ' H ' HG12 ' A' ' 970' ' ' VAL . 88.9 m -86.16 118.26 25.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 112.118 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -82.41 126.01 31.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.915 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.546 ' O ' ' HB2' ' A' 1046 ' ' TYR . 40.9 ttt85 -67.2 -9.37 39.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.256 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.437 HD13 ' HB2' ' A' ' 995' ' ' ARG . 45.9 mt 54.01 56.77 12.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.428 . . . . 0.0 110.445 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.504 ' CB ' ' HA ' ' A' 1045 ' ' HIS . 58.0 Cg_endo -71.6 138.28 31.89 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.273 . . . . 0.0 113.019 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.417 ' HB2' ' H ' ' A' 1026 ' ' GLY . 3.8 p -88.42 -136.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.317 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1026 ' ' GLY . . . . . 0.51 ' HA3' ' CE1' ' A' 1044 ' ' PHE . . . -148.4 -151.35 5.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.809 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.464 HD22 ' HE2' ' A' 1044 ' ' PHE . 70.6 mt -64.73 132.84 95.55 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-O 120.711 0.291 . . . . 0.0 111.567 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.478 ' HB2' ' HH ' ' A' 1052 ' ' TYR . 27.5 Cg_endo -61.58 149.81 88.18 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 111.092 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.772 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 95.9 Cg_exo -45.47 119.59 2.74 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.287 1.992 . . . . 0.0 112.283 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 81.3 p -81.81 139.9 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.958 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' 1031 ' ' ILE . 45.6 pt -148.45 120.6 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.433 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -73.56 14.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.111 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' 1031 ' ' ILE . 3.5 m120 -80.36 -31.83 37.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.22 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.659 ' HA3' ' ND2' ' A' 1055 ' ' ASN . . . -163.14 -125.2 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.302 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' 1034 ' ' GLY . 53.3 m-20 -156.66 -151.7 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.633 ' HB2' HG11 ' A' 1050 ' ' VAL . 45.9 p90 -155.96 129.65 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 111.945 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.414 HD12 HG22 ' A' 1037 ' ' ILE . 55.9 mt -88.28 78.2 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.986 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' 1039 ' ' THR . 39.6 t -167.39 154.0 8.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 111.492 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' 1041 ' ' ARG . 60.7 m -55.8 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' 1041 ' ' ARG . 7.0 m120 52.91 -125.1 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' 1039 ' ' THR . 76.0 mtp180 74.92 -47.34 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.662 0.385 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' 1044 ' ' PHE . 3.9 tm-20 -162.89 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.68 0.276 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -71.63 38.09 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.665 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.567 ' HD1' ' H ' ' A' 1045 ' ' HIS . 0.3 OUTLIER -76.7 -46.82 24.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.567 ' H ' ' HD1' ' A' 1044 ' ' PHE . 24.2 m-70 40.62 -147.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.18 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.723 ' O ' ' HB3' ' A' 1074 ' ' CYS . 14.8 t80 -63.45 -49.18 74.68 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -96.1 121.6 7.01 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.891 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 47.2 t 178.6 122.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.64 0.734 . . . . 0.0 111.344 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.567 HG21 ' N ' ' A' 1050 ' ' VAL . 11.2 p -102.3 157.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.546 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' 1036 ' ' PHE . 87.4 t -146.81 117.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.951 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' 1036 ' ' PHE . 96.2 m -99.55 109.94 22.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.909 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.478 ' HH ' ' HB2' ' A' 1028 ' ' PRO . 31.4 m-85 -80.98 124.66 29.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.976 0.417 . . . . 0.0 111.684 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' 1054 ' ' CYS . 18.2 tpt85 -97.07 -137.02 0.26 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.643 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.486 ' H ' ' HG3' ' A' 1053 ' ' ARG . 99.1 m -161.43 156.23 23.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 110.512 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.659 ' ND2' ' HA3' ' A' 1034 ' ' GLY . 5.2 m120 -65.85 62.1 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.631 ' HB3' ' HA3' ' A' 1060 ' ' GLY . 3.6 mm? -70.33 135.72 49.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 110.731 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' 1058 ' ' SER . . . -82.74 131.75 10.6 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.864 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' 1057 ' ' GLY . 55.1 m 74.91 -49.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.502 0.321 . . . . 0.0 111.731 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -167.75 -51.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.863 0.363 . . . . 0.0 111.543 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . -172.62 37.8 0.15 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.298 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -66.17 165.82 13.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' 1063 ' ' VAL . 39.5 ttmt -65.38 78.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.277 0.561 . . . . 0.0 111.025 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' 1064 ' ' PHE . 7.9 m -155.08 95.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.559 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.1 m-85 75.77 139.58 0.07 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.026 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 143.63 31.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.66 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' 1070 ' ' PRO . 47.5 tp -68.47 142.36 55.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.564 ' O ' ' HB2' ' A' 1089 ' ' PRO . 77.7 t -149.05 132.5 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.867 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 77.42 145.31 2.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.373 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.726 ' HG2' ' HB3' ' A' 1089 ' ' PRO . 16.3 pt-20 18.12 67.83 0.22 Allowed Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 112.689 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.813 ' HB3' HD22 ' A' 1066 ' ' LEU . 13.9 Cg_endo -56.18 -11.56 6.15 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.539 2.159 . . . . 0.0 111.907 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' 1050 ' ' VAL . 79.6 p -156.23 152.05 27.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.452 HG22 HD11 ' A' 1072 ' ' ILE . 26.3 pt -140.96 -166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.821 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.564 ' CE1' ' HB3' ' A' 1085 ' ' SER . 0.6 OUTLIER -160.09 158.14 29.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.958 0.409 . . . . 0.0 111.359 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.723 ' HB3' ' O ' ' A' 1046 ' ' TYR . 51.5 t -64.63 -42.6 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.97 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.536 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 14.7 t 45.95 -161.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.231 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.801 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 81.2 p -165.38 139.49 4.76 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.579 0.228 . . . . 0.0 111.381 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.872 HD22 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -177.01 -39.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.784 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.744 ' H ' HD21 ' A' 1077 ' ' ASN . 38.7 t70 -82.97 47.22 1.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.196 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.433 ' O ' HG22 ' A' 1023 ' ' ILE . 1.6 m-20 61.34 -130.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.529 ' C ' HG21 ' A' 1081 ' ' VAL . 12.0 mp0 -76.96 49.92 0.69 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.648 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.724 HG13 HG21 ' A' 1083 ' ' ILE . 18.4 t -145.9 -46.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' 1076 ' ' SER . . . 77.67 -45.84 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.24 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.872 HG12 HD22 ' A' 1077 ' ' ASN . 6.6 pt 52.58 135.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.449 0.642 . . . . 0.0 111.752 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 42.0 m95 -71.92 147.21 47.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.46 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.564 ' HB3' ' CE1' ' A' 1073 ' ' TYR . 80.2 p -48.02 -23.88 0.93 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.795 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . -166.49 140.52 6.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.783 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 12.8 Cg_exo -72.44 47.85 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.528 2.818 . . . . 0.0 113.079 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.772 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 64.44 138.99 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.023 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.726 ' HB3' ' HG2' ' A' 1069 ' ' GLU . 97.4 Cg_endo -81.73 -140.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.963 2.442 . . . . 0.0 112.2 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.477 ' H ' ' HB2' ' A' 1089 ' ' PRO . 39.8 tt0 -152.46 153.59 33.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.859 ' O ' HG12 ' A' 1092 ' ' ILE . 90.4 m -80.76 -146.82 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.859 HG12 ' O ' ' A' 1091 ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . 0.429 ' HB2' ' H ' ' A' ' 959' ' ' GLU . . . -69.17 -141.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.279 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 958' ' ' ALA . 23.4 pt-20 -170.46 132.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.529 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . 0.404 ' HB1' ' H ' ' A' ' 961' ' ' LYS . . . 53.44 -92.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.593 ' HG2' HD23 ' A' 1006 ' ' LEU . 17.2 tppt? 65.51 151.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 78.3 p -149.78 149.82 31.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.928 0.394 . . . . 0.0 111.497 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 89.1 m -79.93 147.61 31.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.335 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -63.75 138.2 58.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.898 0.38 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 62.2 m -51.94 125.19 30.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.065 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.662 ' HG2' HG13 ' A' ' 974' ' ' VAL . 56.6 Cg_endo -70.86 127.53 13.84 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.325 2.016 . . . . 0.0 111.824 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.85 139.01 50.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.289 1.992 . . . . 0.0 111.564 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -43.81 115.3 2.01 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 110.847 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.606 ' HG3' ' HD2' ' A' ' 988' ' ' TYR . 45.7 Cg_endo -67.45 149.5 80.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.792 2.328 . . . . 0.0 112.301 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' 1020 ' ' CYS . 0.6 OUTLIER -44.86 102.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.206 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.51 ' OD1' HG21 ' A' ' 970' ' ' VAL . 4.8 m120 74.2 -37.28 0.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -68.86 -172.82 8.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.57 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 64.6 mtm -154.56 135.12 13.46 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 110.916 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.662 HG13 ' HG2' ' A' ' 966' ' ' PRO . 6.3 p -92.93 149.55 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.424 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 15.4 m170 -119.09 113.76 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 980' ' ' ILE . 78.5 t -60.89 -51.64 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.152 0.501 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 33.6 mt 74.93 -33.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.195 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.5 p -138.0 -64.95 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.487 ' HB3' HE21 ' A' ' 981' ' ' GLN . 38.7 t70 -172.47 2.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.633 HG22 HG23 ' A' ' 976' ' ' VAL . 49.8 pt 52.81 72.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.431 0.634 . . . . 0.0 110.893 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' 1004 ' ' CYS . 22.6 pt20 -152.34 174.74 13.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.128 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' 1004 ' ' CYS . 48.4 t -43.38 138.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.337 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 80.54 -44.87 2.99 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.998 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.575 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 53.4 m -68.43 123.21 20.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.976 0.388 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 74.9 ttt180 -101.43 121.12 41.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . . . . . . . . . 31.7 pt -93.46 160.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.411 HG21 ' HA ' ' A' 1001 ' ' SER . 78.0 p -143.99 132.38 22.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 111.911 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.606 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 3.7 m-85 -84.85 -168.11 2.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 11.1 t -161.59 -47.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.195 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.795 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 3.2 t 70.05 -137.64 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.33 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 158.28 4.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.641 0.734 . . . . 0.0 112.43 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 28.5 m -53.99 114.77 1.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.755 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 147.24 -28.15 1.53 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HA ' HG12 ' A' 1023 ' ' ILE . 7.2 m80 -139.07 143.0 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.571 ' H ' HD12 ' A' 1023 ' ' ILE . 22.8 ptt-85 -80.02 127.34 32.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.143 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.636 HD22 ' HB2' ' A' 1018 ' ' PRO . 3.3 tt -76.13 129.86 37.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.7 mp -104.33 146.68 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.119 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 74.75 169.9 24.28 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.78 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -75.01 125.71 29.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.455 ' O ' ' HD1' ' A' ' 988' ' ' TYR . 79.3 p -64.88 -44.05 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.437 ' HB3' ' NE ' ' A' ' 985' ' ' ARG . 50.5 m -82.72 142.95 31.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.409 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -161.66 116.4 1.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 37.5 tt0 -85.93 132.51 34.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 43.0 t -69.71 93.52 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.32 -178.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.593 HD23 ' HG2' ' A' ' 961' ' ' LYS . 9.9 tp -158.44 125.5 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.5 t -85.42 -48.91 8.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.278 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 171.84 -48.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.659 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.6 t30 -70.99 -55.19 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.817 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.407 HG21 ' N ' ' A' 1011 ' ' ALA . 87.9 m -151.21 149.05 28.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.492 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.407 ' N ' HG21 ' A' 1010 ' ' THR . . . -75.28 143.96 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -150.71 149.98 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.464 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 52.1 m95 -68.78 132.53 46.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.713 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 78.5 p -52.36 -24.74 8.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.976 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 75.3 p -131.43 141.17 49.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -56.88 155.45 15.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 17.0 Cg_endo -57.71 118.11 4.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.36 2.04 . . . . 0.0 112.037 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.636 ' HB2' HD22 ' A' ' 996' ' ' LEU . 21.6 Cg_endo -61.48 159.15 32.96 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.545 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 26.4 pt -143.9 127.97 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.622 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.599 ' N ' HG12 ' A' ' 970' ' ' VAL . 50.5 m -88.0 112.79 22.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.052 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 995' ' ' ARG . 93.0 mm-40 -86.38 145.02 27.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.955 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.591 ' NH2' ' HB3' ' A' 1046 ' ' TYR . 25.8 tpt85 -63.92 128.12 34.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.237 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 994' ' ' HIS . 48.5 mm -65.34 128.25 93.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -96.97 139.3 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.738 2.959 . . . . 0.0 113.488 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.743 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 98.0 m -112.94 135.14 54.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.208 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.95 -152.35 4.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.789 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 48.8 mt -83.08 146.17 51.0 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.619 0.247 . . . . 0.0 111.059 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.16 149.8 90.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.324 2.016 . . . . 0.0 111.127 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.753 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 2.5 Cg_endo -46.18 119.66 3.16 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.573 2.182 . . . . 0.0 111.862 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 71.8 p -77.43 145.22 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.44 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.538 ' O ' HG21 ' A' 1031 ' ' ILE . 10.3 tt -149.89 114.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.801 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -56.59 144.57 31.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.491 ' HB3' HD21 ' A' 1055 ' ' ASN . 5.0 m120 75.21 -35.95 0.3 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.501 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.867 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -64.62 178.12 8.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.532 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -156.58 127.32 6.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.633 ' HB2' HG22 ' A' 1050 ' ' VAL . 3.7 p90 -84.34 144.57 28.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 0.0 110.664 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.449 HD11 ' O ' ' A' 1036 ' ' PHE . 42.2 mm -133.66 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.655 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.42 ' HG ' ' H ' ' A' 1039 ' ' THR . 11.3 t -167.8 -161.18 0.37 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.974 0.416 . . . . 0.0 111.289 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.42 ' H ' ' HG ' ' A' 1038 ' ' SER . 68.9 p -75.16 -13.4 60.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.279 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.533 ' OD1' ' HB ' ' A' 1050 ' ' VAL . 3.7 m120 -47.42 136.39 9.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.4 ' HB3' ' OE1' ' A' 1042 ' ' GLU . 25.3 mmm180 -154.18 -82.73 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.611 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.5 OUTLIER -163.01 145.16 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' 1042 ' ' GLU . 3.5 m120 70.27 58.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.893 0.377 . . . . 0.0 110.419 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' 1025 ' ' CYS . 2.5 m-85 -76.73 132.46 39.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' 1046 ' ' TYR . 20.4 m80 -90.32 -65.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.619 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.679 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.0 t80 171.91 44.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.548 0.69 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.45 89.2 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.73 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' 1047 ' ' GLY . 77.6 p 172.38 141.66 0.03 OUTLIER 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 111.515 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.585 HG11 ' HB3' ' A' 1073 ' ' TYR . 12.3 m -107.2 -173.53 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.431 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' 1036 ' ' PHE . 7.3 p -153.93 129.57 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.981 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 50.1 m -116.83 110.66 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.772 ' HB2' HD23 ' A' 1066 ' ' LEU . 2.2 m-85 -70.58 158.03 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -149.75 -13.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.867 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 65.1 m 66.16 166.02 0.2 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.491 HD21 ' HB3' ' A' 1033 ' ' ASN . 19.1 p30 -55.68 -44.64 77.52 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.599 ' HB3' ' HA3' ' A' 1060 ' ' GLY . 2.8 mm? 38.69 33.32 0.07 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 68.89 -52.63 0.53 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.906 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.574 ' C ' ' HD2' ' A' 1059 ' ' ARG . 70.8 m -161.53 -28.62 0.05 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.321 0.56 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.574 ' HD2' ' C ' ' A' 1058 ' ' SER . 5.6 mpt_? -150.06 -50.58 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.526 0.203 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.599 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . -174.75 37.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.892 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.492 ' O ' HD11 ' A' 1056 ' ' LEU . 70.1 mtt-85 -70.96 163.15 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' 1062 ' ' LYS . 39.9 ttpt -67.85 70.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.17 0.51 . . . . 0.0 110.934 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' 1064 ' ' PHE . 6.7 m -155.07 89.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.747 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.501 ' O ' HD12 ' A' 1056 ' ' LEU . 77.4 m-85 75.55 145.5 0.08 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.951 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -145.09 143.7 30.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.649 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.772 HD23 ' HB2' ' A' 1052 ' ' TYR . 61.7 tp -68.57 135.54 51.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.0 111.314 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' 1089 ' ' PRO . 61.5 t -138.25 123.03 22.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.114 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 71.82 161.3 4.9 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.285 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' 1069 ' ' GLU . 83.4 tt0 30.37 62.47 0.95 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.593 ' HA ' HD22 ' A' 1066 ' ' LEU . 57.3 Cg_endo -72.68 -24.59 18.25 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.993 1.795 . . . . 0.0 112.302 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' 1050 ' ' VAL . 42.7 m -156.25 137.67 13.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 111.567 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' 1049 ' ' VAL . 44.6 pt -145.43 -169.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.585 ' HB3' HG11 ' A' 1049 ' ' VAL . 0.6 OUTLIER -162.14 156.89 22.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.051 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.7 t -62.24 148.31 45.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.384 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 6.5 t -146.04 -7.89 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.743 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.487 ' HB3' ' HA3' ' A' 1082 ' ' GLY . 89.3 p 47.81 54.74 9.49 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.773 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -55.14 -46.23 75.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.739 ' HB2' HG23 ' A' 1081 ' ' VAL . 22.9 m-20 -75.71 -3.1 32.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.301 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.619 ' OD1' ' HG3' ' A' 1080 ' ' GLN . 9.8 t70 65.4 134.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.376 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.619 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 27.6 mt-30 56.87 43.3 25.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' 1078 ' ' ASP . 24.5 m -148.6 -35.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.253 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 63.98 41.15 98.73 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.084 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.633 ' HB ' HD22 ' A' 1077 ' ' ASN . 73.7 mt -85.73 136.5 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.837 0.351 . . . . 0.0 111.345 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' 1084 ' ' TRP . 8.1 m95 -76.15 141.12 41.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.704 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 78.9 p -59.78 -61.73 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.898 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.616 ' O ' ' HG3' ' A' 1029 ' ' PRO . . . -71.09 126.67 13.72 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.843 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -88.9 46.34 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.945 2.43 . . . . 0.0 112.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.753 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 62.37 130.89 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' 1069 ' ' GLU . 86.3 Cg_endo -78.43 -137.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.821 2.347 . . . . 0.0 112.85 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.417 ' H ' ' HB2' ' A' 1089 ' ' PRO . 40.3 tt0 -152.37 140.14 19.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.012 0.435 . . . . 0.0 111.587 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 66.8 m -100.75 130.72 46.82 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.772 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.409 HG22 HE21 ' A' 1090 ' ' GLN . 21.5 pt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.053 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.756 0.313 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -60.77 -44.87 96.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -172.2 131.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -67.01 99.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.115 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.556 ' N ' HG22 ' A' ' 982' ' ' VAL . 17.1 tppt? -84.9 132.62 34.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.968 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.9 p -82.08 133.31 35.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.016 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 98.9 m -80.52 36.26 0.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.022 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 962' ' ' SER . 58.7 tptt 63.38 133.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 56.5 m -70.9 116.99 51.87 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.321 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.771 ' HG2' HG13 ' A' ' 974' ' ' VAL . 61.2 Cg_endo -72.99 120.68 6.76 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.243 1.962 . . . . 0.0 112.168 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 23.5 Cg_exo -63.98 -61.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.232 1.955 . . . . 0.0 111.299 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 170.65 96.93 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.262 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.596 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 58.0 Cg_exo -53.79 179.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.759 2.306 . . . . 0.0 112.668 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 972' ' ' GLY . 92.9 t -48.92 90.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.796 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.801 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 75.0 m-20 71.22 -26.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.262 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -68.52 114.2 5.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.415 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.566 ' H ' ' HA ' ' A' ' 990' ' ' CYS . 77.3 mmm -80.84 124.06 28.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.771 HG13 ' HG2' ' A' ' 966' ' ' PRO . 0.3 OUTLIER -92.38 138.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.45 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.414 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 23.3 m170 -122.65 108.96 13.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.4 98.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.097 0.475 . . . . 0.0 109.832 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.19 -93.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.197 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -68.96 -58.4 4.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 0.0 110.182 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.574 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 54.6 m-20 -164.62 -133.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.191 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.58 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 5.0 pt -155.63 -16.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.254 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.968 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 68.1 mt-30 -73.53 177.36 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.621 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.556 HG22 ' N ' ' A' ' 961' ' ' LYS . 99.9 t -44.28 144.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.528 ' N ' HG11 ' A' ' 982' ' ' VAL . . . 77.25 -38.24 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.295 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.574 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 49.2 m -68.51 148.1 51.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.845 0.323 . . . . 0.0 110.373 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' 1002 ' ' ALA . 5.3 tmm_? -138.44 127.6 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 111.336 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.675 HD11 HG23 ' A' ' 974' ' ' VAL . 17.4 pt -96.97 -176.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.095 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' 1001 ' ' SER . 50.5 p -150.14 127.96 11.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.004 0.43 . . . . 0.0 111.605 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' 1000 ' ' SER . 1.4 m-85 -85.18 -176.58 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 69.2 m -161.47 -34.41 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.676 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.566 ' HA ' ' H ' ' A' ' 973' ' ' MET . 43.0 t 68.36 167.14 0.26 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 81.1 p -60.15 -170.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 51.6 m -88.8 129.55 35.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.155 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 72.25 39.56 57.38 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.788 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -146.87 133.24 19.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.414 HH11 ' HG3' ' A' ' 995' ' ' ARG . 35.2 ttt85 -98.68 113.74 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.0 111.283 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.998 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 4.1 pp -76.14 138.39 40.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.498 . . . . 0.0 111.467 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.633 ' O ' ' HB2' ' A' 1018 ' ' PRO . 1.7 mp -95.6 153.18 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.632 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.37 23.45 58.63 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.354 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 80.2 m-70 65.58 141.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.744 ' HB3' HD23 ' A' ' 996' ' ' LEU . 86.9 p -86.26 50.3 1.96 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.726 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 23.0 t -161.81 165.96 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.484 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' 1015 ' ' THR . . . -165.2 129.56 2.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -104.94 124.6 49.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.031 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 49.1 t -74.6 123.7 25.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 13.0 pt -136.99 150.92 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.658 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 961' ' ' LYS . 0.4 OUTLIER -98.89 121.82 41.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.009 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 50.7 m -78.54 -55.5 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.36 37.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.127 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.55 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 0.0 110.33 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.512 HG21 ' N ' ' A' 1011 ' ' ALA . 53.2 m -151.26 149.9 29.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.923 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 963' ' ' CYS . . . -75.1 141.4 43.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.92 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.4 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.5 m-70 -149.45 140.19 22.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.58 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 66.9 m95 -71.81 127.13 31.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.794 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.0 p -52.49 -28.8 21.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.673 ' O ' ' HG2' ' A' 1016 ' ' LYS . 48.2 p -90.64 -24.85 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' 1015 ' ' THR . 15.0 pttp 59.9 152.62 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 123.657 0.598 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.29 105.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.481 2.121 . . . . 0.0 112.157 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.633 ' HB2' ' O ' ' A' ' 997' ' ' ILE . 94.3 Cg_endo -80.14 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' 1018 ' ' PRO . 35.4 pt -148.94 -169.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.44 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.998 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 15.8 t -153.98 110.82 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.626 ' HG3' ' H ' ' A' 1023 ' ' ILE . 3.2 tp-100 -77.66 134.13 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -76.49 6.36 5.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.452 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.666 HG22 ' HA ' ' A' 1080 ' ' GLN . 57.2 mt 53.29 76.55 0.52 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.665 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' 1045 ' ' HIS . 31.3 Cg_exo -59.39 116.83 3.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.242 1.961 . . . . 0.0 111.759 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 10.0 p -91.11 34.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.829 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 43.97 -142.37 2.61 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.062 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' 1042 ' ' GLU . 72.2 mt -106.49 136.35 19.39 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-O 120.619 0.247 . . . . 0.0 111.381 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.405 ' HB3' ' CH2' ' A' 1084 ' ' TRP . 35.3 Cg_endo -64.34 143.32 82.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.588 2.192 . . . . 0.0 111.714 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.86 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 49.4 Cg_exo -55.3 108.88 0.34 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.255 1.97 . . . . 0.0 112.046 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 54.9 m -93.4 124.68 37.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.583 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 62.7 mt -85.26 139.32 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.369 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -56.53 -55.39 34.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.245 0.545 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -80.23 -36.45 34.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.933 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.877 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -72.78 121.83 8.04 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.614 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -83.4 -151.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.403 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 9.3 p90 -155.93 138.97 15.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.545 HD13 ' HD2' ' A' 1053 ' ' ARG . 46.3 mt -122.5 67.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 74.5 m -157.18 -140.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.347 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 11.1 m -119.58 38.63 3.83 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 110.978 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.715 HD22 ' HB ' ' A' 1050 ' ' VAL . 5.1 m120 -80.89 121.32 25.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -156.42 43.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' 1043 ' ' ASN . 37.7 tt0 62.94 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' 1042 ' ' GLU . 73.4 m-80 78.64 52.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' 1045 ' ' HIS . 5.1 m-85 -76.74 -56.75 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.137 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' 1046 ' ' TYR . 21.9 m80 72.62 -44.44 0.59 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.699 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 43.3 t80 171.73 148.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.958 0.409 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 73.6 97.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.754 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' 1047 ' ' GLY . 81.4 p 173.45 156.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 110.979 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' 1072 ' ' ILE . 3.5 p -137.78 155.44 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.967 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.715 ' HB ' HD22 ' A' 1040 ' ' ASN . 13.5 p -143.52 127.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 89.4 m -104.46 120.21 40.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.224 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.544 ' HH ' HD12 ' A' 1072 ' ' ILE . 13.1 m-85 -83.84 148.01 27.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.642 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.545 ' HD2' HD13 ' A' 1037 ' ' ILE . 44.9 ttt85 -142.77 -27.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.017 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.877 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 11.7 t 67.66 154.99 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -51.19 -93.45 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.601 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.752 HD22 ' HB2' ' A' 1064 ' ' PHE . 5.7 mt 61.71 -166.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.226 0.536 . . . . 0.0 111.843 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.544 ' N ' ' N ' ' A' 1061 ' ' ARG . . . 54.28 -121.38 19.52 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.206 -0.906 . . . . 0.0 114.136 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 75.1 p -45.59 -66.43 0.4 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.26 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -87.21 35.62 0.71 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' 1056 ' ' LEU . . . -174.68 -117.68 0.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.563 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.544 ' N ' ' N ' ' A' 1057 ' ' GLY . 11.2 tpt180 85.32 108.22 0.05 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.547 0.739 . . . . 0.0 110.103 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.517 ' O ' ' HG2' ' A' 1062 ' ' LYS . 63.9 tttp 44.65 36.16 1.67 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 122.093 0.949 . . . . 0.0 109.609 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' 1060 ' ' GLY . 31.1 m -104.37 -12.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.591 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.752 ' HB2' HD22 ' A' 1056 ' ' LEU . 70.3 m-85 -156.09 162.99 40.19 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.921 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1065 ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' 1091 ' ' CYS . 44.7 mt-10 -142.4 131.27 22.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.016 0.436 . . . . 0.0 110.826 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 31.0 tp -68.48 147.21 52.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.646 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 58.4 t -138.34 135.46 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.21 -148.03 26.44 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.302 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' 1069 ' ' GLU . 7.0 pm0 -72.1 120.67 81.57 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.452 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 62.7 Cg_endo -75.84 -25.73 10.31 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.747 2.298 . . . . 0.0 112.395 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 54.3 m -137.57 153.95 49.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.739 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.544 HD12 ' HH ' ' A' 1052 ' ' TYR . 36.1 pt -143.01 -169.07 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.098 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' 1085 ' ' SER . 0.4 OUTLIER -160.01 158.26 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.284 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.699 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 10.2 t -62.16 -51.92 65.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.458 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.448 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 15.3 t 45.59 -172.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.974 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.3 p -165.47 143.73 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.681 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.695 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -162.82 -45.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.737 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.695 ' H ' HD21 ' A' 1077 ' ' ASN . 40.3 t0 -81.12 -146.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.499 ' H ' ' CG ' ' A' 1078 ' ' ASP . 36.3 m-20 -82.04 -137.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.666 ' HA ' HG22 ' A' 1023 ' ' ILE . 73.8 mt-30 -81.0 26.16 0.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.549 HG13 HG21 ' A' 1083 ' ' ILE . 17.7 t -77.58 -44.25 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.298 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 59.66 63.22 5.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.191 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.549 HG21 HG13 ' A' 1081 ' ' VAL . 34.4 pt -81.93 129.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.462 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.405 ' CH2' ' HB3' ' A' 1028 ' ' PRO . 20.0 m95 -76.53 163.88 26.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.1 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.491 ' HB2' ' CE1' ' A' 1073 ' ' TYR . 43.8 t -48.62 -32.86 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.641 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.51 147.58 12.26 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.033 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.771 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 73.9 Cg_endo -75.38 49.42 2.36 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.988 2.459 . . . . 0.0 112.78 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.86 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 63.73 133.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.742 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.434 ' HB2' HD13 ' A' 1066 ' ' LEU . 56.1 Cg_endo -71.65 -149.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.116 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -151.93 117.93 5.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.724 0.297 . . . . 0.0 111.442 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' 1065 ' ' GLU . 28.1 p -103.11 88.39 3.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.248 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.404 ' HA ' ' HD1' ' A' 1064 ' ' PHE . 27.8 pt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.841 0.353 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.33 -40.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 51.6 42.93 30.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 45.32 34.83 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.735 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.668 ' HG3' HD13 ' A' 1006 ' ' LEU . 71.9 mmtt -79.38 148.78 31.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.1 p -157.86 127.25 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.253 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.449 ' N ' ' HB2' ' A' 1011 ' ' ALA . 3.7 p -79.86 142.69 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.755 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.82 141.07 58.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.386 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.449 HG21 ' HD2' ' A' ' 966' ' ' PRO . 62.4 m -64.8 130.49 94.82 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.449 ' HD2' HG21 ' A' ' 965' ' ' THR . 31.5 Cg_exo -59.35 120.51 8.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.188 1.925 . . . . 0.0 111.634 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 46.1 Cg_exo -55.97 -50.24 12.98 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.167 1.911 . . . . 0.0 111.659 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 59.2 t0 174.03 106.96 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.92 155.16 19.09 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.366 2.044 . . . . 0.0 111.232 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.688 ' HB ' ' HA ' ' A' 1019 ' ' ILE . 80.4 t -46.55 106.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.79 0.329 . . . . 0.0 111.445 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.669 HD21 ' HB2' ' A' 1020 ' ' CYS . 73.7 m-20 74.72 -53.98 0.67 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.078 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -79.5 138.34 20.22 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.274 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.423 ' HB3' ' HE1' ' A' ' 973' ' ' MET . 86.7 mmm -81.87 -156.65 0.16 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 110.812 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 988' ' ' TYR . 3.3 p -159.29 148.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.441 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.448 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 17.1 m170 -120.15 109.84 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 986' ' ' ILE . 43.3 t -65.33 105.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.645 HG13 HG22 ' A' ' 987' ' ' THR . 44.7 mm -75.23 -94.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.753 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.7 p -67.93 -65.99 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.476 ' OD1' HG12 ' A' ' 980' ' ' ILE . 46.7 t0 -165.71 -132.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.63 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.476 HG12 ' OD1' ' A' ' 979' ' ' ASP . 1.6 pt -155.95 14.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.355 0.597 . . . . 0.0 110.33 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.4 171.24 10.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.353 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.542 HG23 HD23 ' A' 1006 ' ' LEU . 61.9 t -47.51 141.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.646 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.38 -46.95 2.6 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.489 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 151.28 47.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.262 0.531 . . . . 0.0 110.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.842 ' HB3' ' HA ' ' A' 1003 ' ' GLU . 0.0 OUTLIER -138.43 -168.53 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.679 HG23 ' HA ' ' A' ' 976' ' ' VAL . 23.6 pt -148.55 -160.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.97 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.645 HG22 HG13 ' A' ' 977' ' ' ILE . 68.5 p -142.03 124.55 15.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 112.028 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.519 ' HA ' HG21 ' A' ' 974' ' ' VAL . 1.3 m-85 -98.89 150.94 21.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.319 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 19.3 m -150.25 138.95 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.261 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.669 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 42.4 t -81.97 154.39 25.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.285 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 11.0 t -64.87 -139.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.392 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 993' ' ' GLY . 12.8 t -60.94 -142.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.045 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 992' ' ' THR . . . -63.42 75.35 0.04 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 113.971 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.622 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 37.6 m80 -145.94 140.81 27.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.497 HH22 ' HB3' ' A' 1079 ' ' ASP . 41.3 ttm-85 -81.96 118.98 23.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.996 0.427 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.674 HD12 ' HB3' ' A' 1018 ' ' PRO . 5.9 tp -76.2 126.09 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.964 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.649 ' N ' HD13 ' A' ' 996' ' ' LEU . 1.8 mp -107.83 150.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.794 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.614 ' N ' HG21 ' A' ' 997' ' ' ILE . . . 76.58 54.58 4.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.677 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.56 -143.85 0.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.196 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m -160.81 27.27 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.031 0.443 . . . . 0.0 110.152 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 65.9 p -162.17 162.51 28.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.223 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.731 ' HB2' ' HB3' ' A' 1013 ' ' TRP . . . -153.79 130.65 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.837 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.842 ' HA ' ' HB3' ' A' ' 985' ' ' ARG . 21.1 pt-20 -101.74 129.6 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.946 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' 1011 ' ' ALA . 5.9 t -72.17 128.54 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.334 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.403 HD12 ' OG ' ' A' 1014 ' ' SER . 37.5 pt -145.55 169.36 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.103 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.668 HD13 ' HG3' ' A' ' 961' ' ' LYS . 4.0 mm? -81.57 146.43 30.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.938 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.616 ' HB2' ' HD2' ' A' 1012 ' ' HIS . 71.2 m -159.8 59.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 104.99 51.39 0.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.166 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 58.87 24.97 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 110.399 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 71.4 m -151.32 139.21 19.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.679 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.47 ' HB3' ' SG ' ' A' 1004 ' ' CYS . . . -75.33 136.7 40.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.959 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.616 ' HD2' ' HB2' ' A' 1007 ' ' SER . 92.1 m-70 -149.47 141.32 23.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.731 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 70.6 m95 -67.75 123.6 20.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.127 0.489 . . . . 0.0 110.854 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.403 ' OG ' HD12 ' A' 1005 ' ' ILE . 20.7 m -52.39 -24.44 7.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.947 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 55.2 p -103.65 142.02 35.05 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 61.5 pttt -62.61 149.74 88.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.868 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 120.99 9.16 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.304 2.003 . . . . 0.0 111.7 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.674 ' HB3' HD12 ' A' ' 996' ' ' LEU . 32.7 Cg_exo -59.18 145.29 98.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.829 2.353 . . . . 0.0 112.903 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.688 ' HA ' ' HB ' ' A' ' 970' ' ' VAL . 40.3 pt -140.05 130.4 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.669 ' HB2' HD21 ' A' ' 971' ' ' ASN . 74.2 m -86.35 108.93 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.181 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -81.62 130.49 35.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.524 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -71.65 120.14 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' 1080 ' ' GLN . 77.4 mt -67.24 110.97 6.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.741 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.06 125.22 17.51 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.898 2.399 . . . . 0.0 113.424 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.596 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 66.9 m -95.94 133.11 40.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.087 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -79.87 -154.0 8.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.394 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' 1027 ' ' LEU . 0.3 OUTLIER -67.45 138.99 94.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.788 0.328 . . . . 0.0 111.321 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.721 ' HB2' ' HH ' ' A' 1052 ' ' TYR . 51.1 Cg_endo -68.64 148.73 72.75 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.774 2.316 . . . . 0.0 112.048 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.71 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 34.7 Cg_exo -59.15 111.18 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.081 1.854 . . . . 0.0 111.476 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 26.9 p -77.52 122.46 25.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.641 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.502 HG23 HD11 ' A' 1031 ' ' ILE . 18.4 pt -88.59 29.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.851 0.358 . . . . 0.0 111.855 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' 1034 ' ' GLY . . . 52.87 125.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.495 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' 1032 ' ' ALA . 77.1 m-20 71.43 -26.6 0.17 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.234 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -69.54 124.73 16.09 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.717 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' 1053 ' ' ARG . 1.5 m-20 -76.46 -159.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.657 0.265 . . . . 0.0 110.368 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' 1051 ' ' THR . 45.6 p90 -155.99 137.8 14.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 20.3 mm -128.77 37.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.74 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 78.2 p -69.24 145.48 53.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.615 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 38.2 m -59.42 -38.37 80.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.647 HD21 ' HB3' ' A' 1048 ' ' SER . 23.4 p30 -72.19 -155.44 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.597 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' 1040 ' ' ASN . 18.3 mmt85 -162.2 -54.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.701 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' 1043 ' ' ASN . 42.0 tt0 -162.89 148.73 12.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' 1042 ' ' GLU . 75.4 m-20 78.12 65.2 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.59 134.92 39.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.308 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' 1046 ' ' TYR . 13.1 m80 -96.93 -51.52 4.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.546 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 69.7 t80 171.06 144.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.412 0.445 . . . . 0.0 110.55 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 76.5 -14.54 6.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.221 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.647 ' HB3' HD21 ' A' 1040 ' ' ASN . 65.5 m -47.36 136.15 9.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.033 0.444 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' 1072 ' ' ILE . 88.7 t -102.19 146.88 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.224 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.74 ' HA ' ' HB3' ' A' 1038 ' ' SER . 30.8 m -142.57 126.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.398 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' 1036 ' ' PHE . 59.1 m -100.49 108.69 20.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.721 ' HH ' ' HB2' ' A' 1028 ' ' PRO . 21.0 m-85 -77.08 163.13 26.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.307 0.575 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.742 ' HB2' ' HB2' ' A' 1035 ' ' ASP . 75.6 mtp180 -142.76 -138.96 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.655 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.486 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 48.7 t -163.7 145.42 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 111.686 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.1 68.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.243 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.6 ' N ' HD21 ' A' 1056 ' ' LEU . 3.7 mm? -72.22 41.91 0.09 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 53.37 -106.15 0.39 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.525 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.544 ' HB2' ' HD3' ' A' 1061 ' ' ARG . 66.8 m -67.37 -48.28 67.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.432 ' HG2' HH11 ' A' 1059 ' ' ARG . 11.6 tpt180 -165.83 -49.85 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.044 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' A' 1056 ' ' LEU . . . -164.38 39.91 0.31 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.752 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.656 ' HD2' ' N ' ' A' 1061 ' ' ARG . 0.7 OUTLIER -83.14 172.76 12.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 110.769 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 58.5 tttm -65.48 79.91 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' 1064 ' ' PHE . 6.9 m -155.14 92.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.637 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.643 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 0.8 OUTLIER 74.27 141.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.695 -178.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1065 ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.8 mt-10 -137.27 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.064 0.459 . . . . 0.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' 1070 ' ' PRO . 38.7 tp -68.44 152.09 45.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.156 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' 1089 ' ' PRO . 65.1 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 77.51 -168.37 54.39 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' 1069 ' ' GLU . 15.2 pm0 -72.05 126.85 91.13 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.702 ' HB3' HD23 ' A' 1066 ' ' LEU . 96.8 Cg_endo -82.17 -36.95 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.38 2.053 . . . . 0.0 111.87 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.8 p -83.81 140.87 31.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.179 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.466 HD12 ' CE1' ' A' 1052 ' ' TYR . 36.3 pt -147.78 -171.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.899 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.3 p90 -162.26 143.87 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.699 0.285 . . . . 0.0 111.386 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.937 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 52.1 t -66.51 154.15 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.075 0.464 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.48 HG21 ' O ' ' A' 1083 ' ' ILE . 10.2 t -147.59 -144.62 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.106 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.405 ' HG ' HD11 ' A' 1023 ' ' ILE . 47.5 t -155.76 137.77 14.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.018 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.506 ' N ' HD21 ' A' 1077 ' ' ASN . 0.0 OUTLIER -166.58 31.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.757 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.7 t70 175.84 50.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.255 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.497 ' HB3' HH22 ' A' ' 995' ' ' ARG . 1.5 m-20 61.88 -125.24 0.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.607 ' HA ' HG22 ' A' 1023 ' ' ILE . 25.3 pt20 -66.01 -140.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.51 0.195 . . . . 0.0 110.71 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.498 HG21 ' HG3' ' A' 1080 ' ' GLN . 25.9 t 74.22 -45.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.992 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 66.36 62.61 4.5 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.48 ' O ' HG21 ' A' 1075 ' ' THR . 74.3 mt -80.19 130.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 110.972 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.937 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 26.1 m95 -72.6 177.09 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.0 t -55.52 -64.2 0.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.684 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.57 131.66 1.6 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.628 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.71 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 93.7 Cg_endo -79.72 48.64 2.92 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.828 2.352 . . . . 0.0 111.698 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.684 ' N ' ' HD2' ' A' 1089 ' ' PRO . . . -62.57 -47.34 88.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.34 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' 1088 ' ' ALA . 4.9 Cg_endo -48.45 137.12 25.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.432 2.088 . . . . 0.0 112.112 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.89 132.99 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 15.2 t -102.49 137.79 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.415 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' 1091 ' ' CYS . 8.1 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.353 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.602 0.239 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -176.2 -42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -170.48 52.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.121 0.486 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.95 41.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.424 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 982' ' ' VAL . 1.0 OUTLIER 55.86 47.11 20.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.439 . . . . 0.0 111.436 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 964' ' ' LYS . 81.4 p -89.95 132.2 35.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 73.0 m -79.93 39.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.798 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.4 OUTLIER 60.58 116.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.595 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 51.0 m -59.84 112.81 5.89 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.081 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.621 ' HB2' HG23 ' A' ' 974' ' ' VAL . 27.2 Cg_exo -62.0 113.05 1.7 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.11 1.873 . . . . 0.0 111.761 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 968' ' ' ASP . 26.5 Cg_endo -62.39 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.203 1.935 . . . . 0.0 111.277 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 967' ' ' PRO . 2.5 p30 176.19 119.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.811 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 37.4 Cg_endo -66.92 149.34 83.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.339 2.026 . . . . 0.0 111.267 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 98.6 t -40.65 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.826 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.551 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 75.6 m-20 75.27 -51.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.662 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -68.56 -172.37 7.33 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.88 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.811 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 67.3 mtm -156.7 136.29 12.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.675 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.783 ' HB ' HD13 ' A' ' 986' ' ' ILE . 2.6 m -85.27 149.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.469 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 32.8 m170 -114.93 104.0 11.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.501 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 59.5 t -70.43 92.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.043 0.449 . . . . 0.0 110.333 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.18 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.881 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 38.0 p -71.53 -68.83 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.343 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 18.6 t70 -165.67 -153.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.353 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.493 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 11.4 pt -155.94 11.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.618 0.247 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.669 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 25.7 mt-30 -87.22 30.81 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.669 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 67.4 t 100.61 143.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.553 0.741 . . . . 0.0 111.762 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.575 ' N ' HG11 ' A' ' 982' ' ' VAL . . . 75.87 -46.22 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.626 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.496 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 57.9 m -68.41 150.79 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.538 ' H ' ' HD2' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -138.4 135.87 35.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.228 0.537 . . . . 0.0 111.113 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.783 HD13 ' HB ' ' A' ' 974' ' ' VAL . 20.1 pt -91.06 -163.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.226 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 45.5 p -146.38 123.72 11.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.004 0.43 . . . . 0.0 111.561 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.62 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.6 OUTLIER -91.86 151.12 20.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.565 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.8 p -155.18 125.7 6.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 61.3 m -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 992' ' ' THR . 62.5 p 27.94 -143.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.054 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 991' ' ' THR . 7.3 t -117.32 -24.72 7.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.396 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -135.5 45.49 1.1 Allowed Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.111 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.413 ' HB2' ' OG1' ' A' ' 991' ' ' THR . 27.5 m80 -139.91 144.92 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.693 0.283 . . . . 0.0 110.589 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.563 ' NH2' ' HA ' ' A' 1079 ' ' ASP . 43.7 ttm-85 -81.97 125.97 31.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.617 HD11 ' HG ' ' A' 1000 ' ' SER . 7.0 tt -76.24 123.14 25.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.658 ' HB ' HG13 ' A' 1019 ' ' ILE . 51.7 mm -86.64 148.42 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.402 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.519 ' HA3' ' HZ2' ' A' 1016 ' ' LYS . . . 82.79 -107.04 2.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.832 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' A' 1001 ' ' SER . 91.2 m-70 -149.76 133.02 16.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 15.6 m -78.43 27.41 0.2 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.522 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 999' ' ' HIS . 81.4 p -162.22 145.77 11.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.451 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.98 132.27 10.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.411 . . . . 0.0 111.435 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -104.95 133.53 49.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.197 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 53.1 t -73.46 129.39 37.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' 1012 ' ' HIS . 38.1 pt -130.49 -167.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.802 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.95 127.06 17.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.895 0.379 . . . . 0.0 110.79 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.703 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 56.5 p -81.75 -59.4 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.856 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.52 35.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -37.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 110.361 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 27.6 m -149.98 142.73 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 963' ' ' CYS . . . -75.31 141.18 43.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.226 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.703 ' HE2' ' HB3' ' A' 1007 ' ' SER . 10.9 p80 -149.68 147.19 27.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.3 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 84.2 m95 -67.19 129.61 40.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 111.021 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.4 p -52.37 -27.16 14.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.865 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 75.9 p -107.99 138.35 44.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.583 ' HD3' ' H ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -58.23 152.38 42.3 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.5 103.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.381 2.054 . . . . 0.0 112.532 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.1 154.35 72.7 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.993 2.462 . . . . 0.0 111.767 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.658 HG13 ' HB ' ' A' ' 997' ' ' ILE . 37.1 pt -135.84 -147.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.403 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 971' ' ' ASN . 23.0 m -143.06 -178.78 6.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -166.86 126.54 1.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -74.3 120.71 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.35 119.51 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.213 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.06 122.45 7.64 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.188 1.926 . . . . 0.0 111.758 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 28.8 m -88.41 134.93 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.591 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 161.79 52.24 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.051 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' 1044 ' ' PHE . 10.4 mt -49.75 138.83 17.01 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 117.018 0.409 . . . . 0.0 111.895 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.584 ' HG3' HG22 ' A' 1050 ' ' VAL . 59.2 Cg_endo -70.85 150.31 61.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.893 2.396 . . . . 0.0 111.516 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.512 ' HG2' ' O ' ' A' 1087 ' ' PRO . 83.4 Cg_exo -47.01 126.12 10.89 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.415 2.077 . . . . 0.0 111.985 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.0 p -77.53 126.56 31.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.709 HD11 ' HD2' ' A' 1052 ' ' TYR . 6.7 tt -88.59 111.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -67.11 141.77 57.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 68.84 26.93 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.308 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -175.34 135.06 2.9 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.28 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -74.17 -155.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.564 ' HB2' ' CG1' ' A' 1050 ' ' VAL . 49.0 p90 -156.0 131.89 9.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 111.251 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.546 HG13 ' CZ ' ' A' 1053 ' ' ARG . 47.9 mm -91.3 99.97 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.835 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 44.3 t -171.12 146.58 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.911 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 90.9 m -58.94 -33.61 70.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.485 ' H ' ' HG ' ' A' 1038 ' ' SER . 44.7 t30 -56.53 128.39 35.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -151.69 -31.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.635 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -147.16 -51.73 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.163 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -71.57 135.71 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.585 ' HD2' HD22 ' A' 1027 ' ' LEU . 0.1 OUTLIER -162.21 55.09 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 12.2 m80 -63.5 -47.9 79.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.196 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' 1045 ' ' HIS . 74.0 t80 172.37 161.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.53 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.9 -24.11 3.47 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 49.7 m -47.59 143.87 3.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 110.92 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -142.47 123.53 11.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.782 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.835 ' HA ' ' HB2' ' A' 1038 ' ' SER . 98.1 t -106.55 129.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.042 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.7 m -99.43 125.05 45.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.709 ' HD2' HD11 ' A' 1031 ' ' ILE . 4.6 m-85 -72.24 146.79 47.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.546 ' CZ ' HG13 ' A' 1037 ' ' ILE . 38.3 ttm180 -146.11 -29.24 0.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.75 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 47.7 t 65.44 160.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.464 ' N ' ' HA3' ' A' 1034 ' ' GLY . 75.1 m-20 -62.13 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.584 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.75 ' HB3' ' HA3' ' A' 1060 ' ' GLY . 23.0 mt -154.94 27.0 0.43 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.285 0.564 . . . . 0.0 110.65 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.454 ' HA2' HG22 ' A' 1063 ' ' VAL . . . 53.71 -113.15 2.89 Favored Glycine 0 C--N 1.317 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.859 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 49.3 m -51.44 -50.48 59.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.508 ' O ' HD11 ' A' 1056 ' ' LEU . 25.9 tpt180 -167.7 -53.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.352 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.75 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . -176.89 38.2 0.09 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.942 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' 1061 ' ' ARG . 34.6 ttm180 -93.86 33.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' 1062 ' ' LYS . 26.2 ttpp 41.09 52.19 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.172 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.527 HG21 ' N ' ' A' 1064 ' ' PHE . 16.1 m -85.02 -39.27 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.253 0.549 . . . . 0.0 110.728 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.582 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 2.9 m-85 -85.96 147.76 26.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.066 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -134.44 128.91 34.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 111.658 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.716 HD22 ' N ' ' A' 1067 ' ' VAL . 4.5 tt -68.6 140.31 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.309 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.716 ' N ' HD22 ' A' 1066 ' ' LEU . 78.5 t -135.49 109.51 10.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 111.142 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.561 ' O ' ' HG3' ' A' 1089 ' ' PRO . . . 76.98 156.55 7.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.754 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.653 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 38.2 tt0 30.37 77.39 0.32 Allowed Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.632 ' HA ' HD12 ' A' 1066 ' ' LEU . 90.0 Cg_endo -86.66 7.39 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.588 2.192 . . . . 0.0 112.473 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 53.1 m -156.23 150.01 24.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.387 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.533 ' O ' HG21 ' A' 1049 ' ' VAL . 15.5 pt -148.0 150.15 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.591 ' HB3' HG21 ' A' 1049 ' ' VAL . 2.8 p90 -160.12 145.67 15.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.601 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.907 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 42.0 t -66.28 144.12 56.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.7 t -144.07 -7.55 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' 1082 ' ' GLY . 57.8 m 66.11 136.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.308 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.47 HD22 ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -172.18 43.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.867 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -170.07 -122.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.453 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.563 ' HA ' ' NH2' ' A' ' 995' ' ' ARG . 9.5 t70 -163.09 121.48 2.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.771 0.319 . . . . 0.0 110.757 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.473 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 86.7 mt-30 55.88 42.35 28.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' 1079 ' ' ASP . 21.1 t -147.59 -38.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 110.46 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 76.73 -68.96 2.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.753 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.47 ' HB ' HD22 ' A' 1077 ' ' ASN . 75.5 mt 60.57 130.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.981 0.419 . . . . 0.0 111.202 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.907 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.6 m95 -74.58 -153.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -62.96 -46.84 85.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . 178.66 -149.05 8.69 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.906 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' 1029 ' ' PRO . 10.4 Cg_exo -71.57 -127.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.387 2.725 . . . . 0.0 112.74 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.481 ' H ' ' HB2' ' A' 1087 ' ' PRO . . . -159.33 138.84 8.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 58.5 Cg_endo -68.36 -138.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.505 2.803 . . . . 0.0 113.105 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.464 ' H ' ' HB2' ' A' 1089 ' ' PRO . 40.5 tt0 -152.4 143.51 23.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.177 0.513 . . . . 0.0 111.734 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 42.6 t -103.13 139.38 38.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.48 HG12 HG22 ' A' 1067 ' ' VAL . 11.9 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.127 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -77.42 43.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.548 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.4 mm-40 -68.98 -159.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -80.06 55.36 2.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.548 ' NZ ' ' HB2' ' A' ' 959' ' ' GLU . 47.9 mmtm -77.51 140.97 39.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 83.6 p -155.41 139.85 16.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.464 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.0 m -80.0 140.85 36.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.268 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.93 148.66 49.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.008 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 41.8 m -39.71 119.66 1.37 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.537 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.653 ' HG2' HG13 ' A' ' 974' ' ' VAL . 11.2 Cg_endo -55.03 127.2 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.358 2.039 . . . . 0.0 111.725 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.14 125.14 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.038 1.825 . . . . 0.0 111.37 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.483 ' OD2' ' HE2' ' A' ' 973' ' ' MET . 1.5 m-20 -50.06 120.03 11.17 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.457 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.544 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 77.2 Cg_exo -50.51 140.34 35.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.479 2.119 . . . . 0.0 112.247 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.743 HG22 ' HA ' ' A' 1019 ' ' ILE . 66.9 t -47.03 110.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.508 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.2 m-20 75.66 -45.91 0.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -72.62 -156.02 3.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.896 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.544 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 94.9 mmm -158.85 143.3 15.69 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.51 0.324 . . . . 0.0 110.418 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.653 HG13 ' HG2' ' A' ' 966' ' ' PRO . 0.5 OUTLIER -91.61 144.73 8.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.387 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -117.06 107.96 15.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.736 0.303 . . . . 0.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.717 ' HA ' HG23 ' A' ' 986' ' ' ILE . 57.3 t -66.42 119.59 11.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.731 HG13 ' HA ' ' A' ' 986' ' ' ILE . 31.3 mt -84.43 -89.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.802 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 30.9 p -75.25 -69.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.452 ' O ' HG21 ' A' ' 980' ' ' ILE . 2.6 m-20 -153.13 -147.57 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.95 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 979' ' ' ASP . 12.1 pt -155.95 25.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.705 0.288 . . . . 0.0 111.21 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.681 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 71.3 mt-30 -87.26 -55.75 3.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.474 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.596 HG21 ' C ' ' A' ' 981' ' ' GLN . 13.1 t -173.42 140.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 124.142 0.901 . . . . 0.0 109.469 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.24 -20.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.888 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.437 ' HB2' ' H ' ' A' ' 979' ' ' ASP . 81.1 p -68.34 129.15 39.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.452 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 48.3 ttm-85 -97.47 156.74 16.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.731 ' HA ' HG13 ' A' ' 977' ' ' ILE . 28.2 pt -143.16 136.22 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.455 HG21 HD13 ' A' ' 977' ' ' ILE . 59.4 p -91.0 126.24 36.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.06 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.898 ' HB2' ' HA ' ' A' 1000 ' ' SER . 2.4 m-85 -96.48 146.93 24.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 15.3 t -145.53 169.34 18.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.827 ' HB2' HD11 ' A' ' 996' ' ' LEU . 4.7 t -158.11 107.07 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.483 ' HB ' ' H ' ' A' ' 992' ' ' THR . 35.6 p 34.73 -150.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.971 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.483 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.4 t -117.91 -37.09 3.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.819 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.525 ' HA2' ' CZ ' ' A' 1046 ' ' TYR . . . -118.05 48.9 0.9 Allowed Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.275 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -144.71 131.81 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.621 HH21 ' HA ' ' A' 1079 ' ' ASP . 39.1 ttm-85 -82.04 109.88 16.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.703 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.827 HD11 ' HB2' ' A' ' 990' ' ' CYS . 6.6 tt -76.44 113.69 14.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.564 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' 1019 ' ' ILE . 2.0 mp -90.11 91.41 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.922 0.868 . . . . 0.0 110.663 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -161.05 -113.71 0.32 Allowed Glycine 0 C--N 1.315 -0.621 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.023 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -154.19 -10.43 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.898 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 19.4 m 57.58 18.52 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.432 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.6 p -162.18 144.39 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -162.97 153.67 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.779 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.436 ' N ' ' OE1' ' A' 1003 ' ' GLU . 11.2 pm0 -135.04 135.46 41.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.724 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 31.6 t -71.41 88.65 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.304 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.43 HD11 HG22 ' A' 1005 ' ' ILE . 37.8 pt -87.33 -167.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.487 ' C ' HD21 ' A' 1006 ' ' LEU . 4.0 tt -158.38 121.89 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.474 ' N ' HD21 ' A' 1006 ' ' LEU . 44.3 t -77.51 -48.04 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.74 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.441 ' N ' HD21 ' A' 1006 ' ' LEU . . . 175.83 -45.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.793 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.32 -48.86 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.2 153.3 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.924 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.32 141.33 43.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.113 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.1 p80 -154.92 147.87 24.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.698 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 41.2 m95 -70.76 126.87 30.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 110.531 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 t -52.43 -25.54 10.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.788 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 30.9 p -95.5 138.81 32.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.589 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 24.0 pttm -79.16 163.8 57.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.354 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.589 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 11.2 Cg_endo -54.28 120.0 7.28 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.086 1.858 . . . . 0.0 111.405 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.662 ' HB2' HD22 ' A' ' 996' ' ' LEU . 72.3 Cg_endo -76.66 136.22 16.92 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.769 2.313 . . . . 0.0 113.521 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.743 ' HA ' HG22 ' A' ' 970' ' ' VAL . 30.0 pt -116.37 124.07 72.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.648 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 84.6 m -91.12 121.46 32.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.615 ' HG2' HD12 ' A' ' 997' ' ' ILE . 96.9 mm-40 -86.52 129.92 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.166 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.561 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.01 129.68 40.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.677 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.1 mm -73.93 107.64 3.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.21 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 92.4 Cg_endo -81.4 123.57 4.43 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.297 1.998 . . . . 0.0 112.477 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.595 ' O ' ' HB2' ' A' 1044 ' ' PHE . 73.3 m -88.64 132.97 34.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.202 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -82.93 -154.61 16.4 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.064 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.742 HD21 ' N ' ' A' 1027 ' ' LEU . 1.7 mm? -72.75 144.9 86.34 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 120.711 0.291 . . . . 0.0 111.519 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.642 ' HG3' HD22 ' A' 1040 ' ' ASN . 27.1 Cg_endo -61.45 166.65 11.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.879 2.386 . . . . 0.0 112.284 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.731 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 81.9 Cg_exo -47.98 -24.35 5.2 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.757 2.305 . . . . 0.0 112.449 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 46.4 p 56.91 144.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.733 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.485 HD11 ' O ' ' A' 1089 ' ' PRO . 2.9 pt -152.88 117.97 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -70.11 67.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.148 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' 1034 ' ' GLY . 15.0 p30 -174.25 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.609 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -79.25 -177.18 49.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.367 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' 1053 ' ' ARG . 3.2 m-20 -156.47 132.65 9.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 5.1 p90 -84.02 152.71 24.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.425 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 39.1 mm -127.71 66.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.328 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.406 ' O ' ' HE1' ' A' 1036 ' ' PHE . 9.6 t -171.08 -141.52 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' 1040 ' ' ASN . 39.7 m -67.57 -103.92 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.685 ' HB2' HG13 ' A' 1050 ' ' VAL . 24.2 t-20 50.1 118.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' 1040 ' ' ASN . 22.0 mmt180 -164.57 -69.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.242 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -156.62 -51.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.188 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.427 HD21 ' N ' ' A' 1043 ' ' ASN . 2.5 m120 -72.87 61.58 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.75 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.595 ' HB2' ' O ' ' A' 1025 ' ' CYS . 73.1 m-85 -76.72 -58.08 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.314 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.697 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 7.2 m80 55.54 -172.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.525 ' CZ ' ' HA2' ' A' ' 993' ' ' GLY . 34.4 t80 -56.9 142.78 40.11 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.48 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.445 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.47 124.34 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' 1073 ' ' TYR . 38.2 m 178.37 144.55 0.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.374 0.67 . . . . 0.0 110.041 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' 1072 ' ' ILE . 11.2 p -155.83 145.32 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' 1040 ' ' ASN . 27.3 m -149.54 141.88 17.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.638 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.5 m -88.68 124.46 34.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.327 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.555 ' HB2' ' HA ' ' A' 1070 ' ' PRO . 11.3 m-85 -85.26 147.95 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.722 0.772 . . . . 0.0 112.789 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' 1035 ' ' ASP . 43.1 ttt85 -148.71 129.75 14.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.29 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 12.8 t -76.44 153.54 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.675 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -49.19 -70.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.02 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.8 HD21 ' HA3' ' A' 1060 ' ' GLY . 4.3 mt 62.37 164.99 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.8 42.25 2.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.394 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.575 ' O ' ' HD2' ' A' 1059 ' ' ARG . 84.0 p 49.73 29.12 2.99 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.349 . . . . 0.0 111.391 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' 1058 ' ' SER . 0.7 OUTLIER -152.77 -37.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.8 ' HA3' HD21 ' A' 1056 ' ' LEU . . . 98.08 46.36 2.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.702 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' 1061 ' ' ARG . 13.5 tpp85 -76.93 40.2 0.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' 1062 ' ' LYS . 24.7 ttmm 44.17 35.04 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.528 0.68 . . . . 0.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 11.3 m -95.9 -10.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.452 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.69 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 88.3 m-85 -153.93 141.48 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.606 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -142.16 119.14 11.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.01 0.433 . . . . 0.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.898 HD12 ' HB3' ' A' 1070 ' ' PRO . 5.5 tt -73.42 130.16 39.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.651 ' N ' HD21 ' A' 1066 ' ' LEU . 7.5 p -156.64 73.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.038 0.923 . . . . 0.0 110.88 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' 1089 ' ' PRO . . . -172.64 23.05 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.218 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.727 ' HB3' ' O ' ' A' 1068 ' ' GLY . 7.8 tt0 81.99 104.4 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.898 ' HB3' HD12 ' A' 1066 ' ' LEU . 89.0 Cg_endo -82.96 31.64 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.912 2.408 . . . . 0.0 113.229 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.9 p -158.86 134.65 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.561 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' 1049 ' ' VAL . 42.2 pt -140.89 152.31 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.06 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' 1048 ' ' SER . 9.9 p90 -146.77 137.08 23.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.421 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.628 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 41.7 t -75.18 148.01 39.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.229 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.51 ' O ' HG21 ' A' 1075 ' ' THR . 5.2 t -155.07 130.32 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.631 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.424 ' HB3' HG22 ' A' 1023 ' ' ILE . 80.9 p -75.66 153.72 37.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.327 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.64 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -165.34 -22.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.64 ' H ' HD21 ' A' 1077 ' ' ASN . 57.9 m-20 -116.46 -128.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.216 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.621 ' HA ' HH21 ' A' ' 995' ' ' ARG . 54.5 m-20 -76.78 -150.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -85.53 29.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.044 0.45 . . . . 0.0 110.495 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.603 HG13 HG21 ' A' 1083 ' ' ILE . 32.4 t -79.97 -35.45 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.489 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' 1083 ' ' ILE . . . 85.09 -48.98 4.15 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.729 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.603 HG21 HG13 ' A' 1081 ' ' VAL . 0.1 OUTLIER 39.38 118.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.628 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 22.2 m95 -72.23 138.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.507 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 79.8 p -64.46 -54.31 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' 1072 ' ' ILE . . . -72.07 125.51 11.02 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.285 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.13 41.13 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.579 2.186 . . . . 0.0 112.953 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 60.46 134.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.489 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.832 ' HA ' ' HA2' ' A' 1068 ' ' GLY . 40.4 Cg_endo -68.13 156.74 64.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.226 2.617 . . . . 0.0 113.71 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.552 HE21 HG22 ' A' 1092 ' ' ILE . 60.9 tp60 -104.69 114.73 29.12 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.797 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 48.1 t -97.29 132.15 43.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.327 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.552 HG22 HE21 ' A' 1090 ' ' GLN . 7.0 pt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.422 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -173.06 135.31 0.59 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.988 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.532 ' HA ' ' HZ1' ' A' ' 961' ' ' LYS . 17.3 tp10 56.87 52.68 9.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -167.78 45.09 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.066 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 961' ' ' LYS . 2.6 mppt? -77.63 137.35 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.927 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 86.5 p -82.09 136.29 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' 1012 ' ' HIS . 87.8 m -79.96 34.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 962' ' ' SER . 86.3 tttt 62.73 139.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.71 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.4 m -61.61 124.75 82.55 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.336 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.05 118.29 5.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.6 2.2 . . . . 0.0 112.561 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 135.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 111.271 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -48.39 104.28 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.19 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 54.7 Cg_endo -69.15 -151.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.607 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' 1020 ' ' CYS . 45.5 t -52.76 73.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.812 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 969' ' ' PRO . 75.5 m-20 72.57 -35.85 0.34 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.558 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.44 130.35 26.18 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.923 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.1 mtp -92.27 145.5 24.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.47 HG23 HD11 ' A' ' 986' ' ' ILE . 3.1 p -84.88 151.15 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -114.02 99.33 7.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.674 ' HA ' HG23 ' A' ' 986' ' ' ILE . 39.2 t -75.31 85.65 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 987' ' ' THR . 46.1 mt -74.75 -92.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.778 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 23.3 p -61.84 -65.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.582 ' O ' HG21 ' A' ' 980' ' ' ILE . 3.6 m-20 -159.16 -136.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.578 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 979' ' ' ASP . 6.5 pt -154.31 -19.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.06 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.927 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 25.2 mt-30 -73.01 175.8 6.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.654 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' 1004 ' ' CYS . 64.2 t -44.29 147.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.832 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.86 -36.82 1.89 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.354 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.47 ' HG ' ' N ' ' A' ' 985' ' ' ARG . 43.1 t -68.38 158.86 32.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 0.0 111.092 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.647 ' HE ' ' HB2' ' A' 1003 ' ' GLU . 39.4 ttm180 -145.16 120.75 10.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.8 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.674 HG23 ' HA ' ' A' ' 976' ' ' VAL . 18.8 pt -97.16 -168.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.351 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 986' ' ' ILE . 73.7 p -153.09 124.09 7.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.5 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 2.0 m-85 -94.76 154.47 17.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.184 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 72.5 p -152.91 127.47 9.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.111 0.482 . . . . 0.0 111.13 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' A' ' 996' ' ' LEU . 73.3 m -82.94 148.13 27.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.052 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 26.1 p -62.06 157.65 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.182 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 60.7 m -48.68 138.29 11.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.583 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 95.9 -41.86 2.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.572 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -82.41 133.46 35.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.979 0.389 . . . . 0.0 111.286 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' 1021 ' ' GLN . 40.5 ttt85 -82.25 120.65 25.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.583 HD22 ' HB3' ' A' 1000 ' ' SER . 7.3 tp -65.97 124.47 22.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.177 0.513 . . . . 0.0 111.804 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.789 ' HB ' HG21 ' A' 1019 ' ' ILE . 46.7 mm -107.83 145.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.919 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.45 169.92 30.29 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.525 ' HD2' HG23 ' A' 1015 ' ' THR . 88.5 m-70 -74.98 125.56 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 0.0 111.587 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.583 ' HB3' HD22 ' A' ' 996' ' ' LEU . 81.6 p -68.18 -46.8 69.69 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.066 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.408 ' N ' ' HG ' ' A' 1000 ' ' SER . 80.6 p -77.93 139.77 39.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.215 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.64 127.62 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.282 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.647 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 43.4 tt0 -98.02 132.09 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.709 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 52.9 t -66.7 94.54 0.3 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' 1014 ' ' SER . 22.2 pt -90.07 -155.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.872 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.684 HD21 ' HA ' ' A' 1011 ' ' ALA . 2.0 tm? -149.96 124.21 9.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.599 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.502 ' N ' HD11 ' A' 1006 ' ' LEU . 46.1 t -80.53 -48.4 12.82 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.403 ' N ' HD11 ' A' 1006 ' ' LEU . . . -161.44 -54.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.305 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -123.53 -52.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.1 m -88.9 144.34 26.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.29 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.684 ' HA ' HD21 ' A' 1006 ' ' LEU . . . -75.24 145.02 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.044 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.478 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 93.3 m-70 -149.17 140.69 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.448 ' CH2' HD12 ' A' ' 986' ' ' ILE . 82.5 m95 -68.12 135.68 52.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.671 ' HA ' HD12 ' A' 1005 ' ' ILE . 46.1 m -52.34 -24.68 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.184 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.525 HG23 ' HD2' ' A' ' 999' ' ' HIS . 53.4 p -132.94 137.59 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 111.817 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -56.51 150.1 36.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.06 117.99 2.16 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.342 2.028 . . . . 0.0 112.521 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.5 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 72.5 Cg_exo -51.06 138.35 43.91 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.693 2.262 . . . . 0.0 112.063 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.789 HG21 ' HB ' ' A' ' 997' ' ' ILE . 0.0 OUTLIER -110.08 139.7 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.41 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.644 ' HB2' HG13 ' A' ' 970' ' ' VAL . 63.0 m -97.68 128.91 44.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.816 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 995' ' ' ARG . 3.1 tp-100 -82.17 125.52 31.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.314 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' 1022 ' ' ARG . 11.4 tpt180 -67.71 -26.36 66.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.487 HG21 ' HA ' ' A' 1080 ' ' GLN . 49.7 mt 58.24 61.53 5.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.245 0.545 . . . . 0.0 109.678 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.641 ' HA ' ' N ' ' A' 1046 ' ' TYR . 38.1 Cg_endo -65.68 138.49 54.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.13 2.553 . . . . 0.0 114.008 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.482 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 38.5 m -88.43 141.23 28.71 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.744 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.19 -153.36 4.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.143 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.462 ' HA ' HD21 ' A' 1027 ' ' LEU . 26.9 mt -71.95 155.51 91.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.113 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.629 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 31.2 Cg_exo -58.01 154.48 38.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.265 . . . . 0.0 111.879 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.546 ' HD2' ' OH ' ' A' 1052 ' ' TYR . 55.3 Cg_exo -51.13 -17.3 3.55 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.435 2.09 . . . . 0.0 112.274 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 73.8 p 49.08 94.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.663 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' 1031 ' ' ILE . 29.5 pt -84.1 104.3 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . 43.03 -139.36 0.21 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -79.64 41.74 0.5 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.44 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -64.68 -141.43 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.361 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' 1036 ' ' PHE . 19.6 t70 -168.03 -159.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.32 . . . . 0.0 110.795 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.544 ' H ' ' CG ' ' A' 1035 ' ' ASP . 1.4 t80 -156.0 125.82 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.221 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.465 HD13 ' C ' ' A' 1036 ' ' PHE . 4.3 mp -143.98 70.46 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.148 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.578 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 40.4 t -159.63 -119.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' 1040 ' ' ASN . 65.3 p -140.5 111.73 7.19 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.832 0.348 . . . . 0.0 111.917 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.506 ' HB2' ' CE2' ' A' 1044 ' ' PHE . 19.7 p30 165.31 130.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.062 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' 1043 ' ' ASN . 84.0 mtm180 -153.17 117.25 4.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.745 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.563 ' N ' ' HE1' ' A' 1044 ' ' PHE . 0.5 OUTLIER 53.1 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.551 179.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' 1041 ' ' ARG . 72.1 m-20 -70.37 65.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.13 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.629 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 1.9 m-85 -76.79 135.69 38.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.335 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.515 ' HA ' ' CB ' ' A' 1024 ' ' PRO . 52.0 m-70 -141.91 -165.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.553 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.641 ' N ' ' HA ' ' A' 1024 ' ' PRO . 10.5 t80 -58.02 139.25 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.414 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 64.87 111.18 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.453 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' 1073 ' ' TYR . 79.6 p 176.54 128.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.265 0.555 . . . . 0.0 110.521 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.795 HG21 ' HB3' ' A' 1073 ' ' TYR . 97.4 t -102.16 147.04 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.965 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.578 ' HA ' ' HB3' ' A' 1038 ' ' SER . 12.3 p -138.46 126.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.927 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.439 HG21 ' O ' ' A' 1070 ' ' PRO . 87.9 m -101.04 117.32 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 111.559 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.546 ' OH ' ' HD2' ' A' 1029 ' ' PRO . 4.8 m-85 -83.94 134.71 34.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.186 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.46 ' HB2' HD12 ' A' 1037 ' ' ILE . 50.9 mtp85 -148.19 25.02 1.02 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.812 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.558 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 57.9 m 58.78 150.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' 1056 ' ' LEU . 13.5 t-20 -68.29 39.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.576 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' 1062 ' ' LYS . 0.4 OUTLIER 27.59 50.56 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.685 ' HA3' ' HE1' ' A' 1064 ' ' PHE . . . 73.7 -40.02 0.95 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.269 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 47.0 t -169.87 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.906 0.353 . . . . 0.0 111.274 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.636 ' HD3' ' N ' ' A' 1059 ' ' ARG . 0.0 OUTLIER -163.0 -28.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.451 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' 1061 ' ' ARG . . . -151.02 149.39 21.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.837 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.47 ' N ' ' HB3' ' A' 1056 ' ' LEU . 44.5 ttm-85 71.61 116.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' 1056 ' ' LEU . 40.1 ttmt -72.99 146.0 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.469 HG21 ' CD1' ' A' 1064 ' ' PHE . 28.5 m -143.87 -22.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.733 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 4.7 m-85 -73.82 -26.36 60.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.72 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1065 ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' 1062 ' ' LYS . 58.5 mm-40 61.39 111.66 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.751 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.801 HD23 ' H ' ' A' 1067 ' ' VAL . 3.2 tm? -71.23 149.48 46.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.323 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.801 ' H ' HD23 ' A' 1066 ' ' LEU . 21.3 t -129.56 138.57 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.95 -153.94 42.55 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.536 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.515 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.0 pt-20 -72.11 113.46 20.69 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-O 120.504 0.192 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.707 ' HB3' HD13 ' A' 1066 ' ' LEU . 93.2 Cg_endo -84.67 24.41 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.274 1.982 . . . . 0.0 112.929 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' 1050 ' ' VAL . 40.4 t -158.87 142.11 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 111.678 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.522 ' O ' HG11 ' A' 1049 ' ' VAL . 42.2 pt -141.92 -177.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.482 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.795 ' HB3' HG21 ' A' 1049 ' ' VAL . 2.3 p90 -160.21 151.09 18.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 32.3 t -62.14 149.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.611 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.538 HG23 ' HA ' ' A' 1085 ' ' SER . 7.4 t -149.01 -27.44 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.646 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 58.3 m 58.78 54.3 5.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.703 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -63.84 -43.04 97.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.173 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.703 ' H ' HD21 ' A' 1077 ' ' ASN . 33.2 m-20 -74.15 -82.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.395 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.504 ' OD1' HG21 ' A' 1081 ' ' VAL . 2.2 p30 -163.18 -135.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.026 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.487 ' HA ' HG21 ' A' 1023 ' ' ILE . 64.5 mt-30 -68.34 12.17 0.14 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.504 HG21 ' OD1' ' A' 1079 ' ' ASP . 14.0 t -68.04 -43.56 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.311 0.577 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . 82.57 42.06 8.65 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.471 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 62.7 mt -82.02 142.3 13.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.668 0.271 . . . . 0.0 110.295 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.516 ' CZ3' HG13 ' A' 1050 ' ' VAL . 28.4 m95 -70.5 -163.97 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.358 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.538 ' HA ' HG23 ' A' 1075 ' ' THR . 81.6 p -65.02 -63.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 177.86 127.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.224 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.41 140.62 70.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.518 2.145 . . . . 0.0 111.537 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.68 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -165.69 -50.88 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.611 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.68 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.4 Cg_endo -52.36 145.55 35.71 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.395 2.063 . . . . 0.0 111.76 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -152.37 136.8 16.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.662 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 94.7 m -91.9 123.15 35.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.015 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.454 HG23 HD11 ' A' 1092 ' ' ILE . 7.6 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.662 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.23 -135.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -169.16 50.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.045 0.45 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -76.94 52.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.669 ' HA ' ' HE3' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -77.58 134.01 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.113 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.545 ' OG ' ' HG2' ' A' ' 981' ' ' GLN . 25.1 m -154.4 135.0 13.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 92.8 m -79.92 136.62 36.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -63.78 138.68 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.477 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 7.1 t -57.44 122.65 56.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.842 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.805 ' HG2' HG12 ' A' ' 974' ' ' VAL . 42.4 Cg_endo -66.95 107.62 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.384 2.056 . . . . 0.0 111.98 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 965' ' ' THR . 26.4 Cg_exo -61.69 134.6 51.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.549 2.166 . . . . 0.0 111.694 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -53.26 106.97 0.73 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.777 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 97.4 Cg_endo -82.34 -150.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.534 2.156 . . . . 0.0 112.903 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' 1020 ' ' CYS . 1.4 p -48.94 83.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.52 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 969' ' ' PRO . 76.6 m-20 69.83 -28.37 0.17 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.703 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -68.4 147.27 46.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.444 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 63.4 mtm -143.19 131.8 22.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 110.413 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.805 HG12 ' HG2' ' A' ' 966' ' ' PRO . 3.3 p -87.4 154.03 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.366 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.405 ' H ' HG21 ' A' ' 974' ' ' VAL . 14.5 m170 -114.7 100.02 7.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.774 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.487 ' HA ' HG23 ' A' ' 986' ' ' ILE . 35.6 t -65.73 106.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.6 mt -75.27 -94.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 22.0 p -72.44 -56.35 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 0.0 110.144 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -165.75 -131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.563 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.511 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 1.8 pt -153.59 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.017 0.437 . . . . 0.0 111.113 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.545 ' HG2' ' OG ' ' A' ' 962' ' ' SER . 19.8 mt-30 -87.33 -176.44 5.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.69 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 983' ' ' GLY . 97.8 t -48.57 139.99 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.251 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.44 ' N ' HG11 ' A' ' 982' ' ' VAL . . . 77.35 -34.17 1.55 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 981' ' ' GLN . 92.1 p -67.92 130.31 42.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.899 0.849 . . . . 0.0 111.127 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.691 ' HG2' ' HB3' ' A' 1003 ' ' GLU . 99.1 mtt180 -101.58 163.63 12.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 974' ' ' VAL . 26.0 pt -150.68 139.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.083 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' 1000 ' ' SER . 81.1 p -102.95 122.25 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -92.33 155.51 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.263 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 989' ' ' SER . . . . . 0.62 ' HA ' HD13 ' A' ' 996' ' ' LEU . 16.6 m -160.3 122.6 3.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.38 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.703 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 94.4 m -82.25 68.16 8.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 992' ' ' THR . 33.7 p 45.95 -155.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.479 . . . . 0.0 111.864 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.4 ' H ' ' HB ' ' A' ' 991' ' ' THR . 13.6 t -97.4 -45.39 6.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.211 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -93.17 43.73 2.53 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.419 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.493 ' CE1' ' HB2' ' A' 1022 ' ' ARG . 56.1 m-70 -157.53 135.21 10.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.66 ' HG3' ' HG3' ' A' 1080 ' ' GLN . 77.7 ttt180 -82.19 129.68 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.692 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 4.0 tt -75.01 100.18 4.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.443 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.597 ' HB ' ' O ' ' A' 1019 ' ' ILE . 26.6 mm -87.35 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.126 0.965 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.49 ' H ' HD21 ' A' ' 996' ' ' LEU . . . -156.52 -118.55 0.58 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.291 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -153.08 109.92 3.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -57.2 -54.64 44.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.174 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.5 p -77.86 137.23 38.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.485 ' HB1' ' HE1' ' A' ' 988' ' ' TYR . . . -157.94 150.06 22.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.691 ' HB3' ' HG2' ' A' ' 985' ' ' ARG . 10.1 pt-20 -135.11 132.02 37.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 44.2 t -66.68 93.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.766 HG22 ' HB2' ' A' 1014 ' ' SER . 40.8 pt -87.33 -168.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 11.0 tp -158.36 120.94 3.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 25.4 m -81.51 -55.17 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.085 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 164.57 47.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -175.61 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.08 0.467 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 82.3 m -151.35 146.7 26.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.018 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -72.94 135.92 45.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.437 . . . . 0.0 110.77 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.45 145.05 26.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.703 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.511 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 58.9 m95 -69.68 128.2 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.766 ' HB2' HG22 ' A' 1005 ' ' ILE . 48.0 t -52.47 -26.2 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.257 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 64.2 p -86.93 130.87 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.776 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.72 155.63 81.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.874 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -41.42 112.44 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.154 1.902 . . . . 0.0 111.905 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.438 ' HG3' ' CD2' ' A' ' 988' ' ' TYR . 51.0 Cg_endo -69.9 129.1 16.88 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.928 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.597 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 8.1 tt -116.62 147.24 20.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.558 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.631 ' H ' HG12 ' A' ' 970' ' ' VAL . 72.1 m -106.88 156.83 18.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.15 124.1 6.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.985 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.705 ' HD3' ' HB3' ' A' 1046 ' ' TYR . 40.6 ttm180 -59.43 132.71 54.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.851 HD12 ' HA ' ' A' 1080 ' ' GLN . 68.1 mt -73.15 122.4 87.54 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.426 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' 1045 ' ' HIS . 96.2 Cg_endo -84.95 130.79 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.861 2.374 . . . . 0.0 112.532 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.498 ' HB3' ' NE1' ' A' 1084 ' ' TRP . 22.5 m -88.39 32.33 0.78 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.525 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1026 ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' 1044 ' ' PHE . . . 40.18 -130.69 2.77 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.287 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.772 HD11 ' HD2' ' A' 1028 ' ' PRO . 24.1 tp -121.94 126.56 26.3 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.772 ' HD2' HD11 ' A' 1027 ' ' LEU . 26.2 Cg_endo -61.42 156.26 47.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.824 2.349 . . . . 0.0 112.42 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.792 ' HG3' ' HA ' ' A' 1087 ' ' PRO . 19.2 Cg_endo -58.67 126.1 20.25 Favored 'Trans proline' 0 CA--C 1.518 -0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 112.036 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1030 ' ' THR . . . . . 0.49 HG21 ' N ' ' A' 1031 ' ' ILE . 17.9 m -93.27 151.19 19.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.016 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.704 HG13 ' O ' ' A' 1034 ' ' GLY . 11.1 pt -142.57 134.58 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.261 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -67.86 163.99 20.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' 1032 ' ' ALA . 6.6 m120 76.8 -41.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.452 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.915 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -168.28 136.54 4.14 Favored Glycine 0 CA--C 1.507 -0.455 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.444 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.452 ' HB3' HG13 ' A' 1031 ' ' ILE . 2.8 p30 -171.17 142.71 1.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.069 0.462 . . . . 0.0 112.034 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 12.3 t80 60.4 115.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.349 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.799 HD11 ' HD3' ' A' 1053 ' ' ARG . 38.2 mt -152.09 60.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.143 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.74 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 22.9 t -163.78 -137.09 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.032 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' 1040 ' ' ASN . 85.9 m -111.64 128.09 55.95 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' 1039 ' ' THR . 26.4 t-20 174.87 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.451 HH11 ' HG3' ' A' 1041 ' ' ARG . 52.7 mtt85 58.84 67.67 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.239 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.689 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 47.9 mt-10 58.87 -169.85 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.534 ' HB3' ' HD1' ' A' 1045 ' ' HIS . 2.6 m120 76.62 -70.3 0.14 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.969 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' 1042 ' ' GLU . 7.6 m-85 52.66 47.27 25.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.97 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.585 ' O ' ' HA ' ' A' 1024 ' ' PRO . 27.3 m80 -62.63 -51.5 67.05 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.039 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.775 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 62.4 t80 173.24 139.07 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 72.29 92.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.414 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.4 p 172.15 130.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' 1072 ' ' ILE . 11.3 p -102.25 156.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.997 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.74 ' HA ' ' HB3' ' A' 1038 ' ' SER . 18.8 m -149.15 130.13 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 40.2 m -89.93 110.42 21.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.545 ' HH ' ' HB2' ' A' 1028 ' ' PRO . 15.8 m-85 -85.22 135.79 33.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.453 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.799 ' HD3' HD11 ' A' 1037 ' ' ILE . 41.2 mtp85 -146.28 -143.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.235 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.915 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 32.6 t -163.66 135.3 4.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -65.81 97.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.483 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.713 ' HG ' ' HA3' ' A' 1060 ' ' GLY . 0.0 OUTLIER -80.76 43.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.784 179.054 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.637 ' HA2' HG22 ' A' 1063 ' ' VAL . . . 79.1 -62.48 4.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.296 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' 1059 ' ' ARG . 69.2 m -167.29 93.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.242 0.521 . . . . 0.0 111.686 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.589 ' C ' HD22 ' A' 1056 ' ' LEU . 39.5 mmt-85 72.54 -42.24 0.53 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.713 ' HA3' ' HG ' ' A' 1056 ' ' LEU . . . 174.57 39.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.531 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' 1061 ' ' ARG . 35.9 ttm180 -83.96 32.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' 1063 ' ' VAL . 23.4 ttmm 42.47 83.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.607 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.637 HG22 ' HA2' ' A' 1057 ' ' GLY . 6.0 t -149.99 89.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.605 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 29.8 m-85 71.21 90.35 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -90.74 136.26 33.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.901 HD22 ' HB3' ' A' 1070 ' ' PRO . 47.5 tp -68.35 155.96 38.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.607 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' 1089 ' ' PRO . 72.5 t -142.62 139.82 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.926 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 86.0 -158.91 32.26 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.417 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.7 pt-20 -64.08 111.15 4.84 Favored Pre-proline 0 CA--C 1.528 0.107 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.901 ' HB3' HD22 ' A' 1066 ' ' LEU . 94.8 Cg_endo -90.79 23.07 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.885 2.39 . . . . 0.0 113.152 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.4 p -157.64 143.79 17.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.514 ' O ' HG21 ' A' 1049 ' ' VAL . 44.2 pt -148.16 171.12 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.137 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.5 p90 -161.67 145.3 12.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 4.2 t -66.04 144.98 56.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.907 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.4 t -144.41 -151.41 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.231 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.452 ' OG ' HD11 ' A' 1023 ' ' ILE . 44.9 t -161.29 131.34 4.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.016 0.436 . . . . 0.0 111.563 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.524 HD22 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER 178.96 -146.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.115 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 63.3 t0 52.48 -87.63 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' 1077 ' ' ASN . 11.6 p-10 -163.13 51.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.151 0.501 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.851 ' HA ' HD12 ' A' 1023 ' ' ILE . 3.5 mm100 65.42 41.24 4.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 25.4 t -94.05 -40.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' 1025 ' ' CYS . . . 86.28 47.15 5.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.238 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.524 HG12 HD22 ' A' 1077 ' ' ASN . 35.6 pt -81.97 135.1 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.581 ' HZ2' ' HB3' ' A' 1044 ' ' PHE . 26.3 m95 -70.64 147.27 49.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.1 t -40.36 -36.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.581 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.94 150.05 16.43 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.442 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.792 ' HA ' ' HG3' ' A' 1029 ' ' PRO . 31.5 Cg_endo -63.01 157.54 48.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.884 2.389 . . . . 0.0 112.336 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . -62.62 144.91 95.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.109 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.547 ' HB2' ' O ' ' A' 1067 ' ' VAL . 56.5 Cg_endo -68.0 -144.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.784 2.322 . . . . 0.0 112.271 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' 1089 ' ' PRO . 0.1 OUTLIER -152.41 136.33 16.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.064 0.459 . . . . 0.0 111.702 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 50.7 t -98.37 132.97 43.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' 1091 ' ' CYS . 26.2 pt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.117 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 957' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.784 0.326 . . . . 0.0 111.174 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 57.41 44.68 21.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -68.03 136.13 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -79.37 46.9 0.77 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.431 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? 66.3 149.19 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.959 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.5 p -156.44 129.8 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.285 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' 1011 ' ' ALA . 2.0 p -84.63 35.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.893 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 963' ' ' CYS . 58.0 tptt 56.63 129.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.709 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 85.6 m -61.56 122.4 70.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.73 110.24 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.287 1.991 . . . . 0.0 112.519 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.85 139.55 24.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.559 2.173 . . . . 0.0 111.47 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 11.7 p-10 -49.42 107.25 0.74 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 971' ' ' ASN . 6.3 Cg_exo -78.87 -146.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.064 2.509 . . . . 0.0 111.938 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' 1020 ' ' CYS . 64.4 t -49.1 81.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.434 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 969' ' ' PRO . 22.0 p30 42.72 27.77 0.11 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.148 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.599 ' HA3' ' SG ' ' A' ' 990' ' ' CYS . . . -83.01 -161.11 30.23 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.858 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 45.4 ttm -159.17 114.55 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.418 HG23 HD11 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.9 144.22 9.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.284 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -119.75 91.72 3.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.148 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.764 ' HA ' HG23 ' A' ' 986' ' ' ILE . 64.0 t -66.47 103.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.179 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.2 mt -84.14 -92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 41.2 p -84.14 62.84 7.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 111.819 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.92 -153.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.706 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.423 HG22 HG12 ' A' ' 976' ' ' VAL . 21.5 pt -155.81 26.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.945 0.403 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.65 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 22.6 pt20 -87.34 28.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.061 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.65 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 70.8 t 100.43 142.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 111.34 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 70.71 -7.46 5.2 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.234 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 982' ' ' VAL . 34.9 m -68.33 160.05 30.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.273 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -143.13 109.4 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.227 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.764 HG23 ' HA ' ' A' ' 976' ' ' VAL . 27.2 pt -96.77 -174.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 986' ' ' ILE . 65.9 p -149.43 131.3 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.691 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.4 m-85 -96.23 165.08 12.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.0 p -149.75 -40.56 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 111.408 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.599 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 12.8 t 71.26 177.99 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.893 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 971' ' ' ASN . 22.2 p -62.98 -161.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.321 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 11.8 t -94.7 -44.94 7.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.145 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.407 ' HA2' ' OH ' ' A' 1046 ' ' TYR . . . -94.62 39.05 2.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.411 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.619 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 45.3 m80 -149.08 132.76 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.952 0.376 . . . . 0.0 110.681 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.499 ' HG2' HD12 ' A' ' 997' ' ' ILE . 79.1 ttt180 -82.01 123.4 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' 1000 ' ' SER . 8.4 tp -71.25 132.16 44.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' 1021 ' ' GLN . 17.6 mm -132.13 62.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.628 0.728 . . . . 0.0 110.792 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.596 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . -154.27 33.51 0.71 Allowed Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.122 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 59.11 4.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.691 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 81.7 p 43.65 31.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.07 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 83.2 p -162.23 151.12 15.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.528 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.731 ' HA ' HG22 ' A' 1015 ' ' THR . . . -158.04 128.94 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.335 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.81 127.22 47.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.812 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -77.48 82.29 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.611 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.688 HD12 ' HB3' ' A' 1014 ' ' SER . 46.3 pt -87.21 -152.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' 1008 ' ' GLY . 3.0 tm? -141.9 121.12 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.593 ' HB2' ' HD2' ' A' 1012 ' ' HIS . 45.5 m -93.42 -39.14 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.486 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.528 ' N ' HD12 ' A' 1006 ' ' LEU . . . -169.05 -126.27 0.84 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.084 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -68.38 8.2 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.224 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' 1008 ' ' GLY . 99.3 m -151.87 145.28 24.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 963' ' ' CYS . . . -75.31 147.95 39.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.593 ' HD2' ' HB2' ' A' 1007 ' ' SER . 92.3 m-70 -149.43 149.92 31.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 111.539 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.476 ' CE3' ' HB1' ' A' 1002 ' ' ALA . 60.8 m95 -81.11 117.25 21.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.197 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.688 ' HB3' HD12 ' A' 1005 ' ' ILE . 80.1 p -53.35 -25.52 15.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' 1002 ' ' ALA . 82.2 p -86.93 141.81 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -65.72 150.1 96.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.371 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.31 115.32 2.11 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.124 1.883 . . . . 0.0 111.883 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.608 ' HG2' ' CE2' ' A' ' 988' ' ' TYR . 31.1 Cg_exo -61.12 140.5 89.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.913 2.409 . . . . 0.0 112.873 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.626 HG21 ' HB ' ' A' ' 997' ' ' ILE . 5.2 tt -129.78 136.48 58.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.725 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 64.6 m -97.25 126.08 42.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.541 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.661 ' HG2' HG13 ' A' ' 997' ' ' ILE . 99.1 mm-40 -75.77 124.34 27.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.81 -12.49 59.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' 1080 ' ' GLN . 53.5 mt 56.28 70.82 1.34 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 109.939 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' 1045 ' ' HIS . 9.4 Cg_endo -51.44 132.47 40.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.117 2.545 . . . . 0.0 113.519 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.682 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 3.0 m -86.43 -146.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1026 ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -153.24 -155.44 7.15 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.19 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.569 HD22 ' HE2' ' A' 1044 ' ' PHE . 75.4 mt -68.36 143.88 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.714 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' 1027 ' ' LEU . 20.5 Cg_exo -64.72 147.55 89.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 111.472 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.818 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 83.7 Cg_exo -47.34 113.38 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 112.213 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 68.5 p -77.6 140.45 39.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' 1032 ' ' ALA . 29.2 pt -151.32 31.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.559 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 52.04 117.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.376 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' 1032 ' ' ALA . 75.6 m-20 74.74 -25.97 0.2 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.362 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' 1032 ' ' ALA . . . -70.7 68.77 0.76 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.702 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.75 -150.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.133 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.478 ' HB3' HG12 ' A' 1050 ' ' VAL . 12.3 p90 -155.99 141.6 17.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.559 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 42.6 mm -92.62 63.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.055 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 69.2 m -159.98 -159.13 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 111.707 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 64.9 m -83.59 -92.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.553 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.603 ' OD1' ' HB3' ' A' 1048 ' ' SER . 73.3 m-80 54.06 -138.89 1.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 61.88 109.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' 1043 ' ' ASN . 16.6 pt-20 38.42 41.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.842 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' 1042 ' ' GLU . 72.3 m-80 -167.74 116.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.569 ' HE2' HD22 ' A' 1027 ' ' LEU . 0.8 OUTLIER -163.39 143.66 8.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' 1024 ' ' PRO . 16.9 m-70 -140.82 -58.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.449 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.706 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 48.3 t80 175.22 47.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.43 -25.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.032 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.603 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 63.3 m -47.62 147.69 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.262 0.554 . . . . 0.0 111.962 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.604 HG23 ' HB3' ' A' 1073 ' ' TYR . 69.2 t -137.62 145.98 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.124 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' 1072 ' ' ILE . 3.4 t -133.38 120.38 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.026 0.441 . . . . 0.0 112.183 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 76.7 m -100.23 119.44 38.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.196 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.546 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 26.5 m-85 -74.5 145.54 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.442 0.639 . . . . 0.0 112.431 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -150.99 -30.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.03 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1054 ' ' CYS . . . . . . . . . . . . . 9.6 t 70.31 142.68 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.115 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.44 ' O ' ' HE2' ' A' 1064 ' ' PHE . 12.6 t-20 -65.06 129.02 38.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.855 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.799 ' N ' HD21 ' A' 1056 ' ' LEU . 1.8 mm? -73.48 43.26 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.835 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 56.27 48.17 76.87 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' 1059 ' ' ARG . 45.6 t 58.02 39.23 26.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' 1058 ' ' SER . 23.9 mmm180 -157.54 -128.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.871 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -149.76 -26.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -57.74 147.6 27.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -65.2 133.02 50.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.973 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 10.8 p -155.07 27.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.446 0.641 . . . . 0.0 111.137 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.44 ' HE2' ' O ' ' A' 1055 ' ' ASN . 0.4 OUTLIER -168.77 -175.3 2.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.672 -179.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1065 ' ' GLU . . . . . 0.538 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 72.4 mt-10 -150.11 122.39 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 110.592 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 53.7 tp -68.56 119.67 13.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 85.0 t -101.62 86.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 62.1 -163.08 26.38 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.961 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' 1089 ' ' PRO . 29.9 tp10 30.25 58.43 0.89 Allowed Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.491 0.716 . . . . 0.0 112.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 83.4 Cg_endo -80.75 2.76 8.3 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.473 2.115 . . . . 0.0 113.186 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 51.1 m -156.27 144.69 19.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.557 HG13 ' HB ' ' A' 1050 ' ' VAL . 19.5 pt -146.39 157.25 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.604 ' HB3' HG23 ' A' 1049 ' ' VAL . 0.3 OUTLIER -160.1 147.91 16.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 50.8 t -62.18 133.17 54.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.083 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 8.2 t -144.51 -20.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' 1078 ' ' ASP . 57.9 m 58.82 59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.528 HD22 HD11 ' A' 1083 ' ' ILE . 0.0 OUTLIER -72.96 31.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.708 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' 1076 ' ' SER . 64.3 t0 179.43 53.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' 1076 ' ' SER . 59.3 m-20 62.15 -127.65 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.196 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.527 ' HA ' HG22 ' A' 1023 ' ' ILE . 0.0 OUTLIER -66.19 -140.17 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 121.369 -0.133 . . . . 0.0 111.194 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.5 ' H ' ' HB2' ' A' 1080 ' ' GLN . 33.4 t 75.74 -44.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.682 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 78.26 46.86 8.71 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.762 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.528 HD11 HD22 ' A' 1077 ' ' ASN . 69.1 mt -82.0 130.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.829 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 15.3 m95 -72.87 -150.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.054 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 48.2 t -74.19 -41.68 61.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -178.06 153.24 12.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.506 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' 1069 ' ' GLU . 89.2 Cg_exo -46.41 153.82 1.05 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . -62.54 143.61 96.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.872 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.546 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 51.9 Cg_endo -67.72 -143.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.96 2.44 . . . . 0.0 112.181 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.695 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.5 mm100 -135.46 125.0 25.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.975 0.417 . . . . 0.0 111.74 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 43.0 t -85.78 66.91 9.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.593 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.538 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 34.6 pt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -175.36 -147.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.57 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 961' ' ' LYS . 38.6 tt0 -69.6 137.51 52.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.566 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -75.77 35.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.671 ' HG3' ' HB3' ' A' 1011 ' ' ALA . 0.0 OUTLIER 61.88 145.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 50.3 m -153.74 132.48 12.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.054 0.454 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.496 ' HB3' ' HB1' ' A' 1011 ' ' ALA . 14.5 p -79.89 140.54 36.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.647 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 1.1 tpmt? -63.73 146.29 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.267 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.567 ' H ' ' HE2' ' A' ' 964' ' ' LYS . 93.0 m -46.39 128.31 7.86 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.348 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.564 ' HG3' HD12 ' A' ' 986' ' ' ILE . 38.7 Cg_endo -66.65 130.94 24.64 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.18 1.92 . . . . 0.0 111.601 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.47 124.63 12.35 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.977 1.785 . . . . 0.0 111.428 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -47.32 122.95 8.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.671 ' HB3' ' HB2' ' A' 1018 ' ' PRO . 6.6 Cg_endo -50.43 153.46 7.39 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 112.22 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.769 ' HB ' ' H ' ' A' 1020 ' ' CYS . 23.3 t -41.96 117.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.633 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.551 ' ND2' HG11 ' A' ' 970' ' ' VAL . 23.8 p30 41.91 46.3 3.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.938 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.598 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -159.11 133.7 3.48 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.736 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.448 ' HB3' ' HE1' ' A' ' 973' ' ' MET . 22.3 ptp -97.66 150.37 21.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.977 0.418 . . . . 0.0 111.849 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 19.3 m -92.88 -157.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.632 ' HB2' ' HG1' ' A' ' 987' ' ' THR . 97.9 m-70 -157.8 100.58 1.76 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.28 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.89 111.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.032 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.73 HD12 HG22 ' A' ' 987' ' ' THR . 35.5 mt -84.93 -81.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.06 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 23.6 p -67.98 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.912 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.617 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.4 m-20 -163.26 17.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.587 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 979' ' ' ASP . 20.1 pt 52.1 28.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.269 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.34 160.08 18.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.386 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' 1004 ' ' CYS . 86.3 t -44.44 142.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.174 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.96 -33.8 1.93 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.134 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.593 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 49.4 m -68.48 177.38 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.878 0.339 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' 1002 ' ' ALA . 48.2 ttp85 -156.78 132.2 9.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.118 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.647 ' O ' HG21 ' A' ' 987' ' ' THR . 36.6 pt -96.56 -159.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.73 HG22 HD12 ' A' ' 977' ' ' ILE . 40.6 p -152.17 128.38 10.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.631 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.833 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.1 OUTLIER -93.92 167.01 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 989' ' ' SER . . . . . 0.425 ' HG ' ' HE2' ' A' ' 975' ' ' HIS . 52.7 p -145.46 -43.39 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.598 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 36.3 t 74.05 164.88 0.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.061 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 992' ' ' THR . 11.3 t -60.77 -141.22 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.406 0.622 . . . . 0.0 112.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.527 HG21 ' HD1' ' A' ' 994' ' ' HIS . 13.4 t -61.24 -137.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.82 -178.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 992' ' ' THR . . . -70.6 30.39 0.48 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.537 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 17.1 m80 -83.34 129.14 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.473 0.637 . . . . 0.0 109.976 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.63 HH22 ' HB3' ' A' 1079 ' ' ASP . 33.1 ttm180 -81.9 91.59 6.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.832 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 2.4 pp -61.51 137.53 58.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.371 0.605 . . . . 0.0 110.71 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.491 HG21 ' N ' ' A' ' 998' ' ' GLY . 41.2 mm -100.13 160.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.785 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.4 12.49 81.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.709 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 84.3 m-70 71.02 138.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.833 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 83.5 p -80.53 41.15 0.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.808 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 13.1 t -162.13 159.67 26.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' 1015 ' ' THR . . . -165.19 132.51 3.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -100.05 126.24 46.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.656 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 49.9 t -74.84 81.66 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' 1014 ' ' SER . 46.1 pt -87.3 -157.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 5.4 tt -158.43 124.36 4.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 50.1 m -77.56 -54.1 6.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.218 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.84 43.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.652 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 48.6 t30 -177.86 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.564 HG21 ' N ' ' A' 1011 ' ' ALA . 59.1 m -151.22 154.59 37.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.201 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 961' ' ' LYS . . . -74.42 135.81 42.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.253 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.41 146.39 27.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' 1002 ' ' ALA . 21.7 m95 -76.17 118.03 18.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.787 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.573 ' HB3' HD12 ' A' 1005 ' ' ILE . 90.4 p -52.95 -21.35 4.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.126 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' 1002 ' ' ALA . 37.9 p -86.93 134.29 33.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.046 0.45 . . . . 0.0 111.771 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.19 152.36 88.32 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.3 125.56 7.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.671 ' HB2' ' HB3' ' A' ' 969' ' ' PRO . 96.7 Cg_endo -77.33 149.87 28.2 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.012 2.474 . . . . 0.0 113.459 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' 1019 ' ' ILE . 32.7 pt -148.79 121.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.863 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.832 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 82.9 m -81.8 127.15 32.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.304 0.573 . . . . 0.0 112.196 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -84.33 129.48 34.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.145 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.671 ' NH1' ' HB3' ' A' 1046 ' ' TYR . 21.3 tpt85 -67.65 -10.29 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.582 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.443 HG12 HE22 ' A' 1080 ' ' GLN . 56.6 mt 51.74 64.59 7.56 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.607 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' 1045 ' ' HIS . 52.0 Cg_exo -53.72 124.12 15.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.542 2.161 . . . . 0.0 112.81 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.854 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 33.0 m -88.47 153.41 21.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.14 140.47 25.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.44 ' HA ' ' HZ ' ' A' 1044 ' ' PHE . 68.5 mt -41.57 142.01 1.09 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.977 0.389 . . . . 0.0 111.243 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.458 ' HB3' ' CH2' ' A' 1084 ' ' TRP . 17.9 Cg_endo -57.68 140.21 92.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.083 1.855 . . . . 0.0 110.455 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.441 ' HD2' HD13 ' A' 1072 ' ' ILE . 99.5 Cg_exo -38.03 127.95 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.142 1.895 . . . . 0.0 111.493 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 70.2 p -76.62 137.35 39.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.529 HD13 ' HB2' ' A' 1091 ' ' CYS . 5.8 tt -147.46 107.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.574 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -64.43 143.41 57.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.173 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.638 ' HA ' ' ND2' ' A' 1055 ' ' ASN . 4.7 m120 76.76 -40.92 0.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.394 0.434 . . . . 0.0 111.264 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -74.76 72.64 1.52 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.672 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -68.81 133.44 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 111.076 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.575 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 22.4 p90 -84.01 150.68 25.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.246 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 33.4 mm -110.32 58.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.478 ' H ' ' HD1' ' A' 1036 ' ' PHE . 68.6 m -162.89 -154.54 0.3 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.082 0.467 . . . . 0.0 111.869 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' 1038 ' ' SER . 41.7 p -86.1 -129.85 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.192 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.479 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 4.7 m120 59.65 44.91 13.76 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.481 ' HG2' HH11 ' A' 1041 ' ' ARG . 62.2 mtt-85 -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.543 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 63.29 37.28 11.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.594 HD21 ' N ' ' A' 1043 ' ' ASN . 0.0 OUTLIER -179.5 128.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.923 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' 1025 ' ' CYS . 5.5 p90 -163.27 -41.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.625 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' 1046 ' ' TYR . 90.1 m-70 72.65 -36.58 0.36 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.671 ' HB3' ' NH1' ' A' 1022 ' ' ARG . 25.1 t80 170.63 148.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.446 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.59 94.36 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.827 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' 1047 ' ' GLY . 29.2 m 178.0 143.56 0.1 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.938 0.495 . . . . 0.0 109.966 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' 1073 ' ' TYR . 12.3 p -138.21 161.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.289 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' 1036 ' ' PHE . 29.5 m -146.42 137.08 18.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 34.9 m -102.21 120.24 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.977 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.688 ' HB2' HD23 ' A' 1066 ' ' LEU . 2.9 m-85 -72.83 156.23 39.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' 1054 ' ' CYS . 78.4 ttt180 -154.53 -30.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.59 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.606 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 54.4 m 68.59 146.35 0.05 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.077 0.465 . . . . 0.0 111.046 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.69 ' O ' ' HG ' ' A' 1056 ' ' LEU . 75.9 m-20 -54.7 162.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.983 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' 1055 ' ' ASN . 3.3 mt -154.98 162.32 41.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.82 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.484 ' H ' ' HB3' ' A' 1061 ' ' ARG . . . -82.09 41.79 2.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.562 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 12.8 t 57.27 18.96 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -167.66 46.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.281 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 53.39 33.56 46.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.317 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' 1057 ' ' GLY . 78.4 ttt180 -71.41 142.2 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 110.978 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.33 102.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.042 0.449 . . . . 0.0 110.413 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.673 ' CG1' ' HA ' ' A' 1056 ' ' LEU . 3.4 p -155.7 87.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.806 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.604 ' HD1' HG23 ' A' 1063 ' ' VAL . 80.5 m-85 70.84 139.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.757 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -134.26 134.91 42.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.883 0.373 . . . . 0.0 111.659 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' 1052 ' ' TYR . 17.0 tp -68.54 149.55 49.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 60.0 t -150.19 147.24 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.27 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.546 ' N ' HG11 ' A' 1067 ' ' VAL . . . 90.43 -50.13 3.25 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.512 ' HG3' ' HG3' ' A' 1089 ' ' PRO . 22.0 pt-20 -167.89 130.94 1.35 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 117.72 0.76 . . . . 0.0 112.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.682 ' HA ' HD23 ' A' 1066 ' ' LEU . 94.9 Cg_endo -98.53 8.83 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.512 2.808 . . . . 0.0 113.698 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 60.3 m -156.9 142.75 17.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.575 ' O ' HG21 ' A' 1049 ' ' VAL . 19.6 pt -149.37 147.13 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.996 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.594 ' HB3' ' HB ' ' A' 1049 ' ' VAL . 1.9 p90 -153.47 149.32 27.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.5 t -65.06 150.7 47.65 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.0 t -140.1 -25.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.529 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 43.5 t 59.06 51.13 7.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.738 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.807 ' ND2' ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -67.32 -59.05 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.473 -179.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.807 ' H ' ' ND2' ' A' 1077 ' ' ASN . 1.6 m-20 -81.52 58.8 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 111.087 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.63 ' HB3' HH22 ' A' ' 995' ' ' ARG . 1.5 m-20 63.85 -132.07 0.38 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.071 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.443 HE22 HG12 ' A' 1023 ' ' ILE . 3.0 mm100 -64.33 -144.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.561 0.22 . . . . 0.0 110.525 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.47 HG13 ' CG1' ' A' 1083 ' ' ILE . 21.8 t 72.59 -36.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 66.28 55.42 18.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.758 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.725 ' HB ' HD22 ' A' 1077 ' ' ASN . 74.4 mt -81.95 132.93 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.479 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 10.0 m95 -84.17 165.31 18.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.19 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 86.9 p -53.77 -31.72 49.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.526 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.65 148.97 14.15 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.3 -154.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.742 2.295 . . . . 0.0 112.689 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' 1089 ' ' PRO . . . -77.03 136.83 65.79 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.142 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.512 ' HG3' ' HG3' ' A' 1069 ' ' GLU . 3.1 Cg_exo -74.99 -134.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.237 2.624 . . . . 0.0 111.205 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.657 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -145.12 115.9 7.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.529 ' HB2' HD13 ' A' 1031 ' ' ILE . 22.0 t -97.37 63.98 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.099 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.299 -179.083 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 957' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.89 0.376 . . . . 0.0 111.202 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 58.28 -135.51 0.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.74 139.18 56.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -78.64 50.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.481 ' HB2' HG13 ' A' ' 982' ' ' VAL . 47.4 mmtm 66.36 131.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.746 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.782 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 79.6 p -157.96 141.4 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.758 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 85.3 m -80.2 32.31 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 962' ' ' SER . 57.6 tptt 60.95 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.304 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.9 m -56.73 130.32 77.72 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.293 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.554 ' HB2' HG13 ' A' ' 974' ' ' VAL . 31.9 Cg_exo -58.57 120.88 9.04 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.4 Cg_endo -76.69 66.75 7.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.838 2.359 . . . . 0.0 111.949 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 967' ' ' PRO . 17.6 m-20 22.38 83.33 0.12 Allowed Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.675 0.609 . . . . 0.0 111.56 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.56 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 83.6 Cg_exo -42.69 148.67 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.139 2.56 . . . . 0.0 112.761 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.692 HG22 HG23 ' A' 1019 ' ' ILE . 76.8 t -46.98 122.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.226 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.815 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 2.2 m120 71.92 -70.51 0.16 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.736 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 989' ' ' SER . . . -75.65 128.73 9.87 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.798 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 973' ' ' MET . 1.8 mpt? -84.35 155.7 22.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.645 0.26 . . . . 0.0 110.332 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 966' ' ' PRO . 1.3 p -89.93 148.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.721 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -117.49 96.55 5.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.374 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.671 HG12 HG22 ' A' ' 980' ' ' ILE . 60.8 t -71.17 81.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.339 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.862 HD13 HG22 ' A' ' 987' ' ' THR . 48.8 mt -75.29 -78.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.371 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.7 p -68.41 -77.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.56 ' HB2' ' HG ' ' A' ' 984' ' ' SER . 52.2 m-20 -165.7 149.57 8.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.072 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.671 HG22 HG12 ' A' ' 976' ' ' VAL . 16.8 pt -84.11 -20.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.176 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.782 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 26.3 mt-30 -72.46 157.91 36.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.459 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' A' ' 961' ' ' LYS . 9.0 p -44.24 144.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.191 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.84 43.97 21.12 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.166 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.56 ' HG ' ' HB2' ' A' ' 979' ' ' ASP . 66.9 m -168.36 129.73 1.34 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 32.0 ttm-85 -101.61 128.38 47.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.897 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 987' ' ' THR . 29.3 pt -97.15 -164.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.229 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.862 HG22 HD13 ' A' ' 977' ' ' ILE . 66.7 p -150.29 127.96 11.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.569 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.56 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 2.8 m-85 -99.49 163.14 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.538 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 989' ' ' SER . . . . . 0.595 ' O ' ' HA2' ' A' ' 972' ' ' GLY . 22.7 t -145.53 -156.92 0.75 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.004 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.471 ' H ' ' HG ' ' A' ' 989' ' ' SER . 23.4 m -158.06 157.89 33.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.592 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 992' ' ' THR . 17.9 p -68.64 -151.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.772 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.494 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.0 t -85.4 132.58 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.07 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.78 91.62 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.765 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.568 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 13.8 m80 -142.12 129.46 21.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 111.508 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.634 HH11 HD12 ' A' ' 997' ' ' ILE . 6.6 ptm180 -95.91 135.86 37.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.407 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' 1000 ' ' SER . 4.6 tt -76.18 132.18 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.936 0.398 . . . . 0.0 111.653 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.857 ' HB ' HG13 ' A' 1019 ' ' ILE . 44.2 mm -97.85 144.04 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.331 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.79 43.81 Favored Glycine 0 C--N 1.328 0.116 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.1 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.13 132.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.658 ' HA ' HD12 ' A' ' 996' ' ' LEU . 79.6 p -90.85 38.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.0 p -162.15 145.7 11.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.487 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -158.41 130.98 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.182 0.515 . . . . 0.0 111.396 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 86.8 tt0 -105.0 132.49 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.528 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -70.93 127.08 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.103 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.81 152.24 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.632 HD12 ' H ' ' A' 1007 ' ' SER . 0.2 OUTLIER -85.62 141.04 30.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.431 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.632 ' H ' HD12 ' A' 1006 ' ' LEU . 48.0 t -155.17 131.54 10.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 65.66 -82.4 0.08 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.316 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -157.77 16.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.004 0.43 . . . . 0.0 110.331 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.473 HG21 ' N ' ' A' 1011 ' ' ALA . 99.5 m -151.84 142.37 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.095 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.503 ' HB2' ' SG ' ' A' ' 963' ' ' CYS . . . -75.22 141.86 43.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.449 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.0 m-70 -149.57 141.63 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.563 ' HB2' ' HA ' ' A' 1016 ' ' LYS . 89.5 m95 -66.65 132.65 48.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.3 t -52.48 -21.53 3.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 71.7 p -131.47 -14.19 3.31 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.514 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.691 ' HB3' ' HZ3' ' A' 1016 ' ' LYS . 2.0 mmmp? 66.69 148.33 0.11 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.632 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.509 ' HD2' ' HZ1' ' A' 1016 ' ' LYS . 79.7 Cg_exo -45.21 104.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.56 2.173 . . . . 0.0 112.283 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.621 ' HB2' HD22 ' A' ' 996' ' ' LEU . 12.6 Cg_exo -71.34 -144.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.127 2.551 . . . . 0.0 112.957 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.857 HG13 ' HB ' ' A' ' 997' ' ' ILE . 21.4 pt -149.75 -159.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.201 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.815 ' HB3' ' HB2' ' A' ' 971' ' ' ASN . 8.6 t -153.59 111.7 3.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.979 0.418 . . . . 0.0 110.465 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.408 ' HB2' ' CG1' ' A' ' 997' ' ' ILE . 3.1 tp-100 -81.62 132.93 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.152 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.754 ' HE ' ' HB3' ' A' 1045 ' ' HIS . 17.1 ttp-105 -66.84 128.48 36.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.331 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' 1046 ' ' TYR . 33.1 mm -53.76 107.71 0.93 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.31 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' 1045 ' ' HIS . 86.4 Cg_endo -86.93 126.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.733 2.289 . . . . 0.0 113.953 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' 1044 ' ' PHE . 26.2 p -108.17 127.85 54.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.922 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.36 -154.77 7.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.5 HD23 ' HE1' ' A' 1044 ' ' PHE . 1.9 mm? -62.44 155.27 68.46 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 122.245 0.218 . . . . 0.0 111.139 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.494 ' HD2' HD11 ' A' 1027 ' ' LEU . 9.2 Cg_endo -50.35 140.8 33.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.683 2.255 . . . . 0.0 111.627 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' 1030 ' ' THR . 33.8 Cg_exo -57.73 -9.1 5.05 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.606 2.204 . . . . 0.0 112.86 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1030 ' ' THR . . . . . 0.409 ' O ' ' O ' ' A' 1029 ' ' PRO . 13.5 t 47.08 176.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.469 HG22 HD11 ' A' 1031 ' ' ILE . 28.3 pt -152.08 30.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.605 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 54.64 123.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.403 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' 1032 ' ' ALA . 74.6 m-80 74.87 -36.84 0.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -76.09 121.05 6.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.38 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.535 ' CG ' ' HA ' ' A' 1055 ' ' ASN . 61.0 m-20 -75.4 -159.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.582 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.836 ' HB2' HG22 ' A' 1050 ' ' VAL . 21.4 p90 -156.03 142.13 18.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.358 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 43.4 mm -123.68 109.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.691 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 97.6 p -171.07 151.5 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 88.4 m -60.58 -39.41 87.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.617 HD21 ' HE2' ' A' 1044 ' ' PHE . 1.9 p-10 -61.54 143.56 55.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.348 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.36 -36.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.01 -44.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.031 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -73.39 59.11 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.617 ' HE2' HD21 ' A' 1040 ' ' ASN . 64.1 m-85 -76.66 -57.11 4.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.747 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.754 ' HB3' ' HE ' ' A' 1022 ' ' ARG . 64.4 m170 66.9 -67.66 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.885 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' 1045 ' ' HIS . 33.8 t80 173.96 35.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.536 0.684 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.48 ' O ' ' OG ' ' A' 1048 ' ' SER . . . -160.48 98.81 0.17 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.135 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.564 ' HG ' ' HB3' ' A' 1040 ' ' ASN . 26.2 m 177.35 153.39 0.25 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.366 0.603 . . . . 0.0 111.054 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' 1050 ' ' VAL . 76.5 t -137.82 144.12 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.166 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.836 HG22 ' HB2' ' A' 1036 ' ' PHE . 15.0 p -135.86 147.87 28.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' 1070 ' ' PRO . 88.2 m -118.54 125.88 50.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.757 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.586 ' HB2' HD23 ' A' 1066 ' ' LEU . 9.5 m-85 -78.45 149.37 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.003 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' 1053 ' ' ARG . 35.7 ttt85 -152.9 25.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.56 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 64.6 m 57.69 153.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.535 ' HA ' ' CG ' ' A' 1035 ' ' ASP . 28.3 t-20 -65.91 -57.27 8.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.41 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.537 HD11 ' O ' ' A' 1059 ' ' ARG . 2.9 mt 66.17 159.61 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.479 ' HA2' ' NH2' ' A' 1061 ' ' ARG . . . -81.92 -33.9 25.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.175 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.7 p -153.86 62.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.745 0.272 . . . . 0.0 111.171 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.537 ' O ' HD11 ' A' 1056 ' ' LEU . 35.1 mmt180 77.83 -40.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.819 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.432 ' HA3' ' CD2' ' A' 1056 ' ' LEU . . . 178.62 127.82 1.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.731 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.647 ' HG3' HG12 ' A' 1063 ' ' VAL . 40.3 ptt180 -172.74 41.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 0.0 110.634 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt 44.32 71.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.56 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.647 HG12 ' HG3' ' A' 1061 ' ' ARG . 23.9 m -142.68 -7.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.78 0.8 . . . . 0.0 110.116 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.695 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 70.6 m-85 -155.73 140.79 17.38 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.682 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -143.33 121.22 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 0.0 111.291 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.955 HD22 ' HB3' ' A' 1070 ' ' PRO . 36.3 tp -71.86 153.96 41.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.808 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' 1089 ' ' PRO . 85.2 t -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.237 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 83.17 -157.7 35.41 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.723 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.539 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.9 pt-20 -64.41 118.77 50.48 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-O 120.769 0.318 . . . . 0.0 111.474 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.955 ' HB3' HD22 ' A' 1066 ' ' LEU . 56.8 Cg_endo -96.26 27.21 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.092 2.528 . . . . 0.0 113.564 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' 1050 ' ' VAL . 58.6 m -156.18 142.06 18.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 112.036 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1072 ' ' ILE . . . . . . . . . . . . . 31.2 pt -144.93 174.78 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.766 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.27 148.0 24.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.996 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 60.4 m -63.26 125.25 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.347 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' A' 1085 ' ' SER . 11.4 t -157.84 145.78 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.516 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 79.3 p -74.6 149.13 40.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.35 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.774 HD22 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -164.55 -42.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.773 ' H ' HD21 ' A' 1077 ' ' ASN . 38.1 t70 -83.05 -80.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.978 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.12 -130.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.311 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -59.58 -34.44 72.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 110.808 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.433 HG11 HG21 ' A' 1083 ' ' ILE . 2.6 t -59.02 -53.2 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.15 0.5 . . . . 0.0 110.989 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' 1083 ' ' ILE . . . 77.55 -44.51 2.25 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.63 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.774 HG12 HD22 ' A' 1077 ' ' ASN . 17.1 pt 46.28 -163.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.445 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 36.2 m95 -85.26 -163.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.908 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' 1075 ' ' THR . 76.7 p -67.48 -65.1 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.984 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . 178.21 131.84 1.62 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.596 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 16.5 Cg_exo -68.52 143.05 55.81 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.698 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -168.02 -49.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.698 ' HD2' ' H ' ' A' 1088 ' ' ALA . 11.9 Cg_endo -55.65 148.91 51.82 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.333 2.022 . . . . 0.0 112.149 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.453 ' HA ' HD13 ' A' 1031 ' ' ILE . 37.7 tt0 -152.36 133.47 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 41.5 t -92.63 141.3 28.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.104 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.15 136.45 57.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.201 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 40.2 tt0 58.05 45.82 17.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.652 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -79.6 40.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.914 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.618 ' HD2' HD23 ' A' 1006 ' ' LEU . 28.5 mttm -77.6 142.09 39.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 77.9 p -157.28 141.07 15.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.059 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 71.4 m -79.93 134.02 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.594 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.75 140.57 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 97.4 m -53.52 120.31 21.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.143 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 42.9 Cg_exo -57.94 112.6 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.342 2.028 . . . . 0.0 112.656 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.68 134.38 32.55 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.575 2.183 . . . . 0.0 111.013 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -48.48 106.81 0.65 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.903 0.382 . . . . 0.0 111.216 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 72.9 Cg_endo -75.33 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.591 2.194 . . . . 0.0 112.295 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' 1020 ' ' CYS . 95.6 t -49.01 85.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 969' ' ' PRO . 71.2 m-80 44.68 63.8 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.896 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.822 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -157.04 124.97 1.5 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.783 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 37.8 ttp -97.75 134.49 40.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.698 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 3.9 p -93.69 151.32 3.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.401 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 15.9 m170 -116.79 106.82 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.376 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.488 ' HA ' HG21 ' A' ' 986' ' ' ILE . 22.0 t -65.44 113.3 2.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.672 HG12 ' HA ' ' A' ' 986' ' ' ILE . 46.5 mm -80.38 -91.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.312 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.467 HG21 HG23 ' A' ' 977' ' ' ILE . 41.3 p -80.68 -58.63 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.834 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.551 ' HB2' ' HG ' ' A' ' 984' ' ' SER . 30.0 m-20 -164.58 -154.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.657 HG21 ' HH2' ' A' 1013 ' ' TRP . 14.2 pt -155.89 25.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.737 0.303 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.589 ' C ' HG21 ' A' ' 982' ' ' VAL . 87.1 mt-30 -87.33 -56.26 3.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.351 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.589 HG21 ' C ' ' A' ' 981' ' ' GLN . 21.6 t -173.1 141.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.24 1.016 . . . . 0.0 109.412 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.42 -34.82 0.97 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.573 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.551 ' HG ' ' HB2' ' A' ' 979' ' ' ASP . 50.3 m -68.41 126.85 30.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.403 ' HD2' ' C ' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -101.39 -179.63 4.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.391 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.672 ' HA ' HG12 ' A' ' 977' ' ' ILE . 20.3 pt -154.01 171.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.616 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' 1001 ' ' SER . 77.8 p -141.71 129.56 21.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.317 . . . . 0.0 111.47 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.4 m-85 -83.27 -164.46 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 75.5 p -153.83 -46.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.397 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.822 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 42.7 t 71.96 150.76 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.868 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -62.42 152.0 35.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.811 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 54.4 m -58.06 137.51 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.482 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 75.63 35.5 46.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.267 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 30.6 m80 -147.0 132.49 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.639 ' NH1' HG12 ' A' ' 997' ' ' ILE . 50.8 ttt-85 -81.58 117.47 21.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.43 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 988' ' ' TYR . 5.7 tt -76.05 111.83 11.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.457 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.689 ' HB ' HG13 ' A' 1019 ' ' ILE . 18.3 mt -99.47 59.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.528 0.68 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.734 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . -154.32 20.3 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.787 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 57.07 17.58 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.604 0.24 . . . . 0.0 111.122 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.614 ' H ' HD23 ' A' ' 996' ' ' LEU . 83.2 p 36.99 39.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 18.0 t -162.14 161.86 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.482 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -165.28 126.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' 1013 ' ' TRP . 43.5 tt0 -105.0 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.1 t -73.19 81.3 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' 1014 ' ' SER . 44.3 pt -86.87 -172.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.359 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.618 HD23 ' HD2' ' A' ' 961' ' ' LYS . 10.8 tp -158.36 124.42 4.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.47 . . . . 0.0 111.919 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 45.7 t -83.67 -45.56 13.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.153 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.478 ' H ' HD13 ' A' 1006 ' ' LEU . . . 167.77 -45.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.752 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.23 -52.41 10.09 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.606 HG21 ' N ' ' A' 1011 ' ' ALA . 86.9 m -151.26 149.16 29.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.606 ' N ' HG21 ' A' 1010 ' ' THR . . . -74.72 140.75 44.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.1 p80 -153.08 151.91 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.657 ' HH2' HG21 ' A' ' 980' ' ' ILE . 53.4 m95 -72.08 120.04 17.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.958 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.458 ' HB3' HD11 ' A' 1005 ' ' ILE . 80.1 p -52.5 -25.32 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 44.6 p -86.9 133.8 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 111.954 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 25.3 pttm -62.7 152.42 81.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.681 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 74.9 Cg_exo -47.55 118.09 2.75 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.323 2.015 . . . . 0.0 111.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.734 ' HB3' ' HA2' ' A' ' 998' ' ' GLY . 15.9 Cg_exo -69.43 139.94 42.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.015 2.477 . . . . 0.0 112.987 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.689 HG13 ' HB ' ' A' ' 997' ' ' ILE . 16.7 pt -134.28 126.26 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.921 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 92.5 m -86.43 95.67 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 111.211 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -77.02 138.43 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.191 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.457 ' HE ' ' HD2' ' A' 1045 ' ' HIS . 39.3 ttt85 -54.76 127.61 29.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.695 ' O ' ' HB2' ' A' 1046 ' ' TYR . 47.1 mm -56.02 110.38 2.27 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.683 ' HG2' ' HB2' ' A' 1080 ' ' GLN . 93.6 Cg_endo -81.17 133.09 8.61 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.511 2.141 . . . . 0.0 113.374 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 8.1 p -113.02 143.81 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.896 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.06 -148.63 2.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.095 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' 1027 ' ' LEU . 10.1 mt -70.02 148.82 96.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' 1029 ' ' PRO . 16.4 Cg_exo -66.5 137.07 45.28 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 110.499 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' 1028 ' ' PRO . 49.9 Cg_exo -34.11 135.28 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.667 2.244 . . . . 0.0 111.782 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 77.2 p -76.54 139.39 40.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' 1089 ' ' PRO . 7.8 tt -142.67 117.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.321 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -44.7 131.42 6.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.529 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.475 ' OD1' ' HB2' ' A' 1091 ' ' CYS . 22.5 p30 42.58 30.12 0.2 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.482 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.441 ' HA2' HG21 ' A' 1031 ' ' ILE . . . -79.16 160.8 46.59 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.526 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.721 ' HB2' ' HA ' ' A' 1055 ' ' ASN . 31.3 t0 -156.56 156.62 33.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.697 ' HA ' ' O ' ' A' 1051 ' ' THR . 23.4 p90 -155.88 145.37 20.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 111.91 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.568 HD13 ' HD2' ' A' 1053 ' ' ARG . 29.5 mt -109.23 111.27 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.775 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 57.1 m -171.12 -140.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.441 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 11.6 t -117.79 -27.87 6.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -45.56 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.951 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 54.39 -126.69 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -77.03 -40.73 45.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.136 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -67.5 148.45 51.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.31 152.91 15.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.307 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' 1046 ' ' TYR . 15.7 p-80 -155.08 -62.07 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.809 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.695 ' HB2' ' O ' ' A' 1023 ' ' ILE . 6.2 t80 169.11 40.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.594 0.235 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.46 -43.87 0.02 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.568 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 66.7 m -47.58 128.51 12.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 112.001 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' 1072 ' ' ILE . 7.7 p -97.17 175.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.558 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.571 HG11 ' O ' ' A' 1049 ' ' VAL . 30.9 m -151.41 131.77 4.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.172 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.697 ' O ' ' HA ' ' A' 1036 ' ' PHE . 42.4 m -104.33 102.64 12.32 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.433 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' 1035 ' ' ASP . 2.5 m-85 -70.57 135.08 48.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 111.254 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.568 ' HD2' HD13 ' A' 1037 ' ' ILE . 3.1 ptp85 -159.63 34.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.388 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.558 ' HB3' ' CD1' ' A' 1064 ' ' PHE . 77.5 m 62.03 149.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.188 0.518 . . . . 0.0 111.809 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.721 ' HA ' ' HB2' ' A' 1035 ' ' ASP . 47.3 t30 -63.45 -35.38 80.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.279 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.954 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 21.7 mt -70.31 -157.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 58.68 39.8 93.96 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.607 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 11.6 p -175.04 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 110.552 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -155.88 45.58 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.839 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.722 ' HA2' HD22 ' A' 1056 ' ' LEU . . . -172.19 -41.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.834 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.655 ' O ' ' HB3' ' A' 1062 ' ' LYS . 20.8 tpp180 67.6 158.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.461 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.655 ' HB3' ' O ' ' A' 1061 ' ' ARG . 20.2 tptm 94.97 -35.97 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.014 0.821 . . . . 0.0 110.077 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.954 ' HA ' ' HB2' ' A' 1056 ' ' LEU . 0.1 OUTLIER 43.1 32.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.537 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' 1091 ' ' CYS . 0.1 OUTLIER 36.93 -135.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1065 ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' 1092 ' ' ILE . 98.7 mt-10 -150.14 105.71 3.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.205 0.526 . . . . 0.0 110.814 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' 1070 ' ' PRO . 43.6 tp -70.51 149.73 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.112 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' 1089 ' ' PRO . 97.2 t -139.18 137.51 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.325 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.13 -158.79 35.0 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.561 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' 1089 ' ' PRO . 18.6 pt-20 -69.03 125.97 92.4 Favored Pre-proline 0 C--O 1.227 -0.117 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.76 ' HB3' HD22 ' A' 1066 ' ' LEU . 84.7 Cg_endo -96.16 26.15 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.114 2.542 . . . . 0.0 112.869 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.584 ' O ' HG21 ' A' 1072 ' ' ILE . 78.8 p -157.4 143.59 17.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.684 ' O ' HG21 ' A' 1049 ' ' VAL . 13.4 pt -155.19 171.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.881 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.8 p90 -137.46 144.07 42.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 0.0 111.315 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.57 ' HA ' ' CE2' ' A' 1084 ' ' TRP . 0.9 OUTLIER -62.19 121.37 12.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.55 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.433 HG23 ' HA ' ' A' 1084 ' ' TRP . 11.8 t -157.72 140.68 15.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.719 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' 1082 ' ' GLY . 69.7 m -89.77 -154.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.716 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER 179.22 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.409 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.716 ' H ' HD21 ' A' 1077 ' ' ASN . 29.5 m-20 -80.67 -54.92 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -163.24 -46.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.009 0.433 . . . . 0.0 111.635 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.683 ' HB2' ' HG2' ' A' 1024 ' ' PRO . 17.0 pt20 -175.3 32.81 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' 1082 ' ' GLY . 2.5 p -88.93 -104.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.612 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.75 ' H ' HG12 ' A' 1081 ' ' VAL . . . -153.24 -115.15 0.58 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.705 HD12 HD22 ' A' 1077 ' ' ASN . 4.2 mp 56.02 82.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.57 ' CE2' ' HA ' ' A' 1074 ' ' CYS . 15.4 m0 -70.66 -153.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.707 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' 1084 ' ' TRP . 47.9 t -56.42 -57.01 14.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 131.8 1.63 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.478 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.5 130.67 9.05 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 111.184 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.736 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -169.92 -46.74 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.736 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.7 Cg_endo -52.02 132.82 44.4 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.195 1.93 . . . . 0.0 112.54 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.627 ' NE2' HG22 ' A' 1092 ' ' ILE . 0.0 OUTLIER -153.21 138.51 17.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.427 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 74.5 m -103.04 135.32 44.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.627 HG22 ' NE2' ' A' 1090 ' ' GLN . 13.5 pt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.381 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -78.77 43.36 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.31 46.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.008 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 48.44 40.63 15.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.469 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.738 ' HD2' ' H ' ' A' 1011 ' ' ALA . 4.4 tppp? -77.46 140.85 39.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.794 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 67.2 p -157.99 144.84 17.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 76.8 m -79.9 31.7 0.26 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.82 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 59.47 142.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.841 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 966' ' ' PRO . 54.8 m -52.15 122.13 22.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.571 ' HG3' HD11 ' A' ' 986' ' ' ILE . 10.1 Cg_endo -53.53 115.52 2.36 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.495 2.13 . . . . 0.0 112.168 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.51 127.71 19.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.502 2.134 . . . . 0.0 111.559 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.18 109.74 2.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.864 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.641 ' HG3' ' HG2' ' A' 1018 ' ' PRO . 26.4 Cg_exo -61.94 147.25 95.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 111.571 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.575 HG23 HG13 ' A' 1019 ' ' ILE . 35.9 m -47.43 127.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 990' ' ' CYS . 75.4 m-20 51.23 46.35 26.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.718 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -171.53 124.1 1.08 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.198 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.73 144.53 27.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.696 0.284 . . . . 0.0 111.53 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.57 HG13 ' HG2' ' A' ' 966' ' ' PRO . 1.4 p -89.57 147.13 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.041 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.448 ' O ' HG13 ' A' ' 977' ' ' ILE . 17.7 m170 -115.43 95.27 5.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 979' ' ' ASP . 73.7 t -67.56 89.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.643 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 975' ' ' HIS . 42.5 mt -75.13 -90.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.512 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.412 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.8 p -59.65 -63.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.378 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.541 ' HB3' ' H ' ' A' ' 980' ' ' ILE . 25.4 m-20 -165.68 -137.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.24 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.541 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 8.3 pt -152.51 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.518 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.794 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 22.4 mt-30 -72.35 164.42 26.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.595 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' 1004 ' ' CYS . 3.5 p -43.99 135.84 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.887 0.375 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.19 54.74 4.29 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.795 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.412 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 94.4 p -164.52 130.37 2.87 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.617 ' NE ' ' HB2' ' A' 1003 ' ' GLU . 35.9 mmt180 -94.11 149.63 21.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.586 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 966' ' ' PRO . 48.7 pt -142.83 141.38 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -106.37 123.97 48.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.372 . . . . 0.0 111.951 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.7 ' HB2' HD12 ' A' ' 996' ' ' LEU . 1.3 m-85 -86.66 172.04 10.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.7 t -145.47 -174.24 4.34 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.081 0.467 . . . . 0.0 111.852 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.545 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 92.2 m -158.12 159.67 36.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 41.3 p -67.72 -160.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 111.378 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 43.7 m -82.53 130.26 35.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.694 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 68.44 45.39 68.69 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.538 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -148.08 123.13 10.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.489 ' HG3' HE22 ' A' 1080 ' ' GLN . 78.7 ttt180 -84.98 129.05 34.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.354 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 988' ' ' TYR . 3.7 tt -74.66 130.79 40.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.52 ' N ' HD21 ' A' ' 996' ' ' LEU . 49.6 mm -99.87 144.61 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.878 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.426 ' HA2' ' HE3' ' A' 1016 ' ' LYS . . . 77.26 36.23 35.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.872 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 59.4 131.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.401 ' HB3' HD11 ' A' ' 996' ' ' LEU . 79.1 p -84.59 36.4 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 986' ' ' ILE . 80.9 p -162.09 145.89 12.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.07 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -161.07 141.51 11.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.145 0.497 . . . . 0.0 112.162 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.617 ' HB2' ' NE ' ' A' ' 985' ' ' ARG . 89.0 tt0 -104.78 134.43 47.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.953 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 54.0 t -74.62 98.2 3.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 26.7 pt -90.73 -166.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.073 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.496 HD11 ' H ' ' A' 1008 ' ' GLY . 0.4 OUTLIER -141.08 121.78 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.147 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 37.8 t -90.38 41.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.496 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.496 ' H ' HD11 ' A' 1006 ' ' LEU . . . 50.92 39.84 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.599 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.65 -46.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.094 0.474 . . . . 0.0 110.571 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 67.8 m -151.24 147.85 27.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.738 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.19 134.78 41.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.522 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 88.9 m-70 -149.46 141.71 24.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.455 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 78.3 m95 -68.9 125.56 27.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.351 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 32.7 m -52.62 -25.36 10.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.899 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.473 HG22 ' O ' ' A' 1001 ' ' SER . 72.9 p -87.95 143.11 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' 1017 ' ' PRO . 0.0 OUTLIER -68.3 162.13 63.55 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.089 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.485 ' O ' ' HD2' ' A' 1016 ' ' LYS . 99.2 Cg_exo -43.18 116.57 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.519 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.641 ' HG2' ' HG3' ' A' ' 969' ' ' PRO . 56.1 Cg_endo -69.49 138.22 38.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.881 2.387 . . . . 0.0 112.728 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.575 HG13 HG23 ' A' ' 970' ' ' VAL . 12.1 tt -148.81 133.27 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 79.2 m -86.38 113.33 22.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 111.575 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -78.79 129.05 34.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.926 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -71.16 122.4 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.841 HG22 ' HB2' ' A' 1077 ' ' ASN . 37.7 mt -52.55 121.62 22.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.413 ' O ' ' HA2' ' A' 1082 ' ' GLY . 84.9 Cg_endo -81.64 125.25 4.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.872 2.382 . . . . 0.0 111.03 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.667 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 0.5 OUTLIER -97.06 25.29 5.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 36.67 -143.96 0.13 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.328 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.542 HD22 ' CE2' ' A' 1044 ' ' PHE . 22.3 mt -93.27 141.84 24.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.592 0.235 . . . . 0.0 111.225 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.771 ' HG3' HD22 ' A' 1040 ' ' ASN . 56.6 Cg_endo -68.8 156.93 63.84 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.493 2.129 . . . . 0.0 111.307 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.632 ' HB2' ' HH ' ' A' 1052 ' ' TYR . 82.8 Cg_exo -42.7 126.29 4.17 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.526 2.151 . . . . 0.0 112.273 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 66.6 p -77.41 98.27 5.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.545 HD11 ' HD2' ' A' 1052 ' ' TYR . 7.4 tt -86.41 106.73 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.563 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -76.22 148.01 37.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.968 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.8 m120 73.7 28.35 1.64 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.524 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.648 ' HA3' ' N ' ' A' 1055 ' ' ASN . . . -160.86 -46.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.78 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' 1034 ' ' GLY . 57.8 m-20 71.44 147.38 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.611 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' 1040 ' ' ASN . 14.4 p90 -84.0 145.59 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.098 0.475 . . . . 0.0 112.017 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' 1038 ' ' SER . 58.8 mt -90.72 164.01 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' 1037 ' ' ILE . 75.1 m 72.57 166.43 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.598 0.237 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' 1040 ' ' ASN . 57.5 p -49.54 -64.93 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.771 HD22 ' HG3' ' A' 1028 ' ' PRO . 18.7 t-20 33.46 49.09 0.21 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.031 0.444 . . . . 0.0 110.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -86.4 -60.71 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -147.5 -42.76 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 1.1 m120 -71.48 123.29 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.581 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.542 ' CE2' HD22 ' A' 1027 ' ' LEU . 86.3 m-85 -148.56 -46.88 0.15 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.633 ' C ' ' H ' ' A' 1047 ' ' GLY . 23.8 m80 58.1 -111.66 0.59 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' 1074 ' ' CYS . 10.0 t80 -64.31 27.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.059 0.456 . . . . 0.0 110.556 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' 1045 ' ' HIS . . . 76.51 -84.85 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.519 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' 1047 ' ' GLY . 34.2 t 115.72 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.885 0.874 . . . . 0.0 109.669 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.521 HG21 ' H ' ' A' 1050 ' ' VAL . 13.2 p -156.4 153.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.434 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.522 ' HB ' HD21 ' A' 1040 ' ' ASN . 5.0 p -153.81 129.08 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.945 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 71.7 m -86.74 120.62 28.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.128 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.632 ' HH ' ' HB2' ' A' 1029 ' ' PRO . 3.1 m-85 -80.28 139.44 36.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -147.63 142.84 27.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.546 ' O ' HD13 ' A' 1056 ' ' LEU . 40.9 m -77.97 149.93 34.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.525 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.648 ' N ' ' HA3' ' A' 1034 ' ' GLY . 44.5 t30 -56.31 -51.74 67.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.642 ' HA ' HG11 ' A' 1063 ' ' VAL . 1.7 mt 49.47 34.79 7.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.718 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.16 0.37 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.307 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' 1059 ' ' ARG . 85.8 p -68.35 -54.14 19.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' 1058 ' ' SER . 24.9 mmm180 -159.52 -47.02 0.05 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.697 0.284 . . . . 0.0 111.278 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.548 ' HA3' ' HB3' ' A' 1056 ' ' LEU . . . -167.14 50.58 0.25 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.43 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' 1062 ' ' LYS . 0.0 OUTLIER -77.06 47.7 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.403 0.281 . . . . 0.0 110.491 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' 1061 ' ' ARG . 61.9 tttp 38.45 61.98 1.07 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' 1056 ' ' LEU . 3.3 p -147.26 87.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.207 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.722 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 1.5 m-30 88.26 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.189 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -147.94 145.61 28.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.458 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.861 HD21 ' N ' ' A' 1067 ' ' VAL . 3.8 tt -68.58 142.1 55.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.391 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.861 ' N ' HD21 ' A' 1066 ' ' LEU . 56.3 t -133.48 111.37 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.475 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' 1089 ' ' PRO . . . 77.03 133.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.355 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.729 ' O ' ' HG3' ' A' 1089 ' ' PRO . 5.2 tp10 46.0 107.94 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 111.833 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.804 ' HA ' HD12 ' A' 1066 ' ' LEU . 68.8 Cg_endo -87.18 -28.15 0.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.48 2.12 . . . . 0.0 113.106 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 87.6 p -151.2 129.97 12.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.545 HD13 ' HD2' ' A' 1029 ' ' PRO . 45.6 pt -106.86 175.84 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.436 0.636 . . . . 0.0 112.514 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.13 144.62 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.04 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.722 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 34.9 t -67.43 125.31 25.73 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.736 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.428 HG21 ' N ' ' A' 1076 ' ' SER . 3.3 t -92.05 -40.98 10.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.221 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.428 ' N ' HG21 ' A' 1075 ' ' THR . 10.9 p -166.49 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 0.0 111.421 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.841 ' HB2' HG22 ' A' 1023 ' ' ILE . 0.8 OUTLIER -170.97 143.33 1.98 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.385 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.708 ' H ' HD21 ' A' 1077 ' ' ASN . 61.7 t0 -57.52 -48.37 79.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.929 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -150.4 -55.65 0.16 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.489 HE22 ' HG3' ' A' ' 995' ' ' ARG . 13.3 mm-40 -148.21 -26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.494 ' O ' HG21 ' A' 1023 ' ' ILE . 21.8 t -68.89 -110.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . -165.81 136.13 4.03 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.068 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' 1077 ' ' ASN . 8.1 tp -145.91 132.94 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.722 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 20.8 m95 -83.98 -155.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 67.2 m -79.75 -57.5 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.701 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.59 134.11 2.04 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.047 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.422 ' HB3' ' CG ' ' A' 1029 ' ' PRO . 87.8 Cg_endo -79.71 48.93 3.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.858 2.372 . . . . 0.0 112.017 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -69.92 -41.0 14.18 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.729 ' HG3' ' O ' ' A' 1069 ' ' GLU . 78.3 Cg_exo -48.96 120.42 5.43 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.759 1.639 . . . . 0.0 112.552 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.515 HE21 HG21 ' A' 1092 ' ' ILE . 58.6 tp60 -134.04 116.38 15.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.106 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.722 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 49.9 t -87.26 117.02 25.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.128 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.515 HG21 HE21 ' A' 1090 ' ' GLN . 10.2 pt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.213 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 958' ' ' ALA . 23.6 pt-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 957' ' ' GLU . . . -178.7 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 88.9 tt0 -169.07 58.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.756 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.58 56.47 1.45 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 962' ' ' SER . 45.4 mmtm -77.6 -127.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.746 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.96 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 47.3 t 74.19 139.76 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.224 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.53 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 79.0 m -79.98 37.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.008 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 962' ' ' SER . 22.9 tptm 61.27 134.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.34 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 95.1 m -59.69 114.34 9.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 24.1 Cg_exo -63.82 118.49 5.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.372 2.048 . . . . 0.0 112.08 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.56 132.37 15.96 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.396 2.064 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 30.4 m-20 -55.65 110.02 2.0 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.771 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.457 ' HD2' ' HA2' ' A' ' 972' ' ' GLY . 5.5 Cg_exo -79.84 -146.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.053 2.502 . . . . 0.0 111.923 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' 1019 ' ' ILE . 1.6 p -48.95 93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.456 ' HB3' HG22 ' A' ' 991' ' ' THR . 76.6 m-20 49.28 22.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.393 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -83.05 159.31 37.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.6 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.528 ' N ' ' HA ' ' A' ' 990' ' ' CYS . 11.4 tpt -157.45 110.67 2.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 9.0 p -87.98 145.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.993 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.4 ' N ' ' CD2' ' A' ' 975' ' ' HIS . 11.8 m170 -106.58 97.45 7.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.823 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.691 ' HA ' HG23 ' A' ' 986' ' ' ILE . 16.3 t -65.29 96.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 977' ' ' ILE . 37.4 mt -75.24 -92.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.264 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.0 p -68.84 -73.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 110.359 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -161.2 151.04 17.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 980' ' ' ILE . 11.5 pt -84.18 3.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.363 0.601 . . . . 0.0 109.793 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.96 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 88.6 mt-30 -82.03 157.08 24.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.945 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.618 HG21 ' N ' ' A' ' 983' ' ' GLY . 7.2 p -44.35 150.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.644 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.618 ' N ' HG21 ' A' ' 982' ' ' VAL . . . 81.02 -44.19 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.712 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.515 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 54.4 m -74.14 -170.1 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.83 0.315 . . . . 0.0 111.035 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' 1003 ' ' GLU . 79.6 mtp180 -151.51 169.53 21.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.295 0.569 . . . . 0.0 111.991 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.691 HG23 ' HA ' ' A' ' 976' ' ' VAL . 37.6 pt -150.01 139.05 15.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.499 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' 1001 ' ' SER . 48.7 p -107.36 122.67 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 5.4 m-85 -83.28 160.1 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.995 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 75.1 m -161.5 -6.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.74 ' SG ' ' HG ' ' A' ' 996' ' ' LEU . 65.8 m 62.29 -158.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.07 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 971' ' ' ASN . 34.2 p -75.08 -142.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.604 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.483 HG21 ' HD1' ' A' ' 994' ' ' HIS . 9.8 t -62.4 -127.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.537 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -72.57 43.75 0.93 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 114.501 0.56 . . . . 0.0 114.501 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.483 ' HD1' HG21 ' A' ' 992' ' ' THR . 18.4 m80 -93.96 139.6 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.201 0.5 . . . . 0.0 110.646 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -81.99 117.22 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.738 0.304 . . . . 0.0 110.553 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' 1000 ' ' SER . 1.7 tt -76.16 133.28 40.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.647 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.948 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -105.16 155.1 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.406 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 79.41 -75.81 2.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.818 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.474 ' O ' HD23 ' A' ' 996' ' ' LEU . 35.0 p80 -165.28 139.13 4.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.772 ' HA ' HD12 ' A' ' 996' ' ' LEU . 21.7 m -100.15 22.04 11.98 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 83.8 p -162.27 148.16 13.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.903 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.49 134.4 13.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 111.547 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 985' ' ' ARG . 87.7 tt0 -101.62 128.78 47.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.05 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -79.38 125.69 29.86 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.535 HD11 ' N ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -138.26 153.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 0.0 110.286 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.58 124.2 29.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.473 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.473 ' HG ' ' N ' ' A' 1008 ' ' GLY . 81.2 p -86.63 -125.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.09 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' 1007 ' ' SER . . . -65.08 -54.89 24.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.154 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -153.35 20.79 0.56 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.447 HG21 ' N ' ' A' 1011 ' ' ALA . 95.4 m -151.37 147.45 26.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.53 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.3 136.39 40.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.591 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.513 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 82.9 m-70 -149.14 142.78 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.733 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.5 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 83.2 m95 -71.66 136.2 47.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.985 0.421 . . . . 0.0 111.428 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 74.8 p -52.44 -24.46 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.839 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 25.2 p -132.38 130.57 40.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.45 . . . . 0.0 111.858 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.532 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -57.95 158.9 11.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.629 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -41.56 126.49 3.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.123 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.695 ' HB2' HD22 ' A' ' 996' ' ' LEU . 64.2 Cg_endo -72.57 -156.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.511 2.141 . . . . 0.0 112.217 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.948 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 11.3 mt -143.04 -179.26 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.783 ' H ' HG21 ' A' 1019 ' ' ILE . 21.1 m -145.81 79.06 1.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.377 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.695 ' H ' HD12 ' A' ' 997' ' ' ILE . 3.0 tp-100 -71.6 138.57 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.008 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.643 ' HB3' ' HB3' ' A' 1046 ' ' TYR . 9.5 mpt_? -72.33 126.61 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.998 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.2 mt -67.32 113.25 12.88 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.638 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' 1045 ' ' HIS . 30.1 Cg_endo -63.69 114.37 2.54 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.758 2.305 . . . . 0.0 113.679 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.57 ' O ' ' HB2' ' A' 1044 ' ' PHE . 9.1 p -95.67 135.97 36.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.208 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.13 -150.59 3.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.104 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.87 139.03 97.26 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.12 168.33 19.4 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.024 2.483 . . . . 0.0 111.291 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 65.5 Cg_exo -50.86 110.3 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.873 1.716 . . . . 0.0 111.529 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.6 p -77.42 141.02 39.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.269 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.567 HG13 ' HA2' ' A' 1034 ' ' GLY . 24.1 pt -149.68 124.33 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.446 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.96 139.38 10.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-20 75.1 -28.41 0.19 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.344 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.567 ' HA2' HG13 ' A' 1031 ' ' ILE . . . -64.62 160.07 41.39 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' A' 1036 ' ' PHE . 71.5 m-20 -153.78 -156.53 0.69 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.717 ' HB2' HG22 ' A' 1050 ' ' VAL . 36.7 p90 -155.95 142.33 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 112.298 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.402 HD12 ' HD2' ' A' 1053 ' ' ARG . 53.9 mt -111.26 57.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.054 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 60.1 m -157.76 -163.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 22.6 m -96.91 49.15 1.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.265 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.613 HD22 ' HB ' ' A' 1050 ' ' VAL . 5.3 m120 -62.93 -52.26 63.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.765 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 56.81 -137.27 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -149.23 50.38 0.96 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -168.42 60.99 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.164 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' 1025 ' ' CYS . 5.3 m-85 -76.77 129.99 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.744 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' 1046 ' ' TYR . 20.8 m80 -98.42 -58.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.643 ' HB3' ' HB3' ' A' 1022 ' ' ARG . 42.3 t80 172.17 31.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.71 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.46 98.09 0.16 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.79 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.8 p 175.72 134.41 0.05 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.535 0.683 . . . . 0.0 111.391 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.529 HG21 ' N ' ' A' 1050 ' ' VAL . 12.7 p -102.17 155.52 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.448 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.717 HG22 ' HB2' ' A' 1036 ' ' PHE . 6.4 p -133.47 126.47 52.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.012 0.435 . . . . 0.0 111.05 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 33.2 m -106.69 109.84 21.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.524 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 10.3 m-85 -71.92 147.65 46.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.726 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' 1054 ' ' CYS . 14.0 ptm180 -142.8 -14.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.201 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' 1053 ' ' ARG . 66.1 m 71.29 146.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.104 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' 1033 ' ' ASN . 28.7 t30 -62.64 -133.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 111.665 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.73 HD12 ' HA3' ' A' 1060 ' ' GLY . 8.6 mt -155.04 133.57 11.93 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.96 31.43 3.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.184 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.642 ' O ' ' HG2' ' A' 1059 ' ' ARG . 68.0 m -169.36 -70.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.783 0.292 . . . . 0.0 111.615 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' 1058 ' ' SER . 31.8 mmt-85 -167.21 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.65 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.73 ' HA3' HD12 ' A' 1056 ' ' LEU . . . -153.29 -32.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.444 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' 1061 ' ' ARG . 41.4 ttt85 -55.43 120.53 7.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.93 133.73 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.469 HG21 ' N ' ' A' 1064 ' ' PHE . 32.5 m -147.0 -29.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 111.302 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.514 ' HD2' ' HB3' ' A' 1091 ' ' CYS . 15.6 m-85 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1065 ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' 1092 ' ' ILE . 34.6 mt-10 -98.52 126.43 44.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.718 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.586 HD12 ' HB3' ' A' 1070 ' ' PRO . 3.6 tt -68.81 143.47 54.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.517 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.755 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 96.2 t -135.1 117.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 88.77 -142.82 17.28 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.658 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1069 ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -62.52 122.87 76.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.018 0.437 . . . . 0.0 112.17 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.586 ' HB3' HD12 ' A' 1066 ' ' LEU . 87.0 Cg_endo -85.33 -17.46 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.812 2.341 . . . . 0.0 112.175 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 77.9 p -156.37 155.66 32.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.502 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' 1049 ' ' VAL . 34.8 pt -150.29 -162.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.656 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -160.28 150.06 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 2.4 t -62.39 141.03 58.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.698 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 12.8 t -145.73 -146.89 0.2 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' 1082 ' ' GLY . 46.9 t -165.46 147.92 7.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.886 0.374 . . . . 0.0 111.46 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.696 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -163.97 -33.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.696 ' H ' HD21 ' A' 1077 ' ' ASN . 5.0 t0 -73.78 -139.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.49 -39.87 11.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -162.91 -16.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 50.5 t -58.74 -28.9 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.501 . . . . 0.0 110.776 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 81.13 -63.06 4.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.901 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.517 ' HB ' HD22 ' A' 1077 ' ' ASN . 75.4 mt 60.69 130.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.106 0.479 . . . . 0.0 111.847 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 18.1 m95 -80.19 138.2 36.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.587 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 71.5 p -55.47 -61.73 2.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -71.38 121.85 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.643 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.39 39.87 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.087 2.525 . . . . 0.0 112.012 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.809 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 61.98 135.02 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.504 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.524 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 36.3 Cg_endo -64.9 -138.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.657 2.238 . . . . 0.0 112.399 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.755 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -151.84 128.09 10.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.514 ' HB3' ' HD2' ' A' 1064 ' ' PHE . 98.8 m -102.74 104.06 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.361 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' 1065 ' ' GLU . 17.8 pt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.304 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.748 0.309 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -174.62 48.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 959' ' ' GLU . 17.5 tp10 54.71 42.6 31.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.333 0.587 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -71.27 -43.32 67.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.111 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.594 ' HB2' ' HZ2' ' A' ' 961' ' ' LYS . 0.0 OUTLIER 64.39 143.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 81.2 p -157.99 146.73 19.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.97 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.02 152.23 29.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 0.0 OUTLIER -63.87 133.57 53.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.598 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.438 ' O ' HG21 ' A' ' 965' ' ' THR . 6.5 t -73.73 125.73 90.2 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.857 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.62 ' HG2' HG12 ' A' ' 974' ' ' VAL . 93.5 Cg_endo -79.73 113.14 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.296 1.997 . . . . 0.0 111.219 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 95.5 Cg_exo -42.2 -48.96 6.25 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.435 2.09 . . . . 0.0 112.051 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 174.5 126.95 0.11 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.339 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.654 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 50.2 Cg_exo -54.04 150.91 29.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.686 HG22 HG13 ' A' 1019 ' ' ILE . 93.6 t -46.65 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.507 ' ND2' HG11 ' A' ' 970' ' ' VAL . 73.4 m-20 75.28 -43.42 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.829 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -69.13 -145.09 0.17 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.094 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.654 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 25.8 ptm -159.22 139.83 12.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.738 0.304 . . . . 0.0 110.668 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.62 HG12 ' HG2' ' A' ' 966' ' ' PRO . 9.9 p -92.08 142.68 12.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.225 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -106.88 93.97 4.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 979' ' ' ASP . 84.3 t -65.35 -44.73 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.393 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.0 mt 61.06 -100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.4 p -67.35 -60.4 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.617 ' O ' HG11 ' A' ' 976' ' ' VAL . 39.5 t0 -172.53 -141.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.493 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 9.0 pt -152.83 20.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 110.815 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 70.5 mt-30 -87.32 -157.59 0.4 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.517 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 983' ' ' GLY . 94.2 t -46.57 140.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.751 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 984' ' ' SER . . . 74.11 -79.46 0.89 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.06 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' 1003 ' ' GLU . 95.8 p 21.15 106.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.391 0.676 . . . . 0.0 112.802 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -98.77 77.16 2.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . . . . . . . . . 41.0 pt -80.37 137.45 21.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.509 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -108.62 130.51 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.486 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 6.6 m-85 -98.21 147.21 24.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.514 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.5 p -152.48 128.26 10.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.8 t -86.87 -133.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.41 163.82 15.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.415 0.626 . . . . 0.0 111.593 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 25.4 m -53.8 123.57 12.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 131.87 -31.53 3.05 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.232 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -139.73 142.2 36.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.094 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -82.03 121.1 26.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' 1018 ' ' PRO . 4.4 tp -67.63 123.6 20.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.579 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.773 ' HB ' HG21 ' A' 1019 ' ' ILE . 43.3 mm -94.65 149.55 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.193 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 75.91 177.67 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.222 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.475 ' C ' ' H ' ' A' 1001 ' ' SER . 95.6 m-70 -74.98 131.68 40.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 0.0 111.006 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.457 ' OG ' HD22 ' A' ' 996' ' ' LEU . 10.0 m -75.21 28.82 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.992 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 999' ' ' HIS . 82.2 p -162.13 151.19 15.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.11 122.74 6.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 111.847 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 984' ' ' SER . 10.4 pt-20 -107.07 135.86 47.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.231 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.408 ' SG ' ' CZ3' ' A' 1013 ' ' TRP . 19.3 m -70.55 126.78 30.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.085 0.469 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.505 HD11 ' N ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -136.74 147.47 27.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.523 178.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.55 127.02 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.709 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 46.4 t -90.09 -42.03 11.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -163.34 -36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.321 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.449 ' O ' ' HE2' ' A' ' 961' ' ' LYS . 77.0 m-20 -150.61 -49.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 111.175 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 89.4 m -97.49 137.82 35.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 111.626 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.558 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.21 140.26 43.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.752 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.709 ' HE2' ' HB2' ' A' 1007 ' ' SER . 9.3 p80 -149.52 153.29 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.408 ' CZ3' ' SG ' ' A' 1004 ' ' CYS . 74.8 m95 -67.95 131.61 45.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.432 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.419 ' HA ' HD13 ' A' 1005 ' ' ILE . 46.8 t -52.43 -22.28 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.235 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.4 HG22 ' CD2' ' A' ' 999' ' ' HIS . 81.7 p -136.64 142.09 43.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.021 0.439 . . . . 0.0 112.148 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.581 ' HD2' ' H ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -54.94 148.66 26.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.789 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.86 120.42 7.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.447 2.098 . . . . 0.0 112.462 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.666 ' HB3' HD12 ' A' ' 996' ' ' LEU . 50.6 Cg_exo -54.95 152.21 30.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.773 HG21 ' HB ' ' A' ' 997' ' ' ILE . 3.6 tt -143.08 131.7 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.586 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.509 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 49.7 m -86.39 113.11 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 111.267 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -84.55 129.15 34.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.928 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.5 ' HD2' ' CD2' ' A' 1045 ' ' HIS . 20.0 ptt-85 -72.8 134.78 45.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.525 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.61 HG21 ' HD2' ' A' 1024 ' ' PRO . 63.7 mt -100.72 131.07 24.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.315 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.61 ' HD2' HG21 ' A' 1023 ' ' ILE . 65.4 Cg_endo -74.0 115.06 4.19 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.2 1.933 . . . . 0.0 111.715 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.602 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 44.0 t -89.75 148.96 22.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.347 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 149.64 37.88 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.545 HD21 ' HZ ' ' A' 1044 ' ' PHE . 0.1 OUTLIER -52.52 141.4 34.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 117.048 0.424 . . . . 0.0 111.417 -179.159 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.11 145.01 99.13 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.547 2.164 . . . . 0.0 111.229 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.95 134.24 14.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.314 2.009 . . . . 0.0 112.128 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 73.3 p -77.5 126.17 30.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' 1034 ' ' GLY . 6.0 tt -89.56 113.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.445 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -60.86 141.17 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.932 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.6 m-20 57.55 35.37 25.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.966 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' 1031 ' ' ILE . . . -168.33 131.8 2.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.605 ' HB2' ' HD3' ' A' 1053 ' ' ARG . 35.8 m-20 -76.57 -148.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 110.82 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.409 ' H ' ' HB3' ' A' 1035 ' ' ASP . 36.3 p90 -155.88 141.22 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.656 HD13 HG23 ' A' 1051 ' ' THR . 59.5 mt -87.99 154.98 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.406 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' 1037 ' ' ILE . 73.6 m 73.79 138.33 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.265 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' 1040 ' ' ASN . 70.7 p -50.27 -61.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.978 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' 1039 ' ' THR . 55.1 t30 33.1 44.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.099 0.476 . . . . 0.0 111.091 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -76.26 -161.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.956 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.08 67.86 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.672 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.2 p30 -169.72 23.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.862 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.57 ' O ' ' HD1' ' A' 1044 ' ' PHE . 0.1 OUTLIER -92.44 132.26 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.511 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' 1047 ' ' GLY . 5.6 m80 -84.26 -114.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1046 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -56.41 71.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.963 0.347 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.833 ' HA2' ' HB3' ' A' 1074 ' ' CYS . . . 43.5 -107.31 0.12 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.686 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' 1047 ' ' GLY . 95.6 p 135.06 -142.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.371 1.068 . . . . 0.0 109.806 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' 1073 ' ' TYR . 71.8 t -148.96 141.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.701 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 30.2 m -140.84 137.21 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.656 HG23 HD13 ' A' 1037 ' ' ILE . 72.6 m -92.5 125.41 37.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.077 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.593 ' HB2' HD23 ' A' 1066 ' ' LEU . 4.0 m-85 -72.0 156.33 39.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.666 HH22 HD12 ' A' 1056 ' ' LEU . 7.4 ptm180 -145.6 -145.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.112 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.649 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 62.0 m -155.1 145.54 22.08 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.95 0.405 . . . . 0.0 111.707 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -55.16 150.64 10.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.373 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.822 ' H ' HD21 ' A' 1056 ' ' LEU . 1.6 mm? -70.4 -149.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -143.6 -29.28 0.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 54.8 m -144.58 -31.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 31.9 tpt85 -167.66 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' 1056 ' ' LEU . . . -165.68 39.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.828 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.773 ' HG2' ' H ' ' A' 1062 ' ' LYS . 27.0 ttm180 -81.26 -147.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.773 ' H ' ' HG2' ' A' 1061 ' ' ARG . 87.5 tttt -173.49 67.42 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.594 HG21 ' N ' ' A' 1064 ' ' PHE . 18.2 m -84.92 -38.37 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.223 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' 1054 ' ' CYS . 56.3 m-85 -72.71 147.54 45.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.114 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.98 120.48 32.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' 1052 ' ' TYR . 53.3 tp -68.46 144.26 54.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' 1089 ' ' PRO . 57.9 t -138.3 123.87 24.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 71.57 156.94 2.65 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.779 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' 1069 ' ' GLU . 41.4 tt0 30.32 65.81 0.85 Allowed Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.588 ' HB3' HD22 ' A' 1066 ' ' LEU . 88.1 Cg_endo -79.99 7.01 4.88 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.072 1.848 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 40.1 t -156.47 149.73 24.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.56 HG12 ' HE1' ' A' 1052 ' ' TYR . 25.2 pt -140.91 165.22 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.275 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.624 ' HB3' HG23 ' A' 1049 ' ' VAL . 9.9 p90 -151.58 138.72 19.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.386 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.833 ' HB3' ' HA2' ' A' 1047 ' ' GLY . 41.2 t -76.84 133.43 39.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.468 HG21 ' N ' ' A' 1076 ' ' SER . 5.2 t -90.01 -35.05 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.468 ' N ' HG21 ' A' 1075 ' ' THR . 73.4 m 61.84 135.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.82 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' 1077 ' ' ASN . 0.1 OUTLIER -175.25 -137.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.298 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' 1079 ' ' ASP . 27.6 t70 53.1 -138.53 1.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.459 ' H ' ' CG ' ' A' 1078 ' ' ASP . 1.6 m-20 -92.44 -49.22 6.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.983 0.42 . . . . 0.0 110.446 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.466 ' HA ' HG22 ' A' 1023 ' ' ILE . 3.2 pt20 -179.86 31.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.432 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 41.3 t -87.21 -45.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 67.51 124.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.217 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.424 HD11 HG22 ' A' 1083 ' ' ILE . 0.2 OUTLIER -153.96 137.32 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.622 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.0 m95 -70.68 126.94 30.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' 1075 ' ' THR . 44.8 t -70.96 -39.56 72.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' 1087 ' ' PRO . . . -62.28 122.77 29.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.166 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' A' 1088 ' ' ALA . 17.9 Cg_exo -67.15 -121.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.298 2.665 . . . . 0.0 112.093 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.458 ' H ' ' HB2' ' A' 1087 ' ' PRO . . . -160.85 129.34 2.97 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.571 ' HB2' ' O ' ' A' 1067 ' ' VAL . 73.3 Cg_endo -74.76 -141.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.885 2.39 . . . . 0.0 113.486 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.537 HE21 HG22 ' A' 1092 ' ' ILE . 57.1 tp60 -152.39 127.28 9.61 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.439 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 44.6 t -103.11 123.49 46.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.537 HG22 HE21 ' A' 1090 ' ' GLN . 11.8 pt . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -168.38 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 41.99 36.97 0.73 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.709 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 41.36 38.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.23 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 961' ' ' LYS . 0.4 OUTLIER 61.32 125.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.398 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.3 p -157.97 135.21 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.521 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 980' ' ' ILE . 2.9 p -84.71 148.65 26.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.171 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -63.64 140.16 58.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 -179.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 73.9 m -60.72 126.07 84.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.378 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 19.7 Cg_exo -66.87 121.5 8.71 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.47 2.113 . . . . 0.0 112.329 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 133.92 26.84 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.412 2.075 . . . . 0.0 111.676 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.26 109.4 1.41 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.769 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 971' ' ' ASN . 68.7 Cg_endo -87.83 -153.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 112.605 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' 1021 ' ' GLN . 2.2 p -49.42 88.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.32 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 969' ' ' PRO . 74.3 m-20 45.28 34.21 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.157 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.729 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -76.3 -56.88 4.15 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.786 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.611 ' HB2' ' HB2' ' A' ' 989' ' ' SER . 60.8 mtt 61.04 96.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 987' ' ' THR . 0.3 OUTLIER -92.99 143.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.374 179.278 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.407 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 26.0 m170 -122.07 111.61 17.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.442 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.473 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 69.6 t -67.45 99.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.94 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 986' ' ' ILE . 41.8 mm -75.23 -90.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.685 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.0 p -65.59 -60.43 2.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.211 0.529 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.502 ' O ' HG21 ' A' ' 980' ' ' ILE . 7.5 t0 -167.49 -128.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.982 178.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.502 HG21 ' O ' ' A' ' 979' ' ' ASP . 5.2 pt -154.76 -21.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.742 0.306 . . . . 0.0 110.313 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' 1004 ' ' CYS . 23.5 pt20 -72.43 -164.29 0.14 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' 1006 ' ' LEU . 40.4 t -47.27 137.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 64.81 12.41 53.58 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.416 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' 1003 ' ' GLU . 87.7 p -77.0 171.06 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.199 0.5 . . . . 0.0 110.684 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.73 ' HD3' ' N ' ' A' ' 986' ' ' ILE . 0.0 OUTLIER -151.14 138.23 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.967 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.73 ' N ' ' HD3' ' A' ' 985' ' ' ARG . 28.2 pt -142.7 173.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 111.538 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' 1000 ' ' SER . 69.6 p -136.98 124.8 22.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.603 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.6 m-85 -87.17 47.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.922 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 989' ' ' SER . . . . . 0.671 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 66.9 m 30.03 -77.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.674 ' SG ' HD23 ' A' ' 996' ' ' LEU . 33.8 m 67.02 70.65 0.38 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 1.2 t -60.16 154.54 19.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.53 HG22 ' HD1' ' A' ' 994' ' ' HIS . 11.0 t 38.94 -156.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 113.626 -1.625 . . . . 0.0 113.39 178.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.565 ' O ' HD13 ' A' 1023 ' ' ILE . . . -80.29 50.23 3.95 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.199 -0.455 . . . . 0.0 113.829 -178.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.53 ' HD1' HG22 ' A' ' 992' ' ' THR . 2.5 m80 -82.67 149.8 27.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.85 0.325 . . . . 0.0 110.907 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.742 ' HB2' HG12 ' A' 1023 ' ' ILE . 79.5 ttt180 -80.26 93.2 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.874 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.699 HD23 ' HB3' ' A' 1000 ' ' SER . 4.7 tp -76.05 124.6 27.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.65 ' HB ' HG13 ' A' 1019 ' ' ILE . 1.8 mp -98.15 137.55 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.128 178.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.46 ' O ' ' CD2' ' A' ' 999' ' ' HIS . . . 76.76 -118.66 5.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.481 -178.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.496 ' C ' ' H ' ' A' 1001 ' ' SER . 19.0 m170 -149.36 130.95 14.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.085 0.443 . . . . 0.0 111.278 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.699 ' HB3' HD23 ' A' ' 996' ' ' LEU . 88.1 p -79.95 34.0 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.351 0.596 . . . . 0.0 109.817 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.533 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 79.6 p -162.2 138.56 7.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.888 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.519 ' HB3' ' OG1' ' A' 1015 ' ' THR . . . -160.45 141.63 12.14 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 984' ' ' SER . 21.5 pt-20 -105.06 132.86 50.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 8.3 t -71.3 84.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -179.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' 1014 ' ' SER . 18.8 pt -87.27 158.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.711 HD22 HG23 ' A' ' 982' ' ' VAL . 3.3 mm? -95.31 136.18 35.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.67 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.631 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 48.0 t -162.43 131.02 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.18 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 58.44 39.02 92.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.86 36.31 27.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.676 0.274 . . . . 0.0 111.464 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.1 m -151.25 129.83 12.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.578 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 961' ' ' LYS . . . -75.64 136.79 40.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.098 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.631 ' HE2' ' HB3' ' A' 1007 ' ' SER . 7.6 p80 -163.06 156.51 19.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.942 0.401 . . . . 0.0 111.105 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.498 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 29.6 m95 -74.35 118.28 17.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.517 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.526 ' HB3' HD12 ' A' 1005 ' ' ILE . 79.7 p -52.41 -22.37 4.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.239 -178.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.519 ' OG1' ' HB3' ' A' 1002 ' ' ALA . 53.7 p -105.05 20.92 18.0 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.508 ' O ' ' HD3' ' A' 1018 ' ' PRO . 21.7 ptmt 47.49 165.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.46 107.15 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.121 1.88 . . . . 0.0 111.903 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' 1016 ' ' LYS . 90.5 Cg_endo -82.37 168.14 14.99 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.786 2.324 . . . . 0.0 112.352 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.666 ' HB ' HG13 ' A' ' 970' ' ' VAL . 18.1 pt -148.85 118.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.408 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.729 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 1.9 m -86.39 73.24 10.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.998 ' HA ' HG23 ' A' ' 970' ' ' VAL . 3.5 pt20 -71.73 -166.91 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.691 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.449 ' O ' ' HD3' ' A' 1024 ' ' PRO . 38.4 ptt180 -96.94 136.18 37.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' 1076 ' ' SER . 53.6 mt -79.19 106.32 4.34 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.502 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.478 ' HB3' ' HA ' ' A' 1045 ' ' HIS . 45.6 Cg_endo -67.43 135.48 36.64 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.825 179.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.684 ' HB3' ' H ' ' A' 1075 ' ' THR . 3.4 p -87.62 144.03 26.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.739 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.15 174.32 53.34 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.074 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 14.4 mt -53.49 150.03 13.53 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.906 0.353 . . . . 0.0 111.142 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.503 ' HB3' HD13 ' A' 1072 ' ' ILE . 19.0 Cg_endo -59.74 174.75 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.956 ' HD3' ' HA ' ' A' 1085 ' ' SER . 56.6 Cg_endo -68.56 -0.78 6.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.933 2.422 . . . . 0.0 112.62 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1030 ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' 1029 ' ' PRO . 70.8 p 55.71 145.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.946 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 13.8 tt -151.1 112.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.364 0.602 . . . . 0.0 111.425 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -66.88 155.73 37.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.76 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' 1032 ' ' ALA . 69.1 m-20 75.53 -40.57 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.685 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.497 ' HA3' ' CA ' ' A' 1054 ' ' CYS . . . -70.69 -157.13 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.953 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.593 ' HB2' ' HB3' ' A' 1053 ' ' ARG . 55.3 m-20 -160.01 135.91 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.547 ' HD1' HG22 ' A' 1050 ' ' VAL . 0.1 OUTLIER -84.03 148.36 26.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.435 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' 1051 ' ' THR . 67.7 mt -121.78 148.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.36 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.496 ' N ' HG21 ' A' 1037 ' ' ILE . 11.7 t 75.93 -136.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.727 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 45.7 p -100.82 130.79 46.89 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.461 HD21 ' HB ' ' A' 1050 ' ' VAL . 22.2 t-20 -179.71 68.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.249 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.481 ' N ' ' HE1' ' A' 1044 ' ' PHE . 32.0 ptt180 -170.38 105.6 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' 1041 ' ' ARG . 56.8 mt-10 69.24 -51.86 0.6 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.453 HD21 ' N ' ' A' 1043 ' ' ASN . 0.0 OUTLIER -71.48 52.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.043 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.481 ' HE1' ' N ' ' A' 1041 ' ' ARG . 6.6 m-85 -88.5 148.93 23.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.732 0.777 . . . . 0.0 112.692 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.582 ' O ' ' SG ' ' A' 1074 ' ' CYS . 14.3 p-80 -166.88 179.03 5.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.264 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.495 ' HE1' HG13 ' A' 1081 ' ' VAL . 4.1 t80 -65.44 31.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' 1045 ' ' HIS . . . -161.19 104.4 0.24 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.379 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' 1074 ' ' CYS . 79.7 p 177.48 145.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.552 0.691 . . . . 0.0 111.585 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1049 ' ' VAL . . . . . . . . . . . . . 6.6 p -137.79 146.23 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.594 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.547 HG22 ' HD1' ' A' 1036 ' ' PHE . 7.6 p -137.71 133.5 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.968 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.544 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 91.3 m -102.48 134.22 46.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.401 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.837 ' HB2' HD13 ' A' 1066 ' ' LEU . 0.4 OUTLIER -70.56 -167.15 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.174 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' 1035 ' ' ASP . 6.0 tpm_? -159.62 -41.39 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.497 ' CA ' ' HA3' ' A' 1034 ' ' GLY . 88.2 m 68.4 121.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.815 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.602 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 19.0 t-20 21.66 -118.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.615 0.572 . . . . 0.0 112.068 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.668 ' HB3' ' O ' ' A' 1059 ' ' ARG . 93.4 mt 62.18 117.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.106 0.479 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -100.66 129.56 9.94 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.572 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 15.7 t 72.73 -47.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.428 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.668 ' O ' ' HB3' ' A' 1056 ' ' LEU . 8.6 ttt85 -162.61 -135.51 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.244 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.49 ' H ' ' HG2' ' A' 1059 ' ' ARG . . . -88.62 46.6 3.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.202 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' 1061 ' ' ARG . 17.9 mmt85 -62.24 157.41 19.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.621 0.248 . . . . 0.0 111.197 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.57 71.7 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.994 0.426 . . . . 0.0 110.847 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' 1064 ' ' PHE . 4.0 m -154.51 86.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.602 ' HB2' ' HB3' ' A' 1055 ' ' ASN . 0.4 OUTLIER 70.1 143.42 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.69 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 1065 ' ' GLU . . . . . 0.444 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 49.4 mt-10 -141.98 139.53 32.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.837 HD13 ' HB2' ' A' 1052 ' ' TYR . 2.2 tt -68.38 133.06 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.064 0.459 . . . . 0.0 111.397 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.819 ' HB ' HE21 ' A' 1090 ' ' GLN . 47.1 t -138.24 129.73 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 93.89 -133.06 11.47 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.681 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.744 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 37.0 tt0 -57.11 106.06 0.62 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 117.153 0.476 . . . . 0.0 111.131 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.423 ' HA ' HD12 ' A' 1066 ' ' LEU . 81.7 Cg_endo -96.24 -12.19 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.098 2.532 . . . . 0.0 113.968 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.432 ' HG ' ' HA ' ' A' 1051 ' ' THR . 52.8 m -156.16 167.45 30.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.412 0.625 . . . . 0.0 112.268 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.503 HD13 ' HB3' ' A' 1028 ' ' PRO . 18.4 pt -141.22 157.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.637 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -117.7 149.71 40.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' 1045 ' ' HIS . 37.2 t -61.61 159.19 13.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.188 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.915 HG23 ' H ' ' A' 1084 ' ' TRP . 15.0 t -157.59 -150.61 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1076 ' ' SER . . . . . 1.139 ' HB2' ' HB ' ' A' 1081 ' ' VAL . 47.2 t -89.79 -107.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 112.339 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.773 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -174.62 -30.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.317 -177.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.773 ' H ' HD21 ' A' 1077 ' ' ASN . 54.4 t0 177.47 -9.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.353 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.92 -141.05 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.951 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.7 -52.47 51.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 1.139 ' HB ' ' HB2' ' A' 1076 ' ' SER . 19.7 t -56.98 -24.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' 1076 ' ' SER . . . 80.75 -140.19 21.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.215 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.844 ' HA ' HG22 ' A' 1075 ' ' THR . 0.0 OUTLIER -149.75 138.16 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.472 0.653 . . . . 0.0 112.639 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.915 ' H ' HG23 ' A' 1075 ' ' THR . 0.2 OUTLIER -77.38 -114.76 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.567 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 1085 ' ' SER . . . . . 0.956 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 30.6 t 69.52 59.14 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' 1088 ' ' ALA . . . -59.22 124.36 36.34 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.688 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' 1088 ' ' ALA . 23.9 Cg_exo -64.54 22.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.329 2.019 . . . . 0.0 113.749 -178.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' 1086 ' ' GLY . . . 53.88 139.22 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 113.112 178.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 84.7 Cg_endo -76.11 -122.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.762 2.308 . . . . 0.0 110.725 178.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.819 HE21 ' HB ' ' A' 1067 ' ' VAL . 1.8 pm0 -152.41 143.48 23.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.939 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 3.6 m -103.13 133.91 47.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.479 HG12 HG22 ' A' 1067 ' ' VAL . 23.4 pt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.112 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -171.78 -138.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.041 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.16 134.89 0.74 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.745 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -78.55 46.45 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' A' 1010 ' ' THR . 55.3 tptt -77.61 150.01 34.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.396 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 64.1 p -157.42 154.74 29.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 90.0 m -79.31 159.6 27.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.094 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -63.88 132.96 52.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 0.0 111.039 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.582 ' HG1' HD13 ' A' ' 980' ' ' ILE . 59.9 m -73.14 112.87 17.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.038 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.459 ' HB2' HG13 ' A' ' 974' ' ' VAL . 30.8 Cg_exo -61.84 123.46 12.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.242 1.961 . . . . 0.0 111.963 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.83 -50.78 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.263 1.975 . . . . 0.0 111.497 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 179.26 115.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.679 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 32.2 Cg_endo -66.03 144.73 77.1 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.462 2.108 . . . . 0.0 111.969 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' 1019 ' ' ILE . 0.2 OUTLIER -44.97 116.92 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.888 179.879 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' A' 1020 ' ' CYS . 14.8 t30 70.94 -50.31 0.68 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -77.93 -152.53 5.71 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.392 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.64 ' HG3' ' HE2' ' A' ' 975' ' ' HIS . 24.0 ptm -159.2 133.36 7.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 988' ' ' TYR . 3.3 p -81.91 146.76 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.64 ' HE2' ' HG3' ' A' ' 973' ' ' MET . 22.2 m170 -123.54 105.24 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 980' ' ' ILE . 52.1 t -65.31 -65.74 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 47.9 mt 75.31 -51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.255 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 45.6 p -86.62 -80.91 0.23 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.002 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.59 ' O ' HG12 ' A' ' 980' ' ' ILE . 9.2 t70 -173.35 -18.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.404 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.655 HG21 HG11 ' A' ' 976' ' ' VAL . 28.6 pt 54.97 72.46 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.21 0.604 . . . . 0.0 111.419 -178.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 24.3 mt-30 -152.63 38.89 0.54 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.667 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 76.6 t 101.06 133.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.924 0.889 . . . . 0.0 112.096 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 71.79 -29.93 0.62 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.361 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.582 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 79.9 p -68.45 124.01 22.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.448 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 5.1 tmm_? -101.64 118.85 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.558 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.612 HG23 ' HA ' ' A' ' 976' ' ' VAL . 28.7 pt -95.42 -169.0 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.312 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' 1001 ' ' SER . 35.2 p -153.01 128.71 10.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.0 m-85 -93.95 149.8 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.024 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.0 m -157.35 133.43 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.659 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 9.1 m -82.02 -131.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 110.693 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.417 ' O ' ' ND1' ' A' ' 994' ' ' HIS . 1.2 t -165.02 159.24 17.74 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.796 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 992' ' ' THR . 50.8 m 37.66 54.12 1.47 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.972 0.891 . . . . 0.0 110.266 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 994' ' ' HIS . . . 78.85 -99.53 1.66 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.957 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.553 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 24.9 m80 54.85 140.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.892 0.477 . . . . 0.0 111.53 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -89.86 106.5 18.51 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.229 -0.294 . . . . 0.0 111.018 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.542 ' C ' HD21 ' A' ' 996' ' ' LEU . 1.7 tt -76.15 121.23 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' 1019 ' ' ILE . 38.6 mm -89.16 153.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.832 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.77 -112.54 3.53 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.732 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' 1001 ' ' SER . 92.1 m-70 -149.72 133.75 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 111.402 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 81.2 p -80.61 30.25 0.3 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 61.3 m -162.14 151.24 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.646 ' HB2' ' HB3' ' A' 1013 ' ' TRP . . . -157.59 127.49 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.577 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -103.57 126.8 50.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.598 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' 1011 ' ' ALA . 41.9 t -73.56 126.52 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.537 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 20.8 pt -147.41 155.32 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.696 HD12 ' HG2' ' A' ' 961' ' ' LYS . 3.8 mm? -92.36 146.33 23.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.292 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.727 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 44.7 t -162.44 -58.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -94.2 47.4 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.129 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.422 ' N ' HD21 ' A' 1009 ' ' ASN . 2.6 m120 60.49 13.84 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.037 0.446 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.77 ' HA ' ' HE2' ' A' ' 961' ' ' LYS . 89.2 m -151.25 146.21 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.519 ' HB3' ' SG ' ' A' 1004 ' ' CYS . . . -75.29 134.14 41.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.96 0.409 . . . . 0.0 110.714 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.727 ' HE2' ' HB3' ' A' 1007 ' ' SER . 8.1 p80 -152.18 146.34 25.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.402 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.646 ' HB3' ' HB2' ' A' 1002 ' ' ALA . 57.0 m95 -70.13 124.85 25.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.7 t -52.52 -25.44 10.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 77.1 p -92.2 137.82 32.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.065 0.459 . . . . 0.0 112.046 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.636 ' HB3' ' NZ ' ' A' 1016 ' ' LYS . 0.2 OUTLIER -62.19 152.5 78.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.272 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -43.9 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.54 147.77 92.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.052 2.502 . . . . 0.0 112.413 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.763 HG13 HG13 ' A' ' 970' ' ' VAL . 5.5 tt -148.01 122.8 2.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 994' ' ' HIS . 4.4 t -86.36 113.66 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.121 0.486 . . . . 0.0 111.411 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -84.75 130.1 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.971 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.528 HH12 ' HG3' ' A' 1024 ' ' PRO . 0.0 OUTLIER -82.07 124.25 29.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.319 179.319 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.651 HG22 ' HA ' ' A' 1080 ' ' GLN . 64.1 mt -71.8 112.71 15.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.412 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.528 ' HG3' HH12 ' A' 1022 ' ' ARG . 34.4 Cg_exo -61.6 133.21 44.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.831 2.354 . . . . 0.0 113.063 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.728 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 92.4 m -98.39 -150.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.451 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1026 ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -163.84 156.23 27.98 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.659 HD11 ' H ' ' A' 1027 ' ' LEU . 8.7 mp -40.3 132.17 1.63 Allowed Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.161 0.481 . . . . 0.0 111.459 -179.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.469 ' HB2' HD12 ' A' 1072 ' ' ILE . 54.4 Cg_endo -69.8 155.44 65.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.0 102.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.088 1.859 . . . . 0.0 111.363 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.3 p -77.39 118.35 19.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.661 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' 1089 ' ' PRO . 10.4 pt -93.63 116.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.474 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -49.54 141.0 9.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.722 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' 1054 ' ' CYS . 5.1 m120 74.91 -13.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.58 -140.62 0.02 OUTLIER Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.273 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.598 ' HB3' ' H ' ' A' 1053 ' ' ARG . 30.4 t70 -168.9 -168.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.561 -0.376 . . . . 0.0 110.842 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.547 ' H ' ' CG ' ' A' 1035 ' ' ASP . 1.2 t80 -155.99 127.52 7.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.749 HD11 ' HD2' ' A' 1053 ' ' ARG . 52.5 mt -147.78 77.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.791 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.586 ' HG ' ' H ' ' A' 1051 ' ' THR . 68.8 m -160.32 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.003 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 7.0 m -136.99 41.67 2.47 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.593 ' ND2' ' HB ' ' A' 1050 ' ' VAL . 5.0 m120 -72.01 -99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.762 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 60.85 48.46 6.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.653 ' HG2' ' H ' ' A' 1043 ' ' ASN . 66.9 tt0 62.95 -136.37 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.653 ' H ' ' HG2' ' A' 1042 ' ' GLU . 23.2 p30 34.23 44.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' 1042 ' ' GLU . 88.4 m-85 -77.48 147.88 35.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.401 . . . . 0.0 111.533 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' 1046 ' ' TYR . 79.3 m-70 -147.13 -49.79 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.48 179.25 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.638 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 53.9 t80 171.87 149.03 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.303 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 78.71 -17.63 6.64 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.888 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 58.8 m -47.72 144.55 3.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.85 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' 1072 ' ' ILE . 12.8 p -137.79 148.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.273 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.593 ' HB ' ' ND2' ' A' 1040 ' ' ASN . 2.5 p -143.13 136.11 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.253 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.586 ' H ' ' HG ' ' A' 1038 ' ' SER . 87.8 m -106.54 111.97 24.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.449 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.551 ' HE1' HG12 ' A' 1072 ' ' ILE . 11.4 m-85 -85.25 142.18 29.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.749 ' HD2' HD11 ' A' 1037 ' ' ILE . 99.9 mtt180 -156.44 30.76 0.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' 1033 ' ' ASN . 71.3 m 59.13 143.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 0.0 111.739 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 8.9 m120 -65.86 97.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.665 ' H ' HD21 ' A' 1056 ' ' LEU . 3.2 mm? -70.37 177.23 3.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.593 178.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.74 -28.49 38.38 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 52.5 m -160.07 -29.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.69 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 33.9 tpt85 -163.83 -45.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.526 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.52 ' HA3' ' HG ' ' A' 1056 ' ' LEU . . . 178.61 43.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.775 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -77.3 46.76 0.52 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.633 0.254 . . . . 0.0 111.625 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.7 tttt 44.61 81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.173 0.511 . . . . 0.0 111.703 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' 1056 ' ' LEU . 3.3 m -155.13 95.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.465 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.684 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 65.8 m-85 72.82 136.44 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.437 -178.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -141.09 130.04 23.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.308 0.575 . . . . 0.0 111.693 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.832 HD22 ' HA ' ' A' 1070 ' ' PRO . 35.5 tp -68.47 158.87 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.557 HG22 HG12 ' A' 1092 ' ' ILE . 75.4 t -139.39 143.82 30.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.527 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1068 ' ' GLY . . . . . 0.421 ' N ' HG11 ' A' 1067 ' ' VAL . . . 79.72 -144.56 26.66 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.12 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' 1089 ' ' PRO . 79.4 tt0 -60.41 127.81 87.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.817 0.309 . . . . 0.0 110.623 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.832 ' HA ' HD22 ' A' 1066 ' ' LEU . 26.0 Cg_endo -92.3 -54.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.813 2.342 . . . . 0.0 112.802 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 41.7 t -98.85 152.86 19.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.579 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.571 ' O ' HG22 ' A' 1049 ' ' VAL . 31.5 pt -141.42 162.06 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.258 179.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 6.3 p90 -151.02 141.14 22.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.417 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.917 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 46.9 t -65.11 152.41 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.233 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.447 ' C ' ' HE1' ' A' 1046 ' ' TYR . 13.1 t -140.09 -147.41 0.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.021 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.6 t -153.28 145.79 24.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.972 0.415 . . . . 0.0 111.537 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.687 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -162.7 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.064 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.687 ' H ' HD21 ' A' 1077 ' ' ASN . 1.2 m-20 -77.22 -147.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.568 0.223 . . . . 0.0 110.626 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1079 ' ' ASP . . . . . 0.422 ' H ' ' HB3' ' A' 1078 ' ' ASP . 29.4 p-10 -83.61 -45.38 13.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.286 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.651 ' HA ' HG22 ' A' 1023 ' ' ILE . 3.0 pt20 -178.22 30.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.737 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.575 ' HB ' HD13 ' A' 1083 ' ' ILE . 43.7 t -77.25 -34.84 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 85.37 61.37 1.73 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.994 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.575 HD13 ' HB ' ' A' 1081 ' ' VAL . 2.1 mp -81.99 135.11 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.917 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 14.4 m95 -72.57 -173.93 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.978 0.418 . . . . 0.0 112.003 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.3 t -59.51 -71.24 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.149 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 137.43 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.308 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.93 136.23 34.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.672 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -167.6 -44.99 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' A' 1088 ' ' ALA . 63.3 Cg_exo -48.23 137.98 23.38 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.122 1.881 . . . . 0.0 112.138 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.442 ' HB2' HE21 ' A' 1090 ' ' GLN . 0.3 OUTLIER -149.7 134.57 17.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 0.0 111.619 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 29.1 t -90.67 132.54 35.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.557 HG12 HG22 ' A' 1067 ' ' VAL . 39.2 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.074 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.675 0.274 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -175.3 -134.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.662 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 57.53 47.41 16.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.192 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -164.2 39.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.874 ' HD2' ' H ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -79.18 132.02 36.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.878 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.756 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -92.44 135.57 33.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' 1012 ' ' HIS . 80.9 m -81.1 26.42 0.44 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.037 0.446 . . . . 0.0 110.652 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 962' ' ' SER . 59.6 tttm 61.12 136.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.573 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.741 ' HA ' HG22 ' A' ' 980' ' ' ILE . 4.7 t -58.06 129.11 82.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.148 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.85 ' HG2' HG13 ' A' ' 974' ' ' VAL . 55.7 Cg_endo -69.72 107.2 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.115 1.877 . . . . 0.0 112.197 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 10.4 Cg_endo -53.47 143.68 54.26 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.546 2.164 . . . . 0.0 111.078 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -40.4 113.33 0.95 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.171 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.792 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 24.2 Cg_exo -64.03 148.24 91.54 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.044 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' 1020 ' ' CYS . 0.2 OUTLIER -43.92 114.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.458 179.853 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 7.7 t30 71.01 -57.45 0.6 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.096 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.594 ' HA2' ' SG ' ' A' ' 990' ' ' CYS . . . -70.06 -162.47 3.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.978 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.792 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 88.5 mtp -158.15 140.12 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.85 HG13 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -83.66 148.85 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.592 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -109.81 87.15 2.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.997 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.473 ' HA ' HG23 ' A' ' 986' ' ' ILE . 58.4 t -65.45 109.85 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 29.3 mm -75.14 -83.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.909 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.4 p -81.42 -61.04 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.266 0.555 . . . . 0.0 109.979 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -165.94 -130.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.558 179.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.741 HG22 ' HA ' ' A' ' 965' ' ' THR . 0.2 OUTLIER -144.97 10.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 111.109 178.871 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.756 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 26.0 mt-30 -85.68 171.76 11.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.988 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.1 t -44.31 143.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.2 -31.25 1.83 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.276 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 36.2 m -68.4 124.02 22.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.028 0.414 . . . . 0.0 110.928 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.781 ' HD2' ' N ' ' A' ' 986' ' ' ILE . 5.5 tmm_? -101.63 152.2 21.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.562 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.781 ' N ' ' HD2' ' A' ' 985' ' ' ARG . 38.3 pt -142.25 138.41 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 80.8 p -107.53 125.68 51.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.672 ' HB2' ' HA ' ' A' 1000 ' ' SER . 5.2 m-85 -92.08 149.24 21.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.761 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.9 m -159.93 121.3 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.075 0.464 . . . . 0.0 111.335 179.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.594 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 85.0 m -99.91 155.15 17.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 35.9 p -61.6 161.16 10.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.089 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.1 m -57.45 145.68 32.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.695 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.59 -45.62 1.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.184 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.566 ' CD2' ' HA ' ' A' 1022 ' ' ARG . 7.5 m80 -82.45 136.06 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.758 0.313 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 995' ' ' ARG . 44.0 ttm-85 -82.03 130.47 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.619 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.696 ' HA ' ' SG ' ' A' 1020 ' ' CYS . 0.9 OUTLIER -76.11 126.91 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.058 0.456 . . . . 0.0 111.59 -179.474 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.717 HD12 ' HG2' ' A' 1021 ' ' GLN . 1.7 mp -107.14 148.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.443 178.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.44 -119.35 4.84 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.021 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.447 ' C ' ' H ' ' A' 1001 ' ' SER . 92.0 m-70 -149.67 133.53 16.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.132 0.466 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.672 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.2 p -78.44 30.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.2 p -162.19 140.07 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.356 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.434 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -164.13 131.12 3.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.603 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -104.94 137.52 42.57 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.487 ' O ' HG21 ' A' 1005 ' ' ILE . 53.4 t -71.1 131.69 43.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.487 HG21 ' O ' ' A' 1004 ' ' CYS . 45.9 pt -148.04 -165.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 111.285 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.04 163.42 12.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.643 ' HB3' ' HD2' ' A' 1012 ' ' HIS . 47.4 t -162.51 -116.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -49.96 -43.86 40.58 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.779 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.9 t30 -167.73 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 110.981 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 7.7 t -96.48 -162.52 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.227 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.45 ' HB1' ' C ' ' A' ' 962' ' ' SER . . . -80.05 139.11 37.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.996 0.426 . . . . 0.0 110.925 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.643 ' HD2' ' HB3' ' A' 1007 ' ' SER . 94.5 m-70 -149.4 140.03 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.412 ' HZ2' ' HB ' ' A' ' 980' ' ' ILE . 89.3 m95 -66.71 133.6 50.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.069 0.461 . . . . 0.0 110.956 -178.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' 1005 ' ' ILE . 87.7 p -52.33 -23.97 6.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.883 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 81.0 p -121.4 140.37 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 111.695 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -54.26 151.73 12.84 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.083 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.02 105.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.321 2.014 . . . . 0.0 112.028 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.15 143.72 96.35 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.603 2.202 . . . . 0.0 111.942 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 997' ' ' ILE . 36.5 pt -138.67 -171.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 89.9 m -153.78 131.4 11.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.506 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.717 ' HG2' HD12 ' A' ' 997' ' ' ILE . 98.2 mm-40 -80.32 132.31 35.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.566 ' HA ' ' CD2' ' A' ' 994' ' ' HIS . 15.7 ptp180 -67.98 -25.17 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.813 ' HA ' HE22 ' A' 1080 ' ' GLN . 46.4 mt 59.96 73.11 0.68 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.833 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 78.1 Cg_exo -49.8 126.98 17.78 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.362 2.041 . . . . 0.0 112.447 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 23.8 t -88.49 147.18 24.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.661 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.07 142.66 28.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.64 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 28.4 tp -54.73 131.41 65.37 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.887 ' HB3' HD12 ' A' 1072 ' ' ILE . 67.0 Cg_exo -52.6 153.77 13.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.195 2.597 . . . . 0.0 112.821 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.692 ' HB2' ' HB3' ' A' 1088 ' ' ALA . 37.4 Cg_exo -58.98 127.83 25.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.353 2.035 . . . . 0.0 111.664 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.5 p -77.47 142.24 39.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.206 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 29.7 pt -140.37 123.07 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.417 178.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.42 141.74 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.278 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 75.63 -37.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.765 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -65.04 121.13 20.77 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.4 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' 1036 ' ' PHE . 35.5 t0 -82.23 -158.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.832 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -157.18 142.67 17.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 111.339 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.865 HD12 ' HD3' ' A' 1053 ' ' ARG . 6.9 mt -149.69 -138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.851 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.527 ' H ' ' CG2' ' A' 1037 ' ' ILE . 58.2 m 71.81 -163.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 7.9 t -73.66 -46.63 45.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.689 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.559 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 73.0 m-80 -54.06 151.13 7.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.18 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.832 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 83.1 mtm180 -143.02 -48.57 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.256 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.1 OUTLIER -162.94 145.24 10.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.48 179.656 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' 1042 ' ' GLU . 2.7 m120 82.13 -46.59 0.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.515 ' HD2' ' HZ2' ' A' 1084 ' ' TRP . 1.1 m-85 54.82 57.07 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.738 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.714 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 50.6 m170 -52.52 -44.65 65.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.454 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.595 ' HB2' ' O ' ' A' 1045 ' ' HIS . 9.7 t80 166.89 70.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.999 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1047 ' ' GLY . . . . . 0.483 ' O ' ' OG ' ' A' 1048 ' ' SER . . . -77.59 -77.02 0.85 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.935 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1048 ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' 1047 ' ' GLY . 4.3 m 167.71 -53.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.818 HG23 ' HB3' ' A' 1073 ' ' TYR . 20.4 t -147.56 153.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.635 ' N ' HG11 ' A' 1049 ' ' VAL . 10.4 p -135.65 120.22 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.3 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' A' 1071 ' ' SER . 91.4 m -93.85 126.37 39.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.391 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.633 ' O ' ' HG2' ' A' 1053 ' ' ARG . 13.2 m-85 -82.42 -41.29 20.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.865 ' HD3' HD12 ' A' 1037 ' ' ILE . 17.2 ptt180 66.5 -34.04 0.2 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.165 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.645 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 83.9 m 66.95 135.53 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.693 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 2.2 m120 21.58 -105.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.698 HD11 ' O ' ' A' 1061 ' ' ARG . 0.2 OUTLIER -154.9 139.36 16.83 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.96 0.409 . . . . 0.0 111.032 -179.225 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' 1061 ' ' ARG . . . -88.92 -48.44 3.86 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.205 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 66.7 m -102.3 -57.39 2.07 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' 1061 ' ' ARG . 27.2 mtt85 -76.98 117.41 18.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.405 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 74.49 -37.7 1.01 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.77 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.698 ' O ' HD11 ' A' 1056 ' ' LEU . 0.0 OUTLIER 62.3 -139.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.483 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.545 ' H ' ' CD ' ' A' 1061 ' ' ARG . 59.6 tttm 69.02 25.2 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.514 0.673 . . . . 0.0 110.053 -178.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.693 ' HA ' ' HB2' ' A' 1055 ' ' ASN . 11.7 p -84.86 23.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.787 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' 1064 ' ' PHE . 0.2 OUTLIER 39.24 -131.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.086 0.47 . . . . 0.0 109.932 179.459 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -132.1 123.79 27.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.919 178.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1066 ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 48.3 tp -68.85 129.04 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 111.678 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' 1090 ' ' GLN . 62.0 t -106.35 121.45 58.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.986 179.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.42 -147.58 34.48 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.548 179.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' 1069 ' ' GLU . 0.3 OUTLIER -69.01 131.3 90.89 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.509 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 54.1 Cg_endo -70.77 -32.84 13.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 111.777 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' 1051 ' ' THR . 80.4 p -142.58 132.01 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.363 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.887 HD12 ' HB3' ' A' 1028 ' ' PRO . 18.4 pt -87.81 -167.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.167 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.818 ' HB3' HG23 ' A' 1049 ' ' VAL . 7.9 p90 -158.89 137.37 10.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 0.0 112.072 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 49.0 t -76.7 164.0 26.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.915 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1075 ' ' THR . . . . . 0.408 ' O ' ' OG ' ' A' 1076 ' ' SER . 6.5 t -155.04 -33.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1076 ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' 1075 ' ' THR . 89.8 p 58.97 148.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.303 0.377 . . . . 0.0 110.904 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.706 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -164.81 -30.1 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.706 ' H ' HD21 ' A' 1077 ' ' ASN . 62.2 t0 -55.42 -87.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.708 0.29 . . . . 0.0 111.14 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -163.2 -38.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.813 HE22 ' HA ' ' A' 1023 ' ' ILE . 72.2 tp60 -166.22 51.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.701 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 15.6 t -130.38 -48.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.568 -178.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.524 ' O ' HG21 ' A' 1083 ' ' ILE . . . 66.28 125.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.989 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' 1082 ' ' GLY . 0.2 OUTLIER -150.42 137.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.025 0.44 . . . . 0.0 111.141 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.559 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 18.4 m95 -70.53 135.83 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.196 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 46.8 t -65.93 -50.93 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.622 ' HA2' HG23 ' A' 1072 ' ' ILE . . . -65.99 125.88 28.21 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.705 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.96 41.52 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.6 2.2 . . . . 0.0 112.817 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' 1029 ' ' PRO . . . 58.71 138.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.319 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' 1090 ' ' GLN . 84.6 Cg_endo -80.39 -150.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.748 2.299 . . . . 0.0 112.237 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.779 ' HG2' HG12 ' A' 1092 ' ' ILE . 35.0 tt0 -152.36 134.07 14.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.272 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 37.0 m -91.96 78.6 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.795 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1092 ' ' ILE . . . . . 0.779 HG12 ' HG2' ' A' 1090 ' ' GLN . 46.0 pt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.442 179.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 57.03 -141.45 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -172.25 143.81 1.52 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 960' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 982' ' ' VAL . . . 54.26 42.28 31.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.672 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.451 ' HG2' HD22 ' A' 1006 ' ' LEU . 4.3 mptp? 61.63 159.07 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.407 0.623 . . . . 0.0 112.153 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.438 ' C ' ' HB3' ' A' 1011 ' ' ALA . 49.6 m -157.94 138.96 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.678 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.428 ' O ' ' NE1' ' A' 1013 ' ' TRP . 73.8 m -79.93 38.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 111.608 -179.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 55.6 tptt 63.68 130.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.467 ' OG1' HD13 ' A' ' 980' ' ' ILE . 88.8 m -74.43 130.04 82.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.733 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.676 ' HG2' HG13 ' A' ' 974' ' ' VAL . 68.8 Cg_endo -101.34 72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.912 3.075 . . . . 0.0 113.38 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 968' ' ' ASP . 57.1 Cg_endo -70.02 125.9 12.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.985 1.79 . . . . 0.0 111.731 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 967' ' ' PRO . 59.0 m-20 16.5 62.8 0.18 Allowed Pre-proline 0 N--CA 1.467 0.378 0 O-C-N 123.759 0.662 . . . . 0.0 112.167 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 39.2 Cg_exo -58.83 -143.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.002 2.468 . . . . 0.0 113.185 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.902 HG13 ' HA ' ' A' 1019 ' ' ILE . 4.0 p -49.05 85.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.819 -179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 969' ' ' PRO . 6.7 p-10 38.95 48.73 1.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.979 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.625 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -162.44 128.57 1.9 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.805 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.424 ' HB2' ' HE1' ' A' ' 973' ' ' MET . 22.2 ptm -88.77 135.92 33.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 111.548 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.676 HG13 ' HG2' ' A' ' 966' ' ' PRO . 4.1 p -91.56 146.85 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.459 ' HE2' ' HG ' ' A' ' 989' ' ' SER . 12.6 m170 -107.59 96.71 6.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.24 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.751 ' HA ' HG23 ' A' ' 986' ' ' ILE . 14.0 m -65.37 113.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.298 0.57 . . . . 0.0 110.801 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 985' ' ' ARG . 38.8 mt -79.92 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.315 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.1 p -149.33 54.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.572 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.57 -154.32 0.37 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.942 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.467 HD13 ' OG1' ' A' ' 965' ' ' THR . 6.1 pt -155.91 95.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.117 0.484 . . . . 0.0 111.463 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.65 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 24.0 mt-30 -152.62 28.98 0.54 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.55 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.65 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 66.0 t 102.13 135.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 124.239 0.962 . . . . 0.0 111.099 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.34 -29.75 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.862 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 982' ' ' VAL . 49.7 m -68.4 132.93 47.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 111.058 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 38.2 ttm180 -101.71 147.42 26.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.751 HG23 ' HA ' ' A' ' 976' ' ' VAL . 39.7 pt -143.14 134.08 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.17 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' 1001 ' ' SER . 80.3 p -100.72 122.96 44.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.058 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.607 ' HH ' ' HG3' ' A' ' 966' ' ' PRO . 3.8 m-85 -88.36 120.47 29.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 989' ' ' SER . . . . . 0.459 ' HG ' ' HE2' ' A' ' 975' ' ' HIS . 80.9 p -88.82 -54.09 4.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.577 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 13.0 t 69.54 142.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -178.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.1 p -60.25 146.75 42.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.284 0.564 . . . . 0.0 111.849 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.1 t -52.99 -26.65 15.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.38 41.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.52 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -139.87 139.99 36.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.245 0.522 . . . . 0.0 111.413 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' 1080 ' ' GLN . 57.0 ttt-85 -81.97 125.62 30.98 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.029 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.67 HD21 ' N ' ' A' ' 997' ' ' ILE . 0.7 OUTLIER -72.78 140.37 47.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.226 0.536 . . . . 0.0 111.605 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.911 ' HB ' HG21 ' A' 1019 ' ' ILE . 45.6 mm -107.92 148.53 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.501 ' N ' HG21 ' A' ' 997' ' ' ILE . . . 77.1 41.49 21.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.674 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' 1001 ' ' SER . 89.8 m-70 62.46 136.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 112.122 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 82.7 p -79.16 36.36 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.439 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.728 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 46.2 m -158.58 160.61 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.471 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.556 ' HB3' ' OG1' ' A' 1015 ' ' THR . . . -159.81 128.8 5.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.392 . . . . 0.0 111.892 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -104.99 125.16 50.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.116 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.613 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 31.1 t -68.8 129.3 39.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.731 0.3 . . . . 0.0 110.753 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' 1014 ' ' SER . 15.0 pt -138.51 152.52 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.451 HD22 ' HG2' ' A' ' 961' ' ' LYS . 0.3 OUTLIER -95.47 120.38 35.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.0 t -80.9 -45.17 17.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.363 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -166.09 -34.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.079 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -148.84 -49.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.15 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 86.8 m -99.75 135.87 40.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 179.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.438 ' HB3' ' C ' ' A' ' 962' ' ' SER . . . -75.36 143.05 43.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.268 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.417 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 90.7 m-70 -149.45 142.94 25.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.428 ' NE1' ' O ' ' A' ' 963' ' ' CYS . 79.3 m95 -68.14 116.71 9.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.105 0.478 . . . . 0.0 110.642 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.632 ' HB2' HD11 ' A' 1005 ' ' ILE . 47.2 t -52.42 -22.35 4.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.243 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' 1002 ' ' ALA . 81.1 p -90.1 16.34 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.827 ' HE3' ' HA ' ' A' 1016 ' ' LYS . 0.0 OUTLIER 58.58 159.27 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.275 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.39 127.31 25.45 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.25 1.967 . . . . 0.0 112.104 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.486 ' HG3' ' CE2' ' A' ' 988' ' ' TYR . 67.2 Cg_endo -73.09 148.55 44.84 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.797 2.332 . . . . 0.0 112.371 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.911 HG21 ' HB ' ' A' ' 997' ' ' ILE . 6.4 tt -148.81 125.31 2.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.592 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 61.7 m -85.45 101.28 12.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.493 . . . . 0.0 112.006 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.401 ' HB3' HD13 ' A' ' 997' ' ' ILE . 7.6 tt0 -79.7 140.06 37.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.112 178.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.459 ' HG2' HH11 ' A' 1022 ' ' ARG . 11.5 tpt180 -50.03 135.8 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.377 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' 1046 ' ' TYR . 26.6 mm -55.59 119.29 23.82 Favored Pre-proline 0 C--O 1.226 -0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.368 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -92.37 138.5 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.184 2.589 . . . . 0.0 112.877 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1025 ' ' CYS . . . . . 0.659 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 71.8 m -112.93 30.08 7.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.752 0.311 . . . . 0.0 111.622 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 42.84 -138.03 3.26 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.776 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1027 ' ' LEU . . . . . 0.539 ' HB3' ' HD2' ' A' 1028 ' ' PRO . 19.9 mt -108.74 164.96 13.56 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1028 ' ' PRO . . . . . 0.625 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 37.9 Cg_endo -66.0 152.22 81.91 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.72 2.28 . . . . 0.0 112.3 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1029 ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' 1030 ' ' THR . 86.1 Cg_exo -47.44 -29.2 9.69 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.626 2.217 . . . . 0.0 112.935 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1030 ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' 1029 ' ' PRO . 20.1 m 64.71 147.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1031 ' ' ILE . . . . . 0.511 HG23 ' CD2' ' A' 1052 ' ' TYR . 13.2 tt -152.47 125.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1032 ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -65.75 135.62 55.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.518 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1033 ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' 1032 ' ' ALA . 4.4 m120 74.81 -38.19 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.574 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1034 ' ' GLY . . . . . 0.804 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -64.66 121.6 22.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.699 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1035 ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' 1036 ' ' PHE . 9.6 t70 -74.46 163.34 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1036 ' ' PHE . . . . . 0.468 ' HB2' ' CG2' ' A' 1050 ' ' VAL . 29.9 p90 -144.31 136.35 26.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.204 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1037 ' ' ILE . . . . . 0.574 ' CG2' ' H ' ' A' 1038 ' ' SER . 5.7 mt -87.91 -160.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1038 ' ' SER . . . . . 0.574 ' H ' ' CG2' ' A' 1037 ' ' ILE . 57.0 m 55.26 -133.04 1.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1039 ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' 1041 ' ' ARG . 41.1 p -152.96 70.1 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1040 ' ' ASN . . . . . 0.648 HD22 ' HB ' ' A' 1050 ' ' VAL . 5.8 m120 -78.29 44.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.499 0.666 . . . . 0.0 109.69 178.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1041 ' ' ARG . . . . . 0.463 ' H ' ' C ' ' A' 1039 ' ' THR . 32.6 ptt180 -82.5 -43.93 16.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.209 -178.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1042 ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' 1043 ' ' ASN . 74.3 tt0 -162.92 -126.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.922 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1043 ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' 1044 ' ' PHE . 3.1 m120 37.48 -125.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.212 0.205 . . . . 0.0 111.136 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1044 ' ' PHE . . . . . 0.625 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 5.3 m-30 69.52 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.969 0.414 . . . . 0.0 111.589 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1045 ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' 1023 ' ' ILE . 70.6 m-70 -149.42 -49.48 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.704 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1046 ' ' TYR . . . . . 0.659 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.5 t80 176.32 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.743 0.782 . . . . 0.0 110.343 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.48 -18.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.049 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 70.0 p -47.6 145.53 2.61 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.877 -0.662 . . . . 0.0 112.78 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1049 ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' 1072 ' ' ILE . 14.7 p -145.59 155.26 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.457 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1050 ' ' VAL . . . . . 0.648 ' HB ' HD22 ' A' 1040 ' ' ASN . 5.9 p -153.97 130.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.981 0.419 . . . . 0.0 112.041 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1051 ' ' THR . . . . . 0.533 ' O ' HG13 ' A' 1037 ' ' ILE . 85.8 m -103.43 116.55 32.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1052 ' ' TYR . . . . . 0.582 ' HE1' HG12 ' A' 1072 ' ' ILE . 7.4 m-85 -74.92 151.37 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1053 ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' 1053 ' ' ARG . 50.1 ttt-85 -142.75 -13.89 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.948 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1054 ' ' CYS . . . . . 0.804 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 91.9 m 69.88 152.19 0.1 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.895 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1055 ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' 1033 ' ' ASN . 27.9 t-20 -50.34 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.577 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1056 ' ' LEU . . . . . 0.703 ' HA ' HG22 ' A' 1063 ' ' VAL . 15.8 mt 61.02 -148.27 0.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.591 0.71 . . . . 0.0 111.393 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1057 ' ' GLY . . . . . 0.464 ' C ' ' N ' ' A' 1059 ' ' ARG . . . 71.84 -34.49 0.61 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.903 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1058 ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' 1059 ' ' ARG . 53.2 m -47.67 -26.99 1.71 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1059 ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' 1057 ' ' GLY . 39.3 mmm-85 -157.07 -1.24 0.11 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.488 -1.687 . . . . 0.0 108.656 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1060 ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' 1061 ' ' ARG . . . 48.31 30.46 7.97 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1061 ' ' ARG . . . . . 0.639 ' H ' HG23 ' A' 1063 ' ' VAL . 4.8 tmm_? 178.65 134.98 0.08 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.064 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1062 ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' 1061 ' ' ARG . 39.5 ttpt 54.64 42.34 31.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.904 0.859 . . . . 0.0 109.37 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1063 ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' 1056 ' ' LEU . 14.8 m -140.59 57.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.466 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1064 ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 71.3 m-85 83.9 95.59 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.081 -178.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -89.85 151.15 21.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.185 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1066 ' ' LEU . . . . . . . . . . . . . 27.6 tp -68.56 142.67 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.484 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1067 ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 58.9 t -139.0 133.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.29 -139.12 21.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.956 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1069 ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' 1069 ' ' GLU . 1.1 pm0 -66.4 125.6 90.66 Favored Pre-proline 0 N--CA 1.453 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 111.837 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1070 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1069 ' ' GLU . 3.3 Cg_endo -83.8 -26.94 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.142 2.562 . . . . 0.0 112.134 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1071 ' ' SER . . . . . 0.522 ' HG ' HG21 ' A' 1051 ' ' THR . 49.1 m -144.09 147.84 34.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1072 ' ' ILE . . . . . 0.582 HG12 ' HE1' ' A' 1052 ' ' TYR . 26.6 pt -143.61 160.65 16.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.336 0.588 . . . . 0.0 111.761 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1073 ' ' TYR . . . . . 0.465 ' HB3' HG21 ' A' 1049 ' ' VAL . 0.6 OUTLIER -160.19 148.61 16.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.504 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A 1074 ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 48.3 t -65.66 145.33 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 9.9 t -157.7 23.13 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.767 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 99.2 p 52.59 176.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.575 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1077 ' ' ASN . . . . . 0.694 HD21 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -174.1 -40.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.508 179.903 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A 1078 ' ' ASP . . . . . 0.732 ' HB3' HG22 ' A' 1081 ' ' VAL . 7.9 t70 -84.04 -75.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.841 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.14 -41.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1080 ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 995' ' ' ARG . 3.0 pm0 -162.87 29.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1081 ' ' VAL . . . . . 0.732 HG22 ' HB3' ' A' 1078 ' ' ASP . 21.9 t -83.92 -37.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1082 ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' 1025 ' ' CYS . . . 78.85 45.82 8.93 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.165 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1083 ' ' ILE . . . . . 0.43 HG23 HD11 ' A' 1083 ' ' ILE . 67.7 mt -81.98 136.04 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.008 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1084 ' ' TRP . . . . . 0.596 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.4 m95 -70.54 146.76 49.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.862 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 85.2 p -44.93 -37.25 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.885 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1086 ' ' GLY . . . . . 0.438 ' O ' HD11 ' A' 1072 ' ' ILE . . . -166.63 141.07 6.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.907 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1087 ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' 1086 ' ' GLY . 34.0 Cg_exo -57.79 177.29 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.928 2.419 . . . . 0.0 112.758 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1088 ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' 1031 ' ' ILE . . . -63.63 141.34 97.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.618 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1089 ' ' PRO . . . . . 0.471 ' HA ' ' OE2' ' A' 1069 ' ' GLU . 37.6 Cg_endo -66.72 -141.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.916 2.411 . . . . 0.0 112.586 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1090 ' ' GLN . . . . . 0.657 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -145.37 132.65 20.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.019 0.437 . . . . 0.0 111.206 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1091 ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 95.9 m -99.53 72.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.197 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 35.9 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.044 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 121.139 0.495 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.46 126.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.453 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -99.49 141.84 31.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.161 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.664 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 93.7 m -80.0 33.02 0.27 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.792 0.33 . . . . 0.0 110.809 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 962' ' ' SER . 60.5 tttp 60.8 136.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.546 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 42.8 m -63.94 124.55 85.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.167 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.671 ' HG2' HG11 ' A' ' 974' ' ' VAL . 37.0 Cg_endo -66.06 109.73 1.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.217 1.945 . . . . 0.0 111.958 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 9.0 Cg_exo -71.41 129.93 16.6 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.642 2.228 . . . . 0.0 111.805 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -51.33 104.9 0.46 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 2.6 Cg_exo -76.6 -152.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.734 2.289 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 970' ' ' VAL . 2.2 p -50.47 83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.156 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 991' ' ' THR . 3.4 t30 68.68 -34.9 0.28 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.622 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.4 116.4 7.48 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.253 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.27 140.17 31.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.584 0.23 . . . . 0.0 111.162 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.671 HG11 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -89.94 147.69 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.208 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 977' ' ' ILE . 18.8 m170 -111.94 82.53 1.64 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 976' ' ' VAL . 4.3 p -69.04 85.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 975' ' ' HIS . 50.5 mt -75.37 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.25 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.9 p -55.9 -72.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.671 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 3.4 m-20 -157.42 -133.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 979' ' ' ASP . 1.5 pt -155.87 -21.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 83.7 mt-30 -72.52 176.42 5.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.447 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' 1004 ' ' CYS . 71.4 t -44.35 144.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.938 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.66 -30.43 1.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.439 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.671 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 34.6 m -68.47 153.53 43.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' 1002 ' ' ALA . 53.0 ttt-85 -138.32 150.02 46.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.906 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.484 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 36.4 pt -142.8 -169.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 68.3 p -148.49 130.63 15.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.486 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.5 OUTLIER -98.31 154.95 17.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.076 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 94.1 p -161.23 128.1 4.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 111.851 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.612 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 85.1 m -82.92 51.15 1.86 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.944 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.531 HG22 HD21 ' A' ' 971' ' ' ASN . 14.9 t 38.22 -149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.262 0.553 . . . . 0.0 111.907 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 19.4 m -95.65 141.21 29.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.46 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.47 82.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.161 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.534 ' HB2' ' O ' ' A' ' 990' ' ' CYS . 50.4 m80 -152.83 135.03 14.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.92 0.36 . . . . 0.0 110.846 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.428 ' HG3' HH11 ' A' ' 995' ' ' ARG . 38.4 ttt85 -81.94 121.45 26.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 997' ' ' ILE . 2.9 tt -76.2 128.86 35.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.456 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.679 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -102.22 146.87 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.13 -118.86 4.71 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.503 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -149.65 129.54 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.164 0.482 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.0 p -69.9 -43.99 70.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 95.7 p -77.85 136.08 38.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.64 149.62 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.454 . . . . 0.0 111.433 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -134.0 131.63 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 50.3 t -70.43 96.88 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' 1012 ' ' HIS . 27.5 pt -90.43 -175.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' 1011 ' ' ALA . 9.6 tp -158.42 120.41 3.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 43.8 m -81.77 -48.65 11.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.495 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.88 -48.21 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.96 -49.83 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 91.6 m -151.19 149.95 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.304 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.664 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.16 140.48 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.553 ' O ' HG12 ' A' 1005 ' ' ILE . 90.5 m-70 -149.39 145.88 27.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 71.7 m95 -71.27 132.66 45.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.735 0.303 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.8 p -52.46 -29.07 22.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 72.9 p -87.76 -134.62 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -166.95 150.13 6.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.731 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -40.62 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.17 . . . . 0.0 112.503 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 29.8 Cg_exo -63.1 135.64 52.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.907 2.405 . . . . 0.0 112.028 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.917 HG22 ' H ' ' A' 1020 ' ' CYS . 5.0 mt -95.75 -170.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.006 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.917 ' H ' HG22 ' A' 1019 ' ' ILE . 67.6 m -152.31 98.02 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.473 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.597 ' H ' HD13 ' A' ' 997' ' ' ILE . 34.2 tp60 -82.53 131.51 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.684 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.8 tpt180 -65.9 127.93 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.61 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.3 mm -63.25 106.63 0.94 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.504 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' 1045 ' ' HIS . 3.5 Cg_exo -76.12 136.37 18.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.7 2.267 . . . . 0.0 112.881 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.78 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 29.8 p -124.73 133.94 53.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.03 -154.45 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.733 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.54 147.97 87.54 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 120.66 0.266 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.712 ' HD3' ' HE2' ' A' 1044 ' ' PHE . 78.6 Cg_endo -75.86 142.97 25.94 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.533 2.155 . . . . 0.0 111.6 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.752 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.0 Cg_exo -51.67 106.29 0.13 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 121.997 1.798 . . . . 0.0 111.508 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 90.3 m -77.46 126.81 31.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.665 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.936 HD13 ' HB2' ' A' 1089 ' ' PRO . 18.0 pt -90.41 136.53 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.893 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -52.0 138.38 25.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.774 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' 1032 ' ' ALA . 4.4 m120 75.14 -36.18 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.799 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -72.23 132.86 19.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.814 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -81.64 -159.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.148 0.499 . . . . 0.0 111.335 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.638 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -155.99 133.18 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.587 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' 1050 ' ' VAL . 39.4 pt -142.04 -148.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.963 0.411 . . . . 0.0 111.484 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.486 ' HB2' ' H ' ' A' 1051 ' ' THR . 8.2 t 78.21 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.861 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 28.7 p -66.46 -43.3 85.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.755 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' 1044 ' ' PHE . 4.5 m120 -52.21 140.18 21.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.254 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.638 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 86.3 mtm180 -155.16 -47.17 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.402 ' C ' ' HD1' ' A' 1044 ' ' PHE . 23.4 pt-20 -162.99 -43.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -71.67 58.26 0.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.461 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.712 ' HE2' ' HD3' ' A' 1028 ' ' PRO . 2.3 m-85 -76.68 132.21 39.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' 1046 ' ' TYR . 3.2 m-70 -130.71 -56.29 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.16 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' 1023 ' ' ILE . 78.0 t80 170.79 150.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.443 0.464 . . . . 0.0 110.386 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.577 ' N ' ' HB2' ' A' 1074 ' ' CYS . . . 76.46 -31.12 1.42 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.681 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.427 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 49.4 m -45.85 131.26 9.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' 1072 ' ' ILE . 6.8 p -102.2 146.45 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' 1037 ' ' ILE . 7.3 p -133.39 135.15 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.504 ' HB ' HG13 ' A' 1037 ' ' ILE . 44.1 m -98.63 122.57 42.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.53 ' OH ' ' HB2' ' A' 1028 ' ' PRO . 3.6 m-85 -85.64 167.11 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.508 ' HG3' HH11 ' A' 1053 ' ' ARG . 28.9 mtt85 -159.59 -149.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.972 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.799 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 8.5 t -163.57 157.68 19.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 110.531 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.699 ' O ' ' HG ' ' A' 1056 ' ' LEU . 31.3 m120 -55.13 153.47 6.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.513 . . . . 0.0 112.316 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' 1055 ' ' ASN . 1.4 mt -154.97 43.25 0.47 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.937 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' 1058 ' ' SER . . . 72.48 -59.48 1.59 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.387 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' 1057 ' ' GLY . 43.3 t 174.38 -18.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 0.0 110.681 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -155.27 55.47 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.28 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . 72.49 129.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.285 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.501 ' O ' HD23 ' A' 1056 ' ' LEU . 39.6 ttm180 -178.15 145.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.577 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -65.25 81.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' 1056 ' ' LEU . 9.6 m -151.82 88.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.516 0.674 . . . . 0.0 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.905 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 72.5 m-85 70.79 141.86 0.05 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.511 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1065 ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.7 mt-10 -142.39 142.33 32.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.103 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' 1067 ' ' VAL . 1.4 tt -68.57 137.71 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.295 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.825 ' N ' HD23 ' A' 1066 ' ' LEU . 7.3 p -139.49 127.43 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.663 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.55 138.56 1.4 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.395 -0.821 . . . . 0.0 114.056 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.807 ' O ' ' HG3' ' A' 1089 ' ' PRO . 32.9 tt0 36.75 59.21 3.64 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.193 0.597 . . . . 0.0 112.457 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1070 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.21 6.58 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.231 1.954 . . . . 0.0 112.612 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' 1069 ' ' GLU . 81.0 p -156.17 147.12 22.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.308 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' 1028 ' ' PRO . 44.7 pt -142.22 179.73 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -160.06 154.68 24.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.447 . . . . 0.0 111.828 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.577 ' HB2' ' N ' ' A' 1047 ' ' GLY . 65.8 m -62.6 146.23 52.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.907 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.0 t -155.76 -158.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.055 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.6 p -151.48 143.37 23.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' 1078 ' ' ASP . 46.5 p-10 -164.82 29.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.6 t70 176.38 52.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.258 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.25 -129.08 0.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.503 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.684 ' HG2' ' H ' ' A' 1081 ' ' VAL . 47.6 tt0 -67.59 -139.85 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.684 ' H ' ' HG2' ' A' 1080 ' ' GLN . 27.2 t 72.99 -43.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 122.541 0.336 . . . . 0.0 111.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.78 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 67.85 64.51 3.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.658 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' 1083 ' ' ILE . 3.4 mp -81.89 135.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 110.555 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 26.0 m95 -78.14 -160.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 77.6 p -81.58 -65.03 1.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 144.14 5.53 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.696 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.752 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 98.5 Cg_endo -83.71 49.9 3.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.097 2.531 . . . . 0.0 112.034 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.495 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -64.33 -41.62 61.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.936 ' HB2' HD13 ' A' 1031 ' ' ILE . 86.6 Cg_exo -45.78 137.78 12.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.507 2.138 . . . . 0.0 113.051 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.802 ' O ' HG12 ' A' 1067 ' ' VAL . 38.3 tt0 -150.32 143.08 24.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.905 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 73.9 m -84.32 137.18 33.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.458 ' H ' ' H ' ' A' 1065 ' ' GLU . 31.0 pt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.542 ' HG3' HD11 ' A' 1006 ' ' LEU . 46.6 mmtm 62.1 145.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.987 0.423 . . . . 0.0 111.422 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 82.1 p -157.97 136.01 10.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.5 m -79.95 164.45 23.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.317 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.84 126.77 28.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 965' ' ' THR . 4.2 t -76.77 114.09 35.81 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.855 ' HG2' HG11 ' A' ' 974' ' ' VAL . 86.5 Cg_endo -85.48 111.06 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.485 2.123 . . . . 0.0 112.142 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 19.6 Cg_endo -58.88 -39.55 80.24 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.282 1.988 . . . . 0.0 110.951 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 62.9 t0 179.25 119.14 0.21 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.443 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 974' ' ' VAL . 35.5 Cg_endo -64.84 -150.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 112.613 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.786 HG11 ' H ' ' A' 1020 ' ' CYS . 9.6 p -53.13 -136.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.559 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.751 ' H ' HG22 ' A' ' 970' ' ' VAL . 4.7 m120 -65.33 -33.39 75.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.066 0.46 . . . . 0.0 110.583 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.439 ' H ' HG13 ' A' ' 970' ' ' VAL . . . -69.08 -147.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.803 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 85.5 mtp -156.35 142.51 18.2 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.327 0.251 . . . . 0.0 110.408 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.855 HG11 ' HG2' ' A' ' 966' ' ' PRO . 1.1 p -92.18 144.94 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.004 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -121.22 112.38 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.14 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 980' ' ' ILE . 90.5 t -64.72 -41.49 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.773 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 978' ' ' THR . 20.2 mt 64.88 -98.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.144 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 977' ' ' ILE . 12.6 p -80.73 -52.85 7.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.528 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 980' ' ' ILE . 21.1 m-20 -169.3 -157.69 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.235 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 976' ' ' VAL . 20.1 pt -155.91 10.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.837 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 74.3 mt-30 -73.2 -45.72 54.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.624 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 7.5 p 167.38 151.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 79.43 -40.32 2.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.361 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 14.4 t -69.83 141.99 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.39 . . . . 0.0 111.049 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 37.3 ttm180 -110.96 118.29 35.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.118 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.615 HD12 ' CG2' ' A' ' 974' ' ' VAL . 36.7 pt -91.28 138.46 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.203 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 82.6 p -103.51 132.18 49.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 4.7 m-85 -101.41 152.62 20.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.7 m -154.21 126.05 7.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.594 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 991' ' ' THR . 37.3 t -98.64 178.68 4.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.422 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 61.2 p -65.11 -158.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.216 0.532 . . . . 0.0 111.84 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 46.0 m -86.04 -68.02 0.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.001 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' 1046 ' ' TYR . . . -81.02 42.29 2.7 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.424 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.6 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 41.6 m80 -149.48 125.35 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 0.0 110.726 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.416 ' HB3' ' OE1' ' A' 1080 ' ' GLN . 52.2 ttt-85 -95.14 121.63 36.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.745 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 1.4 tt -76.21 137.34 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.66 ' HB ' HG23 ' A' 1019 ' ' ILE . 1.8 mp -101.29 149.81 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.017 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.79 34.68 38.01 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.691 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 58.96 130.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.223 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 988' ' ' TYR . 49.8 m -83.05 41.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.62 ' O ' HG21 ' A' 1015 ' ' THR . 68.8 m -162.18 148.39 13.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -159.22 128.06 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.5 tt0 -103.25 125.67 50.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.527 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 44.6 t -68.4 84.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' 1014 ' ' SER . 49.7 pt -87.3 -162.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.737 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' 1007 ' ' SER . 5.2 tt -158.36 125.81 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.346 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.544 ' N ' HD23 ' A' 1006 ' ' LEU . 45.3 m -78.39 -55.88 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.413 ' N ' HD23 ' A' 1006 ' ' LEU . . . 169.55 42.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.727 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.521 ' H ' HD21 ' A' 1006 ' ' LEU . 21.7 p30 -177.9 -36.95 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.26 149.58 29.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.527 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.26 132.95 41.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.129 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -149.43 145.81 27.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.501 ' HH2' HG22 ' A' ' 980' ' ' ILE . 52.3 m95 -70.82 122.83 20.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.328 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.6 p -52.48 -25.69 10.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.708 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.62 HG21 ' O ' ' A' 1001 ' ' SER . 50.5 p -87.72 -144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' 1016 ' ' LYS . 10.7 mtmp? -151.57 161.27 30.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.281 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 78.6 Cg_exo -40.95 124.69 2.08 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.61 2.206 . . . . 0.0 112.692 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.647 ' HB2' HD21 ' A' ' 996' ' ' LEU . 90.7 Cg_endo -80.67 145.59 16.32 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.143 2.562 . . . . 0.0 113.376 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 997' ' ' ILE . 7.2 tt -148.84 113.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.99 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.786 ' H ' HG11 ' A' ' 970' ' ' VAL . 9.7 t -86.44 121.16 28.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.124 0.488 . . . . 0.0 111.382 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -85.55 136.61 33.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.616 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' 1024 ' ' PRO . 57.8 mtt85 -75.93 127.75 33.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.177 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.775 HG12 ' HG3' ' A' 1080 ' ' GLN . 84.9 mt -76.73 108.54 6.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.282 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.912 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 66.7 Cg_endo -74.0 121.54 7.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.384 2.056 . . . . 0.0 111.384 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.529 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 16.8 m -89.16 28.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1026 ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' A' 1044 ' ' PHE . . . 37.22 -158.83 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.668 -0.697 . . . . 0.0 114.273 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' 1027 ' ' LEU . 7.7 mp -74.01 145.78 84.09 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 122.599 0.36 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.843 ' HB3' HD11 ' A' 1072 ' ' ILE . 23.1 Cg_exo -63.43 144.8 91.57 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.731 2.287 . . . . 0.0 111.375 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' 1072 ' ' ILE . 5.9 Cg_endo -47.86 113.9 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.243 1.962 . . . . 0.0 111.396 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 64.0 p -77.78 141.36 39.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.304 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.501 HD13 ' HB1' ' A' 1088 ' ' ALA . 25.6 pt -147.82 121.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.64 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.08 135.63 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.123 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' 1032 ' ' ALA . 76.4 m-20 75.01 -38.36 0.38 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.516 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -69.98 76.97 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.81 126.26 29.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' 1038 ' ' SER . 17.8 p90 -93.26 147.3 23.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.98 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' 1038 ' ' SER . 49.8 mm -87.37 159.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.822 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.484 ' N ' HG22 ' A' 1037 ' ' ILE . 23.1 t 75.39 144.65 0.08 Allowed 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' 1041 ' ' ARG . 17.0 p -66.13 -57.02 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.486 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 61.28 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' 1039 ' ' THR . 49.8 mtt85 40.27 -128.36 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.29 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' 1043 ' ' ASN . 8.2 pt-20 -77.15 -145.75 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' 1042 ' ' GLU . 62.9 m-20 34.85 36.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.212 0.529 . . . . 0.0 110.61 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.474 ' CZ ' ' HA2' ' A' 1026 ' ' GLY . 1.2 p90 -89.02 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.048 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.912 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 21.0 p-80 -165.36 -164.59 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.174 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.512 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 22.1 t80 -59.24 153.76 17.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 111.56 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' 1049 ' ' VAL . . . 68.77 10.52 61.24 Favored Glycine 0 C--N 1.33 0.222 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.296 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' A' 1025 ' ' CYS . 74.4 p -48.39 134.32 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.179 0.49 . . . . 0.0 109.929 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.766 HG22 ' HA ' ' A' 1073 ' ' TYR . 38.3 t -146.72 142.86 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 28.4 m -152.64 134.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.192 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.419 HG23 ' OG ' ' A' 1071 ' ' SER . 91.2 m -92.9 124.72 37.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.695 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.583 ' OH ' HD13 ' A' 1072 ' ' ILE . 8.2 m-85 -73.72 154.67 39.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.473 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.458 ' HG3' HH11 ' A' 1053 ' ' ARG . 38.0 ttt85 -148.3 0.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.959 ' HB2' HG12 ' A' 1063 ' ' VAL . 59.0 m 64.12 152.27 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 111.079 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' 1057 ' ' GLY . 48.5 t30 -62.62 -49.19 76.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' 1060 ' ' GLY . 0.4 OUTLIER -71.31 39.23 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' 1055 ' ' ASN . . . -89.02 -24.17 32.93 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.1 p -151.91 121.14 6.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.324 -0.938 . . . . 0.0 109.52 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' 1058 ' ' SER . 38.5 mmt180 81.71 44.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.32 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.806 ' C ' HD23 ' A' 1056 ' ' LEU . . . 179.99 -44.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' 1062 ' ' LYS . 51.4 mmt-85 64.5 177.59 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 122.499 0.32 . . . . 0.0 111.826 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' 1061 ' ' ARG . 16.0 tptm 75.85 -41.7 0.44 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.367 0.603 . . . . 0.0 109.619 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.959 HG12 ' HB2' ' A' 1054 ' ' CYS . 0.0 OUTLIER 47.64 40.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.346 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.569 ' HE1' ' H ' ' A' 1056 ' ' LEU . 0.1 OUTLIER 42.84 -138.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -150.19 121.07 7.62 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.342 0.591 . . . . 0.0 110.47 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' 1070 ' ' PRO . 55.0 tp -68.5 145.58 53.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.167 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 65.1 t -138.2 131.75 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.889 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.38 -143.67 22.91 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.429 ' OE2' HG22 ' A' 1072 ' ' ILE . 22.5 pt-20 -68.49 126.94 93.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.436 ' HB3' HD21 ' A' 1066 ' ' LEU . 2.7 Cg_endo -83.3 -10.21 10.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.104 2.536 . . . . 0.0 111.759 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.419 ' OG ' HG23 ' A' 1051 ' ' THR . 49.4 m -153.5 127.41 8.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.093 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' 1028 ' ' PRO . 19.4 pt -89.5 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.3 0.572 . . . . 0.0 111.905 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.766 ' HA ' HG22 ' A' 1049 ' ' VAL . 24.8 p90 -145.06 128.94 17.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 13.5 t -63.68 164.15 10.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.113 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.0 t -155.78 -27.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.484 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 56.1 m 65.48 146.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.921 0.391 . . . . 0.0 111.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -164.98 -34.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.853 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 9.5 t70 -60.28 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.62 0.248 . . . . 0.0 110.863 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -162.95 -42.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.761 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.775 ' HG3' HG12 ' A' 1023 ' ' ILE . 17.9 tt0 -175.0 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.23 0.538 . . . . 0.0 110.321 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' 1082 ' ' GLY . 20.5 t -83.33 -117.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.678 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . -165.78 50.85 0.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.776 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' 1083 ' ' ILE . 2.0 mp -81.95 126.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.697 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.8 m95 -85.37 -151.23 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' 1073 ' ' TYR . 80.2 p -95.39 -27.63 15.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.111 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.43 152.66 21.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.612 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 10.7 Cg_exo -73.48 47.35 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 112.883 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' 1031 ' ' ILE . . . 65.36 141.89 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.859 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.504 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 58.6 Cg_endo -69.89 -146.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.726 2.284 . . . . 0.0 112.113 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.472 ' H ' ' HB2' ' A' 1089 ' ' PRO . 46.2 mm-40 -150.65 128.71 11.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 91.9 m -96.69 70.54 2.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.459 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.25 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.724 0.297 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 0.8 OUTLIER 61.63 122.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.628 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 31.0 t -157.95 131.96 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.934 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 2.9 p -79.84 142.22 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.68 126.36 27.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 0.0 110.665 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.775 ' HB ' HD13 ' A' ' 980' ' ' ILE . 9.1 t -67.89 131.91 92.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.111 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.65 ' HG2' HG21 ' A' ' 974' ' ' VAL . 22.7 Cg_exo -64.74 108.83 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.349 2.033 . . . . 0.0 111.649 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 965' ' ' THR . 88.9 Cg_exo -48.02 -46.76 21.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.537 2.158 . . . . 0.0 111.644 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 968' ' ' ASP . 2.1 p30 179.28 111.73 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.223 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.55 152.9 74.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.668 2.245 . . . . 0.0 111.971 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.509 ' HB ' HG13 ' A' 1019 ' ' ILE . 60.0 t -48.02 100.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 31.4 m120 74.44 -50.74 0.68 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.597 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -73.44 141.34 29.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.908 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.4 mtp -89.28 138.12 31.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 966' ' ' PRO . 4.9 p -83.5 151.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.397 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 987' ' ' THR . 1.0 OUTLIER -119.07 76.17 1.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.812 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.535 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 48.5 t -75.21 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.27 -75.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.825 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 33.2 p -56.42 -88.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.567 ' OD1' ' HB2' ' A' ' 981' ' ' GLN . 2.8 p30 -168.7 151.42 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 965' ' ' THR . 5.1 pt -83.93 27.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.337 0.589 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.567 ' HB2' ' OD1' ' A' ' 979' ' ' ASP . 87.6 mt-30 -90.37 151.73 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.07 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' 1004 ' ' CYS . 74.8 t -44.26 146.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.734 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 83.26 -39.85 2.8 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 114.258 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.2 m -68.45 175.72 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.612 0.706 . . . . 0.0 111.143 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.455 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 4.7 tmm_? -156.6 128.72 7.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.194 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.535 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 34.3 pt -97.28 -163.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 975' ' ' HIS . 54.7 p -149.23 130.13 14.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.937 0.398 . . . . 0.0 112.028 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.1 m-85 -99.18 147.82 24.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.376 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -151.13 132.15 14.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.547 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 85.8 m -81.93 -125.93 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 992' ' ' THR . 1.8 t -165.01 176.15 8.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.306 0.574 . . . . 0.0 111.375 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.474 ' N ' ' OG1' ' A' ' 991' ' ' THR . 22.1 m -48.54 131.02 17.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.643 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.19 84.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.459 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.01 122.44 7.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.943 0.371 . . . . 0.0 110.706 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' 1080 ' ' GLN . 38.0 ttm180 -82.24 114.54 20.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 997' ' ' ILE . 7.6 tp -76.27 127.81 33.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.24 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.8 mp -98.75 140.78 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.482 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.2 174.34 40.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.068 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' 1001 ' ' SER . 86.6 m-70 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 0.0 111.357 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.3 p -75.4 31.3 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.838 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 999' ' ' HIS . 63.0 m -162.12 152.18 16.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.048 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.846 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -150.8 129.03 11.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.63 122.96 33.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.097 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 14.9 t -70.13 80.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 40.7 pt -87.33 -142.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.526 ' HG ' ' C ' ' A' 1010 ' ' THR . 5.1 tt -158.39 121.62 3.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.878 0.37 . . . . 0.0 110.566 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 53.0 m -92.03 47.03 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.811 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.48 ' N ' HD23 ' A' 1006 ' ' LEU . . . 75.35 -57.63 2.85 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.092 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.18 -60.08 3.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.855 0.327 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.526 ' C ' ' HG ' ' A' 1006 ' ' LEU . 15.2 t -151.27 -172.51 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.611 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.26 136.89 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 111.003 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -149.44 151.72 34.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.836 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.846 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 61.2 m95 -72.41 127.45 32.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.9 t -52.46 -27.7 17.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.972 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 82.5 p -105.8 142.28 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 111.95 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -57.08 149.2 47.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.276 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.84 108.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.247 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.442 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 34.1 Cg_exo -59.3 148.73 85.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.897 2.398 . . . . 0.0 112.163 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.693 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 9.1 tt -148.82 135.71 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.433 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 50.1 m -86.49 159.42 19.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.912 0.387 . . . . 0.0 110.64 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.444 ' HB3' HD11 ' A' ' 997' ' ' ILE . 55.3 tt0 -153.5 117.69 4.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.666 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -64.21 127.66 32.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.194 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' 1045 ' ' HIS . 76.0 mt -71.05 126.69 92.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 26.0 Cg_endo -61.39 126.49 19.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.563 2.175 . . . . 0.0 112.776 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.734 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 71.6 m -97.21 135.05 39.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -84.74 151.72 26.65 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.49 ' HA ' ' CZ ' ' A' 1044 ' ' PHE . 1.4 mm? -39.44 137.15 1.06 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 117.168 0.484 . . . . 0.0 111.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.557 ' HG3' HG11 ' A' 1050 ' ' VAL . 29.7 Cg_endo -63.68 145.24 91.04 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.677 2.251 . . . . 0.0 112.12 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.629 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.4 Cg_exo -54.61 91.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.295 1.997 . . . . 0.0 111.376 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1030 ' ' THR . . . . . 0.503 HG23 ' O ' ' A' 1028 ' ' PRO . 53.2 p -77.47 118.78 20.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.66 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' 1089 ' ' PRO . 18.4 pt -84.95 119.89 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.46 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -43.55 141.53 1.41 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' 1032 ' ' ALA . 77.3 m-20 78.08 -38.78 0.26 Allowed 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.506 0.504 . . . . 0.0 111.001 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -69.78 120.11 9.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.428 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' 1052 ' ' TYR . 1.4 m-20 -83.06 173.46 11.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.682 ' HA ' ' O ' ' A' 1051 ' ' THR . 43.9 p90 -151.43 133.64 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.169 0.509 . . . . 0.0 111.728 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.719 HD11 ' HD2' ' A' 1053 ' ' ARG . 29.5 mt -108.54 45.34 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.713 ' HB3' HG12 ' A' 1050 ' ' VAL . 81.6 p -71.2 -140.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.701 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' 1041 ' ' ARG . 88.7 m -161.16 -29.53 0.05 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.601 ' HB3' ' OG ' ' A' 1048 ' ' SER . 21.8 p30 -53.35 -39.05 63.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' 1039 ' ' THR . 37.9 mmt180 59.02 -111.43 0.55 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.231 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.12 -131.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.51 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.1 p30 -56.26 145.6 26.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' 1027 ' ' LEU . 29.6 p90 -159.79 129.23 5.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.75 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' O ' ' A' 1023 ' ' ILE . 48.9 m-70 -76.6 -41.54 45.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' 1045 ' ' HIS . 60.1 t80 176.03 157.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.551 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' 1048 ' ' SER . . . 76.54 96.67 0.17 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.284 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.601 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 45.7 t 174.26 153.68 0.11 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1049 ' ' VAL . . . . . 1.001 HG12 ' HB3' ' A' 1073 ' ' TYR . 3.6 m -137.81 159.42 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.258 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' 1038 ' ' SER . 18.1 m -133.37 134.67 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' 1036 ' ' PHE . 86.7 m -104.77 119.05 38.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' 1035 ' ' ASP . 7.7 m-85 -80.56 160.07 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.719 ' HD2' HD11 ' A' 1037 ' ' ILE . 79.6 mtp180 -142.71 -41.6 0.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.777 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 40.1 t 70.73 122.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.818 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' 1064 ' ' PHE . 58.6 m-20 17.57 -123.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.785 ' HA ' HG23 ' A' 1063 ' ' VAL . 79.6 mt 69.5 123.49 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.69 -62.79 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.612 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.474 ' C ' ' HD2' ' A' 1059 ' ' ARG . 38.2 t -90.06 44.02 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.554 ' HD2' ' N ' ' A' 1059 ' ' ARG . 0.0 OUTLIER 39.45 44.98 1.21 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.071 -179.121 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.59 -29.13 0.12 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.098 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -45.75 146.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.605 0.241 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.561 ' HB3' ' NZ ' ' A' 1062 ' ' LYS . 6.3 ttpm? -65.37 80.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.986 0.422 . . . . 0.0 111.59 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' 1056 ' ' LEU . 3.2 m -155.17 90.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' 1055 ' ' ASN . 0.5 OUTLIER 68.75 144.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.566 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -146.18 143.36 29.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 112.338 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' 1070 ' ' PRO . 34.6 tp -68.55 151.7 46.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.969 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.878 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 76.9 t -138.22 136.25 44.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.061 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.1 -148.09 32.6 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.131 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.1 pt-20 -63.45 128.6 92.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.574 ' HB3' HD21 ' A' 1066 ' ' LEU . 79.4 Cg_endo -94.74 11.16 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.974 2.449 . . . . 0.0 113.23 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' 1050 ' ' VAL . 80.2 p -157.02 145.86 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1072 ' ' ILE . . . . . . . . . . . . . 42.9 pt -140.95 174.29 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.631 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1073 ' ' TYR . . . . . 1.001 ' HB3' HG12 ' A' 1049 ' ' VAL . 1.6 p90 -160.04 148.13 16.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.486 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.895 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 44.6 t -65.37 137.37 57.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.409 ' O ' ' O ' ' A' 1076 ' ' SER . 8.0 t -154.98 11.05 0.35 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' 1075 ' ' THR . 99.7 p 55.74 151.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.464 ' OD1' ' HB ' ' A' 1083 ' ' ILE . 47.9 p-10 -168.34 40.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.508 ' HB3' ' CG2' ' A' 1081 ' ' VAL . 54.3 t0 -178.57 -18.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' 1080 ' ' GLN . 33.1 m-20 70.42 134.63 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.604 ' HA ' ' NH2' ' A' ' 995' ' ' ARG . 72.7 mt-30 76.2 21.96 1.4 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 109.211 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' 1080 ' ' GLN . 2.6 m -163.3 109.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.075 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.734 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . -74.31 63.89 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.581 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.464 ' HB ' ' OD1' ' A' 1077 ' ' ASN . 64.4 mt -81.92 138.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.895 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.5 m95 -70.98 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.002 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.0 t -80.61 -65.75 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.999 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.6 145.44 6.08 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.343 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 92.3 Cg_endo -81.71 51.12 3.73 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.116 2.544 . . . . 0.0 112.787 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.486 ' HB3' ' CG ' ' A' 1069 ' ' GLU . . . -66.28 -43.94 56.29 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.602 ' HG3' ' O ' ' A' 1069 ' ' GLU . 87.1 Cg_exo -43.56 137.74 5.75 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.438 2.092 . . . . 0.0 112.699 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.878 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 48.8 mm-40 -129.77 127.96 41.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 36.5 t -93.45 72.41 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.266 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.61 0.243 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -77.62 146.86 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.545 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 80.4 p -157.98 143.29 16.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.524 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 95.5 m -80.01 146.83 31.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.256 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.83 139.43 58.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 111.337 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 62.9 m -68.28 128.12 93.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.981 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.515 ' HG2' HG21 ' A' ' 974' ' ' VAL . 11.0 Cg_exo -70.05 127.38 14.29 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 111.211 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.08 -60.09 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.114 1.876 . . . . 0.0 111.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 175.73 115.18 0.12 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.782 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 18.3 Cg_exo -66.22 134.92 38.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.489 2.126 . . . . 0.0 111.727 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.599 HG22 ' OD1' ' A' ' 971' ' ' ASN . 0.8 OUTLIER -49.11 125.47 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.039 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.599 ' OD1' HG22 ' A' ' 970' ' ' VAL . 32.6 m120 75.29 -58.32 0.57 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.225 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -80.04 -161.54 23.89 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.782 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 40.6 tpp -160.47 135.16 7.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.613 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.569 ' CG2' HD12 ' A' ' 986' ' ' ILE . 2.8 p -81.76 150.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.321 . . . . 0.0 110.779 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 0.7 OUTLIER -117.31 99.5 7.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.498 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.636 HG23 HG23 ' A' ' 980' ' ' ILE . 7.2 p -75.03 86.19 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.704 0.764 . . . . 0.0 109.693 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.22 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.505 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 984' ' ' SER . 41.2 p -79.86 79.27 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 111.044 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 980' ' ' ILE . 1.5 m-20 52.1 -142.38 0.75 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.054 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.636 HG23 HG23 ' A' ' 976' ' ' VAL . 3.6 pt -155.84 23.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 75.5 mt-30 -85.6 169.97 13.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.675 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' 1004 ' ' CYS . 92.3 t -44.33 145.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.368 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.51 ' HA2' ' OE2' ' A' 1003 ' ' GLU . . . 78.97 -44.45 2.59 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.927 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 978' ' ' THR . 92.8 p -68.36 123.64 21.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.463 0.631 . . . . 0.0 111.047 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.758 ' HD3' ' HB2' ' A' 1001 ' ' SER . 33.8 ttm180 -102.71 135.82 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.846 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.569 HD12 ' CG2' ' A' ' 974' ' ' VAL . 16.3 pt -95.52 -170.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.954 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 55.7 p -148.29 123.9 10.44 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.585 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 4.9 m-85 -97.24 154.15 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.539 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 20.8 m -157.64 126.29 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.668 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 85.0 m -85.16 147.83 26.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.518 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 991' ' ' THR . 0.0 OUTLIER -60.37 163.36 5.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.587 0.708 . . . . 0.0 112.154 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.4 m -55.79 138.25 48.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.476 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 71.52 40.1 60.06 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.836 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -151.07 138.53 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.494 0.188 . . . . 0.0 110.545 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 995' ' ' ARG . 37.3 ttt85 -82.02 127.13 32.77 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.218 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.668 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 3.5 tt -76.22 118.72 19.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 111.38 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' 1021 ' ' GLN . 30.4 mm -94.2 140.87 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.93 177.19 32.09 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.105 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.544 ' O ' ' HG3' ' A' 1018 ' ' PRO . 22.7 m170 -75.03 127.27 32.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.299 . . . . 0.0 111.172 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.4 p -79.02 26.36 0.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.044 0.45 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.758 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.1 p -162.16 140.44 8.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.401 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -156.09 128.45 7.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.51 ' OE2' ' HA2' ' A' ' 983' ' ' GLY . 85.6 tt0 -89.99 130.83 36.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.443 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.56 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 51.3 t -67.16 128.54 36.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' 1011 ' ' ALA . 31.2 pt -134.8 -142.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' 1010 ' ' THR . 0.3 OUTLIER -144.08 120.45 10.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 -179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 46.0 t -85.93 -47.89 9.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.414 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 177.28 -50.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.111 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 42.3 t30 -79.79 -51.41 9.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.737 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.404 ' C ' HD22 ' A' 1006 ' ' LEU . 11.8 t -151.28 -161.95 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.56 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.31 140.78 43.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 39.6 m80 -149.49 144.58 26.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.475 ' HH2' HG22 ' A' ' 980' ' ' ILE . 68.6 m95 -67.0 135.21 53.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.883 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 82.4 p -52.49 -22.2 4.58 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.675 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.509 HG21 ' ND1' ' A' ' 999' ' ' HIS . 70.8 p -131.44 139.86 49.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.876 0.369 . . . . 0.0 111.918 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -52.16 145.47 18.45 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.826 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 5.8 Cg_endo -48.57 103.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.396 2.064 . . . . 0.0 111.806 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.585 ' HG2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_endo -62.42 150.79 86.09 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 111.998 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.653 HG13 ' HB ' ' A' ' 997' ' ' ILE . 41.3 pt -125.77 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 971' ' ' ASN . 22.0 m -146.75 121.32 9.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.789 ' HB2' HD11 ' A' ' 997' ' ' ILE . 64.8 tp60 -83.48 128.36 34.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' 1022 ' ' ARG . 40.4 ttt85 -81.55 117.89 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.121 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' 1076 ' ' SER . 75.7 mt -70.94 112.4 13.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.82 127.1 8.46 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.543 2.162 . . . . 0.0 112.139 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.614 ' HB2' ' O ' ' A' 1044 ' ' PHE . 62.8 m -88.43 -145.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 0.0 111.564 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1026 ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' 1044 ' ' PHE . . . -161.08 154.81 25.87 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.629 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.571 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 45.8 mt -42.51 137.93 2.22 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-O 120.81 0.338 . . . . 0.0 111.529 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.516 ' CB ' HG11 ' A' 1050 ' ' VAL . 13.1 Cg_endo -56.31 146.68 71.26 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.777 2.318 . . . . 0.0 111.743 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.41 108.66 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.155 1.903 . . . . 0.0 111.606 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 82.1 p -77.59 116.54 18.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.877 HG21 ' HD2' ' A' 1089 ' ' PRO . 11.6 pt -100.28 29.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.449 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 55.2 120.95 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.415 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 61.7 m-80 69.64 12.41 8.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.745 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.62 134.51 38.34 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.998 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.81 -37.25 79.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.721 ' HD1' HG23 ' A' 1050 ' ' VAL . 0.8 OUTLIER 61.34 108.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.831 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.85 HG22 ' H ' ' A' 1038 ' ' SER . 7.9 mt -111.34 -176.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.715 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.85 ' H ' HG22 ' A' 1037 ' ' ILE . 15.7 t 69.71 -129.51 0.08 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.168 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 25.3 p -145.03 140.26 28.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 111.739 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.449 ' OD1' ' HD3' ' A' 1028 ' ' PRO . 0.4 OUTLIER -169.79 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.469 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' 1041 ' ' ARG . 42.1 mtp85 52.03 -142.18 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.7 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -79.06 -45.2 20.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.0 p30 -65.93 141.56 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' 1025 ' ' CYS . 0.5 OUTLIER -163.21 40.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.837 0.351 . . . . 0.0 111.212 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' 1046 ' ' TYR . 23.9 m80 -53.49 -40.27 65.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' 1045 ' ' HIS . 43.9 t80 173.61 159.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.695 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.99 -24.99 3.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.136 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 69.1 m -47.61 139.78 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' 1072 ' ' ILE . 14.4 p -138.19 157.65 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.721 HG23 ' HD1' ' A' 1036 ' ' PHE . 3.3 p -154.02 135.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.742 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 92.3 m -100.96 123.65 45.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.708 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.739 ' HD2' HD13 ' A' 1031 ' ' ILE . 3.7 m-85 -83.7 144.52 29.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.008 0.433 . . . . 0.0 111.355 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.532 ' HA ' ' HB2' ' A' 1066 ' ' LEU . 42.8 ttm-85 -157.42 -25.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.791 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 16.2 m 64.86 145.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.059 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -62.85 129.77 41.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.288 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.807 ' HG ' ' HA2' ' A' 1060 ' ' GLY . 1.9 mm? -70.33 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.639 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' 1056 ' ' LEU . . . -152.05 29.41 0.9 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 23.8 p 177.44 -51.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.74 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' 1059 ' ' ARG . 19.3 tpt85 -169.61 -49.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.807 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -172.72 29.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.985 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' 1056 ' ' LEU . 40.1 mtp85 -80.35 169.5 17.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.752 0.31 . . . . 0.0 111.09 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.32 83.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' 1064 ' ' PHE . 3.3 m -155.05 99.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.506 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.9 m-30 79.49 62.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.088 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -86.56 130.01 34.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.61 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' 1069 ' ' GLU . 3.2 tm? -68.53 138.66 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.266 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.583 ' H ' HD22 ' A' 1066 ' ' LEU . 11.6 t -151.91 156.68 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1068 ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' 1067 ' ' VAL . . . 79.79 -27.76 2.56 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.989 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.706 ' O ' HD11 ' A' 1066 ' ' LEU . 16.5 tp10 -167.82 103.7 0.57 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.994 0.397 . . . . 0.0 111.323 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.431 ' HA ' ' CD1' ' A' 1066 ' ' LEU . 95.7 Cg_endo -87.5 -28.94 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.0 2.467 . . . . 0.0 114.642 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 48.9 m -152.95 137.19 16.52 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.604 HD11 ' OH ' ' A' 1052 ' ' TYR . 28.6 pt -140.94 166.23 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.641 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.536 ' HB3' HG23 ' A' 1049 ' ' VAL . 2.9 p90 -157.17 145.73 19.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.963 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 52.3 t -63.84 148.54 49.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.497 . . . . 0.0 111.413 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.7 t -140.89 150.56 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.114 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' 1023 ' ' ILE . 54.5 m -74.54 123.34 24.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.462 HD22 HG13 ' A' 1083 ' ' ILE . 36.6 p30 179.31 -165.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.742 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' 1081 ' ' VAL . 8.3 t0 44.35 46.64 7.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' 1080 ' ' GLN . 9.9 t0 72.97 -59.4 0.57 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.178 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.449 ' HG2' ' OD1' ' A' 1079 ' ' ASP . 18.0 pt20 179.61 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' 1078 ' ' ASP . 42.6 t -86.32 -38.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 82.58 55.41 3.02 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.484 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.462 HG13 HD22 ' A' 1077 ' ' ASN . 33.8 pt -81.96 137.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.688 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.499 ' HZ3' HG12 ' A' 1050 ' ' VAL . 11.9 m95 -70.58 146.52 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.641 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 80.1 p -56.54 -9.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.423 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.43 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.42 135.94 3.92 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.36 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.43 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 15.0 Cg_exo -69.44 -153.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.057 2.504 . . . . 0.0 113.038 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.812 ' HB1' HG22 ' A' 1031 ' ' ILE . . . -77.16 138.5 64.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.432 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.877 ' HD2' HG21 ' A' 1031 ' ' ILE . 2.3 Cg_endo -80.47 -136.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.491 2.794 . . . . 0.0 111.898 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.431 ' H ' ' HB2' ' A' 1089 ' ' PRO . 10.8 tp-100 -152.41 119.84 5.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.757 0.313 . . . . 0.0 110.889 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 88.8 m -103.11 128.75 49.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.523 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.367 -179.323 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.854 0.359 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 981' ' ' GLN . 47.6 mmtm 63.26 138.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 56.9 p -157.96 140.51 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 98.6 m -79.85 134.05 36.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -64.96 142.02 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.004 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.7 m -50.8 121.09 14.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' 1013 ' ' TRP . 50.6 Cg_exo -55.69 132.31 51.36 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.392 2.062 . . . . 0.0 112.416 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.72 140.64 62.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.425 2.083 . . . . 0.0 111.355 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.6 m-20 -48.57 117.65 6.24 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 110.719 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.582 ' HG2' ' N ' ' A' ' 973' ' ' MET . 18.8 Cg_endo -58.9 149.2 80.24 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.801 2.334 . . . . 0.0 112.524 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' 1020 ' ' CYS . 79.4 t -42.8 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.426 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 30.9 m120 73.42 -42.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.727 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.607 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -69.1 -156.34 1.09 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.079 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.582 ' N ' ' HG2' ' A' ' 969' ' ' PRO . 22.5 ptp -159.25 138.89 11.61 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.631 0.253 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.953 ' HA ' ' HB3' ' A' ' 988' ' ' TYR . 0.7 OUTLIER -87.33 145.53 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.398 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -119.13 106.78 12.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 68.9 t -69.71 94.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.542 HD11 ' OG1' ' A' ' 987' ' ' THR . 39.3 mt -75.24 -90.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.367 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 37.2 p -62.11 -68.62 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 27.4 t70 -166.89 -138.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.064 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.466 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 10.9 pt -155.81 53.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 961' ' ' LYS . 66.2 tt0 -152.65 158.04 41.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.719 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' 1004 ' ' CYS . 56.5 t -28.29 123.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.31 0.381 . . . . 0.0 111.334 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.58 2.6 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.682 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 88.0 p -157.1 127.23 6.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.818 0.342 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 58.6 mtt85 -101.54 149.57 23.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.7 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.601 HD11 ' HB3' ' A' 1002 ' ' ALA . 38.9 pt -142.78 168.85 13.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.075 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.542 ' OG1' HD11 ' A' ' 977' ' ' ILE . 66.5 p -146.12 147.38 31.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.834 0.349 . . . . 0.0 111.867 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.953 ' HB3' ' HA ' ' A' ' 974' ' ' VAL . 6.5 p90 -145.9 159.29 43.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.8 p -155.23 143.48 20.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.931 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.628 ' H ' HD12 ' A' ' 996' ' ' LEU . 36.8 t -82.01 -179.56 7.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.452 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 38.1 p -60.24 155.06 18.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 112.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 52.2 m -54.82 139.59 39.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.476 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.437 ' O ' HD12 ' A' 1023 ' ' ILE . . . 82.93 -32.41 2.97 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.204 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -82.43 148.67 28.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.812 ' HG2' ' H ' ' A' ' 996' ' ' LEU . 49.2 ttt-85 -81.97 -172.25 3.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.024 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.812 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 5.5 tt -161.77 128.07 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.887 ' HB ' HG12 ' A' 1019 ' ' ILE . 1.7 mp -86.62 144.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.967 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.6 165.18 36.38 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' 1001 ' ' SER . 89.5 m-70 -71.38 137.03 48.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.625 0.213 . . . . 0.0 110.762 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 78.7 p -72.14 39.47 0.07 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.948 0.404 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.474 ' O ' HG21 ' A' 1015 ' ' THR . 36.4 t -160.06 171.44 19.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.98 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.27 134.02 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.4 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -114.05 128.25 56.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.434 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 48.9 t -73.2 85.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' 1014 ' ' SER . 14.7 pt -91.52 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.168 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' 1007 ' ' SER . 0.5 OUTLIER -92.46 128.34 38.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.709 0.29 . . . . 0.0 110.544 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.657 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 46.5 t -162.52 136.75 6.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 66.0 40.37 95.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.381 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.16 21.64 6.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.622 0.249 . . . . 0.0 111.564 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 87.9 m -152.36 133.59 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.818 0.342 . . . . 0.0 111.181 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.551 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.32 134.1 41.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.657 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.1 p80 -153.8 150.86 28.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.765 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.64 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 31.8 m95 -68.14 120.59 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.776 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.537 ' HB2' HD13 ' A' 1005 ' ' ILE . 44.8 t -52.38 -22.58 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.707 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.474 HG21 ' O ' ' A' 1001 ' ' SER . 46.6 p -87.0 132.43 33.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -66.05 156.43 84.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.62 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -46.82 118.32 2.62 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.236 1.958 . . . . 0.0 112.019 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.487 ' HG3' ' CZ ' ' A' ' 988' ' ' TYR . 64.4 Cg_endo -84.62 160.42 12.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.162 2.574 . . . . 0.0 113.169 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.887 HG12 ' HB ' ' A' ' 997' ' ' ILE . 35.2 pt -144.53 -157.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 49.4 t -143.36 171.18 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.309 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.459 ' HA ' ' OE1' ' A' 1021 ' ' GLN . 1.0 OUTLIER -153.51 130.76 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.036 0.446 . . . . 0.0 111.113 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' 1045 ' ' HIS . 77.7 ttt180 -64.37 -17.54 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.527 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 995' ' ' ARG . 61.4 mt 64.21 89.33 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.934 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.62 126.26 21.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.611 2.207 . . . . 0.0 112.931 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 56.1 m -88.43 -145.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.055 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -163.91 155.57 27.01 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.432 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' 1044 ' ' PHE . 8.8 mp -40.92 139.41 1.21 Allowed Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.599 ' HD3' HD21 ' A' 1040 ' ' ASN . 59.6 Cg_endo -71.67 145.37 46.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.882 2.388 . . . . 0.0 112.054 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.507 ' HB2' ' HG3' ' A' 1087 ' ' PRO . 24.0 Cg_endo -61.47 117.19 3.98 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.206 1.938 . . . . 0.0 111.933 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 83.5 m -82.47 121.05 26.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 24.8 pt -86.66 135.55 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.352 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -51.79 138.61 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.482 ' HB3' ' HE2' ' A' 1064 ' ' PHE . 75.3 m-80 75.03 -40.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.172 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -79.16 116.71 4.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' 1053 ' ' ARG . 57.4 m-20 -68.81 -150.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 110.685 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 137.15 13.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.285 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' 1050 ' ' VAL . 34.5 pt -128.87 -161.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.566 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 66.4 m 63.66 159.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.857 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 99.9 m -56.48 130.55 45.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.306 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.599 HD21 ' HD3' ' A' 1028 ' ' PRO . 17.0 t-20 -177.18 -121.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' 1040 ' ' ASN . 21.9 mmt85 75.35 -49.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.606 0.362 . . . . 0.0 111.211 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' 1043 ' ' ASN . 13.5 pt-20 -162.95 -141.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.411 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' 1042 ' ' GLU . 37.0 m-20 33.56 43.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.193 0.52 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.562 ' CD2' HD12 ' A' 1027 ' ' LEU . 0.3 OUTLIER -77.89 43.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.882 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.607 ' HB3' ' HD3' ' A' 1022 ' ' ARG . 58.3 m-70 -53.3 -52.49 58.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.565 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 32.2 t80 171.9 160.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.392 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 77.51 -20.97 3.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.061 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' 1046 ' ' TYR . 55.3 m -47.66 142.2 4.74 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.896 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' 1072 ' ' ILE . 11.3 p -137.79 155.43 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.338 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' 1037 ' ' ILE . 9.4 p -149.03 139.27 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.334 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.533 ' O ' HG12 ' A' 1037 ' ' ILE . 96.6 m -102.55 128.99 48.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -73.5 139.95 46.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.526 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' 1035 ' ' ASP . 79.3 ttt180 -146.54 133.07 19.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.03 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.57 ' O ' HD23 ' A' 1056 ' ' LEU . 75.5 m -76.45 158.1 31.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 111.834 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.515 ' HA ' ' OD2' ' A' 1035 ' ' ASP . 24.4 t-20 -65.6 -22.92 66.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.957 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.609 HD13 ' H ' ' A' 1064 ' ' PHE . 4.1 mm? 46.21 43.77 11.53 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-O 120.786 0.326 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 72.81 -53.94 1.68 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 36.3 t -178.83 126.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' 1059 ' ' ARG . 3.0 mmp_? 72.37 -60.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.124 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.44 29.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.086 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.602 ' O ' ' HB3' ' A' 1056 ' ' LEU . 42.1 ttt85 -66.17 132.13 47.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -65.24 109.28 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.515 0.674 . . . . 0.0 111.992 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.591 HG13 ' HD1' ' A' 1064 ' ' PHE . 3.0 p -157.47 -45.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.156 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.609 ' H ' HD13 ' A' 1056 ' ' LEU . 3.1 m-85 -86.11 155.57 20.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.344 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -146.28 121.34 10.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' 1070 ' ' PRO . 30.9 tp -71.9 142.97 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.466 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' 1089 ' ' PRO . 63.7 t -138.33 138.16 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.1 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.8 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1069 ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -62.42 110.41 3.32 Favored Pre-proline 0 C--O 1.225 -0.186 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.545 ' HB3' HD21 ' A' 1066 ' ' LEU . 74.3 Cg_endo -87.8 -45.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.547 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 83.4 p -94.54 146.86 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 112.009 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.804 HG13 ' HB2' ' A' 1085 ' ' SER . 7.0 tt -149.67 158.39 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.688 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' 1072 ' ' ILE . 0.1 OUTLIER -159.7 171.97 18.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.688 0.28 . . . . 0.0 111.19 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 43.4 t -62.16 -44.22 97.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.243 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 12.4 t 44.16 21.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.668 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.624 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 99.5 p 55.63 141.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.342 0.591 . . . . 0.0 112.483 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1077 ' ' ASN . . . . . 1.012 ' HA ' HG12 ' A' 1083 ' ' ILE . 0.7 OUTLIER -67.05 -98.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.782 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.61 3.03 0.08 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.277 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 7.3 t0 -163.14 -51.01 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.509 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' 1080 ' ' GLN . 1.8 pm0 -174.84 50.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.442 ' HB ' ' CB ' ' A' 1077 ' ' ASN . 45.9 t -134.31 -37.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.954 -0.466 . . . . 0.0 111.867 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' 1076 ' ' SER . . . 73.8 64.79 2.37 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1083 ' ' ILE . . . . . 1.012 HG12 ' HA ' ' A' 1077 ' ' ASN . 20.2 pt -81.98 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.57 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 11.1 m95 -72.43 162.91 28.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.218 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.804 ' HB2' HG13 ' A' 1072 ' ' ILE . 57.6 m -43.58 -41.76 4.73 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.444 ' H ' HD11 ' A' 1072 ' ' ILE . . . 107.43 145.94 12.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.664 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' 1029 ' ' PRO . 68.5 Cg_exo -50.77 149.28 14.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.152 2.568 . . . . 0.0 112.845 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.764 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -171.77 -47.57 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.3 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.764 ' HD2' ' H ' ' A' 1088 ' ' ALA . 20.1 Cg_endo -59.65 149.88 79.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.634 2.223 . . . . 0.0 112.725 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -147.7 149.85 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.757 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 56.4 m -93.73 142.3 27.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.092 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 33.4 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.943 179.582 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 960' ' ' ALA . . . . . 0.632 ' C ' ' HD2' ' A' ' 961' ' ' LYS . . . . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.689 0.28 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.632 ' HD2' ' C ' ' A' ' 960' ' ' ALA . 3.1 mptp? -146.55 155.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 98.6 p -152.99 129.12 10.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.39 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 964' ' ' LYS . 1.6 p -79.92 30.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.254 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 964' ' ' LYS . 10.0 mmpt? 54.5 138.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.478 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 6.9 t -63.14 121.46 69.35 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.45 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 17.3 Cg_exo -67.25 107.25 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.475 2.117 . . . . 0.0 112.307 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 965' ' ' THR . 28.7 Cg_endo -63.39 136.2 53.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.211 1.941 . . . . 0.0 110.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.8 107.97 0.82 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.765 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 970' ' ' VAL . 73.2 Cg_endo -73.11 -133.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.936 2.424 . . . . 0.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.9 HG22 ' H ' ' A' ' 971' ' ' ASN . 8.5 p -51.95 -148.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.914 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.9 ' H ' HG22 ' A' ' 970' ' ' VAL . 5.1 m120 -65.46 -28.44 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.767 -0.583 . . . . 0.0 110.469 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 970' ' ' VAL . . . -72.33 126.6 11.59 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.234 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 988' ' ' TYR . 65.9 mtt -94.42 143.95 25.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.558 HG21 HD12 ' A' ' 986' ' ' ILE . 4.5 p -92.88 148.36 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 O-C-N 123.361 0.413 . . . . 0.0 111.6 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -118.16 109.12 16.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.022 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.759 HG13 HG23 ' A' ' 980' ' ' ILE . 72.6 t -65.38 -48.01 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 22.9 mt 64.69 -98.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.602 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.7 p -62.25 -65.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.526 ' O ' HG13 ' A' ' 976' ' ' VAL . 51.7 p-10 -173.33 -148.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.568 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.759 HG23 HG13 ' A' ' 976' ' ' VAL . 21.1 pt -155.95 25.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.2 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 962' ' ' SER . 85.7 mt-30 -78.81 -57.62 3.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.942 0.401 . . . . 0.0 111.272 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.642 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 7.7 p 167.77 156.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 982' ' ' VAL . . . 79.06 -35.87 1.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.669 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.458 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 80.7 p -68.5 -160.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.12 0.486 . . . . 0.0 111.444 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 986' ' ' ILE . 45.4 ttm-85 -156.66 160.64 39.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.085 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.558 HD12 HG21 ' A' ' 974' ' ' VAL . 47.0 pt -142.75 155.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.117 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' 1001 ' ' SER . 82.2 p -142.25 134.32 27.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' 1000 ' ' SER . 4.0 m-85 -83.23 -161.87 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 73.6 m -148.18 -40.47 0.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.77 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 29.1 t 69.42 137.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.835 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -60.27 145.84 45.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.735 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 74.9 m -51.58 134.64 29.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.361 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 74.03 37.54 49.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.247 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.613 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 33.4 m80 -146.96 125.29 12.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.36 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.671 ' HB2' HD11 ' A' 1023 ' ' ILE . 38.2 ttt85 -82.0 96.82 7.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' 1000 ' ' SER . 3.6 pp -63.62 140.42 58.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.643 ' HB ' HG13 ' A' 1019 ' ' ILE . 50.4 mm -107.96 154.69 9.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.22 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.92 14.63 82.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.071 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 63.68 134.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.688 ' HB3' HD22 ' A' ' 996' ' ' LEU . 77.8 p -87.76 46.78 1.42 Allowed 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -162.14 146.8 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.711 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.685 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -165.19 125.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.717 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.412 ' HB2' ' NH1' ' A' ' 985' ' ' ARG . 89.2 tt0 -87.65 130.96 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 43.4 t -74.13 86.57 1.88 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.888 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.496 ' HB ' ' H ' ' A' 1006 ' ' LEU . 2.4 pp -87.28 -146.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' 1010 ' ' THR . 4.6 tt -158.46 129.37 6.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.519 ' N ' HD23 ' A' 1006 ' ' LEU . 47.1 t -80.25 -59.63 2.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.306 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.27 42.8 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.508 ' H ' HD21 ' A' 1006 ' ' LEU . 16.5 p-10 -176.25 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.377 . . . . 0.0 110.395 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.581 ' O ' ' HG ' ' A' 1006 ' ' LEU . 11.8 t -151.29 175.99 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.56 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -74.8 145.71 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.125 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -149.44 145.61 27.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.438 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.427 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 92.9 m95 -76.42 125.41 29.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.362 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.2 p -53.69 -19.91 4.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.092 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.685 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 30.3 p -131.26 135.84 47.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 112.265 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' 1017 ' ' PRO . 14.7 mmmm -69.81 161.96 71.29 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.891 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 80.2 Cg_exo -45.43 132.31 12.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.735 2.29 . . . . 0.0 112.686 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 88.9 Cg_endo -80.51 170.56 15.74 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.997 2.465 . . . . 0.0 113.143 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.643 HG13 ' HB ' ' A' ' 997' ' ' ILE . 25.4 pt -148.83 121.53 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.811 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.764 ' H ' HG11 ' A' ' 970' ' ' VAL . 88.9 m -86.16 118.26 25.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 112.118 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -82.41 126.01 31.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.915 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' 1046 ' ' TYR . 40.9 ttt85 -67.2 -9.37 39.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.256 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.671 HD11 ' HB2' ' A' ' 995' ' ' ARG . 45.9 mt 54.01 56.77 12.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.428 . . . . 0.0 110.445 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.518 ' CB ' ' HA ' ' A' 1045 ' ' HIS . 58.0 Cg_endo -71.6 138.28 31.89 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.273 . . . . 0.0 113.019 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 3.8 p -88.42 -136.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.317 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1026 ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' 1044 ' ' PHE . . . -148.4 -151.35 5.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.809 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' 1044 ' ' PHE . 70.6 mt -64.73 132.84 95.55 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-O 120.711 0.291 . . . . 0.0 111.567 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.58 149.81 88.18 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 111.092 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.596 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 95.9 Cg_exo -45.47 119.59 2.74 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.287 1.992 . . . . 0.0 112.283 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 81.3 p -81.81 139.9 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.958 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' 1031 ' ' ILE . 45.6 pt -148.45 120.6 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.433 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -73.56 14.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.111 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' 1031 ' ' ILE . 48.0 m-20 -80.36 -31.83 37.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.22 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.509 ' HA2' ' OD1' ' A' 1055 ' ' ASN . . . -163.14 -125.2 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.302 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' 1036 ' ' PHE . 53.3 m-20 -156.66 -151.7 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.597 ' HB2' HG13 ' A' 1050 ' ' VAL . 45.9 p90 -155.96 129.65 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 111.945 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.28 78.2 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.986 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 39.6 t -167.39 154.0 8.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 111.492 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.554 ' O ' ' HG3' ' A' 1041 ' ' ARG . 60.7 m -55.8 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' 1041 ' ' ARG . 2.8 m-80 52.91 -125.1 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' 1039 ' ' THR . 76.0 mtp180 74.92 -47.34 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.662 0.385 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' 1044 ' ' PHE . 3.9 tm-20 -162.89 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.68 0.276 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -71.63 38.09 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.665 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.596 ' HD1' ' H ' ' A' 1045 ' ' HIS . 0.3 OUTLIER -76.7 -46.82 24.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.596 ' H ' ' HD1' ' A' 1044 ' ' PHE . 24.2 m-70 40.62 -147.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.18 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.722 ' O ' ' HB3' ' A' 1074 ' ' CYS . 14.8 t80 -63.45 -49.18 74.68 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -96.1 121.6 7.01 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.891 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 47.2 t 178.6 122.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.64 0.734 . . . . 0.0 111.344 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' 1072 ' ' ILE . 11.2 p -102.3 157.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.546 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.597 HG13 ' HB2' ' A' 1036 ' ' PHE . 87.4 t -146.81 117.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.951 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' 1036 ' ' PHE . 96.2 m -99.55 109.94 22.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.909 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.475 ' O ' HD22 ' A' 1066 ' ' LEU . 31.4 m-85 -80.98 124.66 29.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.976 0.417 . . . . 0.0 111.684 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' 1054 ' ' CYS . 18.2 tpt85 -97.07 -137.02 0.26 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.643 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.483 ' H ' ' HG3' ' A' 1053 ' ' ARG . 99.1 m -161.43 156.23 23.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 110.512 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.509 ' OD1' ' HA2' ' A' 1034 ' ' GLY . 79.0 m-20 -65.85 62.1 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.629 ' HB3' ' HA2' ' A' 1060 ' ' GLY . 3.6 mm? -70.33 135.72 49.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 110.731 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' 1058 ' ' SER . . . -82.74 131.75 10.6 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.864 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' 1057 ' ' GLY . 55.1 m 74.91 -49.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.502 0.321 . . . . 0.0 111.731 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -167.75 -51.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.863 0.363 . . . . 0.0 111.543 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . -172.62 37.8 0.15 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.298 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -66.17 165.82 13.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.38 78.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.277 0.561 . . . . 0.0 111.025 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1064 ' ' PHE . 7.9 m -155.08 95.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.559 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.1 m-85 75.77 139.58 0.07 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.026 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 143.63 31.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.66 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' 1070 ' ' PRO . 47.5 tp -68.47 142.36 55.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' 1089 ' ' PRO . 77.7 t -149.05 132.5 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.867 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1068 ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 77.42 145.31 2.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.373 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' 1089 ' ' PRO . 16.3 pt-20 18.12 67.83 0.22 Allowed Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 112.689 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.596 ' HA ' HD21 ' A' 1066 ' ' LEU . 13.9 Cg_endo -56.18 -11.56 6.15 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.539 2.159 . . . . 0.0 111.907 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' 1050 ' ' VAL . 79.6 p -156.23 152.05 27.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' 1049 ' ' VAL . 26.3 pt -140.96 -166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.821 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' 1085 ' ' SER . 0.6 OUTLIER -160.09 158.14 29.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.958 0.409 . . . . 0.0 111.359 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.722 ' HB3' ' O ' ' A' 1046 ' ' TYR . 51.5 t -64.63 -42.6 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.97 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.547 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 14.7 t 45.95 -161.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.231 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.836 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 81.2 p -165.38 139.49 4.76 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.579 0.228 . . . . 0.0 111.381 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -177.01 -39.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.784 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.7 t70 -82.97 47.22 1.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.196 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.34 -130.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.52 ' HA ' HG23 ' A' 1023 ' ' ILE . 12.0 mp0 -76.96 49.92 0.69 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.648 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 18.4 t -145.9 -46.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.836 ' HA2' ' HA ' ' A' 1076 ' ' SER . . . 77.67 -45.84 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.24 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' 1082 ' ' GLY . 6.6 pt 52.58 135.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.449 0.642 . . . . 0.0 111.752 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.406 ' HB3' HD12 ' A' 1072 ' ' ILE . 42.0 m95 -71.92 147.21 47.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.46 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' 1073 ' ' TYR . 80.2 p -48.02 -23.88 0.93 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.795 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.49 140.52 6.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.783 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 12.8 Cg_exo -72.44 47.85 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.528 2.818 . . . . 0.0 113.079 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 64.44 138.99 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.023 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.755 ' HB3' ' HG2' ' A' 1069 ' ' GLU . 97.4 Cg_endo -81.73 -140.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.963 2.442 . . . . 0.0 112.2 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.498 ' OE1' HD13 ' A' 1092 ' ' ILE . 16.9 tt0 -152.46 153.59 33.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.869 ' O ' HG12 ' A' 1092 ' ' ILE . 90.4 m -80.76 -146.82 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.869 HG12 ' O ' ' A' 1091 ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.651 0.262 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.51 151.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 78.3 p -149.78 149.82 31.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.928 0.394 . . . . 0.0 111.497 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 89.1 m -79.93 147.61 31.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.335 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -63.75 138.2 58.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.898 0.38 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 62.2 m -51.94 125.19 30.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.065 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.691 ' HG2' HG11 ' A' ' 974' ' ' VAL . 56.6 Cg_endo -70.86 127.53 13.84 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.325 2.016 . . . . 0.0 111.824 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.85 139.01 50.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.289 1.992 . . . . 0.0 111.564 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -43.81 115.3 2.01 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 110.847 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.625 ' HG3' ' HD2' ' A' ' 988' ' ' TYR . 45.7 Cg_endo -67.45 149.5 80.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.792 2.328 . . . . 0.0 112.301 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.696 HG13 ' H ' ' A' 1020 ' ' CYS . 0.6 OUTLIER -44.86 102.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.206 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 4.8 m120 74.2 -37.28 0.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.86 -172.82 8.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.57 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 64.6 mtm -154.56 135.12 13.46 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 110.916 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.691 HG11 ' HG2' ' A' ' 966' ' ' PRO . 6.3 p -92.93 149.55 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.09 113.76 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.99 HG13 HG23 ' A' ' 980' ' ' ILE . 78.5 t -60.89 -51.64 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.152 0.501 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 33.6 mt 74.93 -33.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.195 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.5 p -138.0 -64.95 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.457 ' O ' ' CG1' ' A' ' 980' ' ' ILE . 38.7 t70 -172.47 2.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.99 HG23 HG13 ' A' ' 976' ' ' VAL . 49.8 pt 52.81 72.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.431 0.634 . . . . 0.0 110.893 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' 1004 ' ' CYS . 8.7 pt20 -152.34 174.74 13.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.128 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' 1004 ' ' CYS . 48.4 t -43.38 138.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.337 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 80.54 -44.87 2.99 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.998 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.577 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 53.4 m -68.43 123.21 20.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.976 0.388 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.683 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 74.9 ttt180 -101.43 121.12 41.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.871 HG21 HG22 ' A' ' 980' ' ' ILE . 31.7 pt -93.46 160.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 78.0 p -143.99 132.38 22.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 111.911 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.625 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 3.7 m-85 -84.85 -168.11 2.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 11.1 t -161.59 -47.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.195 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.832 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 3.2 t 70.05 -137.64 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.33 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 158.28 4.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.641 0.734 . . . . 0.0 112.43 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 28.5 m -53.99 114.77 1.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.755 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 147.24 -28.15 1.53 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.591 ' HA ' HG12 ' A' 1023 ' ' ILE . 7.2 m80 -139.07 143.0 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.522 ' CZ ' ' HB2' ' A' 1021 ' ' GLN . 22.8 ptt-85 -80.02 127.34 32.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.143 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 997' ' ' ILE . 3.3 tt -76.13 129.86 37.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.7 mp -104.33 146.68 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.119 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 74.75 169.9 24.28 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.78 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.417 ' ND1' HG21 ' A' 1015 ' ' THR . 24.4 m170 -75.01 125.71 29.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.458 ' O ' ' HD1' ' A' ' 988' ' ' TYR . 79.3 p -64.88 -44.05 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.459 ' HB3' ' NE ' ' A' ' 985' ' ' ARG . 50.5 m -82.72 142.95 31.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.409 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.427 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -161.66 116.4 1.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 37.5 tt0 -85.93 132.51 34.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 43.0 t -69.71 93.52 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.32 -178.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' 1007 ' ' SER . 9.9 tp -158.44 125.5 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.469 ' N ' HD12 ' A' 1006 ' ' LEU . 47.5 t -85.42 -48.91 8.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.278 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 171.84 -48.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.659 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.6 t30 -70.99 -55.19 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.817 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.403 ' C ' HD13 ' A' 1006 ' ' LEU . 87.9 m -151.21 149.05 28.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.492 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.432 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.28 143.96 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -150.71 149.98 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.464 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.428 ' CH2' HD13 ' A' ' 986' ' ' ILE . 52.1 m95 -68.78 132.53 46.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.713 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 78.5 p -52.36 -24.74 8.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.976 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.427 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 75.3 p -131.43 141.17 49.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -56.88 155.45 15.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 17.0 Cg_endo -57.71 118.11 4.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.36 2.04 . . . . 0.0 112.037 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.488 ' HB2' HD21 ' A' ' 996' ' ' LEU . 21.6 Cg_endo -61.48 159.15 32.96 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.545 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 26.4 pt -143.9 127.97 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.622 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.696 ' H ' HG13 ' A' ' 970' ' ' VAL . 50.5 m -88.0 112.79 22.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.052 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.566 ' HG2' HD13 ' A' ' 997' ' ' ILE . 28.2 mm100 -86.38 145.02 27.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.955 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.587 ' NH2' ' HB3' ' A' 1046 ' ' TYR . 25.8 tpt85 -63.92 128.12 34.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.237 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 994' ' ' HIS . 48.5 mm -65.34 128.25 93.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 72.6 Cg_endo -96.97 139.3 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.738 2.959 . . . . 0.0 113.488 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.761 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 98.0 m -112.94 135.14 54.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.208 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.95 -152.35 4.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.789 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 48.8 mt -83.08 146.17 51.0 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.619 0.247 . . . . 0.0 111.059 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.16 149.8 90.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.324 2.016 . . . . 0.0 111.127 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.726 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 2.5 Cg_endo -46.18 119.66 3.16 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.573 2.182 . . . . 0.0 111.862 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 71.8 p -77.43 145.22 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.44 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' 1031 ' ' ILE . 10.3 tt -149.89 114.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.801 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -56.59 144.57 31.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.531 ' HB3' HD22 ' A' 1055 ' ' ASN . 5.0 m120 75.21 -35.95 0.3 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.501 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.62 178.12 8.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.532 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -156.58 127.32 6.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.79 ' HB2' HG23 ' A' 1050 ' ' VAL . 3.7 p90 -84.34 144.57 28.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 0.0 110.664 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' 1036 ' ' PHE . 42.2 mm -133.66 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.655 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 11.3 t -167.8 -161.18 0.37 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.974 0.416 . . . . 0.0 111.289 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 68.9 p -75.16 -13.4 60.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.279 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.734 HD22 ' HB ' ' A' 1050 ' ' VAL . 55.4 m-20 -47.42 136.39 9.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.415 ' HB3' ' OE1' ' A' 1042 ' ' GLU . 25.3 mmm180 -154.18 -82.73 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.611 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.5 OUTLIER -163.01 145.16 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' 1042 ' ' GLU . 51.9 m-20 70.27 58.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.893 0.377 . . . . 0.0 110.419 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' 1025 ' ' CYS . 2.5 m-85 -76.73 132.46 39.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' 1046 ' ' TYR . 20.4 m80 -90.32 -65.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.619 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.685 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.0 t80 171.91 44.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.548 0.69 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.45 89.2 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.73 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' 1047 ' ' GLY . 77.6 p 172.38 141.66 0.03 OUTLIER 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 111.515 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.967 HG12 ' HB3' ' A' 1073 ' ' TYR . 12.3 m -107.2 -173.53 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.431 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' 1036 ' ' PHE . 7.3 p -153.93 129.57 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.981 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 50.1 m -116.83 110.66 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.473 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 2.2 m-85 -70.58 158.03 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -149.75 -13.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.869 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 65.1 m 66.16 166.02 0.2 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' 1033 ' ' ASN . 19.1 p30 -55.68 -44.64 77.52 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.617 HD12 ' HA2' ' A' 1060 ' ' GLY . 2.8 mm? 38.69 33.32 0.07 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 68.89 -52.63 0.53 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.906 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.566 ' C ' ' HD2' ' A' 1059 ' ' ARG . 70.8 m -161.53 -28.62 0.05 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.321 0.56 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.566 ' HD2' ' C ' ' A' 1058 ' ' SER . 5.6 mpt_? -150.06 -50.58 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.526 0.203 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' 1056 ' ' LEU . . . -174.75 37.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.892 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -70.96 163.15 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' 1062 ' ' LYS . 39.9 ttpt -67.85 70.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.17 0.51 . . . . 0.0 110.934 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' 1063 ' ' VAL . 6.7 m -155.07 89.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.747 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' 1063 ' ' VAL . 77.4 m-85 75.55 145.5 0.08 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.951 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -145.09 143.7 30.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.649 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' 1070 ' ' PRO . 61.7 tp -68.57 135.54 51.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.0 111.314 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' 1089 ' ' PRO . 61.5 t -138.25 123.03 22.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.114 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1068 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 71.82 161.3 4.9 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.285 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.609 ' OE2' HD13 ' A' 1072 ' ' ILE . 83.4 tt0 30.37 62.47 0.95 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.916 ' HA ' HD21 ' A' 1066 ' ' LEU . 57.3 Cg_endo -72.68 -24.59 18.25 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.993 1.795 . . . . 0.0 112.302 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' 1050 ' ' VAL . 42.7 m -156.25 137.67 13.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 111.567 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.609 HD13 ' OE2' ' A' 1069 ' ' GLU . 44.6 pt -145.43 -169.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.967 ' HB3' HG12 ' A' 1049 ' ' VAL . 0.6 OUTLIER -162.14 156.89 22.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.051 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.7 t -62.24 148.31 45.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.384 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.42 ' HA ' ' HE1' ' A' 1046 ' ' TYR . 6.5 t -146.04 -7.89 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.743 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.51 ' HB3' ' HA2' ' A' 1082 ' ' GLY . 89.3 p 47.81 54.74 9.49 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.773 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -55.14 -46.23 75.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.86 ' HB2' HG21 ' A' 1081 ' ' VAL . 22.9 m-20 -75.71 -3.1 32.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.301 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.626 ' OD1' ' HG3' ' A' 1080 ' ' GLN . 9.8 t70 65.4 134.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.376 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.626 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 27.6 mt-30 56.87 43.3 25.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.86 HG21 ' HB2' ' A' 1078 ' ' ASP . 24.5 m -148.6 -35.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.253 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.761 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 63.98 41.15 98.73 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.084 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.438 ' H ' HG23 ' A' 1081 ' ' VAL . 73.7 mt -85.73 136.5 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.837 0.351 . . . . 0.0 111.345 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' 1084 ' ' TRP . 8.1 m95 -76.15 141.12 41.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.704 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 78.9 p -59.78 -61.73 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.898 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.631 ' O ' ' HG3' ' A' 1029 ' ' PRO . . . -71.09 126.67 13.72 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.843 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -88.9 46.34 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.945 2.43 . . . . 0.0 112.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 62.37 130.89 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.519 ' HB2' ' O ' ' A' 1067 ' ' VAL . 86.3 Cg_endo -78.43 -137.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.821 2.347 . . . . 0.0 112.85 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.517 ' H ' ' HB2' ' A' 1089 ' ' PRO . 15.9 tt0 -152.37 140.14 19.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.012 0.435 . . . . 0.0 111.587 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 66.8 m -100.75 130.72 46.82 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.772 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 21.5 pt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.053 179.424 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.656 ' HB3' HD23 ' A' 1006 ' ' LEU . 17.1 tppt? -84.9 132.62 34.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.987 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.9 p -82.08 133.31 35.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.016 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.748 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 98.9 m -80.52 36.26 0.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.022 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.7 tptt 63.38 133.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 56.5 m -70.9 116.99 51.87 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.321 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.805 ' HG2' HG11 ' A' ' 974' ' ' VAL . 61.2 Cg_endo -72.99 120.68 6.76 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.243 1.962 . . . . 0.0 112.168 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 23.5 Cg_exo -63.98 -61.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.232 1.955 . . . . 0.0 111.299 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 170.65 96.93 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.262 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.616 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 58.0 Cg_exo -53.79 179.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.759 2.306 . . . . 0.0 112.668 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 972' ' ' GLY . 92.9 t -48.92 90.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.796 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.842 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 75.0 m-20 71.22 -26.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.262 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.52 114.2 5.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.415 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.559 ' H ' ' HA ' ' A' ' 990' ' ' CYS . 77.3 mmm -80.84 124.06 28.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.805 HG11 ' HG2' ' A' ' 966' ' ' PRO . 0.3 OUTLIER -92.38 138.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.45 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -122.65 108.96 13.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.544 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 986' ' ' ILE . 62.0 t -66.4 98.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.097 0.475 . . . . 0.0 109.832 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.19 -93.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.197 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -68.96 -58.4 4.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 0.0 110.182 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.583 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 54.6 m-20 -164.62 -133.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.191 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.585 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 5.0 pt -155.63 -16.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.254 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.987 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 34.6 mt-30 -73.53 177.36 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.621 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 961' ' ' LYS . 99.9 t -44.28 144.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.25 -38.24 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.295 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 49.2 m -68.51 148.1 51.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.845 0.323 . . . . 0.0 110.373 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 1002 ' ' ALA . 5.3 tmm_? -138.44 127.6 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 111.336 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 976' ' ' VAL . 17.4 pt -96.97 -176.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.095 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' 1001 ' ' SER . 50.5 p -150.14 127.96 11.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.004 0.43 . . . . 0.0 111.605 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.654 ' HB2' ' HA ' ' A' 1000 ' ' SER . 1.4 m-85 -85.18 -176.58 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 69.2 m -161.47 -34.41 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.676 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.559 ' HA ' ' H ' ' A' ' 973' ' ' MET . 43.0 t 68.36 167.14 0.26 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 81.1 p -60.15 -170.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 51.6 m -88.8 129.55 35.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.155 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 72.25 39.56 57.38 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.788 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' 1022 ' ' ARG . 25.8 m80 -146.87 133.24 19.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 995' ' ' ARG . 35.2 ttt85 -98.68 113.74 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.0 111.283 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 1.015 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 4.1 pp -76.14 138.39 40.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.498 . . . . 0.0 111.467 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' 1018 ' ' PRO . 1.7 mp -95.6 153.18 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.632 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.37 23.45 58.63 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.354 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 80.2 m-70 65.58 141.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.679 ' HB3' HD21 ' A' ' 996' ' ' LEU . 86.9 p -86.26 50.3 1.96 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.726 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 23.0 t -161.81 165.96 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.484 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.2 129.56 2.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -104.94 124.6 49.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.031 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 49.1 t -74.6 123.7 25.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 13.0 pt -136.99 150.92 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.658 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.656 HD23 ' HB3' ' A' ' 961' ' ' LYS . 0.4 OUTLIER -98.89 121.82 41.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.009 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.495 ' N ' HD13 ' A' 1006 ' ' LEU . 50.7 m -78.54 -55.5 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.36 37.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.127 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 46.6 t-20 178.55 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 0.0 110.33 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 53.2 m -151.26 149.9 29.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.923 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.748 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.1 141.4 43.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.92 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.4 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.5 m-70 -149.45 140.19 22.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.585 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 66.9 m95 -71.81 127.13 31.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.794 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.0 p -52.49 -28.8 21.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.691 ' O ' ' HG2' ' A' 1016 ' ' LYS . 48.2 p -90.64 -24.85 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' 1015 ' ' THR . 15.0 pttp 59.9 152.62 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 123.657 0.598 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.29 105.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.481 2.121 . . . . 0.0 112.157 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.656 ' HB2' ' O ' ' A' ' 997' ' ' ILE . 94.3 Cg_endo -80.14 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.446 HG13 ' HB ' ' A' ' 997' ' ' ILE . 35.4 pt -148.94 -169.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.44 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1020 ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 15.8 t -153.98 110.82 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.69 ' HG3' ' H ' ' A' 1023 ' ' ILE . 33.1 tp60 -77.66 134.13 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.401 ' HA ' ' CD2' ' A' ' 994' ' ' HIS . 15.2 ptp180 -76.49 6.36 5.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.452 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.761 HG23 ' HA ' ' A' 1080 ' ' GLN . 57.2 mt 53.29 76.55 0.52 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.665 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' 1045 ' ' HIS . 31.3 Cg_exo -59.39 116.83 3.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.242 1.961 . . . . 0.0 111.759 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 10.0 p -91.11 34.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.829 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 43.97 -142.37 2.61 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.062 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 72.2 mt -106.49 136.35 19.39 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-O 120.619 0.247 . . . . 0.0 111.381 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.428 ' HB3' ' CZ3' ' A' 1084 ' ' TRP . 35.3 Cg_endo -64.34 143.32 82.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.588 2.192 . . . . 0.0 111.714 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.887 ' HG2' ' HA ' ' A' 1087 ' ' PRO . 49.4 Cg_exo -55.3 108.88 0.34 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.255 1.97 . . . . 0.0 112.046 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 54.9 m -93.4 124.68 37.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.583 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' 1034 ' ' GLY . 62.7 mt -85.26 139.32 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.369 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -56.53 -55.39 34.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.245 0.545 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -80.23 -36.45 34.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.933 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.867 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -72.78 121.83 8.04 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.614 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -83.4 -151.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.403 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.475 ' HB2' HG23 ' A' 1050 ' ' VAL . 9.3 p90 -155.93 138.97 15.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' 1053 ' ' ARG . 46.3 mt -122.5 67.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.477 ' HB2' ' ND2' ' A' 1040 ' ' ASN . 74.5 m -157.18 -140.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.347 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.478 HG22 ' O ' ' A' 1039 ' ' THR . 11.1 m -119.58 38.63 3.83 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.477 ' ND2' ' HB2' ' A' 1038 ' ' SER . 1.3 m-80 -80.89 121.32 25.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -156.42 43.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' 1043 ' ' ASN . 37.7 tt0 62.94 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' 1042 ' ' GLU . 73.4 m-80 78.64 52.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' 1045 ' ' HIS . 5.1 m-85 -76.74 -56.75 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.137 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' 1024 ' ' PRO . 21.9 m80 72.62 -44.44 0.59 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.71 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 43.3 t80 171.73 148.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.958 0.409 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 73.6 97.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.754 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' 1047 ' ' GLY . 81.4 p 173.45 156.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 110.979 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' 1072 ' ' ILE . 3.5 p -137.78 155.44 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.967 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' 1036 ' ' PHE . 13.5 p -143.52 127.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.418 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 89.4 m -104.46 120.21 40.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.224 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.425 ' HD2' HD12 ' A' 1031 ' ' ILE . 13.1 m-85 -83.84 148.01 27.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.642 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.656 ' HD2' HD11 ' A' 1037 ' ' ILE . 44.9 ttt85 -142.77 -27.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.017 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.867 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 11.7 t 67.66 154.99 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 34.4 m120 -51.19 -93.45 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.601 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' 1064 ' ' PHE . 5.7 mt 61.71 -166.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.226 0.536 . . . . 0.0 111.843 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.544 ' N ' ' N ' ' A' 1061 ' ' ARG . . . 54.28 -121.38 19.52 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.206 -0.906 . . . . 0.0 114.136 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 75.1 p -45.59 -66.43 0.4 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.26 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -87.21 35.62 0.71 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' 1056 ' ' LEU . . . -174.68 -117.68 0.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.563 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.736 ' O ' HG13 ' A' 1063 ' ' VAL . 11.2 tpt180 85.32 108.22 0.05 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.547 0.739 . . . . 0.0 110.103 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' 1062 ' ' LYS . 63.9 tttp 44.65 36.16 1.67 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 122.093 0.949 . . . . 0.0 109.609 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' 1061 ' ' ARG . 31.1 m -104.37 -12.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.591 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.866 ' HB2' HD21 ' A' 1056 ' ' LEU . 70.3 m-85 -156.09 162.99 40.19 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.921 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1065 ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' 1091 ' ' CYS . 44.7 mt-10 -142.4 131.27 22.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.016 0.436 . . . . 0.0 110.826 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.484 HD11 ' CG ' ' A' 1089 ' ' PRO . 31.0 tp -68.48 147.21 52.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.646 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 58.4 t -138.34 135.46 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.21 -148.03 26.44 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.302 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' 1069 ' ' GLU . 7.0 pm0 -72.1 120.67 81.57 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.476 ' HA ' HD21 ' A' 1066 ' ' LEU . 62.7 Cg_endo -75.84 -25.73 10.31 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.747 2.298 . . . . 0.0 112.395 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 54.3 m -137.57 153.95 49.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.739 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' 1049 ' ' VAL . 36.1 pt -143.01 -169.07 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.098 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' 1085 ' ' SER . 0.4 OUTLIER -160.01 158.26 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.284 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.71 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 10.2 t -62.16 -51.92 65.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.458 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.459 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 15.3 t 45.59 -172.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.974 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.3 p -165.47 143.73 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.681 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.657 HD22 HD11 ' A' 1083 ' ' ILE . 26.1 p-10 -162.82 -45.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.737 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' 1079 ' ' ASP . 40.3 t0 -81.12 -146.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.49 ' H ' ' CG ' ' A' 1078 ' ' ASP . 36.3 m-20 -82.04 -137.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.761 ' HA ' HG23 ' A' 1023 ' ' ILE . 31.1 mt-30 -81.0 26.16 0.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' 1079 ' ' ASP . 17.7 t -77.58 -44.25 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.298 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 59.66 63.22 5.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.191 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.657 HD11 HD22 ' A' 1077 ' ' ASN . 34.4 pt -81.93 129.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.462 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.428 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 20.0 m95 -76.53 163.88 26.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.1 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.49 ' HB2' ' CE1' ' A' 1073 ' ' TYR . 43.8 t -48.62 -32.86 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.641 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.51 147.58 12.26 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.033 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.887 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 73.9 Cg_endo -75.38 49.42 2.36 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.988 2.459 . . . . 0.0 112.78 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 63.73 133.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.742 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.484 ' CG ' HD11 ' A' 1066 ' ' LEU . 56.1 Cg_endo -71.65 -149.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.116 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.417 ' H ' ' HB2' ' A' 1089 ' ' PRO . 50.0 mm-40 -151.93 117.93 5.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.724 0.297 . . . . 0.0 111.442 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1065 ' ' GLU . 28.1 p -103.11 88.39 3.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.248 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.408 ' HA ' ' HD1' ' A' 1064 ' ' PHE . 27.8 pt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.82 0.343 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.732 ' HG3' HD11 ' A' 1006 ' ' LEU . 71.9 mmtt -79.38 148.78 31.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.1 p -157.86 127.25 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.253 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.86 142.69 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.755 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.82 141.07 58.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.386 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.432 ' OG1' HD13 ' A' ' 980' ' ' ILE . 62.4 m -64.8 130.49 94.82 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 31.5 Cg_exo -59.35 120.51 8.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.188 1.925 . . . . 0.0 111.634 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 46.1 Cg_exo -55.97 -50.24 12.98 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.167 1.911 . . . . 0.0 111.659 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 59.2 t0 174.03 106.96 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.92 155.16 19.09 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.366 2.044 . . . . 0.0 111.232 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.7 ' HB ' ' HA ' ' A' 1019 ' ' ILE . 80.4 t -46.55 106.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.79 0.329 . . . . 0.0 111.445 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.509 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 33.3 m120 74.72 -53.98 0.67 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.078 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -79.5 138.34 20.22 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.274 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 86.7 mmm -81.87 -156.65 0.16 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 110.812 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 988' ' ' TYR . 3.3 p -159.29 148.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.441 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.15 109.84 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 43.3 t -65.33 105.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.624 HG13 HG23 ' A' ' 987' ' ' THR . 44.7 mm -75.23 -94.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.753 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.7 p -67.93 -65.99 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.492 ' OD1' HG12 ' A' ' 980' ' ' ILE . 46.7 t0 -165.71 -132.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.63 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.54 HG22 ' CH2' ' A' 1013 ' ' TRP . 1.6 pt -155.95 14.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.355 0.597 . . . . 0.0 110.33 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.4 171.24 10.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.353 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 61.9 t -47.51 141.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.646 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.38 -46.95 2.6 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.489 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 151.28 47.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.262 0.531 . . . . 0.0 110.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.878 ' HB3' ' HA ' ' A' 1003 ' ' GLU . 0.0 OUTLIER -138.43 -168.53 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 977' ' ' ILE . 23.6 pt -148.55 -160.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.97 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.624 HG23 HG13 ' A' ' 977' ' ' ILE . 68.5 p -142.03 124.55 15.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 112.028 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.473 ' HA ' HG23 ' A' ' 974' ' ' VAL . 1.3 m-85 -98.89 150.94 21.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.319 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 19.3 m -150.25 138.95 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.261 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.697 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 42.4 t -81.97 154.39 25.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.285 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 992' ' ' THR . 11.0 t -64.87 -139.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.392 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.557 HG23 ' N ' ' A' ' 993' ' ' GLY . 12.8 t -60.94 -142.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.045 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.557 ' N ' HG23 ' A' ' 992' ' ' THR . . . -63.42 75.35 0.04 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 113.971 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.645 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 37.6 m80 -145.94 140.81 27.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.508 HH22 ' HB3' ' A' 1079 ' ' ASP . 41.3 ttm-85 -81.96 118.98 23.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.996 0.427 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 990' ' ' CYS . 5.9 tp -76.2 126.09 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.964 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 996' ' ' LEU . 1.8 mp -107.83 150.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.794 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.58 54.58 4.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.677 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.56 -143.85 0.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.196 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m -160.81 27.27 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.031 0.443 . . . . 0.0 110.152 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 65.9 p -162.17 162.51 28.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.223 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.759 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -153.79 130.65 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.837 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.878 ' HA ' ' HB3' ' A' ' 985' ' ' ARG . 21.1 pt-20 -101.74 129.6 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.946 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.512 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 5.9 t -72.17 128.54 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.334 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.5 pt -145.55 169.36 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.103 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.732 HD11 ' HG3' ' A' ' 961' ' ' LYS . 4.0 mm? -81.57 146.43 30.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.938 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 71.2 m -159.8 59.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 104.99 51.39 0.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.166 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 58.87 24.97 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 110.399 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 71.4 m -151.32 139.21 19.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.679 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.512 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.33 136.7 40.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.959 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 40.7 m80 -149.47 141.32 23.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.759 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 70.6 m95 -67.75 123.6 20.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.127 0.489 . . . . 0.0 110.854 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 20.7 m -52.39 -24.44 7.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.947 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 55.2 p -103.65 142.02 35.05 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 61.5 pttt -62.61 149.74 88.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.868 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 120.99 9.16 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.304 2.003 . . . . 0.0 111.7 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.672 ' HB3' HD11 ' A' ' 996' ' ' LEU . 32.7 Cg_exo -59.18 145.29 98.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.829 2.353 . . . . 0.0 112.903 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.7 ' HA ' ' HB ' ' A' ' 970' ' ' VAL . 40.3 pt -140.05 130.4 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 74.2 m -86.35 108.93 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.181 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -81.62 130.49 35.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.524 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -71.65 120.14 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' 1079 ' ' ASP . 77.4 mt -67.24 110.97 6.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.741 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.06 125.22 17.51 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.898 2.399 . . . . 0.0 113.424 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.611 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 66.9 m -95.94 133.11 40.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.087 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -79.87 -154.0 8.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.394 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 138.99 94.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.788 0.328 . . . . 0.0 111.321 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.461 ' HB2' ' OH ' ' A' 1052 ' ' TYR . 51.1 Cg_endo -68.64 148.73 72.75 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.774 2.316 . . . . 0.0 112.048 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.759 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 34.7 Cg_exo -59.15 111.18 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.081 1.854 . . . . 0.0 111.476 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 26.9 p -77.52 122.46 25.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.641 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' 1032 ' ' ALA . 18.4 pt -88.59 29.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.851 0.358 . . . . 0.0 111.855 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 52.87 125.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.495 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' 1032 ' ' ALA . 77.1 m-20 71.43 -26.6 0.17 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.234 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -69.54 124.73 16.09 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.717 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' 1053 ' ' ARG . 1.5 m-20 -76.46 -159.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.657 0.265 . . . . 0.0 110.368 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' 1051 ' ' THR . 45.6 p90 -155.99 137.8 14.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.633 HD11 HH11 ' A' 1053 ' ' ARG . 20.3 mm -128.77 37.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.756 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 78.2 p -69.24 145.48 53.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.615 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 38.2 m -59.42 -38.37 80.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.694 HD22 ' HB3' ' A' 1048 ' ' SER . 23.4 p30 -72.19 -155.44 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.597 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' 1040 ' ' ASN . 18.3 mmt85 -162.2 -54.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.701 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' 1043 ' ' ASN . 42.0 tt0 -162.89 148.73 12.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' 1042 ' ' GLU . 75.4 m-20 78.12 65.2 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.59 134.92 39.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.308 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' 1046 ' ' TYR . 13.1 m80 -96.93 -51.52 4.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.555 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 69.7 t80 171.06 144.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.412 0.445 . . . . 0.0 110.55 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 76.5 -14.54 6.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.221 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.694 ' HB3' HD22 ' A' 1040 ' ' ASN . 65.5 m -47.36 136.15 9.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.033 0.444 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' 1038 ' ' SER . 88.7 t -102.19 146.88 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.224 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.756 ' HA ' ' HB3' ' A' 1038 ' ' SER . 30.8 m -142.57 126.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.398 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' 1036 ' ' PHE . 59.1 m -100.49 108.69 20.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.461 ' OH ' ' HB2' ' A' 1028 ' ' PRO . 21.0 m-85 -77.08 163.13 26.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.307 0.575 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.734 ' HB2' ' HB2' ' A' 1035 ' ' ASP . 75.6 mtp180 -142.76 -138.96 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.655 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.526 ' O ' HD23 ' A' 1056 ' ' LEU . 48.7 t -163.7 145.42 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 111.686 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.1 68.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.243 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.568 ' HA ' HG23 ' A' 1063 ' ' VAL . 3.7 mm? -72.22 41.91 0.09 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 53.37 -106.15 0.39 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.525 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.546 ' HB2' ' HD3' ' A' 1061 ' ' ARG . 66.8 m -67.37 -48.28 67.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' 1059 ' ' ARG . 11.6 tpt180 -165.83 -49.85 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.044 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.515 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -164.38 39.91 0.31 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.752 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.666 ' N ' ' HD2' ' A' 1061 ' ' ARG . 0.7 OUTLIER -83.14 172.76 12.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 110.769 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 58.5 tttm -65.48 79.91 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' 1056 ' ' LEU . 6.9 m -155.14 92.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.637 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.664 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 0.8 OUTLIER 74.27 141.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.695 -178.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1065 ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.8 mt-10 -137.27 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.064 0.459 . . . . 0.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.617 HD21 ' HB3' ' A' 1070 ' ' PRO . 38.7 tp -68.44 152.09 45.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.156 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' 1089 ' ' PRO . 65.1 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 77.51 -168.37 54.39 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' 1069 ' ' GLU . 15.2 pm0 -72.05 126.85 91.13 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.617 ' HB3' HD21 ' A' 1066 ' ' LEU . 96.8 Cg_endo -82.17 -36.95 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.38 2.053 . . . . 0.0 111.87 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.8 p -83.81 140.87 31.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.179 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' 1049 ' ' VAL . 36.3 pt -147.78 -171.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.899 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.3 p90 -162.26 143.87 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.699 0.285 . . . . 0.0 111.386 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.929 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 52.1 t -66.51 154.15 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.075 0.464 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.2 t -147.59 -144.62 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.106 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.5 t -155.76 137.77 14.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.018 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' 1078 ' ' ASP . 36.7 p30 -166.58 31.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.757 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.7 t70 175.84 50.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.255 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.544 ' O ' HD13 ' A' 1023 ' ' ILE . 1.5 m-20 61.88 -125.24 0.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.515 ' HA ' HG23 ' A' 1023 ' ' ILE . 25.3 pt20 -66.01 -140.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.51 0.195 . . . . 0.0 110.71 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' 1080 ' ' GLN . 25.9 t 74.22 -45.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.992 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 66.36 62.61 4.5 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 74.3 mt -80.19 130.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 110.972 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.929 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 26.1 m95 -72.6 177.09 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.0 t -55.52 -64.2 0.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.684 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.57 131.66 1.6 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.628 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.759 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 93.7 Cg_endo -79.72 48.64 2.92 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.828 2.352 . . . . 0.0 111.698 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.689 ' N ' ' HD2' ' A' 1089 ' ' PRO . . . -62.57 -47.34 88.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.34 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' 1088 ' ' ALA . 4.9 Cg_endo -48.45 137.12 25.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.432 2.088 . . . . 0.0 112.112 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -149.89 132.99 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 15.2 t -102.49 137.79 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.415 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.353 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.645 0.26 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.592 ' O ' HG23 ' A' ' 982' ' ' VAL . 1.0 OUTLIER 55.86 47.11 20.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.439 . . . . 0.0 111.436 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 81.4 p -89.95 132.2 35.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.644 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 73.0 m -79.93 39.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.816 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.4 OUTLIER 60.58 116.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.595 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 51.0 m -59.84 112.81 5.89 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.081 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.497 ' HB2' HG21 ' A' ' 974' ' ' VAL . 27.2 Cg_exo -62.0 113.05 1.7 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.11 1.873 . . . . 0.0 111.761 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 26.5 Cg_endo -62.39 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.203 1.935 . . . . 0.0 111.277 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 967' ' ' PRO . 2.5 p30 176.19 119.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.823 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 37.4 Cg_endo -66.92 149.34 83.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.339 2.026 . . . . 0.0 111.267 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 98.6 t -40.65 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.826 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.567 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 30.5 m120 75.27 -51.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.662 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.56 -172.37 7.33 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.88 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.823 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 67.3 mtm -156.7 136.29 12.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.675 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.876 ' HB ' HD12 ' A' ' 986' ' ' ILE . 2.6 m -85.27 149.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.475 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 1.9 m-70 -114.93 104.0 11.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.75 ' HA ' HG22 ' A' ' 986' ' ' ILE . 59.5 t -70.43 92.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.043 0.449 . . . . 0.0 110.333 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.18 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.881 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 38.0 p -71.53 -68.83 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.343 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 18.6 t70 -165.67 -153.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.353 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.651 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.4 pt -155.94 11.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.618 0.247 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.648 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 89.3 mt-30 -87.22 30.81 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 67.4 t 100.61 143.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.553 0.741 . . . . 0.0 111.762 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.87 -46.22 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.626 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.488 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 57.9 m -68.41 150.79 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.569 ' HD2' ' H ' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -138.4 135.87 35.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.228 0.537 . . . . 0.0 111.113 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.876 HD12 ' HB ' ' A' ' 974' ' ' VAL . 20.1 pt -91.06 -163.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.226 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 45.5 p -146.38 123.72 11.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.004 0.43 . . . . 0.0 111.561 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.647 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.6 OUTLIER -91.86 151.12 20.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.565 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.8 p -155.18 125.7 6.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 61.3 m -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 994' ' ' HIS . 62.5 p 27.94 -143.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.054 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 7.3 t -117.32 -24.72 7.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.396 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -135.5 45.49 1.1 Allowed Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.111 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.402 ' HB2' ' OG1' ' A' ' 991' ' ' THR . 27.5 m80 -139.91 144.92 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.693 0.283 . . . . 0.0 110.589 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' 1079 ' ' ASP . 43.7 ttm-85 -81.97 125.97 31.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.671 HD13 ' OG ' ' A' 1000 ' ' SER . 7.0 tt -76.24 123.14 25.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.695 ' HB ' HG13 ' A' 1019 ' ' ILE . 51.7 mm -86.64 148.42 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.402 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.79 -107.04 2.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.832 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' 1001 ' ' SER . 91.2 m-70 -149.76 133.02 16.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 996' ' ' LEU . 15.6 m -78.43 27.41 0.2 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.522 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 999' ' ' HIS . 81.4 p -162.22 145.77 11.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.451 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.98 132.27 10.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.411 . . . . 0.0 111.435 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -104.95 133.53 49.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.197 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 53.1 t -73.46 129.39 37.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' 1012 ' ' HIS . 38.1 pt -130.49 -167.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.802 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.573 HD13 ' N ' ' A' 1007 ' ' SER . 0.4 OUTLIER -142.95 127.06 17.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.895 0.379 . . . . 0.0 110.79 -179.089 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.573 ' N ' HD13 ' A' 1006 ' ' LEU . 56.5 p -81.75 -59.4 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.856 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.52 35.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 50.6 t-20 178.77 -37.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 110.361 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 27.6 m -149.98 142.73 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.644 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.31 141.18 43.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.226 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.9 p80 -149.68 147.19 27.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.3 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.651 ' HH2' HG22 ' A' ' 980' ' ' ILE . 84.2 m95 -67.19 129.61 40.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 111.021 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.4 p -52.37 -27.16 14.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.865 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 75.9 p -107.99 138.35 44.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -58.23 152.38 42.3 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.5 103.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.381 2.054 . . . . 0.0 112.532 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.1 154.35 72.7 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.993 2.462 . . . . 0.0 111.767 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 997' ' ' ILE . 37.1 pt -135.84 -147.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.403 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 971' ' ' ASN . 23.0 m -143.06 -178.78 6.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -166.86 126.54 1.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -74.3 120.71 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.35 119.51 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.213 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.06 122.45 7.64 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.188 1.926 . . . . 0.0 111.758 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 28.8 m -88.41 134.93 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.591 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 161.79 52.24 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.051 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.567 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 10.4 mt -49.75 138.83 17.01 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 117.018 0.409 . . . . 0.0 111.895 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.497 ' HB3' ' CD2' ' A' 1084 ' ' TRP . 59.2 Cg_endo -70.85 150.31 61.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.893 2.396 . . . . 0.0 111.516 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 83.4 Cg_exo -47.01 126.12 10.89 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.415 2.077 . . . . 0.0 111.985 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.0 p -77.53 126.56 31.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' 1034 ' ' GLY . 6.7 tt -88.59 111.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -67.11 141.77 57.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 68.84 26.93 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.308 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.779 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -175.34 135.06 2.9 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.28 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -74.17 -155.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.572 ' HB2' ' CG1' ' A' 1050 ' ' VAL . 49.0 p90 -156.0 131.89 9.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 111.251 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.546 HG13 ' CZ ' ' A' 1053 ' ' ARG . 47.9 mm -91.3 99.97 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.822 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 44.3 t -171.12 146.58 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.911 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 90.9 m -58.94 -33.61 70.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -56.53 128.39 35.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -151.69 -31.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.635 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -147.16 -51.73 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.163 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -71.57 135.71 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.567 ' HE2' ' HG ' ' A' 1027 ' ' LEU . 0.1 OUTLIER -162.21 55.09 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' 1046 ' ' TYR . 12.2 m80 -63.5 -47.9 79.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.196 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' 1045 ' ' HIS . 74.0 t80 172.37 161.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.53 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.9 -24.11 3.47 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 49.7 m -47.59 143.87 3.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 110.92 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -142.47 123.53 11.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.782 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.822 ' HA ' ' HB2' ' A' 1038 ' ' SER . 98.1 t -106.55 129.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.042 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.7 m -99.43 125.05 45.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.632 ' HB2' HD11 ' A' 1066 ' ' LEU . 4.6 m-85 -72.24 146.79 47.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.546 ' CZ ' HG13 ' A' 1037 ' ' ILE . 38.3 ttm180 -146.11 -29.24 0.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.779 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 47.7 t 65.44 160.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.483 ' N ' ' HA2' ' A' 1034 ' ' GLY . 22.9 m120 -62.13 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.584 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.763 ' HB3' ' HA2' ' A' 1060 ' ' GLY . 23.0 mt -154.94 27.0 0.43 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.285 0.564 . . . . 0.0 110.65 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' 1063 ' ' VAL . . . 53.71 -113.15 2.89 Favored Glycine 0 C--N 1.317 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.859 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 49.3 m -51.44 -50.48 59.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -167.7 -53.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.352 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.763 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . -176.89 38.2 0.09 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.942 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' 1061 ' ' ARG . 34.6 ttm180 -93.86 33.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' 1062 ' ' LYS . 26.2 ttpp 41.09 52.19 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.172 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.722 HG23 ' HD1' ' A' 1064 ' ' PHE . 16.1 m -85.02 -39.27 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.253 0.549 . . . . 0.0 110.728 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.722 ' HD1' HG23 ' A' 1063 ' ' VAL . 2.9 m-85 -85.96 147.76 26.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.066 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -134.44 128.91 34.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 111.658 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' 1067 ' ' VAL . 4.5 tt -68.6 140.31 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.309 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.875 ' N ' HD23 ' A' 1066 ' ' LEU . 78.5 t -135.49 109.51 10.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 111.142 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1068 ' ' GLY . . . . . 0.558 ' O ' ' HG3' ' A' 1089 ' ' PRO . . . 76.98 156.55 7.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.754 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 38.2 tt0 30.37 77.39 0.32 Allowed Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' 1066 ' ' LEU . 90.0 Cg_endo -86.66 7.39 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.588 2.192 . . . . 0.0 112.473 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 53.1 m -156.23 150.01 24.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.387 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' 1049 ' ' VAL . 15.5 pt -148.0 150.15 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.635 ' HB3' HG23 ' A' 1049 ' ' VAL . 2.8 p90 -160.12 145.67 15.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.601 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.919 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 42.0 t -66.28 144.12 56.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.7 t -144.07 -7.55 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' 1082 ' ' GLY . 57.8 m 66.11 136.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.308 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -172.18 43.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -170.07 -122.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.453 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' 1081 ' ' VAL . 9.5 t70 -163.09 121.48 2.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.771 0.319 . . . . 0.0 110.757 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.467 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 86.7 mt-30 55.88 42.35 28.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' 1079 ' ' ASP . 21.1 t -147.59 -38.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 110.46 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 76.73 -68.96 2.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.753 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 75.5 mt 60.57 130.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.981 0.419 . . . . 0.0 111.202 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.919 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.6 m95 -74.58 -153.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -62.96 -46.84 85.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.501 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . 178.66 -149.05 8.69 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.906 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' 1029 ' ' PRO . 10.4 Cg_exo -71.57 -127.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.387 2.725 . . . . 0.0 112.74 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . -159.33 138.84 8.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 58.5 Cg_endo -68.36 -138.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.505 2.803 . . . . 0.0 113.105 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.452 ' H ' ' HB2' ' A' 1089 ' ' PRO . 16.4 tt0 -152.4 143.51 23.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.177 0.513 . . . . 0.0 111.734 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 42.6 t -103.13 139.38 38.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.573 HD11 HG21 ' A' 1067 ' ' VAL . 11.9 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.127 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.803 0.335 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -77.51 140.97 39.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 83.6 p -155.41 139.85 16.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.464 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.0 m -80.0 140.85 36.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.268 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.93 148.66 49.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.008 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 41.8 m -39.71 119.66 1.37 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.537 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.78 ' HG2' HG11 ' A' ' 974' ' ' VAL . 11.2 Cg_endo -55.03 127.2 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.358 2.039 . . . . 0.0 111.725 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.14 125.14 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.038 1.825 . . . . 0.0 111.37 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.06 120.03 11.17 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.457 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.554 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 77.2 Cg_exo -50.51 140.34 35.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.479 2.119 . . . . 0.0 112.247 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.657 ' HB ' ' H ' ' A' 1020 ' ' CYS . 66.9 t -47.03 110.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.508 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 32.9 m120 75.66 -45.91 0.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.581 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -72.62 -156.02 3.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.896 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.554 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 94.9 mmm -158.85 143.3 15.69 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.51 0.324 . . . . 0.0 110.418 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.78 HG11 ' HG2' ' A' ' 966' ' ' PRO . 0.5 OUTLIER -91.61 144.73 8.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.387 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -117.06 107.96 15.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.736 0.303 . . . . 0.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.766 ' HA ' HG22 ' A' ' 986' ' ' ILE . 57.3 t -66.42 119.59 11.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.943 HD11 HG23 ' A' ' 987' ' ' THR . 31.3 mt -84.43 -89.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.802 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 30.9 p -75.25 -69.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.54 ' H ' ' HB2' ' A' ' 984' ' ' SER . 2.6 m-20 -153.13 -147.57 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.95 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.434 HG22 ' CH2' ' A' 1013 ' ' TRP . 12.1 pt -155.95 25.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.705 0.288 . . . . 0.0 111.21 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 71.3 mt-30 -87.26 -55.75 3.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.474 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 981' ' ' GLN . 13.1 t -173.42 140.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 124.142 0.901 . . . . 0.0 109.469 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.24 -20.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.888 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.54 ' HB2' ' H ' ' A' ' 979' ' ' ASP . 81.1 p -68.34 129.15 39.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 48.3 ttm-85 -97.47 156.74 16.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 976' ' ' VAL . 28.2 pt -143.16 136.22 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.943 HG23 HD11 ' A' ' 977' ' ' ILE . 59.4 p -91.0 126.24 36.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.06 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.917 ' HB2' ' HA ' ' A' 1000 ' ' SER . 2.4 m-85 -96.48 146.93 24.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 15.3 t -145.53 169.34 18.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.973 ' HB2' HD12 ' A' ' 996' ' ' LEU . 4.7 t -158.11 107.07 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 992' ' ' THR . 35.6 p 34.73 -150.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.971 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.4 t -117.91 -37.09 3.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.819 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' 1046 ' ' TYR . . . -118.05 48.9 0.9 Allowed Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.275 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -144.71 131.81 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.639 HH21 ' HA ' ' A' 1079 ' ' ASP . 39.1 ttm-85 -82.04 109.88 16.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.703 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.973 HD12 ' HB2' ' A' ' 990' ' ' CYS . 6.6 tt -76.44 113.69 14.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.564 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' 1019 ' ' ILE . 2.0 mp -90.11 91.41 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.922 0.868 . . . . 0.0 110.663 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -161.05 -113.71 0.32 Allowed Glycine 0 C--N 1.315 -0.621 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.023 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' 1000 ' ' SER . 92.8 m-70 -154.19 -10.43 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.917 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 19.4 m 57.58 18.52 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.432 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.603 ' O ' HG21 ' A' 1015 ' ' THR . 79.6 p -162.18 144.39 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.433 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -162.97 153.67 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.779 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' 1003 ' ' GLU . 11.2 pm0 -135.04 135.46 41.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.724 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.421 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 31.6 t -71.41 88.65 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.304 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.411 HG23 ' HG2' ' A' 1003 ' ' GLU . 37.8 pt -87.33 -167.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' 1008 ' ' GLY . 4.0 tt -158.38 121.89 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.417 ' N ' HD23 ' A' 1006 ' ' LEU . 44.3 t -77.51 -48.04 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.74 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.439 ' N ' HD23 ' A' 1006 ' ' LEU . . . 175.83 -45.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.793 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.32 -48.86 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.2 153.3 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.924 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.421 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.32 141.33 43.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.1 p80 -154.92 147.87 24.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.698 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.434 ' CH2' HG22 ' A' ' 980' ' ' ILE . 41.2 m95 -70.76 126.87 30.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 110.531 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 t -52.43 -25.54 10.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.788 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.603 HG21 ' O ' ' A' 1001 ' ' SER . 30.9 p -95.5 138.81 32.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.59 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 24.0 pttm -79.16 163.8 57.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.354 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 11.2 Cg_endo -54.28 120.0 7.28 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.086 1.858 . . . . 0.0 111.405 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.507 ' HB2' HD21 ' A' ' 996' ' ' LEU . 72.3 Cg_endo -76.66 136.22 16.92 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.769 2.313 . . . . 0.0 113.521 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.674 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 30.0 pt -116.37 124.07 72.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.657 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 84.6 m -91.12 121.46 32.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.575 ' HG2' HD13 ' A' ' 997' ' ' ILE . 96.9 mm-40 -86.52 129.92 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.166 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.616 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.01 129.68 40.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.677 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.1 mm -73.93 107.64 3.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.21 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 92.4 Cg_endo -81.4 123.57 4.43 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.297 1.998 . . . . 0.0 112.477 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' 1044 ' ' PHE . 73.3 m -88.64 132.97 34.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.202 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -82.93 -154.61 16.4 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.064 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' 1027 ' ' LEU . 1.7 mm? -72.75 144.9 86.34 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 120.711 0.291 . . . . 0.0 111.519 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.593 ' O ' HG23 ' A' 1030 ' ' THR . 27.1 Cg_endo -61.45 166.65 11.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.879 2.386 . . . . 0.0 112.284 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' 1086 ' ' GLY . 81.9 Cg_exo -47.98 -24.35 5.2 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.757 2.305 . . . . 0.0 112.449 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1030 ' ' THR . . . . . 0.593 HG23 ' O ' ' A' 1028 ' ' PRO . 46.4 p 56.91 144.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.733 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.78 HD13 ' HB1' ' A' 1088 ' ' ALA . 2.9 pt -152.88 117.97 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -70.11 67.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.148 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' 1034 ' ' GLY . 15.0 p30 -174.25 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.609 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -79.25 -177.18 49.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.367 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' 1053 ' ' ARG . 3.2 m-20 -156.47 132.65 9.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 5.1 p90 -84.02 152.71 24.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.425 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.508 HD13 ' O ' ' A' 1036 ' ' PHE . 39.1 mm -127.71 66.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' 1050 ' ' VAL . 9.6 t -171.08 -141.52 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' 1040 ' ' ASN . 39.7 m -67.57 -103.92 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.72 ' HB2' HG11 ' A' 1050 ' ' VAL . 0.4 OUTLIER 50.1 118.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' 1040 ' ' ASN . 22.0 mmt180 -164.57 -69.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.242 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -156.62 -51.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.188 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -72.87 61.58 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.75 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' 1025 ' ' CYS . 73.1 m-85 -76.72 -58.08 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.314 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.74 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 7.2 m80 55.54 -172.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.53 ' CZ ' ' HA3' ' A' ' 993' ' ' GLY . 34.4 t80 -56.9 142.78 40.11 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.48 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.433 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.47 124.34 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' 1073 ' ' TYR . 38.2 m 178.37 144.55 0.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.374 0.67 . . . . 0.0 110.041 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' 1072 ' ' ILE . 11.2 p -155.83 145.32 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' 1040 ' ' ASN . 27.3 m -149.54 141.88 17.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.638 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.5 m -88.68 124.46 34.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.327 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' A' 1070 ' ' PRO . 11.3 m-85 -85.26 147.95 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.722 0.772 . . . . 0.0 112.789 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' 1035 ' ' ASP . 43.1 ttt85 -148.71 129.75 14.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.29 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 12.8 t -76.44 153.54 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.675 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -49.19 -70.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.02 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.817 HD22 ' HA2' ' A' 1060 ' ' GLY . 4.3 mt 62.37 164.99 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.403 ' C ' ' HG ' ' A' 1058 ' ' SER . . . -82.8 42.25 2.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.394 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' 1059 ' ' ARG . 84.0 p 49.73 29.12 2.99 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.349 . . . . 0.0 111.391 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' 1058 ' ' SER . 0.7 OUTLIER -152.77 -37.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.817 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 98.08 46.36 2.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.702 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' 1061 ' ' ARG . 13.5 tpp85 -76.93 40.2 0.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' 1062 ' ' LYS . 24.7 ttmm 44.17 35.04 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.528 0.68 . . . . 0.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.755 HG23 ' HD1' ' A' 1064 ' ' PHE . 11.3 m -95.9 -10.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.755 ' HD1' HG23 ' A' 1063 ' ' VAL . 88.3 m-85 -153.93 141.48 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.606 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -142.16 119.14 11.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.01 0.433 . . . . 0.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' 1067 ' ' VAL . 5.5 tt -73.42 130.16 39.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.64 ' N ' HD23 ' A' 1066 ' ' LEU . 7.5 p -156.64 73.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.038 0.923 . . . . 0.0 110.88 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1068 ' ' GLY . . . . . 0.837 ' HA3' ' HA ' ' A' 1089 ' ' PRO . . . -172.64 23.05 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.218 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.729 ' HB3' ' O ' ' A' 1068 ' ' GLY . 7.8 tt0 81.99 104.4 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.629 ' HA ' ' HB2' ' A' 1052 ' ' TYR . 89.0 Cg_endo -82.96 31.64 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.912 2.408 . . . . 0.0 113.229 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.9 p -158.86 134.65 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.561 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' 1049 ' ' VAL . 42.2 pt -140.89 152.31 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.06 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' 1048 ' ' SER . 9.9 p90 -146.77 137.08 23.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.421 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 41.7 t -75.18 148.01 39.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.229 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' 1082 ' ' GLY . 5.2 t -155.07 130.32 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.631 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' 1023 ' ' ILE . 80.9 p -75.66 153.72 37.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.327 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -165.34 -22.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -116.46 -128.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.216 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.639 ' HA ' HH21 ' A' ' 995' ' ' ARG . 54.5 m-20 -76.78 -150.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -85.53 29.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.044 0.45 . . . . 0.0 110.495 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 32.4 t -79.97 -35.45 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.489 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.65 ' C ' HD13 ' A' 1083 ' ' ILE . . . 85.09 -48.98 4.15 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.729 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.65 HD13 ' C ' ' A' 1082 ' ' GLY . 0.1 OUTLIER 39.38 118.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.643 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 22.2 m95 -72.23 138.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.507 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 79.8 p -64.46 -54.31 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -72.07 125.51 11.02 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.285 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.13 41.13 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.579 2.186 . . . . 0.0 112.953 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.78 ' HB1' HD13 ' A' 1031 ' ' ILE . . . 60.46 134.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.489 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.837 ' HA ' ' HA3' ' A' 1068 ' ' GLY . 40.4 Cg_endo -68.13 156.74 64.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.226 2.617 . . . . 0.0 113.71 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.473 ' H ' ' HA3' ' A' 1068 ' ' GLY . 9.9 tp-100 -104.69 114.73 29.12 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.797 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 48.1 t -97.29 132.15 43.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.327 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 7.0 pt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.422 -179.594 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.868 0.366 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.561 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 2.6 mppt? -77.63 137.35 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.94 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 86.5 p -82.09 136.29 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.598 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 87.8 m -79.96 34.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 962' ' ' SER . 86.3 tttt 62.73 139.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.71 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.4 m -61.61 124.75 82.55 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.336 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.413 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 17.0 Cg_exo -68.05 118.29 5.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.6 2.2 . . . . 0.0 112.561 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 135.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 111.271 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -48.39 104.28 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.19 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 54.7 Cg_endo -69.15 -151.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.607 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' 1019 ' ' ILE . 45.5 t -52.76 73.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.812 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 969' ' ' PRO . 75.5 m-20 72.57 -35.85 0.34 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.44 130.35 26.18 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.923 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.1 mtp -92.27 145.5 24.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.621 ' CG2' HD12 ' A' ' 986' ' ' ILE . 3.1 p -84.88 151.15 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -114.02 99.33 7.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 980' ' ' ILE . 39.2 t -75.31 85.65 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.75 -92.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.778 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 23.3 p -61.84 -65.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -159.16 -136.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.578 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.559 HG23 HG13 ' A' ' 976' ' ' VAL . 6.5 pt -154.31 -19.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.06 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.94 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 85.6 mt-30 -73.01 175.8 6.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.654 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' 1004 ' ' CYS . 64.2 t -44.29 147.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.832 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.86 -36.82 1.89 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.354 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 43.1 t -68.38 158.86 32.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 0.0 111.092 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.699 ' HE ' ' HB2' ' A' 1003 ' ' GLU . 39.4 ttm180 -145.16 120.75 10.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.8 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.621 HD12 ' CG2' ' A' ' 974' ' ' VAL . 18.8 pt -97.16 -168.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.351 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 73.7 p -153.09 124.09 7.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.0 m-85 -94.76 154.47 17.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.184 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 72.5 p -152.91 127.47 9.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.111 0.482 . . . . 0.0 111.13 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 73.3 m -82.94 148.13 27.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.052 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 26.1 p -62.06 157.65 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.182 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 60.7 m -48.68 138.29 11.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.583 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.543 ' O ' HD12 ' A' 1023 ' ' ILE . . . 95.9 -41.86 2.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.572 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -82.41 133.46 35.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.979 0.389 . . . . 0.0 111.286 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.727 ' HB2' HD11 ' A' 1023 ' ' ILE . 40.5 ttt85 -82.25 120.65 25.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.851 HD21 ' HB3' ' A' 1000 ' ' SER . 7.3 tp -65.97 124.47 22.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.177 0.513 . . . . 0.0 111.804 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' 1019 ' ' ILE . 46.7 mm -107.83 145.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.919 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.45 169.92 30.29 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.458 ' O ' ' HG3' ' A' 1018 ' ' PRO . 88.5 m-70 -74.98 125.56 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 0.0 111.587 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.851 ' HB3' HD21 ' A' ' 996' ' ' LEU . 81.6 p -68.18 -46.8 69.69 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.066 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.6 p -77.93 139.77 39.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.64 127.62 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.282 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.699 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 43.4 tt0 -98.02 132.09 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.709 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 52.9 t -66.7 94.54 0.3 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 22.2 pt -90.07 -155.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.872 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' 1008 ' ' GLY . 2.0 tm? -149.96 124.21 9.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.599 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.467 ' N ' HD13 ' A' 1006 ' ' LEU . 46.1 t -80.53 -48.4 12.82 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.509 ' N ' HD13 ' A' 1006 ' ' LEU . . . -161.44 -54.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.305 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -123.53 -52.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.1 m -88.9 144.34 26.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.29 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.598 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.24 145.02 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.044 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.478 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 93.3 m-70 -149.17 140.69 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.456 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 82.5 m95 -68.12 135.68 52.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 m -52.34 -24.68 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.184 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 53.4 p -132.94 137.59 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 111.817 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -56.51 150.1 36.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.06 117.99 2.16 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.342 2.028 . . . . 0.0 112.521 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.502 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 72.5 Cg_exo -51.06 138.35 43.91 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.693 2.262 . . . . 0.0 112.063 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 997' ' ' ILE . 0.0 OUTLIER -110.08 139.7 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.41 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.686 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 63.0 m -97.68 128.91 44.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.816 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 995' ' ' ARG . 33.0 tp60 -82.17 125.52 31.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.314 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.4 tpt180 -67.71 -26.36 66.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.727 HD11 ' HB2' ' A' ' 995' ' ' ARG . 49.7 mt 58.24 61.53 5.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.245 0.545 . . . . 0.0 109.678 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.652 ' HA ' ' N ' ' A' 1046 ' ' TYR . 38.1 Cg_endo -65.68 138.49 54.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.13 2.553 . . . . 0.0 114.008 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.491 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 38.5 m -88.43 141.23 28.71 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.744 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.19 -153.36 4.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.143 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.95 155.51 91.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.113 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.657 ' O ' HG23 ' A' 1030 ' ' THR . 31.2 Cg_exo -58.01 154.48 38.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.265 . . . . 0.0 111.879 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.547 ' HD2' ' OH ' ' A' 1052 ' ' TYR . 55.3 Cg_exo -51.13 -17.3 3.55 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.435 2.09 . . . . 0.0 112.274 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1030 ' ' THR . . . . . 0.657 HG23 ' O ' ' A' 1028 ' ' PRO . 73.8 p 49.08 94.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.663 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' 1031 ' ' ILE . 29.5 pt -84.1 104.3 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . 43.03 -139.36 0.21 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -79.64 41.74 0.5 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.44 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.68 -141.43 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.361 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' 1036 ' ' PHE . 19.6 t70 -168.03 -159.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.32 . . . . 0.0 110.795 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.73 ' CD1' HG23 ' A' 1050 ' ' VAL . 1.4 t80 -156.0 125.82 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.221 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' 1036 ' ' PHE . 4.3 mp -143.98 70.46 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.148 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 40.4 t -159.63 -119.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' 1040 ' ' ASN . 65.3 p -140.5 111.73 7.19 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.832 0.348 . . . . 0.0 111.917 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.503 ' HB2' ' CE2' ' A' 1044 ' ' PHE . 0.5 OUTLIER 165.31 130.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.062 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' 1043 ' ' ASN . 84.0 mtm180 -153.17 117.25 4.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.745 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.564 ' N ' ' HE1' ' A' 1044 ' ' PHE . 0.5 OUTLIER 53.1 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.551 179.051 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' 1041 ' ' ARG . 72.1 m-20 -70.37 65.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.13 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.643 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 1.9 m-85 -76.79 135.69 38.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.335 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.525 ' HA ' ' CB ' ' A' 1024 ' ' PRO . 52.0 m-70 -141.91 -165.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.553 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.652 ' N ' ' HA ' ' A' 1024 ' ' PRO . 10.5 t80 -58.02 139.25 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.414 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 64.87 111.18 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.453 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' 1073 ' ' TYR . 79.6 p 176.54 128.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.265 0.555 . . . . 0.0 110.521 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' 1073 ' ' TYR . 97.4 t -102.16 147.04 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.965 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.73 HG23 ' CD1' ' A' 1036 ' ' PHE . 12.3 p -138.46 126.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.927 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' 1037 ' ' ILE . 87.9 m -101.04 117.32 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 111.559 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.547 ' OH ' ' HD2' ' A' 1029 ' ' PRO . 4.8 m-85 -83.94 134.71 34.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.186 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.464 ' O ' ' HE2' ' A' 1062 ' ' LYS . 50.9 mtp85 -148.19 25.02 1.02 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.812 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.57 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 57.9 m 58.78 150.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.443 ' O ' ' ND2' ' A' 1055 ' ' ASN . 0.3 OUTLIER -68.29 39.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.576 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.585 ' HA ' ' HA ' ' A' 1062 ' ' LYS . 0.4 OUTLIER 27.59 50.56 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.681 ' HA2' ' HE1' ' A' 1064 ' ' PHE . . . 73.7 -40.02 0.95 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.269 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 47.0 t -169.87 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.906 0.353 . . . . 0.0 111.274 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.643 ' N ' ' HD3' ' A' 1059 ' ' ARG . 0.0 OUTLIER -163.0 -28.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.451 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' 1056 ' ' LEU . . . -151.02 149.39 21.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.837 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' 1056 ' ' LEU . 44.5 ttm-85 71.61 116.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' 1056 ' ' LEU . 40.1 ttmt -72.99 146.0 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 28.5 m -143.87 -22.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 4.7 m-85 -73.82 -26.36 60.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.72 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1065 ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' 1062 ' ' LYS . 58.5 mm-40 61.39 111.66 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.751 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.781 HD22 ' H ' ' A' 1067 ' ' VAL . 3.2 tm? -71.23 149.48 46.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.323 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.781 ' H ' HD22 ' A' 1066 ' ' LEU . 21.3 t -129.56 138.57 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.95 -153.94 42.55 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.536 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.545 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.0 pt-20 -72.11 113.46 20.69 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-O 120.504 0.192 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' A' 1051 ' ' THR . 93.2 Cg_endo -84.67 24.41 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.274 1.982 . . . . 0.0 112.929 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' 1050 ' ' VAL . 40.4 t -158.87 142.11 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 111.678 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.503 HG12 ' HE1' ' A' 1052 ' ' TYR . 42.2 pt -141.92 -177.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.482 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.799 ' HB3' HG22 ' A' 1049 ' ' VAL . 2.3 p90 -160.21 151.09 18.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 32.3 t -62.14 149.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.611 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 -27.44 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.646 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 58.3 m 58.78 54.3 5.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -63.84 -43.04 97.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.173 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -74.15 -82.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.395 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' 1081 ' ' VAL . 2.2 p30 -163.18 -135.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.026 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.529 ' HA ' HG23 ' A' 1023 ' ' ILE . 28.6 mt-30 -68.34 12.17 0.14 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' 1079 ' ' ASP . 14.0 t -68.04 -43.56 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.311 0.577 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . 82.57 42.06 8.65 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.471 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 62.7 mt -82.02 142.3 13.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.668 0.271 . . . . 0.0 110.295 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.47 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 28.4 m95 -70.5 -163.97 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.358 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.458 ' OG ' ' HB ' ' A' 1072 ' ' ILE . 81.6 p -65.02 -63.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 177.86 127.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.224 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.41 140.62 70.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.518 2.145 . . . . 0.0 111.537 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.709 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -165.69 -50.88 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.611 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.709 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.4 Cg_endo -52.36 145.55 35.71 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.395 2.063 . . . . 0.0 111.76 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -152.37 136.8 16.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.662 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 94.7 m -91.9 123.15 35.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.015 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.662 -179.308 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.889 0.376 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.674 ' HA ' ' HE3' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -77.58 134.01 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.113 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 25.1 m -154.4 135.0 13.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 92.8 m -79.92 136.62 36.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -63.78 138.68 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.458 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 7.1 t -57.44 122.65 56.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.842 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.871 ' HG2' HG11 ' A' ' 974' ' ' VAL . 42.4 Cg_endo -66.95 107.62 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.384 2.056 . . . . 0.0 111.98 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 965' ' ' THR . 26.4 Cg_exo -61.69 134.6 51.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.549 2.166 . . . . 0.0 111.694 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -53.26 106.97 0.73 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.777 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 97.4 Cg_endo -82.34 -150.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.534 2.156 . . . . 0.0 112.903 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 970' ' ' VAL . 1.4 p -48.94 83.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.52 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 969' ' ' PRO . 76.6 m-20 69.83 -28.37 0.17 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.73 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.4 147.27 46.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.444 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 63.4 mtm -143.19 131.8 22.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 110.413 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.991 HG21 HD12 ' A' ' 986' ' ' ILE . 3.3 p -87.4 154.03 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.366 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -114.7 100.02 7.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.774 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 986' ' ' ILE . 35.6 t -65.73 106.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.6 mt -75.27 -94.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 22.0 p -72.44 -56.35 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 0.0 110.144 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 976' ' ' VAL . 5.7 p-10 -165.75 -131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.563 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.517 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 1.8 pt -153.59 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.017 0.437 . . . . 0.0 111.113 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 70.6 mt-30 -87.33 -176.44 5.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.69 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 97.8 t -48.57 139.99 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.251 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.17 1.55 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 92.1 p -67.92 130.31 42.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.899 0.849 . . . . 0.0 111.127 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.716 ' HG2' ' HB3' ' A' 1003 ' ' GLU . 99.1 mtt180 -101.58 163.63 12.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.991 HD12 HG21 ' A' ' 974' ' ' VAL . 26.0 pt -150.68 139.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.083 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' 1000 ' ' SER . 81.1 p -102.95 122.25 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -92.33 155.51 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.263 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 996' ' ' LEU . 16.6 m -160.3 122.6 3.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.38 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.73 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 94.4 m -82.25 68.16 8.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 992' ' ' THR . 33.7 p 45.95 -155.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.479 . . . . 0.0 111.864 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 993' ' ' GLY . 13.6 t -97.4 -45.39 6.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.211 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 992' ' ' THR . . . -93.17 43.73 2.53 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.419 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' 1022 ' ' ARG . 56.1 m-70 -157.53 135.21 10.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.651 ' HG3' ' HG3' ' A' 1080 ' ' GLN . 77.7 ttt180 -82.19 129.68 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.7 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 4.0 tt -75.01 100.18 4.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.443 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.684 ' HB ' HG23 ' A' 1019 ' ' ILE . 26.6 mm -87.35 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.126 0.965 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -156.52 -118.55 0.58 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.291 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -153.08 109.92 3.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -57.2 -54.64 44.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.174 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.5 p -77.86 137.23 38.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.475 ' HB3' ' HE1' ' A' ' 988' ' ' TYR . . . -157.94 150.06 22.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.716 ' HB3' ' HG2' ' A' ' 985' ' ' ARG . 10.1 pt-20 -135.11 132.02 37.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.601 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 44.2 t -66.68 93.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.33 -168.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 11.0 tp -158.36 120.94 3.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 25.4 m -81.51 -55.17 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.085 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 164.57 47.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -175.61 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.08 0.467 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 82.3 m -151.35 146.7 26.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.018 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.601 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -72.94 135.92 45.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.437 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.45 145.05 26.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.703 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.517 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 58.9 m95 -69.68 128.2 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -52.47 -26.2 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 64.2 p -86.93 130.87 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.776 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.72 155.63 81.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.874 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 81.3 Cg_exo -41.42 112.44 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.154 1.902 . . . . 0.0 111.905 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.458 ' HG3' ' CD2' ' A' ' 988' ' ' TYR . 51.0 Cg_endo -69.9 129.1 16.88 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.928 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.684 HG23 ' HB ' ' A' ' 997' ' ' ILE . 8.1 tt -116.62 147.24 20.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.558 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.559 ' HB2' HG22 ' A' ' 970' ' ' VAL . 72.1 m -106.88 156.83 18.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -154.15 124.1 6.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.985 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.722 ' HD3' ' HB3' ' A' 1046 ' ' TYR . 40.6 ttm180 -59.43 132.71 54.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.839 HD13 ' HA ' ' A' 1080 ' ' GLN . 68.1 mt -73.15 122.4 87.54 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.426 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' 1045 ' ' HIS . 96.2 Cg_endo -84.95 130.79 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.861 2.374 . . . . 0.0 112.532 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.512 ' HB3' ' NE1' ' A' 1084 ' ' TRP . 22.5 m -88.39 32.33 0.78 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.525 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1026 ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' 1044 ' ' PHE . . . 40.18 -130.69 2.77 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.287 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.921 HD12 ' HD2' ' A' 1028 ' ' PRO . 24.1 tp -121.94 126.56 26.3 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.921 ' HD2' HD12 ' A' 1027 ' ' LEU . 26.2 Cg_endo -61.42 156.26 47.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.824 2.349 . . . . 0.0 112.42 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.833 ' HG3' ' HA ' ' A' 1087 ' ' PRO . 19.2 Cg_endo -58.67 126.1 20.25 Favored 'Trans proline' 0 CA--C 1.518 -0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 112.036 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 17.9 m -93.27 151.19 19.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.016 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' 1034 ' ' GLY . 11.1 pt -142.57 134.58 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.261 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -67.86 163.99 20.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.514 ' HB3' ' SG ' ' A' 1054 ' ' CYS . 6.6 m120 76.8 -41.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.452 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -168.28 136.54 4.14 Favored Glycine 0 CA--C 1.507 -0.455 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.444 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.488 ' HB3' HG13 ' A' 1031 ' ' ILE . 2.8 p30 -171.17 142.71 1.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.069 0.462 . . . . 0.0 112.034 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 12.3 t80 60.4 115.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.349 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.625 HD12 ' HD3' ' A' 1053 ' ' ARG . 38.2 mt -152.09 60.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.143 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.767 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 22.9 t -163.78 -137.09 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.032 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' 1040 ' ' ASN . 85.9 m -111.64 128.09 55.95 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' 1039 ' ' THR . 0.2 OUTLIER 174.87 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.451 ' HG3' HH11 ' A' 1041 ' ' ARG . 52.7 mtt85 58.84 67.67 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.239 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.701 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 47.9 mt-10 58.87 -169.85 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' 1042 ' ' GLU . 29.4 m-20 76.62 -70.3 0.14 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.969 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.701 ' CE2' ' HA ' ' A' 1042 ' ' GLU . 7.6 m-85 52.66 47.27 25.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.97 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' 1024 ' ' PRO . 27.3 m80 -62.63 -51.5 67.05 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.039 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.787 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 62.4 t80 173.24 139.07 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 72.29 92.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.414 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.4 p 172.15 130.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' 1050 ' ' VAL . 11.3 p -102.25 156.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.997 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.767 ' HA ' ' HB3' ' A' 1038 ' ' SER . 18.8 m -149.15 130.13 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 40.2 m -89.93 110.42 21.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.437 ' CE1' HD11 ' A' 1072 ' ' ILE . 15.8 m-85 -85.22 135.79 33.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.453 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1053 ' ' ARG . . . . . 1.01 ' HA ' HD22 ' A' 1066 ' ' LEU . 41.2 mtp85 -146.28 -143.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.235 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.931 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 32.6 t -163.66 135.3 4.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -65.81 97.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.483 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.734 ' HG ' ' HA2' ' A' 1060 ' ' GLY . 0.0 OUTLIER -80.76 43.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.784 179.054 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.506 ' N ' ' HB ' ' A' 1063 ' ' VAL . . . 79.1 -62.48 4.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.296 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' 1059 ' ' ARG . 69.2 m -167.29 93.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.242 0.521 . . . . 0.0 111.686 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' 1059 ' ' ARG . 39.5 mmt-85 72.54 -42.24 0.53 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.734 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . 174.57 39.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.531 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' 1061 ' ' ARG . 35.9 ttm180 -83.96 32.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 42.47 83.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.607 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' 1056 ' ' LEU . 6.0 t -149.99 89.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.629 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 29.8 m-85 71.21 90.35 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -90.74 136.26 33.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1066 ' ' LEU . . . . . 1.01 HD22 ' HA ' ' A' 1053 ' ' ARG . 47.5 tp -68.35 155.96 38.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.607 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' 1089 ' ' PRO . 72.5 t -142.62 139.82 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.926 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 86.0 -158.91 32.26 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.417 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.7 pt-20 -64.08 111.15 4.84 Favored Pre-proline 0 CA--C 1.528 0.107 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.587 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 94.8 Cg_endo -90.79 23.07 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.885 2.39 . . . . 0.0 113.152 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.4 p -157.64 143.79 17.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.437 HD11 ' CE1' ' A' 1052 ' ' TYR . 44.2 pt -148.16 171.12 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.137 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.5 p90 -161.67 145.3 12.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.787 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 4.2 t -66.04 144.98 56.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.907 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.4 t -144.41 -151.41 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.231 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.408 ' OG ' HD12 ' A' 1023 ' ' ILE . 44.9 t -161.29 131.34 4.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.016 0.436 . . . . 0.0 111.563 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' 1079 ' ' ASP . 42.6 p-10 178.96 -146.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.115 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 63.3 t0 52.48 -87.63 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' 1077 ' ' ASN . 11.6 p-10 -163.13 51.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.151 0.501 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.839 ' HA ' HD13 ' A' 1023 ' ' ILE . 3.5 mm100 65.42 41.24 4.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 25.4 t -94.05 -40.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' 1025 ' ' CYS . . . 86.28 47.15 5.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.238 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 35.6 pt -81.97 135.1 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.578 ' HZ2' ' HB3' ' A' 1044 ' ' PHE . 26.3 m95 -70.64 147.27 49.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.1 t -40.36 -36.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.581 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.94 150.05 16.43 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.442 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.833 ' HA ' ' HG3' ' A' 1029 ' ' PRO . 31.5 Cg_endo -63.01 157.54 48.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.884 2.389 . . . . 0.0 112.336 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.431 ' H ' ' CG ' ' A' 1029 ' ' PRO . . . -62.62 144.91 95.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.109 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.568 ' HB2' ' O ' ' A' 1067 ' ' VAL . 56.5 Cg_endo -68.0 -144.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.784 2.322 . . . . 0.0 112.271 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -152.41 136.33 16.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.064 0.459 . . . . 0.0 111.702 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 50.7 t -98.37 132.97 43.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 26.2 pt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.117 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.581 0.229 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' A' 1011 ' ' ALA . 15.3 tppt? 66.3 149.19 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.5 p -156.44 129.8 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.285 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' 1011 ' ' ALA . 2.0 p -84.63 35.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.893 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 963' ' ' CYS . 58.0 tptt 56.63 129.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.709 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 85.6 m -61.56 122.4 70.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.409 ' HB2' HG21 ' A' ' 974' ' ' VAL . 38.1 Cg_exo -57.73 110.24 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.287 1.991 . . . . 0.0 112.519 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.85 139.55 24.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.559 2.173 . . . . 0.0 111.47 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 11.7 p-10 -49.42 107.25 0.74 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 971' ' ' ASN . 6.3 Cg_exo -78.87 -146.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.064 2.509 . . . . 0.0 111.938 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.878 HG21 HG13 ' A' 1019 ' ' ILE . 64.4 t -49.1 81.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.434 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 991' ' ' THR . 22.0 p30 42.72 27.77 0.11 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.148 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.613 ' HA2' ' SG ' ' A' ' 990' ' ' CYS . . . -83.01 -161.11 30.23 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.858 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 45.4 ttm -159.17 114.55 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.629 ' CG2' HD12 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.9 144.22 9.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.284 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -119.75 91.72 3.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.148 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.674 ' HA ' HG22 ' A' ' 986' ' ' ILE . 64.0 t -66.47 103.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.179 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.2 mt -84.14 -92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 41.2 p -84.14 62.84 7.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 111.819 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.92 -153.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.706 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.47 HG22 ' HH2' ' A' 1013 ' ' TRP . 21.5 pt -155.81 26.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.945 0.403 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.629 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 22.6 pt20 -87.34 28.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.061 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 70.8 t 100.43 142.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 111.34 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 70.71 -7.46 5.2 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.234 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 34.9 m -68.33 160.05 30.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.273 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 985' ' ' ARG . 55.9 ttp85 -143.13 109.4 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.227 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 976' ' ' VAL . 27.2 pt -96.77 -174.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 65.9 p -149.43 131.3 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.709 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.4 m-85 -96.23 165.08 12.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.0 p -149.75 -40.56 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 111.408 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.613 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 12.8 t 71.26 177.99 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.893 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 971' ' ' ASN . 22.2 p -62.98 -161.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.321 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 993' ' ' GLY . 11.8 t -94.7 -44.94 7.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.145 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 992' ' ' THR . . . -94.62 39.05 2.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.411 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.66 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 45.3 m80 -149.08 132.76 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.952 0.376 . . . . 0.0 110.681 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' 1021 ' ' GLN . 79.1 ttt180 -82.01 123.4 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 997' ' ' ILE . 8.4 tp -71.25 132.16 44.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.712 HG13 ' HG2' ' A' 1021 ' ' GLN . 17.6 mm -132.13 62.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.628 0.728 . . . . 0.0 110.792 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . -154.27 33.51 0.71 Allowed Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.122 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 59.11 4.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 81.7 p 43.65 31.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.07 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.413 ' O ' HG21 ' A' 1015 ' ' THR . 83.2 p -162.23 151.12 15.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.528 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -158.04 128.94 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.335 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.81 127.22 47.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.812 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -77.48 82.29 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.611 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' 1014 ' ' SER . 46.3 pt -87.21 -152.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.535 ' C ' HD13 ' A' 1006 ' ' LEU . 3.0 tm? -141.9 121.12 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.441 ' N ' HD13 ' A' 1006 ' ' LEU . 45.5 m -93.42 -39.14 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.486 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.522 ' O ' HD11 ' A' 1006 ' ' LEU . . . -169.05 -126.27 0.84 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.084 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -68.38 8.2 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.224 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' 1008 ' ' GLY . 99.3 m -151.87 145.28 24.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 963' ' ' CYS . . . -75.31 147.95 39.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 41.9 m80 -149.43 149.92 31.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 111.539 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.47 ' HH2' HG22 ' A' ' 980' ' ' ILE . 60.8 m95 -81.11 117.25 21.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.197 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.61 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.1 p -53.35 -25.52 15.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.413 HG21 ' O ' ' A' 1001 ' ' SER . 82.2 p -86.93 141.81 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -65.72 150.1 96.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.371 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.31 115.32 2.11 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.124 1.883 . . . . 0.0 111.883 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.61 ' HG2' ' CE2' ' A' ' 988' ' ' TYR . 31.1 Cg_exo -61.12 140.5 89.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.913 2.409 . . . . 0.0 112.873 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.878 HG13 HG21 ' A' ' 970' ' ' VAL . 5.2 tt -129.78 136.48 58.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.725 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 64.6 m -97.25 126.08 42.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.541 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.712 ' HG2' HG13 ' A' ' 997' ' ' ILE . 99.1 mm-40 -75.77 124.34 27.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.62 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.81 -12.49 59.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' 1080 ' ' GLN . 53.5 mt 56.28 70.82 1.34 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 109.939 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' 1045 ' ' HIS . 9.4 Cg_endo -51.44 132.47 40.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.117 2.545 . . . . 0.0 113.519 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.705 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 3.0 m -86.43 -146.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1026 ' ' GLY . . . . . 0.526 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -153.24 -155.44 7.15 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.19 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' 1028 ' ' PRO . 75.4 mt -68.36 143.88 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.714 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.447 ' CG ' HG21 ' A' 1050 ' ' VAL . 20.5 Cg_exo -64.72 147.55 89.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 111.472 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.876 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 83.7 Cg_exo -47.34 113.38 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 112.213 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 68.5 p -77.6 140.45 39.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.495 HD13 ' HB1' ' A' 1088 ' ' ALA . 29.2 pt -151.32 31.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.559 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 52.04 117.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.376 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 1032 ' ' ALA . 75.6 m-20 74.74 -25.97 0.2 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.362 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' 1032 ' ' ALA . . . -70.7 68.77 0.76 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.702 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' 1036 ' ' PHE . 1.5 m-20 -68.75 -150.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.133 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.806 ' HB3' HG13 ' A' 1050 ' ' VAL . 12.3 p90 -155.99 141.6 17.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.559 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' 1037 ' ' ILE . 42.6 mm -92.62 63.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 69.2 m -159.98 -159.13 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 111.707 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 64.9 m -83.59 -92.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.553 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.61 ' OD1' ' HB3' ' A' 1048 ' ' SER . 73.3 m-80 54.06 -138.89 1.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 61.88 109.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' 1043 ' ' ASN . 16.6 pt-20 38.42 41.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.842 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' 1042 ' ' GLU . 72.3 m-80 -167.74 116.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.481 ' CE1' ' HA2' ' A' 1026 ' ' GLY . 0.8 OUTLIER -163.39 143.66 8.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' 1024 ' ' PRO . 16.9 m-70 -140.82 -58.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.449 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.715 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 48.3 t80 175.22 47.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.43 -25.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.032 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.61 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 63.3 m -47.62 147.69 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.262 0.554 . . . . 0.0 111.962 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.932 HG22 ' HB3' ' A' 1073 ' ' TYR . 69.2 t -137.62 145.98 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.124 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.806 HG13 ' HB3' ' A' 1036 ' ' PHE . 3.4 t -133.38 120.38 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.026 0.441 . . . . 0.0 112.183 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 76.7 m -100.23 119.44 38.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.196 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.559 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 26.5 m-85 -74.5 145.54 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.442 0.639 . . . . 0.0 112.431 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -150.99 -30.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.03 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1054 ' ' CYS . . . . . . . . . . . . . 9.6 t 70.31 142.68 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.115 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.442 ' O ' ' HE2' ' A' 1064 ' ' PHE . 12.6 t-20 -65.06 129.02 38.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.855 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.53 HD13 ' CZ ' ' A' 1064 ' ' PHE . 1.8 mm? -73.48 43.26 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.835 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 56.27 48.17 76.87 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' 1059 ' ' ARG . 45.6 t 58.02 39.23 26.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' 1058 ' ' SER . 23.9 mmm180 -157.54 -128.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.871 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -149.76 -26.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -57.74 147.6 27.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -65.2 133.02 50.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.973 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' 1063 ' ' VAL . 10.8 p -155.07 27.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.446 0.641 . . . . 0.0 111.137 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.53 ' CZ ' HD13 ' A' 1056 ' ' LEU . 0.4 OUTLIER -168.77 -175.3 2.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.672 -179.299 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1065 ' ' GLU . . . . . 0.553 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 72.4 mt-10 -150.11 122.39 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 110.592 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.676 HD21 ' HB3' ' A' 1070 ' ' PRO . 53.7 tp -68.56 119.67 13.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.698 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 85.0 t -101.62 86.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 62.1 -163.08 26.38 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.961 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' 1089 ' ' PRO . 29.9 tp10 30.25 58.43 0.89 Allowed Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.491 0.716 . . . . 0.0 112.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.676 ' HB3' HD21 ' A' 1066 ' ' LEU . 83.4 Cg_endo -80.75 2.76 8.3 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.473 2.115 . . . . 0.0 113.186 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 51.1 m -156.27 144.69 19.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' 1050 ' ' VAL . 19.5 pt -146.39 157.25 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.932 ' HB3' HG22 ' A' 1049 ' ' VAL . 0.3 OUTLIER -160.1 147.91 16.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.715 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 50.8 t -62.18 133.17 54.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.083 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 8.2 t -144.51 -20.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' 1079 ' ' ASP . 57.9 m 58.82 59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -72.96 31.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.708 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' 1076 ' ' SER . 64.3 t0 179.43 53.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' 1076 ' ' SER . 59.3 m-20 62.15 -127.65 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.196 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.741 ' OE1' HG23 ' A' 1081 ' ' VAL . 0.0 OUTLIER -66.19 -140.17 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 121.369 -0.133 . . . . 0.0 111.194 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.741 HG23 ' OE1' ' A' 1080 ' ' GLN . 33.4 t 75.74 -44.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.705 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 78.26 46.86 8.71 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.762 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.0 130.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.829 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.412 ' HB3' ' H ' ' A' 1085 ' ' SER . 15.3 m95 -72.87 -150.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.412 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -74.19 -41.68 61.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -178.06 153.24 12.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.506 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' 1069 ' ' GLU . 89.2 Cg_exo -46.41 153.82 1.05 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.876 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . -62.54 143.61 96.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.872 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.559 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 51.9 Cg_endo -67.72 -143.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.96 2.44 . . . . 0.0 112.181 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.698 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 50.4 mm-40 -135.46 125.0 25.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.975 0.417 . . . . 0.0 111.74 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 43.0 t -85.78 66.91 9.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.593 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.553 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 34.6 pt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.559 0.218 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER 61.88 145.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 50.3 m -153.74 132.48 12.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.054 0.454 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.439 ' HB3' ' C ' ' A' 1011 ' ' ALA . 14.5 p -79.89 140.54 36.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.677 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 1.1 tpmt? -63.73 146.29 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.267 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.619 ' H ' ' HE2' ' A' ' 964' ' ' LYS . 93.0 m -46.39 128.31 7.86 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.348 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.533 ' HD3' ' CZ2' ' A' 1013 ' ' TRP . 38.7 Cg_endo -66.65 130.94 24.64 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.18 1.92 . . . . 0.0 111.601 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.47 124.63 12.35 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.977 1.785 . . . . 0.0 111.428 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 32.2 m-20 -47.32 122.95 8.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.691 ' HB3' ' HB2' ' A' 1018 ' ' PRO . 6.6 Cg_endo -50.43 153.46 7.39 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 112.22 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.764 ' HB ' ' H ' ' A' 1020 ' ' CYS . 23.3 t -41.96 117.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.633 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.562 ' ND2' HG12 ' A' ' 970' ' ' VAL . 23.8 p30 41.91 46.3 3.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.938 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.611 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -159.11 133.7 3.48 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.736 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 22.3 ptp -97.66 150.37 21.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.977 0.418 . . . . 0.0 111.849 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 19.3 m -92.88 -157.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.409 ' N ' HG23 ' A' ' 974' ' ' VAL . 97.9 m-70 -157.8 100.58 1.76 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.28 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 980' ' ' ILE . 70.6 t -69.89 111.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.032 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 987' ' ' THR . 35.5 mt -84.93 -81.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.06 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 23.6 p -67.98 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.912 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.643 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.4 m-20 -163.26 17.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.587 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 979' ' ' ASP . 20.1 pt 52.1 28.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.269 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.34 160.08 18.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.386 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' 1004 ' ' CYS . 86.3 t -44.44 142.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.174 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.96 -33.8 1.93 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.134 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.604 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 49.4 m -68.48 177.38 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.878 0.339 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' 1002 ' ' ALA . 48.2 ttp85 -156.78 132.2 9.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.118 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.513 HG21 HG22 ' A' ' 980' ' ' ILE . 36.6 pt -96.56 -159.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 977' ' ' ILE . 40.6 p -152.17 128.38 10.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.631 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.857 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.1 OUTLIER -93.92 167.01 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 52.7 p -145.46 -43.39 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.611 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 36.3 t 74.05 164.88 0.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.061 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 992' ' ' THR . 11.3 t -60.77 -141.22 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.406 0.622 . . . . 0.0 112.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.597 HG23 ' N ' ' A' ' 993' ' ' GLY . 13.4 t -61.24 -137.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.82 -178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.597 ' N ' HG23 ' A' ' 992' ' ' THR . . . -70.6 30.39 0.48 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.573 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 17.1 m80 -83.34 129.14 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.473 0.637 . . . . 0.0 109.976 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.649 HH22 ' HB3' ' A' 1079 ' ' ASP . 33.1 ttm180 -81.9 91.59 6.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' A' 1000 ' ' SER . 2.4 pp -61.51 137.53 58.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.371 0.605 . . . . 0.0 110.71 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 998' ' ' GLY . 41.2 mm -100.13 160.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.785 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.4 12.49 81.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.709 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 84.3 m-70 71.02 138.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.884 ' HB3' HD21 ' A' ' 996' ' ' LEU . 83.5 p -80.53 41.15 0.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.808 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 13.1 t -162.13 159.67 26.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.19 132.51 3.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.602 ' HG3' HG23 ' A' 1005 ' ' ILE . 16.7 pt-20 -100.05 126.24 46.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.656 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 49.9 t -74.84 81.66 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.602 HG23 ' HG3' ' A' 1003 ' ' GLU . 46.1 pt -87.3 -157.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' 1009 ' ' ASN . 5.4 tt -158.43 124.36 4.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.481 ' N ' HD23 ' A' 1006 ' ' LEU . 50.1 m -77.56 -54.1 6.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.218 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.43 ' N ' HD23 ' A' 1006 ' ' LEU . . . 167.84 43.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.652 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.538 ' H ' HD21 ' A' 1006 ' ' LEU . 48.6 t30 -177.86 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 59.1 m -151.22 154.59 37.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.201 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.479 ' HB2' HG22 ' A' ' 982' ' ' VAL . . . -74.42 135.81 42.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.253 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.41 146.39 27.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.538 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 21.7 m95 -76.17 118.03 18.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.787 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.567 ' HB3' HD13 ' A' 1005 ' ' ILE . 90.4 p -52.95 -21.35 4.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.126 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 37.9 p -86.93 134.29 33.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.046 0.45 . . . . 0.0 111.771 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.19 152.36 88.32 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.3 125.56 7.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.691 ' HB2' ' HB3' ' A' ' 969' ' ' PRO . 96.7 Cg_endo -77.33 149.87 28.2 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.012 2.474 . . . . 0.0 113.459 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.621 HG22 HG23 ' A' ' 970' ' ' VAL . 32.7 pt -148.79 121.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.863 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.853 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 82.9 m -81.8 127.15 32.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.304 0.573 . . . . 0.0 112.196 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -84.33 129.48 34.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.145 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.686 ' NH1' ' HB3' ' A' 1046 ' ' TYR . 21.3 tpt85 -67.65 -10.29 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.582 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 995' ' ' ARG . 56.6 mt 51.74 64.59 7.56 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.607 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' 1045 ' ' HIS . 52.0 Cg_exo -53.72 124.12 15.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.542 2.161 . . . . 0.0 112.81 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.87 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 33.0 m -88.47 153.41 21.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.14 140.47 25.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.46 ' HA ' ' HZ ' ' A' 1044 ' ' PHE . 68.5 mt -41.57 142.01 1.09 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.977 0.389 . . . . 0.0 111.243 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.461 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 17.9 Cg_endo -57.68 140.21 92.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.083 1.855 . . . . 0.0 110.455 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.457 ' HD2' HD12 ' A' 1072 ' ' ILE . 99.5 Cg_exo -38.03 127.95 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.142 1.895 . . . . 0.0 111.493 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 70.2 p -76.62 137.35 39.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' 1091 ' ' CYS . 5.8 tt -147.46 107.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.574 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -64.43 143.41 57.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.173 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.509 ' HA ' ' OD1' ' A' 1055 ' ' ASN . 4.7 m120 76.76 -40.92 0.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.394 0.434 . . . . 0.0 111.264 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -74.76 72.64 1.52 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.672 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -68.81 133.44 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 111.076 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.595 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 22.4 p90 -84.01 150.68 25.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.246 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' 1037 ' ' ILE . 33.4 mm -110.32 58.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.513 ' H ' ' HD1' ' A' 1036 ' ' PHE . 68.6 m -162.89 -154.54 0.3 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.082 0.467 . . . . 0.0 111.869 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' 1038 ' ' SER . 41.7 p -86.1 -129.85 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.192 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.48 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 4.7 m120 59.65 44.91 13.76 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' 1041 ' ' ARG . 62.2 mtt-85 -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.543 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 63.29 37.28 11.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -179.5 128.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.923 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' 1025 ' ' CYS . 5.5 p90 -163.27 -41.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.625 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' 1046 ' ' TYR . 90.1 m-70 72.65 -36.58 0.36 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.686 ' HB3' ' NH1' ' A' 1022 ' ' ARG . 25.1 t80 170.63 148.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.422 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.59 94.36 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.827 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.438 ' HB3' ' ND2' ' A' 1040 ' ' ASN . 29.2 m 178.0 143.56 0.1 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.938 0.495 . . . . 0.0 109.966 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' 1073 ' ' TYR . 12.3 p -138.21 161.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.289 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' 1036 ' ' PHE . 29.5 m -146.42 137.08 18.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 34.9 m -102.21 120.24 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.977 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.576 ' CE2' HG21 ' A' 1031 ' ' ILE . 2.9 m-85 -72.83 156.23 39.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' 1054 ' ' CYS . 78.4 ttt180 -154.53 -30.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.59 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.622 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 54.4 m 68.59 146.35 0.05 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.077 0.465 . . . . 0.0 111.046 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.7 ' O ' ' HG ' ' A' 1056 ' ' LEU . 28.9 m120 -54.7 162.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.983 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' 1055 ' ' ASN . 3.3 mt -154.98 162.32 41.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.82 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.587 ' H ' ' HB3' ' A' 1061 ' ' ARG . . . -82.09 41.79 2.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.562 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 12.8 t 57.27 18.96 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -167.66 46.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.281 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.556 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 53.39 33.56 46.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.317 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.587 ' HB3' ' H ' ' A' 1057 ' ' GLY . 78.4 ttt180 -71.41 142.2 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 110.978 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.33 102.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.042 0.449 . . . . 0.0 110.413 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.69 HG22 ' HD1' ' A' 1064 ' ' PHE . 3.4 p -155.7 87.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.806 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.69 ' HD1' HG22 ' A' 1063 ' ' VAL . 80.5 m-85 70.84 139.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.757 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -134.26 134.91 42.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.883 0.373 . . . . 0.0 111.659 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.714 HD21 ' HA ' ' A' 1070 ' ' PRO . 17.0 tp -68.54 149.55 49.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 60.0 t -150.19 147.24 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.27 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 90.43 -50.13 3.25 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' 1089 ' ' PRO . 22.0 pt-20 -167.89 130.94 1.35 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 117.72 0.76 . . . . 0.0 112.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.714 ' HA ' HD21 ' A' 1066 ' ' LEU . 94.9 Cg_endo -98.53 8.83 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.512 2.808 . . . . 0.0 113.698 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 60.3 m -156.9 142.75 17.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' 1049 ' ' VAL . 19.6 pt -149.37 147.13 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.996 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' 1049 ' ' VAL . 1.9 p90 -153.47 149.32 27.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.5 t -65.06 150.7 47.65 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.0 t -140.1 -25.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.529 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 43.5 t 59.06 51.13 7.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.738 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -67.32 -59.05 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.473 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.52 58.8 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 111.087 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.649 ' HB3' HH22 ' A' ' 995' ' ' ARG . 1.5 m-20 63.85 -132.07 0.38 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.071 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.516 ' OE1' HG23 ' A' 1023 ' ' ILE . 46.2 mm-40 -64.33 -144.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.561 0.22 . . . . 0.0 110.525 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 21.8 t 72.59 -36.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.87 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 66.28 55.42 18.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.758 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 74.4 mt -81.95 132.93 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.48 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 10.0 m95 -84.17 165.31 18.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.19 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 86.9 p -53.77 -31.72 49.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.526 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.65 148.97 14.15 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.3 -154.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.742 2.295 . . . . 0.0 112.689 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' 1089 ' ' PRO . . . -77.03 136.83 65.79 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.142 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.533 ' HG3' ' HG3' ' A' 1069 ' ' GLU . 3.1 Cg_exo -74.99 -134.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.237 2.624 . . . . 0.0 111.205 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.675 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 47.0 mm-40 -145.12 115.9 7.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.827 ' HB2' HD11 ' A' 1031 ' ' ILE . 22.0 t -97.37 63.98 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.099 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.299 -179.083 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.736 0.303 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 66.36 131.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.746 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.81 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 79.6 p -157.96 141.4 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.758 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.478 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 85.3 m -80.2 32.31 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.6 tptt 60.95 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.304 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.9 m -56.73 130.32 77.72 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.293 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.567 ' HB2' HG11 ' A' ' 974' ' ' VAL . 31.9 Cg_exo -58.57 120.88 9.04 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.4 Cg_endo -76.69 66.75 7.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.838 2.359 . . . . 0.0 111.949 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 967' ' ' PRO . 17.6 m-20 22.38 83.33 0.12 Allowed Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.675 0.609 . . . . 0.0 111.56 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.586 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 83.6 Cg_exo -42.69 148.67 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.139 2.56 . . . . 0.0 112.761 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 76.8 t -46.98 122.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.226 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.851 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 2.2 m120 71.92 -70.51 0.16 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.736 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 989' ' ' SER . . . -75.65 128.73 9.87 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.798 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 973' ' ' MET . 1.8 mpt? -84.35 155.7 22.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.645 0.26 . . . . 0.0 110.332 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.6 ' CG2' HD12 ' A' ' 986' ' ' ILE . 1.3 p -89.93 148.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.721 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 1.1 m-70 -117.49 96.55 5.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.493 HG13 HG23 ' A' ' 980' ' ' ILE . 60.8 t -71.17 81.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.339 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.29 -78.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.371 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.7 p -68.41 -77.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.45 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 52.2 m-20 -165.7 149.57 8.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.072 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.532 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 16.8 pt -84.11 -20.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.176 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.81 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 85.3 mt-30 -72.46 157.91 36.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.459 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' 1006 ' ' LEU . 9.0 p -44.24 144.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.191 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.84 43.97 21.12 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.166 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 66.9 m -168.36 129.73 1.34 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 32.0 ttm-85 -101.61 128.38 47.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.897 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.6 HD12 ' CG2' ' A' ' 974' ' ' VAL . 29.3 pt -97.15 -164.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.229 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 66.7 p -150.29 127.96 11.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.569 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.586 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 2.8 m-85 -99.49 163.14 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.538 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.613 ' O ' ' HA3' ' A' ' 972' ' ' GLY . 22.7 t -145.53 -156.92 0.75 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.004 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 23.4 m -158.06 157.89 33.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.592 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 992' ' ' THR . 17.9 p -68.64 -151.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.772 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.443 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.0 t -85.4 132.58 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.07 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.78 91.62 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.765 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.591 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 13.8 m80 -142.12 129.46 21.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 111.508 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.511 ' NH1' HD13 ' A' ' 997' ' ' ILE . 6.6 ptm180 -95.91 135.86 37.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.407 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' 1018 ' ' PRO . 4.6 tt -76.18 132.18 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.936 0.398 . . . . 0.0 111.653 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.886 ' HB ' HG13 ' A' 1019 ' ' ILE . 44.2 mm -97.85 144.04 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.331 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.79 43.81 Favored Glycine 0 C--N 1.328 0.116 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.1 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.13 132.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.611 ' CB ' HD13 ' A' ' 996' ' ' LEU . 79.6 p -90.85 38.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.0 p -162.15 145.7 11.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -158.41 130.98 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.182 0.515 . . . . 0.0 111.396 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 86.8 tt0 -105.0 132.49 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.528 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -70.93 127.08 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.103 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.81 152.24 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' 1007 ' ' SER . 0.2 OUTLIER -85.62 141.04 30.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.431 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.636 ' N ' HD13 ' A' 1006 ' ' LEU . 48.0 t -155.17 131.54 10.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 65.66 -82.4 0.08 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.316 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -157.77 16.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.004 0.43 . . . . 0.0 110.331 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.5 m -151.84 142.37 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.095 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.478 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.22 141.86 43.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.449 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.0 m-70 -149.57 141.63 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.573 ' HB2' ' HA ' ' A' 1016 ' ' LYS . 89.5 m95 -66.65 132.65 48.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.3 t -52.48 -21.53 3.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 71.7 p -131.47 -14.19 3.31 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.514 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.621 ' HZ3' ' HD2' ' A' 1017 ' ' PRO . 2.0 mmmp? 66.69 148.33 0.11 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.632 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.621 ' HD2' ' HZ3' ' A' 1016 ' ' LYS . 79.7 Cg_exo -45.21 104.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.56 2.173 . . . . 0.0 112.283 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.631 ' HB2' HD21 ' A' ' 996' ' ' LEU . 12.6 Cg_exo -71.34 -144.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.127 2.551 . . . . 0.0 112.957 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.886 HG13 ' HB ' ' A' ' 997' ' ' ILE . 21.4 pt -149.75 -159.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.201 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.851 ' HB3' ' HB2' ' A' ' 971' ' ' ASN . 8.6 t -153.59 111.7 3.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.979 0.418 . . . . 0.0 110.465 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.428 ' HB2' ' CG1' ' A' ' 997' ' ' ILE . 31.0 tp60 -81.62 132.93 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.152 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.8 ' HE ' ' HB3' ' A' 1045 ' ' HIS . 17.1 ttp-105 -66.84 128.48 36.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.331 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' 1046 ' ' TYR . 33.1 mm -53.76 107.71 0.93 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.31 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' 1045 ' ' HIS . 86.4 Cg_endo -86.93 126.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.733 2.289 . . . . 0.0 113.953 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' 1044 ' ' PHE . 26.2 p -108.17 127.85 54.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.922 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.36 -154.77 7.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.44 155.27 68.46 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 122.245 0.218 . . . . 0.0 111.139 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 9.2 Cg_endo -50.35 140.8 33.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.683 2.255 . . . . 0.0 111.627 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' 1030 ' ' THR . 33.8 Cg_exo -57.73 -9.1 5.05 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.606 2.204 . . . . 0.0 112.86 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1030 ' ' THR . . . . . 0.49 HG22 ' O ' ' A' 1029 ' ' PRO . 13.5 t 47.08 176.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' 1090 ' ' GLN . 28.3 pt -152.08 30.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.605 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 54.64 123.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.403 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-80 74.87 -36.84 0.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -76.09 121.05 6.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.38 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.543 ' CG ' ' HA ' ' A' 1055 ' ' ASN . 61.0 m-20 -75.4 -159.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.582 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.869 ' HB2' HG21 ' A' 1050 ' ' VAL . 21.4 p90 -156.03 142.13 18.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.358 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 43.4 mm -123.68 109.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.691 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.69 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 97.6 p -171.07 151.5 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 88.4 m -60.58 -39.41 87.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.656 HD22 ' HE2' ' A' 1044 ' ' PHE . 1.9 p-10 -61.54 143.56 55.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.348 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.36 -36.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.01 -44.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.031 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -73.39 59.11 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.656 ' HE2' HD22 ' A' 1040 ' ' ASN . 64.1 m-85 -76.66 -57.11 4.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.747 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.8 ' HB3' ' HE ' ' A' 1022 ' ' ARG . 64.4 m170 66.9 -67.66 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.885 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' 1045 ' ' HIS . 33.8 t80 173.96 35.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.536 0.684 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' 1048 ' ' SER . . . -160.48 98.81 0.17 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.135 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 26.2 m 177.35 153.39 0.25 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.366 0.603 . . . . 0.0 111.054 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.835 HG22 ' HB3' ' A' 1073 ' ' TYR . 76.5 t -137.82 144.12 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.166 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.869 HG21 ' HB2' ' A' 1036 ' ' PHE . 15.0 p -135.86 147.87 28.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' 1070 ' ' PRO . 88.2 m -118.54 125.88 50.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.757 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.45 149.37 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' 1053 ' ' ARG . 35.7 ttt85 -152.9 25.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.56 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 64.6 m 57.69 153.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.543 ' HA ' ' CG ' ' A' 1035 ' ' ASP . 28.3 t-20 -65.91 -57.27 8.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.41 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.974 HD22 ' HA2' ' A' 1060 ' ' GLY . 2.9 mt 66.17 159.61 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.493 ' HA3' ' NH2' ' A' 1061 ' ' ARG . . . -81.92 -33.9 25.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.175 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.7 p -153.86 62.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.745 0.272 . . . . 0.0 111.171 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.593 ' O ' HD13 ' A' 1056 ' ' LEU . 35.1 mmt180 77.83 -40.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.819 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.974 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 178.62 127.82 1.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.731 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.493 ' NH2' ' HA3' ' A' 1057 ' ' GLY . 40.3 ptt180 -172.74 41.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 0.0 110.634 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt 44.32 71.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.56 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.776 HG23 ' HD2' ' A' 1064 ' ' PHE . 23.9 m -142.68 -7.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.78 0.8 . . . . 0.0 110.116 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.776 ' HD2' HG23 ' A' 1063 ' ' VAL . 70.6 m-85 -155.73 140.79 17.38 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.682 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -143.33 121.22 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 0.0 111.291 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.612 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 36.3 tp -71.86 153.96 41.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.808 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' 1089 ' ' PRO . 85.2 t -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.237 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 83.17 -157.7 35.41 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.723 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.565 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.9 pt-20 -64.41 118.77 50.48 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-O 120.769 0.318 . . . . 0.0 111.474 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.612 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 56.8 Cg_endo -96.26 27.21 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.092 2.528 . . . . 0.0 113.564 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' 1050 ' ' VAL . 58.6 m -156.18 142.06 18.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 112.036 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' 1049 ' ' VAL . 31.2 pt -144.93 174.78 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.766 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.835 ' HB3' HG22 ' A' 1049 ' ' VAL . 6.2 p90 -155.27 148.0 24.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.996 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 60.4 m -63.26 125.25 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.347 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' 1085 ' ' SER . 11.4 t -157.84 145.78 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.516 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 79.3 p -74.6 149.13 40.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.35 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.493 HD22 HD11 ' A' 1083 ' ' ILE . 39.9 p-10 -164.55 -42.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.1 t70 -83.05 -80.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.978 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.12 -130.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.311 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -59.58 -34.44 72.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 110.808 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' 1081 ' ' VAL . 2.6 t -59.02 -53.2 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.15 0.5 . . . . 0.0 110.989 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.51 ' O ' HG12 ' A' 1083 ' ' ILE . . . 77.55 -44.51 2.25 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.63 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' 1082 ' ' GLY . 17.1 pt 46.28 -163.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.445 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 36.2 m95 -85.26 -163.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.908 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.423 ' HA ' ' CG2' ' A' 1075 ' ' THR . 76.7 p -67.48 -65.1 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.984 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . 178.21 131.84 1.62 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.596 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 16.5 Cg_exo -68.52 143.05 55.81 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.729 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -168.02 -49.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.729 ' HD2' ' H ' ' A' 1088 ' ' ALA . 11.9 Cg_endo -55.65 148.91 51.82 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.333 2.022 . . . . 0.0 112.149 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.632 ' HA ' HD12 ' A' 1031 ' ' ILE . 15.0 tt0 -152.36 133.47 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 41.5 t -92.63 141.3 28.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.104 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.614 ' HD2' HD21 ' A' 1006 ' ' LEU . 28.5 mttm -77.6 142.09 39.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 77.9 p -157.28 141.07 15.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.059 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 71.4 m -79.93 134.02 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.594 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.75 140.57 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 97.4 m -53.52 120.31 21.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.143 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 42.9 Cg_exo -57.94 112.6 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.342 2.028 . . . . 0.0 112.656 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.68 134.38 32.55 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.575 2.183 . . . . 0.0 111.013 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -48.48 106.81 0.65 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.903 0.382 . . . . 0.0 111.216 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 72.9 Cg_endo -75.33 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.591 2.194 . . . . 0.0 112.295 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' 1020 ' ' CYS . 95.6 t -49.01 85.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 969' ' ' PRO . 71.2 m-80 44.68 63.8 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.896 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.851 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -157.04 124.97 1.5 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.783 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 37.8 ttp -97.75 134.49 40.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.698 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.723 HG21 HD12 ' A' ' 986' ' ' ILE . 3.9 p -93.69 151.32 3.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -116.79 106.82 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.376 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 986' ' ' ILE . 22.0 t -65.44 113.3 2.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 986' ' ' ILE . 46.5 mm -80.38 -91.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.312 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 41.3 p -80.68 -58.63 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.834 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' A' ' 984' ' ' SER . 30.0 m-20 -164.58 -154.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.751 HG22 ' HH2' ' A' 1013 ' ' TRP . 14.2 pt -155.89 25.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.737 0.303 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 962' ' ' SER . 87.1 mt-30 -87.33 -56.26 3.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.351 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 981' ' ' GLN . 21.6 t -173.1 141.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.24 1.016 . . . . 0.0 109.412 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.42 -34.82 0.97 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.573 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 979' ' ' ASP . 50.3 m -68.41 126.85 30.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.416 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -101.39 -179.63 4.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.391 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.723 HD12 HG21 ' A' ' 974' ' ' VAL . 20.3 pt -154.01 171.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.616 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' 1001 ' ' SER . 77.8 p -141.71 129.56 21.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.317 . . . . 0.0 111.47 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.706 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.4 m-85 -83.27 -164.46 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 75.5 p -153.83 -46.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.397 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.851 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 42.7 t 71.96 150.76 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.868 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -62.42 152.0 35.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.811 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 54.4 m -58.06 137.51 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.482 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 75.63 35.5 46.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.267 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.602 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 30.6 m80 -147.0 132.49 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.65 ' NH1' HG12 ' A' ' 997' ' ' ILE . 50.8 ttt-85 -81.58 117.47 21.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.43 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 988' ' ' TYR . 5.7 tt -76.05 111.83 11.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.457 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.736 ' HB ' HG13 ' A' 1019 ' ' ILE . 18.3 mt -99.47 59.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.528 0.68 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . -154.32 20.3 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.787 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 57.07 17.58 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.604 0.24 . . . . 0.0 111.122 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.613 ' H ' HD22 ' A' ' 996' ' ' LEU . 83.2 p 36.99 39.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 18.0 t -162.14 161.86 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.637 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.28 126.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' 1013 ' ' TRP . 43.5 tt0 -105.0 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.1 t -73.19 81.3 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' 1014 ' ' SER . 44.3 pt -86.87 -172.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.359 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.614 HD21 ' HD2' ' A' ' 961' ' ' LYS . 10.8 tp -158.36 124.42 4.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.47 . . . . 0.0 111.919 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.435 ' N ' HD12 ' A' 1006 ' ' LEU . 45.7 t -83.67 -45.56 13.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.153 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.77 -45.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.752 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 37.4 m-20 -76.23 -52.41 10.09 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.433 ' C ' HD13 ' A' 1006 ' ' LEU . 86.9 m -151.26 149.16 29.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -74.72 140.75 44.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.1 p80 -153.08 151.91 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.751 ' HH2' HG22 ' A' ' 980' ' ' ILE . 53.4 m95 -72.08 120.04 17.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.958 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.593 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.1 p -52.5 -25.32 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 44.6 p -86.9 133.8 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 111.954 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 25.3 pttm -62.7 152.42 81.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.681 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 74.9 Cg_exo -47.55 118.09 2.75 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.323 2.015 . . . . 0.0 111.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.719 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 15.9 Cg_exo -69.43 139.94 42.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.015 2.477 . . . . 0.0 112.987 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.736 HG13 ' HB ' ' A' ' 997' ' ' ILE . 16.7 pt -134.28 126.26 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.921 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 92.5 m -86.43 95.67 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 111.211 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -77.02 138.43 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.191 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -54.76 127.61 29.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.499 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.698 ' O ' ' HB2' ' A' 1046 ' ' TYR . 47.1 mm -56.02 110.38 2.27 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' 1080 ' ' GLN . 93.6 Cg_endo -81.17 133.09 8.61 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.511 2.141 . . . . 0.0 113.374 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 8.1 p -113.02 143.81 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.896 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.06 -148.63 2.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.095 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' 1027 ' ' LEU . 10.1 mt -70.02 148.82 96.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' 1029 ' ' PRO . 16.4 Cg_exo -66.5 137.07 45.28 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 110.499 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' 1028 ' ' PRO . 49.9 Cg_exo -34.11 135.28 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.667 2.244 . . . . 0.0 111.782 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 77.2 p -76.54 139.39 40.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.755 HG23 ' HA3' ' A' 1034 ' ' GLY . 7.8 tt -142.67 117.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.321 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -44.7 131.42 6.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.529 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' 1091 ' ' CYS . 22.5 p30 42.58 30.12 0.2 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.482 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.755 ' HA3' HG23 ' A' 1031 ' ' ILE . . . -79.16 160.8 46.59 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.526 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.724 ' HB2' ' HA ' ' A' 1055 ' ' ASN . 31.3 t0 -156.56 156.62 33.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.704 ' HA ' ' O ' ' A' 1051 ' ' THR . 23.4 p90 -155.88 145.37 20.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 111.91 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.448 HG13 HH11 ' A' 1053 ' ' ARG . 29.5 mt -109.23 111.27 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.775 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' 1039 ' ' THR . 57.1 m -171.12 -140.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.441 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.448 ' H ' ' HB3' ' A' 1038 ' ' SER . 11.6 t -117.79 -27.87 6.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -45.56 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.951 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.426 ' H ' ' HE1' ' A' 1036 ' ' PHE . 38.9 mmt180 54.39 -126.69 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -77.03 -40.73 45.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.136 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -67.5 148.45 51.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.31 152.91 15.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.307 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' 1046 ' ' TYR . 5.1 p80 -155.08 -62.07 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.809 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.698 ' HB2' ' O ' ' A' 1023 ' ' ILE . 6.2 t80 169.11 40.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.594 0.235 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.46 -43.87 0.02 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.568 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 66.7 m -47.58 128.51 12.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 112.001 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' 1050 ' ' VAL . 7.7 p -97.17 175.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.558 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' 1049 ' ' VAL . 30.9 m -151.41 131.77 4.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.172 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.704 ' O ' ' HA ' ' A' 1036 ' ' PHE . 42.4 m -104.33 102.64 12.32 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.433 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' 1035 ' ' ASP . 2.5 m-85 -70.57 135.08 48.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 111.254 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.532 HH22 HG21 ' A' 1051 ' ' THR . 3.1 ptp85 -159.63 34.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.388 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.811 ' HB2' HG12 ' A' 1063 ' ' VAL . 77.5 m 62.03 149.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.188 0.518 . . . . 0.0 111.809 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.724 ' HA ' ' HB2' ' A' 1035 ' ' ASP . 47.3 t30 -63.45 -35.38 80.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.279 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1056 ' ' LEU . . . . . 1.003 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 21.7 mt -70.31 -157.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 58.68 39.8 93.96 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.607 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 11.6 p -175.04 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 110.552 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -155.88 45.58 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.839 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.792 ' HA3' HD23 ' A' 1056 ' ' LEU . . . -172.19 -41.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.834 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' 1062 ' ' LYS . 20.8 tpp180 67.6 158.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.461 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' A' 1061 ' ' ARG . 20.2 tptm 94.97 -35.97 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.014 0.821 . . . . 0.0 110.077 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1063 ' ' VAL . . . . . 1.003 ' HA ' ' HB2' ' A' 1056 ' ' LEU . 0.1 OUTLIER 43.1 32.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.537 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' 1091 ' ' CYS . 0.1 OUTLIER 36.93 -135.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1065 ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' 1092 ' ' ILE . 98.7 mt-10 -150.14 105.71 3.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.205 0.526 . . . . 0.0 110.814 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' 1070 ' ' PRO . 43.6 tp -70.51 149.73 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.112 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' 1089 ' ' PRO . 97.2 t -139.18 137.51 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.325 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.13 -158.79 35.0 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.561 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' 1089 ' ' PRO . 18.6 pt-20 -69.03 125.97 92.4 Favored Pre-proline 0 C--O 1.227 -0.117 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.76 ' HB3' HD21 ' A' 1066 ' ' LEU . 84.7 Cg_endo -96.16 26.15 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.114 2.542 . . . . 0.0 112.869 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 78.8 p -157.4 143.59 17.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.503 HD11 ' OH ' ' A' 1052 ' ' TYR . 13.4 pt -155.19 171.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.881 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.8 p90 -137.46 144.07 42.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 0.0 111.315 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.579 ' HA ' ' CE2' ' A' 1084 ' ' TRP . 0.9 OUTLIER -62.19 121.37 12.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.55 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' 1084 ' ' TRP . 11.8 t -157.72 140.68 15.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.719 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' 1082 ' ' GLY . 69.7 m -89.77 -154.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.458 ' OD1' HD13 ' A' 1083 ' ' ILE . 42.8 p-10 179.22 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.409 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.462 ' HB2' ' CG1' ' A' 1081 ' ' VAL . 29.5 m-20 -80.67 -54.92 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -163.24 -46.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.009 0.433 . . . . 0.0 111.635 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.688 ' HB2' ' HG2' ' A' 1024 ' ' PRO . 17.0 pt20 -175.3 32.81 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.74 HG13 ' H ' ' A' 1082 ' ' GLY . 2.5 p -88.93 -104.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.612 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.74 ' H ' HG13 ' A' 1081 ' ' VAL . . . -153.24 -115.15 0.58 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.465 HD12 ' C ' ' A' 1082 ' ' GLY . 4.2 mp 56.02 82.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.579 ' CE2' ' HA ' ' A' 1074 ' ' CYS . 15.4 m0 -70.66 -153.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.707 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' 1084 ' ' TRP . 47.9 t -56.42 -57.01 14.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 131.8 1.63 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.478 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.5 130.67 9.05 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 111.184 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.785 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -169.92 -46.74 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.785 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.7 Cg_endo -52.02 132.82 44.4 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.195 1.93 . . . . 0.0 112.54 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -153.21 138.51 17.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.427 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.596 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 74.5 m -103.04 135.32 44.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' 1065 ' ' GLU . 13.5 pt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.381 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.85 0.357 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.758 ' HD2' ' H ' ' A' 1011 ' ' ALA . 4.4 tppp? -77.46 140.85 39.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.823 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 67.2 p -157.99 144.84 17.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.545 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 76.8 m -79.9 31.7 0.26 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.838 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 59.47 142.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.841 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 966' ' ' PRO . 54.8 m -52.15 122.13 22.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.6 ' HG2' HG11 ' A' ' 974' ' ' VAL . 10.1 Cg_endo -53.53 115.52 2.36 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.495 2.13 . . . . 0.0 112.168 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 22.8 Cg_exo -64.51 127.71 19.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.502 2.134 . . . . 0.0 111.559 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.18 109.74 2.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.864 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.669 ' HG3' ' HG2' ' A' 1018 ' ' PRO . 26.4 Cg_exo -61.94 147.25 95.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 111.571 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 970' ' ' VAL . 35.9 m -47.43 127.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 990' ' ' CYS . 75.4 m-20 51.23 46.35 26.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.718 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -171.53 124.1 1.08 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.198 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.73 144.53 27.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.696 0.284 . . . . 0.0 111.53 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' ' 966' ' ' PRO . 1.4 p -89.57 147.13 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.041 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.462 ' O ' HG13 ' A' ' 977' ' ' ILE . 1.0 OUTLIER -115.43 95.27 5.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.088 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 979' ' ' ASP . 73.7 t -67.56 89.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.643 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 975' ' ' HIS . 42.5 mt -75.13 -90.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.512 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.8 p -59.65 -63.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.378 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 976' ' ' VAL . 25.4 m-20 -165.68 -137.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.24 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.477 HG23 HG13 ' A' ' 976' ' ' VAL . 8.3 pt -152.51 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.518 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.823 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 76.8 mt-30 -72.35 164.42 26.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.595 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' 1004 ' ' CYS . 3.5 p -43.99 135.84 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.887 0.375 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.19 54.74 4.29 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.795 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.421 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 94.4 p -164.52 130.37 2.87 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.625 ' NE ' ' HB2' ' A' 1003 ' ' GLU . 35.9 mmt180 -94.11 149.63 21.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.586 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' 1001 ' ' SER . 48.7 pt -142.83 141.38 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -106.37 123.97 48.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.372 . . . . 0.0 111.951 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.578 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 1.3 m-85 -86.66 172.04 10.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.7 t -145.47 -174.24 4.34 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.081 0.467 . . . . 0.0 111.852 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.568 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 92.2 m -158.12 159.67 36.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 992' ' ' THR . 41.3 p -67.72 -160.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 111.378 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' A' ' 991' ' ' THR . 43.7 m -82.53 130.26 35.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.694 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' 1023 ' ' ILE . . . 68.44 45.39 68.69 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.538 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -148.08 123.13 10.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.507 ' HG3' HE22 ' A' 1080 ' ' GLN . 78.7 ttt180 -84.98 129.05 34.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.354 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' 1000 ' ' SER . 3.7 tt -74.66 130.79 40.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.562 ' N ' HD23 ' A' ' 996' ' ' LEU . 49.6 mm -99.87 144.61 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.878 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.451 ' HA3' ' HE3' ' A' 1016 ' ' LYS . . . 77.26 36.23 35.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.872 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 59.4 131.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.63 ' HB3' HD13 ' A' ' 996' ' ' LEU . 79.1 p -84.59 36.4 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.527 ' O ' HG21 ' A' 1015 ' ' THR . 80.9 p -162.09 145.89 12.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.07 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.448 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -161.07 141.51 11.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.145 0.497 . . . . 0.0 112.162 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.625 ' HB2' ' NE ' ' A' ' 985' ' ' ARG . 89.0 tt0 -104.78 134.43 47.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.953 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 54.0 t -74.62 98.2 3.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 26.7 pt -90.73 -166.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.073 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' 1011 ' ' ALA . 0.4 OUTLIER -141.08 121.78 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.147 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.404 ' N ' HD13 ' A' 1006 ' ' LEU . 37.8 t -90.38 41.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.496 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 50.92 39.84 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.599 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -176.65 -46.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.094 0.474 . . . . 0.0 110.571 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 67.8 m -151.24 147.85 27.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.758 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.19 134.78 41.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.522 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 88.9 m-70 -149.46 141.71 24.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.473 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 78.3 m95 -68.9 125.56 27.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.351 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 32.7 m -52.62 -25.36 10.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.899 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.527 HG21 ' O ' ' A' 1001 ' ' SER . 72.9 p -87.95 143.11 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' 1017 ' ' PRO . 0.0 OUTLIER -68.3 162.13 63.55 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.089 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.494 ' O ' ' HD2' ' A' 1016 ' ' LYS . 99.2 Cg_exo -43.18 116.57 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.519 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.669 ' HG2' ' HG3' ' A' ' 969' ' ' PRO . 56.1 Cg_endo -69.49 138.22 38.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.881 2.387 . . . . 0.0 112.728 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 997' ' ' ILE . 12.1 tt -148.81 133.27 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 79.2 m -86.38 113.33 22.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 111.575 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -78.79 129.05 34.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.926 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -71.16 122.4 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.893 HG21 ' HB2' ' A' 1077 ' ' ASN . 37.7 mt -52.55 121.62 22.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.427 ' O ' ' HA3' ' A' 1082 ' ' GLY . 84.9 Cg_endo -81.64 125.25 4.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.872 2.382 . . . . 0.0 111.03 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.699 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 0.5 OUTLIER -97.06 25.29 5.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 36.67 -143.96 0.13 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.328 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' 1044 ' ' PHE . 22.3 mt -93.27 141.84 24.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.592 0.235 . . . . 0.0 111.225 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.761 ' HG3' HD21 ' A' 1040 ' ' ASN . 56.6 Cg_endo -68.8 156.93 63.84 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.493 2.129 . . . . 0.0 111.307 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.545 ' HD2' HD11 ' A' 1072 ' ' ILE . 82.8 Cg_exo -42.7 126.29 4.17 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.526 2.151 . . . . 0.0 112.273 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 66.6 p -77.41 98.27 5.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' 1031 ' ' ILE . 7.4 tt -86.41 106.73 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.563 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -76.22 148.01 37.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.968 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' 1032 ' ' ALA . 84.8 m-20 73.7 28.35 1.64 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.524 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.656 ' HA2' ' N ' ' A' 1055 ' ' ASN . . . -160.86 -46.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.78 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' 1034 ' ' GLY . 57.8 m-20 71.44 147.38 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.611 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.519 ' HB2' HG21 ' A' 1050 ' ' VAL . 14.4 p90 -84.0 145.59 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.098 0.475 . . . . 0.0 112.017 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' 1053 ' ' ARG . 58.8 mt -90.72 164.01 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.56 ' N ' HG22 ' A' 1037 ' ' ILE . 75.1 m 72.57 166.43 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.598 0.237 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' 1040 ' ' ASN . 57.5 p -49.54 -64.93 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.761 HD21 ' HG3' ' A' 1028 ' ' PRO . 18.7 t-20 33.46 49.09 0.21 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.031 0.444 . . . . 0.0 110.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -86.4 -60.71 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -147.5 -42.76 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 1.1 m120 -71.48 123.29 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.581 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.512 ' CE2' HD23 ' A' 1027 ' ' LEU . 86.3 m-85 -148.56 -46.88 0.15 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.624 ' C ' ' H ' ' A' 1047 ' ' GLY . 22.5 m-70 58.1 -111.66 0.59 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' 1074 ' ' CYS . 10.0 t80 -64.31 27.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.059 0.456 . . . . 0.0 110.556 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' 1045 ' ' HIS . . . 76.51 -84.85 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.519 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' 1047 ' ' GLY . 34.2 t 115.72 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.885 0.874 . . . . 0.0 109.669 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' 1072 ' ' ILE . 13.2 p -156.4 153.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.434 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.567 ' HB ' HD22 ' A' 1040 ' ' ASN . 5.0 p -153.81 129.08 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.945 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 71.7 m -86.74 120.62 28.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.128 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.492 ' CE1' HG12 ' A' 1072 ' ' ILE . 3.1 m-85 -80.28 139.44 36.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.592 ' HB2' HD11 ' A' 1037 ' ' ILE . 33.7 ttp180 -147.63 142.84 27.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.552 ' O ' HD12 ' A' 1056 ' ' LEU . 40.9 m -77.97 149.93 34.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.525 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.656 ' N ' ' HA2' ' A' 1034 ' ' GLY . 44.5 t30 -56.31 -51.74 67.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.861 ' HA ' HG13 ' A' 1063 ' ' VAL . 1.7 mt 49.47 34.79 7.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.718 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.16 0.37 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.307 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' 1059 ' ' ARG . 85.8 p -68.35 -54.14 19.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 1058 ' ' SER . 24.9 mmm180 -159.52 -47.02 0.05 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.697 0.284 . . . . 0.0 111.278 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.672 ' HA2' HD22 ' A' 1056 ' ' LEU . . . -167.14 50.58 0.25 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.43 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' 1062 ' ' LYS . 0.0 OUTLIER -77.06 47.7 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.403 0.281 . . . . 0.0 110.491 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' 1062 ' ' LYS . 61.9 tttp 38.45 61.98 1.07 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' 1056 ' ' LEU . 3.3 p -147.26 87.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.207 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.74 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 1.5 m-30 88.26 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.189 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -147.94 145.61 28.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.458 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' 1067 ' ' VAL . 3.8 tt -68.58 142.1 55.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.391 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.795 ' N ' HD23 ' A' 1066 ' ' LEU . 56.3 t -133.48 111.37 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.475 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1068 ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' 1089 ' ' PRO . . . 77.03 133.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.355 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.723 ' O ' ' HG3' ' A' 1089 ' ' PRO . 5.2 tp10 46.0 107.94 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 111.833 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.558 ' HA ' ' CD1' ' A' 1066 ' ' LEU . 68.8 Cg_endo -87.18 -28.15 0.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.48 2.12 . . . . 0.0 113.106 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 87.6 p -151.2 129.97 12.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' 1049 ' ' VAL . 45.6 pt -106.86 175.84 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.436 0.636 . . . . 0.0 112.514 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.13 144.62 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.04 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 34.9 t -67.43 125.31 25.73 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.736 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.3 t -92.05 -40.98 10.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 10.9 p -166.49 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 0.0 111.421 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.893 ' HB2' HG21 ' A' 1023 ' ' ILE . 0.8 OUTLIER -170.97 143.33 1.98 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.385 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.717 ' H ' HD22 ' A' 1077 ' ' ASN . 61.7 t0 -57.52 -48.37 79.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.929 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -150.4 -55.65 0.16 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.507 HE22 ' HG3' ' A' ' 995' ' ' ARG . 13.3 mm-40 -148.21 -26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' 1023 ' ' ILE . 21.8 t -68.89 -110.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . -165.81 136.13 4.03 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.068 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.729 HG22 ' HA ' ' A' 1077 ' ' ASN . 8.1 tp -145.91 132.94 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.744 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 20.8 m95 -83.98 -155.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 67.2 m -79.75 -57.5 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.701 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.59 134.11 2.04 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.047 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.417 ' HB3' ' CG ' ' A' 1029 ' ' PRO . 87.8 Cg_endo -79.71 48.93 3.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.858 2.372 . . . . 0.0 112.017 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -69.92 -41.0 14.18 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.723 ' HG3' ' O ' ' A' 1069 ' ' GLU . 78.3 Cg_exo -48.96 120.42 5.43 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.759 1.639 . . . . 0.0 112.552 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -134.04 116.38 15.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.106 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 49.9 t -87.26 117.02 25.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.128 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.213 179.71 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.961 0.41 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 962' ' ' SER . 45.4 mmtm -77.6 -127.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.746 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.978 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 47.3 t 74.19 139.76 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.224 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.569 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 79.0 m -79.98 37.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.008 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 61.27 134.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.34 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 95.1 m -59.69 114.34 9.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 24.1 Cg_exo -63.82 118.49 5.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.372 2.048 . . . . 0.0 112.08 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.56 132.37 15.96 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.396 2.064 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 30.4 m-20 -55.65 110.02 2.0 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.771 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.466 ' HD2' ' HA3' ' A' ' 972' ' ' GLY . 5.5 Cg_exo -79.84 -146.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.053 2.502 . . . . 0.0 111.923 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.672 HG11 HG23 ' A' 1019 ' ' ILE . 1.6 p -48.95 93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.647 ' O ' HG23 ' A' ' 991' ' ' THR . 33.8 m120 49.28 22.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.393 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -83.05 159.31 37.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.6 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.542 ' N ' ' HA ' ' A' ' 990' ' ' CYS . 11.4 tpt -157.45 110.67 2.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.954 HG21 HD12 ' A' ' 986' ' ' ILE . 9.0 p -87.98 145.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.993 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 989' ' ' SER . 0.5 OUTLIER -106.58 97.45 7.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.823 179.432 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.704 HG13 HG23 ' A' ' 980' ' ' ILE . 16.3 t -65.29 96.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.427 HD11 ' OG1' ' A' ' 987' ' ' THR . 37.4 mt -75.24 -92.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.264 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.0 p -68.84 -73.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 110.359 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 984' ' ' SER . 3.9 m-20 -161.2 151.04 17.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 976' ' ' VAL . 11.5 pt -84.18 3.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.363 0.601 . . . . 0.0 109.793 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.978 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 88.6 mt-30 -82.03 157.08 24.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.945 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' 1005 ' ' ILE . 7.2 p -44.35 150.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.644 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 81.02 -44.19 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.712 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.511 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 54.4 m -74.14 -170.1 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.83 0.315 . . . . 0.0 111.035 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' 1003 ' ' GLU . 79.6 mtp180 -151.51 169.53 21.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.295 0.569 . . . . 0.0 111.991 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.954 HD12 HG21 ' A' ' 974' ' ' VAL . 37.6 pt -150.01 139.05 15.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.499 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' 1001 ' ' SER . 48.7 p -107.36 122.67 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 5.4 m-85 -83.28 160.1 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.995 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.495 ' HB2' ' CE1' ' A' ' 975' ' ' HIS . 75.1 m -161.5 -6.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.752 ' SG ' ' HG ' ' A' ' 996' ' ' LEU . 65.8 m 62.29 -158.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.07 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 971' ' ' ASN . 34.2 p -75.08 -142.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.604 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 993' ' ' GLY . 9.8 t -62.4 -127.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.537 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 992' ' ' THR . . . -72.57 43.75 0.93 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 114.501 0.56 . . . . 0.0 114.501 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -93.96 139.6 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.201 0.5 . . . . 0.0 110.646 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -81.99 117.22 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.738 0.304 . . . . 0.0 110.553 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.752 ' HG ' ' SG ' ' A' ' 990' ' ' CYS . 1.7 tt -76.16 133.28 40.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.647 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.969 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -105.16 155.1 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.406 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 79.41 -75.81 2.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.818 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -165.28 139.13 4.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.545 ' HA ' HD13 ' A' ' 996' ' ' LEU . 21.7 m -100.15 22.04 11.98 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 83.8 p -162.27 148.16 13.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.903 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.409 ' HB3' ' HE1' ' A' ' 988' ' ' TYR . . . -154.49 134.4 13.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 111.547 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 985' ' ' ARG . 87.7 tt0 -101.62 128.78 47.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.05 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -79.38 125.69 29.86 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' 1012 ' ' HIS . 0.2 OUTLIER -138.26 153.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 0.0 110.286 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' 1007 ' ' SER . 0.6 OUTLIER -81.58 124.2 29.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.473 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.536 ' N ' HD13 ' A' 1006 ' ' LEU . 81.2 p -86.63 -125.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.09 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -65.08 -54.89 24.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.154 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -153.35 20.79 0.56 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 95.4 m -151.37 147.45 26.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.569 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.3 136.39 40.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.591 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.655 ' O ' HD13 ' A' 1005 ' ' ILE . 37.0 m80 -149.14 142.78 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.733 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.516 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 83.2 m95 -71.66 136.2 47.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.985 0.421 . . . . 0.0 111.428 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 74.8 p -52.44 -24.46 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.839 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 25.2 p -132.38 130.57 40.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.45 . . . . 0.0 111.858 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -57.95 158.9 11.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.629 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 97.9 Cg_exo -41.56 126.49 3.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.123 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.534 ' HB2' HD21 ' A' ' 996' ' ' LEU . 64.2 Cg_endo -72.57 -156.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.511 2.141 . . . . 0.0 112.217 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.969 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 11.3 mt -143.04 -179.26 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.866 ' H ' HG22 ' A' 1019 ' ' ILE . 21.1 m -145.81 79.06 1.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.377 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.784 ' H ' HD13 ' A' ' 997' ' ' ILE . 35.2 tp60 -71.6 138.57 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.008 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.664 ' HB3' ' HB3' ' A' 1046 ' ' TYR . 9.5 mpt_? -72.33 126.61 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.998 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.2 mt -67.32 113.25 12.88 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.638 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' 1045 ' ' HIS . 30.1 Cg_endo -63.69 114.37 2.54 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.758 2.305 . . . . 0.0 113.679 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.586 ' O ' ' HB2' ' A' 1044 ' ' PHE . 9.1 p -95.67 135.97 36.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.208 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.13 -150.59 3.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.104 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.485 HD11 ' OE1' ' A' 1042 ' ' GLU . 1.5 mm? -62.87 139.03 97.26 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.12 168.33 19.4 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.024 2.483 . . . . 0.0 111.291 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.781 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 65.5 Cg_exo -50.86 110.3 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.873 1.716 . . . . 0.0 111.529 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.6 p -77.42 141.02 39.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.269 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.567 HG13 ' HA3' ' A' 1034 ' ' GLY . 24.1 pt -149.68 124.33 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.446 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.96 139.38 10.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-20 75.1 -28.41 0.19 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.344 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.567 ' HA3' HG13 ' A' 1031 ' ' ILE . . . -64.62 160.07 41.39 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' 1034 ' ' GLY . 71.5 m-20 -153.78 -156.53 0.69 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.741 ' HB2' HG23 ' A' 1050 ' ' VAL . 36.7 p90 -155.95 142.33 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 112.298 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' 1037 ' ' ILE . 53.9 mt -111.26 57.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.054 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.413 ' H ' ' HD1' ' A' 1036 ' ' PHE . 60.1 m -157.76 -163.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.488 HG22 ' O ' ' A' 1039 ' ' THR . 22.6 m -96.91 49.15 1.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.265 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.463 ' HB2' ' CE1' ' A' 1036 ' ' PHE . 2.2 m-80 -62.93 -52.26 63.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.765 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 56.81 -137.27 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.485 ' OE1' HD11 ' A' 1027 ' ' LEU . 67.3 mm-40 -149.23 50.38 0.96 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.354 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -168.42 60.99 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.164 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.586 ' HB2' ' O ' ' A' 1025 ' ' CYS . 5.3 m-85 -76.77 129.99 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.744 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.583 ' O ' ' HA ' ' A' 1024 ' ' PRO . 20.8 m80 -98.42 -58.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.664 ' HB3' ' HB3' ' A' 1022 ' ' ARG . 42.3 t80 172.17 31.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.71 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.46 98.09 0.16 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.79 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.8 p 175.72 134.41 0.05 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.535 0.683 . . . . 0.0 111.391 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' 1072 ' ' ILE . 12.7 p -102.17 155.52 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.448 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.741 HG23 ' HB2' ' A' 1036 ' ' PHE . 6.4 p -133.47 126.47 52.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.012 0.435 . . . . 0.0 111.05 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 33.2 m -106.69 109.84 21.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.545 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 10.3 m-85 -71.92 147.65 46.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.726 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' 1054 ' ' CYS . 14.0 ptm180 -142.8 -14.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.201 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' 1053 ' ' ARG . 66.1 m 71.29 146.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.104 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' 1033 ' ' ASN . 7.2 t-20 -62.64 -133.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 111.665 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.583 HD13 ' HA2' ' A' 1060 ' ' GLY . 8.6 mt -155.04 133.57 11.93 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.96 31.43 3.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.184 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.631 ' O ' ' HG2' ' A' 1059 ' ' ARG . 68.0 m -169.36 -70.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.783 0.292 . . . . 0.0 111.615 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' 1058 ' ' SER . 31.8 mmt-85 -167.21 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.65 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.583 ' HA2' HD13 ' A' 1056 ' ' LEU . . . -153.29 -32.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.444 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' 1061 ' ' ARG . 41.4 ttt85 -55.43 120.53 7.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.93 133.73 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 32.5 m -147.0 -29.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 111.302 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.533 ' HD2' ' HB3' ' A' 1091 ' ' CYS . 15.6 m-85 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1065 ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' 1092 ' ' ILE . 34.6 mt-10 -98.52 126.43 44.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.718 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.932 HD23 ' N ' ' A' 1067 ' ' VAL . 3.6 tt -68.81 143.47 54.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.517 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.932 ' N ' HD23 ' A' 1066 ' ' LEU . 96.2 t -135.1 117.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 88.77 -142.82 17.28 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.658 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' 1089 ' ' PRO . 20.8 pt-20 -62.52 122.87 76.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.018 0.437 . . . . 0.0 112.17 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.6 ' HA ' HD11 ' A' 1066 ' ' LEU . 87.0 Cg_endo -85.33 -17.46 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.812 2.341 . . . . 0.0 112.175 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 77.9 p -156.37 155.66 32.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.502 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' 1049 ' ' VAL . 34.8 pt -150.29 -162.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.656 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -160.28 150.06 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 2.4 t -62.39 141.03 58.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.698 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 12.8 t -145.73 -146.89 0.2 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1076 ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' 1082 ' ' GLY . 46.9 t -165.46 147.92 7.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.886 0.374 . . . . 0.0 111.46 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -163.97 -33.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 5.0 t0 -73.78 -139.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.49 -39.87 11.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -162.91 -16.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 50.5 t -58.74 -28.9 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.501 . . . . 0.0 110.776 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 81.13 -63.06 4.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.901 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 75.4 mt 60.69 130.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.106 0.479 . . . . 0.0 111.847 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 18.1 m95 -80.19 138.2 36.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.587 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 71.5 p -55.47 -61.73 2.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.522 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -71.38 121.85 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.643 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.39 39.87 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.087 2.525 . . . . 0.0 112.012 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.781 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 61.98 135.02 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.504 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.545 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 36.3 Cg_endo -64.9 -138.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.657 2.238 . . . . 0.0 112.399 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.787 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 43.1 mm-40 -151.84 128.09 10.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' 1064 ' ' PHE . 98.8 m -102.74 104.06 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.361 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' 1065 ' ' GLU . 17.8 pt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.304 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.995 0.426 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' A' 1011 ' ' ALA . 0.0 OUTLIER 64.39 143.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 81.2 p -157.99 146.73 19.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.97 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.02 152.23 29.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 0.0 OUTLIER -63.87 133.57 53.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.598 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.433 ' HB ' ' CD1' ' A' ' 980' ' ' ILE . 6.5 t -73.73 125.73 90.2 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.857 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.637 ' HG2' HG11 ' A' ' 974' ' ' VAL . 93.5 Cg_endo -79.73 113.14 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.296 1.997 . . . . 0.0 111.219 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 95.5 Cg_exo -42.2 -48.96 6.25 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.435 2.09 . . . . 0.0 112.051 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 174.5 126.95 0.11 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.339 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.667 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 50.2 Cg_exo -54.04 150.91 29.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.69 HG21 HG13 ' A' 1019 ' ' ILE . 93.6 t -46.65 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 32.4 m120 75.28 -43.42 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.829 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -69.13 -145.09 0.17 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.094 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.667 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 25.8 ptm -159.22 139.83 12.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.738 0.304 . . . . 0.0 110.668 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.637 HG11 ' HG2' ' A' ' 966' ' ' PRO . 9.9 p -92.08 142.68 12.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.225 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -106.88 93.97 4.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.746 HG13 HG23 ' A' ' 980' ' ' ILE . 84.3 t -65.35 -44.73 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.393 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.0 mt 61.06 -100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.4 p -67.35 -60.4 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.5 t0 -172.53 -141.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.746 HG23 HG13 ' A' ' 976' ' ' VAL . 9.0 pt -152.83 20.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 110.815 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 70.5 mt-30 -87.32 -157.59 0.4 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.517 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 94.2 t -46.57 140.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.751 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 984' ' ' SER . . . 74.11 -79.46 0.89 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.06 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' 1003 ' ' GLU . 95.8 p 21.15 106.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.391 0.676 . . . . 0.0 112.802 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -98.77 77.16 2.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 976' ' ' VAL . 41.0 pt -80.37 137.45 21.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.509 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -108.62 130.51 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.493 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 6.6 m-85 -98.21 147.21 24.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.514 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.5 p -152.48 128.26 10.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.8 t -86.87 -133.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.41 163.82 15.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.415 0.626 . . . . 0.0 111.593 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 25.4 m -53.8 123.57 12.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 131.87 -31.53 3.05 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.232 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -139.73 142.2 36.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.094 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -82.03 121.1 26.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' 1018 ' ' PRO . 4.4 tp -67.63 123.6 20.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.579 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 996' ' ' LEU . 43.3 mm -94.65 149.55 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.193 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 75.91 177.67 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.222 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' A' 1001 ' ' SER . 44.2 m80 -74.98 131.68 40.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 0.0 111.006 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 10.0 m -75.21 28.82 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.992 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 999' ' ' HIS . 82.2 p -162.13 151.19 15.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -154.11 122.74 6.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 111.847 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 984' ' ' SER . 10.4 pt-20 -107.07 135.86 47.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.231 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.408 ' SG ' ' CZ3' ' A' 1013 ' ' TRP . 19.3 m -70.55 126.78 30.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.085 0.469 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' 1012 ' ' HIS . 0.2 OUTLIER -136.74 147.47 27.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.523 178.472 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' 1007 ' ' SER . 0.2 OUTLIER -86.55 127.02 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.613 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 46.4 t -90.09 -42.03 11.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -163.34 -36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.321 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 961' ' ' LYS . 77.0 m-20 -150.61 -49.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 111.175 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 89.4 m -97.49 137.82 35.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 111.626 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.572 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.21 140.26 43.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.752 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.671 ' O ' HD13 ' A' 1005 ' ' ILE . 9.3 p80 -149.52 153.29 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.492 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 74.8 m95 -67.95 131.61 45.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.432 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -52.43 -22.28 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.235 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.7 p -136.64 142.09 43.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.021 0.439 . . . . 0.0 112.148 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -54.94 148.66 26.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.789 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.86 120.42 7.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.447 2.098 . . . . 0.0 112.462 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.788 ' HB3' HD11 ' A' ' 996' ' ' LEU . 50.6 Cg_exo -54.95 152.21 30.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.69 HG13 HG21 ' A' ' 970' ' ' VAL . 3.6 tt -143.08 131.7 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.586 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.503 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 49.7 m -86.39 113.11 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 111.267 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -84.55 129.15 34.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.928 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.495 ' HD2' ' CD2' ' A' 1045 ' ' HIS . 20.0 ptt-85 -72.8 134.78 45.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.525 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 63.7 mt -100.72 131.07 24.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.315 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.0 115.06 4.19 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.2 1.933 . . . . 0.0 111.715 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.612 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 44.0 t -89.75 148.96 22.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.347 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 149.64 37.88 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.738 ' H ' HD23 ' A' 1027 ' ' LEU . 0.1 OUTLIER -52.52 141.4 34.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 117.048 0.424 . . . . 0.0 111.417 -179.159 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.409 ' HB2' HD11 ' A' 1072 ' ' ILE . 18.2 Cg_endo -59.11 145.01 99.13 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.547 2.164 . . . . 0.0 111.229 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.95 134.24 14.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.314 2.009 . . . . 0.0 112.128 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 73.3 p -77.5 126.17 30.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' 1034 ' ' GLY . 6.0 tt -89.56 113.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.445 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -60.86 141.17 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.932 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.6 m-20 57.55 35.37 25.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.966 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' 1031 ' ' ILE . . . -168.33 131.8 2.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.62 ' HB2' ' HD3' ' A' 1053 ' ' ARG . 35.8 m-20 -76.57 -148.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 110.82 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -155.88 141.22 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.614 HD12 ' HB ' ' A' 1051 ' ' THR . 59.5 mt -87.99 154.98 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.406 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' 1037 ' ' ILE . 73.6 m 73.79 138.33 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.265 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' 1040 ' ' ASN . 70.7 p -50.27 -61.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.978 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' 1039 ' ' THR . 55.1 t30 33.1 44.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.099 0.476 . . . . 0.0 111.091 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' 1041 ' ' ARG . 21.0 mmt85 -76.26 -161.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.956 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.08 67.86 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.672 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.2 p30 -169.72 23.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.862 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.571 ' O ' ' HD1' ' A' 1044 ' ' PHE . 0.1 OUTLIER -92.44 132.26 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.511 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' 1047 ' ' GLY . 5.6 m80 -84.26 -114.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1046 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -56.41 71.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.963 0.347 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.857 ' HA3' ' HB3' ' A' 1074 ' ' CYS . . . 43.5 -107.31 0.12 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.686 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' 1047 ' ' GLY . 95.6 p 135.06 -142.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.371 1.068 . . . . 0.0 109.806 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.846 HG22 ' HB3' ' A' 1073 ' ' TYR . 71.8 t -148.96 141.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.701 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 30.2 m -140.84 137.21 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.614 ' HB ' HD12 ' A' 1037 ' ' ILE . 72.6 m -92.5 125.41 37.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.077 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.715 ' OH ' HD13 ' A' 1072 ' ' ILE . 4.0 m-85 -72.0 156.33 39.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.62 ' HD3' ' HB2' ' A' 1035 ' ' ASP . 7.4 ptm180 -145.6 -145.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.112 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 62.0 m -155.1 145.54 22.08 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.95 0.405 . . . . 0.0 111.707 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -55.16 150.64 10.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.373 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' 1056 ' ' LEU . 1.6 mm? -70.4 -149.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -143.6 -29.28 0.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 54.8 m -144.58 -31.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' 1059 ' ' ARG . 31.9 tpt85 -167.66 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.586 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -165.68 39.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.828 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.749 ' HG2' ' H ' ' A' 1062 ' ' LYS . 27.0 ttm180 -81.26 -147.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.749 ' H ' ' HG2' ' A' 1061 ' ' ARG . 87.5 tttt -173.49 67.42 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 18.2 m -84.92 -38.37 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.223 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.687 ' HB2' ' HB3' ' A' 1054 ' ' CYS . 56.3 m-85 -72.71 147.54 45.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.114 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.98 120.48 32.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.662 HD21 ' HA ' ' A' 1070 ' ' PRO . 53.3 tp -68.46 144.26 54.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' 1089 ' ' PRO . 57.9 t -138.3 123.87 24.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 71.57 156.94 2.65 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.779 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' 1069 ' ' GLU . 41.4 tt0 30.32 65.81 0.85 Allowed Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.662 ' HA ' HD21 ' A' 1066 ' ' LEU . 88.1 Cg_endo -79.99 7.01 4.88 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.072 1.848 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 40.1 t -156.47 149.73 24.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.715 HD13 ' OH ' ' A' 1052 ' ' TYR . 25.2 pt -140.91 165.22 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.275 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.846 ' HB3' HG22 ' A' 1049 ' ' VAL . 9.9 p90 -151.58 138.72 19.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.386 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.857 ' HB3' ' HA3' ' A' 1047 ' ' GLY . 41.2 t -76.84 133.43 39.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 5.2 t -90.01 -35.05 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 73.4 m 61.84 135.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.82 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -175.25 -137.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.298 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' 1079 ' ' ASP . 27.6 t70 53.1 -138.53 1.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1079 ' ' ASP . . . . . 0.453 ' H ' ' CG ' ' A' 1078 ' ' ASP . 1.6 m-20 -92.44 -49.22 6.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.983 0.42 . . . . 0.0 110.446 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -179.86 31.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.432 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 41.3 t -87.21 -45.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 67.51 124.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.217 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.617 ' N ' HD13 ' A' 1083 ' ' ILE . 0.2 OUTLIER -153.96 137.32 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.0 m95 -70.68 126.94 30.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.8 t -70.96 -39.56 72.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -62.28 122.77 29.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.166 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 17.9 Cg_exo -67.15 -121.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.298 2.665 . . . . 0.0 112.093 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' 1087 ' ' PRO . . . -160.85 129.34 2.97 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.594 ' HB2' ' O ' ' A' 1067 ' ' VAL . 73.3 Cg_endo -74.76 -141.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.885 2.39 . . . . 0.0 113.486 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.453 ' H ' ' HB2' ' A' 1089 ' ' PRO . 9.5 tp-100 -152.39 127.28 9.61 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.439 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 44.6 t -103.11 123.49 46.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.118 -179.913 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.791 ' HG3' ' HB2' ' A' 1011 ' ' ALA . 0.4 OUTLIER 61.32 125.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.398 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.3 p -157.97 135.21 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.521 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 980' ' ' ILE . 2.9 p -84.71 148.65 26.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.171 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -63.64 140.16 58.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 -179.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 73.9 m -60.72 126.07 84.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.378 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 19.7 Cg_exo -66.87 121.5 8.71 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.47 2.113 . . . . 0.0 112.329 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 133.92 26.84 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.412 2.075 . . . . 0.0 111.676 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.26 109.4 1.41 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.769 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 971' ' ' ASN . 68.7 Cg_endo -87.83 -153.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 112.605 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' 1021 ' ' GLN . 2.2 p -49.42 88.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.32 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 969' ' ' PRO . 74.3 m-20 45.28 34.21 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.157 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.746 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -76.3 -56.88 4.15 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.786 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.631 ' HB2' ' HB2' ' A' ' 989' ' ' SER . 60.8 mtt 61.04 96.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.751 HG21 HD12 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.99 143.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.374 179.278 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.428 ' CE1' ' OG ' ' A' ' 989' ' ' SER . 1.4 m-70 -122.07 111.61 17.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.442 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.885 ' HA ' HG22 ' A' ' 986' ' ' ILE . 69.6 t -67.45 99.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.94 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 986' ' ' ILE . 41.8 mm -75.23 -90.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.685 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.0 p -65.59 -60.43 2.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.211 0.529 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.604 ' O ' HG13 ' A' ' 976' ' ' VAL . 7.5 t0 -167.49 -128.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.982 178.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.469 ' O ' ' SG ' ' A' ' 963' ' ' CYS . 5.2 pt -154.76 -21.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.742 0.306 . . . . 0.0 110.313 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' 1004 ' ' CYS . 23.5 pt20 -72.43 -164.29 0.14 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.684 HG22 HD21 ' A' 1006 ' ' LEU . 40.4 t -47.27 137.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 64.81 12.41 53.58 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.416 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' 1003 ' ' GLU . 87.7 p -77.0 171.06 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.199 0.5 . . . . 0.0 110.684 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.746 ' HD3' ' N ' ' A' ' 986' ' ' ILE . 0.0 OUTLIER -151.14 138.23 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.967 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.885 HG22 ' HA ' ' A' ' 976' ' ' VAL . 28.2 pt -142.7 173.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 111.538 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' 1000 ' ' SER . 69.6 p -136.98 124.8 22.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.61 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.6 m-85 -87.17 47.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.922 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 66.9 m 30.03 -77.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.685 ' SG ' HD13 ' A' ' 996' ' ' LEU . 33.8 m 67.02 70.65 0.38 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 1.2 t -60.16 154.54 19.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 11.0 t 38.94 -156.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 113.626 -1.625 . . . . 0.0 113.39 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -80.29 50.23 3.95 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.199 -0.455 . . . . 0.0 113.829 -178.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -82.67 149.8 27.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.85 0.325 . . . . 0.0 110.907 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.765 ' HB2' HG12 ' A' 1023 ' ' ILE . 79.5 ttt180 -80.26 93.2 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.874 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 997' ' ' ILE . 4.7 tp -76.05 124.6 27.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 996' ' ' LEU . 1.8 mp -98.15 137.55 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.128 178.144 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.76 -118.66 5.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.481 -178.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.493 ' HB2' ' HB ' ' A' 1015 ' ' THR . 1.9 m-70 -149.36 130.95 14.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.085 0.443 . . . . 0.0 111.278 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.61 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 88.1 p -79.95 34.0 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.351 0.596 . . . . 0.0 109.817 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.587 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 79.6 p -162.2 138.56 7.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.888 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.638 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -160.45 141.63 12.14 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 984' ' ' SER . 21.5 pt-20 -105.06 132.86 50.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.599 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 8.3 t -71.3 84.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -179.046 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' 1014 ' ' SER . 18.8 pt -87.27 158.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.684 HD21 HG22 ' A' ' 982' ' ' VAL . 3.3 mm? -95.31 136.18 35.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.67 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.609 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -162.43 131.02 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.18 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 58.44 39.02 92.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 61.5 m-20 56.86 36.31 27.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.676 0.274 . . . . 0.0 111.464 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.1 m -151.25 129.83 12.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.578 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.791 ' HB2' ' HG3' ' A' ' 961' ' ' LYS . . . -75.64 136.79 40.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.098 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.609 ' NE2' ' HB3' ' A' 1007 ' ' SER . 7.6 p80 -163.06 156.51 19.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.942 0.401 . . . . 0.0 111.105 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.577 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 29.6 m95 -74.35 118.28 17.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.517 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.517 ' HB3' HD13 ' A' 1005 ' ' ILE . 79.7 p -52.41 -22.37 4.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.239 -178.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.638 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 53.7 p -105.05 20.92 18.0 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.216 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' 1015 ' ' THR . 21.7 ptmt 47.49 165.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.46 107.15 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.121 1.88 . . . . 0.0 111.903 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' 1016 ' ' LYS . 90.5 Cg_endo -82.37 168.14 14.99 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.786 2.324 . . . . 0.0 112.352 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.677 HG13 ' HB ' ' A' ' 997' ' ' ILE . 18.1 pt -148.85 118.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.408 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.746 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 1.9 m -86.39 73.24 10.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.734 ' HA ' HG21 ' A' ' 970' ' ' VAL . 3.5 pt20 -71.73 -166.91 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.691 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' 1024 ' ' PRO . 38.4 ptt180 -96.94 136.18 37.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.765 HG12 ' HB2' ' A' ' 995' ' ' ARG . 53.6 mt -79.19 106.32 4.34 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.502 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' 1045 ' ' HIS . 45.6 Cg_endo -67.43 135.48 36.64 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.825 179.272 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.772 ' HB3' ' H ' ' A' 1075 ' ' THR . 3.4 p -87.62 144.03 26.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.739 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.15 174.32 53.34 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.074 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.406 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 14.4 mt -53.49 150.03 13.53 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.906 0.353 . . . . 0.0 111.142 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.439 ' CB ' ' HD2' ' A' 1029 ' ' PRO . 19.0 Cg_endo -59.74 174.75 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.987 ' HD3' ' HA ' ' A' 1085 ' ' SER . 56.6 Cg_endo -68.56 -0.78 6.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.933 2.422 . . . . 0.0 112.62 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1030 ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' 1029 ' ' PRO . 70.8 p 55.71 145.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.946 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.65 HD12 ' HB1' ' A' 1088 ' ' ALA . 13.8 tt -151.1 112.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.364 0.602 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -66.88 155.73 37.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.76 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' 1032 ' ' ALA . 69.1 m-20 75.53 -40.57 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.685 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.516 ' HA2' ' CA ' ' A' 1054 ' ' CYS . . . -70.69 -157.13 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.953 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' 1053 ' ' ARG . 55.3 m-20 -160.01 135.91 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.465 ' HE1' ' O ' ' A' 1038 ' ' SER . 0.1 OUTLIER -84.03 148.36 26.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.435 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' 1051 ' ' THR . 67.7 mt -121.78 148.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.36 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.465 ' O ' ' HE1' ' A' 1036 ' ' PHE . 11.7 t 75.93 -136.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.727 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 45.7 p -100.82 130.79 46.89 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.495 HD22 ' HB ' ' A' 1050 ' ' VAL . 22.2 t-20 -179.71 68.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.249 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' HE1' ' A' 1044 ' ' PHE . 32.0 ptt180 -170.38 105.6 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' 1041 ' ' ARG . 56.8 mt-10 69.24 -51.86 0.6 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -71.48 52.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.483 ' HE1' ' N ' ' A' 1041 ' ' ARG . 6.6 m-85 -88.5 148.93 23.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.732 0.777 . . . . 0.0 112.692 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.582 ' O ' ' SG ' ' A' 1074 ' ' CYS . 14.3 p-80 -166.88 179.03 5.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.264 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.839 ' HE1' HG11 ' A' 1081 ' ' VAL . 4.1 t80 -65.44 31.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1047 ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' 1045 ' ' HIS . . . -161.19 104.4 0.24 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.379 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1048 ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' 1074 ' ' CYS . 79.7 p 177.48 145.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.552 0.691 . . . . 0.0 111.585 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' 1072 ' ' ILE . 6.6 p -137.79 146.23 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' 1040 ' ' ASN . 7.6 p -137.71 133.5 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.968 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 91.3 m -102.48 134.22 46.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.401 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.47 ' HD2' HD13 ' A' 1031 ' ' ILE . 0.4 OUTLIER -70.56 -167.15 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.174 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.601 ' HB3' ' HB2' ' A' 1035 ' ' ASP . 6.0 tpm_? -159.62 -41.39 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.516 ' CA ' ' HA2' ' A' 1034 ' ' GLY . 88.2 m 68.4 121.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.815 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.629 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 19.0 t-20 21.66 -118.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.615 0.572 . . . . 0.0 112.068 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.692 ' HA ' HG23 ' A' 1063 ' ' VAL . 93.4 mt 62.18 117.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.106 0.479 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -100.66 129.56 9.94 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.572 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 15.7 t 72.73 -47.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.428 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.679 ' O ' ' HB3' ' A' 1056 ' ' LEU . 8.6 ttt85 -162.61 -135.51 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.244 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.494 ' H ' ' HG2' ' A' 1059 ' ' ARG . . . -88.62 46.6 3.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.202 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' 1061 ' ' ARG . 17.9 mmt85 -62.24 157.41 19.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.621 0.248 . . . . 0.0 111.197 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.57 71.7 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.994 0.426 . . . . 0.0 110.847 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' 1056 ' ' LEU . 4.0 m -154.51 86.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' 1055 ' ' ASN . 0.4 OUTLIER 70.1 143.42 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.69 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 1065 ' ' GLU . . . . . 0.442 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 49.4 mt-10 -141.98 139.53 32.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' 1067 ' ' VAL . 2.2 tt -68.38 133.06 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.064 0.459 . . . . 0.0 111.397 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.884 ' N ' HD23 ' A' 1066 ' ' LEU . 47.1 t -138.24 129.73 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 93.89 -133.06 11.47 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.681 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.742 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 37.0 tt0 -57.11 106.06 0.62 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 117.153 0.476 . . . . 0.0 111.131 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.743 ' HA ' HD11 ' A' 1066 ' ' LEU . 81.7 Cg_endo -96.24 -12.19 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.098 2.532 . . . . 0.0 113.968 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 52.8 m -156.16 167.45 30.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.412 0.625 . . . . 0.0 112.268 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' 1049 ' ' VAL . 18.4 pt -141.22 157.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.637 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -117.7 149.71 40.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' 1045 ' ' HIS . 37.2 t -61.61 159.19 13.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.188 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.899 HG21 ' H ' ' A' 1084 ' ' TRP . 15.0 t -157.59 -150.61 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1076 ' ' SER . . . . . 1.14 ' HB2' ' HB ' ' A' 1081 ' ' VAL . 47.2 t -89.79 -107.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 112.339 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' 1077 ' ' ASN . 12.1 p-10 -174.62 -30.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.317 -177.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.43 ' HA ' ' CD1' ' A' 1083 ' ' ILE . 54.4 t0 177.47 -9.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.353 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.92 -141.05 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.951 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.7 -52.47 51.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1081 ' ' VAL . . . . . 1.14 ' HB ' ' HB2' ' A' 1076 ' ' SER . 19.7 t -56.98 -24.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.731 ' C ' HD13 ' A' 1083 ' ' ILE . . . 80.75 -140.19 21.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.215 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.731 HD13 ' C ' ' A' 1082 ' ' GLY . 0.0 OUTLIER -149.75 138.16 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.472 0.653 . . . . 0.0 112.639 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.899 ' H ' HG21 ' A' 1075 ' ' THR . 0.2 OUTLIER -77.38 -114.76 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.567 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 1085 ' ' SER . . . . . 0.987 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 30.6 t 69.52 59.14 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.063 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' 1088 ' ' ALA . . . -59.22 124.36 36.34 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.688 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' 1088 ' ' ALA . 23.9 Cg_exo -64.54 22.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.329 2.019 . . . . 0.0 113.749 -178.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' 1031 ' ' ILE . . . 53.88 139.22 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 113.112 178.073 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 84.7 Cg_endo -76.11 -122.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.762 2.308 . . . . 0.0 110.725 178.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.522 ' OE1' ' HB ' ' A' 1067 ' ' VAL . 0.0 OUTLIER -152.41 143.48 23.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.939 178.824 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 3.6 m -103.13 133.91 47.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.442 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 23.4 pt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.112 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.677 0.275 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.803 ' HG2' HD11 ' A' 1006 ' ' LEU . 55.3 tptt -77.61 150.01 34.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.396 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.53 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 64.1 p -157.42 154.74 29.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.494 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 90.0 m -79.31 159.6 27.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.094 179.446 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -63.88 132.96 52.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 0.0 111.039 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 59.9 m -73.14 112.87 17.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.038 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.506 ' HG2' HG21 ' A' ' 974' ' ' VAL . 30.8 Cg_exo -61.84 123.46 12.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.242 1.961 . . . . 0.0 111.963 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.83 -50.78 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.263 1.975 . . . . 0.0 111.497 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 179.26 115.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.679 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 32.2 Cg_endo -66.03 144.73 77.1 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.462 2.108 . . . . 0.0 111.969 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.847 HG11 HG13 ' A' 1019 ' ' ILE . 0.2 OUTLIER -44.97 116.92 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.888 179.879 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 9.0 t-20 70.94 -50.31 0.68 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -77.93 -152.53 5.71 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.392 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 24.0 ptm -159.2 133.36 7.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.506 HG21 ' HG2' ' A' ' 966' ' ' PRO . 3.3 p -81.91 146.76 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.454 ' O ' ' HB ' ' A' ' 986' ' ' ILE . 22.2 m170 -123.54 105.24 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 1.057 HG13 HG23 ' A' ' 980' ' ' ILE . 52.1 t -65.31 -65.74 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 47.9 mt 75.31 -51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.255 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 45.6 p -86.62 -80.91 0.23 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.002 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.614 ' O ' HG12 ' A' ' 980' ' ' ILE . 9.2 t70 -173.35 -18.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.404 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 1.057 HG23 HG13 ' A' ' 976' ' ' VAL . 28.6 pt 54.97 72.46 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.21 0.604 . . . . 0.0 111.419 -178.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 77.8 mt-30 -152.63 38.89 0.54 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.667 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 76.6 t 101.06 133.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.924 0.889 . . . . 0.0 112.096 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 71.79 -29.93 0.62 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.361 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.598 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 79.9 p -68.45 124.01 22.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.437 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 5.1 tmm_? -101.64 118.85 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.558 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 975' ' ' HIS . 28.7 pt -95.42 -169.0 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.312 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' 1001 ' ' SER . 35.2 p -153.01 128.71 10.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.544 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.0 m-85 -93.95 149.8 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.024 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.0 m -157.35 133.43 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.688 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 9.1 m -82.02 -131.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 110.693 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.417 ' O ' ' ND1' ' A' ' 994' ' ' HIS . 1.2 t -165.02 159.24 17.74 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.796 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 992' ' ' THR . 50.8 m 37.66 54.12 1.47 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.972 0.891 . . . . 0.0 110.266 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 994' ' ' HIS . . . 78.85 -99.53 1.66 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.957 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.578 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 24.9 m80 54.85 140.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.892 0.477 . . . . 0.0 111.53 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -89.86 106.5 18.51 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.229 -0.294 . . . . 0.0 111.018 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' 1000 ' ' SER . 1.7 tt -76.15 121.23 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.8 ' HB ' HG23 ' A' 1019 ' ' ILE . 38.6 mm -89.16 153.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.832 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.77 -112.54 3.53 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.732 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' 1001 ' ' SER . 92.1 m-70 -149.72 133.75 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 111.402 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 996' ' ' LEU . 81.2 p -80.61 30.25 0.3 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 61.3 m -162.14 151.24 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -157.59 127.49 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.577 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 44.7 tt0 -103.57 126.8 50.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.598 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.584 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 41.9 t -73.56 126.52 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.537 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 20.8 pt -147.41 155.32 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.803 HD11 ' HG2' ' A' ' 961' ' ' LYS . 3.8 mm? -92.36 146.33 23.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.292 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.531 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 44.7 t -162.44 -58.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -94.2 47.4 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.129 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 30.1 m-20 60.49 13.84 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.037 0.446 . . . . 0.0 110.512 -179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.784 ' HA ' ' HE2' ' A' ' 961' ' ' LYS . 89.2 m -151.25 146.21 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.584 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.29 134.14 41.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.96 0.409 . . . . 0.0 110.714 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' 1007 ' ' SER . 8.1 p80 -152.18 146.34 25.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.402 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.747 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 57.0 m95 -70.13 124.85 25.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.7 t -52.52 -25.44 10.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 77.1 p -92.2 137.82 32.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.065 0.459 . . . . 0.0 112.046 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.64 ' NZ ' ' HB3' ' A' 1016 ' ' LYS . 0.2 OUTLIER -62.19 152.5 78.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.272 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -43.9 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.54 147.77 92.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.052 2.502 . . . . 0.0 112.413 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.847 HG13 HG11 ' A' ' 970' ' ' VAL . 5.5 tt -148.01 122.8 2.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 994' ' ' HIS . 4.4 t -86.36 113.66 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.121 0.486 . . . . 0.0 111.411 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -84.75 130.1 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.971 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -82.07 124.25 29.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.319 179.319 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.1 mt -71.8 112.71 15.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.412 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.545 ' HG3' HH12 ' A' 1022 ' ' ARG . 34.4 Cg_exo -61.6 133.21 44.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.831 2.354 . . . . 0.0 113.063 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.742 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 92.4 m -98.39 -150.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.451 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1026 ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -163.84 156.23 27.98 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.522 HD12 ' H ' ' A' 1027 ' ' LEU . 8.7 mp -40.3 132.17 1.63 Allowed Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.161 0.481 . . . . 0.0 111.459 -179.53 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.55 ' HB2' HD11 ' A' 1072 ' ' ILE . 54.4 Cg_endo -69.8 155.44 65.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.0 102.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.088 1.859 . . . . 0.0 111.363 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.3 p -77.39 118.35 19.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.661 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.78 HD13 ' HB2' ' A' 1089 ' ' PRO . 10.4 pt -93.63 116.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.474 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -49.54 141.0 9.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.722 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' 1054 ' ' CYS . 5.1 m120 74.91 -13.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.58 -140.62 0.02 OUTLIER Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.273 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' 1053 ' ' ARG . 30.4 t70 -168.9 -168.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.561 -0.376 . . . . 0.0 110.842 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.817 ' HD1' HG23 ' A' 1050 ' ' VAL . 1.2 t80 -155.99 127.52 7.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.882 HD12 ' HD2' ' A' 1053 ' ' ARG . 52.5 mt -147.78 77.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.791 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 68.8 m -160.32 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.003 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.414 HG22 ' O ' ' A' 1039 ' ' THR . 7.0 m -136.99 41.67 2.47 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.599 ' ND2' ' HB ' ' A' 1050 ' ' VAL . 5.0 m120 -72.01 -99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.762 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 60.85 48.46 6.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.63 ' HG2' ' H ' ' A' 1043 ' ' ASN . 66.9 tt0 62.95 -136.37 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.63 ' H ' ' HG2' ' A' 1042 ' ' GLU . 0.5 OUTLIER 34.23 44.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' 1042 ' ' GLU . 88.4 m-85 -77.48 147.88 35.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.401 . . . . 0.0 111.533 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' 1046 ' ' TYR . 79.3 m-70 -147.13 -49.79 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.48 179.25 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.647 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 53.9 t80 171.87 149.03 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.303 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 78.71 -17.63 6.64 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.888 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 58.8 m -47.72 144.55 3.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.85 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' 1072 ' ' ILE . 12.8 p -137.79 148.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.273 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.817 HG23 ' HD1' ' A' 1036 ' ' PHE . 2.5 p -143.13 136.11 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.253 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 87.8 m -106.54 111.97 24.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.449 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.554 ' HE1' HG12 ' A' 1072 ' ' ILE . 11.4 m-85 -85.25 142.18 29.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.882 ' HD2' HD12 ' A' 1037 ' ' ILE . 99.9 mtt180 -156.44 30.76 0.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.795 ' O ' HD22 ' A' 1056 ' ' LEU . 71.3 m 59.13 143.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 0.0 111.739 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 8.9 m120 -65.86 97.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.795 HD22 ' O ' ' A' 1054 ' ' CYS . 3.2 mm? -70.37 177.23 3.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.593 178.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' 1063 ' ' VAL . . . -82.74 -28.49 38.38 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 179.715 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 52.5 m -160.07 -29.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.69 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 33.9 tpt85 -163.83 -45.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.526 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.544 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . 178.61 43.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.775 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -77.3 46.76 0.52 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.633 0.254 . . . . 0.0 111.625 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.7 tttt 44.61 81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.173 0.511 . . . . 0.0 111.703 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' 1056 ' ' LEU . 3.3 m -155.13 95.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.465 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.701 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 65.8 m-85 72.82 136.44 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.437 -178.191 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -141.09 130.04 23.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.308 0.575 . . . . 0.0 111.693 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.828 HD21 ' HA ' ' A' 1070 ' ' PRO . 35.5 tp -68.47 158.87 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.839 HG21 HD11 ' A' 1092 ' ' ILE . 75.4 t -139.39 143.82 30.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.527 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.72 -144.56 26.66 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.12 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' 1089 ' ' PRO . 79.4 tt0 -60.41 127.81 87.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.817 0.309 . . . . 0.0 110.623 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.828 ' HA ' HD21 ' A' 1066 ' ' LEU . 26.0 Cg_endo -92.3 -54.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.813 2.342 . . . . 0.0 112.802 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 41.7 t -98.85 152.86 19.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.579 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.663 ' O ' HG23 ' A' 1049 ' ' VAL . 31.5 pt -141.42 162.06 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.258 179.086 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 6.3 p90 -151.02 141.14 22.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.417 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 46.9 t -65.11 152.41 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.233 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1075 ' ' THR . . . . . 0.443 ' C ' ' HE1' ' A' 1046 ' ' TYR . 13.1 t -140.09 -147.41 0.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.021 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.6 t -153.28 145.79 24.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.972 0.415 . . . . 0.0 111.537 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -162.7 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.064 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.22 -147.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.568 0.223 . . . . 0.0 110.626 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -83.61 -45.38 13.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.286 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -178.22 30.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.737 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.495 ' HB ' ' CD1' ' A' 1083 ' ' ILE . 43.7 t -77.25 -34.84 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 85.37 61.37 1.73 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.994 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' 1083 ' ' ILE . 2.1 mp -81.99 135.11 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.93 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 14.4 m95 -72.57 -173.93 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.978 0.418 . . . . 0.0 112.003 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.3 t -59.51 -71.24 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.149 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 137.43 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.308 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.93 136.23 34.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.735 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -167.6 -44.99 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.78 ' HB2' HD13 ' A' 1031 ' ' ILE . 63.3 Cg_exo -48.23 137.98 23.38 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.122 1.881 . . . . 0.0 112.138 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.405 ' O ' HD12 ' A' 1066 ' ' LEU . 10.5 pt20 -149.7 134.57 17.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 0.0 111.619 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 29.1 t -90.67 132.54 35.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.839 HD11 HG21 ' A' 1067 ' ' VAL . 39.2 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.074 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.933 0.397 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.918 ' HD2' ' H ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -79.18 132.02 36.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.878 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -92.44 135.57 33.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.728 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 80.9 m -81.1 26.42 0.44 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.037 0.446 . . . . 0.0 110.652 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 962' ' ' SER . 59.6 tttm 61.12 136.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.573 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.854 ' HA ' HG21 ' A' ' 980' ' ' ILE . 4.7 t -58.06 129.11 82.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.148 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 1.013 ' HG2' HG11 ' A' ' 974' ' ' VAL . 55.7 Cg_endo -69.72 107.2 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.115 1.877 . . . . 0.0 112.197 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 10.4 Cg_endo -53.47 143.68 54.26 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.546 2.164 . . . . 0.0 111.078 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -40.4 113.33 0.95 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.171 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.809 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 24.2 Cg_exo -64.03 148.24 91.54 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.044 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 971' ' ' ASN . 0.2 OUTLIER -43.92 114.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.458 179.853 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.539 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 5.6 t-20 71.01 -57.45 0.6 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.096 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 990' ' ' CYS . . . -70.06 -162.47 3.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.978 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.809 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 88.5 mtp -158.15 140.12 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 1.013 HG11 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -83.66 148.85 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.592 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.81 87.15 2.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.997 179.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.519 ' HA ' HG22 ' A' ' 986' ' ' ILE . 58.4 t -65.45 109.85 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 29.3 mm -75.14 -83.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.909 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.4 p -81.42 -61.04 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.266 0.555 . . . . 0.0 109.979 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 976' ' ' VAL . 4.3 p-10 -165.94 -130.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.558 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.854 HG21 ' HA ' ' A' ' 965' ' ' THR . 0.2 OUTLIER -144.97 10.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 111.109 178.871 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.771 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 87.2 mt-30 -85.68 171.76 11.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.988 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.1 t -44.31 143.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.2 -31.25 1.83 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.276 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 36.2 m -68.4 124.02 22.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.028 0.414 . . . . 0.0 110.928 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.788 ' HD2' ' N ' ' A' ' 986' ' ' ILE . 5.5 tmm_? -101.63 152.2 21.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.562 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.788 ' N ' ' HD2' ' A' ' 985' ' ' ARG . 38.3 pt -142.25 138.41 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 80.8 p -107.53 125.68 51.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.682 ' HB2' ' HA ' ' A' 1000 ' ' SER . 5.2 m-85 -92.08 149.24 21.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.761 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.9 m -159.93 121.3 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.075 0.464 . . . . 0.0 111.335 179.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.6 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 85.0 m -99.91 155.15 17.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 35.9 p -61.6 161.16 10.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.089 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.1 m -57.45 145.68 32.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.695 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.59 -45.62 1.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.184 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.453 ' N ' ' CD2' ' A' ' 994' ' ' HIS . 11.7 m-70 -82.45 136.06 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.758 0.313 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.582 ' HB2' HD11 ' A' 1023 ' ' ILE . 44.0 ttm-85 -82.03 130.47 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.619 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.703 ' HA ' ' SG ' ' A' 1020 ' ' CYS . 0.9 OUTLIER -76.11 126.91 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.058 0.456 . . . . 0.0 111.59 -179.474 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.591 ' HB ' HG13 ' A' 1019 ' ' ILE . 1.7 mp -107.14 148.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.443 178.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.44 -119.35 4.84 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.021 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.42 ' C ' ' H ' ' A' 1001 ' ' SER . 92.0 m-70 -149.67 133.53 16.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.132 0.466 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.682 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.2 p -78.44 30.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.2 p -162.19 140.07 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.356 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -164.13 131.12 3.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.603 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -104.94 137.52 42.57 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.502 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 53.4 t -71.1 131.69 43.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' 1011 ' ' ALA . 45.9 pt -148.04 -165.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 111.285 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.616 HD21 ' HD3' ' A' ' 961' ' ' LYS . 3.9 mm? -99.04 163.42 12.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.4 t -162.51 -116.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -49.96 -43.86 40.58 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.779 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.9 t30 -167.73 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 110.981 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 7.7 t -96.48 -162.52 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.227 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.728 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -80.05 139.11 37.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.996 0.426 . . . . 0.0 110.925 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.463 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 42.0 m80 -149.4 140.03 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 89.3 m95 -66.71 133.6 50.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.069 0.461 . . . . 0.0 110.956 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.7 p -52.33 -23.97 6.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.883 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.0 p -121.4 140.37 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 111.695 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -54.26 151.73 12.84 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.083 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.02 105.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.321 2.014 . . . . 0.0 112.028 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.15 143.72 96.35 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.603 2.202 . . . . 0.0 111.942 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.591 HG13 ' HB ' ' A' ' 997' ' ' ILE . 36.5 pt -138.67 -171.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 89.9 m -153.78 131.4 11.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.506 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.512 ' HG2' HD11 ' A' ' 997' ' ' ILE . 98.2 mm-40 -80.32 132.31 35.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.412 ' HD3' ' CD2' ' A' 1045 ' ' HIS . 15.7 ptp180 -67.98 -25.17 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 995' ' ' ARG . 46.4 mt 59.96 73.11 0.68 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.833 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.706 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 78.1 Cg_exo -49.8 126.98 17.78 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.362 2.041 . . . . 0.0 112.447 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 23.8 t -88.49 147.18 24.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.661 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.07 142.66 28.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.64 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' 1028 ' ' PRO . 28.4 tp -54.73 131.41 65.37 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1028 ' ' PRO . . . . . 1.012 ' HB3' HD11 ' A' 1072 ' ' ILE . 67.0 Cg_exo -52.6 153.77 13.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.195 2.597 . . . . 0.0 112.821 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 37.4 Cg_exo -58.98 127.83 25.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.353 2.035 . . . . 0.0 111.664 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.5 p -77.47 142.24 39.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.206 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' 1031 ' ' ILE . 29.7 pt -140.37 123.07 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.417 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.42 141.74 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.278 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 75.63 -37.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.765 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -65.04 121.13 20.77 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.4 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.542 ' HB3' ' HG2' ' A' 1053 ' ' ARG . 35.5 t0 -82.23 -158.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.841 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -157.18 142.67 17.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 111.339 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.895 HD11 ' HD3' ' A' 1053 ' ' ARG . 6.9 mt -149.69 -138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.851 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.677 ' H ' HG22 ' A' 1037 ' ' ILE . 58.2 m 71.81 -163.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.499 HG23 ' N ' ' A' 1040 ' ' ASN . 7.9 t -73.66 -46.63 45.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.689 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.564 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 73.0 m-80 -54.06 151.13 7.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.18 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.841 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 83.1 mtm180 -143.02 -48.57 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.256 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.1 OUTLIER -162.94 145.24 10.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.48 179.656 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' 1042 ' ' GLU . 31.7 m-20 82.13 -46.59 0.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.517 ' HD2' ' HZ2' ' A' 1084 ' ' TRP . 1.1 m-85 54.82 57.07 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.738 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.706 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 2.7 m-70 -52.52 -44.65 65.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.454 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.6 ' HB2' ' O ' ' A' 1045 ' ' HIS . 9.7 t80 166.89 70.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.999 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -77.59 -77.02 0.85 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.935 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 4.3 m 167.71 -53.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' 1073 ' ' TYR . 20.4 t -147.56 153.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.658 HG11 ' HG2' ' A' 1028 ' ' PRO . 10.4 p -135.65 120.22 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.3 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' A' 1071 ' ' SER . 91.4 m -93.85 126.37 39.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.391 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' 1053 ' ' ARG . 13.2 m-85 -82.42 -41.29 20.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.895 ' HD3' HD11 ' A' 1037 ' ' ILE . 17.2 ptt180 66.5 -34.04 0.2 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.165 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.665 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 83.9 m 66.95 135.53 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.723 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 33.5 m-20 21.58 -105.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' 1061 ' ' ARG . 0.2 OUTLIER -154.9 139.36 16.83 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.96 0.409 . . . . 0.0 111.032 -179.225 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.542 ' O ' ' HG2' ' A' 1061 ' ' ARG . . . -88.92 -48.44 3.86 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.205 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 66.7 m -102.3 -57.39 2.07 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.464 ' O ' HD22 ' A' 1056 ' ' LEU . 27.2 mtt85 -76.98 117.41 18.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.405 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 74.49 -37.7 1.01 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.77 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' 1056 ' ' LEU . 0.0 OUTLIER 62.3 -139.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.483 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.522 ' H ' ' CD ' ' A' 1061 ' ' ARG . 59.6 tttm 69.02 25.2 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.514 0.673 . . . . 0.0 110.053 -178.602 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' 1055 ' ' ASN . 11.7 p -84.86 23.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.787 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' 1064 ' ' PHE . 0.2 OUTLIER 39.24 -131.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.086 0.47 . . . . 0.0 109.932 179.459 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -132.1 123.79 27.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.919 178.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.611 HD21 ' CA ' ' A' 1070 ' ' PRO . 48.3 tp -68.85 129.04 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 111.678 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' 1090 ' ' GLN . 62.0 t -106.35 121.45 58.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.986 179.289 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.42 -147.58 34.48 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.548 179.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' 1069 ' ' GLU . 0.3 OUTLIER -69.01 131.3 90.89 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.611 ' CA ' HD21 ' A' 1066 ' ' LEU . 54.1 Cg_endo -70.77 -32.84 13.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 111.777 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' 1051 ' ' THR . 80.4 p -142.58 132.01 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.363 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1072 ' ' ILE . . . . . 1.012 HD11 ' HB3' ' A' 1028 ' ' PRO . 18.4 pt -87.81 -167.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.167 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.85 ' HB3' HG22 ' A' 1049 ' ' VAL . 7.9 p90 -158.89 137.37 10.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 0.0 112.072 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 49.0 t -76.7 164.0 26.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.915 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 6.5 t -155.04 -33.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 89.8 p 58.97 148.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.303 0.377 . . . . 0.0 110.904 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.59 ' OD1' HD11 ' A' 1083 ' ' ILE . 44.7 p-10 -164.81 -30.1 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 62.2 t0 -55.42 -87.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.708 0.29 . . . . 0.0 111.14 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -163.2 -38.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.555 ' OE1' ' HA ' ' A' 1023 ' ' ILE . 12.8 tp-100 -166.22 51.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.701 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 15.6 t -130.38 -48.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.568 -178.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 66.28 125.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.989 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.648 ' N ' HD13 ' A' 1083 ' ' ILE . 0.2 OUTLIER -150.42 137.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.025 0.44 . . . . 0.0 111.141 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.564 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 18.4 m95 -70.53 135.83 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.196 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 46.8 t -65.93 -50.93 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' 1072 ' ' ILE . . . -65.99 125.88 28.21 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.705 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.96 41.52 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.6 2.2 . . . . 0.0 112.817 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 58.71 138.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.319 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' 1090 ' ' GLN . 84.6 Cg_endo -80.39 -150.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.748 2.299 . . . . 0.0 112.237 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.774 ' HG2' HG12 ' A' 1092 ' ' ILE . 35.0 tt0 -152.36 134.07 14.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.272 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 37.0 m -91.96 78.6 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.795 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1092 ' ' ILE . . . . . 0.774 HG12 ' HG2' ' A' 1090 ' ' GLN . 46.0 pt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.442 179.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.064 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 4.3 mptp? 61.63 159.07 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.407 0.623 . . . . 0.0 112.153 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.439 ' C ' ' HB3' ' A' 1011 ' ' ALA . 49.6 m -157.94 138.96 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.678 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.587 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -79.93 38.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 111.608 -179.152 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 55.6 tptt 63.68 130.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.564 ' HA ' HD12 ' A' ' 980' ' ' ILE . 88.8 m -74.43 130.04 82.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.733 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.712 ' HG2' HG11 ' A' ' 974' ' ' VAL . 68.8 Cg_endo -101.34 72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.912 3.075 . . . . 0.0 113.38 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 968' ' ' ASP . 57.1 Cg_endo -70.02 125.9 12.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.985 1.79 . . . . 0.0 111.731 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 967' ' ' PRO . 59.0 m-20 16.5 62.8 0.18 Allowed Pre-proline 0 N--CA 1.467 0.378 0 O-C-N 123.759 0.662 . . . . 0.0 112.167 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.634 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 39.2 Cg_exo -58.83 -143.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.002 2.468 . . . . 0.0 113.185 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' 1019 ' ' ILE . 4.0 p -49.05 85.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.819 -179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 969' ' ' PRO . 6.7 p-10 38.95 48.73 1.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.979 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.634 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -162.44 128.57 1.9 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.805 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 22.2 ptm -88.77 135.92 33.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 111.548 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.81 HG21 HD12 ' A' ' 986' ' ' ILE . 4.1 p -91.56 146.85 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -107.59 96.71 6.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.24 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.781 ' HA ' HG22 ' A' ' 986' ' ' ILE . 14.0 m -65.37 113.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.298 0.57 . . . . 0.0 110.801 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 987' ' ' THR . 38.8 mt -79.92 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.315 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.1 p -149.33 54.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.572 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 980' ' ' ILE . 1.6 m-20 59.57 -154.32 0.37 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.942 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.629 HG22 ' HH2' ' A' 1013 ' ' TRP . 6.1 pt -155.91 95.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.117 0.484 . . . . 0.0 111.463 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 84.1 mt-30 -152.62 28.98 0.54 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.55 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 66.0 t 102.13 135.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 124.239 0.962 . . . . 0.0 111.099 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.34 -29.75 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.862 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 982' ' ' VAL . 49.7 m -68.4 132.93 47.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 111.058 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 38.2 ttm180 -101.71 147.42 26.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.81 HD12 HG21 ' A' ' 974' ' ' VAL . 39.7 pt -143.14 134.08 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.17 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.738 ' HA ' ' HA ' ' A' 1001 ' ' SER . 80.3 p -100.72 122.96 44.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.058 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.597 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.8 m-85 -88.36 120.47 29.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.447 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 80.9 p -88.82 -54.09 4.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.609 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 13.0 t 69.54 142.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -178.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.1 p -60.25 146.75 42.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.284 0.564 . . . . 0.0 111.849 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.1 t -52.99 -26.65 15.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.38 41.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.52 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -139.87 139.99 36.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.245 0.522 . . . . 0.0 111.413 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' 1080 ' ' GLN . 57.0 ttt-85 -81.97 125.62 30.98 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.029 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' 1018 ' ' PRO . 0.7 OUTLIER -72.78 140.37 47.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.226 0.536 . . . . 0.0 111.605 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' 1019 ' ' ILE . 45.6 mm -107.92 148.53 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.1 41.49 21.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.674 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.46 136.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 112.122 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 82.7 p -79.16 36.36 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.439 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 46.2 m -158.58 160.61 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.471 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -159.81 128.8 5.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.392 . . . . 0.0 111.892 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -104.99 125.16 50.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.116 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 31.1 t -68.8 129.3 39.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.731 0.3 . . . . 0.0 110.753 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.727 HD13 ' HB2' ' A' 1014 ' ' SER . 15.0 pt -138.51 152.52 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' 1007 ' ' SER . 0.3 OUTLIER -95.47 120.38 35.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.405 ' N ' HD13 ' A' 1006 ' ' LEU . 47.0 t -80.9 -45.17 17.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.363 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -166.09 -34.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.079 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -148.84 -49.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.15 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 86.8 m -99.75 135.87 40.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 179.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.587 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.36 143.05 43.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.268 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.417 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 90.7 m-70 -149.45 142.94 25.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.629 ' HH2' HG22 ' A' ' 980' ' ' ILE . 79.3 m95 -68.14 116.71 9.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.105 0.478 . . . . 0.0 110.642 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.727 ' HB2' HD13 ' A' 1005 ' ' ILE . 47.2 t -52.42 -22.35 4.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.243 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.1 p -90.1 16.34 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.429 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.821 ' HA ' ' HE3' ' A' 1016 ' ' LYS . 0.0 OUTLIER 58.58 159.27 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.275 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.39 127.31 25.45 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.25 1.967 . . . . 0.0 112.104 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.626 ' HB2' HD21 ' A' ' 996' ' ' LEU . 67.2 Cg_endo -73.09 148.55 44.84 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.797 2.332 . . . . 0.0 112.371 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.965 ' HA ' HG11 ' A' ' 970' ' ' VAL . 6.4 tt -148.81 125.31 2.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.592 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 61.7 m -85.45 101.28 12.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.493 . . . . 0.0 112.006 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.453 ' HB3' HD11 ' A' ' 997' ' ' ILE . 59.2 tt0 -79.7 140.06 37.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.112 178.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.5 tpt180 -50.03 135.8 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.377 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' 1046 ' ' TYR . 26.6 mm -55.59 119.29 23.82 Favored Pre-proline 0 C--O 1.226 -0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.368 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' 1045 ' ' HIS . 67.4 Cg_endo -92.37 138.5 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.184 2.589 . . . . 0.0 112.877 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1025 ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 71.8 m -112.93 30.08 7.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.752 0.311 . . . . 0.0 111.622 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 42.84 -138.03 3.26 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.776 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1027 ' ' LEU . . . . . 0.532 ' HB3' ' HD2' ' A' 1028 ' ' PRO . 19.9 mt -108.74 164.96 13.56 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1028 ' ' PRO . . . . . 0.618 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 37.9 Cg_endo -66.0 152.22 81.91 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.72 2.28 . . . . 0.0 112.3 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1029 ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' A' 1030 ' ' THR . 86.1 Cg_exo -47.44 -29.2 9.69 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.626 2.217 . . . . 0.0 112.935 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1030 ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' 1029 ' ' PRO . 20.1 m 64.71 147.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1031 ' ' ILE . . . . . 0.536 ' HB ' ' HB1' ' A' 1088 ' ' ALA . 13.2 tt -152.47 125.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1032 ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -65.75 135.62 55.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.518 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1033 ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' 1032 ' ' ALA . 4.4 m120 74.81 -38.19 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.574 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1034 ' ' GLY . . . . . 0.811 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.66 121.6 22.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.699 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1035 ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' 1036 ' ' PHE . 9.6 t70 -74.46 163.34 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1036 ' ' PHE . . . . . 0.487 ' HB2' ' CG2' ' A' 1050 ' ' VAL . 29.9 p90 -144.31 136.35 26.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.204 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1037 ' ' ILE . . . . . 0.917 HG22 ' H ' ' A' 1038 ' ' SER . 5.7 mt -87.91 -160.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1038 ' ' SER . . . . . 0.917 ' H ' HG22 ' A' 1037 ' ' ILE . 57.0 m 55.26 -133.04 1.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1039 ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' 1041 ' ' ARG . 41.1 p -152.96 70.1 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1040 ' ' ASN . . . . . 0.622 HD22 ' HB ' ' A' 1050 ' ' VAL . 1.9 m-80 -78.29 44.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.499 0.666 . . . . 0.0 109.69 178.472 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1041 ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' 1039 ' ' THR . 32.6 ptt180 -82.5 -43.93 16.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.209 -178.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1042 ' ' GLU . . . . . 0.455 ' HG2' ' H ' ' A' 1043 ' ' ASN . 74.3 tt0 -162.92 -126.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.922 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1043 ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' 1044 ' ' PHE . 39.8 m-20 37.48 -125.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.212 0.205 . . . . 0.0 111.136 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1044 ' ' PHE . . . . . 0.618 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 5.3 m-30 69.52 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.969 0.414 . . . . 0.0 111.589 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1045 ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' 1023 ' ' ILE . 70.6 m-70 -149.42 -49.48 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.704 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1046 ' ' TYR . . . . . 0.665 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.5 t80 176.32 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.743 0.782 . . . . 0.0 110.343 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.48 -18.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.049 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 70.0 p -47.6 145.53 2.61 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.877 -0.662 . . . . 0.0 112.78 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1049 ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -145.59 155.26 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.457 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1050 ' ' VAL . . . . . 0.622 ' HB ' HD22 ' A' 1040 ' ' ASN . 5.9 p -153.97 130.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.981 0.419 . . . . 0.0 112.041 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1051 ' ' THR . . . . . 0.585 ' HB ' HD12 ' A' 1037 ' ' ILE . 85.8 m -103.43 116.55 32.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1052 ' ' TYR . . . . . 0.582 ' HE1' HG12 ' A' 1072 ' ' ILE . 7.4 m-85 -74.92 151.37 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1053 ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' 1053 ' ' ARG . 50.1 ttt-85 -142.75 -13.89 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.948 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1054 ' ' CYS . . . . . 0.811 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 91.9 m 69.88 152.19 0.1 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.895 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1055 ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' 1033 ' ' ASN . 27.9 t-20 -50.34 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.577 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1056 ' ' LEU . . . . . 0.811 HD23 HG23 ' A' 1063 ' ' VAL . 15.8 mt 61.02 -148.27 0.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.591 0.71 . . . . 0.0 111.393 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1057 ' ' GLY . . . . . 0.464 ' C ' ' N ' ' A' 1059 ' ' ARG . . . 71.84 -34.49 0.61 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.903 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1058 ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' 1059 ' ' ARG . 53.2 m -47.67 -26.99 1.71 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1059 ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' 1057 ' ' GLY . 39.3 mmm-85 -157.07 -1.24 0.11 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.488 -1.687 . . . . 0.0 108.656 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1060 ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' 1061 ' ' ARG . . . 48.31 30.46 7.97 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1061 ' ' ARG . . . . . 0.603 ' HD2' ' N ' ' A' 1062 ' ' LYS . 4.8 tmm_? 178.65 134.98 0.08 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.064 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1062 ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' 1061 ' ' ARG . 39.5 ttpt 54.64 42.34 31.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.904 0.859 . . . . 0.0 109.37 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1063 ' ' VAL . . . . . 0.811 HG23 HD23 ' A' 1056 ' ' LEU . 14.8 m -140.59 57.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.466 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1064 ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 71.3 m-85 83.9 95.59 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.081 -178.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -89.85 151.15 21.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.185 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1066 ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' 1070 ' ' PRO . 27.6 tp -68.56 142.67 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.484 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1067 ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 58.9 t -139.0 133.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.29 -139.12 21.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.956 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1069 ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' 1069 ' ' GLU . 1.1 pm0 -66.4 125.6 90.66 Favored Pre-proline 0 N--CA 1.453 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 111.837 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1070 ' ' PRO . . . . . 0.523 ' HB3' HD21 ' A' 1066 ' ' LEU . 3.3 Cg_endo -83.8 -26.94 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.142 2.562 . . . . 0.0 112.134 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1071 ' ' SER . . . . . 0.442 ' OG ' HG23 ' A' 1051 ' ' THR . 49.1 m -144.09 147.84 34.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1072 ' ' ILE . . . . . 0.582 HG12 ' HE1' ' A' 1052 ' ' TYR . 26.6 pt -143.61 160.65 16.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.336 0.588 . . . . 0.0 111.761 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1073 ' ' TYR . . . . . 0.53 ' HB3' HG23 ' A' 1049 ' ' VAL . 0.6 OUTLIER -160.19 148.61 16.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.504 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A 1074 ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 48.3 t -65.66 145.33 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 9.9 t -157.7 23.13 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.767 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 99.2 p 52.59 176.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.575 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1077 ' ' ASN . . . . . 0.565 HD22 HD12 ' A' 1083 ' ' ILE . 33.8 p-10 -174.1 -40.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.508 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1078 ' ' ASP . . . . . 0.431 ' HB3' HG23 ' A' 1081 ' ' VAL . 7.9 t70 -84.04 -75.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.841 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.14 -41.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1080 ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 995' ' ' ARG . 3.0 pm0 -162.87 29.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1081 ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' 1078 ' ' ASP . 21.9 t -83.92 -37.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1082 ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 78.85 45.82 8.93 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.165 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1083 ' ' ILE . . . . . 0.565 HD12 HD22 ' A' 1077 ' ' ASN . 67.7 mt -81.98 136.04 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.008 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1084 ' ' TRP . . . . . 0.616 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.4 m95 -70.54 146.76 49.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.862 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 85.2 p -44.93 -37.25 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.885 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1086 ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.63 141.07 6.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.907 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1087 ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 34.0 Cg_exo -57.79 177.29 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.928 2.419 . . . . 0.0 112.758 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1088 ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' 1031 ' ' ILE . . . -63.63 141.34 97.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.618 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1089 ' ' PRO . . . . . 0.488 ' HB2' ' H ' ' A' 1090 ' ' GLN . 37.6 Cg_endo -66.72 -141.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.916 2.411 . . . . 0.0 112.586 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1090 ' ' GLN . . . . . 0.671 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 47.2 mm-40 -145.37 132.65 20.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.019 0.437 . . . . 0.0 111.206 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1091 ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 95.9 m -99.53 72.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.197 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 35.9 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.044 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.44 -46.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -172.22 123.76 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.824 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -172.75 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.369 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.46 126.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.453 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -99.49 141.84 31.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.161 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.664 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 93.7 m -80.0 33.02 0.27 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.792 0.33 . . . . 0.0 110.809 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 962' ' ' SER . 60.5 tttp 60.8 136.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.546 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 42.8 m -63.94 124.55 85.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.167 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.671 ' HG2' HG11 ' A' ' 974' ' ' VAL . 37.0 Cg_endo -66.06 109.73 1.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.217 1.945 . . . . 0.0 111.958 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 9.0 Cg_exo -71.41 129.93 16.6 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.642 2.228 . . . . 0.0 111.805 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -51.33 104.9 0.46 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 2.6 Cg_exo -76.6 -152.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.734 2.289 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 970' ' ' VAL . 2.2 p -50.47 83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.156 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 991' ' ' THR . 3.4 t30 68.68 -34.9 0.28 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.622 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.4 116.4 7.48 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.253 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.27 140.17 31.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.584 0.23 . . . . 0.0 111.162 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.671 HG11 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -89.94 147.69 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.208 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 977' ' ' ILE . 18.8 m170 -111.94 82.53 1.64 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 976' ' ' VAL . 4.3 p -69.04 85.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 975' ' ' HIS . 50.5 mt -75.37 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.25 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.9 p -55.9 -72.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.671 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 3.4 m-20 -157.42 -133.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 979' ' ' ASP . 1.5 pt -155.87 -21.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 83.7 mt-30 -72.52 176.42 5.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.447 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' 1004 ' ' CYS . 71.4 t -44.35 144.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.938 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.66 -30.43 1.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.439 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.671 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 34.6 m -68.47 153.53 43.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' 1002 ' ' ALA . 53.0 ttt-85 -138.32 150.02 46.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.906 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.484 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 36.4 pt -142.8 -169.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 68.3 p -148.49 130.63 15.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.486 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.5 OUTLIER -98.31 154.95 17.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.076 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 94.1 p -161.23 128.1 4.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 111.851 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.612 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 85.1 m -82.92 51.15 1.86 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.944 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.531 HG22 HD21 ' A' ' 971' ' ' ASN . 14.9 t 38.22 -149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.262 0.553 . . . . 0.0 111.907 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 19.4 m -95.65 141.21 29.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.46 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.47 82.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.161 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.534 ' HB2' ' O ' ' A' ' 990' ' ' CYS . 50.4 m80 -152.83 135.03 14.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.92 0.36 . . . . 0.0 110.846 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.428 ' HG3' HH11 ' A' ' 995' ' ' ARG . 38.4 ttt85 -81.94 121.45 26.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 997' ' ' ILE . 2.9 tt -76.2 128.86 35.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.456 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.679 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -102.22 146.87 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.13 -118.86 4.71 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.503 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -149.65 129.54 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.164 0.482 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.0 p -69.9 -43.99 70.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 95.7 p -77.85 136.08 38.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.64 149.62 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.454 . . . . 0.0 111.433 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -134.0 131.63 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 50.3 t -70.43 96.88 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' 1012 ' ' HIS . 27.5 pt -90.43 -175.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' 1011 ' ' ALA . 9.6 tp -158.42 120.41 3.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 43.8 m -81.77 -48.65 11.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.495 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.88 -48.21 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.96 -49.83 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 91.6 m -151.19 149.95 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.304 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.664 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.16 140.48 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.553 ' O ' HG12 ' A' 1005 ' ' ILE . 90.5 m-70 -149.39 145.88 27.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 71.7 m95 -71.27 132.66 45.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.735 0.303 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.8 p -52.46 -29.07 22.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 72.9 p -87.76 -134.62 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -166.95 150.13 6.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.731 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -40.62 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.17 . . . . 0.0 112.503 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 29.8 Cg_exo -63.1 135.64 52.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.907 2.405 . . . . 0.0 112.028 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.917 HG22 ' H ' ' A' 1020 ' ' CYS . 5.0 mt -95.75 -170.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.006 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.917 ' H ' HG22 ' A' 1019 ' ' ILE . 67.6 m -152.31 98.02 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.473 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.597 ' H ' HD13 ' A' ' 997' ' ' ILE . 34.2 tp60 -82.53 131.51 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.684 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.8 tpt180 -65.9 127.93 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.61 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.3 mm -63.25 106.63 0.94 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.504 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' 1045 ' ' HIS . 3.5 Cg_exo -76.12 136.37 18.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.7 2.267 . . . . 0.0 112.881 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.78 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 29.8 p -124.73 133.94 53.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.03 -154.45 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.733 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.54 147.97 87.54 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 120.66 0.266 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.712 ' HD3' ' HE2' ' A' 1044 ' ' PHE . 78.6 Cg_endo -75.86 142.97 25.94 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.533 2.155 . . . . 0.0 111.6 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.752 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.0 Cg_exo -51.67 106.29 0.13 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 121.997 1.798 . . . . 0.0 111.508 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 90.3 m -77.46 126.81 31.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.665 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.936 HD13 ' HB2' ' A' 1089 ' ' PRO . 18.0 pt -90.41 136.53 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.893 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -52.0 138.38 25.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.774 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' 1032 ' ' ALA . 4.4 m120 75.14 -36.18 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.799 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -72.23 132.86 19.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.814 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -81.64 -159.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.148 0.499 . . . . 0.0 111.335 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.638 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -155.99 133.18 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.587 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' 1050 ' ' VAL . 39.4 pt -142.04 -148.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.963 0.411 . . . . 0.0 111.484 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.486 ' HB2' ' H ' ' A' 1051 ' ' THR . 8.2 t 78.21 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.861 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 28.7 p -66.46 -43.3 85.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.755 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' 1044 ' ' PHE . 4.5 m120 -52.21 140.18 21.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.254 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.638 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 86.3 mtm180 -155.16 -47.17 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.402 ' C ' ' HD1' ' A' 1044 ' ' PHE . 23.4 pt-20 -162.99 -43.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -71.67 58.26 0.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.461 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.712 ' HE2' ' HD3' ' A' 1028 ' ' PRO . 2.3 m-85 -76.68 132.21 39.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' 1046 ' ' TYR . 3.2 m-70 -130.71 -56.29 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.16 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' 1023 ' ' ILE . 78.0 t80 170.79 150.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.443 0.464 . . . . 0.0 110.386 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.577 ' N ' ' HB2' ' A' 1074 ' ' CYS . . . 76.46 -31.12 1.42 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.681 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.427 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 49.4 m -45.85 131.26 9.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' 1072 ' ' ILE . 6.8 p -102.2 146.45 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' 1037 ' ' ILE . 7.3 p -133.39 135.15 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.504 ' HB ' HG13 ' A' 1037 ' ' ILE . 44.1 m -98.63 122.57 42.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.53 ' OH ' ' HB2' ' A' 1028 ' ' PRO . 3.6 m-85 -85.64 167.11 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.508 ' HG3' HH11 ' A' 1053 ' ' ARG . 28.9 mtt85 -159.59 -149.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.972 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.799 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 8.5 t -163.57 157.68 19.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 110.531 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.699 ' O ' ' HG ' ' A' 1056 ' ' LEU . 31.3 m120 -55.13 153.47 6.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.513 . . . . 0.0 112.316 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' 1055 ' ' ASN . 1.4 mt -154.97 43.25 0.47 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.937 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' 1058 ' ' SER . . . 72.48 -59.48 1.59 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.387 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' 1057 ' ' GLY . 43.3 t 174.38 -18.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 0.0 110.681 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -155.27 55.47 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.28 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . 72.49 129.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.285 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.501 ' O ' HD23 ' A' 1056 ' ' LEU . 39.6 ttm180 -178.15 145.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.577 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -65.25 81.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' 1056 ' ' LEU . 9.6 m -151.82 88.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.516 0.674 . . . . 0.0 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.905 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 72.5 m-85 70.79 141.86 0.05 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.511 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1065 ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.7 mt-10 -142.39 142.33 32.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.103 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' 1067 ' ' VAL . 1.4 tt -68.57 137.71 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.295 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.825 ' N ' HD23 ' A' 1066 ' ' LEU . 7.3 p -139.49 127.43 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.663 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.55 138.56 1.4 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.395 -0.821 . . . . 0.0 114.056 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.807 ' O ' ' HG3' ' A' 1089 ' ' PRO . 32.9 tt0 36.75 59.21 3.64 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.193 0.597 . . . . 0.0 112.457 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1070 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.21 6.58 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.231 1.954 . . . . 0.0 112.612 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' 1069 ' ' GLU . 81.0 p -156.17 147.12 22.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.308 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' 1028 ' ' PRO . 44.7 pt -142.22 179.73 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -160.06 154.68 24.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.447 . . . . 0.0 111.828 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.577 ' HB2' ' N ' ' A' 1047 ' ' GLY . 65.8 m -62.6 146.23 52.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.907 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.0 t -155.76 -158.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.055 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.6 p -151.48 143.37 23.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' 1078 ' ' ASP . 46.5 p-10 -164.82 29.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.6 t70 176.38 52.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.258 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.25 -129.08 0.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.503 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.684 ' HG2' ' H ' ' A' 1081 ' ' VAL . 47.6 tt0 -67.59 -139.85 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.684 ' H ' ' HG2' ' A' 1080 ' ' GLN . 27.2 t 72.99 -43.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 122.541 0.336 . . . . 0.0 111.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.78 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 67.85 64.51 3.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.658 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' 1083 ' ' ILE . 3.4 mp -81.89 135.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 110.555 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 26.0 m95 -78.14 -160.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 77.6 p -81.58 -65.03 1.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 144.14 5.53 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.696 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.752 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 98.5 Cg_endo -83.71 49.9 3.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.097 2.531 . . . . 0.0 112.034 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.495 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -64.33 -41.62 61.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.936 ' HB2' HD13 ' A' 1031 ' ' ILE . 86.6 Cg_exo -45.78 137.78 12.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.507 2.138 . . . . 0.0 113.051 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.802 ' O ' HG12 ' A' 1067 ' ' VAL . 38.3 tt0 -150.32 143.08 24.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.905 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 73.9 m -84.32 137.18 33.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.458 ' H ' ' H ' ' A' 1065 ' ' GLU . 31.0 pt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -171.61 -44.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.82 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 63.78 123.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.796 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 43.39 38.23 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.851 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.542 ' HG3' HD11 ' A' 1006 ' ' LEU . 46.6 mmtm 62.1 145.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.987 0.423 . . . . 0.0 111.422 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 82.1 p -157.97 136.01 10.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.5 m -79.95 164.45 23.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.317 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.84 126.77 28.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 965' ' ' THR . 4.2 t -76.77 114.09 35.81 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.855 ' HG2' HG11 ' A' ' 974' ' ' VAL . 86.5 Cg_endo -85.48 111.06 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.485 2.123 . . . . 0.0 112.142 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 19.6 Cg_endo -58.88 -39.55 80.24 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.282 1.988 . . . . 0.0 110.951 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 62.9 t0 179.25 119.14 0.21 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.443 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 974' ' ' VAL . 35.5 Cg_endo -64.84 -150.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 112.613 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.786 HG11 ' H ' ' A' 1020 ' ' CYS . 9.6 p -53.13 -136.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.559 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.751 ' H ' HG22 ' A' ' 970' ' ' VAL . 4.7 m120 -65.33 -33.39 75.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.066 0.46 . . . . 0.0 110.583 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.439 ' H ' HG13 ' A' ' 970' ' ' VAL . . . -69.08 -147.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.803 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 85.5 mtp -156.35 142.51 18.2 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.327 0.251 . . . . 0.0 110.408 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.855 HG11 ' HG2' ' A' ' 966' ' ' PRO . 1.1 p -92.18 144.94 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.004 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -121.22 112.38 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.14 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 980' ' ' ILE . 90.5 t -64.72 -41.49 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.773 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 978' ' ' THR . 20.2 mt 64.88 -98.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.144 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 977' ' ' ILE . 12.6 p -80.73 -52.85 7.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.528 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 980' ' ' ILE . 21.1 m-20 -169.3 -157.69 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.235 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 976' ' ' VAL . 20.1 pt -155.91 10.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.837 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 74.3 mt-30 -73.2 -45.72 54.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.624 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 7.5 p 167.38 151.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 79.43 -40.32 2.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.361 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 14.4 t -69.83 141.99 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.39 . . . . 0.0 111.049 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 37.3 ttm180 -110.96 118.29 35.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.118 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.615 HD12 ' CG2' ' A' ' 974' ' ' VAL . 36.7 pt -91.28 138.46 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.203 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 82.6 p -103.51 132.18 49.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 4.7 m-85 -101.41 152.62 20.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.7 m -154.21 126.05 7.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.594 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 991' ' ' THR . 37.3 t -98.64 178.68 4.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.422 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 61.2 p -65.11 -158.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.216 0.532 . . . . 0.0 111.84 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 46.0 m -86.04 -68.02 0.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.001 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' 1046 ' ' TYR . . . -81.02 42.29 2.7 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.424 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.6 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 41.6 m80 -149.48 125.35 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 0.0 110.726 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.416 ' HB3' ' OE1' ' A' 1080 ' ' GLN . 52.2 ttt-85 -95.14 121.63 36.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.745 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 1.4 tt -76.21 137.34 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.66 ' HB ' HG23 ' A' 1019 ' ' ILE . 1.8 mp -101.29 149.81 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.017 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.79 34.68 38.01 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.691 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 58.96 130.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.223 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 988' ' ' TYR . 49.8 m -83.05 41.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.62 ' O ' HG21 ' A' 1015 ' ' THR . 68.8 m -162.18 148.39 13.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -159.22 128.06 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.5 tt0 -103.25 125.67 50.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.527 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 44.6 t -68.4 84.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' 1014 ' ' SER . 49.7 pt -87.3 -162.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.737 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' 1007 ' ' SER . 5.2 tt -158.36 125.81 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.346 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.544 ' N ' HD23 ' A' 1006 ' ' LEU . 45.3 m -78.39 -55.88 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.413 ' N ' HD23 ' A' 1006 ' ' LEU . . . 169.55 42.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.727 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.521 ' H ' HD21 ' A' 1006 ' ' LEU . 21.7 p30 -177.9 -36.95 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.26 149.58 29.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.527 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.26 132.95 41.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.129 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -149.43 145.81 27.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.501 ' HH2' HG22 ' A' ' 980' ' ' ILE . 52.3 m95 -70.82 122.83 20.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.328 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.6 p -52.48 -25.69 10.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.708 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.62 HG21 ' O ' ' A' 1001 ' ' SER . 50.5 p -87.72 -144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' 1016 ' ' LYS . 10.7 mtmp? -151.57 161.27 30.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.281 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 78.6 Cg_exo -40.95 124.69 2.08 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.61 2.206 . . . . 0.0 112.692 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.647 ' HB2' HD21 ' A' ' 996' ' ' LEU . 90.7 Cg_endo -80.67 145.59 16.32 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.143 2.562 . . . . 0.0 113.376 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 997' ' ' ILE . 7.2 tt -148.84 113.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.99 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.786 ' H ' HG11 ' A' ' 970' ' ' VAL . 9.7 t -86.44 121.16 28.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.124 0.488 . . . . 0.0 111.382 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -85.55 136.61 33.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.616 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' 1024 ' ' PRO . 57.8 mtt85 -75.93 127.75 33.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.177 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.775 HG12 ' HG3' ' A' 1080 ' ' GLN . 84.9 mt -76.73 108.54 6.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.282 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.912 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 66.7 Cg_endo -74.0 121.54 7.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.384 2.056 . . . . 0.0 111.384 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.529 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 16.8 m -89.16 28.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1026 ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' A' 1044 ' ' PHE . . . 37.22 -158.83 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.668 -0.697 . . . . 0.0 114.273 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' 1027 ' ' LEU . 7.7 mp -74.01 145.78 84.09 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 122.599 0.36 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.843 ' HB3' HD11 ' A' 1072 ' ' ILE . 23.1 Cg_exo -63.43 144.8 91.57 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.731 2.287 . . . . 0.0 111.375 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' 1072 ' ' ILE . 5.9 Cg_endo -47.86 113.9 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.243 1.962 . . . . 0.0 111.396 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 64.0 p -77.78 141.36 39.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.304 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.501 HD13 ' HB1' ' A' 1088 ' ' ALA . 25.6 pt -147.82 121.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.64 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.08 135.63 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.123 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' 1032 ' ' ALA . 76.4 m-20 75.01 -38.36 0.38 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.516 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -69.98 76.97 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.81 126.26 29.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' 1038 ' ' SER . 17.8 p90 -93.26 147.3 23.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.98 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' 1038 ' ' SER . 49.8 mm -87.37 159.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.822 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.484 ' N ' HG22 ' A' 1037 ' ' ILE . 23.1 t 75.39 144.65 0.08 Allowed 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' 1041 ' ' ARG . 17.0 p -66.13 -57.02 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.486 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 61.28 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' 1039 ' ' THR . 49.8 mtt85 40.27 -128.36 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.29 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' 1043 ' ' ASN . 8.2 pt-20 -77.15 -145.75 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' 1042 ' ' GLU . 62.9 m-20 34.85 36.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.212 0.529 . . . . 0.0 110.61 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.474 ' CZ ' ' HA2' ' A' 1026 ' ' GLY . 1.2 p90 -89.02 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.048 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.912 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 21.0 p-80 -165.36 -164.59 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.174 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.512 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 22.1 t80 -59.24 153.76 17.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 111.56 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' 1049 ' ' VAL . . . 68.77 10.52 61.24 Favored Glycine 0 C--N 1.33 0.222 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.296 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' A' 1025 ' ' CYS . 74.4 p -48.39 134.32 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.179 0.49 . . . . 0.0 109.929 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.766 HG22 ' HA ' ' A' 1073 ' ' TYR . 38.3 t -146.72 142.86 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 28.4 m -152.64 134.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.192 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.419 HG23 ' OG ' ' A' 1071 ' ' SER . 91.2 m -92.9 124.72 37.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.695 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.583 ' OH ' HD13 ' A' 1072 ' ' ILE . 8.2 m-85 -73.72 154.67 39.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.473 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.458 ' HG3' HH11 ' A' 1053 ' ' ARG . 38.0 ttt85 -148.3 0.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.959 ' HB2' HG12 ' A' 1063 ' ' VAL . 59.0 m 64.12 152.27 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 111.079 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' 1057 ' ' GLY . 48.5 t30 -62.62 -49.19 76.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' 1060 ' ' GLY . 0.4 OUTLIER -71.31 39.23 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' 1055 ' ' ASN . . . -89.02 -24.17 32.93 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.1 p -151.91 121.14 6.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.324 -0.938 . . . . 0.0 109.52 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' 1058 ' ' SER . 38.5 mmt180 81.71 44.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.32 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.806 ' C ' HD23 ' A' 1056 ' ' LEU . . . 179.99 -44.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' 1062 ' ' LYS . 51.4 mmt-85 64.5 177.59 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 122.499 0.32 . . . . 0.0 111.826 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' 1061 ' ' ARG . 16.0 tptm 75.85 -41.7 0.44 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.367 0.603 . . . . 0.0 109.619 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.959 HG12 ' HB2' ' A' 1054 ' ' CYS . 0.0 OUTLIER 47.64 40.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.346 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.569 ' HE1' ' H ' ' A' 1056 ' ' LEU . 0.1 OUTLIER 42.84 -138.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -150.19 121.07 7.62 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.342 0.591 . . . . 0.0 110.47 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' 1070 ' ' PRO . 55.0 tp -68.5 145.58 53.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.167 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 65.1 t -138.2 131.75 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.889 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.38 -143.67 22.91 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.429 ' OE2' HG22 ' A' 1072 ' ' ILE . 22.5 pt-20 -68.49 126.94 93.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.436 ' HB3' HD21 ' A' 1066 ' ' LEU . 2.7 Cg_endo -83.3 -10.21 10.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.104 2.536 . . . . 0.0 111.759 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.419 ' OG ' HG23 ' A' 1051 ' ' THR . 49.4 m -153.5 127.41 8.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.093 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' 1028 ' ' PRO . 19.4 pt -89.5 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.3 0.572 . . . . 0.0 111.905 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.766 ' HA ' HG22 ' A' 1049 ' ' VAL . 24.8 p90 -145.06 128.94 17.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 13.5 t -63.68 164.15 10.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.113 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.0 t -155.78 -27.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.484 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 56.1 m 65.48 146.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.921 0.391 . . . . 0.0 111.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -164.98 -34.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.853 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 9.5 t70 -60.28 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.62 0.248 . . . . 0.0 110.863 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -162.95 -42.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.761 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.775 ' HG3' HG12 ' A' 1023 ' ' ILE . 17.9 tt0 -175.0 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.23 0.538 . . . . 0.0 110.321 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' 1082 ' ' GLY . 20.5 t -83.33 -117.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.678 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . -165.78 50.85 0.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.776 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' 1083 ' ' ILE . 2.0 mp -81.95 126.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.697 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.8 m95 -85.37 -151.23 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' 1073 ' ' TYR . 80.2 p -95.39 -27.63 15.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.111 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.43 152.66 21.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.612 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 10.7 Cg_exo -73.48 47.35 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 112.883 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' 1031 ' ' ILE . . . 65.36 141.89 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.859 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.504 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 58.6 Cg_endo -69.89 -146.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.726 2.284 . . . . 0.0 112.113 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.472 ' H ' ' HB2' ' A' 1089 ' ' PRO . 46.2 mm-40 -150.65 128.71 11.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 91.9 m -96.69 70.54 2.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.459 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.25 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.64 0.257 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.14 132.56 52.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.027 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 86.5 tt0 53.96 45.13 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 110.412 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -78.46 38.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.262 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 0.8 OUTLIER 61.63 122.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.628 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 31.0 t -157.95 131.96 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.934 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 2.9 p -79.84 142.22 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.68 126.36 27.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 0.0 110.665 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.775 ' HB ' HD13 ' A' ' 980' ' ' ILE . 9.1 t -67.89 131.91 92.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.111 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.65 ' HG2' HG21 ' A' ' 974' ' ' VAL . 22.7 Cg_exo -64.74 108.83 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.349 2.033 . . . . 0.0 111.649 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 965' ' ' THR . 88.9 Cg_exo -48.02 -46.76 21.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.537 2.158 . . . . 0.0 111.644 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 968' ' ' ASP . 2.1 p30 179.28 111.73 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.223 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.55 152.9 74.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.668 2.245 . . . . 0.0 111.971 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.509 ' HB ' HG13 ' A' 1019 ' ' ILE . 60.0 t -48.02 100.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 31.4 m120 74.44 -50.74 0.68 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.597 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -73.44 141.34 29.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.908 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.4 mtp -89.28 138.12 31.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 966' ' ' PRO . 4.9 p -83.5 151.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.397 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 987' ' ' THR . 1.0 OUTLIER -119.07 76.17 1.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.812 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.535 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 48.5 t -75.21 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.27 -75.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.825 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 33.2 p -56.42 -88.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.567 ' OD1' ' HB2' ' A' ' 981' ' ' GLN . 2.8 p30 -168.7 151.42 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 965' ' ' THR . 5.1 pt -83.93 27.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.337 0.589 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.567 ' HB2' ' OD1' ' A' ' 979' ' ' ASP . 87.6 mt-30 -90.37 151.73 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.07 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' 1004 ' ' CYS . 74.8 t -44.26 146.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.734 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 83.26 -39.85 2.8 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 114.258 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.2 m -68.45 175.72 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.612 0.706 . . . . 0.0 111.143 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.455 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 4.7 tmm_? -156.6 128.72 7.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.194 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.535 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 34.3 pt -97.28 -163.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 975' ' ' HIS . 54.7 p -149.23 130.13 14.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.937 0.398 . . . . 0.0 112.028 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.1 m-85 -99.18 147.82 24.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.376 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -151.13 132.15 14.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.547 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 85.8 m -81.93 -125.93 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 992' ' ' THR . 1.8 t -165.01 176.15 8.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.306 0.574 . . . . 0.0 111.375 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.474 ' N ' ' OG1' ' A' ' 991' ' ' THR . 22.1 m -48.54 131.02 17.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.643 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.19 84.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.459 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.01 122.44 7.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.943 0.371 . . . . 0.0 110.706 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' 1080 ' ' GLN . 38.0 ttm180 -82.24 114.54 20.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 997' ' ' ILE . 7.6 tp -76.27 127.81 33.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.24 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.8 mp -98.75 140.78 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.482 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.2 174.34 40.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.068 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' 1001 ' ' SER . 86.6 m-70 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 0.0 111.357 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.3 p -75.4 31.3 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.838 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 999' ' ' HIS . 63.0 m -162.12 152.18 16.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.048 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.846 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -150.8 129.03 11.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.63 122.96 33.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.097 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 14.9 t -70.13 80.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 40.7 pt -87.33 -142.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.526 ' HG ' ' C ' ' A' 1010 ' ' THR . 5.1 tt -158.39 121.62 3.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.878 0.37 . . . . 0.0 110.566 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 53.0 m -92.03 47.03 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.811 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.48 ' N ' HD23 ' A' 1006 ' ' LEU . . . 75.35 -57.63 2.85 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.092 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.18 -60.08 3.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.855 0.327 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.526 ' C ' ' HG ' ' A' 1006 ' ' LEU . 15.2 t -151.27 -172.51 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.611 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.26 136.89 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 111.003 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -149.44 151.72 34.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.836 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.846 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 61.2 m95 -72.41 127.45 32.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.9 t -52.46 -27.7 17.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.972 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 82.5 p -105.8 142.28 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 111.95 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -57.08 149.2 47.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.276 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.84 108.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.247 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.442 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 34.1 Cg_exo -59.3 148.73 85.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.897 2.398 . . . . 0.0 112.163 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.693 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 9.1 tt -148.82 135.71 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.433 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 50.1 m -86.49 159.42 19.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.912 0.387 . . . . 0.0 110.64 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.444 ' HB3' HD11 ' A' ' 997' ' ' ILE . 55.3 tt0 -153.5 117.69 4.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.666 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -64.21 127.66 32.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.194 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' 1045 ' ' HIS . 76.0 mt -71.05 126.69 92.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 26.0 Cg_endo -61.39 126.49 19.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.563 2.175 . . . . 0.0 112.776 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.734 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 71.6 m -97.21 135.05 39.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -84.74 151.72 26.65 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.49 ' HA ' ' CZ ' ' A' 1044 ' ' PHE . 1.4 mm? -39.44 137.15 1.06 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 117.168 0.484 . . . . 0.0 111.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.557 ' HG3' HG11 ' A' 1050 ' ' VAL . 29.7 Cg_endo -63.68 145.24 91.04 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.677 2.251 . . . . 0.0 112.12 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.629 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.4 Cg_exo -54.61 91.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.295 1.997 . . . . 0.0 111.376 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1030 ' ' THR . . . . . 0.503 HG23 ' O ' ' A' 1028 ' ' PRO . 53.2 p -77.47 118.78 20.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.66 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' 1089 ' ' PRO . 18.4 pt -84.95 119.89 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.46 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -43.55 141.53 1.41 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' 1032 ' ' ALA . 77.3 m-20 78.08 -38.78 0.26 Allowed 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.506 0.504 . . . . 0.0 111.001 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -69.78 120.11 9.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.428 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' 1052 ' ' TYR . 1.4 m-20 -83.06 173.46 11.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.682 ' HA ' ' O ' ' A' 1051 ' ' THR . 43.9 p90 -151.43 133.64 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.169 0.509 . . . . 0.0 111.728 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.719 HD11 ' HD2' ' A' 1053 ' ' ARG . 29.5 mt -108.54 45.34 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.713 ' HB3' HG12 ' A' 1050 ' ' VAL . 81.6 p -71.2 -140.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.701 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' 1041 ' ' ARG . 88.7 m -161.16 -29.53 0.05 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.601 ' HB3' ' OG ' ' A' 1048 ' ' SER . 21.8 p30 -53.35 -39.05 63.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' 1039 ' ' THR . 37.9 mmt180 59.02 -111.43 0.55 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.231 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.12 -131.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.51 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.1 p30 -56.26 145.6 26.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' 1027 ' ' LEU . 29.6 p90 -159.79 129.23 5.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.75 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' O ' ' A' 1023 ' ' ILE . 48.9 m-70 -76.6 -41.54 45.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' 1045 ' ' HIS . 60.1 t80 176.03 157.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.551 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' 1048 ' ' SER . . . 76.54 96.67 0.17 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.284 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.601 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 45.7 t 174.26 153.68 0.11 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1049 ' ' VAL . . . . . 1.001 HG12 ' HB3' ' A' 1073 ' ' TYR . 3.6 m -137.81 159.42 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.258 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' 1038 ' ' SER . 18.1 m -133.37 134.67 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' 1036 ' ' PHE . 86.7 m -104.77 119.05 38.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' 1035 ' ' ASP . 7.7 m-85 -80.56 160.07 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.719 ' HD2' HD11 ' A' 1037 ' ' ILE . 79.6 mtp180 -142.71 -41.6 0.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.777 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 40.1 t 70.73 122.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.818 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' 1064 ' ' PHE . 58.6 m-20 17.57 -123.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.785 ' HA ' HG23 ' A' 1063 ' ' VAL . 79.6 mt 69.5 123.49 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.69 -62.79 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.612 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.474 ' C ' ' HD2' ' A' 1059 ' ' ARG . 38.2 t -90.06 44.02 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.554 ' HD2' ' N ' ' A' 1059 ' ' ARG . 0.0 OUTLIER 39.45 44.98 1.21 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.071 -179.121 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.59 -29.13 0.12 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.098 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -45.75 146.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.605 0.241 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.561 ' HB3' ' NZ ' ' A' 1062 ' ' LYS . 6.3 ttpm? -65.37 80.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.986 0.422 . . . . 0.0 111.59 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' 1056 ' ' LEU . 3.2 m -155.17 90.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' 1055 ' ' ASN . 0.5 OUTLIER 68.75 144.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.566 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -146.18 143.36 29.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 112.338 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' 1070 ' ' PRO . 34.6 tp -68.55 151.7 46.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.969 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.878 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 76.9 t -138.22 136.25 44.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.061 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.1 -148.09 32.6 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.131 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.1 pt-20 -63.45 128.6 92.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.574 ' HB3' HD21 ' A' 1066 ' ' LEU . 79.4 Cg_endo -94.74 11.16 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.974 2.449 . . . . 0.0 113.23 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' 1050 ' ' VAL . 80.2 p -157.02 145.86 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1072 ' ' ILE . . . . . . . . . . . . . 42.9 pt -140.95 174.29 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.631 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1073 ' ' TYR . . . . . 1.001 ' HB3' HG12 ' A' 1049 ' ' VAL . 1.6 p90 -160.04 148.13 16.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.486 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.895 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 44.6 t -65.37 137.37 57.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.409 ' O ' ' O ' ' A' 1076 ' ' SER . 8.0 t -154.98 11.05 0.35 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' 1075 ' ' THR . 99.7 p 55.74 151.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.464 ' OD1' ' HB ' ' A' 1083 ' ' ILE . 47.9 p-10 -168.34 40.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.508 ' HB3' ' CG2' ' A' 1081 ' ' VAL . 54.3 t0 -178.57 -18.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' 1080 ' ' GLN . 33.1 m-20 70.42 134.63 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.604 ' HA ' ' NH2' ' A' ' 995' ' ' ARG . 72.7 mt-30 76.2 21.96 1.4 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 109.211 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' 1080 ' ' GLN . 2.6 m -163.3 109.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.075 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.734 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . -74.31 63.89 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.581 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.464 ' HB ' ' OD1' ' A' 1077 ' ' ASN . 64.4 mt -81.92 138.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.895 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.5 m95 -70.98 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.002 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.0 t -80.61 -65.75 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.999 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.6 145.44 6.08 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.343 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 92.3 Cg_endo -81.71 51.12 3.73 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.116 2.544 . . . . 0.0 112.787 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.486 ' HB3' ' CG ' ' A' 1069 ' ' GLU . . . -66.28 -43.94 56.29 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.602 ' HG3' ' O ' ' A' 1069 ' ' GLU . 87.1 Cg_exo -43.56 137.74 5.75 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.438 2.092 . . . . 0.0 112.699 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.878 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 48.8 mm-40 -129.77 127.96 41.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 36.5 t -93.45 72.41 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.266 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 957' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 957' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.265 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 59.03 -138.78 0.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -171.37 47.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.938 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.12 51.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.593 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -77.62 146.86 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.545 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 80.4 p -157.98 143.29 16.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.524 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 95.5 m -80.01 146.83 31.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.256 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.83 139.43 58.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 111.337 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 62.9 m -68.28 128.12 93.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.981 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.515 ' HG2' HG21 ' A' ' 974' ' ' VAL . 11.0 Cg_exo -70.05 127.38 14.29 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 111.211 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.08 -60.09 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.114 1.876 . . . . 0.0 111.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 175.73 115.18 0.12 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.782 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 18.3 Cg_exo -66.22 134.92 38.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.489 2.126 . . . . 0.0 111.727 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.599 HG22 ' OD1' ' A' ' 971' ' ' ASN . 0.8 OUTLIER -49.11 125.47 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.039 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.599 ' OD1' HG22 ' A' ' 970' ' ' VAL . 32.6 m120 75.29 -58.32 0.57 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.225 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -80.04 -161.54 23.89 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.782 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 40.6 tpp -160.47 135.16 7.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.613 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.569 ' CG2' HD12 ' A' ' 986' ' ' ILE . 2.8 p -81.76 150.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.321 . . . . 0.0 110.779 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 0.7 OUTLIER -117.31 99.5 7.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.498 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.636 HG23 HG23 ' A' ' 980' ' ' ILE . 7.2 p -75.03 86.19 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.704 0.764 . . . . 0.0 109.693 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.22 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.505 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 984' ' ' SER . 41.2 p -79.86 79.27 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 111.044 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 980' ' ' ILE . 1.5 m-20 52.1 -142.38 0.75 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.054 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.636 HG23 HG23 ' A' ' 976' ' ' VAL . 3.6 pt -155.84 23.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 75.5 mt-30 -85.6 169.97 13.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.675 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' 1004 ' ' CYS . 92.3 t -44.33 145.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.368 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.51 ' HA2' ' OE2' ' A' 1003 ' ' GLU . . . 78.97 -44.45 2.59 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.927 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 978' ' ' THR . 92.8 p -68.36 123.64 21.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.463 0.631 . . . . 0.0 111.047 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.758 ' HD3' ' HB2' ' A' 1001 ' ' SER . 33.8 ttm180 -102.71 135.82 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.846 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.569 HD12 ' CG2' ' A' ' 974' ' ' VAL . 16.3 pt -95.52 -170.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.954 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 55.7 p -148.29 123.9 10.44 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.585 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 4.9 m-85 -97.24 154.15 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.539 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 20.8 m -157.64 126.29 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.668 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 85.0 m -85.16 147.83 26.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.518 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 991' ' ' THR . 0.0 OUTLIER -60.37 163.36 5.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.587 0.708 . . . . 0.0 112.154 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.4 m -55.79 138.25 48.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.476 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 71.52 40.1 60.06 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.836 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -151.07 138.53 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.494 0.188 . . . . 0.0 110.545 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 995' ' ' ARG . 37.3 ttt85 -82.02 127.13 32.77 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.218 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.668 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 3.5 tt -76.22 118.72 19.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 111.38 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' 1021 ' ' GLN . 30.4 mm -94.2 140.87 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.93 177.19 32.09 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.105 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.544 ' O ' ' HG3' ' A' 1018 ' ' PRO . 22.7 m170 -75.03 127.27 32.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.299 . . . . 0.0 111.172 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.4 p -79.02 26.36 0.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.044 0.45 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.758 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.1 p -162.16 140.44 8.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.401 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -156.09 128.45 7.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.51 ' OE2' ' HA2' ' A' ' 983' ' ' GLY . 85.6 tt0 -89.99 130.83 36.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.443 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.56 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 51.3 t -67.16 128.54 36.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' 1011 ' ' ALA . 31.2 pt -134.8 -142.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' 1010 ' ' THR . 0.3 OUTLIER -144.08 120.45 10.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 -179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 46.0 t -85.93 -47.89 9.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.414 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 177.28 -50.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.111 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 42.3 t30 -79.79 -51.41 9.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.737 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.404 ' C ' HD22 ' A' 1006 ' ' LEU . 11.8 t -151.28 -161.95 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.56 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.31 140.78 43.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 39.6 m80 -149.49 144.58 26.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.475 ' HH2' HG22 ' A' ' 980' ' ' ILE . 68.6 m95 -67.0 135.21 53.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.883 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 82.4 p -52.49 -22.2 4.58 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.675 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.509 HG21 ' ND1' ' A' ' 999' ' ' HIS . 70.8 p -131.44 139.86 49.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.876 0.369 . . . . 0.0 111.918 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -52.16 145.47 18.45 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.826 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 5.8 Cg_endo -48.57 103.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.396 2.064 . . . . 0.0 111.806 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.585 ' HG2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_endo -62.42 150.79 86.09 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 111.998 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.653 HG13 ' HB ' ' A' ' 997' ' ' ILE . 41.3 pt -125.77 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 971' ' ' ASN . 22.0 m -146.75 121.32 9.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.789 ' HB2' HD11 ' A' ' 997' ' ' ILE . 64.8 tp60 -83.48 128.36 34.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' 1022 ' ' ARG . 40.4 ttt85 -81.55 117.89 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.121 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' 1076 ' ' SER . 75.7 mt -70.94 112.4 13.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.82 127.1 8.46 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.543 2.162 . . . . 0.0 112.139 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.614 ' HB2' ' O ' ' A' 1044 ' ' PHE . 62.8 m -88.43 -145.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 0.0 111.564 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1026 ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' 1044 ' ' PHE . . . -161.08 154.81 25.87 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.629 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.571 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 45.8 mt -42.51 137.93 2.22 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-O 120.81 0.338 . . . . 0.0 111.529 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.516 ' CB ' HG11 ' A' 1050 ' ' VAL . 13.1 Cg_endo -56.31 146.68 71.26 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.777 2.318 . . . . 0.0 111.743 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.41 108.66 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.155 1.903 . . . . 0.0 111.606 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 82.1 p -77.59 116.54 18.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.877 HG21 ' HD2' ' A' 1089 ' ' PRO . 11.6 pt -100.28 29.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.449 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 55.2 120.95 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.415 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 61.7 m-80 69.64 12.41 8.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.745 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.62 134.51 38.34 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.998 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.81 -37.25 79.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.721 ' HD1' HG23 ' A' 1050 ' ' VAL . 0.8 OUTLIER 61.34 108.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.831 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.85 HG22 ' H ' ' A' 1038 ' ' SER . 7.9 mt -111.34 -176.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.715 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.85 ' H ' HG22 ' A' 1037 ' ' ILE . 15.7 t 69.71 -129.51 0.08 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.168 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 25.3 p -145.03 140.26 28.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 111.739 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.449 ' OD1' ' HD3' ' A' 1028 ' ' PRO . 0.4 OUTLIER -169.79 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.469 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' 1041 ' ' ARG . 42.1 mtp85 52.03 -142.18 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.7 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -79.06 -45.2 20.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.0 p30 -65.93 141.56 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' 1025 ' ' CYS . 0.5 OUTLIER -163.21 40.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.837 0.351 . . . . 0.0 111.212 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' 1046 ' ' TYR . 23.9 m80 -53.49 -40.27 65.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' 1045 ' ' HIS . 43.9 t80 173.61 159.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.695 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.99 -24.99 3.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.136 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 69.1 m -47.61 139.78 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' 1072 ' ' ILE . 14.4 p -138.19 157.65 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.721 HG23 ' HD1' ' A' 1036 ' ' PHE . 3.3 p -154.02 135.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.742 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 92.3 m -100.96 123.65 45.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.708 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.739 ' HD2' HD13 ' A' 1031 ' ' ILE . 3.7 m-85 -83.7 144.52 29.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.008 0.433 . . . . 0.0 111.355 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.532 ' HA ' ' HB2' ' A' 1066 ' ' LEU . 42.8 ttm-85 -157.42 -25.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.791 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 16.2 m 64.86 145.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.059 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -62.85 129.77 41.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.288 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.807 ' HG ' ' HA2' ' A' 1060 ' ' GLY . 1.9 mm? -70.33 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.639 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' 1056 ' ' LEU . . . -152.05 29.41 0.9 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 23.8 p 177.44 -51.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.74 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' 1059 ' ' ARG . 19.3 tpt85 -169.61 -49.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.807 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -172.72 29.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.985 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' 1056 ' ' LEU . 40.1 mtp85 -80.35 169.5 17.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.752 0.31 . . . . 0.0 111.09 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.32 83.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' 1064 ' ' PHE . 3.3 m -155.05 99.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.506 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.9 m-30 79.49 62.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.088 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -86.56 130.01 34.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.61 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' 1069 ' ' GLU . 3.2 tm? -68.53 138.66 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.266 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.583 ' H ' HD22 ' A' 1066 ' ' LEU . 11.6 t -151.91 156.68 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1068 ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' 1067 ' ' VAL . . . 79.79 -27.76 2.56 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.989 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.706 ' O ' HD11 ' A' 1066 ' ' LEU . 16.5 tp10 -167.82 103.7 0.57 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.994 0.397 . . . . 0.0 111.323 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.431 ' HA ' ' CD1' ' A' 1066 ' ' LEU . 95.7 Cg_endo -87.5 -28.94 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.0 2.467 . . . . 0.0 114.642 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 48.9 m -152.95 137.19 16.52 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.604 HD11 ' OH ' ' A' 1052 ' ' TYR . 28.6 pt -140.94 166.23 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.641 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.536 ' HB3' HG23 ' A' 1049 ' ' VAL . 2.9 p90 -157.17 145.73 19.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.963 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 52.3 t -63.84 148.54 49.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.497 . . . . 0.0 111.413 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.7 t -140.89 150.56 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.114 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' 1023 ' ' ILE . 54.5 m -74.54 123.34 24.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.462 HD22 HG13 ' A' 1083 ' ' ILE . 36.6 p30 179.31 -165.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.742 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' 1081 ' ' VAL . 8.3 t0 44.35 46.64 7.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' 1080 ' ' GLN . 9.9 t0 72.97 -59.4 0.57 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.178 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.449 ' HG2' ' OD1' ' A' 1079 ' ' ASP . 18.0 pt20 179.61 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' 1078 ' ' ASP . 42.6 t -86.32 -38.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 82.58 55.41 3.02 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.484 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.462 HG13 HD22 ' A' 1077 ' ' ASN . 33.8 pt -81.96 137.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.688 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.499 ' HZ3' HG12 ' A' 1050 ' ' VAL . 11.9 m95 -70.58 146.52 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.641 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 80.1 p -56.54 -9.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.423 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.43 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.42 135.94 3.92 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.36 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.43 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 15.0 Cg_exo -69.44 -153.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.057 2.504 . . . . 0.0 113.038 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.812 ' HB1' HG22 ' A' 1031 ' ' ILE . . . -77.16 138.5 64.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.432 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.877 ' HD2' HG21 ' A' 1031 ' ' ILE . 2.3 Cg_endo -80.47 -136.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.491 2.794 . . . . 0.0 111.898 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.431 ' H ' ' HB2' ' A' 1089 ' ' PRO . 10.8 tp-100 -152.41 119.84 5.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.757 0.313 . . . . 0.0 110.889 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 88.8 m -103.11 128.75 49.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.523 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.367 -179.323 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.828 0.347 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 56.4 45.47 22.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.535 ' HG3' ' HZ3' ' A' ' 961' ' ' LYS . 39.4 tt0 55.91 47.34 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.516 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -68.0 -48.86 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.535 ' HZ3' ' HG3' ' A' ' 959' ' ' GLU . 47.6 mmtm 63.26 138.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 56.9 p -157.96 140.51 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 98.6 m -79.85 134.05 36.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -64.96 142.02 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.004 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.7 m -50.8 121.09 14.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' 1013 ' ' TRP . 50.6 Cg_exo -55.69 132.31 51.36 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.392 2.062 . . . . 0.0 112.416 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.72 140.64 62.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.425 2.083 . . . . 0.0 111.355 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.6 m-20 -48.57 117.65 6.24 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 110.719 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.582 ' HG2' ' N ' ' A' ' 973' ' ' MET . 18.8 Cg_endo -58.9 149.2 80.24 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.801 2.334 . . . . 0.0 112.524 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' 1020 ' ' CYS . 79.4 t -42.8 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.426 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 30.9 m120 73.42 -42.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.727 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.607 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -69.1 -156.34 1.09 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.079 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.582 ' N ' ' HG2' ' A' ' 969' ' ' PRO . 22.5 ptp -159.25 138.89 11.61 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.631 0.253 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.953 ' HA ' ' HB3' ' A' ' 988' ' ' TYR . 0.7 OUTLIER -87.33 145.53 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.398 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -119.13 106.78 12.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 68.9 t -69.71 94.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.542 HD11 ' OG1' ' A' ' 987' ' ' THR . 39.3 mt -75.24 -90.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.367 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 37.2 p -62.11 -68.62 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 27.4 t70 -166.89 -138.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.064 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.466 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 10.9 pt -155.81 53.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 961' ' ' LYS . 66.2 tt0 -152.65 158.04 41.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.719 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' 1004 ' ' CYS . 56.5 t -28.29 123.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.31 0.381 . . . . 0.0 111.334 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.58 2.6 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.682 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 88.0 p -157.1 127.23 6.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.818 0.342 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 58.6 mtt85 -101.54 149.57 23.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.7 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.601 HD11 ' HB3' ' A' 1002 ' ' ALA . 38.9 pt -142.78 168.85 13.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.075 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.542 ' OG1' HD11 ' A' ' 977' ' ' ILE . 66.5 p -146.12 147.38 31.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.834 0.349 . . . . 0.0 111.867 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.953 ' HB3' ' HA ' ' A' ' 974' ' ' VAL . 6.5 p90 -145.9 159.29 43.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.8 p -155.23 143.48 20.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.931 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.628 ' H ' HD12 ' A' ' 996' ' ' LEU . 36.8 t -82.01 -179.56 7.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.452 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 38.1 p -60.24 155.06 18.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 112.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 52.2 m -54.82 139.59 39.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.476 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.437 ' O ' HD12 ' A' 1023 ' ' ILE . . . 82.93 -32.41 2.97 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.204 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -82.43 148.67 28.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.812 ' HG2' ' H ' ' A' ' 996' ' ' LEU . 49.2 ttt-85 -81.97 -172.25 3.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.024 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.812 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 5.5 tt -161.77 128.07 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.887 ' HB ' HG12 ' A' 1019 ' ' ILE . 1.7 mp -86.62 144.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.967 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.6 165.18 36.38 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' 1001 ' ' SER . 89.5 m-70 -71.38 137.03 48.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.625 0.213 . . . . 0.0 110.762 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 78.7 p -72.14 39.47 0.07 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.948 0.404 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.474 ' O ' HG21 ' A' 1015 ' ' THR . 36.4 t -160.06 171.44 19.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.98 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.27 134.02 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.4 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -114.05 128.25 56.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.434 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 48.9 t -73.2 85.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' 1014 ' ' SER . 14.7 pt -91.52 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.168 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' 1007 ' ' SER . 0.5 OUTLIER -92.46 128.34 38.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.709 0.29 . . . . 0.0 110.544 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.657 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 46.5 t -162.52 136.75 6.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 66.0 40.37 95.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.381 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.16 21.64 6.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.622 0.249 . . . . 0.0 111.564 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 87.9 m -152.36 133.59 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.818 0.342 . . . . 0.0 111.181 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.551 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.32 134.1 41.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.657 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.1 p80 -153.8 150.86 28.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.765 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.64 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 31.8 m95 -68.14 120.59 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.776 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.537 ' HB2' HD13 ' A' 1005 ' ' ILE . 44.8 t -52.38 -22.58 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.707 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.474 HG21 ' O ' ' A' 1001 ' ' SER . 46.6 p -87.0 132.43 33.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -66.05 156.43 84.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.62 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -46.82 118.32 2.62 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.236 1.958 . . . . 0.0 112.019 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.487 ' HG3' ' CZ ' ' A' ' 988' ' ' TYR . 64.4 Cg_endo -84.62 160.42 12.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.162 2.574 . . . . 0.0 113.169 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.887 HG12 ' HB ' ' A' ' 997' ' ' ILE . 35.2 pt -144.53 -157.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 49.4 t -143.36 171.18 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.309 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.459 ' HA ' ' OE1' ' A' 1021 ' ' GLN . 1.0 OUTLIER -153.51 130.76 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.036 0.446 . . . . 0.0 111.113 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' 1045 ' ' HIS . 77.7 ttt180 -64.37 -17.54 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.527 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 995' ' ' ARG . 61.4 mt 64.21 89.33 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.934 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.62 126.26 21.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.611 2.207 . . . . 0.0 112.931 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 56.1 m -88.43 -145.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.055 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -163.91 155.57 27.01 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.432 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' 1044 ' ' PHE . 8.8 mp -40.92 139.41 1.21 Allowed Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.599 ' HD3' HD21 ' A' 1040 ' ' ASN . 59.6 Cg_endo -71.67 145.37 46.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.882 2.388 . . . . 0.0 112.054 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.507 ' HB2' ' HG3' ' A' 1087 ' ' PRO . 24.0 Cg_endo -61.47 117.19 3.98 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.206 1.938 . . . . 0.0 111.933 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 83.5 m -82.47 121.05 26.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 24.8 pt -86.66 135.55 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.352 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -51.79 138.61 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.482 ' HB3' ' HE2' ' A' 1064 ' ' PHE . 75.3 m-80 75.03 -40.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.172 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -79.16 116.71 4.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' 1053 ' ' ARG . 57.4 m-20 -68.81 -150.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 110.685 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 137.15 13.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.285 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' 1050 ' ' VAL . 34.5 pt -128.87 -161.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.566 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 66.4 m 63.66 159.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.857 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 99.9 m -56.48 130.55 45.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.306 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.599 HD21 ' HD3' ' A' 1028 ' ' PRO . 17.0 t-20 -177.18 -121.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' 1040 ' ' ASN . 21.9 mmt85 75.35 -49.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.606 0.362 . . . . 0.0 111.211 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' 1043 ' ' ASN . 13.5 pt-20 -162.95 -141.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.411 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' 1042 ' ' GLU . 37.0 m-20 33.56 43.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.193 0.52 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.562 ' CD2' HD12 ' A' 1027 ' ' LEU . 0.3 OUTLIER -77.89 43.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.882 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.607 ' HB3' ' HD3' ' A' 1022 ' ' ARG . 58.3 m-70 -53.3 -52.49 58.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.565 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 32.2 t80 171.9 160.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.392 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 77.51 -20.97 3.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.061 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' 1046 ' ' TYR . 55.3 m -47.66 142.2 4.74 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.896 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' 1072 ' ' ILE . 11.3 p -137.79 155.43 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.338 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' 1037 ' ' ILE . 9.4 p -149.03 139.27 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.334 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.533 ' O ' HG12 ' A' 1037 ' ' ILE . 96.6 m -102.55 128.99 48.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -73.5 139.95 46.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.526 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' 1035 ' ' ASP . 79.3 ttt180 -146.54 133.07 19.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.03 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.57 ' O ' HD23 ' A' 1056 ' ' LEU . 75.5 m -76.45 158.1 31.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 111.834 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.515 ' HA ' ' OD2' ' A' 1035 ' ' ASP . 24.4 t-20 -65.6 -22.92 66.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.957 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.609 HD13 ' H ' ' A' 1064 ' ' PHE . 4.1 mm? 46.21 43.77 11.53 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-O 120.786 0.326 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 72.81 -53.94 1.68 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 36.3 t -178.83 126.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' 1059 ' ' ARG . 3.0 mmp_? 72.37 -60.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.124 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.44 29.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.086 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.602 ' O ' ' HB3' ' A' 1056 ' ' LEU . 42.1 ttt85 -66.17 132.13 47.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -65.24 109.28 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.515 0.674 . . . . 0.0 111.992 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.591 HG13 ' HD1' ' A' 1064 ' ' PHE . 3.0 p -157.47 -45.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.156 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.609 ' H ' HD13 ' A' 1056 ' ' LEU . 3.1 m-85 -86.11 155.57 20.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.344 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -146.28 121.34 10.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' 1070 ' ' PRO . 30.9 tp -71.9 142.97 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.466 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' 1089 ' ' PRO . 63.7 t -138.33 138.16 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.1 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.8 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1069 ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -62.42 110.41 3.32 Favored Pre-proline 0 C--O 1.225 -0.186 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.545 ' HB3' HD21 ' A' 1066 ' ' LEU . 74.3 Cg_endo -87.8 -45.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.547 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 83.4 p -94.54 146.86 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 112.009 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.804 HG13 ' HB2' ' A' 1085 ' ' SER . 7.0 tt -149.67 158.39 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.688 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' 1072 ' ' ILE . 0.1 OUTLIER -159.7 171.97 18.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.688 0.28 . . . . 0.0 111.19 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 43.4 t -62.16 -44.22 97.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.243 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 12.4 t 44.16 21.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.668 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.624 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 99.5 p 55.63 141.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.342 0.591 . . . . 0.0 112.483 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1077 ' ' ASN . . . . . 1.012 ' HA ' HG12 ' A' 1083 ' ' ILE . 0.7 OUTLIER -67.05 -98.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.782 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.61 3.03 0.08 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.277 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 7.3 t0 -163.14 -51.01 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.509 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' 1080 ' ' GLN . 1.8 pm0 -174.84 50.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.442 ' HB ' ' CB ' ' A' 1077 ' ' ASN . 45.9 t -134.31 -37.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.954 -0.466 . . . . 0.0 111.867 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' 1076 ' ' SER . . . 73.8 64.79 2.37 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1083 ' ' ILE . . . . . 1.012 HG12 ' HA ' ' A' 1077 ' ' ASN . 20.2 pt -81.98 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.57 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 11.1 m95 -72.43 162.91 28.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.218 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.804 ' HB2' HG13 ' A' 1072 ' ' ILE . 57.6 m -43.58 -41.76 4.73 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.444 ' H ' HD11 ' A' 1072 ' ' ILE . . . 107.43 145.94 12.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.664 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' 1029 ' ' PRO . 68.5 Cg_exo -50.77 149.28 14.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.152 2.568 . . . . 0.0 112.845 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.764 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -171.77 -47.57 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.3 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.764 ' HD2' ' H ' ' A' 1088 ' ' ALA . 20.1 Cg_endo -59.65 149.88 79.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.634 2.223 . . . . 0.0 112.725 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -147.7 149.85 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.757 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 56.4 m -93.73 142.3 27.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.092 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 33.4 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.943 179.582 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -61.27 135.95 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -171.0 143.13 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.651 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 960' ' ' ALA . . . . . 0.632 ' C ' ' HD2' ' A' ' 961' ' ' LYS . . . 55.92 -109.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.632 ' HD2' ' C ' ' A' ' 960' ' ' ALA . 3.1 mptp? -146.55 155.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 98.6 p -152.99 129.12 10.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.39 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 964' ' ' LYS . 1.6 p -79.92 30.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.254 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 964' ' ' LYS . 10.0 mmpt? 54.5 138.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.478 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 6.9 t -63.14 121.46 69.35 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.45 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 17.3 Cg_exo -67.25 107.25 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.475 2.117 . . . . 0.0 112.307 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 965' ' ' THR . 28.7 Cg_endo -63.39 136.2 53.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.211 1.941 . . . . 0.0 110.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.8 107.97 0.82 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.765 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 970' ' ' VAL . 73.2 Cg_endo -73.11 -133.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.936 2.424 . . . . 0.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.9 HG22 ' H ' ' A' ' 971' ' ' ASN . 8.5 p -51.95 -148.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.914 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.9 ' H ' HG22 ' A' ' 970' ' ' VAL . 5.1 m120 -65.46 -28.44 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.767 -0.583 . . . . 0.0 110.469 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 970' ' ' VAL . . . -72.33 126.6 11.59 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.234 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 988' ' ' TYR . 65.9 mtt -94.42 143.95 25.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.558 HG21 HD12 ' A' ' 986' ' ' ILE . 4.5 p -92.88 148.36 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 O-C-N 123.361 0.413 . . . . 0.0 111.6 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -118.16 109.12 16.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.022 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.759 HG13 HG23 ' A' ' 980' ' ' ILE . 72.6 t -65.38 -48.01 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 22.9 mt 64.69 -98.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.602 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.7 p -62.25 -65.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.526 ' O ' HG13 ' A' ' 976' ' ' VAL . 51.7 p-10 -173.33 -148.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.568 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.759 HG23 HG13 ' A' ' 976' ' ' VAL . 21.1 pt -155.95 25.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.2 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 962' ' ' SER . 85.7 mt-30 -78.81 -57.62 3.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.942 0.401 . . . . 0.0 111.272 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.642 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 7.7 p 167.77 156.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 982' ' ' VAL . . . 79.06 -35.87 1.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.669 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.458 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 80.7 p -68.5 -160.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.12 0.486 . . . . 0.0 111.444 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 986' ' ' ILE . 45.4 ttm-85 -156.66 160.64 39.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.085 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.558 HD12 HG21 ' A' ' 974' ' ' VAL . 47.0 pt -142.75 155.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.117 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' 1001 ' ' SER . 82.2 p -142.25 134.32 27.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' 1000 ' ' SER . 4.0 m-85 -83.23 -161.87 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 73.6 m -148.18 -40.47 0.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.77 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 29.1 t 69.42 137.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.835 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -60.27 145.84 45.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.735 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 74.9 m -51.58 134.64 29.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.361 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 74.03 37.54 49.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.247 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.613 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 33.4 m80 -146.96 125.29 12.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.36 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.671 ' HB2' HD11 ' A' 1023 ' ' ILE . 38.2 ttt85 -82.0 96.82 7.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' 1000 ' ' SER . 3.6 pp -63.62 140.42 58.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.643 ' HB ' HG13 ' A' 1019 ' ' ILE . 50.4 mm -107.96 154.69 9.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.22 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.92 14.63 82.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.071 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 63.68 134.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.688 ' HB3' HD22 ' A' ' 996' ' ' LEU . 77.8 p -87.76 46.78 1.42 Allowed 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -162.14 146.8 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.711 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.685 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -165.19 125.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.717 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.412 ' HB2' ' NH1' ' A' ' 985' ' ' ARG . 89.2 tt0 -87.65 130.96 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 43.4 t -74.13 86.57 1.88 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.888 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.496 ' HB ' ' H ' ' A' 1006 ' ' LEU . 2.4 pp -87.28 -146.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' 1010 ' ' THR . 4.6 tt -158.46 129.37 6.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.519 ' N ' HD23 ' A' 1006 ' ' LEU . 47.1 t -80.25 -59.63 2.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.306 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.27 42.8 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.508 ' H ' HD21 ' A' 1006 ' ' LEU . 16.5 p-10 -176.25 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.377 . . . . 0.0 110.395 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.581 ' O ' ' HG ' ' A' 1006 ' ' LEU . 11.8 t -151.29 175.99 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.56 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -74.8 145.71 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.125 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -149.44 145.61 27.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.438 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.427 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 92.9 m95 -76.42 125.41 29.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.362 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.2 p -53.69 -19.91 4.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.092 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.685 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 30.3 p -131.26 135.84 47.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 112.265 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' 1017 ' ' PRO . 14.7 mmmm -69.81 161.96 71.29 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.891 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 80.2 Cg_exo -45.43 132.31 12.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.735 2.29 . . . . 0.0 112.686 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 88.9 Cg_endo -80.51 170.56 15.74 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.997 2.465 . . . . 0.0 113.143 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.643 HG13 ' HB ' ' A' ' 997' ' ' ILE . 25.4 pt -148.83 121.53 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.811 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.764 ' H ' HG11 ' A' ' 970' ' ' VAL . 88.9 m -86.16 118.26 25.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 112.118 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -82.41 126.01 31.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.915 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' 1046 ' ' TYR . 40.9 ttt85 -67.2 -9.37 39.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.256 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.671 HD11 ' HB2' ' A' ' 995' ' ' ARG . 45.9 mt 54.01 56.77 12.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.428 . . . . 0.0 110.445 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.518 ' CB ' ' HA ' ' A' 1045 ' ' HIS . 58.0 Cg_endo -71.6 138.28 31.89 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.273 . . . . 0.0 113.019 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 3.8 p -88.42 -136.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.317 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1026 ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' 1044 ' ' PHE . . . -148.4 -151.35 5.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.809 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' 1044 ' ' PHE . 70.6 mt -64.73 132.84 95.55 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-O 120.711 0.291 . . . . 0.0 111.567 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.58 149.81 88.18 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 111.092 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.596 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 95.9 Cg_exo -45.47 119.59 2.74 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.287 1.992 . . . . 0.0 112.283 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 81.3 p -81.81 139.9 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.958 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' 1031 ' ' ILE . 45.6 pt -148.45 120.6 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.433 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -73.56 14.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.111 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' 1031 ' ' ILE . 48.0 m-20 -80.36 -31.83 37.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.22 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.509 ' HA2' ' OD1' ' A' 1055 ' ' ASN . . . -163.14 -125.2 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.302 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' 1036 ' ' PHE . 53.3 m-20 -156.66 -151.7 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.597 ' HB2' HG13 ' A' 1050 ' ' VAL . 45.9 p90 -155.96 129.65 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 111.945 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.28 78.2 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.986 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 39.6 t -167.39 154.0 8.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 111.492 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.554 ' O ' ' HG3' ' A' 1041 ' ' ARG . 60.7 m -55.8 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' 1041 ' ' ARG . 2.8 m-80 52.91 -125.1 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' 1039 ' ' THR . 76.0 mtp180 74.92 -47.34 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.662 0.385 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' 1044 ' ' PHE . 3.9 tm-20 -162.89 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.68 0.276 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -71.63 38.09 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.665 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.596 ' HD1' ' H ' ' A' 1045 ' ' HIS . 0.3 OUTLIER -76.7 -46.82 24.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.596 ' H ' ' HD1' ' A' 1044 ' ' PHE . 24.2 m-70 40.62 -147.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.18 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.722 ' O ' ' HB3' ' A' 1074 ' ' CYS . 14.8 t80 -63.45 -49.18 74.68 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -96.1 121.6 7.01 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.891 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 47.2 t 178.6 122.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.64 0.734 . . . . 0.0 111.344 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' 1072 ' ' ILE . 11.2 p -102.3 157.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.546 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.597 HG13 ' HB2' ' A' 1036 ' ' PHE . 87.4 t -146.81 117.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.951 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' 1036 ' ' PHE . 96.2 m -99.55 109.94 22.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.909 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.475 ' O ' HD22 ' A' 1066 ' ' LEU . 31.4 m-85 -80.98 124.66 29.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.976 0.417 . . . . 0.0 111.684 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' 1054 ' ' CYS . 18.2 tpt85 -97.07 -137.02 0.26 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.643 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.483 ' H ' ' HG3' ' A' 1053 ' ' ARG . 99.1 m -161.43 156.23 23.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 110.512 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.509 ' OD1' ' HA2' ' A' 1034 ' ' GLY . 79.0 m-20 -65.85 62.1 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.629 ' HB3' ' HA2' ' A' 1060 ' ' GLY . 3.6 mm? -70.33 135.72 49.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 110.731 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' 1058 ' ' SER . . . -82.74 131.75 10.6 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.864 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' 1057 ' ' GLY . 55.1 m 74.91 -49.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.502 0.321 . . . . 0.0 111.731 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -167.75 -51.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.863 0.363 . . . . 0.0 111.543 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . -172.62 37.8 0.15 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.298 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -66.17 165.82 13.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.38 78.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.277 0.561 . . . . 0.0 111.025 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1064 ' ' PHE . 7.9 m -155.08 95.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.559 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.1 m-85 75.77 139.58 0.07 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.026 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 143.63 31.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.66 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' 1070 ' ' PRO . 47.5 tp -68.47 142.36 55.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' 1089 ' ' PRO . 77.7 t -149.05 132.5 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.867 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1068 ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 77.42 145.31 2.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.373 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' 1089 ' ' PRO . 16.3 pt-20 18.12 67.83 0.22 Allowed Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 112.689 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.596 ' HA ' HD21 ' A' 1066 ' ' LEU . 13.9 Cg_endo -56.18 -11.56 6.15 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.539 2.159 . . . . 0.0 111.907 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' 1050 ' ' VAL . 79.6 p -156.23 152.05 27.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' 1049 ' ' VAL . 26.3 pt -140.96 -166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.821 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' 1085 ' ' SER . 0.6 OUTLIER -160.09 158.14 29.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.958 0.409 . . . . 0.0 111.359 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.722 ' HB3' ' O ' ' A' 1046 ' ' TYR . 51.5 t -64.63 -42.6 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.97 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.547 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 14.7 t 45.95 -161.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.231 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.836 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 81.2 p -165.38 139.49 4.76 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.579 0.228 . . . . 0.0 111.381 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -177.01 -39.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.784 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.7 t70 -82.97 47.22 1.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.196 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.34 -130.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.52 ' HA ' HG23 ' A' 1023 ' ' ILE . 12.0 mp0 -76.96 49.92 0.69 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.648 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 18.4 t -145.9 -46.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.836 ' HA2' ' HA ' ' A' 1076 ' ' SER . . . 77.67 -45.84 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.24 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' 1082 ' ' GLY . 6.6 pt 52.58 135.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.449 0.642 . . . . 0.0 111.752 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.406 ' HB3' HD12 ' A' 1072 ' ' ILE . 42.0 m95 -71.92 147.21 47.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.46 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' 1073 ' ' TYR . 80.2 p -48.02 -23.88 0.93 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.795 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.49 140.52 6.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.783 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 12.8 Cg_exo -72.44 47.85 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.528 2.818 . . . . 0.0 113.079 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 64.44 138.99 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.023 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.755 ' HB3' ' HG2' ' A' 1069 ' ' GLU . 97.4 Cg_endo -81.73 -140.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.963 2.442 . . . . 0.0 112.2 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.498 ' OE1' HD13 ' A' 1092 ' ' ILE . 16.9 tt0 -152.46 153.59 33.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.869 ' O ' HG12 ' A' 1092 ' ' ILE . 90.4 m -80.76 -146.82 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.869 HG12 ' O ' ' A' 1091 ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.17 -141.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.279 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -170.46 132.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.529 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 53.44 -92.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.51 151.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 78.3 p -149.78 149.82 31.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.928 0.394 . . . . 0.0 111.497 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 89.1 m -79.93 147.61 31.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.335 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -63.75 138.2 58.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.898 0.38 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 62.2 m -51.94 125.19 30.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.065 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.691 ' HG2' HG11 ' A' ' 974' ' ' VAL . 56.6 Cg_endo -70.86 127.53 13.84 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.325 2.016 . . . . 0.0 111.824 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.85 139.01 50.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.289 1.992 . . . . 0.0 111.564 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -43.81 115.3 2.01 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 110.847 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.625 ' HG3' ' HD2' ' A' ' 988' ' ' TYR . 45.7 Cg_endo -67.45 149.5 80.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.792 2.328 . . . . 0.0 112.301 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.696 HG13 ' H ' ' A' 1020 ' ' CYS . 0.6 OUTLIER -44.86 102.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.206 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 4.8 m120 74.2 -37.28 0.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.86 -172.82 8.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.57 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 64.6 mtm -154.56 135.12 13.46 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 110.916 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.691 HG11 ' HG2' ' A' ' 966' ' ' PRO . 6.3 p -92.93 149.55 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.09 113.76 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.99 HG13 HG23 ' A' ' 980' ' ' ILE . 78.5 t -60.89 -51.64 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.152 0.501 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 33.6 mt 74.93 -33.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.195 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.5 p -138.0 -64.95 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.457 ' O ' ' CG1' ' A' ' 980' ' ' ILE . 38.7 t70 -172.47 2.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.99 HG23 HG13 ' A' ' 976' ' ' VAL . 49.8 pt 52.81 72.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.431 0.634 . . . . 0.0 110.893 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' 1004 ' ' CYS . 8.7 pt20 -152.34 174.74 13.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.128 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' 1004 ' ' CYS . 48.4 t -43.38 138.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.337 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 80.54 -44.87 2.99 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.998 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.577 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 53.4 m -68.43 123.21 20.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.976 0.388 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.683 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 74.9 ttt180 -101.43 121.12 41.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.871 HG21 HG22 ' A' ' 980' ' ' ILE . 31.7 pt -93.46 160.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 78.0 p -143.99 132.38 22.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 111.911 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.625 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 3.7 m-85 -84.85 -168.11 2.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 11.1 t -161.59 -47.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.195 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.832 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 3.2 t 70.05 -137.64 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.33 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 158.28 4.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.641 0.734 . . . . 0.0 112.43 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 28.5 m -53.99 114.77 1.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.755 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 147.24 -28.15 1.53 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.591 ' HA ' HG12 ' A' 1023 ' ' ILE . 7.2 m80 -139.07 143.0 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.522 ' CZ ' ' HB2' ' A' 1021 ' ' GLN . 22.8 ptt-85 -80.02 127.34 32.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.143 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 997' ' ' ILE . 3.3 tt -76.13 129.86 37.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.7 mp -104.33 146.68 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.119 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 74.75 169.9 24.28 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.78 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.417 ' ND1' HG21 ' A' 1015 ' ' THR . 24.4 m170 -75.01 125.71 29.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.458 ' O ' ' HD1' ' A' ' 988' ' ' TYR . 79.3 p -64.88 -44.05 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.459 ' HB3' ' NE ' ' A' ' 985' ' ' ARG . 50.5 m -82.72 142.95 31.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.409 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.427 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -161.66 116.4 1.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 37.5 tt0 -85.93 132.51 34.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 43.0 t -69.71 93.52 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.32 -178.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' 1007 ' ' SER . 9.9 tp -158.44 125.5 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.469 ' N ' HD12 ' A' 1006 ' ' LEU . 47.5 t -85.42 -48.91 8.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.278 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 171.84 -48.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.659 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.6 t30 -70.99 -55.19 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.817 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.403 ' C ' HD13 ' A' 1006 ' ' LEU . 87.9 m -151.21 149.05 28.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.492 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.432 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.28 143.96 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -150.71 149.98 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.464 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.428 ' CH2' HD13 ' A' ' 986' ' ' ILE . 52.1 m95 -68.78 132.53 46.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.713 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 78.5 p -52.36 -24.74 8.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.976 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.427 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 75.3 p -131.43 141.17 49.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -56.88 155.45 15.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 17.0 Cg_endo -57.71 118.11 4.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.36 2.04 . . . . 0.0 112.037 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.488 ' HB2' HD21 ' A' ' 996' ' ' LEU . 21.6 Cg_endo -61.48 159.15 32.96 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.545 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 26.4 pt -143.9 127.97 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.622 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.696 ' H ' HG13 ' A' ' 970' ' ' VAL . 50.5 m -88.0 112.79 22.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.052 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.566 ' HG2' HD13 ' A' ' 997' ' ' ILE . 28.2 mm100 -86.38 145.02 27.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.955 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.587 ' NH2' ' HB3' ' A' 1046 ' ' TYR . 25.8 tpt85 -63.92 128.12 34.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.237 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 994' ' ' HIS . 48.5 mm -65.34 128.25 93.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 72.6 Cg_endo -96.97 139.3 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.738 2.959 . . . . 0.0 113.488 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.761 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 98.0 m -112.94 135.14 54.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.208 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.95 -152.35 4.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.789 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 48.8 mt -83.08 146.17 51.0 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.619 0.247 . . . . 0.0 111.059 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.16 149.8 90.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.324 2.016 . . . . 0.0 111.127 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.726 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 2.5 Cg_endo -46.18 119.66 3.16 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.573 2.182 . . . . 0.0 111.862 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 71.8 p -77.43 145.22 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.44 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' 1031 ' ' ILE . 10.3 tt -149.89 114.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.801 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -56.59 144.57 31.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.531 ' HB3' HD22 ' A' 1055 ' ' ASN . 5.0 m120 75.21 -35.95 0.3 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.501 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.62 178.12 8.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.532 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -156.58 127.32 6.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.79 ' HB2' HG23 ' A' 1050 ' ' VAL . 3.7 p90 -84.34 144.57 28.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 0.0 110.664 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' 1036 ' ' PHE . 42.2 mm -133.66 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.655 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 11.3 t -167.8 -161.18 0.37 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.974 0.416 . . . . 0.0 111.289 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 68.9 p -75.16 -13.4 60.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.279 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.734 HD22 ' HB ' ' A' 1050 ' ' VAL . 55.4 m-20 -47.42 136.39 9.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.415 ' HB3' ' OE1' ' A' 1042 ' ' GLU . 25.3 mmm180 -154.18 -82.73 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.611 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.5 OUTLIER -163.01 145.16 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' 1042 ' ' GLU . 51.9 m-20 70.27 58.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.893 0.377 . . . . 0.0 110.419 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' 1025 ' ' CYS . 2.5 m-85 -76.73 132.46 39.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' 1046 ' ' TYR . 20.4 m80 -90.32 -65.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.619 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.685 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.0 t80 171.91 44.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.548 0.69 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.45 89.2 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.73 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' 1047 ' ' GLY . 77.6 p 172.38 141.66 0.03 OUTLIER 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 111.515 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.967 HG12 ' HB3' ' A' 1073 ' ' TYR . 12.3 m -107.2 -173.53 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.431 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' 1036 ' ' PHE . 7.3 p -153.93 129.57 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.981 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 50.1 m -116.83 110.66 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.473 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 2.2 m-85 -70.58 158.03 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -149.75 -13.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.869 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 65.1 m 66.16 166.02 0.2 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' 1033 ' ' ASN . 19.1 p30 -55.68 -44.64 77.52 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.617 HD12 ' HA2' ' A' 1060 ' ' GLY . 2.8 mm? 38.69 33.32 0.07 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 68.89 -52.63 0.53 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.906 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.566 ' C ' ' HD2' ' A' 1059 ' ' ARG . 70.8 m -161.53 -28.62 0.05 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.321 0.56 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.566 ' HD2' ' C ' ' A' 1058 ' ' SER . 5.6 mpt_? -150.06 -50.58 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.526 0.203 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' 1056 ' ' LEU . . . -174.75 37.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.892 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -70.96 163.15 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' 1062 ' ' LYS . 39.9 ttpt -67.85 70.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.17 0.51 . . . . 0.0 110.934 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' 1063 ' ' VAL . 6.7 m -155.07 89.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.747 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' 1063 ' ' VAL . 77.4 m-85 75.55 145.5 0.08 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.951 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -145.09 143.7 30.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.649 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' 1070 ' ' PRO . 61.7 tp -68.57 135.54 51.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.0 111.314 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' 1089 ' ' PRO . 61.5 t -138.25 123.03 22.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.114 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1068 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 71.82 161.3 4.9 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.285 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.609 ' OE2' HD13 ' A' 1072 ' ' ILE . 83.4 tt0 30.37 62.47 0.95 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.916 ' HA ' HD21 ' A' 1066 ' ' LEU . 57.3 Cg_endo -72.68 -24.59 18.25 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.993 1.795 . . . . 0.0 112.302 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' 1050 ' ' VAL . 42.7 m -156.25 137.67 13.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 111.567 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.609 HD13 ' OE2' ' A' 1069 ' ' GLU . 44.6 pt -145.43 -169.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.967 ' HB3' HG12 ' A' 1049 ' ' VAL . 0.6 OUTLIER -162.14 156.89 22.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.051 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.7 t -62.24 148.31 45.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.384 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.42 ' HA ' ' HE1' ' A' 1046 ' ' TYR . 6.5 t -146.04 -7.89 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.743 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.51 ' HB3' ' HA2' ' A' 1082 ' ' GLY . 89.3 p 47.81 54.74 9.49 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.773 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -55.14 -46.23 75.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.86 ' HB2' HG21 ' A' 1081 ' ' VAL . 22.9 m-20 -75.71 -3.1 32.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.301 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.626 ' OD1' ' HG3' ' A' 1080 ' ' GLN . 9.8 t70 65.4 134.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.376 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.626 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 27.6 mt-30 56.87 43.3 25.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.86 HG21 ' HB2' ' A' 1078 ' ' ASP . 24.5 m -148.6 -35.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.253 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.761 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 63.98 41.15 98.73 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.084 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.438 ' H ' HG23 ' A' 1081 ' ' VAL . 73.7 mt -85.73 136.5 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.837 0.351 . . . . 0.0 111.345 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' 1084 ' ' TRP . 8.1 m95 -76.15 141.12 41.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.704 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 78.9 p -59.78 -61.73 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.898 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.631 ' O ' ' HG3' ' A' 1029 ' ' PRO . . . -71.09 126.67 13.72 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.843 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -88.9 46.34 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.945 2.43 . . . . 0.0 112.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 62.37 130.89 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.519 ' HB2' ' O ' ' A' 1067 ' ' VAL . 86.3 Cg_endo -78.43 -137.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.821 2.347 . . . . 0.0 112.85 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.517 ' H ' ' HB2' ' A' 1089 ' ' PRO . 15.9 tt0 -152.37 140.14 19.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.012 0.435 . . . . 0.0 111.587 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 66.8 m -100.75 130.72 46.82 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.772 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 21.5 pt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.053 179.424 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.756 0.313 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -60.77 -44.87 96.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -172.2 131.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -67.01 99.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.115 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.656 ' HB3' HD23 ' A' 1006 ' ' LEU . 17.1 tppt? -84.9 132.62 34.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.987 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.9 p -82.08 133.31 35.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.016 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.748 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 98.9 m -80.52 36.26 0.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.022 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.7 tptt 63.38 133.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 56.5 m -70.9 116.99 51.87 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.321 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.805 ' HG2' HG11 ' A' ' 974' ' ' VAL . 61.2 Cg_endo -72.99 120.68 6.76 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.243 1.962 . . . . 0.0 112.168 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 23.5 Cg_exo -63.98 -61.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.232 1.955 . . . . 0.0 111.299 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 170.65 96.93 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.262 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.616 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 58.0 Cg_exo -53.79 179.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.759 2.306 . . . . 0.0 112.668 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 972' ' ' GLY . 92.9 t -48.92 90.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.796 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.842 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 75.0 m-20 71.22 -26.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.262 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.52 114.2 5.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.415 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.559 ' H ' ' HA ' ' A' ' 990' ' ' CYS . 77.3 mmm -80.84 124.06 28.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.805 HG11 ' HG2' ' A' ' 966' ' ' PRO . 0.3 OUTLIER -92.38 138.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.45 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -122.65 108.96 13.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.544 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 986' ' ' ILE . 62.0 t -66.4 98.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.097 0.475 . . . . 0.0 109.832 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.19 -93.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.197 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -68.96 -58.4 4.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 0.0 110.182 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.583 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 54.6 m-20 -164.62 -133.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.191 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.585 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 5.0 pt -155.63 -16.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.254 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.987 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 34.6 mt-30 -73.53 177.36 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.621 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 961' ' ' LYS . 99.9 t -44.28 144.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.25 -38.24 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.295 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 49.2 m -68.51 148.1 51.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.845 0.323 . . . . 0.0 110.373 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 1002 ' ' ALA . 5.3 tmm_? -138.44 127.6 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 111.336 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 976' ' ' VAL . 17.4 pt -96.97 -176.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.095 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' 1001 ' ' SER . 50.5 p -150.14 127.96 11.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.004 0.43 . . . . 0.0 111.605 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.654 ' HB2' ' HA ' ' A' 1000 ' ' SER . 1.4 m-85 -85.18 -176.58 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 69.2 m -161.47 -34.41 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.676 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.559 ' HA ' ' H ' ' A' ' 973' ' ' MET . 43.0 t 68.36 167.14 0.26 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 81.1 p -60.15 -170.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 51.6 m -88.8 129.55 35.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.155 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 72.25 39.56 57.38 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.788 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' 1022 ' ' ARG . 25.8 m80 -146.87 133.24 19.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 995' ' ' ARG . 35.2 ttt85 -98.68 113.74 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.0 111.283 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 1.015 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 4.1 pp -76.14 138.39 40.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.498 . . . . 0.0 111.467 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' 1018 ' ' PRO . 1.7 mp -95.6 153.18 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.632 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.37 23.45 58.63 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.354 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 80.2 m-70 65.58 141.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.679 ' HB3' HD21 ' A' ' 996' ' ' LEU . 86.9 p -86.26 50.3 1.96 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.726 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 23.0 t -161.81 165.96 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.484 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.2 129.56 2.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -104.94 124.6 49.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.031 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 49.1 t -74.6 123.7 25.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 13.0 pt -136.99 150.92 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.658 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.656 HD23 ' HB3' ' A' ' 961' ' ' LYS . 0.4 OUTLIER -98.89 121.82 41.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.009 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.495 ' N ' HD13 ' A' 1006 ' ' LEU . 50.7 m -78.54 -55.5 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.36 37.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.127 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 46.6 t-20 178.55 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 0.0 110.33 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 53.2 m -151.26 149.9 29.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.923 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.748 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.1 141.4 43.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.92 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.4 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.5 m-70 -149.45 140.19 22.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.585 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 66.9 m95 -71.81 127.13 31.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.794 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.0 p -52.49 -28.8 21.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.691 ' O ' ' HG2' ' A' 1016 ' ' LYS . 48.2 p -90.64 -24.85 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' 1015 ' ' THR . 15.0 pttp 59.9 152.62 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 123.657 0.598 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.29 105.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.481 2.121 . . . . 0.0 112.157 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.656 ' HB2' ' O ' ' A' ' 997' ' ' ILE . 94.3 Cg_endo -80.14 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.446 HG13 ' HB ' ' A' ' 997' ' ' ILE . 35.4 pt -148.94 -169.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.44 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1020 ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 15.8 t -153.98 110.82 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.69 ' HG3' ' H ' ' A' 1023 ' ' ILE . 33.1 tp60 -77.66 134.13 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.401 ' HA ' ' CD2' ' A' ' 994' ' ' HIS . 15.2 ptp180 -76.49 6.36 5.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.452 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.761 HG23 ' HA ' ' A' 1080 ' ' GLN . 57.2 mt 53.29 76.55 0.52 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.665 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' 1045 ' ' HIS . 31.3 Cg_exo -59.39 116.83 3.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.242 1.961 . . . . 0.0 111.759 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 10.0 p -91.11 34.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.829 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 43.97 -142.37 2.61 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.062 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 72.2 mt -106.49 136.35 19.39 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-O 120.619 0.247 . . . . 0.0 111.381 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.428 ' HB3' ' CZ3' ' A' 1084 ' ' TRP . 35.3 Cg_endo -64.34 143.32 82.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.588 2.192 . . . . 0.0 111.714 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.887 ' HG2' ' HA ' ' A' 1087 ' ' PRO . 49.4 Cg_exo -55.3 108.88 0.34 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.255 1.97 . . . . 0.0 112.046 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 54.9 m -93.4 124.68 37.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.583 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' 1034 ' ' GLY . 62.7 mt -85.26 139.32 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.369 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -56.53 -55.39 34.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.245 0.545 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -80.23 -36.45 34.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.933 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.867 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -72.78 121.83 8.04 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.614 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -83.4 -151.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.403 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.475 ' HB2' HG23 ' A' 1050 ' ' VAL . 9.3 p90 -155.93 138.97 15.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' 1053 ' ' ARG . 46.3 mt -122.5 67.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.477 ' HB2' ' ND2' ' A' 1040 ' ' ASN . 74.5 m -157.18 -140.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.347 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.478 HG22 ' O ' ' A' 1039 ' ' THR . 11.1 m -119.58 38.63 3.83 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.477 ' ND2' ' HB2' ' A' 1038 ' ' SER . 1.3 m-80 -80.89 121.32 25.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -156.42 43.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' 1043 ' ' ASN . 37.7 tt0 62.94 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' 1042 ' ' GLU . 73.4 m-80 78.64 52.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' 1045 ' ' HIS . 5.1 m-85 -76.74 -56.75 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.137 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' 1024 ' ' PRO . 21.9 m80 72.62 -44.44 0.59 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.71 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 43.3 t80 171.73 148.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.958 0.409 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 73.6 97.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.754 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' 1047 ' ' GLY . 81.4 p 173.45 156.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 110.979 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' 1072 ' ' ILE . 3.5 p -137.78 155.44 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.967 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' 1036 ' ' PHE . 13.5 p -143.52 127.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.418 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 89.4 m -104.46 120.21 40.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.224 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.425 ' HD2' HD12 ' A' 1031 ' ' ILE . 13.1 m-85 -83.84 148.01 27.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.642 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.656 ' HD2' HD11 ' A' 1037 ' ' ILE . 44.9 ttt85 -142.77 -27.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.017 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.867 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 11.7 t 67.66 154.99 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 34.4 m120 -51.19 -93.45 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.601 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' 1064 ' ' PHE . 5.7 mt 61.71 -166.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.226 0.536 . . . . 0.0 111.843 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.544 ' N ' ' N ' ' A' 1061 ' ' ARG . . . 54.28 -121.38 19.52 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.206 -0.906 . . . . 0.0 114.136 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 75.1 p -45.59 -66.43 0.4 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.26 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -87.21 35.62 0.71 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' 1056 ' ' LEU . . . -174.68 -117.68 0.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.563 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.736 ' O ' HG13 ' A' 1063 ' ' VAL . 11.2 tpt180 85.32 108.22 0.05 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.547 0.739 . . . . 0.0 110.103 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' 1062 ' ' LYS . 63.9 tttp 44.65 36.16 1.67 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 122.093 0.949 . . . . 0.0 109.609 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' 1061 ' ' ARG . 31.1 m -104.37 -12.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.591 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.866 ' HB2' HD21 ' A' 1056 ' ' LEU . 70.3 m-85 -156.09 162.99 40.19 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.921 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1065 ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' 1091 ' ' CYS . 44.7 mt-10 -142.4 131.27 22.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.016 0.436 . . . . 0.0 110.826 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.484 HD11 ' CG ' ' A' 1089 ' ' PRO . 31.0 tp -68.48 147.21 52.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.646 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 58.4 t -138.34 135.46 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.21 -148.03 26.44 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.302 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' 1069 ' ' GLU . 7.0 pm0 -72.1 120.67 81.57 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.476 ' HA ' HD21 ' A' 1066 ' ' LEU . 62.7 Cg_endo -75.84 -25.73 10.31 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.747 2.298 . . . . 0.0 112.395 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 54.3 m -137.57 153.95 49.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.739 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' 1049 ' ' VAL . 36.1 pt -143.01 -169.07 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.098 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' 1085 ' ' SER . 0.4 OUTLIER -160.01 158.26 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.284 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.71 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 10.2 t -62.16 -51.92 65.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.458 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.459 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 15.3 t 45.59 -172.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.974 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.3 p -165.47 143.73 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.681 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.657 HD22 HD11 ' A' 1083 ' ' ILE . 26.1 p-10 -162.82 -45.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.737 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' 1079 ' ' ASP . 40.3 t0 -81.12 -146.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.49 ' H ' ' CG ' ' A' 1078 ' ' ASP . 36.3 m-20 -82.04 -137.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.761 ' HA ' HG23 ' A' 1023 ' ' ILE . 31.1 mt-30 -81.0 26.16 0.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' 1079 ' ' ASP . 17.7 t -77.58 -44.25 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.298 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 59.66 63.22 5.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.191 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.657 HD11 HD22 ' A' 1077 ' ' ASN . 34.4 pt -81.93 129.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.462 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.428 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 20.0 m95 -76.53 163.88 26.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.1 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.49 ' HB2' ' CE1' ' A' 1073 ' ' TYR . 43.8 t -48.62 -32.86 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.641 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.51 147.58 12.26 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.033 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.887 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 73.9 Cg_endo -75.38 49.42 2.36 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.988 2.459 . . . . 0.0 112.78 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 63.73 133.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.742 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.484 ' CG ' HD11 ' A' 1066 ' ' LEU . 56.1 Cg_endo -71.65 -149.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.116 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.417 ' H ' ' HB2' ' A' 1089 ' ' PRO . 50.0 mm-40 -151.93 117.93 5.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.724 0.297 . . . . 0.0 111.442 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1065 ' ' GLU . 28.1 p -103.11 88.39 3.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.248 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.408 ' HA ' ' HD1' ' A' 1064 ' ' PHE . 27.8 pt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.841 0.353 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.33 -40.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 51.6 42.93 30.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 45.32 34.83 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.735 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.732 ' HG3' HD11 ' A' 1006 ' ' LEU . 71.9 mmtt -79.38 148.78 31.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.1 p -157.86 127.25 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.253 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.86 142.69 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.755 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.82 141.07 58.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.386 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.432 ' OG1' HD13 ' A' ' 980' ' ' ILE . 62.4 m -64.8 130.49 94.82 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 31.5 Cg_exo -59.35 120.51 8.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.188 1.925 . . . . 0.0 111.634 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 46.1 Cg_exo -55.97 -50.24 12.98 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.167 1.911 . . . . 0.0 111.659 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 59.2 t0 174.03 106.96 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.92 155.16 19.09 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.366 2.044 . . . . 0.0 111.232 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.7 ' HB ' ' HA ' ' A' 1019 ' ' ILE . 80.4 t -46.55 106.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.79 0.329 . . . . 0.0 111.445 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.509 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 33.3 m120 74.72 -53.98 0.67 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.078 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -79.5 138.34 20.22 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.274 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 86.7 mmm -81.87 -156.65 0.16 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 110.812 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 988' ' ' TYR . 3.3 p -159.29 148.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.441 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.15 109.84 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 43.3 t -65.33 105.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.624 HG13 HG23 ' A' ' 987' ' ' THR . 44.7 mm -75.23 -94.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.753 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.7 p -67.93 -65.99 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.492 ' OD1' HG12 ' A' ' 980' ' ' ILE . 46.7 t0 -165.71 -132.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.63 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.54 HG22 ' CH2' ' A' 1013 ' ' TRP . 1.6 pt -155.95 14.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.355 0.597 . . . . 0.0 110.33 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.4 171.24 10.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.353 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 61.9 t -47.51 141.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.646 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.38 -46.95 2.6 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.489 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 151.28 47.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.262 0.531 . . . . 0.0 110.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.878 ' HB3' ' HA ' ' A' 1003 ' ' GLU . 0.0 OUTLIER -138.43 -168.53 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 977' ' ' ILE . 23.6 pt -148.55 -160.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.97 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.624 HG23 HG13 ' A' ' 977' ' ' ILE . 68.5 p -142.03 124.55 15.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 112.028 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.473 ' HA ' HG23 ' A' ' 974' ' ' VAL . 1.3 m-85 -98.89 150.94 21.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.319 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 19.3 m -150.25 138.95 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.261 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.697 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 42.4 t -81.97 154.39 25.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.285 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 992' ' ' THR . 11.0 t -64.87 -139.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.392 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.557 HG23 ' N ' ' A' ' 993' ' ' GLY . 12.8 t -60.94 -142.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.045 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.557 ' N ' HG23 ' A' ' 992' ' ' THR . . . -63.42 75.35 0.04 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 113.971 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.645 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 37.6 m80 -145.94 140.81 27.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.508 HH22 ' HB3' ' A' 1079 ' ' ASP . 41.3 ttm-85 -81.96 118.98 23.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.996 0.427 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 990' ' ' CYS . 5.9 tp -76.2 126.09 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.964 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 996' ' ' LEU . 1.8 mp -107.83 150.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.794 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.58 54.58 4.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.677 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.56 -143.85 0.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.196 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m -160.81 27.27 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.031 0.443 . . . . 0.0 110.152 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 65.9 p -162.17 162.51 28.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.223 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.759 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -153.79 130.65 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.837 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.878 ' HA ' ' HB3' ' A' ' 985' ' ' ARG . 21.1 pt-20 -101.74 129.6 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.946 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.512 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 5.9 t -72.17 128.54 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.334 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.5 pt -145.55 169.36 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.103 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.732 HD11 ' HG3' ' A' ' 961' ' ' LYS . 4.0 mm? -81.57 146.43 30.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.938 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 71.2 m -159.8 59.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 104.99 51.39 0.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.166 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 58.87 24.97 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 110.399 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 71.4 m -151.32 139.21 19.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.679 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.512 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.33 136.7 40.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.959 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 40.7 m80 -149.47 141.32 23.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.759 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 70.6 m95 -67.75 123.6 20.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.127 0.489 . . . . 0.0 110.854 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 20.7 m -52.39 -24.44 7.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.947 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 55.2 p -103.65 142.02 35.05 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 61.5 pttt -62.61 149.74 88.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.868 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 120.99 9.16 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.304 2.003 . . . . 0.0 111.7 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.672 ' HB3' HD11 ' A' ' 996' ' ' LEU . 32.7 Cg_exo -59.18 145.29 98.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.829 2.353 . . . . 0.0 112.903 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.7 ' HA ' ' HB ' ' A' ' 970' ' ' VAL . 40.3 pt -140.05 130.4 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 74.2 m -86.35 108.93 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.181 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -81.62 130.49 35.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.524 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -71.65 120.14 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' 1079 ' ' ASP . 77.4 mt -67.24 110.97 6.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.741 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.06 125.22 17.51 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.898 2.399 . . . . 0.0 113.424 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.611 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 66.9 m -95.94 133.11 40.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.087 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -79.87 -154.0 8.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.394 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 138.99 94.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.788 0.328 . . . . 0.0 111.321 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.461 ' HB2' ' OH ' ' A' 1052 ' ' TYR . 51.1 Cg_endo -68.64 148.73 72.75 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.774 2.316 . . . . 0.0 112.048 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.759 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 34.7 Cg_exo -59.15 111.18 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.081 1.854 . . . . 0.0 111.476 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 26.9 p -77.52 122.46 25.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.641 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' 1032 ' ' ALA . 18.4 pt -88.59 29.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.851 0.358 . . . . 0.0 111.855 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 52.87 125.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.495 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' 1032 ' ' ALA . 77.1 m-20 71.43 -26.6 0.17 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.234 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -69.54 124.73 16.09 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.717 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' 1053 ' ' ARG . 1.5 m-20 -76.46 -159.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.657 0.265 . . . . 0.0 110.368 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' 1051 ' ' THR . 45.6 p90 -155.99 137.8 14.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.633 HD11 HH11 ' A' 1053 ' ' ARG . 20.3 mm -128.77 37.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.756 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 78.2 p -69.24 145.48 53.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.615 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 38.2 m -59.42 -38.37 80.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.694 HD22 ' HB3' ' A' 1048 ' ' SER . 23.4 p30 -72.19 -155.44 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.597 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' 1040 ' ' ASN . 18.3 mmt85 -162.2 -54.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.701 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' 1043 ' ' ASN . 42.0 tt0 -162.89 148.73 12.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' 1042 ' ' GLU . 75.4 m-20 78.12 65.2 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.59 134.92 39.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.308 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' 1046 ' ' TYR . 13.1 m80 -96.93 -51.52 4.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.555 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 69.7 t80 171.06 144.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.412 0.445 . . . . 0.0 110.55 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 76.5 -14.54 6.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.221 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.694 ' HB3' HD22 ' A' 1040 ' ' ASN . 65.5 m -47.36 136.15 9.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.033 0.444 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' 1038 ' ' SER . 88.7 t -102.19 146.88 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.224 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.756 ' HA ' ' HB3' ' A' 1038 ' ' SER . 30.8 m -142.57 126.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.398 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' 1036 ' ' PHE . 59.1 m -100.49 108.69 20.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.461 ' OH ' ' HB2' ' A' 1028 ' ' PRO . 21.0 m-85 -77.08 163.13 26.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.307 0.575 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.734 ' HB2' ' HB2' ' A' 1035 ' ' ASP . 75.6 mtp180 -142.76 -138.96 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.655 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.526 ' O ' HD23 ' A' 1056 ' ' LEU . 48.7 t -163.7 145.42 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 111.686 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.1 68.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.243 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.568 ' HA ' HG23 ' A' 1063 ' ' VAL . 3.7 mm? -72.22 41.91 0.09 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 53.37 -106.15 0.39 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.525 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.546 ' HB2' ' HD3' ' A' 1061 ' ' ARG . 66.8 m -67.37 -48.28 67.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' 1059 ' ' ARG . 11.6 tpt180 -165.83 -49.85 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.044 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.515 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -164.38 39.91 0.31 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.752 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.666 ' N ' ' HD2' ' A' 1061 ' ' ARG . 0.7 OUTLIER -83.14 172.76 12.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 110.769 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 58.5 tttm -65.48 79.91 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' 1056 ' ' LEU . 6.9 m -155.14 92.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.637 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.664 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 0.8 OUTLIER 74.27 141.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.695 -178.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1065 ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.8 mt-10 -137.27 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.064 0.459 . . . . 0.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.617 HD21 ' HB3' ' A' 1070 ' ' PRO . 38.7 tp -68.44 152.09 45.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.156 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' 1089 ' ' PRO . 65.1 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 77.51 -168.37 54.39 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' 1069 ' ' GLU . 15.2 pm0 -72.05 126.85 91.13 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.617 ' HB3' HD21 ' A' 1066 ' ' LEU . 96.8 Cg_endo -82.17 -36.95 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.38 2.053 . . . . 0.0 111.87 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.8 p -83.81 140.87 31.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.179 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' 1049 ' ' VAL . 36.3 pt -147.78 -171.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.899 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.3 p90 -162.26 143.87 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.699 0.285 . . . . 0.0 111.386 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.929 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 52.1 t -66.51 154.15 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.075 0.464 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.2 t -147.59 -144.62 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.106 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.5 t -155.76 137.77 14.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.018 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' 1078 ' ' ASP . 36.7 p30 -166.58 31.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.757 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.7 t70 175.84 50.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.255 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.544 ' O ' HD13 ' A' 1023 ' ' ILE . 1.5 m-20 61.88 -125.24 0.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.515 ' HA ' HG23 ' A' 1023 ' ' ILE . 25.3 pt20 -66.01 -140.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.51 0.195 . . . . 0.0 110.71 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' 1080 ' ' GLN . 25.9 t 74.22 -45.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.992 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 66.36 62.61 4.5 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 74.3 mt -80.19 130.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 110.972 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.929 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 26.1 m95 -72.6 177.09 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.0 t -55.52 -64.2 0.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.684 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.57 131.66 1.6 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.628 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.759 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 93.7 Cg_endo -79.72 48.64 2.92 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.828 2.352 . . . . 0.0 111.698 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.689 ' N ' ' HD2' ' A' 1089 ' ' PRO . . . -62.57 -47.34 88.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.34 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' 1088 ' ' ALA . 4.9 Cg_endo -48.45 137.12 25.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.432 2.088 . . . . 0.0 112.112 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -149.89 132.99 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 15.2 t -102.49 137.79 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.415 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.353 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.602 0.239 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -176.2 -42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -170.48 52.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.121 0.486 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.95 41.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.424 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.592 ' O ' HG23 ' A' ' 982' ' ' VAL . 1.0 OUTLIER 55.86 47.11 20.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.439 . . . . 0.0 111.436 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 81.4 p -89.95 132.2 35.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.644 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 73.0 m -79.93 39.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.816 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.4 OUTLIER 60.58 116.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.595 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 51.0 m -59.84 112.81 5.89 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.081 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.497 ' HB2' HG21 ' A' ' 974' ' ' VAL . 27.2 Cg_exo -62.0 113.05 1.7 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.11 1.873 . . . . 0.0 111.761 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 26.5 Cg_endo -62.39 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.203 1.935 . . . . 0.0 111.277 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 967' ' ' PRO . 2.5 p30 176.19 119.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.823 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 37.4 Cg_endo -66.92 149.34 83.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.339 2.026 . . . . 0.0 111.267 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 98.6 t -40.65 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.826 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.567 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 30.5 m120 75.27 -51.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.662 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.56 -172.37 7.33 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.88 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.823 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 67.3 mtm -156.7 136.29 12.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.675 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.876 ' HB ' HD12 ' A' ' 986' ' ' ILE . 2.6 m -85.27 149.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.475 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 1.9 m-70 -114.93 104.0 11.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.75 ' HA ' HG22 ' A' ' 986' ' ' ILE . 59.5 t -70.43 92.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.043 0.449 . . . . 0.0 110.333 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.18 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.881 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 38.0 p -71.53 -68.83 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.343 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 18.6 t70 -165.67 -153.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.353 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.651 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.4 pt -155.94 11.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.618 0.247 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.648 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 89.3 mt-30 -87.22 30.81 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 67.4 t 100.61 143.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.553 0.741 . . . . 0.0 111.762 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.87 -46.22 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.626 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.488 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 57.9 m -68.41 150.79 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.569 ' HD2' ' H ' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -138.4 135.87 35.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.228 0.537 . . . . 0.0 111.113 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.876 HD12 ' HB ' ' A' ' 974' ' ' VAL . 20.1 pt -91.06 -163.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.226 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 45.5 p -146.38 123.72 11.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.004 0.43 . . . . 0.0 111.561 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.647 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.6 OUTLIER -91.86 151.12 20.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.565 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.8 p -155.18 125.7 6.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 61.3 m -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 994' ' ' HIS . 62.5 p 27.94 -143.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.054 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 7.3 t -117.32 -24.72 7.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.396 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -135.5 45.49 1.1 Allowed Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.111 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.402 ' HB2' ' OG1' ' A' ' 991' ' ' THR . 27.5 m80 -139.91 144.92 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.693 0.283 . . . . 0.0 110.589 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' 1079 ' ' ASP . 43.7 ttm-85 -81.97 125.97 31.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.671 HD13 ' OG ' ' A' 1000 ' ' SER . 7.0 tt -76.24 123.14 25.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.695 ' HB ' HG13 ' A' 1019 ' ' ILE . 51.7 mm -86.64 148.42 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.402 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.79 -107.04 2.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.832 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' 1001 ' ' SER . 91.2 m-70 -149.76 133.02 16.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 996' ' ' LEU . 15.6 m -78.43 27.41 0.2 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.522 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 999' ' ' HIS . 81.4 p -162.22 145.77 11.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.451 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.98 132.27 10.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.411 . . . . 0.0 111.435 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -104.95 133.53 49.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.197 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 53.1 t -73.46 129.39 37.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' 1012 ' ' HIS . 38.1 pt -130.49 -167.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.802 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.573 HD13 ' N ' ' A' 1007 ' ' SER . 0.4 OUTLIER -142.95 127.06 17.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.895 0.379 . . . . 0.0 110.79 -179.089 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.573 ' N ' HD13 ' A' 1006 ' ' LEU . 56.5 p -81.75 -59.4 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.856 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.52 35.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 50.6 t-20 178.77 -37.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 110.361 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 27.6 m -149.98 142.73 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.644 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.31 141.18 43.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.226 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.9 p80 -149.68 147.19 27.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.3 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.651 ' HH2' HG22 ' A' ' 980' ' ' ILE . 84.2 m95 -67.19 129.61 40.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 111.021 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.4 p -52.37 -27.16 14.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.865 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 75.9 p -107.99 138.35 44.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -58.23 152.38 42.3 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.5 103.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.381 2.054 . . . . 0.0 112.532 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.1 154.35 72.7 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.993 2.462 . . . . 0.0 111.767 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 997' ' ' ILE . 37.1 pt -135.84 -147.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.403 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 971' ' ' ASN . 23.0 m -143.06 -178.78 6.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -166.86 126.54 1.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -74.3 120.71 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.35 119.51 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.213 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.06 122.45 7.64 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.188 1.926 . . . . 0.0 111.758 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 28.8 m -88.41 134.93 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.591 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 161.79 52.24 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.051 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.567 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 10.4 mt -49.75 138.83 17.01 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 117.018 0.409 . . . . 0.0 111.895 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.497 ' HB3' ' CD2' ' A' 1084 ' ' TRP . 59.2 Cg_endo -70.85 150.31 61.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.893 2.396 . . . . 0.0 111.516 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 83.4 Cg_exo -47.01 126.12 10.89 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.415 2.077 . . . . 0.0 111.985 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.0 p -77.53 126.56 31.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' 1034 ' ' GLY . 6.7 tt -88.59 111.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -67.11 141.77 57.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 68.84 26.93 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.308 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.779 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -175.34 135.06 2.9 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.28 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -74.17 -155.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.572 ' HB2' ' CG1' ' A' 1050 ' ' VAL . 49.0 p90 -156.0 131.89 9.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 111.251 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.546 HG13 ' CZ ' ' A' 1053 ' ' ARG . 47.9 mm -91.3 99.97 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.822 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 44.3 t -171.12 146.58 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.911 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 90.9 m -58.94 -33.61 70.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -56.53 128.39 35.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -151.69 -31.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.635 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -147.16 -51.73 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.163 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -71.57 135.71 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.567 ' HE2' ' HG ' ' A' 1027 ' ' LEU . 0.1 OUTLIER -162.21 55.09 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' 1046 ' ' TYR . 12.2 m80 -63.5 -47.9 79.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.196 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' 1045 ' ' HIS . 74.0 t80 172.37 161.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.53 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.9 -24.11 3.47 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 49.7 m -47.59 143.87 3.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 110.92 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -142.47 123.53 11.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.782 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.822 ' HA ' ' HB2' ' A' 1038 ' ' SER . 98.1 t -106.55 129.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.042 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.7 m -99.43 125.05 45.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.632 ' HB2' HD11 ' A' 1066 ' ' LEU . 4.6 m-85 -72.24 146.79 47.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.546 ' CZ ' HG13 ' A' 1037 ' ' ILE . 38.3 ttm180 -146.11 -29.24 0.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.779 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 47.7 t 65.44 160.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.483 ' N ' ' HA2' ' A' 1034 ' ' GLY . 22.9 m120 -62.13 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.584 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.763 ' HB3' ' HA2' ' A' 1060 ' ' GLY . 23.0 mt -154.94 27.0 0.43 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.285 0.564 . . . . 0.0 110.65 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' 1063 ' ' VAL . . . 53.71 -113.15 2.89 Favored Glycine 0 C--N 1.317 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.859 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 49.3 m -51.44 -50.48 59.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -167.7 -53.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.352 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.763 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . -176.89 38.2 0.09 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.942 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' 1061 ' ' ARG . 34.6 ttm180 -93.86 33.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' 1062 ' ' LYS . 26.2 ttpp 41.09 52.19 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.172 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.722 HG23 ' HD1' ' A' 1064 ' ' PHE . 16.1 m -85.02 -39.27 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.253 0.549 . . . . 0.0 110.728 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.722 ' HD1' HG23 ' A' 1063 ' ' VAL . 2.9 m-85 -85.96 147.76 26.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.066 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -134.44 128.91 34.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 111.658 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' 1067 ' ' VAL . 4.5 tt -68.6 140.31 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.309 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.875 ' N ' HD23 ' A' 1066 ' ' LEU . 78.5 t -135.49 109.51 10.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 111.142 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1068 ' ' GLY . . . . . 0.558 ' O ' ' HG3' ' A' 1089 ' ' PRO . . . 76.98 156.55 7.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.754 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 38.2 tt0 30.37 77.39 0.32 Allowed Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' 1066 ' ' LEU . 90.0 Cg_endo -86.66 7.39 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.588 2.192 . . . . 0.0 112.473 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 53.1 m -156.23 150.01 24.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.387 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' 1049 ' ' VAL . 15.5 pt -148.0 150.15 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.635 ' HB3' HG23 ' A' 1049 ' ' VAL . 2.8 p90 -160.12 145.67 15.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.601 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.919 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 42.0 t -66.28 144.12 56.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.7 t -144.07 -7.55 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' 1082 ' ' GLY . 57.8 m 66.11 136.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.308 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -172.18 43.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -170.07 -122.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.453 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' 1081 ' ' VAL . 9.5 t70 -163.09 121.48 2.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.771 0.319 . . . . 0.0 110.757 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.467 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 86.7 mt-30 55.88 42.35 28.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' 1079 ' ' ASP . 21.1 t -147.59 -38.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 110.46 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 76.73 -68.96 2.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.753 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 75.5 mt 60.57 130.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.981 0.419 . . . . 0.0 111.202 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.919 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.6 m95 -74.58 -153.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -62.96 -46.84 85.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.501 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . 178.66 -149.05 8.69 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.906 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' 1029 ' ' PRO . 10.4 Cg_exo -71.57 -127.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.387 2.725 . . . . 0.0 112.74 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . -159.33 138.84 8.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 58.5 Cg_endo -68.36 -138.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.505 2.803 . . . . 0.0 113.105 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.452 ' H ' ' HB2' ' A' 1089 ' ' PRO . 16.4 tt0 -152.4 143.51 23.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.177 0.513 . . . . 0.0 111.734 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 42.6 t -103.13 139.38 38.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.573 HD11 HG21 ' A' 1067 ' ' VAL . 11.9 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.127 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -77.42 43.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.551 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.4 mm-40 -68.98 -159.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -80.06 55.36 2.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.551 ' NZ ' ' HB2' ' A' ' 959' ' ' GLU . 47.9 mmtm -77.51 140.97 39.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 83.6 p -155.41 139.85 16.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.464 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.0 m -80.0 140.85 36.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.268 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.93 148.66 49.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.008 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 41.8 m -39.71 119.66 1.37 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.537 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.78 ' HG2' HG11 ' A' ' 974' ' ' VAL . 11.2 Cg_endo -55.03 127.2 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.358 2.039 . . . . 0.0 111.725 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.14 125.14 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.038 1.825 . . . . 0.0 111.37 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.06 120.03 11.17 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.457 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.554 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 77.2 Cg_exo -50.51 140.34 35.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.479 2.119 . . . . 0.0 112.247 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.657 ' HB ' ' H ' ' A' 1020 ' ' CYS . 66.9 t -47.03 110.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.508 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 32.9 m120 75.66 -45.91 0.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.581 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -72.62 -156.02 3.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.896 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.554 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 94.9 mmm -158.85 143.3 15.69 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.51 0.324 . . . . 0.0 110.418 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.78 HG11 ' HG2' ' A' ' 966' ' ' PRO . 0.5 OUTLIER -91.61 144.73 8.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.387 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -117.06 107.96 15.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.736 0.303 . . . . 0.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.766 ' HA ' HG22 ' A' ' 986' ' ' ILE . 57.3 t -66.42 119.59 11.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.943 HD11 HG23 ' A' ' 987' ' ' THR . 31.3 mt -84.43 -89.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.802 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 30.9 p -75.25 -69.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.54 ' H ' ' HB2' ' A' ' 984' ' ' SER . 2.6 m-20 -153.13 -147.57 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.95 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.434 HG22 ' CH2' ' A' 1013 ' ' TRP . 12.1 pt -155.95 25.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.705 0.288 . . . . 0.0 111.21 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 71.3 mt-30 -87.26 -55.75 3.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.474 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 981' ' ' GLN . 13.1 t -173.42 140.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 124.142 0.901 . . . . 0.0 109.469 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.24 -20.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.888 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.54 ' HB2' ' H ' ' A' ' 979' ' ' ASP . 81.1 p -68.34 129.15 39.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 48.3 ttm-85 -97.47 156.74 16.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 976' ' ' VAL . 28.2 pt -143.16 136.22 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.943 HG23 HD11 ' A' ' 977' ' ' ILE . 59.4 p -91.0 126.24 36.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.06 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.917 ' HB2' ' HA ' ' A' 1000 ' ' SER . 2.4 m-85 -96.48 146.93 24.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 15.3 t -145.53 169.34 18.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.973 ' HB2' HD12 ' A' ' 996' ' ' LEU . 4.7 t -158.11 107.07 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 992' ' ' THR . 35.6 p 34.73 -150.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.971 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.4 t -117.91 -37.09 3.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.819 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' 1046 ' ' TYR . . . -118.05 48.9 0.9 Allowed Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.275 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -144.71 131.81 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.639 HH21 ' HA ' ' A' 1079 ' ' ASP . 39.1 ttm-85 -82.04 109.88 16.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.703 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.973 HD12 ' HB2' ' A' ' 990' ' ' CYS . 6.6 tt -76.44 113.69 14.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.564 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' 1019 ' ' ILE . 2.0 mp -90.11 91.41 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.922 0.868 . . . . 0.0 110.663 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -161.05 -113.71 0.32 Allowed Glycine 0 C--N 1.315 -0.621 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.023 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' 1000 ' ' SER . 92.8 m-70 -154.19 -10.43 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.917 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 19.4 m 57.58 18.52 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.432 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.603 ' O ' HG21 ' A' 1015 ' ' THR . 79.6 p -162.18 144.39 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.433 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -162.97 153.67 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.779 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' 1003 ' ' GLU . 11.2 pm0 -135.04 135.46 41.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.724 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.421 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 31.6 t -71.41 88.65 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.304 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.411 HG23 ' HG2' ' A' 1003 ' ' GLU . 37.8 pt -87.33 -167.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' 1008 ' ' GLY . 4.0 tt -158.38 121.89 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.417 ' N ' HD23 ' A' 1006 ' ' LEU . 44.3 t -77.51 -48.04 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.74 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.439 ' N ' HD23 ' A' 1006 ' ' LEU . . . 175.83 -45.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.793 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.32 -48.86 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.2 153.3 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.924 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.421 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.32 141.33 43.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.1 p80 -154.92 147.87 24.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.698 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.434 ' CH2' HG22 ' A' ' 980' ' ' ILE . 41.2 m95 -70.76 126.87 30.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 110.531 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 t -52.43 -25.54 10.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.788 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.603 HG21 ' O ' ' A' 1001 ' ' SER . 30.9 p -95.5 138.81 32.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.59 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 24.0 pttm -79.16 163.8 57.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.354 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 11.2 Cg_endo -54.28 120.0 7.28 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.086 1.858 . . . . 0.0 111.405 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.507 ' HB2' HD21 ' A' ' 996' ' ' LEU . 72.3 Cg_endo -76.66 136.22 16.92 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.769 2.313 . . . . 0.0 113.521 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.674 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 30.0 pt -116.37 124.07 72.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.657 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 84.6 m -91.12 121.46 32.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.575 ' HG2' HD13 ' A' ' 997' ' ' ILE . 96.9 mm-40 -86.52 129.92 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.166 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.616 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.01 129.68 40.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.677 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.1 mm -73.93 107.64 3.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.21 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 92.4 Cg_endo -81.4 123.57 4.43 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.297 1.998 . . . . 0.0 112.477 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' 1044 ' ' PHE . 73.3 m -88.64 132.97 34.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.202 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -82.93 -154.61 16.4 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.064 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' 1027 ' ' LEU . 1.7 mm? -72.75 144.9 86.34 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 120.711 0.291 . . . . 0.0 111.519 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.593 ' O ' HG23 ' A' 1030 ' ' THR . 27.1 Cg_endo -61.45 166.65 11.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.879 2.386 . . . . 0.0 112.284 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' 1086 ' ' GLY . 81.9 Cg_exo -47.98 -24.35 5.2 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.757 2.305 . . . . 0.0 112.449 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1030 ' ' THR . . . . . 0.593 HG23 ' O ' ' A' 1028 ' ' PRO . 46.4 p 56.91 144.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.733 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.78 HD13 ' HB1' ' A' 1088 ' ' ALA . 2.9 pt -152.88 117.97 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -70.11 67.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.148 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' 1034 ' ' GLY . 15.0 p30 -174.25 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.609 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -79.25 -177.18 49.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.367 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' 1053 ' ' ARG . 3.2 m-20 -156.47 132.65 9.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 5.1 p90 -84.02 152.71 24.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.425 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.508 HD13 ' O ' ' A' 1036 ' ' PHE . 39.1 mm -127.71 66.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' 1050 ' ' VAL . 9.6 t -171.08 -141.52 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' 1040 ' ' ASN . 39.7 m -67.57 -103.92 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.72 ' HB2' HG11 ' A' 1050 ' ' VAL . 0.4 OUTLIER 50.1 118.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' 1040 ' ' ASN . 22.0 mmt180 -164.57 -69.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.242 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -156.62 -51.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.188 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -72.87 61.58 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.75 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' 1025 ' ' CYS . 73.1 m-85 -76.72 -58.08 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.314 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.74 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 7.2 m80 55.54 -172.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.53 ' CZ ' ' HA3' ' A' ' 993' ' ' GLY . 34.4 t80 -56.9 142.78 40.11 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.48 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.433 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.47 124.34 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' 1073 ' ' TYR . 38.2 m 178.37 144.55 0.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.374 0.67 . . . . 0.0 110.041 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' 1072 ' ' ILE . 11.2 p -155.83 145.32 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' 1040 ' ' ASN . 27.3 m -149.54 141.88 17.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.638 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.5 m -88.68 124.46 34.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.327 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' A' 1070 ' ' PRO . 11.3 m-85 -85.26 147.95 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.722 0.772 . . . . 0.0 112.789 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' 1035 ' ' ASP . 43.1 ttt85 -148.71 129.75 14.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.29 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 12.8 t -76.44 153.54 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.675 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -49.19 -70.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.02 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.817 HD22 ' HA2' ' A' 1060 ' ' GLY . 4.3 mt 62.37 164.99 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.403 ' C ' ' HG ' ' A' 1058 ' ' SER . . . -82.8 42.25 2.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.394 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' 1059 ' ' ARG . 84.0 p 49.73 29.12 2.99 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.349 . . . . 0.0 111.391 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' 1058 ' ' SER . 0.7 OUTLIER -152.77 -37.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.817 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 98.08 46.36 2.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.702 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' 1061 ' ' ARG . 13.5 tpp85 -76.93 40.2 0.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' 1062 ' ' LYS . 24.7 ttmm 44.17 35.04 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.528 0.68 . . . . 0.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.755 HG23 ' HD1' ' A' 1064 ' ' PHE . 11.3 m -95.9 -10.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.755 ' HD1' HG23 ' A' 1063 ' ' VAL . 88.3 m-85 -153.93 141.48 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.606 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -142.16 119.14 11.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.01 0.433 . . . . 0.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' 1067 ' ' VAL . 5.5 tt -73.42 130.16 39.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.64 ' N ' HD23 ' A' 1066 ' ' LEU . 7.5 p -156.64 73.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.038 0.923 . . . . 0.0 110.88 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1068 ' ' GLY . . . . . 0.837 ' HA3' ' HA ' ' A' 1089 ' ' PRO . . . -172.64 23.05 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.218 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.729 ' HB3' ' O ' ' A' 1068 ' ' GLY . 7.8 tt0 81.99 104.4 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.629 ' HA ' ' HB2' ' A' 1052 ' ' TYR . 89.0 Cg_endo -82.96 31.64 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.912 2.408 . . . . 0.0 113.229 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.9 p -158.86 134.65 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.561 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' 1049 ' ' VAL . 42.2 pt -140.89 152.31 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.06 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' 1048 ' ' SER . 9.9 p90 -146.77 137.08 23.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.421 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 41.7 t -75.18 148.01 39.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.229 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' 1082 ' ' GLY . 5.2 t -155.07 130.32 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.631 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' 1023 ' ' ILE . 80.9 p -75.66 153.72 37.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.327 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -165.34 -22.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -116.46 -128.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.216 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.639 ' HA ' HH21 ' A' ' 995' ' ' ARG . 54.5 m-20 -76.78 -150.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -85.53 29.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.044 0.45 . . . . 0.0 110.495 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 32.4 t -79.97 -35.45 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.489 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.65 ' C ' HD13 ' A' 1083 ' ' ILE . . . 85.09 -48.98 4.15 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.729 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.65 HD13 ' C ' ' A' 1082 ' ' GLY . 0.1 OUTLIER 39.38 118.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.643 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 22.2 m95 -72.23 138.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.507 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 79.8 p -64.46 -54.31 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -72.07 125.51 11.02 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.285 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.13 41.13 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.579 2.186 . . . . 0.0 112.953 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.78 ' HB1' HD13 ' A' 1031 ' ' ILE . . . 60.46 134.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.489 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.837 ' HA ' ' HA3' ' A' 1068 ' ' GLY . 40.4 Cg_endo -68.13 156.74 64.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.226 2.617 . . . . 0.0 113.71 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.473 ' H ' ' HA3' ' A' 1068 ' ' GLY . 9.9 tp-100 -104.69 114.73 29.12 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.797 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 48.1 t -97.29 132.15 43.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.327 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 7.0 pt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.422 -179.594 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -173.06 135.31 0.59 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.988 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 959' ' ' GLU . 17.3 tp10 56.87 52.68 9.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 960' ' ' ALA . . . . . 0.442 ' H ' ' HD3' ' A' ' 961' ' ' LYS . . . -167.78 45.09 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.066 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.561 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 2.6 mppt? -77.63 137.35 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.94 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 86.5 p -82.09 136.29 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.598 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 87.8 m -79.96 34.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 962' ' ' SER . 86.3 tttt 62.73 139.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.71 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.4 m -61.61 124.75 82.55 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.336 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.413 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 17.0 Cg_exo -68.05 118.29 5.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.6 2.2 . . . . 0.0 112.561 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 135.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 111.271 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -48.39 104.28 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.19 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 54.7 Cg_endo -69.15 -151.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.607 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' 1019 ' ' ILE . 45.5 t -52.76 73.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.812 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 969' ' ' PRO . 75.5 m-20 72.57 -35.85 0.34 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.44 130.35 26.18 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.923 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.1 mtp -92.27 145.5 24.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.621 ' CG2' HD12 ' A' ' 986' ' ' ILE . 3.1 p -84.88 151.15 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -114.02 99.33 7.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 980' ' ' ILE . 39.2 t -75.31 85.65 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.75 -92.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.778 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 23.3 p -61.84 -65.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -159.16 -136.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.578 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.559 HG23 HG13 ' A' ' 976' ' ' VAL . 6.5 pt -154.31 -19.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.06 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.94 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 85.6 mt-30 -73.01 175.8 6.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.654 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' 1004 ' ' CYS . 64.2 t -44.29 147.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.832 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.86 -36.82 1.89 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.354 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 43.1 t -68.38 158.86 32.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 0.0 111.092 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.699 ' HE ' ' HB2' ' A' 1003 ' ' GLU . 39.4 ttm180 -145.16 120.75 10.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.8 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.621 HD12 ' CG2' ' A' ' 974' ' ' VAL . 18.8 pt -97.16 -168.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.351 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 73.7 p -153.09 124.09 7.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.0 m-85 -94.76 154.47 17.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.184 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 72.5 p -152.91 127.47 9.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.111 0.482 . . . . 0.0 111.13 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 73.3 m -82.94 148.13 27.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.052 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 26.1 p -62.06 157.65 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.182 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 60.7 m -48.68 138.29 11.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.583 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.543 ' O ' HD12 ' A' 1023 ' ' ILE . . . 95.9 -41.86 2.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.572 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -82.41 133.46 35.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.979 0.389 . . . . 0.0 111.286 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.727 ' HB2' HD11 ' A' 1023 ' ' ILE . 40.5 ttt85 -82.25 120.65 25.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.851 HD21 ' HB3' ' A' 1000 ' ' SER . 7.3 tp -65.97 124.47 22.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.177 0.513 . . . . 0.0 111.804 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' 1019 ' ' ILE . 46.7 mm -107.83 145.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.919 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.45 169.92 30.29 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.458 ' O ' ' HG3' ' A' 1018 ' ' PRO . 88.5 m-70 -74.98 125.56 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 0.0 111.587 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.851 ' HB3' HD21 ' A' ' 996' ' ' LEU . 81.6 p -68.18 -46.8 69.69 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.066 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.6 p -77.93 139.77 39.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.64 127.62 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.282 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.699 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 43.4 tt0 -98.02 132.09 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.709 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 52.9 t -66.7 94.54 0.3 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 22.2 pt -90.07 -155.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.872 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' 1008 ' ' GLY . 2.0 tm? -149.96 124.21 9.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.599 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.467 ' N ' HD13 ' A' 1006 ' ' LEU . 46.1 t -80.53 -48.4 12.82 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.509 ' N ' HD13 ' A' 1006 ' ' LEU . . . -161.44 -54.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.305 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -123.53 -52.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.1 m -88.9 144.34 26.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.29 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.598 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.24 145.02 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.044 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.478 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 93.3 m-70 -149.17 140.69 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.456 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 82.5 m95 -68.12 135.68 52.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 m -52.34 -24.68 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.184 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 53.4 p -132.94 137.59 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 111.817 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -56.51 150.1 36.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.06 117.99 2.16 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.342 2.028 . . . . 0.0 112.521 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.502 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 72.5 Cg_exo -51.06 138.35 43.91 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.693 2.262 . . . . 0.0 112.063 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 997' ' ' ILE . 0.0 OUTLIER -110.08 139.7 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.41 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.686 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 63.0 m -97.68 128.91 44.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.816 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 995' ' ' ARG . 33.0 tp60 -82.17 125.52 31.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.314 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.4 tpt180 -67.71 -26.36 66.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.727 HD11 ' HB2' ' A' ' 995' ' ' ARG . 49.7 mt 58.24 61.53 5.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.245 0.545 . . . . 0.0 109.678 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.652 ' HA ' ' N ' ' A' 1046 ' ' TYR . 38.1 Cg_endo -65.68 138.49 54.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.13 2.553 . . . . 0.0 114.008 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.491 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 38.5 m -88.43 141.23 28.71 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.744 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.19 -153.36 4.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.143 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.95 155.51 91.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.113 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.657 ' O ' HG23 ' A' 1030 ' ' THR . 31.2 Cg_exo -58.01 154.48 38.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.265 . . . . 0.0 111.879 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.547 ' HD2' ' OH ' ' A' 1052 ' ' TYR . 55.3 Cg_exo -51.13 -17.3 3.55 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.435 2.09 . . . . 0.0 112.274 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1030 ' ' THR . . . . . 0.657 HG23 ' O ' ' A' 1028 ' ' PRO . 73.8 p 49.08 94.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.663 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' 1031 ' ' ILE . 29.5 pt -84.1 104.3 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . 43.03 -139.36 0.21 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -79.64 41.74 0.5 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.44 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.68 -141.43 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.361 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' 1036 ' ' PHE . 19.6 t70 -168.03 -159.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.32 . . . . 0.0 110.795 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.73 ' CD1' HG23 ' A' 1050 ' ' VAL . 1.4 t80 -156.0 125.82 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.221 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' 1036 ' ' PHE . 4.3 mp -143.98 70.46 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.148 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 40.4 t -159.63 -119.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' 1040 ' ' ASN . 65.3 p -140.5 111.73 7.19 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.832 0.348 . . . . 0.0 111.917 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.503 ' HB2' ' CE2' ' A' 1044 ' ' PHE . 0.5 OUTLIER 165.31 130.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.062 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' 1043 ' ' ASN . 84.0 mtm180 -153.17 117.25 4.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.745 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.564 ' N ' ' HE1' ' A' 1044 ' ' PHE . 0.5 OUTLIER 53.1 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.551 179.051 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' 1041 ' ' ARG . 72.1 m-20 -70.37 65.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.13 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.643 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 1.9 m-85 -76.79 135.69 38.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.335 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.525 ' HA ' ' CB ' ' A' 1024 ' ' PRO . 52.0 m-70 -141.91 -165.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.553 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.652 ' N ' ' HA ' ' A' 1024 ' ' PRO . 10.5 t80 -58.02 139.25 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.414 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 64.87 111.18 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.453 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' 1073 ' ' TYR . 79.6 p 176.54 128.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.265 0.555 . . . . 0.0 110.521 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' 1073 ' ' TYR . 97.4 t -102.16 147.04 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.965 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.73 HG23 ' CD1' ' A' 1036 ' ' PHE . 12.3 p -138.46 126.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.927 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' 1037 ' ' ILE . 87.9 m -101.04 117.32 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 111.559 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.547 ' OH ' ' HD2' ' A' 1029 ' ' PRO . 4.8 m-85 -83.94 134.71 34.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.186 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.464 ' O ' ' HE2' ' A' 1062 ' ' LYS . 50.9 mtp85 -148.19 25.02 1.02 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.812 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.57 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 57.9 m 58.78 150.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.443 ' O ' ' ND2' ' A' 1055 ' ' ASN . 0.3 OUTLIER -68.29 39.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.576 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.585 ' HA ' ' HA ' ' A' 1062 ' ' LYS . 0.4 OUTLIER 27.59 50.56 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.681 ' HA2' ' HE1' ' A' 1064 ' ' PHE . . . 73.7 -40.02 0.95 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.269 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 47.0 t -169.87 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.906 0.353 . . . . 0.0 111.274 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.643 ' N ' ' HD3' ' A' 1059 ' ' ARG . 0.0 OUTLIER -163.0 -28.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.451 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' 1056 ' ' LEU . . . -151.02 149.39 21.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.837 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' 1056 ' ' LEU . 44.5 ttm-85 71.61 116.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' 1056 ' ' LEU . 40.1 ttmt -72.99 146.0 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 28.5 m -143.87 -22.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 4.7 m-85 -73.82 -26.36 60.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.72 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1065 ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' 1062 ' ' LYS . 58.5 mm-40 61.39 111.66 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.751 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.781 HD22 ' H ' ' A' 1067 ' ' VAL . 3.2 tm? -71.23 149.48 46.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.323 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.781 ' H ' HD22 ' A' 1066 ' ' LEU . 21.3 t -129.56 138.57 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.95 -153.94 42.55 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.536 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.545 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.0 pt-20 -72.11 113.46 20.69 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-O 120.504 0.192 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' A' 1051 ' ' THR . 93.2 Cg_endo -84.67 24.41 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.274 1.982 . . . . 0.0 112.929 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' 1050 ' ' VAL . 40.4 t -158.87 142.11 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 111.678 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.503 HG12 ' HE1' ' A' 1052 ' ' TYR . 42.2 pt -141.92 -177.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.482 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.799 ' HB3' HG22 ' A' 1049 ' ' VAL . 2.3 p90 -160.21 151.09 18.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 32.3 t -62.14 149.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.611 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 -27.44 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.646 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 58.3 m 58.78 54.3 5.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -63.84 -43.04 97.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.173 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -74.15 -82.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.395 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' 1081 ' ' VAL . 2.2 p30 -163.18 -135.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.026 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.529 ' HA ' HG23 ' A' 1023 ' ' ILE . 28.6 mt-30 -68.34 12.17 0.14 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' 1079 ' ' ASP . 14.0 t -68.04 -43.56 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.311 0.577 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . 82.57 42.06 8.65 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.471 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 62.7 mt -82.02 142.3 13.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.668 0.271 . . . . 0.0 110.295 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.47 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 28.4 m95 -70.5 -163.97 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.358 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.458 ' OG ' ' HB ' ' A' 1072 ' ' ILE . 81.6 p -65.02 -63.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 177.86 127.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.224 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.41 140.62 70.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.518 2.145 . . . . 0.0 111.537 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.709 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -165.69 -50.88 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.611 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.709 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.4 Cg_endo -52.36 145.55 35.71 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.395 2.063 . . . . 0.0 111.76 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -152.37 136.8 16.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.662 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 94.7 m -91.9 123.15 35.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.015 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.662 -179.308 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.23 -135.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -169.16 50.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.045 0.45 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -76.94 52.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.674 ' HA ' ' HE3' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -77.58 134.01 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.113 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 25.1 m -154.4 135.0 13.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 92.8 m -79.92 136.62 36.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -63.78 138.68 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.458 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 7.1 t -57.44 122.65 56.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.842 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.871 ' HG2' HG11 ' A' ' 974' ' ' VAL . 42.4 Cg_endo -66.95 107.62 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.384 2.056 . . . . 0.0 111.98 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 965' ' ' THR . 26.4 Cg_exo -61.69 134.6 51.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.549 2.166 . . . . 0.0 111.694 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -53.26 106.97 0.73 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.777 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 97.4 Cg_endo -82.34 -150.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.534 2.156 . . . . 0.0 112.903 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 970' ' ' VAL . 1.4 p -48.94 83.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.52 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 969' ' ' PRO . 76.6 m-20 69.83 -28.37 0.17 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.73 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.4 147.27 46.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.444 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 63.4 mtm -143.19 131.8 22.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 110.413 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.991 HG21 HD12 ' A' ' 986' ' ' ILE . 3.3 p -87.4 154.03 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.366 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -114.7 100.02 7.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.774 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 986' ' ' ILE . 35.6 t -65.73 106.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.6 mt -75.27 -94.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 22.0 p -72.44 -56.35 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 0.0 110.144 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 976' ' ' VAL . 5.7 p-10 -165.75 -131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.563 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.517 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 1.8 pt -153.59 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.017 0.437 . . . . 0.0 111.113 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 70.6 mt-30 -87.33 -176.44 5.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.69 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 97.8 t -48.57 139.99 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.251 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.17 1.55 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 92.1 p -67.92 130.31 42.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.899 0.849 . . . . 0.0 111.127 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.716 ' HG2' ' HB3' ' A' 1003 ' ' GLU . 99.1 mtt180 -101.58 163.63 12.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.991 HD12 HG21 ' A' ' 974' ' ' VAL . 26.0 pt -150.68 139.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.083 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' 1000 ' ' SER . 81.1 p -102.95 122.25 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -92.33 155.51 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.263 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 996' ' ' LEU . 16.6 m -160.3 122.6 3.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.38 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.73 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 94.4 m -82.25 68.16 8.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 992' ' ' THR . 33.7 p 45.95 -155.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.479 . . . . 0.0 111.864 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 993' ' ' GLY . 13.6 t -97.4 -45.39 6.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.211 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 992' ' ' THR . . . -93.17 43.73 2.53 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.419 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' 1022 ' ' ARG . 56.1 m-70 -157.53 135.21 10.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.651 ' HG3' ' HG3' ' A' 1080 ' ' GLN . 77.7 ttt180 -82.19 129.68 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.7 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 4.0 tt -75.01 100.18 4.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.443 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.684 ' HB ' HG23 ' A' 1019 ' ' ILE . 26.6 mm -87.35 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.126 0.965 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -156.52 -118.55 0.58 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.291 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -153.08 109.92 3.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -57.2 -54.64 44.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.174 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.5 p -77.86 137.23 38.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.475 ' HB3' ' HE1' ' A' ' 988' ' ' TYR . . . -157.94 150.06 22.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.716 ' HB3' ' HG2' ' A' ' 985' ' ' ARG . 10.1 pt-20 -135.11 132.02 37.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.601 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 44.2 t -66.68 93.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.33 -168.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 11.0 tp -158.36 120.94 3.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 25.4 m -81.51 -55.17 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.085 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 164.57 47.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -175.61 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.08 0.467 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 82.3 m -151.35 146.7 26.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.018 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.601 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -72.94 135.92 45.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.437 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.45 145.05 26.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.703 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.517 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 58.9 m95 -69.68 128.2 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -52.47 -26.2 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 64.2 p -86.93 130.87 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.776 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.72 155.63 81.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.874 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 81.3 Cg_exo -41.42 112.44 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.154 1.902 . . . . 0.0 111.905 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.458 ' HG3' ' CD2' ' A' ' 988' ' ' TYR . 51.0 Cg_endo -69.9 129.1 16.88 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.928 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.684 HG23 ' HB ' ' A' ' 997' ' ' ILE . 8.1 tt -116.62 147.24 20.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.558 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.559 ' HB2' HG22 ' A' ' 970' ' ' VAL . 72.1 m -106.88 156.83 18.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -154.15 124.1 6.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.985 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.722 ' HD3' ' HB3' ' A' 1046 ' ' TYR . 40.6 ttm180 -59.43 132.71 54.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.839 HD13 ' HA ' ' A' 1080 ' ' GLN . 68.1 mt -73.15 122.4 87.54 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.426 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' 1045 ' ' HIS . 96.2 Cg_endo -84.95 130.79 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.861 2.374 . . . . 0.0 112.532 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.512 ' HB3' ' NE1' ' A' 1084 ' ' TRP . 22.5 m -88.39 32.33 0.78 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.525 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1026 ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' 1044 ' ' PHE . . . 40.18 -130.69 2.77 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.287 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.921 HD12 ' HD2' ' A' 1028 ' ' PRO . 24.1 tp -121.94 126.56 26.3 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.921 ' HD2' HD12 ' A' 1027 ' ' LEU . 26.2 Cg_endo -61.42 156.26 47.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.824 2.349 . . . . 0.0 112.42 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.833 ' HG3' ' HA ' ' A' 1087 ' ' PRO . 19.2 Cg_endo -58.67 126.1 20.25 Favored 'Trans proline' 0 CA--C 1.518 -0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 112.036 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 17.9 m -93.27 151.19 19.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.016 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' 1034 ' ' GLY . 11.1 pt -142.57 134.58 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.261 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -67.86 163.99 20.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.514 ' HB3' ' SG ' ' A' 1054 ' ' CYS . 6.6 m120 76.8 -41.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.452 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -168.28 136.54 4.14 Favored Glycine 0 CA--C 1.507 -0.455 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.444 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.488 ' HB3' HG13 ' A' 1031 ' ' ILE . 2.8 p30 -171.17 142.71 1.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.069 0.462 . . . . 0.0 112.034 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 12.3 t80 60.4 115.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.349 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.625 HD12 ' HD3' ' A' 1053 ' ' ARG . 38.2 mt -152.09 60.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.143 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.767 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 22.9 t -163.78 -137.09 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.032 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' 1040 ' ' ASN . 85.9 m -111.64 128.09 55.95 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' 1039 ' ' THR . 0.2 OUTLIER 174.87 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.451 ' HG3' HH11 ' A' 1041 ' ' ARG . 52.7 mtt85 58.84 67.67 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.239 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.701 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 47.9 mt-10 58.87 -169.85 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' 1042 ' ' GLU . 29.4 m-20 76.62 -70.3 0.14 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.969 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.701 ' CE2' ' HA ' ' A' 1042 ' ' GLU . 7.6 m-85 52.66 47.27 25.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.97 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' 1024 ' ' PRO . 27.3 m80 -62.63 -51.5 67.05 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.039 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.787 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 62.4 t80 173.24 139.07 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 72.29 92.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.414 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.4 p 172.15 130.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' 1050 ' ' VAL . 11.3 p -102.25 156.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.997 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.767 ' HA ' ' HB3' ' A' 1038 ' ' SER . 18.8 m -149.15 130.13 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 40.2 m -89.93 110.42 21.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.437 ' CE1' HD11 ' A' 1072 ' ' ILE . 15.8 m-85 -85.22 135.79 33.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.453 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1053 ' ' ARG . . . . . 1.01 ' HA ' HD22 ' A' 1066 ' ' LEU . 41.2 mtp85 -146.28 -143.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.235 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.931 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 32.6 t -163.66 135.3 4.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -65.81 97.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.483 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.734 ' HG ' ' HA2' ' A' 1060 ' ' GLY . 0.0 OUTLIER -80.76 43.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.784 179.054 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.506 ' N ' ' HB ' ' A' 1063 ' ' VAL . . . 79.1 -62.48 4.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.296 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' 1059 ' ' ARG . 69.2 m -167.29 93.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.242 0.521 . . . . 0.0 111.686 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' 1059 ' ' ARG . 39.5 mmt-85 72.54 -42.24 0.53 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.734 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . 174.57 39.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.531 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' 1061 ' ' ARG . 35.9 ttm180 -83.96 32.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 42.47 83.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.607 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' 1056 ' ' LEU . 6.0 t -149.99 89.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.629 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 29.8 m-85 71.21 90.35 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -90.74 136.26 33.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1066 ' ' LEU . . . . . 1.01 HD22 ' HA ' ' A' 1053 ' ' ARG . 47.5 tp -68.35 155.96 38.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.607 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' 1089 ' ' PRO . 72.5 t -142.62 139.82 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.926 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 86.0 -158.91 32.26 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.417 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.7 pt-20 -64.08 111.15 4.84 Favored Pre-proline 0 CA--C 1.528 0.107 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.587 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 94.8 Cg_endo -90.79 23.07 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.885 2.39 . . . . 0.0 113.152 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.4 p -157.64 143.79 17.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.437 HD11 ' CE1' ' A' 1052 ' ' TYR . 44.2 pt -148.16 171.12 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.137 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.5 p90 -161.67 145.3 12.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.787 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 4.2 t -66.04 144.98 56.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.907 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.4 t -144.41 -151.41 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.231 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.408 ' OG ' HD12 ' A' 1023 ' ' ILE . 44.9 t -161.29 131.34 4.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.016 0.436 . . . . 0.0 111.563 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' 1079 ' ' ASP . 42.6 p-10 178.96 -146.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.115 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 63.3 t0 52.48 -87.63 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' 1077 ' ' ASN . 11.6 p-10 -163.13 51.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.151 0.501 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.839 ' HA ' HD13 ' A' 1023 ' ' ILE . 3.5 mm100 65.42 41.24 4.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 25.4 t -94.05 -40.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' 1025 ' ' CYS . . . 86.28 47.15 5.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.238 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 35.6 pt -81.97 135.1 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.578 ' HZ2' ' HB3' ' A' 1044 ' ' PHE . 26.3 m95 -70.64 147.27 49.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.1 t -40.36 -36.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.581 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.94 150.05 16.43 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.442 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.833 ' HA ' ' HG3' ' A' 1029 ' ' PRO . 31.5 Cg_endo -63.01 157.54 48.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.884 2.389 . . . . 0.0 112.336 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.431 ' H ' ' CG ' ' A' 1029 ' ' PRO . . . -62.62 144.91 95.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.109 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.568 ' HB2' ' O ' ' A' 1067 ' ' VAL . 56.5 Cg_endo -68.0 -144.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.784 2.322 . . . . 0.0 112.271 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -152.41 136.33 16.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.064 0.459 . . . . 0.0 111.702 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 50.7 t -98.37 132.97 43.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 26.2 pt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.117 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 957' ' ' GLU . . . . . 0.438 ' N ' ' OE1' ' A' ' 957' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.784 0.326 . . . . 0.0 111.174 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 57.41 44.68 21.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -68.03 136.13 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -79.37 46.9 0.77 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.431 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' A' 1011 ' ' ALA . 15.3 tppt? 66.3 149.19 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.5 p -156.44 129.8 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.285 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' 1011 ' ' ALA . 2.0 p -84.63 35.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.893 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 963' ' ' CYS . 58.0 tptt 56.63 129.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.709 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 85.6 m -61.56 122.4 70.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.409 ' HB2' HG21 ' A' ' 974' ' ' VAL . 38.1 Cg_exo -57.73 110.24 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.287 1.991 . . . . 0.0 112.519 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.85 139.55 24.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.559 2.173 . . . . 0.0 111.47 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 11.7 p-10 -49.42 107.25 0.74 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 971' ' ' ASN . 6.3 Cg_exo -78.87 -146.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.064 2.509 . . . . 0.0 111.938 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.878 HG21 HG13 ' A' 1019 ' ' ILE . 64.4 t -49.1 81.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.434 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 991' ' ' THR . 22.0 p30 42.72 27.77 0.11 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.148 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.613 ' HA2' ' SG ' ' A' ' 990' ' ' CYS . . . -83.01 -161.11 30.23 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.858 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 45.4 ttm -159.17 114.55 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.629 ' CG2' HD12 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.9 144.22 9.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.284 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -119.75 91.72 3.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.148 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.674 ' HA ' HG22 ' A' ' 986' ' ' ILE . 64.0 t -66.47 103.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.179 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.2 mt -84.14 -92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 41.2 p -84.14 62.84 7.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 111.819 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.92 -153.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.706 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.47 HG22 ' HH2' ' A' 1013 ' ' TRP . 21.5 pt -155.81 26.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.945 0.403 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.629 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 22.6 pt20 -87.34 28.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.061 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 70.8 t 100.43 142.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 111.34 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 70.71 -7.46 5.2 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.234 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 34.9 m -68.33 160.05 30.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.273 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 985' ' ' ARG . 55.9 ttp85 -143.13 109.4 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.227 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 976' ' ' VAL . 27.2 pt -96.77 -174.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 65.9 p -149.43 131.3 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.709 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.4 m-85 -96.23 165.08 12.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.0 p -149.75 -40.56 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 111.408 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.613 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 12.8 t 71.26 177.99 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.893 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 971' ' ' ASN . 22.2 p -62.98 -161.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.321 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 993' ' ' GLY . 11.8 t -94.7 -44.94 7.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.145 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 992' ' ' THR . . . -94.62 39.05 2.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.411 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.66 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 45.3 m80 -149.08 132.76 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.952 0.376 . . . . 0.0 110.681 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' 1021 ' ' GLN . 79.1 ttt180 -82.01 123.4 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 997' ' ' ILE . 8.4 tp -71.25 132.16 44.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.712 HG13 ' HG2' ' A' 1021 ' ' GLN . 17.6 mm -132.13 62.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.628 0.728 . . . . 0.0 110.792 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . -154.27 33.51 0.71 Allowed Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.122 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 59.11 4.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 81.7 p 43.65 31.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.07 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.413 ' O ' HG21 ' A' 1015 ' ' THR . 83.2 p -162.23 151.12 15.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.528 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -158.04 128.94 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.335 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.81 127.22 47.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.812 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -77.48 82.29 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.611 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' 1014 ' ' SER . 46.3 pt -87.21 -152.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.535 ' C ' HD13 ' A' 1006 ' ' LEU . 3.0 tm? -141.9 121.12 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.441 ' N ' HD13 ' A' 1006 ' ' LEU . 45.5 m -93.42 -39.14 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.486 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.522 ' O ' HD11 ' A' 1006 ' ' LEU . . . -169.05 -126.27 0.84 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.084 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -68.38 8.2 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.224 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' 1008 ' ' GLY . 99.3 m -151.87 145.28 24.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 963' ' ' CYS . . . -75.31 147.95 39.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 41.9 m80 -149.43 149.92 31.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 111.539 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.47 ' HH2' HG22 ' A' ' 980' ' ' ILE . 60.8 m95 -81.11 117.25 21.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.197 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.61 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.1 p -53.35 -25.52 15.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.413 HG21 ' O ' ' A' 1001 ' ' SER . 82.2 p -86.93 141.81 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -65.72 150.1 96.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.371 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.31 115.32 2.11 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.124 1.883 . . . . 0.0 111.883 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.61 ' HG2' ' CE2' ' A' ' 988' ' ' TYR . 31.1 Cg_exo -61.12 140.5 89.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.913 2.409 . . . . 0.0 112.873 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.878 HG13 HG21 ' A' ' 970' ' ' VAL . 5.2 tt -129.78 136.48 58.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.725 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 64.6 m -97.25 126.08 42.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.541 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.712 ' HG2' HG13 ' A' ' 997' ' ' ILE . 99.1 mm-40 -75.77 124.34 27.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.62 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.81 -12.49 59.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' 1080 ' ' GLN . 53.5 mt 56.28 70.82 1.34 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 109.939 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' 1045 ' ' HIS . 9.4 Cg_endo -51.44 132.47 40.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.117 2.545 . . . . 0.0 113.519 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.705 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 3.0 m -86.43 -146.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1026 ' ' GLY . . . . . 0.526 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -153.24 -155.44 7.15 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.19 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' 1028 ' ' PRO . 75.4 mt -68.36 143.88 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.714 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.447 ' CG ' HG21 ' A' 1050 ' ' VAL . 20.5 Cg_exo -64.72 147.55 89.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 111.472 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.876 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 83.7 Cg_exo -47.34 113.38 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 112.213 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 68.5 p -77.6 140.45 39.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.495 HD13 ' HB1' ' A' 1088 ' ' ALA . 29.2 pt -151.32 31.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.559 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 52.04 117.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.376 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 1032 ' ' ALA . 75.6 m-20 74.74 -25.97 0.2 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.362 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' 1032 ' ' ALA . . . -70.7 68.77 0.76 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.702 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' 1036 ' ' PHE . 1.5 m-20 -68.75 -150.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.133 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.806 ' HB3' HG13 ' A' 1050 ' ' VAL . 12.3 p90 -155.99 141.6 17.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.559 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' 1037 ' ' ILE . 42.6 mm -92.62 63.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 69.2 m -159.98 -159.13 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 111.707 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 64.9 m -83.59 -92.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.553 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.61 ' OD1' ' HB3' ' A' 1048 ' ' SER . 73.3 m-80 54.06 -138.89 1.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 61.88 109.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' 1043 ' ' ASN . 16.6 pt-20 38.42 41.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.842 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' 1042 ' ' GLU . 72.3 m-80 -167.74 116.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.481 ' CE1' ' HA2' ' A' 1026 ' ' GLY . 0.8 OUTLIER -163.39 143.66 8.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' 1024 ' ' PRO . 16.9 m-70 -140.82 -58.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.449 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.715 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 48.3 t80 175.22 47.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.43 -25.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.032 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.61 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 63.3 m -47.62 147.69 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.262 0.554 . . . . 0.0 111.962 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.932 HG22 ' HB3' ' A' 1073 ' ' TYR . 69.2 t -137.62 145.98 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.124 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.806 HG13 ' HB3' ' A' 1036 ' ' PHE . 3.4 t -133.38 120.38 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.026 0.441 . . . . 0.0 112.183 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 76.7 m -100.23 119.44 38.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.196 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.559 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 26.5 m-85 -74.5 145.54 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.442 0.639 . . . . 0.0 112.431 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -150.99 -30.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.03 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1054 ' ' CYS . . . . . . . . . . . . . 9.6 t 70.31 142.68 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.115 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.442 ' O ' ' HE2' ' A' 1064 ' ' PHE . 12.6 t-20 -65.06 129.02 38.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.855 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.53 HD13 ' CZ ' ' A' 1064 ' ' PHE . 1.8 mm? -73.48 43.26 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.835 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 56.27 48.17 76.87 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' 1059 ' ' ARG . 45.6 t 58.02 39.23 26.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' 1058 ' ' SER . 23.9 mmm180 -157.54 -128.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.871 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -149.76 -26.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -57.74 147.6 27.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -65.2 133.02 50.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.973 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' 1063 ' ' VAL . 10.8 p -155.07 27.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.446 0.641 . . . . 0.0 111.137 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.53 ' CZ ' HD13 ' A' 1056 ' ' LEU . 0.4 OUTLIER -168.77 -175.3 2.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.672 -179.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1065 ' ' GLU . . . . . 0.553 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 72.4 mt-10 -150.11 122.39 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 110.592 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.676 HD21 ' HB3' ' A' 1070 ' ' PRO . 53.7 tp -68.56 119.67 13.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.698 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 85.0 t -101.62 86.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 62.1 -163.08 26.38 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.961 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' 1089 ' ' PRO . 29.9 tp10 30.25 58.43 0.89 Allowed Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.491 0.716 . . . . 0.0 112.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.676 ' HB3' HD21 ' A' 1066 ' ' LEU . 83.4 Cg_endo -80.75 2.76 8.3 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.473 2.115 . . . . 0.0 113.186 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 51.1 m -156.27 144.69 19.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' 1050 ' ' VAL . 19.5 pt -146.39 157.25 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.932 ' HB3' HG22 ' A' 1049 ' ' VAL . 0.3 OUTLIER -160.1 147.91 16.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.715 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 50.8 t -62.18 133.17 54.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.083 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 8.2 t -144.51 -20.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' 1079 ' ' ASP . 57.9 m 58.82 59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -72.96 31.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.708 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' 1076 ' ' SER . 64.3 t0 179.43 53.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' 1076 ' ' SER . 59.3 m-20 62.15 -127.65 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.196 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.741 ' OE1' HG23 ' A' 1081 ' ' VAL . 0.0 OUTLIER -66.19 -140.17 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 121.369 -0.133 . . . . 0.0 111.194 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.741 HG23 ' OE1' ' A' 1080 ' ' GLN . 33.4 t 75.74 -44.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.705 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 78.26 46.86 8.71 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.762 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.0 130.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.829 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.412 ' HB3' ' H ' ' A' 1085 ' ' SER . 15.3 m95 -72.87 -150.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.412 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -74.19 -41.68 61.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -178.06 153.24 12.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.506 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' 1069 ' ' GLU . 89.2 Cg_exo -46.41 153.82 1.05 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.876 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . -62.54 143.61 96.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.872 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.559 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 51.9 Cg_endo -67.72 -143.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.96 2.44 . . . . 0.0 112.181 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.698 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 50.4 mm-40 -135.46 125.0 25.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.975 0.417 . . . . 0.0 111.74 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 43.0 t -85.78 66.91 9.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.593 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.553 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 34.6 pt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -175.36 -147.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.57 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 961' ' ' LYS . 38.6 tt0 -69.6 137.51 52.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.566 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -75.77 35.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER 61.88 145.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 50.3 m -153.74 132.48 12.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.054 0.454 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.439 ' HB3' ' C ' ' A' 1011 ' ' ALA . 14.5 p -79.89 140.54 36.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.677 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 1.1 tpmt? -63.73 146.29 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.267 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.619 ' H ' ' HE2' ' A' ' 964' ' ' LYS . 93.0 m -46.39 128.31 7.86 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.348 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.533 ' HD3' ' CZ2' ' A' 1013 ' ' TRP . 38.7 Cg_endo -66.65 130.94 24.64 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.18 1.92 . . . . 0.0 111.601 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.47 124.63 12.35 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.977 1.785 . . . . 0.0 111.428 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 32.2 m-20 -47.32 122.95 8.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.691 ' HB3' ' HB2' ' A' 1018 ' ' PRO . 6.6 Cg_endo -50.43 153.46 7.39 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 112.22 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.764 ' HB ' ' H ' ' A' 1020 ' ' CYS . 23.3 t -41.96 117.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.633 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.562 ' ND2' HG12 ' A' ' 970' ' ' VAL . 23.8 p30 41.91 46.3 3.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.938 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.611 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -159.11 133.7 3.48 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.736 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 22.3 ptp -97.66 150.37 21.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.977 0.418 . . . . 0.0 111.849 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 19.3 m -92.88 -157.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.409 ' N ' HG23 ' A' ' 974' ' ' VAL . 97.9 m-70 -157.8 100.58 1.76 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.28 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 980' ' ' ILE . 70.6 t -69.89 111.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.032 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 987' ' ' THR . 35.5 mt -84.93 -81.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.06 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 23.6 p -67.98 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.912 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.643 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.4 m-20 -163.26 17.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.587 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 979' ' ' ASP . 20.1 pt 52.1 28.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.269 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.34 160.08 18.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.386 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' 1004 ' ' CYS . 86.3 t -44.44 142.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.174 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.96 -33.8 1.93 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.134 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.604 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 49.4 m -68.48 177.38 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.878 0.339 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' 1002 ' ' ALA . 48.2 ttp85 -156.78 132.2 9.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.118 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.513 HG21 HG22 ' A' ' 980' ' ' ILE . 36.6 pt -96.56 -159.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 977' ' ' ILE . 40.6 p -152.17 128.38 10.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.631 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.857 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.1 OUTLIER -93.92 167.01 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 52.7 p -145.46 -43.39 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.611 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 36.3 t 74.05 164.88 0.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.061 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 992' ' ' THR . 11.3 t -60.77 -141.22 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.406 0.622 . . . . 0.0 112.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.597 HG23 ' N ' ' A' ' 993' ' ' GLY . 13.4 t -61.24 -137.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.82 -178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.597 ' N ' HG23 ' A' ' 992' ' ' THR . . . -70.6 30.39 0.48 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.573 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 17.1 m80 -83.34 129.14 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.473 0.637 . . . . 0.0 109.976 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.649 HH22 ' HB3' ' A' 1079 ' ' ASP . 33.1 ttm180 -81.9 91.59 6.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' A' 1000 ' ' SER . 2.4 pp -61.51 137.53 58.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.371 0.605 . . . . 0.0 110.71 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 998' ' ' GLY . 41.2 mm -100.13 160.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.785 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.4 12.49 81.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.709 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 84.3 m-70 71.02 138.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.884 ' HB3' HD21 ' A' ' 996' ' ' LEU . 83.5 p -80.53 41.15 0.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.808 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 13.1 t -162.13 159.67 26.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.19 132.51 3.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.602 ' HG3' HG23 ' A' 1005 ' ' ILE . 16.7 pt-20 -100.05 126.24 46.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.656 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 49.9 t -74.84 81.66 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.602 HG23 ' HG3' ' A' 1003 ' ' GLU . 46.1 pt -87.3 -157.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' 1009 ' ' ASN . 5.4 tt -158.43 124.36 4.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.481 ' N ' HD23 ' A' 1006 ' ' LEU . 50.1 m -77.56 -54.1 6.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.218 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.43 ' N ' HD23 ' A' 1006 ' ' LEU . . . 167.84 43.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.652 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.538 ' H ' HD21 ' A' 1006 ' ' LEU . 48.6 t30 -177.86 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 59.1 m -151.22 154.59 37.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.201 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.479 ' HB2' HG22 ' A' ' 982' ' ' VAL . . . -74.42 135.81 42.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.253 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.41 146.39 27.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.538 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 21.7 m95 -76.17 118.03 18.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.787 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.567 ' HB3' HD13 ' A' 1005 ' ' ILE . 90.4 p -52.95 -21.35 4.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.126 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 37.9 p -86.93 134.29 33.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.046 0.45 . . . . 0.0 111.771 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.19 152.36 88.32 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.3 125.56 7.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.691 ' HB2' ' HB3' ' A' ' 969' ' ' PRO . 96.7 Cg_endo -77.33 149.87 28.2 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.012 2.474 . . . . 0.0 113.459 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.621 HG22 HG23 ' A' ' 970' ' ' VAL . 32.7 pt -148.79 121.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.863 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.853 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 82.9 m -81.8 127.15 32.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.304 0.573 . . . . 0.0 112.196 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -84.33 129.48 34.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.145 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.686 ' NH1' ' HB3' ' A' 1046 ' ' TYR . 21.3 tpt85 -67.65 -10.29 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.582 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 995' ' ' ARG . 56.6 mt 51.74 64.59 7.56 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.607 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' 1045 ' ' HIS . 52.0 Cg_exo -53.72 124.12 15.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.542 2.161 . . . . 0.0 112.81 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.87 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 33.0 m -88.47 153.41 21.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.14 140.47 25.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.46 ' HA ' ' HZ ' ' A' 1044 ' ' PHE . 68.5 mt -41.57 142.01 1.09 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.977 0.389 . . . . 0.0 111.243 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.461 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 17.9 Cg_endo -57.68 140.21 92.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.083 1.855 . . . . 0.0 110.455 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.457 ' HD2' HD12 ' A' 1072 ' ' ILE . 99.5 Cg_exo -38.03 127.95 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.142 1.895 . . . . 0.0 111.493 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 70.2 p -76.62 137.35 39.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' 1091 ' ' CYS . 5.8 tt -147.46 107.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.574 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -64.43 143.41 57.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.173 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.509 ' HA ' ' OD1' ' A' 1055 ' ' ASN . 4.7 m120 76.76 -40.92 0.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.394 0.434 . . . . 0.0 111.264 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -74.76 72.64 1.52 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.672 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -68.81 133.44 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 111.076 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.595 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 22.4 p90 -84.01 150.68 25.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.246 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' 1037 ' ' ILE . 33.4 mm -110.32 58.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.513 ' H ' ' HD1' ' A' 1036 ' ' PHE . 68.6 m -162.89 -154.54 0.3 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.082 0.467 . . . . 0.0 111.869 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' 1038 ' ' SER . 41.7 p -86.1 -129.85 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.192 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.48 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 4.7 m120 59.65 44.91 13.76 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' 1041 ' ' ARG . 62.2 mtt-85 -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.543 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 63.29 37.28 11.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -179.5 128.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.923 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' 1025 ' ' CYS . 5.5 p90 -163.27 -41.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.625 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' 1046 ' ' TYR . 90.1 m-70 72.65 -36.58 0.36 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.686 ' HB3' ' NH1' ' A' 1022 ' ' ARG . 25.1 t80 170.63 148.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.422 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.59 94.36 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.827 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.438 ' HB3' ' ND2' ' A' 1040 ' ' ASN . 29.2 m 178.0 143.56 0.1 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.938 0.495 . . . . 0.0 109.966 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' 1073 ' ' TYR . 12.3 p -138.21 161.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.289 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' 1036 ' ' PHE . 29.5 m -146.42 137.08 18.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 34.9 m -102.21 120.24 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.977 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.576 ' CE2' HG21 ' A' 1031 ' ' ILE . 2.9 m-85 -72.83 156.23 39.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' 1054 ' ' CYS . 78.4 ttt180 -154.53 -30.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.59 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.622 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 54.4 m 68.59 146.35 0.05 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.077 0.465 . . . . 0.0 111.046 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.7 ' O ' ' HG ' ' A' 1056 ' ' LEU . 28.9 m120 -54.7 162.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.983 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' 1055 ' ' ASN . 3.3 mt -154.98 162.32 41.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.82 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.587 ' H ' ' HB3' ' A' 1061 ' ' ARG . . . -82.09 41.79 2.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.562 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 12.8 t 57.27 18.96 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -167.66 46.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.281 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.556 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 53.39 33.56 46.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.317 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.587 ' HB3' ' H ' ' A' 1057 ' ' GLY . 78.4 ttt180 -71.41 142.2 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 110.978 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.33 102.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.042 0.449 . . . . 0.0 110.413 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.69 HG22 ' HD1' ' A' 1064 ' ' PHE . 3.4 p -155.7 87.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.806 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.69 ' HD1' HG22 ' A' 1063 ' ' VAL . 80.5 m-85 70.84 139.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.757 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -134.26 134.91 42.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.883 0.373 . . . . 0.0 111.659 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.714 HD21 ' HA ' ' A' 1070 ' ' PRO . 17.0 tp -68.54 149.55 49.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 60.0 t -150.19 147.24 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.27 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 90.43 -50.13 3.25 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' 1089 ' ' PRO . 22.0 pt-20 -167.89 130.94 1.35 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 117.72 0.76 . . . . 0.0 112.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.714 ' HA ' HD21 ' A' 1066 ' ' LEU . 94.9 Cg_endo -98.53 8.83 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.512 2.808 . . . . 0.0 113.698 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 60.3 m -156.9 142.75 17.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' 1049 ' ' VAL . 19.6 pt -149.37 147.13 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.996 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' 1049 ' ' VAL . 1.9 p90 -153.47 149.32 27.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.5 t -65.06 150.7 47.65 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.0 t -140.1 -25.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.529 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 43.5 t 59.06 51.13 7.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.738 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -67.32 -59.05 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.473 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.52 58.8 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 111.087 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.649 ' HB3' HH22 ' A' ' 995' ' ' ARG . 1.5 m-20 63.85 -132.07 0.38 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.071 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.516 ' OE1' HG23 ' A' 1023 ' ' ILE . 46.2 mm-40 -64.33 -144.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.561 0.22 . . . . 0.0 110.525 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 21.8 t 72.59 -36.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.87 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 66.28 55.42 18.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.758 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 74.4 mt -81.95 132.93 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.48 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 10.0 m95 -84.17 165.31 18.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.19 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 86.9 p -53.77 -31.72 49.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.526 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.65 148.97 14.15 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.3 -154.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.742 2.295 . . . . 0.0 112.689 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' 1089 ' ' PRO . . . -77.03 136.83 65.79 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.142 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.533 ' HG3' ' HG3' ' A' 1069 ' ' GLU . 3.1 Cg_exo -74.99 -134.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.237 2.624 . . . . 0.0 111.205 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.675 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 47.0 mm-40 -145.12 115.9 7.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.827 ' HB2' HD11 ' A' 1031 ' ' ILE . 22.0 t -97.37 63.98 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.099 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.299 -179.083 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 957' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 957' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.89 0.376 . . . . 0.0 111.202 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 58.28 -135.51 0.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 959' ' ' GLU . 0.3 OUTLIER -67.74 139.18 56.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.071 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -78.64 50.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 66.36 131.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.746 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.81 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 79.6 p -157.96 141.4 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.758 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.478 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 85.3 m -80.2 32.31 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.6 tptt 60.95 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.304 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.9 m -56.73 130.32 77.72 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.293 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.567 ' HB2' HG11 ' A' ' 974' ' ' VAL . 31.9 Cg_exo -58.57 120.88 9.04 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.4 Cg_endo -76.69 66.75 7.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.838 2.359 . . . . 0.0 111.949 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 967' ' ' PRO . 17.6 m-20 22.38 83.33 0.12 Allowed Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.675 0.609 . . . . 0.0 111.56 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.586 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 83.6 Cg_exo -42.69 148.67 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.139 2.56 . . . . 0.0 112.761 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 76.8 t -46.98 122.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.226 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.851 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 2.2 m120 71.92 -70.51 0.16 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.736 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 989' ' ' SER . . . -75.65 128.73 9.87 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.798 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 973' ' ' MET . 1.8 mpt? -84.35 155.7 22.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.645 0.26 . . . . 0.0 110.332 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.6 ' CG2' HD12 ' A' ' 986' ' ' ILE . 1.3 p -89.93 148.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.721 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 1.1 m-70 -117.49 96.55 5.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.493 HG13 HG23 ' A' ' 980' ' ' ILE . 60.8 t -71.17 81.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.339 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.29 -78.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.371 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.7 p -68.41 -77.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.45 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 52.2 m-20 -165.7 149.57 8.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.072 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.532 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 16.8 pt -84.11 -20.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.176 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.81 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 85.3 mt-30 -72.46 157.91 36.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.459 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' 1006 ' ' LEU . 9.0 p -44.24 144.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.191 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.84 43.97 21.12 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.166 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 66.9 m -168.36 129.73 1.34 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 32.0 ttm-85 -101.61 128.38 47.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.897 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.6 HD12 ' CG2' ' A' ' 974' ' ' VAL . 29.3 pt -97.15 -164.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.229 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 66.7 p -150.29 127.96 11.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.569 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.586 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 2.8 m-85 -99.49 163.14 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.538 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.613 ' O ' ' HA3' ' A' ' 972' ' ' GLY . 22.7 t -145.53 -156.92 0.75 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.004 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 23.4 m -158.06 157.89 33.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.592 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 992' ' ' THR . 17.9 p -68.64 -151.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.772 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.443 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.0 t -85.4 132.58 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.07 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.78 91.62 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.765 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.591 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 13.8 m80 -142.12 129.46 21.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 111.508 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.511 ' NH1' HD13 ' A' ' 997' ' ' ILE . 6.6 ptm180 -95.91 135.86 37.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.407 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' 1018 ' ' PRO . 4.6 tt -76.18 132.18 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.936 0.398 . . . . 0.0 111.653 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.886 ' HB ' HG13 ' A' 1019 ' ' ILE . 44.2 mm -97.85 144.04 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.331 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.79 43.81 Favored Glycine 0 C--N 1.328 0.116 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.1 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.13 132.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.611 ' CB ' HD13 ' A' ' 996' ' ' LEU . 79.6 p -90.85 38.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.0 p -162.15 145.7 11.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -158.41 130.98 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.182 0.515 . . . . 0.0 111.396 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 86.8 tt0 -105.0 132.49 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.528 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -70.93 127.08 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.103 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.81 152.24 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' 1007 ' ' SER . 0.2 OUTLIER -85.62 141.04 30.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.431 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.636 ' N ' HD13 ' A' 1006 ' ' LEU . 48.0 t -155.17 131.54 10.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 65.66 -82.4 0.08 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.316 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -157.77 16.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.004 0.43 . . . . 0.0 110.331 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.5 m -151.84 142.37 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.095 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.478 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.22 141.86 43.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.449 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.0 m-70 -149.57 141.63 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.573 ' HB2' ' HA ' ' A' 1016 ' ' LYS . 89.5 m95 -66.65 132.65 48.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.3 t -52.48 -21.53 3.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 71.7 p -131.47 -14.19 3.31 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.514 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.621 ' HZ3' ' HD2' ' A' 1017 ' ' PRO . 2.0 mmmp? 66.69 148.33 0.11 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.632 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.621 ' HD2' ' HZ3' ' A' 1016 ' ' LYS . 79.7 Cg_exo -45.21 104.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.56 2.173 . . . . 0.0 112.283 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.631 ' HB2' HD21 ' A' ' 996' ' ' LEU . 12.6 Cg_exo -71.34 -144.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.127 2.551 . . . . 0.0 112.957 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.886 HG13 ' HB ' ' A' ' 997' ' ' ILE . 21.4 pt -149.75 -159.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.201 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.851 ' HB3' ' HB2' ' A' ' 971' ' ' ASN . 8.6 t -153.59 111.7 3.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.979 0.418 . . . . 0.0 110.465 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.428 ' HB2' ' CG1' ' A' ' 997' ' ' ILE . 31.0 tp60 -81.62 132.93 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.152 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.8 ' HE ' ' HB3' ' A' 1045 ' ' HIS . 17.1 ttp-105 -66.84 128.48 36.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.331 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' 1046 ' ' TYR . 33.1 mm -53.76 107.71 0.93 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.31 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' 1045 ' ' HIS . 86.4 Cg_endo -86.93 126.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.733 2.289 . . . . 0.0 113.953 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' 1044 ' ' PHE . 26.2 p -108.17 127.85 54.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.922 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.36 -154.77 7.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.44 155.27 68.46 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 122.245 0.218 . . . . 0.0 111.139 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 9.2 Cg_endo -50.35 140.8 33.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.683 2.255 . . . . 0.0 111.627 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' 1030 ' ' THR . 33.8 Cg_exo -57.73 -9.1 5.05 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.606 2.204 . . . . 0.0 112.86 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1030 ' ' THR . . . . . 0.49 HG22 ' O ' ' A' 1029 ' ' PRO . 13.5 t 47.08 176.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' 1090 ' ' GLN . 28.3 pt -152.08 30.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.605 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 54.64 123.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.403 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-80 74.87 -36.84 0.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -76.09 121.05 6.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.38 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.543 ' CG ' ' HA ' ' A' 1055 ' ' ASN . 61.0 m-20 -75.4 -159.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.582 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.869 ' HB2' HG21 ' A' 1050 ' ' VAL . 21.4 p90 -156.03 142.13 18.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.358 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 43.4 mm -123.68 109.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.691 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.69 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 97.6 p -171.07 151.5 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 88.4 m -60.58 -39.41 87.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.656 HD22 ' HE2' ' A' 1044 ' ' PHE . 1.9 p-10 -61.54 143.56 55.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.348 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.36 -36.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.01 -44.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.031 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -73.39 59.11 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.656 ' HE2' HD22 ' A' 1040 ' ' ASN . 64.1 m-85 -76.66 -57.11 4.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.747 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.8 ' HB3' ' HE ' ' A' 1022 ' ' ARG . 64.4 m170 66.9 -67.66 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.885 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' 1045 ' ' HIS . 33.8 t80 173.96 35.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.536 0.684 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' 1048 ' ' SER . . . -160.48 98.81 0.17 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.135 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 26.2 m 177.35 153.39 0.25 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.366 0.603 . . . . 0.0 111.054 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.835 HG22 ' HB3' ' A' 1073 ' ' TYR . 76.5 t -137.82 144.12 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.166 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.869 HG21 ' HB2' ' A' 1036 ' ' PHE . 15.0 p -135.86 147.87 28.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' 1070 ' ' PRO . 88.2 m -118.54 125.88 50.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.757 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.45 149.37 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' 1053 ' ' ARG . 35.7 ttt85 -152.9 25.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.56 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 64.6 m 57.69 153.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.543 ' HA ' ' CG ' ' A' 1035 ' ' ASP . 28.3 t-20 -65.91 -57.27 8.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.41 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.974 HD22 ' HA2' ' A' 1060 ' ' GLY . 2.9 mt 66.17 159.61 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.493 ' HA3' ' NH2' ' A' 1061 ' ' ARG . . . -81.92 -33.9 25.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.175 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.7 p -153.86 62.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.745 0.272 . . . . 0.0 111.171 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.593 ' O ' HD13 ' A' 1056 ' ' LEU . 35.1 mmt180 77.83 -40.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.819 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.974 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 178.62 127.82 1.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.731 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.493 ' NH2' ' HA3' ' A' 1057 ' ' GLY . 40.3 ptt180 -172.74 41.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 0.0 110.634 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt 44.32 71.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.56 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.776 HG23 ' HD2' ' A' 1064 ' ' PHE . 23.9 m -142.68 -7.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.78 0.8 . . . . 0.0 110.116 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.776 ' HD2' HG23 ' A' 1063 ' ' VAL . 70.6 m-85 -155.73 140.79 17.38 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.682 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -143.33 121.22 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 0.0 111.291 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.612 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 36.3 tp -71.86 153.96 41.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.808 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' 1089 ' ' PRO . 85.2 t -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.237 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 83.17 -157.7 35.41 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.723 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.565 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.9 pt-20 -64.41 118.77 50.48 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-O 120.769 0.318 . . . . 0.0 111.474 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.612 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 56.8 Cg_endo -96.26 27.21 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.092 2.528 . . . . 0.0 113.564 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' 1050 ' ' VAL . 58.6 m -156.18 142.06 18.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 112.036 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' 1049 ' ' VAL . 31.2 pt -144.93 174.78 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.766 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.835 ' HB3' HG22 ' A' 1049 ' ' VAL . 6.2 p90 -155.27 148.0 24.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.996 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 60.4 m -63.26 125.25 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.347 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' 1085 ' ' SER . 11.4 t -157.84 145.78 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.516 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 79.3 p -74.6 149.13 40.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.35 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.493 HD22 HD11 ' A' 1083 ' ' ILE . 39.9 p-10 -164.55 -42.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.1 t70 -83.05 -80.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.978 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.12 -130.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.311 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -59.58 -34.44 72.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 110.808 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' 1081 ' ' VAL . 2.6 t -59.02 -53.2 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.15 0.5 . . . . 0.0 110.989 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.51 ' O ' HG12 ' A' 1083 ' ' ILE . . . 77.55 -44.51 2.25 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.63 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' 1082 ' ' GLY . 17.1 pt 46.28 -163.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.445 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 36.2 m95 -85.26 -163.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.908 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.423 ' HA ' ' CG2' ' A' 1075 ' ' THR . 76.7 p -67.48 -65.1 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.984 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . 178.21 131.84 1.62 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.596 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 16.5 Cg_exo -68.52 143.05 55.81 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.729 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -168.02 -49.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.729 ' HD2' ' H ' ' A' 1088 ' ' ALA . 11.9 Cg_endo -55.65 148.91 51.82 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.333 2.022 . . . . 0.0 112.149 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.632 ' HA ' HD12 ' A' 1031 ' ' ILE . 15.0 tt0 -152.36 133.47 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 41.5 t -92.63 141.3 28.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.104 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.15 136.45 57.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.201 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 40.2 tt0 58.05 45.82 17.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.652 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -79.6 40.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.914 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.614 ' HD2' HD21 ' A' 1006 ' ' LEU . 28.5 mttm -77.6 142.09 39.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 77.9 p -157.28 141.07 15.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.059 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 71.4 m -79.93 134.02 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.594 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.75 140.57 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 97.4 m -53.52 120.31 21.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.143 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 42.9 Cg_exo -57.94 112.6 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.342 2.028 . . . . 0.0 112.656 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.68 134.38 32.55 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.575 2.183 . . . . 0.0 111.013 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -48.48 106.81 0.65 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.903 0.382 . . . . 0.0 111.216 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 72.9 Cg_endo -75.33 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.591 2.194 . . . . 0.0 112.295 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' 1020 ' ' CYS . 95.6 t -49.01 85.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 969' ' ' PRO . 71.2 m-80 44.68 63.8 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.896 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.851 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -157.04 124.97 1.5 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.783 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 37.8 ttp -97.75 134.49 40.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.698 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.723 HG21 HD12 ' A' ' 986' ' ' ILE . 3.9 p -93.69 151.32 3.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -116.79 106.82 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.376 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 986' ' ' ILE . 22.0 t -65.44 113.3 2.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 986' ' ' ILE . 46.5 mm -80.38 -91.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.312 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 41.3 p -80.68 -58.63 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.834 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' A' ' 984' ' ' SER . 30.0 m-20 -164.58 -154.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.751 HG22 ' HH2' ' A' 1013 ' ' TRP . 14.2 pt -155.89 25.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.737 0.303 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 962' ' ' SER . 87.1 mt-30 -87.33 -56.26 3.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.351 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 981' ' ' GLN . 21.6 t -173.1 141.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.24 1.016 . . . . 0.0 109.412 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.42 -34.82 0.97 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.573 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 979' ' ' ASP . 50.3 m -68.41 126.85 30.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.416 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -101.39 -179.63 4.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.391 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.723 HD12 HG21 ' A' ' 974' ' ' VAL . 20.3 pt -154.01 171.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.616 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' 1001 ' ' SER . 77.8 p -141.71 129.56 21.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.317 . . . . 0.0 111.47 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.706 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.4 m-85 -83.27 -164.46 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 75.5 p -153.83 -46.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.397 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.851 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 42.7 t 71.96 150.76 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.868 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -62.42 152.0 35.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.811 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 54.4 m -58.06 137.51 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.482 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 75.63 35.5 46.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.267 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.602 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 30.6 m80 -147.0 132.49 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.65 ' NH1' HG12 ' A' ' 997' ' ' ILE . 50.8 ttt-85 -81.58 117.47 21.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.43 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 988' ' ' TYR . 5.7 tt -76.05 111.83 11.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.457 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.736 ' HB ' HG13 ' A' 1019 ' ' ILE . 18.3 mt -99.47 59.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.528 0.68 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . -154.32 20.3 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.787 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 57.07 17.58 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.604 0.24 . . . . 0.0 111.122 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.613 ' H ' HD22 ' A' ' 996' ' ' LEU . 83.2 p 36.99 39.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 18.0 t -162.14 161.86 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.637 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.28 126.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' 1013 ' ' TRP . 43.5 tt0 -105.0 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.1 t -73.19 81.3 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' 1014 ' ' SER . 44.3 pt -86.87 -172.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.359 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.614 HD21 ' HD2' ' A' ' 961' ' ' LYS . 10.8 tp -158.36 124.42 4.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.47 . . . . 0.0 111.919 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.435 ' N ' HD12 ' A' 1006 ' ' LEU . 45.7 t -83.67 -45.56 13.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.153 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.77 -45.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.752 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 37.4 m-20 -76.23 -52.41 10.09 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.433 ' C ' HD13 ' A' 1006 ' ' LEU . 86.9 m -151.26 149.16 29.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -74.72 140.75 44.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.1 p80 -153.08 151.91 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.751 ' HH2' HG22 ' A' ' 980' ' ' ILE . 53.4 m95 -72.08 120.04 17.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.958 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.593 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.1 p -52.5 -25.32 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 44.6 p -86.9 133.8 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 111.954 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 25.3 pttm -62.7 152.42 81.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.681 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 74.9 Cg_exo -47.55 118.09 2.75 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.323 2.015 . . . . 0.0 111.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.719 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 15.9 Cg_exo -69.43 139.94 42.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.015 2.477 . . . . 0.0 112.987 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.736 HG13 ' HB ' ' A' ' 997' ' ' ILE . 16.7 pt -134.28 126.26 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.921 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 92.5 m -86.43 95.67 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 111.211 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -77.02 138.43 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.191 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -54.76 127.61 29.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.499 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.698 ' O ' ' HB2' ' A' 1046 ' ' TYR . 47.1 mm -56.02 110.38 2.27 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' 1080 ' ' GLN . 93.6 Cg_endo -81.17 133.09 8.61 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.511 2.141 . . . . 0.0 113.374 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 8.1 p -113.02 143.81 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.896 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.06 -148.63 2.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.095 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' 1027 ' ' LEU . 10.1 mt -70.02 148.82 96.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' 1029 ' ' PRO . 16.4 Cg_exo -66.5 137.07 45.28 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 110.499 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' 1028 ' ' PRO . 49.9 Cg_exo -34.11 135.28 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.667 2.244 . . . . 0.0 111.782 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 77.2 p -76.54 139.39 40.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.755 HG23 ' HA3' ' A' 1034 ' ' GLY . 7.8 tt -142.67 117.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.321 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -44.7 131.42 6.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.529 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' 1091 ' ' CYS . 22.5 p30 42.58 30.12 0.2 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.482 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.755 ' HA3' HG23 ' A' 1031 ' ' ILE . . . -79.16 160.8 46.59 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.526 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.724 ' HB2' ' HA ' ' A' 1055 ' ' ASN . 31.3 t0 -156.56 156.62 33.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.704 ' HA ' ' O ' ' A' 1051 ' ' THR . 23.4 p90 -155.88 145.37 20.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 111.91 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.448 HG13 HH11 ' A' 1053 ' ' ARG . 29.5 mt -109.23 111.27 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.775 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' 1039 ' ' THR . 57.1 m -171.12 -140.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.441 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.448 ' H ' ' HB3' ' A' 1038 ' ' SER . 11.6 t -117.79 -27.87 6.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -45.56 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.951 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.426 ' H ' ' HE1' ' A' 1036 ' ' PHE . 38.9 mmt180 54.39 -126.69 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -77.03 -40.73 45.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.136 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -67.5 148.45 51.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.31 152.91 15.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.307 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' 1046 ' ' TYR . 5.1 p80 -155.08 -62.07 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.809 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.698 ' HB2' ' O ' ' A' 1023 ' ' ILE . 6.2 t80 169.11 40.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.594 0.235 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.46 -43.87 0.02 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.568 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 66.7 m -47.58 128.51 12.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 112.001 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' 1050 ' ' VAL . 7.7 p -97.17 175.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.558 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' 1049 ' ' VAL . 30.9 m -151.41 131.77 4.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.172 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.704 ' O ' ' HA ' ' A' 1036 ' ' PHE . 42.4 m -104.33 102.64 12.32 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.433 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' 1035 ' ' ASP . 2.5 m-85 -70.57 135.08 48.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 111.254 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.532 HH22 HG21 ' A' 1051 ' ' THR . 3.1 ptp85 -159.63 34.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.388 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.811 ' HB2' HG12 ' A' 1063 ' ' VAL . 77.5 m 62.03 149.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.188 0.518 . . . . 0.0 111.809 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.724 ' HA ' ' HB2' ' A' 1035 ' ' ASP . 47.3 t30 -63.45 -35.38 80.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.279 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1056 ' ' LEU . . . . . 1.003 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 21.7 mt -70.31 -157.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 58.68 39.8 93.96 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.607 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 11.6 p -175.04 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 110.552 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -155.88 45.58 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.839 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.792 ' HA3' HD23 ' A' 1056 ' ' LEU . . . -172.19 -41.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.834 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' 1062 ' ' LYS . 20.8 tpp180 67.6 158.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.461 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' A' 1061 ' ' ARG . 20.2 tptm 94.97 -35.97 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.014 0.821 . . . . 0.0 110.077 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1063 ' ' VAL . . . . . 1.003 ' HA ' ' HB2' ' A' 1056 ' ' LEU . 0.1 OUTLIER 43.1 32.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.537 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' 1091 ' ' CYS . 0.1 OUTLIER 36.93 -135.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1065 ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' 1092 ' ' ILE . 98.7 mt-10 -150.14 105.71 3.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.205 0.526 . . . . 0.0 110.814 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' 1070 ' ' PRO . 43.6 tp -70.51 149.73 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.112 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' 1089 ' ' PRO . 97.2 t -139.18 137.51 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.325 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.13 -158.79 35.0 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.561 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' 1089 ' ' PRO . 18.6 pt-20 -69.03 125.97 92.4 Favored Pre-proline 0 C--O 1.227 -0.117 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.76 ' HB3' HD21 ' A' 1066 ' ' LEU . 84.7 Cg_endo -96.16 26.15 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.114 2.542 . . . . 0.0 112.869 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 78.8 p -157.4 143.59 17.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.503 HD11 ' OH ' ' A' 1052 ' ' TYR . 13.4 pt -155.19 171.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.881 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.8 p90 -137.46 144.07 42.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 0.0 111.315 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.579 ' HA ' ' CE2' ' A' 1084 ' ' TRP . 0.9 OUTLIER -62.19 121.37 12.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.55 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' 1084 ' ' TRP . 11.8 t -157.72 140.68 15.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.719 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' 1082 ' ' GLY . 69.7 m -89.77 -154.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.458 ' OD1' HD13 ' A' 1083 ' ' ILE . 42.8 p-10 179.22 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.409 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.462 ' HB2' ' CG1' ' A' 1081 ' ' VAL . 29.5 m-20 -80.67 -54.92 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -163.24 -46.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.009 0.433 . . . . 0.0 111.635 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.688 ' HB2' ' HG2' ' A' 1024 ' ' PRO . 17.0 pt20 -175.3 32.81 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.74 HG13 ' H ' ' A' 1082 ' ' GLY . 2.5 p -88.93 -104.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.612 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.74 ' H ' HG13 ' A' 1081 ' ' VAL . . . -153.24 -115.15 0.58 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.465 HD12 ' C ' ' A' 1082 ' ' GLY . 4.2 mp 56.02 82.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.579 ' CE2' ' HA ' ' A' 1074 ' ' CYS . 15.4 m0 -70.66 -153.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.707 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' 1084 ' ' TRP . 47.9 t -56.42 -57.01 14.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 131.8 1.63 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.478 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.5 130.67 9.05 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 111.184 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.785 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -169.92 -46.74 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.785 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.7 Cg_endo -52.02 132.82 44.4 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.195 1.93 . . . . 0.0 112.54 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -153.21 138.51 17.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.427 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.596 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 74.5 m -103.04 135.32 44.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' 1065 ' ' GLU . 13.5 pt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.381 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -78.77 43.36 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.31 46.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.008 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 48.44 40.63 15.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.469 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.758 ' HD2' ' H ' ' A' 1011 ' ' ALA . 4.4 tppp? -77.46 140.85 39.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.823 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 67.2 p -157.99 144.84 17.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.545 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 76.8 m -79.9 31.7 0.26 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.838 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 59.47 142.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.841 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 966' ' ' PRO . 54.8 m -52.15 122.13 22.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.6 ' HG2' HG11 ' A' ' 974' ' ' VAL . 10.1 Cg_endo -53.53 115.52 2.36 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.495 2.13 . . . . 0.0 112.168 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 22.8 Cg_exo -64.51 127.71 19.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.502 2.134 . . . . 0.0 111.559 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.18 109.74 2.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.864 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.669 ' HG3' ' HG2' ' A' 1018 ' ' PRO . 26.4 Cg_exo -61.94 147.25 95.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 111.571 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 970' ' ' VAL . 35.9 m -47.43 127.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 990' ' ' CYS . 75.4 m-20 51.23 46.35 26.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.718 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -171.53 124.1 1.08 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.198 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.73 144.53 27.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.696 0.284 . . . . 0.0 111.53 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' ' 966' ' ' PRO . 1.4 p -89.57 147.13 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.041 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.462 ' O ' HG13 ' A' ' 977' ' ' ILE . 1.0 OUTLIER -115.43 95.27 5.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.088 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 979' ' ' ASP . 73.7 t -67.56 89.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.643 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 975' ' ' HIS . 42.5 mt -75.13 -90.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.512 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.8 p -59.65 -63.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.378 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 976' ' ' VAL . 25.4 m-20 -165.68 -137.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.24 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.477 HG23 HG13 ' A' ' 976' ' ' VAL . 8.3 pt -152.51 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.518 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.823 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 76.8 mt-30 -72.35 164.42 26.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.595 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' 1004 ' ' CYS . 3.5 p -43.99 135.84 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.887 0.375 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.19 54.74 4.29 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.795 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.421 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 94.4 p -164.52 130.37 2.87 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.625 ' NE ' ' HB2' ' A' 1003 ' ' GLU . 35.9 mmt180 -94.11 149.63 21.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.586 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' 1001 ' ' SER . 48.7 pt -142.83 141.38 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -106.37 123.97 48.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.372 . . . . 0.0 111.951 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.578 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 1.3 m-85 -86.66 172.04 10.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.7 t -145.47 -174.24 4.34 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.081 0.467 . . . . 0.0 111.852 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.568 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 92.2 m -158.12 159.67 36.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 992' ' ' THR . 41.3 p -67.72 -160.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 111.378 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' A' ' 991' ' ' THR . 43.7 m -82.53 130.26 35.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.694 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' 1023 ' ' ILE . . . 68.44 45.39 68.69 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.538 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -148.08 123.13 10.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.507 ' HG3' HE22 ' A' 1080 ' ' GLN . 78.7 ttt180 -84.98 129.05 34.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.354 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' 1000 ' ' SER . 3.7 tt -74.66 130.79 40.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.562 ' N ' HD23 ' A' ' 996' ' ' LEU . 49.6 mm -99.87 144.61 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.878 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.451 ' HA3' ' HE3' ' A' 1016 ' ' LYS . . . 77.26 36.23 35.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.872 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 59.4 131.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.63 ' HB3' HD13 ' A' ' 996' ' ' LEU . 79.1 p -84.59 36.4 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.527 ' O ' HG21 ' A' 1015 ' ' THR . 80.9 p -162.09 145.89 12.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.07 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.448 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -161.07 141.51 11.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.145 0.497 . . . . 0.0 112.162 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.625 ' HB2' ' NE ' ' A' ' 985' ' ' ARG . 89.0 tt0 -104.78 134.43 47.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.953 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 54.0 t -74.62 98.2 3.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 26.7 pt -90.73 -166.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.073 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' 1011 ' ' ALA . 0.4 OUTLIER -141.08 121.78 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.147 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.404 ' N ' HD13 ' A' 1006 ' ' LEU . 37.8 t -90.38 41.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.496 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 50.92 39.84 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.599 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -176.65 -46.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.094 0.474 . . . . 0.0 110.571 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 67.8 m -151.24 147.85 27.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.758 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.19 134.78 41.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.522 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 88.9 m-70 -149.46 141.71 24.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.473 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 78.3 m95 -68.9 125.56 27.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.351 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 32.7 m -52.62 -25.36 10.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.899 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.527 HG21 ' O ' ' A' 1001 ' ' SER . 72.9 p -87.95 143.11 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' 1017 ' ' PRO . 0.0 OUTLIER -68.3 162.13 63.55 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.089 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.494 ' O ' ' HD2' ' A' 1016 ' ' LYS . 99.2 Cg_exo -43.18 116.57 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.519 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.669 ' HG2' ' HG3' ' A' ' 969' ' ' PRO . 56.1 Cg_endo -69.49 138.22 38.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.881 2.387 . . . . 0.0 112.728 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 997' ' ' ILE . 12.1 tt -148.81 133.27 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 79.2 m -86.38 113.33 22.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 111.575 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -78.79 129.05 34.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.926 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -71.16 122.4 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.893 HG21 ' HB2' ' A' 1077 ' ' ASN . 37.7 mt -52.55 121.62 22.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.427 ' O ' ' HA3' ' A' 1082 ' ' GLY . 84.9 Cg_endo -81.64 125.25 4.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.872 2.382 . . . . 0.0 111.03 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.699 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 0.5 OUTLIER -97.06 25.29 5.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 36.67 -143.96 0.13 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.328 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' 1044 ' ' PHE . 22.3 mt -93.27 141.84 24.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.592 0.235 . . . . 0.0 111.225 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.761 ' HG3' HD21 ' A' 1040 ' ' ASN . 56.6 Cg_endo -68.8 156.93 63.84 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.493 2.129 . . . . 0.0 111.307 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.545 ' HD2' HD11 ' A' 1072 ' ' ILE . 82.8 Cg_exo -42.7 126.29 4.17 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.526 2.151 . . . . 0.0 112.273 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 66.6 p -77.41 98.27 5.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' 1031 ' ' ILE . 7.4 tt -86.41 106.73 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.563 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -76.22 148.01 37.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.968 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' 1032 ' ' ALA . 84.8 m-20 73.7 28.35 1.64 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.524 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.656 ' HA2' ' N ' ' A' 1055 ' ' ASN . . . -160.86 -46.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.78 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' 1034 ' ' GLY . 57.8 m-20 71.44 147.38 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.611 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.519 ' HB2' HG21 ' A' 1050 ' ' VAL . 14.4 p90 -84.0 145.59 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.098 0.475 . . . . 0.0 112.017 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' 1053 ' ' ARG . 58.8 mt -90.72 164.01 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.56 ' N ' HG22 ' A' 1037 ' ' ILE . 75.1 m 72.57 166.43 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.598 0.237 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' 1040 ' ' ASN . 57.5 p -49.54 -64.93 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.761 HD21 ' HG3' ' A' 1028 ' ' PRO . 18.7 t-20 33.46 49.09 0.21 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.031 0.444 . . . . 0.0 110.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -86.4 -60.71 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -147.5 -42.76 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 1.1 m120 -71.48 123.29 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.581 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.512 ' CE2' HD23 ' A' 1027 ' ' LEU . 86.3 m-85 -148.56 -46.88 0.15 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.624 ' C ' ' H ' ' A' 1047 ' ' GLY . 22.5 m-70 58.1 -111.66 0.59 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' 1074 ' ' CYS . 10.0 t80 -64.31 27.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.059 0.456 . . . . 0.0 110.556 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' 1045 ' ' HIS . . . 76.51 -84.85 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.519 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' 1047 ' ' GLY . 34.2 t 115.72 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.885 0.874 . . . . 0.0 109.669 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' 1072 ' ' ILE . 13.2 p -156.4 153.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.434 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.567 ' HB ' HD22 ' A' 1040 ' ' ASN . 5.0 p -153.81 129.08 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.945 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 71.7 m -86.74 120.62 28.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.128 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.492 ' CE1' HG12 ' A' 1072 ' ' ILE . 3.1 m-85 -80.28 139.44 36.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.592 ' HB2' HD11 ' A' 1037 ' ' ILE . 33.7 ttp180 -147.63 142.84 27.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.552 ' O ' HD12 ' A' 1056 ' ' LEU . 40.9 m -77.97 149.93 34.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.525 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.656 ' N ' ' HA2' ' A' 1034 ' ' GLY . 44.5 t30 -56.31 -51.74 67.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.861 ' HA ' HG13 ' A' 1063 ' ' VAL . 1.7 mt 49.47 34.79 7.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.718 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.16 0.37 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.307 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' 1059 ' ' ARG . 85.8 p -68.35 -54.14 19.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 1058 ' ' SER . 24.9 mmm180 -159.52 -47.02 0.05 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.697 0.284 . . . . 0.0 111.278 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.672 ' HA2' HD22 ' A' 1056 ' ' LEU . . . -167.14 50.58 0.25 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.43 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' 1062 ' ' LYS . 0.0 OUTLIER -77.06 47.7 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.403 0.281 . . . . 0.0 110.491 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' 1062 ' ' LYS . 61.9 tttp 38.45 61.98 1.07 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' 1056 ' ' LEU . 3.3 p -147.26 87.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.207 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.74 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 1.5 m-30 88.26 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.189 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -147.94 145.61 28.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.458 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' 1067 ' ' VAL . 3.8 tt -68.58 142.1 55.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.391 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.795 ' N ' HD23 ' A' 1066 ' ' LEU . 56.3 t -133.48 111.37 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.475 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1068 ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' 1089 ' ' PRO . . . 77.03 133.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.355 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.723 ' O ' ' HG3' ' A' 1089 ' ' PRO . 5.2 tp10 46.0 107.94 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 111.833 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.558 ' HA ' ' CD1' ' A' 1066 ' ' LEU . 68.8 Cg_endo -87.18 -28.15 0.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.48 2.12 . . . . 0.0 113.106 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 87.6 p -151.2 129.97 12.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' 1049 ' ' VAL . 45.6 pt -106.86 175.84 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.436 0.636 . . . . 0.0 112.514 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.13 144.62 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.04 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 34.9 t -67.43 125.31 25.73 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.736 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.3 t -92.05 -40.98 10.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 10.9 p -166.49 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 0.0 111.421 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.893 ' HB2' HG21 ' A' 1023 ' ' ILE . 0.8 OUTLIER -170.97 143.33 1.98 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.385 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.717 ' H ' HD22 ' A' 1077 ' ' ASN . 61.7 t0 -57.52 -48.37 79.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.929 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -150.4 -55.65 0.16 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.507 HE22 ' HG3' ' A' ' 995' ' ' ARG . 13.3 mm-40 -148.21 -26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' 1023 ' ' ILE . 21.8 t -68.89 -110.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . -165.81 136.13 4.03 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.068 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.729 HG22 ' HA ' ' A' 1077 ' ' ASN . 8.1 tp -145.91 132.94 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.744 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 20.8 m95 -83.98 -155.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 67.2 m -79.75 -57.5 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.701 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.59 134.11 2.04 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.047 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.417 ' HB3' ' CG ' ' A' 1029 ' ' PRO . 87.8 Cg_endo -79.71 48.93 3.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.858 2.372 . . . . 0.0 112.017 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -69.92 -41.0 14.18 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.723 ' HG3' ' O ' ' A' 1069 ' ' GLU . 78.3 Cg_exo -48.96 120.42 5.43 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.759 1.639 . . . . 0.0 112.552 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -134.04 116.38 15.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.106 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 49.9 t -87.26 117.02 25.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.128 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.213 179.71 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 957' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 958' ' ' ALA . 23.6 pt-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 958' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 957' ' ' GLU . . . -178.7 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 88.9 tt0 -169.07 58.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.756 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.58 56.47 1.45 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 962' ' ' SER . 45.4 mmtm -77.6 -127.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.746 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.978 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 47.3 t 74.19 139.76 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.224 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.569 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 79.0 m -79.98 37.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.008 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 61.27 134.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.34 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 95.1 m -59.69 114.34 9.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 24.1 Cg_exo -63.82 118.49 5.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.372 2.048 . . . . 0.0 112.08 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.56 132.37 15.96 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.396 2.064 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 30.4 m-20 -55.65 110.02 2.0 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.771 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.466 ' HD2' ' HA3' ' A' ' 972' ' ' GLY . 5.5 Cg_exo -79.84 -146.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.053 2.502 . . . . 0.0 111.923 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.672 HG11 HG23 ' A' 1019 ' ' ILE . 1.6 p -48.95 93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.647 ' O ' HG23 ' A' ' 991' ' ' THR . 33.8 m120 49.28 22.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.393 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -83.05 159.31 37.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.6 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.542 ' N ' ' HA ' ' A' ' 990' ' ' CYS . 11.4 tpt -157.45 110.67 2.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.954 HG21 HD12 ' A' ' 986' ' ' ILE . 9.0 p -87.98 145.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.993 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 989' ' ' SER . 0.5 OUTLIER -106.58 97.45 7.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.823 179.432 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.704 HG13 HG23 ' A' ' 980' ' ' ILE . 16.3 t -65.29 96.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.427 HD11 ' OG1' ' A' ' 987' ' ' THR . 37.4 mt -75.24 -92.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.264 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.0 p -68.84 -73.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 110.359 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 984' ' ' SER . 3.9 m-20 -161.2 151.04 17.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 976' ' ' VAL . 11.5 pt -84.18 3.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.363 0.601 . . . . 0.0 109.793 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.978 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 88.6 mt-30 -82.03 157.08 24.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.945 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' 1005 ' ' ILE . 7.2 p -44.35 150.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.644 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 81.02 -44.19 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.712 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.511 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 54.4 m -74.14 -170.1 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.83 0.315 . . . . 0.0 111.035 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' 1003 ' ' GLU . 79.6 mtp180 -151.51 169.53 21.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.295 0.569 . . . . 0.0 111.991 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.954 HD12 HG21 ' A' ' 974' ' ' VAL . 37.6 pt -150.01 139.05 15.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.499 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' 1001 ' ' SER . 48.7 p -107.36 122.67 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 5.4 m-85 -83.28 160.1 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.995 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.495 ' HB2' ' CE1' ' A' ' 975' ' ' HIS . 75.1 m -161.5 -6.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.752 ' SG ' ' HG ' ' A' ' 996' ' ' LEU . 65.8 m 62.29 -158.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.07 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 971' ' ' ASN . 34.2 p -75.08 -142.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.604 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 993' ' ' GLY . 9.8 t -62.4 -127.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.537 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 992' ' ' THR . . . -72.57 43.75 0.93 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 114.501 0.56 . . . . 0.0 114.501 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -93.96 139.6 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.201 0.5 . . . . 0.0 110.646 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -81.99 117.22 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.738 0.304 . . . . 0.0 110.553 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.752 ' HG ' ' SG ' ' A' ' 990' ' ' CYS . 1.7 tt -76.16 133.28 40.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.647 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.969 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -105.16 155.1 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.406 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 79.41 -75.81 2.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.818 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -165.28 139.13 4.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.545 ' HA ' HD13 ' A' ' 996' ' ' LEU . 21.7 m -100.15 22.04 11.98 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 83.8 p -162.27 148.16 13.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.903 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.409 ' HB3' ' HE1' ' A' ' 988' ' ' TYR . . . -154.49 134.4 13.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 111.547 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 985' ' ' ARG . 87.7 tt0 -101.62 128.78 47.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.05 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -79.38 125.69 29.86 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' 1012 ' ' HIS . 0.2 OUTLIER -138.26 153.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 0.0 110.286 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' 1007 ' ' SER . 0.6 OUTLIER -81.58 124.2 29.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.473 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.536 ' N ' HD13 ' A' 1006 ' ' LEU . 81.2 p -86.63 -125.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.09 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -65.08 -54.89 24.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.154 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -153.35 20.79 0.56 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 95.4 m -151.37 147.45 26.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.569 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.3 136.39 40.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.591 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.655 ' O ' HD13 ' A' 1005 ' ' ILE . 37.0 m80 -149.14 142.78 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.733 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.516 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 83.2 m95 -71.66 136.2 47.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.985 0.421 . . . . 0.0 111.428 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 74.8 p -52.44 -24.46 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.839 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 25.2 p -132.38 130.57 40.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.45 . . . . 0.0 111.858 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -57.95 158.9 11.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.629 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 97.9 Cg_exo -41.56 126.49 3.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.123 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.534 ' HB2' HD21 ' A' ' 996' ' ' LEU . 64.2 Cg_endo -72.57 -156.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.511 2.141 . . . . 0.0 112.217 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.969 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 11.3 mt -143.04 -179.26 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.866 ' H ' HG22 ' A' 1019 ' ' ILE . 21.1 m -145.81 79.06 1.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.377 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.784 ' H ' HD13 ' A' ' 997' ' ' ILE . 35.2 tp60 -71.6 138.57 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.008 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.664 ' HB3' ' HB3' ' A' 1046 ' ' TYR . 9.5 mpt_? -72.33 126.61 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.998 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.2 mt -67.32 113.25 12.88 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.638 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' 1045 ' ' HIS . 30.1 Cg_endo -63.69 114.37 2.54 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.758 2.305 . . . . 0.0 113.679 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.586 ' O ' ' HB2' ' A' 1044 ' ' PHE . 9.1 p -95.67 135.97 36.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.208 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.13 -150.59 3.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.104 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.485 HD11 ' OE1' ' A' 1042 ' ' GLU . 1.5 mm? -62.87 139.03 97.26 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.12 168.33 19.4 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.024 2.483 . . . . 0.0 111.291 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.781 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 65.5 Cg_exo -50.86 110.3 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.873 1.716 . . . . 0.0 111.529 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.6 p -77.42 141.02 39.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.269 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.567 HG13 ' HA3' ' A' 1034 ' ' GLY . 24.1 pt -149.68 124.33 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.446 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.96 139.38 10.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-20 75.1 -28.41 0.19 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.344 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.567 ' HA3' HG13 ' A' 1031 ' ' ILE . . . -64.62 160.07 41.39 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' 1034 ' ' GLY . 71.5 m-20 -153.78 -156.53 0.69 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.741 ' HB2' HG23 ' A' 1050 ' ' VAL . 36.7 p90 -155.95 142.33 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 112.298 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' 1037 ' ' ILE . 53.9 mt -111.26 57.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.054 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.413 ' H ' ' HD1' ' A' 1036 ' ' PHE . 60.1 m -157.76 -163.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.488 HG22 ' O ' ' A' 1039 ' ' THR . 22.6 m -96.91 49.15 1.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.265 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.463 ' HB2' ' CE1' ' A' 1036 ' ' PHE . 2.2 m-80 -62.93 -52.26 63.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.765 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 56.81 -137.27 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.485 ' OE1' HD11 ' A' 1027 ' ' LEU . 67.3 mm-40 -149.23 50.38 0.96 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.354 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -168.42 60.99 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.164 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.586 ' HB2' ' O ' ' A' 1025 ' ' CYS . 5.3 m-85 -76.77 129.99 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.744 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.583 ' O ' ' HA ' ' A' 1024 ' ' PRO . 20.8 m80 -98.42 -58.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.664 ' HB3' ' HB3' ' A' 1022 ' ' ARG . 42.3 t80 172.17 31.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.71 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.46 98.09 0.16 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.79 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.8 p 175.72 134.41 0.05 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.535 0.683 . . . . 0.0 111.391 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' 1072 ' ' ILE . 12.7 p -102.17 155.52 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.448 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.741 HG23 ' HB2' ' A' 1036 ' ' PHE . 6.4 p -133.47 126.47 52.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.012 0.435 . . . . 0.0 111.05 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 33.2 m -106.69 109.84 21.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.545 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 10.3 m-85 -71.92 147.65 46.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.726 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' 1054 ' ' CYS . 14.0 ptm180 -142.8 -14.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.201 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' 1053 ' ' ARG . 66.1 m 71.29 146.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.104 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' 1033 ' ' ASN . 7.2 t-20 -62.64 -133.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 111.665 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.583 HD13 ' HA2' ' A' 1060 ' ' GLY . 8.6 mt -155.04 133.57 11.93 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.96 31.43 3.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.184 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.631 ' O ' ' HG2' ' A' 1059 ' ' ARG . 68.0 m -169.36 -70.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.783 0.292 . . . . 0.0 111.615 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' 1058 ' ' SER . 31.8 mmt-85 -167.21 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.65 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.583 ' HA2' HD13 ' A' 1056 ' ' LEU . . . -153.29 -32.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.444 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' 1061 ' ' ARG . 41.4 ttt85 -55.43 120.53 7.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.93 133.73 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 32.5 m -147.0 -29.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 111.302 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.533 ' HD2' ' HB3' ' A' 1091 ' ' CYS . 15.6 m-85 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1065 ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' 1092 ' ' ILE . 34.6 mt-10 -98.52 126.43 44.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.718 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.932 HD23 ' N ' ' A' 1067 ' ' VAL . 3.6 tt -68.81 143.47 54.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.517 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.932 ' N ' HD23 ' A' 1066 ' ' LEU . 96.2 t -135.1 117.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 88.77 -142.82 17.28 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.658 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' 1089 ' ' PRO . 20.8 pt-20 -62.52 122.87 76.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.018 0.437 . . . . 0.0 112.17 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.6 ' HA ' HD11 ' A' 1066 ' ' LEU . 87.0 Cg_endo -85.33 -17.46 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.812 2.341 . . . . 0.0 112.175 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 77.9 p -156.37 155.66 32.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.502 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' 1049 ' ' VAL . 34.8 pt -150.29 -162.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.656 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -160.28 150.06 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 2.4 t -62.39 141.03 58.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.698 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 12.8 t -145.73 -146.89 0.2 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1076 ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' 1082 ' ' GLY . 46.9 t -165.46 147.92 7.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.886 0.374 . . . . 0.0 111.46 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -163.97 -33.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 5.0 t0 -73.78 -139.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.49 -39.87 11.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -162.91 -16.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 50.5 t -58.74 -28.9 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.501 . . . . 0.0 110.776 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 81.13 -63.06 4.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.901 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 75.4 mt 60.69 130.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.106 0.479 . . . . 0.0 111.847 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 18.1 m95 -80.19 138.2 36.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.587 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 71.5 p -55.47 -61.73 2.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.522 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -71.38 121.85 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.643 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.39 39.87 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.087 2.525 . . . . 0.0 112.012 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.781 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 61.98 135.02 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.504 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.545 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 36.3 Cg_endo -64.9 -138.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.657 2.238 . . . . 0.0 112.399 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.787 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 43.1 mm-40 -151.84 128.09 10.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' 1064 ' ' PHE . 98.8 m -102.74 104.06 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.361 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' 1065 ' ' GLU . 17.8 pt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.304 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.748 0.309 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -174.62 48.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 959' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 959' ' ' GLU . 17.5 tp10 54.71 42.6 31.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.333 0.587 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -71.27 -43.32 67.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.111 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' A' 1011 ' ' ALA . 0.0 OUTLIER 64.39 143.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 81.2 p -157.99 146.73 19.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.97 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.02 152.23 29.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 0.0 OUTLIER -63.87 133.57 53.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.598 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.433 ' HB ' ' CD1' ' A' ' 980' ' ' ILE . 6.5 t -73.73 125.73 90.2 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.857 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.637 ' HG2' HG11 ' A' ' 974' ' ' VAL . 93.5 Cg_endo -79.73 113.14 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.296 1.997 . . . . 0.0 111.219 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 95.5 Cg_exo -42.2 -48.96 6.25 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.435 2.09 . . . . 0.0 112.051 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 174.5 126.95 0.11 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.339 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.667 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 50.2 Cg_exo -54.04 150.91 29.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.69 HG21 HG13 ' A' 1019 ' ' ILE . 93.6 t -46.65 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 32.4 m120 75.28 -43.42 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.829 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -69.13 -145.09 0.17 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.094 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.667 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 25.8 ptm -159.22 139.83 12.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.738 0.304 . . . . 0.0 110.668 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.637 HG11 ' HG2' ' A' ' 966' ' ' PRO . 9.9 p -92.08 142.68 12.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.225 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -106.88 93.97 4.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.746 HG13 HG23 ' A' ' 980' ' ' ILE . 84.3 t -65.35 -44.73 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.393 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.0 mt 61.06 -100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.4 p -67.35 -60.4 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.5 t0 -172.53 -141.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.746 HG23 HG13 ' A' ' 976' ' ' VAL . 9.0 pt -152.83 20.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 110.815 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 70.5 mt-30 -87.32 -157.59 0.4 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.517 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 94.2 t -46.57 140.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.751 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 984' ' ' SER . . . 74.11 -79.46 0.89 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.06 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' 1003 ' ' GLU . 95.8 p 21.15 106.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.391 0.676 . . . . 0.0 112.802 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -98.77 77.16 2.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 976' ' ' VAL . 41.0 pt -80.37 137.45 21.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.509 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -108.62 130.51 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.493 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 6.6 m-85 -98.21 147.21 24.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.514 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.5 p -152.48 128.26 10.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.8 t -86.87 -133.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.41 163.82 15.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.415 0.626 . . . . 0.0 111.593 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 25.4 m -53.8 123.57 12.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 131.87 -31.53 3.05 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.232 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -139.73 142.2 36.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.094 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -82.03 121.1 26.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' 1018 ' ' PRO . 4.4 tp -67.63 123.6 20.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.579 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 996' ' ' LEU . 43.3 mm -94.65 149.55 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.193 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 75.91 177.67 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.222 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' A' 1001 ' ' SER . 44.2 m80 -74.98 131.68 40.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 0.0 111.006 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 10.0 m -75.21 28.82 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.992 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 999' ' ' HIS . 82.2 p -162.13 151.19 15.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -154.11 122.74 6.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 111.847 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 984' ' ' SER . 10.4 pt-20 -107.07 135.86 47.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.231 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.408 ' SG ' ' CZ3' ' A' 1013 ' ' TRP . 19.3 m -70.55 126.78 30.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.085 0.469 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' 1012 ' ' HIS . 0.2 OUTLIER -136.74 147.47 27.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.523 178.472 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' 1007 ' ' SER . 0.2 OUTLIER -86.55 127.02 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.613 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 46.4 t -90.09 -42.03 11.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -163.34 -36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.321 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 961' ' ' LYS . 77.0 m-20 -150.61 -49.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 111.175 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 89.4 m -97.49 137.82 35.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 111.626 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.572 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.21 140.26 43.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.752 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.671 ' O ' HD13 ' A' 1005 ' ' ILE . 9.3 p80 -149.52 153.29 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.492 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 74.8 m95 -67.95 131.61 45.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.432 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -52.43 -22.28 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.235 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.7 p -136.64 142.09 43.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.021 0.439 . . . . 0.0 112.148 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -54.94 148.66 26.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.789 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.86 120.42 7.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.447 2.098 . . . . 0.0 112.462 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.788 ' HB3' HD11 ' A' ' 996' ' ' LEU . 50.6 Cg_exo -54.95 152.21 30.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.69 HG13 HG21 ' A' ' 970' ' ' VAL . 3.6 tt -143.08 131.7 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.586 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.503 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 49.7 m -86.39 113.11 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 111.267 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -84.55 129.15 34.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.928 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.495 ' HD2' ' CD2' ' A' 1045 ' ' HIS . 20.0 ptt-85 -72.8 134.78 45.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.525 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 63.7 mt -100.72 131.07 24.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.315 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.0 115.06 4.19 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.2 1.933 . . . . 0.0 111.715 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.612 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 44.0 t -89.75 148.96 22.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.347 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 149.64 37.88 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.738 ' H ' HD23 ' A' 1027 ' ' LEU . 0.1 OUTLIER -52.52 141.4 34.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 117.048 0.424 . . . . 0.0 111.417 -179.159 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.409 ' HB2' HD11 ' A' 1072 ' ' ILE . 18.2 Cg_endo -59.11 145.01 99.13 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.547 2.164 . . . . 0.0 111.229 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.95 134.24 14.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.314 2.009 . . . . 0.0 112.128 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 73.3 p -77.5 126.17 30.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' 1034 ' ' GLY . 6.0 tt -89.56 113.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.445 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -60.86 141.17 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.932 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.6 m-20 57.55 35.37 25.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.966 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' 1031 ' ' ILE . . . -168.33 131.8 2.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.62 ' HB2' ' HD3' ' A' 1053 ' ' ARG . 35.8 m-20 -76.57 -148.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 110.82 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -155.88 141.22 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.614 HD12 ' HB ' ' A' 1051 ' ' THR . 59.5 mt -87.99 154.98 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.406 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' 1037 ' ' ILE . 73.6 m 73.79 138.33 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.265 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' 1040 ' ' ASN . 70.7 p -50.27 -61.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.978 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' 1039 ' ' THR . 55.1 t30 33.1 44.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.099 0.476 . . . . 0.0 111.091 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' 1041 ' ' ARG . 21.0 mmt85 -76.26 -161.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.956 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.08 67.86 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.672 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.2 p30 -169.72 23.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.862 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.571 ' O ' ' HD1' ' A' 1044 ' ' PHE . 0.1 OUTLIER -92.44 132.26 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.511 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' 1047 ' ' GLY . 5.6 m80 -84.26 -114.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1046 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -56.41 71.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.963 0.347 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.857 ' HA3' ' HB3' ' A' 1074 ' ' CYS . . . 43.5 -107.31 0.12 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.686 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' 1047 ' ' GLY . 95.6 p 135.06 -142.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.371 1.068 . . . . 0.0 109.806 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.846 HG22 ' HB3' ' A' 1073 ' ' TYR . 71.8 t -148.96 141.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.701 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 30.2 m -140.84 137.21 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.614 ' HB ' HD12 ' A' 1037 ' ' ILE . 72.6 m -92.5 125.41 37.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.077 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.715 ' OH ' HD13 ' A' 1072 ' ' ILE . 4.0 m-85 -72.0 156.33 39.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.62 ' HD3' ' HB2' ' A' 1035 ' ' ASP . 7.4 ptm180 -145.6 -145.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.112 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 62.0 m -155.1 145.54 22.08 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.95 0.405 . . . . 0.0 111.707 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -55.16 150.64 10.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.373 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' 1056 ' ' LEU . 1.6 mm? -70.4 -149.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -143.6 -29.28 0.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 54.8 m -144.58 -31.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' 1059 ' ' ARG . 31.9 tpt85 -167.66 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.586 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -165.68 39.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.828 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.749 ' HG2' ' H ' ' A' 1062 ' ' LYS . 27.0 ttm180 -81.26 -147.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.749 ' H ' ' HG2' ' A' 1061 ' ' ARG . 87.5 tttt -173.49 67.42 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 18.2 m -84.92 -38.37 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.223 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.687 ' HB2' ' HB3' ' A' 1054 ' ' CYS . 56.3 m-85 -72.71 147.54 45.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.114 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.98 120.48 32.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.662 HD21 ' HA ' ' A' 1070 ' ' PRO . 53.3 tp -68.46 144.26 54.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' 1089 ' ' PRO . 57.9 t -138.3 123.87 24.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 71.57 156.94 2.65 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.779 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' 1069 ' ' GLU . 41.4 tt0 30.32 65.81 0.85 Allowed Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.662 ' HA ' HD21 ' A' 1066 ' ' LEU . 88.1 Cg_endo -79.99 7.01 4.88 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.072 1.848 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 40.1 t -156.47 149.73 24.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.715 HD13 ' OH ' ' A' 1052 ' ' TYR . 25.2 pt -140.91 165.22 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.275 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.846 ' HB3' HG22 ' A' 1049 ' ' VAL . 9.9 p90 -151.58 138.72 19.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.386 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.857 ' HB3' ' HA3' ' A' 1047 ' ' GLY . 41.2 t -76.84 133.43 39.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 5.2 t -90.01 -35.05 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 73.4 m 61.84 135.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.82 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -175.25 -137.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.298 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' 1079 ' ' ASP . 27.6 t70 53.1 -138.53 1.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1079 ' ' ASP . . . . . 0.453 ' H ' ' CG ' ' A' 1078 ' ' ASP . 1.6 m-20 -92.44 -49.22 6.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.983 0.42 . . . . 0.0 110.446 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -179.86 31.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.432 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 41.3 t -87.21 -45.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 67.51 124.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.217 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.617 ' N ' HD13 ' A' 1083 ' ' ILE . 0.2 OUTLIER -153.96 137.32 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.0 m95 -70.68 126.94 30.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.8 t -70.96 -39.56 72.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -62.28 122.77 29.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.166 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 17.9 Cg_exo -67.15 -121.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.298 2.665 . . . . 0.0 112.093 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' 1087 ' ' PRO . . . -160.85 129.34 2.97 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.594 ' HB2' ' O ' ' A' 1067 ' ' VAL . 73.3 Cg_endo -74.76 -141.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.885 2.39 . . . . 0.0 113.486 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.453 ' H ' ' HB2' ' A' 1089 ' ' PRO . 9.5 tp-100 -152.39 127.28 9.61 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.439 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 44.6 t -103.11 123.49 46.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.118 -179.913 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -168.38 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 41.99 36.97 0.73 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.709 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 41.36 38.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.23 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.791 ' HG3' ' HB2' ' A' 1011 ' ' ALA . 0.4 OUTLIER 61.32 125.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.398 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.3 p -157.97 135.21 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.521 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 980' ' ' ILE . 2.9 p -84.71 148.65 26.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.171 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -63.64 140.16 58.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 -179.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 73.9 m -60.72 126.07 84.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.378 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 19.7 Cg_exo -66.87 121.5 8.71 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.47 2.113 . . . . 0.0 112.329 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 133.92 26.84 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.412 2.075 . . . . 0.0 111.676 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.26 109.4 1.41 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.769 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 971' ' ' ASN . 68.7 Cg_endo -87.83 -153.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 112.605 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' 1021 ' ' GLN . 2.2 p -49.42 88.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.32 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 969' ' ' PRO . 74.3 m-20 45.28 34.21 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.157 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.746 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -76.3 -56.88 4.15 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.786 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.631 ' HB2' ' HB2' ' A' ' 989' ' ' SER . 60.8 mtt 61.04 96.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.751 HG21 HD12 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.99 143.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.374 179.278 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.428 ' CE1' ' OG ' ' A' ' 989' ' ' SER . 1.4 m-70 -122.07 111.61 17.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.442 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.885 ' HA ' HG22 ' A' ' 986' ' ' ILE . 69.6 t -67.45 99.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.94 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 986' ' ' ILE . 41.8 mm -75.23 -90.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.685 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.0 p -65.59 -60.43 2.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.211 0.529 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.604 ' O ' HG13 ' A' ' 976' ' ' VAL . 7.5 t0 -167.49 -128.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.982 178.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.469 ' O ' ' SG ' ' A' ' 963' ' ' CYS . 5.2 pt -154.76 -21.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.742 0.306 . . . . 0.0 110.313 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' 1004 ' ' CYS . 23.5 pt20 -72.43 -164.29 0.14 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.684 HG22 HD21 ' A' 1006 ' ' LEU . 40.4 t -47.27 137.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 64.81 12.41 53.58 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.416 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' 1003 ' ' GLU . 87.7 p -77.0 171.06 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.199 0.5 . . . . 0.0 110.684 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.746 ' HD3' ' N ' ' A' ' 986' ' ' ILE . 0.0 OUTLIER -151.14 138.23 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.967 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.885 HG22 ' HA ' ' A' ' 976' ' ' VAL . 28.2 pt -142.7 173.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 111.538 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' 1000 ' ' SER . 69.6 p -136.98 124.8 22.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.61 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.6 m-85 -87.17 47.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.922 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 66.9 m 30.03 -77.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.685 ' SG ' HD13 ' A' ' 996' ' ' LEU . 33.8 m 67.02 70.65 0.38 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 1.2 t -60.16 154.54 19.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 11.0 t 38.94 -156.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 113.626 -1.625 . . . . 0.0 113.39 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -80.29 50.23 3.95 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.199 -0.455 . . . . 0.0 113.829 -178.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -82.67 149.8 27.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.85 0.325 . . . . 0.0 110.907 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.765 ' HB2' HG12 ' A' 1023 ' ' ILE . 79.5 ttt180 -80.26 93.2 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.874 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 997' ' ' ILE . 4.7 tp -76.05 124.6 27.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 996' ' ' LEU . 1.8 mp -98.15 137.55 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.128 178.144 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.76 -118.66 5.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.481 -178.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.493 ' HB2' ' HB ' ' A' 1015 ' ' THR . 1.9 m-70 -149.36 130.95 14.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.085 0.443 . . . . 0.0 111.278 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.61 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 88.1 p -79.95 34.0 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.351 0.596 . . . . 0.0 109.817 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.587 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 79.6 p -162.2 138.56 7.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.888 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.638 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -160.45 141.63 12.14 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 984' ' ' SER . 21.5 pt-20 -105.06 132.86 50.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.599 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 8.3 t -71.3 84.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -179.046 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' 1014 ' ' SER . 18.8 pt -87.27 158.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.684 HD21 HG22 ' A' ' 982' ' ' VAL . 3.3 mm? -95.31 136.18 35.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.67 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.609 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -162.43 131.02 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.18 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 58.44 39.02 92.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 61.5 m-20 56.86 36.31 27.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.676 0.274 . . . . 0.0 111.464 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.1 m -151.25 129.83 12.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.578 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.791 ' HB2' ' HG3' ' A' ' 961' ' ' LYS . . . -75.64 136.79 40.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.098 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.609 ' NE2' ' HB3' ' A' 1007 ' ' SER . 7.6 p80 -163.06 156.51 19.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.942 0.401 . . . . 0.0 111.105 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.577 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 29.6 m95 -74.35 118.28 17.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.517 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.517 ' HB3' HD13 ' A' 1005 ' ' ILE . 79.7 p -52.41 -22.37 4.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.239 -178.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.638 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 53.7 p -105.05 20.92 18.0 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.216 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' 1015 ' ' THR . 21.7 ptmt 47.49 165.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.46 107.15 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.121 1.88 . . . . 0.0 111.903 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' 1016 ' ' LYS . 90.5 Cg_endo -82.37 168.14 14.99 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.786 2.324 . . . . 0.0 112.352 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.677 HG13 ' HB ' ' A' ' 997' ' ' ILE . 18.1 pt -148.85 118.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.408 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.746 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 1.9 m -86.39 73.24 10.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.734 ' HA ' HG21 ' A' ' 970' ' ' VAL . 3.5 pt20 -71.73 -166.91 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.691 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' 1024 ' ' PRO . 38.4 ptt180 -96.94 136.18 37.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.765 HG12 ' HB2' ' A' ' 995' ' ' ARG . 53.6 mt -79.19 106.32 4.34 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.502 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' 1045 ' ' HIS . 45.6 Cg_endo -67.43 135.48 36.64 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.825 179.272 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.772 ' HB3' ' H ' ' A' 1075 ' ' THR . 3.4 p -87.62 144.03 26.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.739 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.15 174.32 53.34 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.074 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.406 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 14.4 mt -53.49 150.03 13.53 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.906 0.353 . . . . 0.0 111.142 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.439 ' CB ' ' HD2' ' A' 1029 ' ' PRO . 19.0 Cg_endo -59.74 174.75 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.987 ' HD3' ' HA ' ' A' 1085 ' ' SER . 56.6 Cg_endo -68.56 -0.78 6.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.933 2.422 . . . . 0.0 112.62 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1030 ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' 1029 ' ' PRO . 70.8 p 55.71 145.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.946 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.65 HD12 ' HB1' ' A' 1088 ' ' ALA . 13.8 tt -151.1 112.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.364 0.602 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -66.88 155.73 37.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.76 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' 1032 ' ' ALA . 69.1 m-20 75.53 -40.57 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.685 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.516 ' HA2' ' CA ' ' A' 1054 ' ' CYS . . . -70.69 -157.13 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.953 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' 1053 ' ' ARG . 55.3 m-20 -160.01 135.91 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.465 ' HE1' ' O ' ' A' 1038 ' ' SER . 0.1 OUTLIER -84.03 148.36 26.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.435 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' 1051 ' ' THR . 67.7 mt -121.78 148.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.36 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.465 ' O ' ' HE1' ' A' 1036 ' ' PHE . 11.7 t 75.93 -136.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.727 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 45.7 p -100.82 130.79 46.89 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.495 HD22 ' HB ' ' A' 1050 ' ' VAL . 22.2 t-20 -179.71 68.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.249 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' HE1' ' A' 1044 ' ' PHE . 32.0 ptt180 -170.38 105.6 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' 1041 ' ' ARG . 56.8 mt-10 69.24 -51.86 0.6 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -71.48 52.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.483 ' HE1' ' N ' ' A' 1041 ' ' ARG . 6.6 m-85 -88.5 148.93 23.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.732 0.777 . . . . 0.0 112.692 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.582 ' O ' ' SG ' ' A' 1074 ' ' CYS . 14.3 p-80 -166.88 179.03 5.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.264 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.839 ' HE1' HG11 ' A' 1081 ' ' VAL . 4.1 t80 -65.44 31.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1047 ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' 1045 ' ' HIS . . . -161.19 104.4 0.24 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.379 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1048 ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' 1074 ' ' CYS . 79.7 p 177.48 145.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.552 0.691 . . . . 0.0 111.585 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' 1072 ' ' ILE . 6.6 p -137.79 146.23 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' 1040 ' ' ASN . 7.6 p -137.71 133.5 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.968 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 91.3 m -102.48 134.22 46.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.401 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.47 ' HD2' HD13 ' A' 1031 ' ' ILE . 0.4 OUTLIER -70.56 -167.15 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.174 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.601 ' HB3' ' HB2' ' A' 1035 ' ' ASP . 6.0 tpm_? -159.62 -41.39 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.516 ' CA ' ' HA2' ' A' 1034 ' ' GLY . 88.2 m 68.4 121.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.815 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.629 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 19.0 t-20 21.66 -118.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.615 0.572 . . . . 0.0 112.068 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.692 ' HA ' HG23 ' A' 1063 ' ' VAL . 93.4 mt 62.18 117.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.106 0.479 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -100.66 129.56 9.94 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.572 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 15.7 t 72.73 -47.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.428 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.679 ' O ' ' HB3' ' A' 1056 ' ' LEU . 8.6 ttt85 -162.61 -135.51 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.244 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.494 ' H ' ' HG2' ' A' 1059 ' ' ARG . . . -88.62 46.6 3.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.202 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' 1061 ' ' ARG . 17.9 mmt85 -62.24 157.41 19.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.621 0.248 . . . . 0.0 111.197 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.57 71.7 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.994 0.426 . . . . 0.0 110.847 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' 1056 ' ' LEU . 4.0 m -154.51 86.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' 1055 ' ' ASN . 0.4 OUTLIER 70.1 143.42 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.69 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 1065 ' ' GLU . . . . . 0.442 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 49.4 mt-10 -141.98 139.53 32.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' 1067 ' ' VAL . 2.2 tt -68.38 133.06 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.064 0.459 . . . . 0.0 111.397 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.884 ' N ' HD23 ' A' 1066 ' ' LEU . 47.1 t -138.24 129.73 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 93.89 -133.06 11.47 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.681 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.742 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 37.0 tt0 -57.11 106.06 0.62 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 117.153 0.476 . . . . 0.0 111.131 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.743 ' HA ' HD11 ' A' 1066 ' ' LEU . 81.7 Cg_endo -96.24 -12.19 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.098 2.532 . . . . 0.0 113.968 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 52.8 m -156.16 167.45 30.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.412 0.625 . . . . 0.0 112.268 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' 1049 ' ' VAL . 18.4 pt -141.22 157.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.637 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -117.7 149.71 40.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' 1045 ' ' HIS . 37.2 t -61.61 159.19 13.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.188 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.899 HG21 ' H ' ' A' 1084 ' ' TRP . 15.0 t -157.59 -150.61 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1076 ' ' SER . . . . . 1.14 ' HB2' ' HB ' ' A' 1081 ' ' VAL . 47.2 t -89.79 -107.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 112.339 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' 1077 ' ' ASN . 12.1 p-10 -174.62 -30.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.317 -177.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.43 ' HA ' ' CD1' ' A' 1083 ' ' ILE . 54.4 t0 177.47 -9.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.353 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.92 -141.05 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.951 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.7 -52.47 51.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1081 ' ' VAL . . . . . 1.14 ' HB ' ' HB2' ' A' 1076 ' ' SER . 19.7 t -56.98 -24.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.731 ' C ' HD13 ' A' 1083 ' ' ILE . . . 80.75 -140.19 21.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.215 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.731 HD13 ' C ' ' A' 1082 ' ' GLY . 0.0 OUTLIER -149.75 138.16 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.472 0.653 . . . . 0.0 112.639 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.899 ' H ' HG21 ' A' 1075 ' ' THR . 0.2 OUTLIER -77.38 -114.76 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.567 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 1085 ' ' SER . . . . . 0.987 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 30.6 t 69.52 59.14 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' 1088 ' ' ALA . . . -59.22 124.36 36.34 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.688 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' 1088 ' ' ALA . 23.9 Cg_exo -64.54 22.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.329 2.019 . . . . 0.0 113.749 -178.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' 1031 ' ' ILE . . . 53.88 139.22 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 113.112 178.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 84.7 Cg_endo -76.11 -122.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.762 2.308 . . . . 0.0 110.725 178.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.522 ' OE1' ' HB ' ' A' 1067 ' ' VAL . 0.0 OUTLIER -152.41 143.48 23.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.939 178.824 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 3.6 m -103.13 133.91 47.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.442 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 23.4 pt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.112 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -171.78 -138.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.041 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.16 134.89 0.74 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.745 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -78.55 46.45 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.803 ' HG2' HD11 ' A' 1006 ' ' LEU . 55.3 tptt -77.61 150.01 34.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.396 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.53 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 64.1 p -157.42 154.74 29.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.494 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 90.0 m -79.31 159.6 27.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.094 179.446 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -63.88 132.96 52.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 0.0 111.039 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 59.9 m -73.14 112.87 17.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.038 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.506 ' HG2' HG21 ' A' ' 974' ' ' VAL . 30.8 Cg_exo -61.84 123.46 12.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.242 1.961 . . . . 0.0 111.963 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.83 -50.78 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.263 1.975 . . . . 0.0 111.497 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 179.26 115.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.679 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 32.2 Cg_endo -66.03 144.73 77.1 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.462 2.108 . . . . 0.0 111.969 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.847 HG11 HG13 ' A' 1019 ' ' ILE . 0.2 OUTLIER -44.97 116.92 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.888 179.879 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 9.0 t-20 70.94 -50.31 0.68 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -77.93 -152.53 5.71 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.392 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 24.0 ptm -159.2 133.36 7.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.506 HG21 ' HG2' ' A' ' 966' ' ' PRO . 3.3 p -81.91 146.76 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.454 ' O ' ' HB ' ' A' ' 986' ' ' ILE . 22.2 m170 -123.54 105.24 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 1.057 HG13 HG23 ' A' ' 980' ' ' ILE . 52.1 t -65.31 -65.74 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 47.9 mt 75.31 -51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.255 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 45.6 p -86.62 -80.91 0.23 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.002 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.614 ' O ' HG12 ' A' ' 980' ' ' ILE . 9.2 t70 -173.35 -18.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.404 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 1.057 HG23 HG13 ' A' ' 976' ' ' VAL . 28.6 pt 54.97 72.46 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.21 0.604 . . . . 0.0 111.419 -178.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 77.8 mt-30 -152.63 38.89 0.54 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.667 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 76.6 t 101.06 133.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.924 0.889 . . . . 0.0 112.096 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 71.79 -29.93 0.62 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.361 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.598 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 79.9 p -68.45 124.01 22.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.437 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 5.1 tmm_? -101.64 118.85 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.558 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 975' ' ' HIS . 28.7 pt -95.42 -169.0 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.312 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' 1001 ' ' SER . 35.2 p -153.01 128.71 10.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.544 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.0 m-85 -93.95 149.8 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.024 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.0 m -157.35 133.43 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.688 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 9.1 m -82.02 -131.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 110.693 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.417 ' O ' ' ND1' ' A' ' 994' ' ' HIS . 1.2 t -165.02 159.24 17.74 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.796 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 992' ' ' THR . 50.8 m 37.66 54.12 1.47 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.972 0.891 . . . . 0.0 110.266 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 994' ' ' HIS . . . 78.85 -99.53 1.66 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.957 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.578 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 24.9 m80 54.85 140.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.892 0.477 . . . . 0.0 111.53 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -89.86 106.5 18.51 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.229 -0.294 . . . . 0.0 111.018 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' 1000 ' ' SER . 1.7 tt -76.15 121.23 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.8 ' HB ' HG23 ' A' 1019 ' ' ILE . 38.6 mm -89.16 153.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.832 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.77 -112.54 3.53 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.732 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' 1001 ' ' SER . 92.1 m-70 -149.72 133.75 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 111.402 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 996' ' ' LEU . 81.2 p -80.61 30.25 0.3 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 61.3 m -162.14 151.24 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -157.59 127.49 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.577 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 44.7 tt0 -103.57 126.8 50.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.598 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.584 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 41.9 t -73.56 126.52 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.537 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 20.8 pt -147.41 155.32 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.803 HD11 ' HG2' ' A' ' 961' ' ' LYS . 3.8 mm? -92.36 146.33 23.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.292 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.531 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 44.7 t -162.44 -58.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -94.2 47.4 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.129 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 30.1 m-20 60.49 13.84 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.037 0.446 . . . . 0.0 110.512 -179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.784 ' HA ' ' HE2' ' A' ' 961' ' ' LYS . 89.2 m -151.25 146.21 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.584 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.29 134.14 41.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.96 0.409 . . . . 0.0 110.714 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' 1007 ' ' SER . 8.1 p80 -152.18 146.34 25.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.402 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.747 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 57.0 m95 -70.13 124.85 25.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.7 t -52.52 -25.44 10.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 77.1 p -92.2 137.82 32.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.065 0.459 . . . . 0.0 112.046 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.64 ' NZ ' ' HB3' ' A' 1016 ' ' LYS . 0.2 OUTLIER -62.19 152.5 78.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.272 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -43.9 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.54 147.77 92.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.052 2.502 . . . . 0.0 112.413 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.847 HG13 HG11 ' A' ' 970' ' ' VAL . 5.5 tt -148.01 122.8 2.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 994' ' ' HIS . 4.4 t -86.36 113.66 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.121 0.486 . . . . 0.0 111.411 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -84.75 130.1 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.971 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -82.07 124.25 29.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.319 179.319 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.1 mt -71.8 112.71 15.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.412 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.545 ' HG3' HH12 ' A' 1022 ' ' ARG . 34.4 Cg_exo -61.6 133.21 44.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.831 2.354 . . . . 0.0 113.063 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.742 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 92.4 m -98.39 -150.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.451 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1026 ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -163.84 156.23 27.98 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.522 HD12 ' H ' ' A' 1027 ' ' LEU . 8.7 mp -40.3 132.17 1.63 Allowed Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.161 0.481 . . . . 0.0 111.459 -179.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.55 ' HB2' HD11 ' A' 1072 ' ' ILE . 54.4 Cg_endo -69.8 155.44 65.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.0 102.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.088 1.859 . . . . 0.0 111.363 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.3 p -77.39 118.35 19.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.661 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.78 HD13 ' HB2' ' A' 1089 ' ' PRO . 10.4 pt -93.63 116.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.474 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -49.54 141.0 9.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.722 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' 1054 ' ' CYS . 5.1 m120 74.91 -13.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.58 -140.62 0.02 OUTLIER Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.273 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' 1053 ' ' ARG . 30.4 t70 -168.9 -168.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.561 -0.376 . . . . 0.0 110.842 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.817 ' HD1' HG23 ' A' 1050 ' ' VAL . 1.2 t80 -155.99 127.52 7.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.882 HD12 ' HD2' ' A' 1053 ' ' ARG . 52.5 mt -147.78 77.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.791 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 68.8 m -160.32 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.003 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.414 HG22 ' O ' ' A' 1039 ' ' THR . 7.0 m -136.99 41.67 2.47 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.599 ' ND2' ' HB ' ' A' 1050 ' ' VAL . 5.0 m120 -72.01 -99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.762 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 60.85 48.46 6.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.63 ' HG2' ' H ' ' A' 1043 ' ' ASN . 66.9 tt0 62.95 -136.37 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.63 ' H ' ' HG2' ' A' 1042 ' ' GLU . 0.5 OUTLIER 34.23 44.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' 1042 ' ' GLU . 88.4 m-85 -77.48 147.88 35.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.401 . . . . 0.0 111.533 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' 1046 ' ' TYR . 79.3 m-70 -147.13 -49.79 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.48 179.25 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.647 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 53.9 t80 171.87 149.03 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.303 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 78.71 -17.63 6.64 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.888 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 58.8 m -47.72 144.55 3.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.85 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' 1072 ' ' ILE . 12.8 p -137.79 148.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.273 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.817 HG23 ' HD1' ' A' 1036 ' ' PHE . 2.5 p -143.13 136.11 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.253 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 87.8 m -106.54 111.97 24.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.449 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.554 ' HE1' HG12 ' A' 1072 ' ' ILE . 11.4 m-85 -85.25 142.18 29.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.882 ' HD2' HD12 ' A' 1037 ' ' ILE . 99.9 mtt180 -156.44 30.76 0.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.795 ' O ' HD22 ' A' 1056 ' ' LEU . 71.3 m 59.13 143.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 0.0 111.739 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 8.9 m120 -65.86 97.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.795 HD22 ' O ' ' A' 1054 ' ' CYS . 3.2 mm? -70.37 177.23 3.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.593 178.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' 1063 ' ' VAL . . . -82.74 -28.49 38.38 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 179.715 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 52.5 m -160.07 -29.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.69 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 33.9 tpt85 -163.83 -45.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.526 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.544 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . 178.61 43.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.775 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -77.3 46.76 0.52 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.633 0.254 . . . . 0.0 111.625 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.7 tttt 44.61 81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.173 0.511 . . . . 0.0 111.703 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' 1056 ' ' LEU . 3.3 m -155.13 95.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.465 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.701 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 65.8 m-85 72.82 136.44 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.437 -178.191 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -141.09 130.04 23.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.308 0.575 . . . . 0.0 111.693 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.828 HD21 ' HA ' ' A' 1070 ' ' PRO . 35.5 tp -68.47 158.87 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.839 HG21 HD11 ' A' 1092 ' ' ILE . 75.4 t -139.39 143.82 30.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.527 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.72 -144.56 26.66 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.12 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' 1089 ' ' PRO . 79.4 tt0 -60.41 127.81 87.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.817 0.309 . . . . 0.0 110.623 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.828 ' HA ' HD21 ' A' 1066 ' ' LEU . 26.0 Cg_endo -92.3 -54.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.813 2.342 . . . . 0.0 112.802 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 41.7 t -98.85 152.86 19.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.579 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.663 ' O ' HG23 ' A' 1049 ' ' VAL . 31.5 pt -141.42 162.06 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.258 179.086 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 6.3 p90 -151.02 141.14 22.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.417 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 46.9 t -65.11 152.41 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.233 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1075 ' ' THR . . . . . 0.443 ' C ' ' HE1' ' A' 1046 ' ' TYR . 13.1 t -140.09 -147.41 0.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.021 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.6 t -153.28 145.79 24.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.972 0.415 . . . . 0.0 111.537 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1077 ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -162.7 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.064 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.22 -147.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.568 0.223 . . . . 0.0 110.626 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -83.61 -45.38 13.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.286 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -178.22 30.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.737 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.495 ' HB ' ' CD1' ' A' 1083 ' ' ILE . 43.7 t -77.25 -34.84 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 85.37 61.37 1.73 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.994 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' 1083 ' ' ILE . 2.1 mp -81.99 135.11 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.93 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 14.4 m95 -72.57 -173.93 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.978 0.418 . . . . 0.0 112.003 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.3 t -59.51 -71.24 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.149 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 137.43 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.308 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.93 136.23 34.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.735 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -167.6 -44.99 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.78 ' HB2' HD13 ' A' 1031 ' ' ILE . 63.3 Cg_exo -48.23 137.98 23.38 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.122 1.881 . . . . 0.0 112.138 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.405 ' O ' HD12 ' A' 1066 ' ' LEU . 10.5 pt20 -149.7 134.57 17.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 0.0 111.619 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 29.1 t -90.67 132.54 35.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.839 HD11 HG21 ' A' 1067 ' ' VAL . 39.2 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.074 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.675 0.274 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -175.3 -134.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.662 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 57.53 47.41 16.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.192 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -164.2 39.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.918 ' HD2' ' H ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -79.18 132.02 36.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.878 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -92.44 135.57 33.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.728 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 80.9 m -81.1 26.42 0.44 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.037 0.446 . . . . 0.0 110.652 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 962' ' ' SER . 59.6 tttm 61.12 136.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.573 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.854 ' HA ' HG21 ' A' ' 980' ' ' ILE . 4.7 t -58.06 129.11 82.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.148 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 1.013 ' HG2' HG11 ' A' ' 974' ' ' VAL . 55.7 Cg_endo -69.72 107.2 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.115 1.877 . . . . 0.0 112.197 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 10.4 Cg_endo -53.47 143.68 54.26 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.546 2.164 . . . . 0.0 111.078 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -40.4 113.33 0.95 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.171 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.809 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 24.2 Cg_exo -64.03 148.24 91.54 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.044 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 971' ' ' ASN . 0.2 OUTLIER -43.92 114.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.458 179.853 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.539 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 5.6 t-20 71.01 -57.45 0.6 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.096 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 990' ' ' CYS . . . -70.06 -162.47 3.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.978 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.809 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 88.5 mtp -158.15 140.12 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 1.013 HG11 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -83.66 148.85 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.592 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.81 87.15 2.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.997 179.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.519 ' HA ' HG22 ' A' ' 986' ' ' ILE . 58.4 t -65.45 109.85 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 29.3 mm -75.14 -83.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.909 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.4 p -81.42 -61.04 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.266 0.555 . . . . 0.0 109.979 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 976' ' ' VAL . 4.3 p-10 -165.94 -130.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.558 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.854 HG21 ' HA ' ' A' ' 965' ' ' THR . 0.2 OUTLIER -144.97 10.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 111.109 178.871 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.771 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 87.2 mt-30 -85.68 171.76 11.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.988 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.1 t -44.31 143.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.2 -31.25 1.83 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.276 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 36.2 m -68.4 124.02 22.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.028 0.414 . . . . 0.0 110.928 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.788 ' HD2' ' N ' ' A' ' 986' ' ' ILE . 5.5 tmm_? -101.63 152.2 21.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.562 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.788 ' N ' ' HD2' ' A' ' 985' ' ' ARG . 38.3 pt -142.25 138.41 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 80.8 p -107.53 125.68 51.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.682 ' HB2' ' HA ' ' A' 1000 ' ' SER . 5.2 m-85 -92.08 149.24 21.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.761 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.9 m -159.93 121.3 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.075 0.464 . . . . 0.0 111.335 179.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.6 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 85.0 m -99.91 155.15 17.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 35.9 p -61.6 161.16 10.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.089 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.1 m -57.45 145.68 32.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.695 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.59 -45.62 1.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.184 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.453 ' N ' ' CD2' ' A' ' 994' ' ' HIS . 11.7 m-70 -82.45 136.06 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.758 0.313 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.582 ' HB2' HD11 ' A' 1023 ' ' ILE . 44.0 ttm-85 -82.03 130.47 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.619 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.703 ' HA ' ' SG ' ' A' 1020 ' ' CYS . 0.9 OUTLIER -76.11 126.91 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.058 0.456 . . . . 0.0 111.59 -179.474 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.591 ' HB ' HG13 ' A' 1019 ' ' ILE . 1.7 mp -107.14 148.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.443 178.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.44 -119.35 4.84 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.021 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.42 ' C ' ' H ' ' A' 1001 ' ' SER . 92.0 m-70 -149.67 133.53 16.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.132 0.466 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.682 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.2 p -78.44 30.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.2 p -162.19 140.07 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.356 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -164.13 131.12 3.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.603 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -104.94 137.52 42.57 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.502 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 53.4 t -71.1 131.69 43.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' 1011 ' ' ALA . 45.9 pt -148.04 -165.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 111.285 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.616 HD21 ' HD3' ' A' ' 961' ' ' LYS . 3.9 mm? -99.04 163.42 12.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.4 t -162.51 -116.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -49.96 -43.86 40.58 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.779 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.9 t30 -167.73 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 110.981 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 7.7 t -96.48 -162.52 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.227 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.728 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -80.05 139.11 37.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.996 0.426 . . . . 0.0 110.925 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.463 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 42.0 m80 -149.4 140.03 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 89.3 m95 -66.71 133.6 50.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.069 0.461 . . . . 0.0 110.956 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.7 p -52.33 -23.97 6.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.883 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.0 p -121.4 140.37 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 111.695 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -54.26 151.73 12.84 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.083 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.02 105.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.321 2.014 . . . . 0.0 112.028 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.15 143.72 96.35 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.603 2.202 . . . . 0.0 111.942 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.591 HG13 ' HB ' ' A' ' 997' ' ' ILE . 36.5 pt -138.67 -171.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 89.9 m -153.78 131.4 11.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.506 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.512 ' HG2' HD11 ' A' ' 997' ' ' ILE . 98.2 mm-40 -80.32 132.31 35.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.412 ' HD3' ' CD2' ' A' 1045 ' ' HIS . 15.7 ptp180 -67.98 -25.17 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 995' ' ' ARG . 46.4 mt 59.96 73.11 0.68 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.833 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.706 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 78.1 Cg_exo -49.8 126.98 17.78 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.362 2.041 . . . . 0.0 112.447 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 23.8 t -88.49 147.18 24.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.661 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.07 142.66 28.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.64 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' 1028 ' ' PRO . 28.4 tp -54.73 131.41 65.37 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1028 ' ' PRO . . . . . 1.012 ' HB3' HD11 ' A' 1072 ' ' ILE . 67.0 Cg_exo -52.6 153.77 13.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.195 2.597 . . . . 0.0 112.821 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 37.4 Cg_exo -58.98 127.83 25.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.353 2.035 . . . . 0.0 111.664 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.5 p -77.47 142.24 39.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.206 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' 1031 ' ' ILE . 29.7 pt -140.37 123.07 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.417 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.42 141.74 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.278 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 75.63 -37.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.765 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -65.04 121.13 20.77 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.4 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.542 ' HB3' ' HG2' ' A' 1053 ' ' ARG . 35.5 t0 -82.23 -158.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.841 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -157.18 142.67 17.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 111.339 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.895 HD11 ' HD3' ' A' 1053 ' ' ARG . 6.9 mt -149.69 -138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.851 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.677 ' H ' HG22 ' A' 1037 ' ' ILE . 58.2 m 71.81 -163.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.499 HG23 ' N ' ' A' 1040 ' ' ASN . 7.9 t -73.66 -46.63 45.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.689 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.564 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 73.0 m-80 -54.06 151.13 7.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.18 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.841 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 83.1 mtm180 -143.02 -48.57 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.256 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.1 OUTLIER -162.94 145.24 10.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.48 179.656 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' 1042 ' ' GLU . 31.7 m-20 82.13 -46.59 0.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.517 ' HD2' ' HZ2' ' A' 1084 ' ' TRP . 1.1 m-85 54.82 57.07 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.738 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.706 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 2.7 m-70 -52.52 -44.65 65.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.454 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.6 ' HB2' ' O ' ' A' 1045 ' ' HIS . 9.7 t80 166.89 70.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.999 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -77.59 -77.02 0.85 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.935 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 4.3 m 167.71 -53.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' 1073 ' ' TYR . 20.4 t -147.56 153.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.658 HG11 ' HG2' ' A' 1028 ' ' PRO . 10.4 p -135.65 120.22 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.3 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' A' 1071 ' ' SER . 91.4 m -93.85 126.37 39.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.391 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' 1053 ' ' ARG . 13.2 m-85 -82.42 -41.29 20.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.895 ' HD3' HD11 ' A' 1037 ' ' ILE . 17.2 ptt180 66.5 -34.04 0.2 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.165 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.665 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 83.9 m 66.95 135.53 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.723 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 33.5 m-20 21.58 -105.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' 1061 ' ' ARG . 0.2 OUTLIER -154.9 139.36 16.83 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.96 0.409 . . . . 0.0 111.032 -179.225 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.542 ' O ' ' HG2' ' A' 1061 ' ' ARG . . . -88.92 -48.44 3.86 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.205 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 66.7 m -102.3 -57.39 2.07 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.464 ' O ' HD22 ' A' 1056 ' ' LEU . 27.2 mtt85 -76.98 117.41 18.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.405 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 74.49 -37.7 1.01 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.77 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' 1056 ' ' LEU . 0.0 OUTLIER 62.3 -139.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.483 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.522 ' H ' ' CD ' ' A' 1061 ' ' ARG . 59.6 tttm 69.02 25.2 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.514 0.673 . . . . 0.0 110.053 -178.602 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' 1055 ' ' ASN . 11.7 p -84.86 23.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.787 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' 1064 ' ' PHE . 0.2 OUTLIER 39.24 -131.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.086 0.47 . . . . 0.0 109.932 179.459 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -132.1 123.79 27.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.919 178.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.611 HD21 ' CA ' ' A' 1070 ' ' PRO . 48.3 tp -68.85 129.04 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 111.678 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' 1090 ' ' GLN . 62.0 t -106.35 121.45 58.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.986 179.289 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.42 -147.58 34.48 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.548 179.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' 1069 ' ' GLU . 0.3 OUTLIER -69.01 131.3 90.89 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.611 ' CA ' HD21 ' A' 1066 ' ' LEU . 54.1 Cg_endo -70.77 -32.84 13.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 111.777 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' 1051 ' ' THR . 80.4 p -142.58 132.01 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.363 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1072 ' ' ILE . . . . . 1.012 HD11 ' HB3' ' A' 1028 ' ' PRO . 18.4 pt -87.81 -167.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.167 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.85 ' HB3' HG22 ' A' 1049 ' ' VAL . 7.9 p90 -158.89 137.37 10.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 0.0 112.072 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 49.0 t -76.7 164.0 26.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.915 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 6.5 t -155.04 -33.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 89.8 p 58.97 148.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.303 0.377 . . . . 0.0 110.904 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.59 ' OD1' HD11 ' A' 1083 ' ' ILE . 44.7 p-10 -164.81 -30.1 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 62.2 t0 -55.42 -87.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.708 0.29 . . . . 0.0 111.14 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -163.2 -38.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.555 ' OE1' ' HA ' ' A' 1023 ' ' ILE . 12.8 tp-100 -166.22 51.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.701 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 15.6 t -130.38 -48.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.568 -178.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 66.28 125.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.989 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.648 ' N ' HD13 ' A' 1083 ' ' ILE . 0.2 OUTLIER -150.42 137.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.025 0.44 . . . . 0.0 111.141 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.564 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 18.4 m95 -70.53 135.83 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.196 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 46.8 t -65.93 -50.93 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' 1072 ' ' ILE . . . -65.99 125.88 28.21 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.705 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.96 41.52 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.6 2.2 . . . . 0.0 112.817 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 58.71 138.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.319 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' 1090 ' ' GLN . 84.6 Cg_endo -80.39 -150.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.748 2.299 . . . . 0.0 112.237 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.774 ' HG2' HG12 ' A' 1092 ' ' ILE . 35.0 tt0 -152.36 134.07 14.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.272 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 37.0 m -91.96 78.6 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.795 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1092 ' ' ILE . . . . . 0.774 HG12 ' HG2' ' A' 1090 ' ' GLN . 46.0 pt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.442 179.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 57.03 -141.45 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -172.25 143.81 1.52 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 54.26 42.28 31.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.672 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 4.3 mptp? 61.63 159.07 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.407 0.623 . . . . 0.0 112.153 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.439 ' C ' ' HB3' ' A' 1011 ' ' ALA . 49.6 m -157.94 138.96 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.678 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.587 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -79.93 38.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 111.608 -179.152 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 55.6 tptt 63.68 130.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.564 ' HA ' HD12 ' A' ' 980' ' ' ILE . 88.8 m -74.43 130.04 82.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.733 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.712 ' HG2' HG11 ' A' ' 974' ' ' VAL . 68.8 Cg_endo -101.34 72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.912 3.075 . . . . 0.0 113.38 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 968' ' ' ASP . 57.1 Cg_endo -70.02 125.9 12.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.985 1.79 . . . . 0.0 111.731 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 967' ' ' PRO . 59.0 m-20 16.5 62.8 0.18 Allowed Pre-proline 0 N--CA 1.467 0.378 0 O-C-N 123.759 0.662 . . . . 0.0 112.167 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.634 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 39.2 Cg_exo -58.83 -143.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.002 2.468 . . . . 0.0 113.185 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' 1019 ' ' ILE . 4.0 p -49.05 85.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.819 -179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 969' ' ' PRO . 6.7 p-10 38.95 48.73 1.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.979 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.634 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -162.44 128.57 1.9 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.805 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 22.2 ptm -88.77 135.92 33.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 111.548 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.81 HG21 HD12 ' A' ' 986' ' ' ILE . 4.1 p -91.56 146.85 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -107.59 96.71 6.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.24 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.781 ' HA ' HG22 ' A' ' 986' ' ' ILE . 14.0 m -65.37 113.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.298 0.57 . . . . 0.0 110.801 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 987' ' ' THR . 38.8 mt -79.92 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.315 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.1 p -149.33 54.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.572 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 980' ' ' ILE . 1.6 m-20 59.57 -154.32 0.37 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.942 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.629 HG22 ' HH2' ' A' 1013 ' ' TRP . 6.1 pt -155.91 95.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.117 0.484 . . . . 0.0 111.463 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 84.1 mt-30 -152.62 28.98 0.54 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.55 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 66.0 t 102.13 135.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 124.239 0.962 . . . . 0.0 111.099 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.34 -29.75 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.862 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 982' ' ' VAL . 49.7 m -68.4 132.93 47.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 111.058 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 38.2 ttm180 -101.71 147.42 26.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.81 HD12 HG21 ' A' ' 974' ' ' VAL . 39.7 pt -143.14 134.08 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.17 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.738 ' HA ' ' HA ' ' A' 1001 ' ' SER . 80.3 p -100.72 122.96 44.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.058 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.597 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.8 m-85 -88.36 120.47 29.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.447 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 80.9 p -88.82 -54.09 4.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.609 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 13.0 t 69.54 142.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -178.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.1 p -60.25 146.75 42.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.284 0.564 . . . . 0.0 111.849 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.1 t -52.99 -26.65 15.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.38 41.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.52 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -139.87 139.99 36.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.245 0.522 . . . . 0.0 111.413 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' 1080 ' ' GLN . 57.0 ttt-85 -81.97 125.62 30.98 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.029 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' 1018 ' ' PRO . 0.7 OUTLIER -72.78 140.37 47.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.226 0.536 . . . . 0.0 111.605 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' 1019 ' ' ILE . 45.6 mm -107.92 148.53 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.1 41.49 21.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.674 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.46 136.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 112.122 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 82.7 p -79.16 36.36 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.439 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 46.2 m -158.58 160.61 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.471 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -159.81 128.8 5.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.392 . . . . 0.0 111.892 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -104.99 125.16 50.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.116 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 31.1 t -68.8 129.3 39.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.731 0.3 . . . . 0.0 110.753 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.727 HD13 ' HB2' ' A' 1014 ' ' SER . 15.0 pt -138.51 152.52 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' 1007 ' ' SER . 0.3 OUTLIER -95.47 120.38 35.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.405 ' N ' HD13 ' A' 1006 ' ' LEU . 47.0 t -80.9 -45.17 17.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.363 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -166.09 -34.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.079 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -148.84 -49.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.15 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 86.8 m -99.75 135.87 40.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 179.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.587 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.36 143.05 43.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.268 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.417 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 90.7 m-70 -149.45 142.94 25.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.629 ' HH2' HG22 ' A' ' 980' ' ' ILE . 79.3 m95 -68.14 116.71 9.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.105 0.478 . . . . 0.0 110.642 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.727 ' HB2' HD13 ' A' 1005 ' ' ILE . 47.2 t -52.42 -22.35 4.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.243 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.1 p -90.1 16.34 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.429 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.821 ' HA ' ' HE3' ' A' 1016 ' ' LYS . 0.0 OUTLIER 58.58 159.27 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.275 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.39 127.31 25.45 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.25 1.967 . . . . 0.0 112.104 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.626 ' HB2' HD21 ' A' ' 996' ' ' LEU . 67.2 Cg_endo -73.09 148.55 44.84 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.797 2.332 . . . . 0.0 112.371 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.965 ' HA ' HG11 ' A' ' 970' ' ' VAL . 6.4 tt -148.81 125.31 2.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.592 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 61.7 m -85.45 101.28 12.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.493 . . . . 0.0 112.006 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.453 ' HB3' HD11 ' A' ' 997' ' ' ILE . 59.2 tt0 -79.7 140.06 37.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.112 178.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.5 tpt180 -50.03 135.8 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.377 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' 1046 ' ' TYR . 26.6 mm -55.59 119.29 23.82 Favored Pre-proline 0 C--O 1.226 -0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.368 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' 1045 ' ' HIS . 67.4 Cg_endo -92.37 138.5 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.184 2.589 . . . . 0.0 112.877 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1025 ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 71.8 m -112.93 30.08 7.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.752 0.311 . . . . 0.0 111.622 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 42.84 -138.03 3.26 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.776 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1027 ' ' LEU . . . . . 0.532 ' HB3' ' HD2' ' A' 1028 ' ' PRO . 19.9 mt -108.74 164.96 13.56 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1028 ' ' PRO . . . . . 0.618 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 37.9 Cg_endo -66.0 152.22 81.91 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.72 2.28 . . . . 0.0 112.3 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1029 ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' A' 1030 ' ' THR . 86.1 Cg_exo -47.44 -29.2 9.69 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.626 2.217 . . . . 0.0 112.935 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1030 ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' 1029 ' ' PRO . 20.1 m 64.71 147.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1031 ' ' ILE . . . . . 0.536 ' HB ' ' HB1' ' A' 1088 ' ' ALA . 13.2 tt -152.47 125.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1032 ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -65.75 135.62 55.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.518 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1033 ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' 1032 ' ' ALA . 4.4 m120 74.81 -38.19 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.574 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1034 ' ' GLY . . . . . 0.811 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.66 121.6 22.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.699 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1035 ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' 1036 ' ' PHE . 9.6 t70 -74.46 163.34 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1036 ' ' PHE . . . . . 0.487 ' HB2' ' CG2' ' A' 1050 ' ' VAL . 29.9 p90 -144.31 136.35 26.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.204 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1037 ' ' ILE . . . . . 0.917 HG22 ' H ' ' A' 1038 ' ' SER . 5.7 mt -87.91 -160.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1038 ' ' SER . . . . . 0.917 ' H ' HG22 ' A' 1037 ' ' ILE . 57.0 m 55.26 -133.04 1.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1039 ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' 1041 ' ' ARG . 41.1 p -152.96 70.1 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1040 ' ' ASN . . . . . 0.622 HD22 ' HB ' ' A' 1050 ' ' VAL . 1.9 m-80 -78.29 44.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.499 0.666 . . . . 0.0 109.69 178.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1041 ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' 1039 ' ' THR . 32.6 ptt180 -82.5 -43.93 16.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.209 -178.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1042 ' ' GLU . . . . . 0.455 ' HG2' ' H ' ' A' 1043 ' ' ASN . 74.3 tt0 -162.92 -126.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.922 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1043 ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' 1044 ' ' PHE . 39.8 m-20 37.48 -125.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.212 0.205 . . . . 0.0 111.136 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1044 ' ' PHE . . . . . 0.618 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 5.3 m-30 69.52 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.969 0.414 . . . . 0.0 111.589 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1045 ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' 1023 ' ' ILE . 70.6 m-70 -149.42 -49.48 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.704 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1046 ' ' TYR . . . . . 0.665 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.5 t80 176.32 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.743 0.782 . . . . 0.0 110.343 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.48 -18.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.049 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 70.0 p -47.6 145.53 2.61 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.877 -0.662 . . . . 0.0 112.78 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1049 ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -145.59 155.26 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.457 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1050 ' ' VAL . . . . . 0.622 ' HB ' HD22 ' A' 1040 ' ' ASN . 5.9 p -153.97 130.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.981 0.419 . . . . 0.0 112.041 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1051 ' ' THR . . . . . 0.585 ' HB ' HD12 ' A' 1037 ' ' ILE . 85.8 m -103.43 116.55 32.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1052 ' ' TYR . . . . . 0.582 ' HE1' HG12 ' A' 1072 ' ' ILE . 7.4 m-85 -74.92 151.37 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1053 ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' 1053 ' ' ARG . 50.1 ttt-85 -142.75 -13.89 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.948 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1054 ' ' CYS . . . . . 0.811 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 91.9 m 69.88 152.19 0.1 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.895 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1055 ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' 1033 ' ' ASN . 27.9 t-20 -50.34 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.577 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1056 ' ' LEU . . . . . 0.811 HD23 HG23 ' A' 1063 ' ' VAL . 15.8 mt 61.02 -148.27 0.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.591 0.71 . . . . 0.0 111.393 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1057 ' ' GLY . . . . . 0.464 ' C ' ' N ' ' A' 1059 ' ' ARG . . . 71.84 -34.49 0.61 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.903 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1058 ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' 1059 ' ' ARG . 53.2 m -47.67 -26.99 1.71 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1059 ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' 1057 ' ' GLY . 39.3 mmm-85 -157.07 -1.24 0.11 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.488 -1.687 . . . . 0.0 108.656 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1060 ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' 1061 ' ' ARG . . . 48.31 30.46 7.97 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1061 ' ' ARG . . . . . 0.603 ' HD2' ' N ' ' A' 1062 ' ' LYS . 4.8 tmm_? 178.65 134.98 0.08 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.064 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1062 ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' 1061 ' ' ARG . 39.5 ttpt 54.64 42.34 31.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.904 0.859 . . . . 0.0 109.37 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1063 ' ' VAL . . . . . 0.811 HG23 HD23 ' A' 1056 ' ' LEU . 14.8 m -140.59 57.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.466 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1064 ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 71.3 m-85 83.9 95.59 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.081 -178.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -89.85 151.15 21.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.185 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1066 ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' 1070 ' ' PRO . 27.6 tp -68.56 142.67 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.484 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1067 ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 58.9 t -139.0 133.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.29 -139.12 21.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.956 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1069 ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' 1069 ' ' GLU . 1.1 pm0 -66.4 125.6 90.66 Favored Pre-proline 0 N--CA 1.453 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 111.837 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1070 ' ' PRO . . . . . 0.523 ' HB3' HD21 ' A' 1066 ' ' LEU . 3.3 Cg_endo -83.8 -26.94 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.142 2.562 . . . . 0.0 112.134 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1071 ' ' SER . . . . . 0.442 ' OG ' HG23 ' A' 1051 ' ' THR . 49.1 m -144.09 147.84 34.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1072 ' ' ILE . . . . . 0.582 HG12 ' HE1' ' A' 1052 ' ' TYR . 26.6 pt -143.61 160.65 16.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.336 0.588 . . . . 0.0 111.761 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1073 ' ' TYR . . . . . 0.53 ' HB3' HG23 ' A' 1049 ' ' VAL . 0.6 OUTLIER -160.19 148.61 16.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.504 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A 1074 ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 48.3 t -65.66 145.33 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 9.9 t -157.7 23.13 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.767 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 99.2 p 52.59 176.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.575 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1077 ' ' ASN . . . . . 0.565 HD22 HD12 ' A' 1083 ' ' ILE . 33.8 p-10 -174.1 -40.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.508 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1078 ' ' ASP . . . . . 0.431 ' HB3' HG23 ' A' 1081 ' ' VAL . 7.9 t70 -84.04 -75.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.841 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.14 -41.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1080 ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 995' ' ' ARG . 3.0 pm0 -162.87 29.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1081 ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' 1078 ' ' ASP . 21.9 t -83.92 -37.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1082 ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 78.85 45.82 8.93 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.165 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1083 ' ' ILE . . . . . 0.565 HD12 HD22 ' A' 1077 ' ' ASN . 67.7 mt -81.98 136.04 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.008 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1084 ' ' TRP . . . . . 0.616 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.4 m95 -70.54 146.76 49.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.862 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 85.2 p -44.93 -37.25 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.885 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1086 ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.63 141.07 6.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.907 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1087 ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 34.0 Cg_exo -57.79 177.29 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.928 2.419 . . . . 0.0 112.758 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1088 ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' 1031 ' ' ILE . . . -63.63 141.34 97.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.618 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1089 ' ' PRO . . . . . 0.488 ' HB2' ' H ' ' A' 1090 ' ' GLN . 37.6 Cg_endo -66.72 -141.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.916 2.411 . . . . 0.0 112.586 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1090 ' ' GLN . . . . . 0.671 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 47.2 mm-40 -145.37 132.65 20.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.019 0.437 . . . . 0.0 111.206 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1091 ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 95.9 m -99.53 72.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.197 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 35.9 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.044 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 121.139 0.495 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.46 126.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.453 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -99.49 141.84 31.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.161 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.664 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 93.7 m -80.0 33.02 0.27 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.792 0.33 . . . . 0.0 110.809 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 962' ' ' SER . 60.5 tttp 60.8 136.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.546 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 42.8 m -63.94 124.55 85.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.167 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.671 ' HG2' HG11 ' A' ' 974' ' ' VAL . 37.0 Cg_endo -66.06 109.73 1.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.217 1.945 . . . . 0.0 111.958 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 9.0 Cg_exo -71.41 129.93 16.6 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.642 2.228 . . . . 0.0 111.805 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -51.33 104.9 0.46 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 2.6 Cg_exo -76.6 -152.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.734 2.289 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 970' ' ' VAL . 2.2 p -50.47 83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.156 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 991' ' ' THR . 3.4 t30 68.68 -34.9 0.28 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.622 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.4 116.4 7.48 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.253 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.27 140.17 31.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.584 0.23 . . . . 0.0 111.162 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.671 HG11 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -89.94 147.69 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.208 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 977' ' ' ILE . 18.8 m170 -111.94 82.53 1.64 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 976' ' ' VAL . 4.3 p -69.04 85.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 975' ' ' HIS . 50.5 mt -75.37 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.25 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.9 p -55.9 -72.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.671 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 3.4 m-20 -157.42 -133.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 979' ' ' ASP . 1.5 pt -155.87 -21.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 25.3 mt-30 -72.52 176.42 5.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.447 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' 1004 ' ' CYS . 71.4 t -44.35 144.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.938 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.66 -30.43 1.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.439 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.671 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 34.6 m -68.47 153.53 43.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' 1002 ' ' ALA . 53.0 ttt-85 -138.32 150.02 46.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.906 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.484 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 36.4 pt -142.8 -169.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 68.3 p -148.49 130.63 15.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.486 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.5 OUTLIER -98.31 154.95 17.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.076 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 94.1 p -161.23 128.1 4.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 111.851 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.612 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 85.1 m -82.92 51.15 1.86 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.944 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.531 HG22 HD21 ' A' ' 971' ' ' ASN . 14.9 t 38.22 -149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.262 0.553 . . . . 0.0 111.907 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 19.4 m -95.65 141.21 29.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.46 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.47 82.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.161 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.534 ' HB2' ' O ' ' A' ' 990' ' ' CYS . 50.4 m80 -152.83 135.03 14.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.92 0.36 . . . . 0.0 110.846 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.428 ' HG3' HH11 ' A' ' 995' ' ' ARG . 38.4 ttt85 -81.94 121.45 26.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 997' ' ' ILE . 2.9 tt -76.2 128.86 35.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.456 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.679 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -102.22 146.87 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.13 -118.86 4.71 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.503 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -149.65 129.54 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.164 0.482 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.0 p -69.9 -43.99 70.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 95.7 p -77.85 136.08 38.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.64 149.62 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.454 . . . . 0.0 111.433 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -134.0 131.63 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 50.3 t -70.43 96.88 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' 1012 ' ' HIS . 27.5 pt -90.43 -175.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' 1011 ' ' ALA . 9.6 tp -158.42 120.41 3.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 43.8 m -81.77 -48.65 11.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.495 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.88 -48.21 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.96 -49.83 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 91.6 m -151.19 149.95 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.304 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.664 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.16 140.48 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.553 ' O ' HG12 ' A' 1005 ' ' ILE . 90.5 m-70 -149.39 145.88 27.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 71.7 m95 -71.27 132.66 45.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.735 0.303 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.8 p -52.46 -29.07 22.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 72.9 p -87.76 -134.62 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -166.95 150.13 6.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.731 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -40.62 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.17 . . . . 0.0 112.503 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 29.8 Cg_exo -63.1 135.64 52.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.907 2.405 . . . . 0.0 112.028 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.917 HG22 ' H ' ' A' 1020 ' ' CYS . 5.0 mt -95.75 -170.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.006 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.917 ' H ' HG22 ' A' 1019 ' ' ILE . 67.6 m -152.31 98.02 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.473 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.597 ' H ' HD13 ' A' ' 997' ' ' ILE . 3.4 tp-100 -82.53 131.51 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.684 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.8 tpt180 -65.9 127.93 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.61 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.3 mm -63.25 106.63 0.94 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.504 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' 1045 ' ' HIS . 3.5 Cg_exo -76.12 136.37 18.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.7 2.267 . . . . 0.0 112.881 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.78 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 29.8 p -124.73 133.94 53.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.03 -154.45 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.733 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.54 147.97 87.54 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 120.66 0.266 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.712 ' HD3' ' HE2' ' A' 1044 ' ' PHE . 78.6 Cg_endo -75.86 142.97 25.94 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.533 2.155 . . . . 0.0 111.6 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.752 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.0 Cg_exo -51.67 106.29 0.13 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 121.997 1.798 . . . . 0.0 111.508 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 90.3 m -77.46 126.81 31.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.665 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.936 HD13 ' HB2' ' A' 1089 ' ' PRO . 18.0 pt -90.41 136.53 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.893 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -52.0 138.38 25.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.774 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.559 ' HA ' ' ND2' ' A' 1055 ' ' ASN . 4.4 m120 75.14 -36.18 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.799 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -72.23 132.86 19.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.814 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -81.64 -159.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.148 0.499 . . . . 0.0 111.335 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.638 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -155.99 133.18 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.587 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' 1050 ' ' VAL . 39.4 pt -142.04 -148.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.963 0.411 . . . . 0.0 111.484 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.486 ' HB2' ' H ' ' A' 1051 ' ' THR . 8.2 t 78.21 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.861 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 28.7 p -66.46 -43.3 85.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.755 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' 1044 ' ' PHE . 4.5 m120 -52.21 140.18 21.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.254 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.638 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 86.3 mtm180 -155.16 -47.17 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.402 ' C ' ' HD1' ' A' 1044 ' ' PHE . 23.4 pt-20 -162.99 -43.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -71.67 58.26 0.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.461 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.712 ' HE2' ' HD3' ' A' 1028 ' ' PRO . 2.3 m-85 -76.68 132.21 39.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' 1046 ' ' TYR . 55.4 m170 -130.71 -56.29 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.16 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' 1023 ' ' ILE . 78.0 t80 170.79 150.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.443 0.464 . . . . 0.0 110.386 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.577 ' N ' ' HB2' ' A' 1074 ' ' CYS . . . 76.46 -31.12 1.42 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.681 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.427 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 49.4 m -45.85 131.26 9.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' 1072 ' ' ILE . 6.8 p -102.2 146.45 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' 1037 ' ' ILE . 7.3 p -133.39 135.15 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.504 ' HB ' HG13 ' A' 1037 ' ' ILE . 44.1 m -98.63 122.57 42.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.53 ' OH ' ' HB2' ' A' 1028 ' ' PRO . 3.6 m-85 -85.64 167.11 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.508 ' HG3' HH11 ' A' 1053 ' ' ARG . 28.9 mtt85 -159.59 -149.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.972 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.799 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 8.5 t -163.57 157.68 19.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 110.531 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.699 ' O ' ' HG ' ' A' 1056 ' ' LEU . 77.2 m-20 -55.13 153.47 6.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.513 . . . . 0.0 112.316 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' 1055 ' ' ASN . 1.4 mt -154.97 43.25 0.47 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.937 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' 1058 ' ' SER . . . 72.48 -59.48 1.59 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.387 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' 1057 ' ' GLY . 43.3 t 174.38 -18.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 0.0 110.681 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -155.27 55.47 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.28 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . 72.49 129.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.285 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.501 ' O ' HD23 ' A' 1056 ' ' LEU . 39.6 ttm180 -178.15 145.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.577 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -65.25 81.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' 1056 ' ' LEU . 9.6 m -151.82 88.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.516 0.674 . . . . 0.0 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.905 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 72.5 m-85 70.79 141.86 0.05 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.511 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.7 mt-10 -142.39 142.33 32.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.103 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' 1067 ' ' VAL . 1.4 tt -68.57 137.71 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.295 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.825 ' N ' HD23 ' A' 1066 ' ' LEU . 7.3 p -139.49 127.43 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.663 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.55 138.56 1.4 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.395 -0.821 . . . . 0.0 114.056 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.807 ' O ' ' HG3' ' A' 1089 ' ' PRO . 32.9 tt0 36.75 59.21 3.64 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.193 0.597 . . . . 0.0 112.457 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.21 6.58 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.231 1.954 . . . . 0.0 112.612 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' 1069 ' ' GLU . 81.0 p -156.17 147.12 22.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.308 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' 1028 ' ' PRO . 44.7 pt -142.22 179.73 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -160.06 154.68 24.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.447 . . . . 0.0 111.828 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.577 ' HB2' ' N ' ' A' 1047 ' ' GLY . 65.8 m -62.6 146.23 52.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.907 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.0 t -155.76 -158.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.055 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.6 p -151.48 143.37 23.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' 1077 ' ' ASN . 0.0 OUTLIER -164.82 29.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.6 t70 176.38 52.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.258 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.25 -129.08 0.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.503 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.684 ' HG2' ' H ' ' A' 1081 ' ' VAL . 6.7 tt0 -67.59 -139.85 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.684 ' H ' ' HG2' ' A' 1080 ' ' GLN . 27.2 t 72.99 -43.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 122.541 0.336 . . . . 0.0 111.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.78 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 67.85 64.51 3.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.658 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' 1083 ' ' ILE . 3.4 mp -81.89 135.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 110.555 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 26.0 m95 -78.14 -160.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 77.6 p -81.58 -65.03 1.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 144.14 5.53 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.696 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.752 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 98.5 Cg_endo -83.71 49.9 3.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.097 2.531 . . . . 0.0 112.034 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.495 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -64.33 -41.62 61.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.936 ' HB2' HD13 ' A' 1031 ' ' ILE . 86.6 Cg_exo -45.78 137.78 12.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.507 2.138 . . . . 0.0 113.051 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.802 ' O ' HG12 ' A' 1067 ' ' VAL . 38.3 tt0 -150.32 143.08 24.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.905 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 73.9 m -84.32 137.18 33.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.458 ' H ' ' H ' ' A' 1065 ' ' GLU . 31.0 pt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.542 ' HG3' HD11 ' A' 1006 ' ' LEU . 46.6 mmtm 62.1 145.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.987 0.423 . . . . 0.0 111.422 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 82.1 p -157.97 136.01 10.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.5 m -79.95 164.45 23.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.317 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.84 126.77 28.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 965' ' ' THR . 4.2 t -76.77 114.09 35.81 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.855 ' HG2' HG11 ' A' ' 974' ' ' VAL . 86.5 Cg_endo -85.48 111.06 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.485 2.123 . . . . 0.0 112.142 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 19.6 Cg_endo -58.88 -39.55 80.24 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.282 1.988 . . . . 0.0 110.951 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 62.9 t0 179.25 119.14 0.21 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.443 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 974' ' ' VAL . 35.5 Cg_endo -64.84 -150.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 112.613 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.786 HG11 ' H ' ' A' 1020 ' ' CYS . 9.6 p -53.13 -136.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.559 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.751 ' H ' HG22 ' A' ' 970' ' ' VAL . 4.7 m120 -65.33 -33.39 75.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.066 0.46 . . . . 0.0 110.583 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.439 ' H ' HG13 ' A' ' 970' ' ' VAL . . . -69.08 -147.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.803 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 85.5 mtp -156.35 142.51 18.2 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.327 0.251 . . . . 0.0 110.408 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.855 HG11 ' HG2' ' A' ' 966' ' ' PRO . 1.1 p -92.18 144.94 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.004 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.405 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 23.1 m170 -121.22 112.38 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 980' ' ' ILE . 90.5 t -64.72 -41.49 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.773 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 978' ' ' THR . 20.2 mt 64.88 -98.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.144 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 977' ' ' ILE . 12.6 p -80.73 -52.85 7.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.528 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 980' ' ' ILE . 21.1 m-20 -169.3 -157.69 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.235 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 976' ' ' VAL . 20.1 pt -155.91 10.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.837 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 74.3 mt-30 -73.2 -45.72 54.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.624 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 7.5 p 167.38 151.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 79.43 -40.32 2.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.361 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 14.4 t -69.83 141.99 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.39 . . . . 0.0 111.049 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 37.3 ttm180 -110.96 118.29 35.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.118 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.615 HD12 ' CG2' ' A' ' 974' ' ' VAL . 36.7 pt -91.28 138.46 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.203 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 82.6 p -103.51 132.18 49.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 4.7 m-85 -101.41 152.62 20.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.7 m -154.21 126.05 7.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.594 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 991' ' ' THR . 37.3 t -98.64 178.68 4.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.422 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 61.2 p -65.11 -158.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.216 0.532 . . . . 0.0 111.84 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 46.0 m -86.04 -68.02 0.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.001 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' 1046 ' ' TYR . . . -81.02 42.29 2.7 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.424 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.6 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 41.6 m80 -149.48 125.35 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 0.0 110.726 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.58 ' HB3' ' NE2' ' A' 1080 ' ' GLN . 52.2 ttt-85 -95.14 121.63 36.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.745 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 1.4 tt -76.21 137.34 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.66 ' HB ' HG23 ' A' 1019 ' ' ILE . 1.8 mp -101.29 149.81 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.017 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.79 34.68 38.01 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.691 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 58.96 130.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.223 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 988' ' ' TYR . 49.8 m -83.05 41.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.62 ' O ' HG21 ' A' 1015 ' ' THR . 68.8 m -162.18 148.39 13.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -159.22 128.06 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.5 tt0 -103.25 125.67 50.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.527 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 44.6 t -68.4 84.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' 1014 ' ' SER . 49.7 pt -87.3 -162.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.737 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' 1007 ' ' SER . 5.2 tt -158.36 125.81 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.346 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.544 ' N ' HD23 ' A' 1006 ' ' LEU . 45.3 m -78.39 -55.88 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.413 ' N ' HD23 ' A' 1006 ' ' LEU . . . 169.55 42.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.727 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.521 ' H ' HD21 ' A' 1006 ' ' LEU . 21.7 p30 -177.9 -36.95 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.26 149.58 29.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.527 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.26 132.95 41.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.129 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -149.43 145.81 27.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.501 ' HH2' HG22 ' A' ' 980' ' ' ILE . 52.3 m95 -70.82 122.83 20.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.328 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.6 p -52.48 -25.69 10.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.708 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.62 HG21 ' O ' ' A' 1001 ' ' SER . 50.5 p -87.72 -144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' 1016 ' ' LYS . 10.7 mtmp? -151.57 161.27 30.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.281 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 78.6 Cg_exo -40.95 124.69 2.08 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.61 2.206 . . . . 0.0 112.692 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.647 ' HB2' HD21 ' A' ' 996' ' ' LEU . 90.7 Cg_endo -80.67 145.59 16.32 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.143 2.562 . . . . 0.0 113.376 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 997' ' ' ILE . 7.2 tt -148.84 113.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.99 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.786 ' H ' HG11 ' A' ' 970' ' ' VAL . 9.7 t -86.44 121.16 28.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.124 0.488 . . . . 0.0 111.382 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -85.55 136.61 33.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.616 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' 1024 ' ' PRO . 57.8 mtt85 -75.93 127.75 33.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.177 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.775 HG12 ' HG3' ' A' 1080 ' ' GLN . 84.9 mt -76.73 108.54 6.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.282 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.912 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 66.7 Cg_endo -74.0 121.54 7.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.384 2.056 . . . . 0.0 111.384 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.529 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 16.8 m -89.16 28.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' A' 1044 ' ' PHE . . . 37.22 -158.83 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.668 -0.697 . . . . 0.0 114.273 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' 1027 ' ' LEU . 7.7 mp -74.01 145.78 84.09 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 122.599 0.36 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.843 ' HB3' HD11 ' A' 1072 ' ' ILE . 23.1 Cg_exo -63.43 144.8 91.57 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.731 2.287 . . . . 0.0 111.375 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' 1072 ' ' ILE . 5.9 Cg_endo -47.86 113.9 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.243 1.962 . . . . 0.0 111.396 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 64.0 p -77.78 141.36 39.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.304 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.501 HD13 ' HB1' ' A' 1088 ' ' ALA . 25.6 pt -147.82 121.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.64 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.08 135.63 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.123 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' 1032 ' ' ALA . 76.4 m-20 75.01 -38.36 0.38 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.516 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -69.98 76.97 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.81 126.26 29.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' 1038 ' ' SER . 17.8 p90 -93.26 147.3 23.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.98 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' 1038 ' ' SER . 49.8 mm -87.37 159.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.822 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.484 ' N ' HG22 ' A' 1037 ' ' ILE . 23.1 t 75.39 144.65 0.08 Allowed 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' 1041 ' ' ARG . 17.0 p -66.13 -57.02 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.486 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 61.28 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' 1039 ' ' THR . 49.8 mtt85 40.27 -128.36 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.29 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' 1043 ' ' ASN . 8.2 pt-20 -77.15 -145.75 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' 1042 ' ' GLU . 62.9 m-20 34.85 36.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.212 0.529 . . . . 0.0 110.61 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.474 ' CZ ' ' HA2' ' A' 1026 ' ' GLY . 1.2 p90 -89.02 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.048 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.912 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 21.0 p-80 -165.36 -164.59 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.174 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.512 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 22.1 t80 -59.24 153.76 17.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 111.56 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' 1049 ' ' VAL . . . 68.77 10.52 61.24 Favored Glycine 0 C--N 1.33 0.222 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.296 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' A' 1025 ' ' CYS . 74.4 p -48.39 134.32 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.179 0.49 . . . . 0.0 109.929 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.766 HG22 ' HA ' ' A' 1073 ' ' TYR . 38.3 t -146.72 142.86 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 28.4 m -152.64 134.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.192 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.419 HG23 ' OG ' ' A' 1071 ' ' SER . 91.2 m -92.9 124.72 37.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.695 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.583 ' OH ' HD13 ' A' 1072 ' ' ILE . 8.2 m-85 -73.72 154.67 39.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.473 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.458 ' HG3' HH11 ' A' 1053 ' ' ARG . 38.0 ttt85 -148.3 0.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.959 ' HB2' HG12 ' A' 1063 ' ' VAL . 59.0 m 64.12 152.27 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 111.079 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' 1057 ' ' GLY . 48.5 t30 -62.62 -49.19 76.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' 1060 ' ' GLY . 0.4 OUTLIER -71.31 39.23 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' 1055 ' ' ASN . . . -89.02 -24.17 32.93 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.1 p -151.91 121.14 6.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.324 -0.938 . . . . 0.0 109.52 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' 1058 ' ' SER . 38.5 mmt180 81.71 44.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.32 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.806 ' C ' HD23 ' A' 1056 ' ' LEU . . . 179.99 -44.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' 1062 ' ' LYS . 51.4 mmt-85 64.5 177.59 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 122.499 0.32 . . . . 0.0 111.826 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' 1061 ' ' ARG . 16.0 tptm 75.85 -41.7 0.44 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.367 0.603 . . . . 0.0 109.619 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.959 HG12 ' HB2' ' A' 1054 ' ' CYS . 0.0 OUTLIER 47.64 40.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.346 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.569 ' HE1' ' H ' ' A' 1056 ' ' LEU . 0.1 OUTLIER 42.84 -138.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -150.19 121.07 7.62 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.342 0.591 . . . . 0.0 110.47 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' 1070 ' ' PRO . 55.0 tp -68.5 145.58 53.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.167 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 65.1 t -138.2 131.75 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.889 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.38 -143.67 22.91 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.429 ' OE2' HG22 ' A' 1072 ' ' ILE . 22.5 pt-20 -68.49 126.94 93.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.436 ' HB3' HD21 ' A' 1066 ' ' LEU . 2.7 Cg_endo -83.3 -10.21 10.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.104 2.536 . . . . 0.0 111.759 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.419 ' OG ' HG23 ' A' 1051 ' ' THR . 49.4 m -153.5 127.41 8.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.093 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' 1028 ' ' PRO . 19.4 pt -89.5 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.3 0.572 . . . . 0.0 111.905 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.766 ' HA ' HG22 ' A' 1049 ' ' VAL . 24.8 p90 -145.06 128.94 17.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 13.5 t -63.68 164.15 10.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.113 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.0 t -155.78 -27.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.484 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 56.1 m 65.48 146.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.921 0.391 . . . . 0.0 111.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.725 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -164.98 -34.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.725 ' H ' HD22 ' A' 1077 ' ' ASN . 9.5 t70 -60.28 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.62 0.248 . . . . 0.0 110.863 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -162.95 -42.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.761 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.775 ' HG3' HG12 ' A' 1023 ' ' ILE . 52.4 tt0 -175.0 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.23 0.538 . . . . 0.0 110.321 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' 1082 ' ' GLY . 20.5 t -83.33 -117.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.678 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . -165.78 50.85 0.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.776 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' 1083 ' ' ILE . 2.0 mp -81.95 126.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.697 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.8 m95 -85.37 -151.23 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' 1073 ' ' TYR . 80.2 p -95.39 -27.63 15.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.111 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.43 152.66 21.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.612 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 10.7 Cg_exo -73.48 47.35 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 112.883 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' 1031 ' ' ILE . . . 65.36 141.89 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.859 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.504 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 58.6 Cg_endo -69.89 -146.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.726 2.284 . . . . 0.0 112.113 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.472 ' H ' ' HB2' ' A' 1089 ' ' PRO . 3.3 mm100 -150.65 128.71 11.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 91.9 m -96.69 70.54 2.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.459 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.25 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.724 0.297 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 0.8 OUTLIER 61.63 122.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.628 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 31.0 t -157.95 131.96 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.934 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 2.9 p -79.84 142.22 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.68 126.36 27.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 0.0 110.665 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.775 ' HB ' HD13 ' A' ' 980' ' ' ILE . 9.1 t -67.89 131.91 92.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.111 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.65 ' HG2' HG21 ' A' ' 974' ' ' VAL . 22.7 Cg_exo -64.74 108.83 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.349 2.033 . . . . 0.0 111.649 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 965' ' ' THR . 88.9 Cg_exo -48.02 -46.76 21.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.537 2.158 . . . . 0.0 111.644 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 968' ' ' ASP . 2.1 p30 179.28 111.73 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.223 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.55 152.9 74.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.668 2.245 . . . . 0.0 111.971 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.509 ' HB ' HG13 ' A' 1019 ' ' ILE . 60.0 t -48.02 100.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 75.3 m-20 74.44 -50.74 0.68 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.597 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -73.44 141.34 29.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.908 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.4 mtp -89.28 138.12 31.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 966' ' ' PRO . 4.9 p -83.5 151.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.397 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 987' ' ' THR . 21.8 m170 -119.07 76.17 1.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.812 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.535 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 48.5 t -75.21 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.27 -75.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.825 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 33.2 p -56.42 -88.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.567 ' OD1' ' HB2' ' A' ' 981' ' ' GLN . 2.8 p30 -168.7 151.42 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 965' ' ' THR . 5.1 pt -83.93 27.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.337 0.589 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.567 ' HB2' ' OD1' ' A' ' 979' ' ' ASP . 27.2 mt-30 -90.37 151.73 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.07 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' 1004 ' ' CYS . 74.8 t -44.26 146.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.734 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 83.26 -39.85 2.8 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 114.258 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.2 m -68.45 175.72 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.612 0.706 . . . . 0.0 111.143 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.455 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 4.7 tmm_? -156.6 128.72 7.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.194 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.535 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 34.3 pt -97.28 -163.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 975' ' ' HIS . 54.7 p -149.23 130.13 14.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.937 0.398 . . . . 0.0 112.028 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.1 m-85 -99.18 147.82 24.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.376 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -151.13 132.15 14.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.547 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 85.8 m -81.93 -125.93 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 992' ' ' THR . 1.8 t -165.01 176.15 8.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.306 0.574 . . . . 0.0 111.375 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.474 ' N ' ' OG1' ' A' ' 991' ' ' THR . 22.1 m -48.54 131.02 17.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.643 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.19 84.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.459 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.01 122.44 7.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.943 0.371 . . . . 0.0 110.706 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' 1080 ' ' GLN . 38.0 ttm180 -82.24 114.54 20.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 997' ' ' ILE . 7.6 tp -76.27 127.81 33.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.24 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.8 mp -98.75 140.78 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.482 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.2 174.34 40.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.068 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' 1001 ' ' SER . 86.6 m-70 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 0.0 111.357 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.3 p -75.4 31.3 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.838 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 999' ' ' HIS . 63.0 m -162.12 152.18 16.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.048 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.846 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -150.8 129.03 11.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.63 122.96 33.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.097 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 14.9 t -70.13 80.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 40.7 pt -87.33 -142.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.526 ' HG ' ' C ' ' A' 1010 ' ' THR . 5.1 tt -158.39 121.62 3.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.878 0.37 . . . . 0.0 110.566 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 53.0 m -92.03 47.03 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.811 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.48 ' N ' HD23 ' A' 1006 ' ' LEU . . . 75.35 -57.63 2.85 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.092 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.18 -60.08 3.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.855 0.327 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.526 ' C ' ' HG ' ' A' 1006 ' ' LEU . 15.2 t -151.27 -172.51 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.611 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.26 136.89 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 111.003 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -149.44 151.72 34.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.836 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.846 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 61.2 m95 -72.41 127.45 32.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.9 t -52.46 -27.7 17.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.972 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 82.5 p -105.8 142.28 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 111.95 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -57.08 149.2 47.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.276 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.84 108.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.247 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.442 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 34.1 Cg_exo -59.3 148.73 85.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.897 2.398 . . . . 0.0 112.163 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.693 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 9.1 tt -148.82 135.71 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.433 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 50.1 m -86.49 159.42 19.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.912 0.387 . . . . 0.0 110.64 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.444 ' HB3' HD11 ' A' ' 997' ' ' ILE . 7.0 tt0 -153.5 117.69 4.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.666 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -64.21 127.66 32.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.194 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' 1045 ' ' HIS . 76.0 mt -71.05 126.69 92.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 26.0 Cg_endo -61.39 126.49 19.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.563 2.175 . . . . 0.0 112.776 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.734 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 71.6 m -97.21 135.05 39.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -84.74 151.72 26.65 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.49 ' HA ' ' CZ ' ' A' 1044 ' ' PHE . 1.4 mm? -39.44 137.15 1.06 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 117.168 0.484 . . . . 0.0 111.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.557 ' HG3' HG11 ' A' 1050 ' ' VAL . 29.7 Cg_endo -63.68 145.24 91.04 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.677 2.251 . . . . 0.0 112.12 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.629 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.4 Cg_exo -54.61 91.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.295 1.997 . . . . 0.0 111.376 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . 0.503 HG23 ' O ' ' A' 1028 ' ' PRO . 53.2 p -77.47 118.78 20.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.66 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' 1089 ' ' PRO . 18.4 pt -84.95 119.89 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.46 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -43.55 141.53 1.41 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 78.08 -38.78 0.26 Allowed 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.506 0.504 . . . . 0.0 111.001 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -69.78 120.11 9.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.428 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' 1052 ' ' TYR . 1.4 m-20 -83.06 173.46 11.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.682 ' HA ' ' O ' ' A' 1051 ' ' THR . 43.9 p90 -151.43 133.64 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.169 0.509 . . . . 0.0 111.728 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.719 HD11 ' HD2' ' A' 1053 ' ' ARG . 29.5 mt -108.54 45.34 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.713 ' HB3' HG12 ' A' 1050 ' ' VAL . 81.6 p -71.2 -140.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.701 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' 1041 ' ' ARG . 88.7 m -161.16 -29.53 0.05 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.601 ' HB3' ' OG ' ' A' 1048 ' ' SER . 21.8 p30 -53.35 -39.05 63.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' 1039 ' ' THR . 37.9 mmt180 59.02 -111.43 0.55 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.231 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.12 -131.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.51 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.1 p30 -56.26 145.6 26.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' 1027 ' ' LEU . 29.6 p90 -159.79 129.23 5.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.75 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' O ' ' A' 1023 ' ' ILE . 48.9 m-70 -76.6 -41.54 45.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' 1045 ' ' HIS . 60.1 t80 176.03 157.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.551 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' 1048 ' ' SER . . . 76.54 96.67 0.17 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.284 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.601 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 45.7 t 174.26 153.68 0.11 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 1.001 HG12 ' HB3' ' A' 1073 ' ' TYR . 3.6 m -137.81 159.42 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.258 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' 1038 ' ' SER . 18.1 m -133.37 134.67 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' 1036 ' ' PHE . 86.7 m -104.77 119.05 38.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' 1035 ' ' ASP . 7.7 m-85 -80.56 160.07 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.719 ' HD2' HD11 ' A' 1037 ' ' ILE . 79.6 mtp180 -142.71 -41.6 0.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.777 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 40.1 t 70.73 122.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.818 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' 1064 ' ' PHE . 3.5 m120 17.57 -123.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.785 ' HA ' HG23 ' A' 1063 ' ' VAL . 79.6 mt 69.5 123.49 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.69 -62.79 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.612 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.474 ' C ' ' HD2' ' A' 1059 ' ' ARG . 38.2 t -90.06 44.02 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.554 ' HD2' ' N ' ' A' 1059 ' ' ARG . 0.0 OUTLIER 39.45 44.98 1.21 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.071 -179.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.59 -29.13 0.12 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.098 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -45.75 146.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.605 0.241 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.561 ' HB3' ' NZ ' ' A' 1062 ' ' LYS . 6.3 ttpm? -65.37 80.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.986 0.422 . . . . 0.0 111.59 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' 1056 ' ' LEU . 3.2 m -155.17 90.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' 1055 ' ' ASN . 0.5 OUTLIER 68.75 144.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.566 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -146.18 143.36 29.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 112.338 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' 1070 ' ' PRO . 34.6 tp -68.55 151.7 46.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.969 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.878 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 76.9 t -138.22 136.25 44.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.061 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.1 -148.09 32.6 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.131 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.1 pt-20 -63.45 128.6 92.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.574 ' HB3' HD21 ' A' 1066 ' ' LEU . 79.4 Cg_endo -94.74 11.16 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.974 2.449 . . . . 0.0 113.23 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' 1050 ' ' VAL . 80.2 p -157.02 145.86 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . . . . . . . . . 42.9 pt -140.95 174.29 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.631 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 1.001 ' HB3' HG12 ' A' 1049 ' ' VAL . 1.6 p90 -160.04 148.13 16.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.486 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.895 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 44.6 t -65.37 137.37 57.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.409 ' O ' ' O ' ' A' 1076 ' ' SER . 8.0 t -154.98 11.05 0.35 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' 1075 ' ' THR . 99.7 p 55.74 151.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.614 ' ND2' ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -168.34 40.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.508 ' HB3' ' CG2' ' A' 1081 ' ' VAL . 54.3 t0 -178.57 -18.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' 1080 ' ' GLN . 33.1 m-20 70.42 134.63 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.604 ' HA ' ' NH2' ' A' ' 995' ' ' ARG . 72.7 mt-30 76.2 21.96 1.4 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 109.211 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' 1080 ' ' GLN . 2.6 m -163.3 109.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.075 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.734 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . -74.31 63.89 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.581 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.614 ' HB ' ' ND2' ' A' 1077 ' ' ASN . 64.4 mt -81.92 138.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.895 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.5 m95 -70.98 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.002 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.0 t -80.61 -65.75 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.999 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.6 145.44 6.08 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.343 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 92.3 Cg_endo -81.71 51.12 3.73 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.116 2.544 . . . . 0.0 112.787 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.486 ' HB3' ' CG ' ' A' 1069 ' ' GLU . . . -66.28 -43.94 56.29 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.602 ' HG3' ' O ' ' A' 1069 ' ' GLU . 87.1 Cg_exo -43.56 137.74 5.75 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.438 2.092 . . . . 0.0 112.699 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.878 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.4 mm100 -129.77 127.96 41.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 36.5 t -93.45 72.41 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.266 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.61 0.243 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -77.62 146.86 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.545 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 80.4 p -157.98 143.29 16.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.524 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 95.5 m -80.01 146.83 31.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.256 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.83 139.43 58.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 111.337 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 62.9 m -68.28 128.12 93.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.981 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.515 ' HG2' HG21 ' A' ' 974' ' ' VAL . 11.0 Cg_exo -70.05 127.38 14.29 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 111.211 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.08 -60.09 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.114 1.876 . . . . 0.0 111.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 175.73 115.18 0.12 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.782 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 18.3 Cg_exo -66.22 134.92 38.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.489 2.126 . . . . 0.0 111.727 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.762 HG22 ' ND2' ' A' ' 971' ' ' ASN . 0.8 OUTLIER -49.11 125.47 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.039 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.762 ' ND2' HG22 ' A' ' 970' ' ' VAL . 73.4 m-20 75.29 -58.32 0.57 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.225 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -80.04 -161.54 23.89 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.782 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 40.6 tpp -160.47 135.16 7.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.613 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.569 ' CG2' HD12 ' A' ' 986' ' ' ILE . 2.8 p -81.76 150.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.321 . . . . 0.0 110.779 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 20.2 m170 -117.31 99.5 7.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.498 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.636 HG23 HG23 ' A' ' 980' ' ' ILE . 7.2 p -75.03 86.19 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.704 0.764 . . . . 0.0 109.693 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.22 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.505 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 984' ' ' SER . 41.2 p -79.86 79.27 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 111.044 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 980' ' ' ILE . 1.5 m-20 52.1 -142.38 0.75 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.054 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.636 HG23 HG23 ' A' ' 976' ' ' VAL . 3.6 pt -155.84 23.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 75.5 mt-30 -85.6 169.97 13.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.675 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' 1004 ' ' CYS . 92.3 t -44.33 145.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.368 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.51 ' HA2' ' OE2' ' A' 1003 ' ' GLU . . . 78.97 -44.45 2.59 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.927 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 978' ' ' THR . 92.8 p -68.36 123.64 21.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.463 0.631 . . . . 0.0 111.047 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.758 ' HD3' ' HB2' ' A' 1001 ' ' SER . 33.8 ttm180 -102.71 135.82 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.846 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.569 HD12 ' CG2' ' A' ' 974' ' ' VAL . 16.3 pt -95.52 -170.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.954 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 55.7 p -148.29 123.9 10.44 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.585 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 4.9 m-85 -97.24 154.15 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.539 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 20.8 m -157.64 126.29 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.668 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 85.0 m -85.16 147.83 26.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.518 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 991' ' ' THR . 0.0 OUTLIER -60.37 163.36 5.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.587 0.708 . . . . 0.0 112.154 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.4 m -55.79 138.25 48.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.476 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 71.52 40.1 60.06 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.836 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -151.07 138.53 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.494 0.188 . . . . 0.0 110.545 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 995' ' ' ARG . 37.3 ttt85 -82.02 127.13 32.77 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.218 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.668 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 3.5 tt -76.22 118.72 19.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 111.38 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' 1021 ' ' GLN . 30.4 mm -94.2 140.87 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.93 177.19 32.09 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.105 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.544 ' O ' ' HG3' ' A' 1018 ' ' PRO . 22.7 m170 -75.03 127.27 32.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.299 . . . . 0.0 111.172 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.4 p -79.02 26.36 0.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.044 0.45 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.758 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.1 p -162.16 140.44 8.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.401 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -156.09 128.45 7.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.51 ' OE2' ' HA2' ' A' ' 983' ' ' GLY . 85.6 tt0 -89.99 130.83 36.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.443 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.56 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 51.3 t -67.16 128.54 36.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' 1011 ' ' ALA . 31.2 pt -134.8 -142.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' 1010 ' ' THR . 0.3 OUTLIER -144.08 120.45 10.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 -179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.489 ' HB3' ' HD2' ' A' 1012 ' ' HIS . 46.0 t -85.93 -47.89 9.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.414 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 177.28 -50.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.111 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 42.3 t30 -79.79 -51.41 9.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.737 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.404 ' C ' HD22 ' A' 1006 ' ' LEU . 11.8 t -151.28 -161.95 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.56 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.31 140.78 43.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.489 ' HD2' ' HB3' ' A' 1007 ' ' SER . 90.2 m-70 -149.49 144.58 26.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.475 ' HH2' HG22 ' A' ' 980' ' ' ILE . 68.6 m95 -67.0 135.21 53.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.883 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 82.4 p -52.49 -22.2 4.58 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.675 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.509 HG21 ' ND1' ' A' ' 999' ' ' HIS . 70.8 p -131.44 139.86 49.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.876 0.369 . . . . 0.0 111.918 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -52.16 145.47 18.45 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.826 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 5.8 Cg_endo -48.57 103.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.396 2.064 . . . . 0.0 111.806 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.585 ' HG2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_endo -62.42 150.79 86.09 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 111.998 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.653 HG13 ' HB ' ' A' ' 997' ' ' ILE . 41.3 pt -125.77 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.572 ' HB2' HD22 ' A' ' 971' ' ' ASN . 22.0 m -146.75 121.32 9.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.789 ' HB2' HD11 ' A' ' 997' ' ' ILE . 64.8 tp60 -83.48 128.36 34.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' 1022 ' ' ARG . 40.4 ttt85 -81.55 117.89 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.121 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' 1076 ' ' SER . 75.7 mt -70.94 112.4 13.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.82 127.1 8.46 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.543 2.162 . . . . 0.0 112.139 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.614 ' HB2' ' O ' ' A' 1044 ' ' PHE . 62.8 m -88.43 -145.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 0.0 111.564 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' 1044 ' ' PHE . . . -161.08 154.81 25.87 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.629 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.571 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 45.8 mt -42.51 137.93 2.22 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-O 120.81 0.338 . . . . 0.0 111.529 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.588 ' HD3' ' ND2' ' A' 1040 ' ' ASN . 13.1 Cg_endo -56.31 146.68 71.26 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.777 2.318 . . . . 0.0 111.743 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.41 108.66 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.155 1.903 . . . . 0.0 111.606 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 82.1 p -77.59 116.54 18.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.877 HG21 ' HD2' ' A' 1089 ' ' PRO . 11.6 pt -100.28 29.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.449 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 55.2 120.95 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.415 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 61.7 m-80 69.64 12.41 8.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.745 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.62 134.51 38.34 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.998 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.81 -37.25 79.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.721 ' HD1' HG23 ' A' 1050 ' ' VAL . 0.8 OUTLIER 61.34 108.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.831 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.85 HG22 ' H ' ' A' 1038 ' ' SER . 7.9 mt -111.34 -176.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.715 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.85 ' H ' HG22 ' A' 1037 ' ' ILE . 15.7 t 69.71 -129.51 0.08 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.168 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 25.3 p -145.03 140.26 28.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 111.739 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.588 ' ND2' ' HD3' ' A' 1028 ' ' PRO . 23.9 t-20 -169.79 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' 1041 ' ' ARG . 42.1 mtp85 52.03 -142.18 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.7 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -79.06 -45.2 20.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.0 p30 -65.93 141.56 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' 1025 ' ' CYS . 0.5 OUTLIER -163.21 40.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.837 0.351 . . . . 0.0 111.212 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' 1046 ' ' TYR . 23.9 m80 -53.49 -40.27 65.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' 1045 ' ' HIS . 43.9 t80 173.61 159.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.695 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.99 -24.99 3.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.136 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 69.1 m -47.61 139.78 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' 1072 ' ' ILE . 14.4 p -138.19 157.65 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.721 HG23 ' HD1' ' A' 1036 ' ' PHE . 3.3 p -154.02 135.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.742 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 92.3 m -100.96 123.65 45.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.708 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.739 ' HD2' HD13 ' A' 1031 ' ' ILE . 3.7 m-85 -83.7 144.52 29.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.008 0.433 . . . . 0.0 111.355 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.532 ' HA ' ' HB2' ' A' 1066 ' ' LEU . 42.8 ttm-85 -157.42 -25.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.791 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 16.2 m 64.86 145.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.059 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 3.4 m120 -62.85 129.77 41.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.288 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.807 ' HG ' ' HA2' ' A' 1060 ' ' GLY . 1.9 mm? -70.33 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.639 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' 1056 ' ' LEU . . . -152.05 29.41 0.9 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 23.8 p 177.44 -51.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.74 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' 1059 ' ' ARG . 19.3 tpt85 -169.61 -49.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.807 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -172.72 29.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.985 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' 1056 ' ' LEU . 40.1 mtp85 -80.35 169.5 17.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.752 0.31 . . . . 0.0 111.09 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.32 83.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' 1064 ' ' PHE . 3.3 m -155.05 99.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.506 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.9 m-30 79.49 62.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.088 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -86.56 130.01 34.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.61 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' 1069 ' ' GLU . 3.2 tm? -68.53 138.66 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.266 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.583 ' H ' HD22 ' A' 1066 ' ' LEU . 11.6 t -151.91 156.68 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' 1067 ' ' VAL . . . 79.79 -27.76 2.56 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.989 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.706 ' O ' HD11 ' A' 1066 ' ' LEU . 16.5 tp10 -167.82 103.7 0.57 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.994 0.397 . . . . 0.0 111.323 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.431 ' HA ' ' CD1' ' A' 1066 ' ' LEU . 95.7 Cg_endo -87.5 -28.94 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.0 2.467 . . . . 0.0 114.642 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 48.9 m -152.95 137.19 16.52 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.604 HD11 ' OH ' ' A' 1052 ' ' TYR . 28.6 pt -140.94 166.23 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.641 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.536 ' HB3' HG23 ' A' 1049 ' ' VAL . 2.9 p90 -157.17 145.73 19.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.963 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 52.3 t -63.84 148.54 49.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.497 . . . . 0.0 111.413 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.7 t -140.89 150.56 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.114 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' 1023 ' ' ILE . 54.5 m -74.54 123.34 24.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.527 ' ND2' HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER 179.31 -165.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.742 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' 1081 ' ' VAL . 8.3 t0 44.35 46.64 7.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' 1080 ' ' GLN . 9.9 t0 72.97 -59.4 0.57 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.178 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.449 ' HG2' ' OD1' ' A' 1079 ' ' ASP . 18.0 pt20 179.61 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' 1078 ' ' ASP . 42.6 t -86.32 -38.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 82.58 55.41 3.02 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.484 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.527 HG12 ' ND2' ' A' 1077 ' ' ASN . 33.8 pt -81.96 137.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.688 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.499 ' HZ3' HG12 ' A' 1050 ' ' VAL . 11.9 m95 -70.58 146.52 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.641 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 80.1 p -56.54 -9.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.423 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.43 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.42 135.94 3.92 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.36 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.43 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 15.0 Cg_exo -69.44 -153.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.057 2.504 . . . . 0.0 113.038 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.812 ' HB1' HG22 ' A' 1031 ' ' ILE . . . -77.16 138.5 64.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.432 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.877 ' HD2' HG21 ' A' 1031 ' ' ILE . 2.3 Cg_endo -80.47 -136.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.491 2.794 . . . . 0.0 111.898 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.622 HE21 HG23 ' A' 1092 ' ' ILE . 62.5 tp60 -152.41 119.84 5.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.757 0.313 . . . . 0.0 110.889 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 88.8 m -103.11 128.75 49.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.523 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.622 HG23 HE21 ' A' 1090 ' ' GLN . 6.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.367 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.854 0.359 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 981' ' ' GLN . 47.6 mmtm 63.26 138.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 56.9 p -157.96 140.51 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 98.6 m -79.85 134.05 36.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -64.96 142.02 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.004 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.7 m -50.8 121.09 14.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' 1013 ' ' TRP . 50.6 Cg_exo -55.69 132.31 51.36 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.392 2.062 . . . . 0.0 112.416 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.72 140.64 62.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.425 2.083 . . . . 0.0 111.355 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.6 m-20 -48.57 117.65 6.24 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 110.719 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.582 ' HG2' ' N ' ' A' ' 973' ' ' MET . 18.8 Cg_endo -58.9 149.2 80.24 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.801 2.334 . . . . 0.0 112.524 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' 1020 ' ' CYS . 79.4 t -42.8 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.426 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 78.1 m-20 73.42 -42.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.727 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.607 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -69.1 -156.34 1.09 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.079 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.582 ' N ' ' HG2' ' A' ' 969' ' ' PRO . 22.5 ptp -159.25 138.89 11.61 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.631 0.253 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.953 ' HA ' ' HB3' ' A' ' 988' ' ' TYR . 0.7 OUTLIER -87.33 145.53 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.398 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -119.13 106.78 12.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 68.9 t -69.71 94.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.542 HD11 ' OG1' ' A' ' 987' ' ' THR . 39.3 mt -75.24 -90.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.367 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 37.2 p -62.11 -68.62 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 27.4 t70 -166.89 -138.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.064 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.466 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 10.9 pt -155.81 53.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 961' ' ' LYS . 8.4 tt0 -152.65 158.04 41.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.719 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' 1004 ' ' CYS . 56.5 t -28.29 123.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.31 0.381 . . . . 0.0 111.334 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.58 2.6 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.682 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 88.0 p -157.1 127.23 6.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.818 0.342 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 58.6 mtt85 -101.54 149.57 23.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.7 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.601 HD11 ' HB3' ' A' 1002 ' ' ALA . 38.9 pt -142.78 168.85 13.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.075 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.542 ' OG1' HD11 ' A' ' 977' ' ' ILE . 66.5 p -146.12 147.38 31.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.834 0.349 . . . . 0.0 111.867 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.953 ' HB3' ' HA ' ' A' ' 974' ' ' VAL . 6.5 p90 -145.9 159.29 43.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.8 p -155.23 143.48 20.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.931 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.628 ' H ' HD12 ' A' ' 996' ' ' LEU . 36.8 t -82.01 -179.56 7.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.452 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 38.1 p -60.24 155.06 18.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 112.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 52.2 m -54.82 139.59 39.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.476 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.437 ' O ' HD12 ' A' 1023 ' ' ILE . . . 82.93 -32.41 2.97 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.204 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -82.43 148.67 28.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.812 ' HG2' ' H ' ' A' ' 996' ' ' LEU . 49.2 ttt-85 -81.97 -172.25 3.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.024 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.812 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 5.5 tt -161.77 128.07 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.887 ' HB ' HG12 ' A' 1019 ' ' ILE . 1.7 mp -86.62 144.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.967 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.6 165.18 36.38 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' 1001 ' ' SER . 89.5 m-70 -71.38 137.03 48.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.625 0.213 . . . . 0.0 110.762 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 78.7 p -72.14 39.47 0.07 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.948 0.404 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.474 ' O ' HG21 ' A' 1015 ' ' THR . 36.4 t -160.06 171.44 19.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.98 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.27 134.02 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.4 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -114.05 128.25 56.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.434 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 48.9 t -73.2 85.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' 1014 ' ' SER . 14.7 pt -91.52 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.168 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' 1007 ' ' SER . 0.5 OUTLIER -92.46 128.34 38.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.709 0.29 . . . . 0.0 110.544 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.657 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 46.5 t -162.52 136.75 6.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 66.0 40.37 95.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.381 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.16 21.64 6.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.622 0.249 . . . . 0.0 111.564 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 87.9 m -152.36 133.59 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.818 0.342 . . . . 0.0 111.181 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.551 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.32 134.1 41.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.657 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.1 p80 -153.8 150.86 28.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.765 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.64 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 31.8 m95 -68.14 120.59 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.776 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.537 ' HB2' HD13 ' A' 1005 ' ' ILE . 44.8 t -52.38 -22.58 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.707 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.474 HG21 ' O ' ' A' 1001 ' ' SER . 46.6 p -87.0 132.43 33.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -66.05 156.43 84.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.62 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -46.82 118.32 2.62 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.236 1.958 . . . . 0.0 112.019 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.487 ' HG3' ' CZ ' ' A' ' 988' ' ' TYR . 64.4 Cg_endo -84.62 160.42 12.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.162 2.574 . . . . 0.0 113.169 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.887 HG12 ' HB ' ' A' ' 997' ' ' ILE . 35.2 pt -144.53 -157.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 49.4 t -143.36 171.18 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.309 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.459 ' HA ' ' OE1' ' A' 1021 ' ' GLN . 1.0 OUTLIER -153.51 130.76 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.036 0.446 . . . . 0.0 111.113 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' 1045 ' ' HIS . 77.7 ttt180 -64.37 -17.54 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.527 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 995' ' ' ARG . 61.4 mt 64.21 89.33 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.934 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.62 126.26 21.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.611 2.207 . . . . 0.0 112.931 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 56.1 m -88.43 -145.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.055 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -163.91 155.57 27.01 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.432 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' 1044 ' ' PHE . 8.8 mp -40.92 139.41 1.21 Allowed Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.599 ' HD3' HD21 ' A' 1040 ' ' ASN . 59.6 Cg_endo -71.67 145.37 46.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.882 2.388 . . . . 0.0 112.054 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.507 ' HB2' ' HG3' ' A' 1087 ' ' PRO . 24.0 Cg_endo -61.47 117.19 3.98 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.206 1.938 . . . . 0.0 111.933 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 83.5 m -82.47 121.05 26.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 24.8 pt -86.66 135.55 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.352 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -51.79 138.61 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.482 ' HB3' ' HE2' ' A' 1064 ' ' PHE . 75.3 m-80 75.03 -40.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.172 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -79.16 116.71 4.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' 1053 ' ' ARG . 57.4 m-20 -68.81 -150.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 110.685 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 137.15 13.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.285 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' 1050 ' ' VAL . 34.5 pt -128.87 -161.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.566 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 66.4 m 63.66 159.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.857 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 99.9 m -56.48 130.55 45.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.306 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.599 HD21 ' HD3' ' A' 1028 ' ' PRO . 17.0 t-20 -177.18 -121.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' 1040 ' ' ASN . 21.9 mmt85 75.35 -49.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.606 0.362 . . . . 0.0 111.211 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' 1043 ' ' ASN . 13.5 pt-20 -162.95 -141.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.411 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.422 HD22 ' H ' ' A' 1043 ' ' ASN . 2.9 m120 33.56 43.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.193 0.52 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.562 ' CD2' HD12 ' A' 1027 ' ' LEU . 0.3 OUTLIER -77.89 43.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.882 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.607 ' HB3' ' HD3' ' A' 1022 ' ' ARG . 58.3 m-70 -53.3 -52.49 58.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.565 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 32.2 t80 171.9 160.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.392 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 77.51 -20.97 3.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.061 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' 1046 ' ' TYR . 55.3 m -47.66 142.2 4.74 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.896 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' 1072 ' ' ILE . 11.3 p -137.79 155.43 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.338 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' 1037 ' ' ILE . 9.4 p -149.03 139.27 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.334 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.533 ' O ' HG12 ' A' 1037 ' ' ILE . 96.6 m -102.55 128.99 48.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -73.5 139.95 46.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.526 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' 1035 ' ' ASP . 79.3 ttt180 -146.54 133.07 19.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.03 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.57 ' O ' HD23 ' A' 1056 ' ' LEU . 75.5 m -76.45 158.1 31.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 111.834 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.515 ' HA ' ' OD2' ' A' 1035 ' ' ASP . 24.4 t-20 -65.6 -22.92 66.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.957 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.609 HD13 ' H ' ' A' 1064 ' ' PHE . 4.1 mm? 46.21 43.77 11.53 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-O 120.786 0.326 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 72.81 -53.94 1.68 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 36.3 t -178.83 126.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' 1059 ' ' ARG . 3.0 mmp_? 72.37 -60.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.124 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.44 29.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.086 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.602 ' O ' ' HB3' ' A' 1056 ' ' LEU . 42.1 ttt85 -66.17 132.13 47.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -65.24 109.28 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.515 0.674 . . . . 0.0 111.992 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.591 HG13 ' HD1' ' A' 1064 ' ' PHE . 3.0 p -157.47 -45.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.156 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.609 ' H ' HD13 ' A' 1056 ' ' LEU . 3.1 m-85 -86.11 155.57 20.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.344 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -146.28 121.34 10.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' 1070 ' ' PRO . 30.9 tp -71.9 142.97 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.466 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' 1089 ' ' PRO . 63.7 t -138.33 138.16 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.1 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.8 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -62.42 110.41 3.32 Favored Pre-proline 0 C--O 1.225 -0.186 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.545 ' HB3' HD21 ' A' 1066 ' ' LEU . 74.3 Cg_endo -87.8 -45.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.547 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 83.4 p -94.54 146.86 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 112.009 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.804 HG13 ' HB2' ' A' 1085 ' ' SER . 7.0 tt -149.67 158.39 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.688 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' 1072 ' ' ILE . 0.1 OUTLIER -159.7 171.97 18.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.688 0.28 . . . . 0.0 111.19 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 43.4 t -62.16 -44.22 97.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.243 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 12.4 t 44.16 21.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.668 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.624 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 99.5 p 55.63 141.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.342 0.591 . . . . 0.0 112.483 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 1.012 ' HA ' HG12 ' A' 1083 ' ' ILE . 0.7 OUTLIER -67.05 -98.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.782 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.61 3.03 0.08 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.277 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 7.3 t0 -163.14 -51.01 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.509 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' 1080 ' ' GLN . 1.8 pm0 -174.84 50.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.442 ' HB ' ' CB ' ' A' 1077 ' ' ASN . 45.9 t -134.31 -37.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.954 -0.466 . . . . 0.0 111.867 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' 1076 ' ' SER . . . 73.8 64.79 2.37 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 1.012 HG12 ' HA ' ' A' 1077 ' ' ASN . 20.2 pt -81.98 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.57 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 11.1 m95 -72.43 162.91 28.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.218 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.804 ' HB2' HG13 ' A' 1072 ' ' ILE . 57.6 m -43.58 -41.76 4.73 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.444 ' H ' HD11 ' A' 1072 ' ' ILE . . . 107.43 145.94 12.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.664 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' 1029 ' ' PRO . 68.5 Cg_exo -50.77 149.28 14.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.152 2.568 . . . . 0.0 112.845 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.764 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -171.77 -47.57 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.3 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.764 ' HD2' ' H ' ' A' 1088 ' ' ALA . 20.1 Cg_endo -59.65 149.88 79.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.634 2.223 . . . . 0.0 112.725 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -147.7 149.85 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.757 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 56.4 m -93.73 142.3 27.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.092 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 33.4 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.943 179.582 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . 0.632 ' C ' ' HD2' ' A' ' 961' ' ' LYS . . . . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.689 0.28 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.632 ' HD2' ' C ' ' A' ' 960' ' ' ALA . 3.1 mptp? -146.55 155.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 98.6 p -152.99 129.12 10.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.39 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 964' ' ' LYS . 1.6 p -79.92 30.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.254 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 964' ' ' LYS . 10.0 mmpt? 54.5 138.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.478 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 6.9 t -63.14 121.46 69.35 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.45 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 17.3 Cg_exo -67.25 107.25 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.475 2.117 . . . . 0.0 112.307 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 965' ' ' THR . 28.7 Cg_endo -63.39 136.2 53.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.211 1.941 . . . . 0.0 110.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.8 107.97 0.82 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.765 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 970' ' ' VAL . 73.2 Cg_endo -73.11 -133.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.936 2.424 . . . . 0.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.9 HG22 ' H ' ' A' ' 971' ' ' ASN . 8.5 p -51.95 -148.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.914 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.9 ' H ' HG22 ' A' ' 970' ' ' VAL . 5.1 m120 -65.46 -28.44 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.767 -0.583 . . . . 0.0 110.469 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 970' ' ' VAL . . . -72.33 126.6 11.59 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.234 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 988' ' ' TYR . 65.9 mtt -94.42 143.95 25.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.558 HG21 HD12 ' A' ' 986' ' ' ILE . 4.5 p -92.88 148.36 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 O-C-N 123.361 0.413 . . . . 0.0 111.6 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.16 109.12 16.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.022 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.759 HG13 HG23 ' A' ' 980' ' ' ILE . 72.6 t -65.38 -48.01 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 22.9 mt 64.69 -98.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.602 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.7 p -62.25 -65.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.526 ' O ' HG13 ' A' ' 976' ' ' VAL . 51.7 p-10 -173.33 -148.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.568 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.759 HG23 HG13 ' A' ' 976' ' ' VAL . 21.1 pt -155.95 25.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.2 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 962' ' ' SER . 85.7 mt-30 -78.81 -57.62 3.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.942 0.401 . . . . 0.0 111.272 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.642 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 7.7 p 167.77 156.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 982' ' ' VAL . . . 79.06 -35.87 1.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.669 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.458 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 80.7 p -68.5 -160.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.12 0.486 . . . . 0.0 111.444 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 986' ' ' ILE . 45.4 ttm-85 -156.66 160.64 39.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.085 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.558 HD12 HG21 ' A' ' 974' ' ' VAL . 47.0 pt -142.75 155.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.117 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' 1001 ' ' SER . 82.2 p -142.25 134.32 27.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' 1000 ' ' SER . 4.0 m-85 -83.23 -161.87 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 73.6 m -148.18 -40.47 0.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.77 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 29.1 t 69.42 137.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.835 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -60.27 145.84 45.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.735 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 74.9 m -51.58 134.64 29.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.361 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 74.03 37.54 49.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.247 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.613 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 33.4 m80 -146.96 125.29 12.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.36 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.671 ' HB2' HD11 ' A' 1023 ' ' ILE . 38.2 ttt85 -82.0 96.82 7.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' 1000 ' ' SER . 3.6 pp -63.62 140.42 58.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.643 ' HB ' HG13 ' A' 1019 ' ' ILE . 50.4 mm -107.96 154.69 9.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.22 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.92 14.63 82.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.071 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 63.68 134.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.688 ' HB3' HD22 ' A' ' 996' ' ' LEU . 77.8 p -87.76 46.78 1.42 Allowed 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -162.14 146.8 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.711 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.685 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -165.19 125.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.717 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.412 ' HB2' ' NH1' ' A' ' 985' ' ' ARG . 89.2 tt0 -87.65 130.96 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 43.4 t -74.13 86.57 1.88 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.888 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.496 ' HB ' ' H ' ' A' 1006 ' ' LEU . 2.4 pp -87.28 -146.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' 1010 ' ' THR . 4.6 tt -158.46 129.37 6.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.519 ' N ' HD23 ' A' 1006 ' ' LEU . 47.1 t -80.25 -59.63 2.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.306 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.27 42.8 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.508 ' H ' HD21 ' A' 1006 ' ' LEU . 16.5 p-10 -176.25 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.377 . . . . 0.0 110.395 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.581 ' O ' ' HG ' ' A' 1006 ' ' LEU . 11.8 t -151.29 175.99 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.56 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -74.8 145.71 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.125 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -149.44 145.61 27.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.438 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.427 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 92.9 m95 -76.42 125.41 29.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.362 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.2 p -53.69 -19.91 4.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.092 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.685 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 30.3 p -131.26 135.84 47.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 112.265 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' 1017 ' ' PRO . 14.7 mmmm -69.81 161.96 71.29 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.891 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 80.2 Cg_exo -45.43 132.31 12.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.735 2.29 . . . . 0.0 112.686 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 88.9 Cg_endo -80.51 170.56 15.74 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.997 2.465 . . . . 0.0 113.143 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.643 HG13 ' HB ' ' A' ' 997' ' ' ILE . 25.4 pt -148.83 121.53 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.811 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.764 ' H ' HG11 ' A' ' 970' ' ' VAL . 88.9 m -86.16 118.26 25.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 112.118 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -82.41 126.01 31.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.915 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' 1046 ' ' TYR . 40.9 ttt85 -67.2 -9.37 39.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.256 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.671 HD11 ' HB2' ' A' ' 995' ' ' ARG . 45.9 mt 54.01 56.77 12.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.428 . . . . 0.0 110.445 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.518 ' CB ' ' HA ' ' A' 1045 ' ' HIS . 58.0 Cg_endo -71.6 138.28 31.89 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.273 . . . . 0.0 113.019 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 3.8 p -88.42 -136.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.317 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' 1044 ' ' PHE . . . -148.4 -151.35 5.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.809 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' 1044 ' ' PHE . 70.6 mt -64.73 132.84 95.55 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-O 120.711 0.291 . . . . 0.0 111.567 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.58 149.81 88.18 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 111.092 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.596 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 95.9 Cg_exo -45.47 119.59 2.74 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.287 1.992 . . . . 0.0 112.283 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 81.3 p -81.81 139.9 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.958 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' 1031 ' ' ILE . 45.6 pt -148.45 120.6 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.433 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -73.56 14.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.111 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' 1031 ' ' ILE . 3.5 m120 -80.36 -31.83 37.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.22 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.659 ' HA2' ' ND2' ' A' 1055 ' ' ASN . . . -163.14 -125.2 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.302 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' 1036 ' ' PHE . 53.3 m-20 -156.66 -151.7 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.597 ' HB2' HG13 ' A' 1050 ' ' VAL . 45.9 p90 -155.96 129.65 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 111.945 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.28 78.2 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.986 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 39.6 t -167.39 154.0 8.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 111.492 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.554 ' O ' ' HG3' ' A' 1041 ' ' ARG . 60.7 m -55.8 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' 1041 ' ' ARG . 7.0 m120 52.91 -125.1 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' 1039 ' ' THR . 76.0 mtp180 74.92 -47.34 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.662 0.385 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' 1044 ' ' PHE . 3.9 tm-20 -162.89 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.68 0.276 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -71.63 38.09 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.665 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.596 ' HD1' ' H ' ' A' 1045 ' ' HIS . 0.3 OUTLIER -76.7 -46.82 24.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.596 ' H ' ' HD1' ' A' 1044 ' ' PHE . 24.2 m-70 40.62 -147.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.18 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.722 ' O ' ' HB3' ' A' 1074 ' ' CYS . 14.8 t80 -63.45 -49.18 74.68 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -96.1 121.6 7.01 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.891 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 47.2 t 178.6 122.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.64 0.734 . . . . 0.0 111.344 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' 1072 ' ' ILE . 11.2 p -102.3 157.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.546 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.597 HG13 ' HB2' ' A' 1036 ' ' PHE . 87.4 t -146.81 117.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.951 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' 1036 ' ' PHE . 96.2 m -99.55 109.94 22.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.909 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.475 ' O ' HD22 ' A' 1066 ' ' LEU . 31.4 m-85 -80.98 124.66 29.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.976 0.417 . . . . 0.0 111.684 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' 1054 ' ' CYS . 18.2 tpt85 -97.07 -137.02 0.26 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.643 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.483 ' H ' ' HG3' ' A' 1053 ' ' ARG . 99.1 m -161.43 156.23 23.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 110.512 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.659 ' ND2' ' HA2' ' A' 1034 ' ' GLY . 5.2 m120 -65.85 62.1 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.629 ' HB3' ' HA2' ' A' 1060 ' ' GLY . 3.6 mm? -70.33 135.72 49.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 110.731 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' 1058 ' ' SER . . . -82.74 131.75 10.6 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.864 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' 1057 ' ' GLY . 55.1 m 74.91 -49.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.502 0.321 . . . . 0.0 111.731 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -167.75 -51.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.863 0.363 . . . . 0.0 111.543 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . -172.62 37.8 0.15 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.298 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -66.17 165.82 13.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.38 78.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.277 0.561 . . . . 0.0 111.025 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1064 ' ' PHE . 7.9 m -155.08 95.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.559 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.1 m-85 75.77 139.58 0.07 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.026 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 143.63 31.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.66 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' 1070 ' ' PRO . 47.5 tp -68.47 142.36 55.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' 1089 ' ' PRO . 77.7 t -149.05 132.5 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.867 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 77.42 145.31 2.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.373 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' 1089 ' ' PRO . 16.3 pt-20 18.12 67.83 0.22 Allowed Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 112.689 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.596 ' HA ' HD21 ' A' 1066 ' ' LEU . 13.9 Cg_endo -56.18 -11.56 6.15 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.539 2.159 . . . . 0.0 111.907 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' 1050 ' ' VAL . 79.6 p -156.23 152.05 27.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' 1049 ' ' VAL . 26.3 pt -140.96 -166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.821 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' 1085 ' ' SER . 0.6 OUTLIER -160.09 158.14 29.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.958 0.409 . . . . 0.0 111.359 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.722 ' HB3' ' O ' ' A' 1046 ' ' TYR . 51.5 t -64.63 -42.6 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.97 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.547 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 14.7 t 45.95 -161.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.231 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.836 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 81.2 p -165.38 139.49 4.76 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.579 0.228 . . . . 0.0 111.381 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.921 HD21 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -177.01 -39.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.784 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.721 ' H ' HD22 ' A' 1077 ' ' ASN . 38.7 t70 -82.97 47.22 1.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.196 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.34 -130.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.52 ' HA ' HG23 ' A' 1023 ' ' ILE . 12.0 mp0 -76.96 49.92 0.69 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.648 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 18.4 t -145.9 -46.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.836 ' HA2' ' HA ' ' A' 1076 ' ' SER . . . 77.67 -45.84 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.24 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.921 HG12 HD21 ' A' 1077 ' ' ASN . 6.6 pt 52.58 135.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.449 0.642 . . . . 0.0 111.752 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.443 ' HH2' HD21 ' A' 1040 ' ' ASN . 42.0 m95 -71.92 147.21 47.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.46 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' 1073 ' ' TYR . 80.2 p -48.02 -23.88 0.93 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.795 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.49 140.52 6.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.783 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 12.8 Cg_exo -72.44 47.85 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.528 2.818 . . . . 0.0 113.079 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 64.44 138.99 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.023 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.755 ' HB3' ' HG2' ' A' 1069 ' ' GLU . 97.4 Cg_endo -81.73 -140.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.963 2.442 . . . . 0.0 112.2 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.736 HE21 HD13 ' A' 1092 ' ' ILE . 39.8 tt0 -152.46 153.59 33.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.869 ' O ' HG12 ' A' 1092 ' ' ILE . 90.4 m -80.76 -146.82 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.869 HG12 ' O ' ' A' 1091 ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.651 0.262 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.51 151.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 78.3 p -149.78 149.82 31.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.928 0.394 . . . . 0.0 111.497 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 89.1 m -79.93 147.61 31.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.335 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -63.75 138.2 58.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.898 0.38 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 62.2 m -51.94 125.19 30.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.065 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.691 ' HG2' HG11 ' A' ' 974' ' ' VAL . 56.6 Cg_endo -70.86 127.53 13.84 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.325 2.016 . . . . 0.0 111.824 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.85 139.01 50.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.289 1.992 . . . . 0.0 111.564 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -43.81 115.3 2.01 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 110.847 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.625 ' HG3' ' HD2' ' A' ' 988' ' ' TYR . 45.7 Cg_endo -67.45 149.5 80.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.792 2.328 . . . . 0.0 112.301 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.696 HG13 ' H ' ' A' 1020 ' ' CYS . 0.6 OUTLIER -44.86 102.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.206 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 4.8 m120 74.2 -37.28 0.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.86 -172.82 8.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.57 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 64.6 mtm -154.56 135.12 13.46 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 110.916 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.691 HG11 ' HG2' ' A' ' 966' ' ' PRO . 6.3 p -92.93 149.55 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.418 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 15.4 m170 -119.09 113.76 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.99 HG13 HG23 ' A' ' 980' ' ' ILE . 78.5 t -60.89 -51.64 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.152 0.501 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 33.6 mt 74.93 -33.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.195 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.5 p -138.0 -64.95 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.538 ' HB3' HE21 ' A' ' 981' ' ' GLN . 38.7 t70 -172.47 2.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.99 HG23 HG13 ' A' ' 976' ' ' VAL . 49.8 pt 52.81 72.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.431 0.634 . . . . 0.0 110.893 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' 1004 ' ' CYS . 22.6 pt20 -152.34 174.74 13.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.128 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' 1004 ' ' CYS . 48.4 t -43.38 138.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.337 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 80.54 -44.87 2.99 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.998 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.577 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 53.4 m -68.43 123.21 20.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.976 0.388 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.683 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 74.9 ttt180 -101.43 121.12 41.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.871 HG21 HG22 ' A' ' 980' ' ' ILE . 31.7 pt -93.46 160.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 78.0 p -143.99 132.38 22.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 111.911 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.625 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 3.7 m-85 -84.85 -168.11 2.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 11.1 t -161.59 -47.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.195 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.832 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 3.2 t 70.05 -137.64 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.33 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 158.28 4.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.641 0.734 . . . . 0.0 112.43 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 28.5 m -53.99 114.77 1.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.755 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 147.24 -28.15 1.53 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.591 ' HA ' HG12 ' A' 1023 ' ' ILE . 7.2 m80 -139.07 143.0 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.522 ' CZ ' ' HB2' ' A' 1021 ' ' GLN . 22.8 ptt-85 -80.02 127.34 32.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.143 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 997' ' ' ILE . 3.3 tt -76.13 129.86 37.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.7 mp -104.33 146.68 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.119 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 74.75 169.9 24.28 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.78 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.417 ' ND1' HG21 ' A' 1015 ' ' THR . 24.4 m170 -75.01 125.71 29.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.458 ' O ' ' HD1' ' A' ' 988' ' ' TYR . 79.3 p -64.88 -44.05 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.459 ' HB3' ' NE ' ' A' ' 985' ' ' ARG . 50.5 m -82.72 142.95 31.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.409 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.427 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -161.66 116.4 1.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 37.5 tt0 -85.93 132.51 34.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 43.0 t -69.71 93.52 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.32 -178.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' 1007 ' ' SER . 9.9 tp -158.44 125.5 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.469 ' N ' HD12 ' A' 1006 ' ' LEU . 47.5 t -85.42 -48.91 8.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.278 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 171.84 -48.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.659 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.6 t30 -70.99 -55.19 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.817 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.403 ' C ' HD13 ' A' 1006 ' ' LEU . 87.9 m -151.21 149.05 28.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.492 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.432 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.28 143.96 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -150.71 149.98 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.464 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.428 ' CH2' HD13 ' A' ' 986' ' ' ILE . 52.1 m95 -68.78 132.53 46.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.713 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 78.5 p -52.36 -24.74 8.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.976 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.427 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 75.3 p -131.43 141.17 49.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -56.88 155.45 15.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 17.0 Cg_endo -57.71 118.11 4.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.36 2.04 . . . . 0.0 112.037 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.488 ' HB2' HD21 ' A' ' 996' ' ' LEU . 21.6 Cg_endo -61.48 159.15 32.96 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.545 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 26.4 pt -143.9 127.97 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.622 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.696 ' H ' HG13 ' A' ' 970' ' ' VAL . 50.5 m -88.0 112.79 22.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.052 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.566 ' HG2' HD13 ' A' ' 997' ' ' ILE . 93.0 mm-40 -86.38 145.02 27.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.955 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.587 ' NH2' ' HB3' ' A' 1046 ' ' TYR . 25.8 tpt85 -63.92 128.12 34.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.237 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 994' ' ' HIS . 48.5 mm -65.34 128.25 93.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 72.6 Cg_endo -96.97 139.3 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.738 2.959 . . . . 0.0 113.488 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.761 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 98.0 m -112.94 135.14 54.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.208 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.95 -152.35 4.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.789 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 48.8 mt -83.08 146.17 51.0 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.619 0.247 . . . . 0.0 111.059 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.16 149.8 90.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.324 2.016 . . . . 0.0 111.127 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.726 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 2.5 Cg_endo -46.18 119.66 3.16 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.573 2.182 . . . . 0.0 111.862 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 71.8 p -77.43 145.22 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.44 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' 1031 ' ' ILE . 10.3 tt -149.89 114.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.801 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -56.59 144.57 31.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.531 ' HB3' HD22 ' A' 1055 ' ' ASN . 5.0 m120 75.21 -35.95 0.3 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.501 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.62 178.12 8.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.532 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -156.58 127.32 6.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.79 ' HB2' HG23 ' A' 1050 ' ' VAL . 3.7 p90 -84.34 144.57 28.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 0.0 110.664 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' 1036 ' ' PHE . 42.2 mm -133.66 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.655 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 11.3 t -167.8 -161.18 0.37 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.974 0.416 . . . . 0.0 111.289 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 68.9 p -75.16 -13.4 60.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.279 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.541 ' OD1' ' HB ' ' A' 1050 ' ' VAL . 3.7 m120 -47.42 136.39 9.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.415 ' HB3' ' OE1' ' A' 1042 ' ' GLU . 25.3 mmm180 -154.18 -82.73 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.611 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.5 OUTLIER -163.01 145.16 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' 1042 ' ' GLU . 3.5 m120 70.27 58.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.893 0.377 . . . . 0.0 110.419 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' 1025 ' ' CYS . 2.5 m-85 -76.73 132.46 39.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' 1046 ' ' TYR . 20.4 m80 -90.32 -65.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.619 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.685 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.0 t80 171.91 44.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.548 0.69 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.45 89.2 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.73 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' 1047 ' ' GLY . 77.6 p 172.38 141.66 0.03 OUTLIER 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 111.515 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.967 HG12 ' HB3' ' A' 1073 ' ' TYR . 12.3 m -107.2 -173.53 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.431 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' 1036 ' ' PHE . 7.3 p -153.93 129.57 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.981 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 50.1 m -116.83 110.66 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.473 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 2.2 m-85 -70.58 158.03 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -149.75 -13.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.869 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 65.1 m 66.16 166.02 0.2 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' 1033 ' ' ASN . 19.1 p30 -55.68 -44.64 77.52 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.617 HD12 ' HA2' ' A' 1060 ' ' GLY . 2.8 mm? 38.69 33.32 0.07 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 68.89 -52.63 0.53 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.906 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.566 ' C ' ' HD2' ' A' 1059 ' ' ARG . 70.8 m -161.53 -28.62 0.05 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.321 0.56 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.566 ' HD2' ' C ' ' A' 1058 ' ' SER . 5.6 mpt_? -150.06 -50.58 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.526 0.203 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' 1056 ' ' LEU . . . -174.75 37.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.892 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -70.96 163.15 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' 1062 ' ' LYS . 39.9 ttpt -67.85 70.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.17 0.51 . . . . 0.0 110.934 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' 1063 ' ' VAL . 6.7 m -155.07 89.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.747 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' 1063 ' ' VAL . 77.4 m-85 75.55 145.5 0.08 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.951 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -145.09 143.7 30.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.649 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' 1070 ' ' PRO . 61.7 tp -68.57 135.54 51.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.0 111.314 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' 1089 ' ' PRO . 61.5 t -138.25 123.03 22.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.114 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 71.82 161.3 4.9 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.285 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.609 ' OE2' HD13 ' A' 1072 ' ' ILE . 83.4 tt0 30.37 62.47 0.95 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.916 ' HA ' HD21 ' A' 1066 ' ' LEU . 57.3 Cg_endo -72.68 -24.59 18.25 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.993 1.795 . . . . 0.0 112.302 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' 1050 ' ' VAL . 42.7 m -156.25 137.67 13.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 111.567 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.609 HD13 ' OE2' ' A' 1069 ' ' GLU . 44.6 pt -145.43 -169.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.967 ' HB3' HG12 ' A' 1049 ' ' VAL . 0.6 OUTLIER -162.14 156.89 22.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.051 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.7 t -62.24 148.31 45.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.384 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.42 ' HA ' ' HE1' ' A' 1046 ' ' TYR . 6.5 t -146.04 -7.89 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.743 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.51 ' HB3' ' HA2' ' A' 1082 ' ' GLY . 89.3 p 47.81 54.74 9.49 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.773 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.692 HD21 ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -55.14 -46.23 75.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.86 ' HB2' HG21 ' A' 1081 ' ' VAL . 22.9 m-20 -75.71 -3.1 32.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.301 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.626 ' OD1' ' HG3' ' A' 1080 ' ' GLN . 9.8 t70 65.4 134.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.376 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.626 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 27.6 mt-30 56.87 43.3 25.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.86 HG21 ' HB2' ' A' 1078 ' ' ASP . 24.5 m -148.6 -35.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.253 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.761 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 63.98 41.15 98.73 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.084 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.692 ' HB ' HD21 ' A' 1077 ' ' ASN . 73.7 mt -85.73 136.5 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.837 0.351 . . . . 0.0 111.345 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' 1084 ' ' TRP . 8.1 m95 -76.15 141.12 41.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.704 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 78.9 p -59.78 -61.73 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.898 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.631 ' O ' ' HG3' ' A' 1029 ' ' PRO . . . -71.09 126.67 13.72 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.843 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -88.9 46.34 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.945 2.43 . . . . 0.0 112.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 62.37 130.89 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.519 ' HB2' ' O ' ' A' 1067 ' ' VAL . 86.3 Cg_endo -78.43 -137.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.821 2.347 . . . . 0.0 112.85 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.517 ' H ' ' HB2' ' A' 1089 ' ' PRO . 40.3 tt0 -152.37 140.14 19.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.012 0.435 . . . . 0.0 111.587 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 66.8 m -100.75 130.72 46.82 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.772 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.417 ' CG2' HE21 ' A' 1090 ' ' GLN . 21.5 pt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.053 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.656 ' HB3' HD23 ' A' 1006 ' ' LEU . 17.1 tppt? -84.9 132.62 34.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.987 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.9 p -82.08 133.31 35.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.016 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.748 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 98.9 m -80.52 36.26 0.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.022 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.7 tptt 63.38 133.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 56.5 m -70.9 116.99 51.87 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.321 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.805 ' HG2' HG11 ' A' ' 974' ' ' VAL . 61.2 Cg_endo -72.99 120.68 6.76 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.243 1.962 . . . . 0.0 112.168 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 23.5 Cg_exo -63.98 -61.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.232 1.955 . . . . 0.0 111.299 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 170.65 96.93 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.262 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.616 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 58.0 Cg_exo -53.79 179.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.759 2.306 . . . . 0.0 112.668 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 972' ' ' GLY . 92.9 t -48.92 90.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.796 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.842 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 75.0 m-20 71.22 -26.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.262 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.52 114.2 5.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.415 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.559 ' H ' ' HA ' ' A' ' 990' ' ' CYS . 77.3 mmm -80.84 124.06 28.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.805 HG11 ' HG2' ' A' ' 966' ' ' PRO . 0.3 OUTLIER -92.38 138.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.45 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.411 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 23.3 m170 -122.65 108.96 13.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 986' ' ' ILE . 62.0 t -66.4 98.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.097 0.475 . . . . 0.0 109.832 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.19 -93.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.197 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -68.96 -58.4 4.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 0.0 110.182 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.583 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 54.6 m-20 -164.62 -133.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.191 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.585 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 5.0 pt -155.63 -16.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.254 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.987 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 68.1 mt-30 -73.53 177.36 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.621 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 961' ' ' LYS . 99.9 t -44.28 144.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.25 -38.24 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.295 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 49.2 m -68.51 148.1 51.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.845 0.323 . . . . 0.0 110.373 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 1002 ' ' ALA . 5.3 tmm_? -138.44 127.6 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 111.336 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 976' ' ' VAL . 17.4 pt -96.97 -176.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.095 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' 1001 ' ' SER . 50.5 p -150.14 127.96 11.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.004 0.43 . . . . 0.0 111.605 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.654 ' HB2' ' HA ' ' A' 1000 ' ' SER . 1.4 m-85 -85.18 -176.58 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 69.2 m -161.47 -34.41 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.676 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.559 ' HA ' ' H ' ' A' ' 973' ' ' MET . 43.0 t 68.36 167.14 0.26 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 81.1 p -60.15 -170.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 51.6 m -88.8 129.55 35.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.155 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 72.25 39.56 57.38 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.788 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' 1022 ' ' ARG . 25.8 m80 -146.87 133.24 19.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 995' ' ' ARG . 35.2 ttt85 -98.68 113.74 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.0 111.283 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 1.015 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 4.1 pp -76.14 138.39 40.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.498 . . . . 0.0 111.467 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' 1018 ' ' PRO . 1.7 mp -95.6 153.18 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.632 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.37 23.45 58.63 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.354 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 80.2 m-70 65.58 141.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.679 ' HB3' HD21 ' A' ' 996' ' ' LEU . 86.9 p -86.26 50.3 1.96 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.726 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 23.0 t -161.81 165.96 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.484 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.2 129.56 2.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -104.94 124.6 49.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.031 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 49.1 t -74.6 123.7 25.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 13.0 pt -136.99 150.92 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.658 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.656 HD23 ' HB3' ' A' ' 961' ' ' LYS . 0.4 OUTLIER -98.89 121.82 41.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.009 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.495 ' N ' HD13 ' A' 1006 ' ' LEU . 50.7 m -78.54 -55.5 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.36 37.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.127 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.55 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 0.0 110.33 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 53.2 m -151.26 149.9 29.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.923 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.748 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.1 141.4 43.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.92 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.4 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.5 m-70 -149.45 140.19 22.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.585 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 66.9 m95 -71.81 127.13 31.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.794 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.0 p -52.49 -28.8 21.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.691 ' O ' ' HG2' ' A' 1016 ' ' LYS . 48.2 p -90.64 -24.85 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' 1015 ' ' THR . 15.0 pttp 59.9 152.62 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 123.657 0.598 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.29 105.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.481 2.121 . . . . 0.0 112.157 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.656 ' HB2' ' O ' ' A' ' 997' ' ' ILE . 94.3 Cg_endo -80.14 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.446 HG13 ' HB ' ' A' ' 997' ' ' ILE . 35.4 pt -148.94 -169.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.44 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 15.8 t -153.98 110.82 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.69 ' HG3' ' H ' ' A' 1023 ' ' ILE . 3.2 tp-100 -77.66 134.13 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.401 ' HA ' ' CD2' ' A' ' 994' ' ' HIS . 15.2 ptp180 -76.49 6.36 5.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.452 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.761 HG23 ' HA ' ' A' 1080 ' ' GLN . 57.2 mt 53.29 76.55 0.52 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.665 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' 1045 ' ' HIS . 31.3 Cg_exo -59.39 116.83 3.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.242 1.961 . . . . 0.0 111.759 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 10.0 p -91.11 34.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.829 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 43.97 -142.37 2.61 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.062 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 72.2 mt -106.49 136.35 19.39 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-O 120.619 0.247 . . . . 0.0 111.381 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.428 ' HB3' ' CZ3' ' A' 1084 ' ' TRP . 35.3 Cg_endo -64.34 143.32 82.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.588 2.192 . . . . 0.0 111.714 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.887 ' HG2' ' HA ' ' A' 1087 ' ' PRO . 49.4 Cg_exo -55.3 108.88 0.34 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.255 1.97 . . . . 0.0 112.046 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 54.9 m -93.4 124.68 37.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.583 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' 1034 ' ' GLY . 62.7 mt -85.26 139.32 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.369 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -56.53 -55.39 34.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.245 0.545 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -80.23 -36.45 34.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.933 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.867 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -72.78 121.83 8.04 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.614 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -83.4 -151.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.403 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.475 ' HB2' HG23 ' A' 1050 ' ' VAL . 9.3 p90 -155.93 138.97 15.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' 1053 ' ' ARG . 46.3 mt -122.5 67.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 74.5 m -157.18 -140.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.347 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.478 HG22 ' O ' ' A' 1039 ' ' THR . 11.1 m -119.58 38.63 3.83 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.731 HD21 ' HB ' ' A' 1050 ' ' VAL . 5.1 m120 -80.89 121.32 25.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -156.42 43.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' 1043 ' ' ASN . 37.7 tt0 62.94 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' 1042 ' ' GLU . 73.4 m-80 78.64 52.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' 1045 ' ' HIS . 5.1 m-85 -76.74 -56.75 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.137 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' 1024 ' ' PRO . 21.9 m80 72.62 -44.44 0.59 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.71 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 43.3 t80 171.73 148.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.958 0.409 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 73.6 97.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.754 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' 1047 ' ' GLY . 81.4 p 173.45 156.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 110.979 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' 1072 ' ' ILE . 3.5 p -137.78 155.44 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.967 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.731 ' HB ' HD21 ' A' 1040 ' ' ASN . 13.5 p -143.52 127.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.418 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 89.4 m -104.46 120.21 40.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.224 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.425 ' HD2' HD12 ' A' 1031 ' ' ILE . 13.1 m-85 -83.84 148.01 27.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.642 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.656 ' HD2' HD11 ' A' 1037 ' ' ILE . 44.9 ttt85 -142.77 -27.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.017 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.867 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 11.7 t 67.66 154.99 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -51.19 -93.45 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.601 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' 1064 ' ' PHE . 5.7 mt 61.71 -166.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.226 0.536 . . . . 0.0 111.843 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.544 ' N ' ' N ' ' A' 1061 ' ' ARG . . . 54.28 -121.38 19.52 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.206 -0.906 . . . . 0.0 114.136 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 75.1 p -45.59 -66.43 0.4 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.26 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -87.21 35.62 0.71 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' 1056 ' ' LEU . . . -174.68 -117.68 0.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.563 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.736 ' O ' HG13 ' A' 1063 ' ' VAL . 11.2 tpt180 85.32 108.22 0.05 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.547 0.739 . . . . 0.0 110.103 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' 1062 ' ' LYS . 63.9 tttp 44.65 36.16 1.67 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 122.093 0.949 . . . . 0.0 109.609 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' 1061 ' ' ARG . 31.1 m -104.37 -12.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.591 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.866 ' HB2' HD21 ' A' 1056 ' ' LEU . 70.3 m-85 -156.09 162.99 40.19 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.921 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' 1091 ' ' CYS . 44.7 mt-10 -142.4 131.27 22.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.016 0.436 . . . . 0.0 110.826 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.484 HD11 ' CG ' ' A' 1089 ' ' PRO . 31.0 tp -68.48 147.21 52.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.646 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 58.4 t -138.34 135.46 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.21 -148.03 26.44 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.302 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' 1069 ' ' GLU . 7.0 pm0 -72.1 120.67 81.57 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.476 ' HA ' HD21 ' A' 1066 ' ' LEU . 62.7 Cg_endo -75.84 -25.73 10.31 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.747 2.298 . . . . 0.0 112.395 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 54.3 m -137.57 153.95 49.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.739 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' 1049 ' ' VAL . 36.1 pt -143.01 -169.07 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.098 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' 1085 ' ' SER . 0.4 OUTLIER -160.01 158.26 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.284 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.71 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 10.2 t -62.16 -51.92 65.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.458 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.459 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 15.3 t 45.59 -172.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.974 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.3 p -165.47 143.73 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.681 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -162.82 -45.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.737 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.67 ' H ' ' ND2' ' A' 1077 ' ' ASN . 40.3 t0 -81.12 -146.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.49 ' H ' ' CG ' ' A' 1078 ' ' ASP . 36.3 m-20 -82.04 -137.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.761 ' HA ' HG23 ' A' 1023 ' ' ILE . 73.8 mt-30 -81.0 26.16 0.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' 1079 ' ' ASP . 17.7 t -77.58 -44.25 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.298 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 59.66 63.22 5.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.191 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.546 HG12 HD21 ' A' 1077 ' ' ASN . 34.4 pt -81.93 129.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.462 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.428 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 20.0 m95 -76.53 163.88 26.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.1 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.49 ' HB2' ' CE1' ' A' 1073 ' ' TYR . 43.8 t -48.62 -32.86 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.641 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.51 147.58 12.26 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.033 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.887 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 73.9 Cg_endo -75.38 49.42 2.36 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.988 2.459 . . . . 0.0 112.78 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 63.73 133.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.742 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.484 ' CG ' HD11 ' A' 1066 ' ' LEU . 56.1 Cg_endo -71.65 -149.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.116 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.417 ' H ' ' HB2' ' A' 1089 ' ' PRO . 3.6 mm100 -151.93 117.93 5.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.724 0.297 . . . . 0.0 111.442 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1065 ' ' GLU . 28.1 p -103.11 88.39 3.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.248 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.408 ' HA ' ' HD1' ' A' 1064 ' ' PHE . 27.8 pt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.82 0.343 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.732 ' HG3' HD11 ' A' 1006 ' ' LEU . 71.9 mmtt -79.38 148.78 31.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.1 p -157.86 127.25 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.253 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.86 142.69 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.755 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.82 141.07 58.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.386 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.432 ' OG1' HD13 ' A' ' 980' ' ' ILE . 62.4 m -64.8 130.49 94.82 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 31.5 Cg_exo -59.35 120.51 8.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.188 1.925 . . . . 0.0 111.634 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 46.1 Cg_exo -55.97 -50.24 12.98 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.167 1.911 . . . . 0.0 111.659 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 59.2 t0 174.03 106.96 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.92 155.16 19.09 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.366 2.044 . . . . 0.0 111.232 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.7 ' HB ' ' HA ' ' A' 1019 ' ' ILE . 80.4 t -46.55 106.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.79 0.329 . . . . 0.0 111.445 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.693 HD22 ' HB2' ' A' 1020 ' ' CYS . 73.7 m-20 74.72 -53.98 0.67 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.078 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -79.5 138.34 20.22 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.274 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 86.7 mmm -81.87 -156.65 0.16 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 110.812 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 988' ' ' TYR . 3.3 p -159.29 148.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.441 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.444 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 17.1 m170 -120.15 109.84 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 43.3 t -65.33 105.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.624 HG13 HG23 ' A' ' 987' ' ' THR . 44.7 mm -75.23 -94.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.753 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.7 p -67.93 -65.99 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.492 ' OD1' HG12 ' A' ' 980' ' ' ILE . 46.7 t0 -165.71 -132.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.63 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.54 HG22 ' CH2' ' A' 1013 ' ' TRP . 1.6 pt -155.95 14.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.355 0.597 . . . . 0.0 110.33 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.4 171.24 10.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.353 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 61.9 t -47.51 141.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.646 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.38 -46.95 2.6 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.489 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 151.28 47.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.262 0.531 . . . . 0.0 110.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.878 ' HB3' ' HA ' ' A' 1003 ' ' GLU . 0.0 OUTLIER -138.43 -168.53 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 977' ' ' ILE . 23.6 pt -148.55 -160.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.97 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.624 HG23 HG13 ' A' ' 977' ' ' ILE . 68.5 p -142.03 124.55 15.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 112.028 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.473 ' HA ' HG23 ' A' ' 974' ' ' VAL . 1.3 m-85 -98.89 150.94 21.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.319 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 19.3 m -150.25 138.95 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.261 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.697 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 42.4 t -81.97 154.39 25.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.285 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 992' ' ' THR . 11.0 t -64.87 -139.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.392 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.557 HG23 ' N ' ' A' ' 993' ' ' GLY . 12.8 t -60.94 -142.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.045 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.557 ' N ' HG23 ' A' ' 992' ' ' THR . . . -63.42 75.35 0.04 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 113.971 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.645 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 37.6 m80 -145.94 140.81 27.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.508 HH22 ' HB3' ' A' 1079 ' ' ASP . 41.3 ttm-85 -81.96 118.98 23.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.996 0.427 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 990' ' ' CYS . 5.9 tp -76.2 126.09 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.964 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 996' ' ' LEU . 1.8 mp -107.83 150.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.794 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.58 54.58 4.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.677 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.56 -143.85 0.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.196 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m -160.81 27.27 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.031 0.443 . . . . 0.0 110.152 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 65.9 p -162.17 162.51 28.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.223 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.759 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -153.79 130.65 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.837 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.878 ' HA ' ' HB3' ' A' ' 985' ' ' ARG . 21.1 pt-20 -101.74 129.6 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.946 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.512 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 5.9 t -72.17 128.54 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.334 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.5 pt -145.55 169.36 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.103 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.732 HD11 ' HG3' ' A' ' 961' ' ' LYS . 4.0 mm? -81.57 146.43 30.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.938 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.631 ' HB2' ' HD2' ' A' 1012 ' ' HIS . 71.2 m -159.8 59.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 104.99 51.39 0.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.166 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 58.87 24.97 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 110.399 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 71.4 m -151.32 139.21 19.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.679 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.512 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.33 136.7 40.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.959 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.631 ' HD2' ' HB2' ' A' 1007 ' ' SER . 92.1 m-70 -149.47 141.32 23.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.759 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 70.6 m95 -67.75 123.6 20.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.127 0.489 . . . . 0.0 110.854 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 20.7 m -52.39 -24.44 7.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.947 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 55.2 p -103.65 142.02 35.05 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 61.5 pttt -62.61 149.74 88.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.868 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 120.99 9.16 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.304 2.003 . . . . 0.0 111.7 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.672 ' HB3' HD11 ' A' ' 996' ' ' LEU . 32.7 Cg_exo -59.18 145.29 98.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.829 2.353 . . . . 0.0 112.903 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.7 ' HA ' ' HB ' ' A' ' 970' ' ' VAL . 40.3 pt -140.05 130.4 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.693 ' HB2' HD22 ' A' ' 971' ' ' ASN . 74.2 m -86.35 108.93 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.181 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.419 HE21 ' HA ' ' A' 1021 ' ' GLN . 2.7 tp-100 -81.62 130.49 35.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.524 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -71.65 120.14 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' 1079 ' ' ASP . 77.4 mt -67.24 110.97 6.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.741 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.06 125.22 17.51 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.898 2.399 . . . . 0.0 113.424 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.611 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 66.9 m -95.94 133.11 40.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.087 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -79.87 -154.0 8.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.394 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 138.99 94.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.788 0.328 . . . . 0.0 111.321 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.461 ' HB2' ' OH ' ' A' 1052 ' ' TYR . 51.1 Cg_endo -68.64 148.73 72.75 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.774 2.316 . . . . 0.0 112.048 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.759 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 34.7 Cg_exo -59.15 111.18 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.081 1.854 . . . . 0.0 111.476 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 26.9 p -77.52 122.46 25.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.641 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' 1032 ' ' ALA . 18.4 pt -88.59 29.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.851 0.358 . . . . 0.0 111.855 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 52.87 125.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.495 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' 1032 ' ' ALA . 77.1 m-20 71.43 -26.6 0.17 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.234 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -69.54 124.73 16.09 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.717 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' 1053 ' ' ARG . 1.5 m-20 -76.46 -159.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.657 0.265 . . . . 0.0 110.368 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' 1051 ' ' THR . 45.6 p90 -155.99 137.8 14.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.633 HD11 HH11 ' A' 1053 ' ' ARG . 20.3 mm -128.77 37.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.756 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 78.2 p -69.24 145.48 53.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.615 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 38.2 m -59.42 -38.37 80.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.694 HD22 ' HB3' ' A' 1048 ' ' SER . 23.4 p30 -72.19 -155.44 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.597 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' 1040 ' ' ASN . 18.3 mmt85 -162.2 -54.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.701 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' 1043 ' ' ASN . 42.0 tt0 -162.89 148.73 12.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' 1042 ' ' GLU . 75.4 m-20 78.12 65.2 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.59 134.92 39.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.308 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' 1046 ' ' TYR . 13.1 m80 -96.93 -51.52 4.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.555 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 69.7 t80 171.06 144.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.412 0.445 . . . . 0.0 110.55 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 76.5 -14.54 6.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.221 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.694 ' HB3' HD22 ' A' 1040 ' ' ASN . 65.5 m -47.36 136.15 9.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.033 0.444 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' 1038 ' ' SER . 88.7 t -102.19 146.88 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.224 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.756 ' HA ' ' HB3' ' A' 1038 ' ' SER . 30.8 m -142.57 126.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.398 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' 1036 ' ' PHE . 59.1 m -100.49 108.69 20.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.461 ' OH ' ' HB2' ' A' 1028 ' ' PRO . 21.0 m-85 -77.08 163.13 26.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.307 0.575 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.734 ' HB2' ' HB2' ' A' 1035 ' ' ASP . 75.6 mtp180 -142.76 -138.96 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.655 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.526 ' O ' HD23 ' A' 1056 ' ' LEU . 48.7 t -163.7 145.42 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 111.686 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.1 68.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.243 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.568 ' HA ' HG23 ' A' 1063 ' ' VAL . 3.7 mm? -72.22 41.91 0.09 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 53.37 -106.15 0.39 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.525 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.546 ' HB2' ' HD3' ' A' 1061 ' ' ARG . 66.8 m -67.37 -48.28 67.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' 1059 ' ' ARG . 11.6 tpt180 -165.83 -49.85 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.044 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.515 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -164.38 39.91 0.31 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.752 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.666 ' N ' ' HD2' ' A' 1061 ' ' ARG . 0.7 OUTLIER -83.14 172.76 12.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 110.769 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 58.5 tttm -65.48 79.91 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' 1056 ' ' LEU . 6.9 m -155.14 92.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.637 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.664 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 0.8 OUTLIER 74.27 141.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.695 -178.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.8 mt-10 -137.27 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.064 0.459 . . . . 0.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.617 HD21 ' HB3' ' A' 1070 ' ' PRO . 38.7 tp -68.44 152.09 45.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.156 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' 1089 ' ' PRO . 65.1 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 77.51 -168.37 54.39 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' 1069 ' ' GLU . 15.2 pm0 -72.05 126.85 91.13 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.617 ' HB3' HD21 ' A' 1066 ' ' LEU . 96.8 Cg_endo -82.17 -36.95 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.38 2.053 . . . . 0.0 111.87 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.8 p -83.81 140.87 31.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.179 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' 1049 ' ' VAL . 36.3 pt -147.78 -171.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.899 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.3 p90 -162.26 143.87 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.699 0.285 . . . . 0.0 111.386 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.929 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 52.1 t -66.51 154.15 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.075 0.464 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.2 t -147.59 -144.62 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.106 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.5 t -155.76 137.77 14.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.018 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.599 HD21 HD12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -166.58 31.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.757 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.7 t70 175.84 50.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.255 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.544 ' O ' HD13 ' A' 1023 ' ' ILE . 1.5 m-20 61.88 -125.24 0.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.515 ' HA ' HG23 ' A' 1023 ' ' ILE . 25.3 pt20 -66.01 -140.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.51 0.195 . . . . 0.0 110.71 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' 1080 ' ' GLN . 25.9 t 74.22 -45.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.992 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 66.36 62.61 4.5 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.599 HD12 HD21 ' A' 1077 ' ' ASN . 74.3 mt -80.19 130.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 110.972 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.929 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 26.1 m95 -72.6 177.09 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.0 t -55.52 -64.2 0.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.684 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.57 131.66 1.6 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.628 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.759 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 93.7 Cg_endo -79.72 48.64 2.92 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.828 2.352 . . . . 0.0 111.698 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.689 ' N ' ' HD2' ' A' 1089 ' ' PRO . . . -62.57 -47.34 88.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.34 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' 1088 ' ' ALA . 4.9 Cg_endo -48.45 137.12 25.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.432 2.088 . . . . 0.0 112.112 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.89 132.99 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 15.2 t -102.49 137.79 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.415 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.353 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.645 0.26 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.592 ' O ' HG23 ' A' ' 982' ' ' VAL . 1.0 OUTLIER 55.86 47.11 20.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.439 . . . . 0.0 111.436 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 81.4 p -89.95 132.2 35.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.644 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 73.0 m -79.93 39.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.816 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.4 OUTLIER 60.58 116.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.595 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 51.0 m -59.84 112.81 5.89 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.081 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.497 ' HB2' HG21 ' A' ' 974' ' ' VAL . 27.2 Cg_exo -62.0 113.05 1.7 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.11 1.873 . . . . 0.0 111.761 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 26.5 Cg_endo -62.39 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.203 1.935 . . . . 0.0 111.277 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 967' ' ' PRO . 2.5 p30 176.19 119.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.823 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 37.4 Cg_endo -66.92 149.34 83.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.339 2.026 . . . . 0.0 111.267 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.539 HG12 ' ND2' ' A' ' 971' ' ' ASN . 98.6 t -40.65 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.826 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.567 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 75.6 m-20 75.27 -51.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.662 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.56 -172.37 7.33 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.88 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.823 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 67.3 mtm -156.7 136.29 12.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.675 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.876 ' HB ' HD12 ' A' ' 986' ' ' ILE . 2.6 m -85.27 149.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.475 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 32.8 m170 -114.93 104.0 11.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.75 ' HA ' HG22 ' A' ' 986' ' ' ILE . 59.5 t -70.43 92.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.043 0.449 . . . . 0.0 110.333 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.18 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.881 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 38.0 p -71.53 -68.83 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.343 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 18.6 t70 -165.67 -153.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.353 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.651 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.4 pt -155.94 11.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.618 0.247 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.648 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 25.7 mt-30 -87.22 30.81 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 67.4 t 100.61 143.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.553 0.741 . . . . 0.0 111.762 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.87 -46.22 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.626 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.488 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 57.9 m -68.41 150.79 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.569 ' HD2' ' H ' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -138.4 135.87 35.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.228 0.537 . . . . 0.0 111.113 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.876 HD12 ' HB ' ' A' ' 974' ' ' VAL . 20.1 pt -91.06 -163.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.226 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 45.5 p -146.38 123.72 11.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.004 0.43 . . . . 0.0 111.561 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.647 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.6 OUTLIER -91.86 151.12 20.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.565 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.8 p -155.18 125.7 6.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 61.3 m -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 994' ' ' HIS . 62.5 p 27.94 -143.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.054 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 7.3 t -117.32 -24.72 7.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.396 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -135.5 45.49 1.1 Allowed Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.111 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.402 ' HB2' ' OG1' ' A' ' 991' ' ' THR . 27.5 m80 -139.91 144.92 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.693 0.283 . . . . 0.0 110.589 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' 1079 ' ' ASP . 43.7 ttm-85 -81.97 125.97 31.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.671 HD13 ' OG ' ' A' 1000 ' ' SER . 7.0 tt -76.24 123.14 25.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.695 ' HB ' HG13 ' A' 1019 ' ' ILE . 51.7 mm -86.64 148.42 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.402 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.79 -107.04 2.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.832 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' 1001 ' ' SER . 91.2 m-70 -149.76 133.02 16.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 996' ' ' LEU . 15.6 m -78.43 27.41 0.2 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.522 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 999' ' ' HIS . 81.4 p -162.22 145.77 11.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.451 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.98 132.27 10.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.411 . . . . 0.0 111.435 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -104.95 133.53 49.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.197 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 53.1 t -73.46 129.39 37.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' 1012 ' ' HIS . 38.1 pt -130.49 -167.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.802 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.573 HD13 ' N ' ' A' 1007 ' ' SER . 0.4 OUTLIER -142.95 127.06 17.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.895 0.379 . . . . 0.0 110.79 -179.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.573 ' N ' HD13 ' A' 1006 ' ' LEU . 56.5 p -81.75 -59.4 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.856 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.52 35.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -37.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 110.361 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 27.6 m -149.98 142.73 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.644 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.31 141.18 43.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.226 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.9 p80 -149.68 147.19 27.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.3 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.651 ' HH2' HG22 ' A' ' 980' ' ' ILE . 84.2 m95 -67.19 129.61 40.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 111.021 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.4 p -52.37 -27.16 14.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.865 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 75.9 p -107.99 138.35 44.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -58.23 152.38 42.3 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.5 103.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.381 2.054 . . . . 0.0 112.532 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.1 154.35 72.7 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.993 2.462 . . . . 0.0 111.767 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 997' ' ' ILE . 37.1 pt -135.84 -147.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.403 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 971' ' ' ASN . 23.0 m -143.06 -178.78 6.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -166.86 126.54 1.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -74.3 120.71 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.35 119.51 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.213 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.06 122.45 7.64 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.188 1.926 . . . . 0.0 111.758 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 28.8 m -88.41 134.93 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.591 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 161.79 52.24 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.051 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.567 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 10.4 mt -49.75 138.83 17.01 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 117.018 0.409 . . . . 0.0 111.895 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.497 ' HB3' ' CD2' ' A' 1084 ' ' TRP . 59.2 Cg_endo -70.85 150.31 61.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.893 2.396 . . . . 0.0 111.516 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 83.4 Cg_exo -47.01 126.12 10.89 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.415 2.077 . . . . 0.0 111.985 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.0 p -77.53 126.56 31.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' 1034 ' ' GLY . 6.7 tt -88.59 111.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -67.11 141.77 57.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 68.84 26.93 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.308 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.779 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -175.34 135.06 2.9 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.28 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -74.17 -155.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.572 ' HB2' ' CG1' ' A' 1050 ' ' VAL . 49.0 p90 -156.0 131.89 9.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 111.251 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.546 HG13 ' CZ ' ' A' 1053 ' ' ARG . 47.9 mm -91.3 99.97 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.822 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 44.3 t -171.12 146.58 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.911 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 90.9 m -58.94 -33.61 70.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 44.7 t30 -56.53 128.39 35.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -151.69 -31.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.635 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -147.16 -51.73 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.163 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -71.57 135.71 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.567 ' HE2' ' HG ' ' A' 1027 ' ' LEU . 0.1 OUTLIER -162.21 55.09 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' 1046 ' ' TYR . 12.2 m80 -63.5 -47.9 79.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.196 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' 1045 ' ' HIS . 74.0 t80 172.37 161.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.53 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.9 -24.11 3.47 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 49.7 m -47.59 143.87 3.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 110.92 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -142.47 123.53 11.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.782 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.822 ' HA ' ' HB2' ' A' 1038 ' ' SER . 98.1 t -106.55 129.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.042 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.7 m -99.43 125.05 45.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.632 ' HB2' HD11 ' A' 1066 ' ' LEU . 4.6 m-85 -72.24 146.79 47.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.546 ' CZ ' HG13 ' A' 1037 ' ' ILE . 38.3 ttm180 -146.11 -29.24 0.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.779 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 47.7 t 65.44 160.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.483 ' N ' ' HA2' ' A' 1034 ' ' GLY . 75.1 m-20 -62.13 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.584 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.763 ' HB3' ' HA2' ' A' 1060 ' ' GLY . 23.0 mt -154.94 27.0 0.43 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.285 0.564 . . . . 0.0 110.65 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' 1063 ' ' VAL . . . 53.71 -113.15 2.89 Favored Glycine 0 C--N 1.317 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.859 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 49.3 m -51.44 -50.48 59.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -167.7 -53.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.352 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.763 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . -176.89 38.2 0.09 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.942 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' 1061 ' ' ARG . 34.6 ttm180 -93.86 33.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' 1062 ' ' LYS . 26.2 ttpp 41.09 52.19 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.172 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.722 HG23 ' HD1' ' A' 1064 ' ' PHE . 16.1 m -85.02 -39.27 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.253 0.549 . . . . 0.0 110.728 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.722 ' HD1' HG23 ' A' 1063 ' ' VAL . 2.9 m-85 -85.96 147.76 26.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.066 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -134.44 128.91 34.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 111.658 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' 1067 ' ' VAL . 4.5 tt -68.6 140.31 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.309 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.875 ' N ' HD23 ' A' 1066 ' ' LEU . 78.5 t -135.49 109.51 10.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 111.142 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . 0.558 ' O ' ' HG3' ' A' 1089 ' ' PRO . . . 76.98 156.55 7.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.754 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 38.2 tt0 30.37 77.39 0.32 Allowed Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' 1066 ' ' LEU . 90.0 Cg_endo -86.66 7.39 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.588 2.192 . . . . 0.0 112.473 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 53.1 m -156.23 150.01 24.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.387 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' 1049 ' ' VAL . 15.5 pt -148.0 150.15 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.635 ' HB3' HG23 ' A' 1049 ' ' VAL . 2.8 p90 -160.12 145.67 15.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.601 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.919 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 42.0 t -66.28 144.12 56.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.7 t -144.07 -7.55 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' 1082 ' ' GLY . 57.8 m 66.11 136.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.308 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.518 HD21 ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -172.18 43.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.867 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -170.07 -122.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.453 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' 1081 ' ' VAL . 9.5 t70 -163.09 121.48 2.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.771 0.319 . . . . 0.0 110.757 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.467 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 86.7 mt-30 55.88 42.35 28.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' 1079 ' ' ASP . 21.1 t -147.59 -38.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 110.46 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 76.73 -68.96 2.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.753 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.518 ' HB ' HD21 ' A' 1077 ' ' ASN . 75.5 mt 60.57 130.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.981 0.419 . . . . 0.0 111.202 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.919 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.6 m95 -74.58 -153.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -62.96 -46.84 85.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.501 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . 178.66 -149.05 8.69 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.906 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' 1029 ' ' PRO . 10.4 Cg_exo -71.57 -127.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.387 2.725 . . . . 0.0 112.74 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . -159.33 138.84 8.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 58.5 Cg_endo -68.36 -138.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.505 2.803 . . . . 0.0 113.105 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.452 ' H ' ' HB2' ' A' 1089 ' ' PRO . 40.5 tt0 -152.4 143.51 23.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.177 0.513 . . . . 0.0 111.734 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 42.6 t -103.13 139.38 38.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.573 HD11 HG21 ' A' 1067 ' ' VAL . 11.9 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.127 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.803 0.335 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -77.51 140.97 39.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 83.6 p -155.41 139.85 16.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.464 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.0 m -80.0 140.85 36.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.268 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.93 148.66 49.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.008 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 41.8 m -39.71 119.66 1.37 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.537 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.78 ' HG2' HG11 ' A' ' 974' ' ' VAL . 11.2 Cg_endo -55.03 127.2 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.358 2.039 . . . . 0.0 111.725 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.14 125.14 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.038 1.825 . . . . 0.0 111.37 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.06 120.03 11.17 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.457 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.554 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 77.2 Cg_exo -50.51 140.34 35.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.479 2.119 . . . . 0.0 112.247 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.657 ' HB ' ' H ' ' A' 1020 ' ' CYS . 66.9 t -47.03 110.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.508 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.2 m-20 75.66 -45.91 0.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.581 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -72.62 -156.02 3.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.896 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.554 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 94.9 mmm -158.85 143.3 15.69 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.51 0.324 . . . . 0.0 110.418 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.78 HG11 ' HG2' ' A' ' 966' ' ' PRO . 0.5 OUTLIER -91.61 144.73 8.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.387 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -117.06 107.96 15.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.736 0.303 . . . . 0.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.766 ' HA ' HG22 ' A' ' 986' ' ' ILE . 57.3 t -66.42 119.59 11.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.943 HD11 HG23 ' A' ' 987' ' ' THR . 31.3 mt -84.43 -89.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.802 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 30.9 p -75.25 -69.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.54 ' H ' ' HB2' ' A' ' 984' ' ' SER . 2.6 m-20 -153.13 -147.57 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.95 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.434 HG22 ' CH2' ' A' 1013 ' ' TRP . 12.1 pt -155.95 25.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.705 0.288 . . . . 0.0 111.21 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 71.3 mt-30 -87.26 -55.75 3.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.474 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 981' ' ' GLN . 13.1 t -173.42 140.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 124.142 0.901 . . . . 0.0 109.469 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.24 -20.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.888 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.54 ' HB2' ' H ' ' A' ' 979' ' ' ASP . 81.1 p -68.34 129.15 39.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 48.3 ttm-85 -97.47 156.74 16.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 976' ' ' VAL . 28.2 pt -143.16 136.22 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.943 HG23 HD11 ' A' ' 977' ' ' ILE . 59.4 p -91.0 126.24 36.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.06 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.917 ' HB2' ' HA ' ' A' 1000 ' ' SER . 2.4 m-85 -96.48 146.93 24.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 15.3 t -145.53 169.34 18.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.973 ' HB2' HD12 ' A' ' 996' ' ' LEU . 4.7 t -158.11 107.07 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 992' ' ' THR . 35.6 p 34.73 -150.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.971 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.4 t -117.91 -37.09 3.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.819 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' 1046 ' ' TYR . . . -118.05 48.9 0.9 Allowed Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.275 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -144.71 131.81 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.639 HH21 ' HA ' ' A' 1079 ' ' ASP . 39.1 ttm-85 -82.04 109.88 16.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.703 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.973 HD12 ' HB2' ' A' ' 990' ' ' CYS . 6.6 tt -76.44 113.69 14.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.564 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' 1019 ' ' ILE . 2.0 mp -90.11 91.41 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.922 0.868 . . . . 0.0 110.663 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -161.05 -113.71 0.32 Allowed Glycine 0 C--N 1.315 -0.621 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.023 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' 1000 ' ' SER . 92.8 m-70 -154.19 -10.43 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.917 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 19.4 m 57.58 18.52 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.432 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.603 ' O ' HG21 ' A' 1015 ' ' THR . 79.6 p -162.18 144.39 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.433 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -162.97 153.67 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.779 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' 1003 ' ' GLU . 11.2 pm0 -135.04 135.46 41.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.724 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.421 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 31.6 t -71.41 88.65 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.304 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.411 HG23 ' HG2' ' A' 1003 ' ' GLU . 37.8 pt -87.33 -167.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' 1008 ' ' GLY . 4.0 tt -158.38 121.89 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.417 ' N ' HD23 ' A' 1006 ' ' LEU . 44.3 t -77.51 -48.04 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.74 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.439 ' N ' HD23 ' A' 1006 ' ' LEU . . . 175.83 -45.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.793 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.32 -48.86 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.2 153.3 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.924 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.421 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.32 141.33 43.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.1 p80 -154.92 147.87 24.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.698 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.434 ' CH2' HG22 ' A' ' 980' ' ' ILE . 41.2 m95 -70.76 126.87 30.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 110.531 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 t -52.43 -25.54 10.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.788 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.603 HG21 ' O ' ' A' 1001 ' ' SER . 30.9 p -95.5 138.81 32.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.59 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 24.0 pttm -79.16 163.8 57.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.354 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 11.2 Cg_endo -54.28 120.0 7.28 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.086 1.858 . . . . 0.0 111.405 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.507 ' HB2' HD21 ' A' ' 996' ' ' LEU . 72.3 Cg_endo -76.66 136.22 16.92 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.769 2.313 . . . . 0.0 113.521 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.674 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 30.0 pt -116.37 124.07 72.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.657 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 84.6 m -91.12 121.46 32.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.575 ' HG2' HD13 ' A' ' 997' ' ' ILE . 96.9 mm-40 -86.52 129.92 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.166 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.616 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.01 129.68 40.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.677 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.1 mm -73.93 107.64 3.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.21 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 92.4 Cg_endo -81.4 123.57 4.43 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.297 1.998 . . . . 0.0 112.477 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' 1044 ' ' PHE . 73.3 m -88.64 132.97 34.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.202 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -82.93 -154.61 16.4 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.064 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' 1027 ' ' LEU . 1.7 mm? -72.75 144.9 86.34 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 120.711 0.291 . . . . 0.0 111.519 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.702 ' HG3' HD21 ' A' 1040 ' ' ASN . 27.1 Cg_endo -61.45 166.65 11.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.879 2.386 . . . . 0.0 112.284 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' 1086 ' ' GLY . 81.9 Cg_exo -47.98 -24.35 5.2 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.757 2.305 . . . . 0.0 112.449 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . 0.593 HG23 ' O ' ' A' 1028 ' ' PRO . 46.4 p 56.91 144.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.733 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.78 HD13 ' HB1' ' A' 1088 ' ' ALA . 2.9 pt -152.88 117.97 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -70.11 67.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.148 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' 1034 ' ' GLY . 15.0 p30 -174.25 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.609 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -79.25 -177.18 49.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.367 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' 1053 ' ' ARG . 3.2 m-20 -156.47 132.65 9.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 5.1 p90 -84.02 152.71 24.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.425 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.508 HD13 ' O ' ' A' 1036 ' ' PHE . 39.1 mm -127.71 66.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' 1050 ' ' VAL . 9.6 t -171.08 -141.52 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' 1040 ' ' ASN . 39.7 m -67.57 -103.92 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.72 ' HB2' HG11 ' A' 1050 ' ' VAL . 24.2 t-20 50.1 118.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' 1040 ' ' ASN . 22.0 mmt180 -164.57 -69.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.242 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -156.62 -51.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.188 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' 1043 ' ' ASN . 2.5 m120 -72.87 61.58 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.75 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' 1025 ' ' CYS . 73.1 m-85 -76.72 -58.08 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.314 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.74 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 7.2 m80 55.54 -172.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.53 ' CZ ' ' HA3' ' A' ' 993' ' ' GLY . 34.4 t80 -56.9 142.78 40.11 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.48 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.433 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.47 124.34 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' 1073 ' ' TYR . 38.2 m 178.37 144.55 0.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.374 0.67 . . . . 0.0 110.041 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' 1072 ' ' ILE . 11.2 p -155.83 145.32 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' 1040 ' ' ASN . 27.3 m -149.54 141.88 17.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.638 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.5 m -88.68 124.46 34.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.327 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' A' 1070 ' ' PRO . 11.3 m-85 -85.26 147.95 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.722 0.772 . . . . 0.0 112.789 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' 1035 ' ' ASP . 43.1 ttt85 -148.71 129.75 14.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.29 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 12.8 t -76.44 153.54 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.675 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -49.19 -70.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.02 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.817 HD22 ' HA2' ' A' 1060 ' ' GLY . 4.3 mt 62.37 164.99 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.403 ' C ' ' HG ' ' A' 1058 ' ' SER . . . -82.8 42.25 2.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.394 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' 1059 ' ' ARG . 84.0 p 49.73 29.12 2.99 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.349 . . . . 0.0 111.391 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' 1058 ' ' SER . 0.7 OUTLIER -152.77 -37.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.817 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 98.08 46.36 2.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.702 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' 1061 ' ' ARG . 13.5 tpp85 -76.93 40.2 0.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' 1062 ' ' LYS . 24.7 ttmm 44.17 35.04 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.528 0.68 . . . . 0.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.755 HG23 ' HD1' ' A' 1064 ' ' PHE . 11.3 m -95.9 -10.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.755 ' HD1' HG23 ' A' 1063 ' ' VAL . 88.3 m-85 -153.93 141.48 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.606 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -142.16 119.14 11.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.01 0.433 . . . . 0.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' 1067 ' ' VAL . 5.5 tt -73.42 130.16 39.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.64 ' N ' HD23 ' A' 1066 ' ' LEU . 7.5 p -156.64 73.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.038 0.923 . . . . 0.0 110.88 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . 0.837 ' HA3' ' HA ' ' A' 1089 ' ' PRO . . . -172.64 23.05 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.218 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.729 ' HB3' ' O ' ' A' 1068 ' ' GLY . 7.8 tt0 81.99 104.4 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.629 ' HA ' ' HB2' ' A' 1052 ' ' TYR . 89.0 Cg_endo -82.96 31.64 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.912 2.408 . . . . 0.0 113.229 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.9 p -158.86 134.65 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.561 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' 1049 ' ' VAL . 42.2 pt -140.89 152.31 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.06 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' 1048 ' ' SER . 9.9 p90 -146.77 137.08 23.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.421 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 41.7 t -75.18 148.01 39.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.229 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' 1082 ' ' GLY . 5.2 t -155.07 130.32 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.631 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' 1023 ' ' ILE . 80.9 p -75.66 153.72 37.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.327 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.661 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -165.34 -22.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.661 ' H ' HD22 ' A' 1077 ' ' ASN . 57.9 m-20 -116.46 -128.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.216 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.639 ' HA ' HH21 ' A' ' 995' ' ' ARG . 54.5 m-20 -76.78 -150.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -85.53 29.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.044 0.45 . . . . 0.0 110.495 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 32.4 t -79.97 -35.45 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.489 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.65 ' C ' HD13 ' A' 1083 ' ' ILE . . . 85.09 -48.98 4.15 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.729 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.65 HD13 ' C ' ' A' 1082 ' ' GLY . 0.1 OUTLIER 39.38 118.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.643 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 22.2 m95 -72.23 138.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.507 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 79.8 p -64.46 -54.31 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -72.07 125.51 11.02 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.285 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.13 41.13 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.579 2.186 . . . . 0.0 112.953 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.78 ' HB1' HD13 ' A' 1031 ' ' ILE . . . 60.46 134.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.489 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.837 ' HA ' ' HA3' ' A' 1068 ' ' GLY . 40.4 Cg_endo -68.13 156.74 64.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.226 2.617 . . . . 0.0 113.71 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.637 HE21 HG23 ' A' 1092 ' ' ILE . 60.9 tp60 -104.69 114.73 29.12 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.797 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 48.1 t -97.29 132.15 43.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.327 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.637 HG23 HE21 ' A' 1090 ' ' GLN . 7.0 pt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.422 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.868 0.366 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.561 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 2.6 mppt? -77.63 137.35 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.94 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 86.5 p -82.09 136.29 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.598 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 87.8 m -79.96 34.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 962' ' ' SER . 86.3 tttt 62.73 139.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.71 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.4 m -61.61 124.75 82.55 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.336 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.413 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 17.0 Cg_exo -68.05 118.29 5.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.6 2.2 . . . . 0.0 112.561 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 135.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 111.271 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -48.39 104.28 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.19 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 54.7 Cg_endo -69.15 -151.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.607 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' 1019 ' ' ILE . 45.5 t -52.76 73.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.812 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 969' ' ' PRO . 75.5 m-20 72.57 -35.85 0.34 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.44 130.35 26.18 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.923 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.1 mtp -92.27 145.5 24.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.621 ' CG2' HD12 ' A' ' 986' ' ' ILE . 3.1 p -84.88 151.15 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -114.02 99.33 7.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 980' ' ' ILE . 39.2 t -75.31 85.65 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.75 -92.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.778 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 23.3 p -61.84 -65.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -159.16 -136.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.578 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.559 HG23 HG13 ' A' ' 976' ' ' VAL . 6.5 pt -154.31 -19.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.06 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.94 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 25.2 mt-30 -73.01 175.8 6.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.654 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' 1004 ' ' CYS . 64.2 t -44.29 147.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.832 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.86 -36.82 1.89 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.354 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 43.1 t -68.38 158.86 32.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 0.0 111.092 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.699 ' HE ' ' HB2' ' A' 1003 ' ' GLU . 39.4 ttm180 -145.16 120.75 10.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.8 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.621 HD12 ' CG2' ' A' ' 974' ' ' VAL . 18.8 pt -97.16 -168.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.351 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 73.7 p -153.09 124.09 7.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.0 m-85 -94.76 154.47 17.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.184 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 72.5 p -152.91 127.47 9.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.111 0.482 . . . . 0.0 111.13 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 73.3 m -82.94 148.13 27.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.052 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 26.1 p -62.06 157.65 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.182 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 60.7 m -48.68 138.29 11.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.583 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.543 ' O ' HD12 ' A' 1023 ' ' ILE . . . 95.9 -41.86 2.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.572 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -82.41 133.46 35.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.979 0.389 . . . . 0.0 111.286 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.727 ' HB2' HD11 ' A' 1023 ' ' ILE . 40.5 ttt85 -82.25 120.65 25.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.851 HD21 ' HB3' ' A' 1000 ' ' SER . 7.3 tp -65.97 124.47 22.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.177 0.513 . . . . 0.0 111.804 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' 1019 ' ' ILE . 46.7 mm -107.83 145.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.919 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.45 169.92 30.29 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.458 ' O ' ' HG3' ' A' 1018 ' ' PRO . 88.5 m-70 -74.98 125.56 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 0.0 111.587 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.851 ' HB3' HD21 ' A' ' 996' ' ' LEU . 81.6 p -68.18 -46.8 69.69 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.066 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.6 p -77.93 139.77 39.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.64 127.62 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.282 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.699 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 43.4 tt0 -98.02 132.09 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.709 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 52.9 t -66.7 94.54 0.3 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 22.2 pt -90.07 -155.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.872 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' 1008 ' ' GLY . 2.0 tm? -149.96 124.21 9.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.599 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.467 ' N ' HD13 ' A' 1006 ' ' LEU . 46.1 t -80.53 -48.4 12.82 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.509 ' N ' HD13 ' A' 1006 ' ' LEU . . . -161.44 -54.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.305 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -123.53 -52.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.1 m -88.9 144.34 26.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.29 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.598 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.24 145.02 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.044 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.478 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 93.3 m-70 -149.17 140.69 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.456 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 82.5 m95 -68.12 135.68 52.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 m -52.34 -24.68 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.184 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 53.4 p -132.94 137.59 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 111.817 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -56.51 150.1 36.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.06 117.99 2.16 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.342 2.028 . . . . 0.0 112.521 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.502 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 72.5 Cg_exo -51.06 138.35 43.91 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.693 2.262 . . . . 0.0 112.063 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 997' ' ' ILE . 0.0 OUTLIER -110.08 139.7 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.41 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.686 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 63.0 m -97.68 128.91 44.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.816 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 995' ' ' ARG . 3.1 tp-100 -82.17 125.52 31.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.314 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.4 tpt180 -67.71 -26.36 66.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.727 HD11 ' HB2' ' A' ' 995' ' ' ARG . 49.7 mt 58.24 61.53 5.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.245 0.545 . . . . 0.0 109.678 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.652 ' HA ' ' N ' ' A' 1046 ' ' TYR . 38.1 Cg_endo -65.68 138.49 54.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.13 2.553 . . . . 0.0 114.008 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.491 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 38.5 m -88.43 141.23 28.71 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.744 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.19 -153.36 4.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.143 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.95 155.51 91.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.113 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.657 ' O ' HG23 ' A' 1030 ' ' THR . 31.2 Cg_exo -58.01 154.48 38.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.265 . . . . 0.0 111.879 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.547 ' HD2' ' OH ' ' A' 1052 ' ' TYR . 55.3 Cg_exo -51.13 -17.3 3.55 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.435 2.09 . . . . 0.0 112.274 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . 0.657 HG23 ' O ' ' A' 1028 ' ' PRO . 73.8 p 49.08 94.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.663 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' 1031 ' ' ILE . 29.5 pt -84.1 104.3 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . 43.03 -139.36 0.21 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -79.64 41.74 0.5 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.44 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.68 -141.43 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.361 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' 1036 ' ' PHE . 19.6 t70 -168.03 -159.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.32 . . . . 0.0 110.795 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.73 ' CD1' HG23 ' A' 1050 ' ' VAL . 1.4 t80 -156.0 125.82 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.221 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' 1036 ' ' PHE . 4.3 mp -143.98 70.46 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.148 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 40.4 t -159.63 -119.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' 1040 ' ' ASN . 65.3 p -140.5 111.73 7.19 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.832 0.348 . . . . 0.0 111.917 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.503 ' HB2' ' CE2' ' A' 1044 ' ' PHE . 19.7 p30 165.31 130.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.062 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' 1043 ' ' ASN . 84.0 mtm180 -153.17 117.25 4.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.745 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.564 ' N ' ' HE1' ' A' 1044 ' ' PHE . 0.5 OUTLIER 53.1 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.551 179.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' 1041 ' ' ARG . 72.1 m-20 -70.37 65.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.13 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.643 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 1.9 m-85 -76.79 135.69 38.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.335 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.525 ' HA ' ' CB ' ' A' 1024 ' ' PRO . 52.0 m-70 -141.91 -165.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.553 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.652 ' N ' ' HA ' ' A' 1024 ' ' PRO . 10.5 t80 -58.02 139.25 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.414 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 64.87 111.18 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.453 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' 1073 ' ' TYR . 79.6 p 176.54 128.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.265 0.555 . . . . 0.0 110.521 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' 1073 ' ' TYR . 97.4 t -102.16 147.04 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.965 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.73 HG23 ' CD1' ' A' 1036 ' ' PHE . 12.3 p -138.46 126.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.927 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' 1037 ' ' ILE . 87.9 m -101.04 117.32 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 111.559 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.547 ' OH ' ' HD2' ' A' 1029 ' ' PRO . 4.8 m-85 -83.94 134.71 34.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.186 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.464 ' O ' ' HE2' ' A' 1062 ' ' LYS . 50.9 mtp85 -148.19 25.02 1.02 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.812 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.57 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 57.9 m 58.78 150.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' 1056 ' ' LEU . 13.5 t-20 -68.29 39.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.576 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.585 ' HA ' ' HA ' ' A' 1062 ' ' LYS . 0.4 OUTLIER 27.59 50.56 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.681 ' HA2' ' HE1' ' A' 1064 ' ' PHE . . . 73.7 -40.02 0.95 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.269 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 47.0 t -169.87 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.906 0.353 . . . . 0.0 111.274 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.643 ' N ' ' HD3' ' A' 1059 ' ' ARG . 0.0 OUTLIER -163.0 -28.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.451 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' 1056 ' ' LEU . . . -151.02 149.39 21.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.837 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' 1056 ' ' LEU . 44.5 ttm-85 71.61 116.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' 1056 ' ' LEU . 40.1 ttmt -72.99 146.0 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 28.5 m -143.87 -22.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 4.7 m-85 -73.82 -26.36 60.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.72 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' 1062 ' ' LYS . 58.5 mm-40 61.39 111.66 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.751 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.781 HD22 ' H ' ' A' 1067 ' ' VAL . 3.2 tm? -71.23 149.48 46.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.323 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.781 ' H ' HD22 ' A' 1066 ' ' LEU . 21.3 t -129.56 138.57 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.95 -153.94 42.55 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.536 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.545 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.0 pt-20 -72.11 113.46 20.69 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-O 120.504 0.192 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' A' 1051 ' ' THR . 93.2 Cg_endo -84.67 24.41 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.274 1.982 . . . . 0.0 112.929 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' 1050 ' ' VAL . 40.4 t -158.87 142.11 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 111.678 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.503 HG12 ' HE1' ' A' 1052 ' ' TYR . 42.2 pt -141.92 -177.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.482 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.799 ' HB3' HG22 ' A' 1049 ' ' VAL . 2.3 p90 -160.21 151.09 18.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 32.3 t -62.14 149.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.611 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 -27.44 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.646 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 58.3 m 58.78 54.3 5.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.702 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -63.84 -43.04 97.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.173 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.702 ' H ' HD22 ' A' 1077 ' ' ASN . 33.2 m-20 -74.15 -82.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.395 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' 1081 ' ' VAL . 2.2 p30 -163.18 -135.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.026 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.529 ' HA ' HG23 ' A' 1023 ' ' ILE . 64.5 mt-30 -68.34 12.17 0.14 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' 1079 ' ' ASP . 14.0 t -68.04 -43.56 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.311 0.577 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . 82.57 42.06 8.65 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.471 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 62.7 mt -82.02 142.3 13.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.668 0.271 . . . . 0.0 110.295 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.47 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 28.4 m95 -70.5 -163.97 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.358 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.458 ' OG ' ' HB ' ' A' 1072 ' ' ILE . 81.6 p -65.02 -63.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 177.86 127.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.224 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.41 140.62 70.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.518 2.145 . . . . 0.0 111.537 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.709 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -165.69 -50.88 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.611 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.709 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.4 Cg_endo -52.36 145.55 35.71 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.395 2.063 . . . . 0.0 111.76 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -152.37 136.8 16.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.662 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 94.7 m -91.9 123.15 35.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.015 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.662 -179.308 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.889 0.376 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.674 ' HA ' ' HE3' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -77.58 134.01 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.113 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 25.1 m -154.4 135.0 13.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 92.8 m -79.92 136.62 36.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -63.78 138.68 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.458 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 7.1 t -57.44 122.65 56.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.842 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.871 ' HG2' HG11 ' A' ' 974' ' ' VAL . 42.4 Cg_endo -66.95 107.62 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.384 2.056 . . . . 0.0 111.98 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 965' ' ' THR . 26.4 Cg_exo -61.69 134.6 51.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.549 2.166 . . . . 0.0 111.694 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -53.26 106.97 0.73 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.777 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 97.4 Cg_endo -82.34 -150.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.534 2.156 . . . . 0.0 112.903 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 970' ' ' VAL . 1.4 p -48.94 83.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.52 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 969' ' ' PRO . 76.6 m-20 69.83 -28.37 0.17 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.73 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.4 147.27 46.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.444 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 63.4 mtm -143.19 131.8 22.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 110.413 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.991 HG21 HD12 ' A' ' 986' ' ' ILE . 3.3 p -87.4 154.03 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.366 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -114.7 100.02 7.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.774 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 986' ' ' ILE . 35.6 t -65.73 106.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.6 mt -75.27 -94.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 22.0 p -72.44 -56.35 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 0.0 110.144 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 976' ' ' VAL . 5.7 p-10 -165.75 -131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.563 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.517 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 1.8 pt -153.59 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.017 0.437 . . . . 0.0 111.113 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 19.8 mt-30 -87.33 -176.44 5.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.69 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 97.8 t -48.57 139.99 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.251 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.17 1.55 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 92.1 p -67.92 130.31 42.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.899 0.849 . . . . 0.0 111.127 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.716 ' HG2' ' HB3' ' A' 1003 ' ' GLU . 99.1 mtt180 -101.58 163.63 12.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.991 HD12 HG21 ' A' ' 974' ' ' VAL . 26.0 pt -150.68 139.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.083 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' 1000 ' ' SER . 81.1 p -102.95 122.25 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -92.33 155.51 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.263 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 996' ' ' LEU . 16.6 m -160.3 122.6 3.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.38 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.73 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 94.4 m -82.25 68.16 8.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 992' ' ' THR . 33.7 p 45.95 -155.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.479 . . . . 0.0 111.864 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 993' ' ' GLY . 13.6 t -97.4 -45.39 6.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.211 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 992' ' ' THR . . . -93.17 43.73 2.53 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.419 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' 1022 ' ' ARG . 56.1 m-70 -157.53 135.21 10.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.651 ' HG3' ' HG3' ' A' 1080 ' ' GLN . 77.7 ttt180 -82.19 129.68 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.7 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 4.0 tt -75.01 100.18 4.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.443 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.684 ' HB ' HG23 ' A' 1019 ' ' ILE . 26.6 mm -87.35 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.126 0.965 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -156.52 -118.55 0.58 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.291 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -153.08 109.92 3.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -57.2 -54.64 44.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.174 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.5 p -77.86 137.23 38.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.475 ' HB3' ' HE1' ' A' ' 988' ' ' TYR . . . -157.94 150.06 22.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.716 ' HB3' ' HG2' ' A' ' 985' ' ' ARG . 10.1 pt-20 -135.11 132.02 37.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.601 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 44.2 t -66.68 93.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.33 -168.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 11.0 tp -158.36 120.94 3.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 25.4 m -81.51 -55.17 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.085 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 164.57 47.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -175.61 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.08 0.467 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 82.3 m -151.35 146.7 26.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.018 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.601 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -72.94 135.92 45.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.437 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.45 145.05 26.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.703 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.517 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 58.9 m95 -69.68 128.2 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -52.47 -26.2 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 64.2 p -86.93 130.87 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.776 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.72 155.63 81.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.874 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 81.3 Cg_exo -41.42 112.44 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.154 1.902 . . . . 0.0 111.905 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.458 ' HG3' ' CD2' ' A' ' 988' ' ' TYR . 51.0 Cg_endo -69.9 129.1 16.88 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.928 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.684 HG23 ' HB ' ' A' ' 997' ' ' ILE . 8.1 tt -116.62 147.24 20.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.558 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.559 ' HB2' HG22 ' A' ' 970' ' ' VAL . 72.1 m -106.88 156.83 18.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.15 124.1 6.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.985 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.722 ' HD3' ' HB3' ' A' 1046 ' ' TYR . 40.6 ttm180 -59.43 132.71 54.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.839 HD13 ' HA ' ' A' 1080 ' ' GLN . 68.1 mt -73.15 122.4 87.54 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.426 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' 1045 ' ' HIS . 96.2 Cg_endo -84.95 130.79 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.861 2.374 . . . . 0.0 112.532 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.512 ' HB3' ' NE1' ' A' 1084 ' ' TRP . 22.5 m -88.39 32.33 0.78 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.525 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' 1044 ' ' PHE . . . 40.18 -130.69 2.77 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.287 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.921 HD12 ' HD2' ' A' 1028 ' ' PRO . 24.1 tp -121.94 126.56 26.3 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.921 ' HD2' HD12 ' A' 1027 ' ' LEU . 26.2 Cg_endo -61.42 156.26 47.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.824 2.349 . . . . 0.0 112.42 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.833 ' HG3' ' HA ' ' A' 1087 ' ' PRO . 19.2 Cg_endo -58.67 126.1 20.25 Favored 'Trans proline' 0 CA--C 1.518 -0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 112.036 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 17.9 m -93.27 151.19 19.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.016 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' 1034 ' ' GLY . 11.1 pt -142.57 134.58 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.261 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -67.86 163.99 20.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.514 ' HB3' ' SG ' ' A' 1054 ' ' CYS . 6.6 m120 76.8 -41.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.452 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -168.28 136.54 4.14 Favored Glycine 0 CA--C 1.507 -0.455 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.444 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.488 ' HB3' HG13 ' A' 1031 ' ' ILE . 2.8 p30 -171.17 142.71 1.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.069 0.462 . . . . 0.0 112.034 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 12.3 t80 60.4 115.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.349 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.625 HD12 ' HD3' ' A' 1053 ' ' ARG . 38.2 mt -152.09 60.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.143 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.767 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 22.9 t -163.78 -137.09 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.032 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' 1040 ' ' ASN . 85.9 m -111.64 128.09 55.95 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' 1039 ' ' THR . 26.4 t-20 174.87 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.451 ' HG3' HH11 ' A' 1041 ' ' ARG . 52.7 mtt85 58.84 67.67 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.239 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.701 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 47.9 mt-10 58.87 -169.85 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' 1042 ' ' GLU . 2.6 m120 76.62 -70.3 0.14 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.969 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.701 ' CE2' ' HA ' ' A' 1042 ' ' GLU . 7.6 m-85 52.66 47.27 25.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.97 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' 1024 ' ' PRO . 27.3 m80 -62.63 -51.5 67.05 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.039 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.787 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 62.4 t80 173.24 139.07 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 72.29 92.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.414 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.4 p 172.15 130.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' 1050 ' ' VAL . 11.3 p -102.25 156.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.997 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.767 ' HA ' ' HB3' ' A' 1038 ' ' SER . 18.8 m -149.15 130.13 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 40.2 m -89.93 110.42 21.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.437 ' CE1' HD11 ' A' 1072 ' ' ILE . 15.8 m-85 -85.22 135.79 33.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.453 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 1.01 ' HA ' HD22 ' A' 1066 ' ' LEU . 41.2 mtp85 -146.28 -143.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.235 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.931 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 32.6 t -163.66 135.3 4.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -65.81 97.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.483 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.734 ' HG ' ' HA2' ' A' 1060 ' ' GLY . 0.0 OUTLIER -80.76 43.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.784 179.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.506 ' N ' ' HB ' ' A' 1063 ' ' VAL . . . 79.1 -62.48 4.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.296 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' 1059 ' ' ARG . 69.2 m -167.29 93.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.242 0.521 . . . . 0.0 111.686 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' 1059 ' ' ARG . 39.5 mmt-85 72.54 -42.24 0.53 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.734 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . 174.57 39.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.531 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' 1061 ' ' ARG . 35.9 ttm180 -83.96 32.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 42.47 83.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.607 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' 1056 ' ' LEU . 6.0 t -149.99 89.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.629 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 29.8 m-85 71.21 90.35 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -90.74 136.26 33.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 1.01 HD22 ' HA ' ' A' 1053 ' ' ARG . 47.5 tp -68.35 155.96 38.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.607 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' 1089 ' ' PRO . 72.5 t -142.62 139.82 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.926 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 86.0 -158.91 32.26 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.417 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.7 pt-20 -64.08 111.15 4.84 Favored Pre-proline 0 CA--C 1.528 0.107 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.587 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 94.8 Cg_endo -90.79 23.07 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.885 2.39 . . . . 0.0 113.152 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.4 p -157.64 143.79 17.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.437 HD11 ' CE1' ' A' 1052 ' ' TYR . 44.2 pt -148.16 171.12 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.137 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.5 p90 -161.67 145.3 12.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.787 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 4.2 t -66.04 144.98 56.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.907 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.4 t -144.41 -151.41 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.231 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.408 ' OG ' HD12 ' A' 1023 ' ' ILE . 44.9 t -161.29 131.34 4.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.016 0.436 . . . . 0.0 111.563 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.582 HD21 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER 178.96 -146.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.115 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 63.3 t0 52.48 -87.63 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' 1077 ' ' ASN . 11.6 p-10 -163.13 51.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.151 0.501 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.839 ' HA ' HD13 ' A' 1023 ' ' ILE . 3.5 mm100 65.42 41.24 4.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 25.4 t -94.05 -40.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' 1025 ' ' CYS . . . 86.28 47.15 5.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.238 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.582 HG12 HD21 ' A' 1077 ' ' ASN . 35.6 pt -81.97 135.1 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.578 ' HZ2' ' HB3' ' A' 1044 ' ' PHE . 26.3 m95 -70.64 147.27 49.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.1 t -40.36 -36.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.581 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.94 150.05 16.43 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.442 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.833 ' HA ' ' HG3' ' A' 1029 ' ' PRO . 31.5 Cg_endo -63.01 157.54 48.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.884 2.389 . . . . 0.0 112.336 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.431 ' H ' ' CG ' ' A' 1029 ' ' PRO . . . -62.62 144.91 95.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.109 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.568 ' HB2' ' O ' ' A' 1067 ' ' VAL . 56.5 Cg_endo -68.0 -144.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.784 2.322 . . . . 0.0 112.271 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.455 HE21 ' HB2' ' A' 1090 ' ' GLN . 0.1 OUTLIER -152.41 136.33 16.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.064 0.459 . . . . 0.0 111.702 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 50.7 t -98.37 132.97 43.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 26.2 pt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.117 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.581 0.229 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' A' 1011 ' ' ALA . 15.3 tppt? 66.3 149.19 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.5 p -156.44 129.8 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.285 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' 1011 ' ' ALA . 2.0 p -84.63 35.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.893 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 963' ' ' CYS . 58.0 tptt 56.63 129.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.709 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 85.6 m -61.56 122.4 70.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.409 ' HB2' HG21 ' A' ' 974' ' ' VAL . 38.1 Cg_exo -57.73 110.24 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.287 1.991 . . . . 0.0 112.519 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.85 139.55 24.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.559 2.173 . . . . 0.0 111.47 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 11.7 p-10 -49.42 107.25 0.74 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 971' ' ' ASN . 6.3 Cg_exo -78.87 -146.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.064 2.509 . . . . 0.0 111.938 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.878 HG21 HG13 ' A' 1019 ' ' ILE . 64.4 t -49.1 81.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.434 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 991' ' ' THR . 22.0 p30 42.72 27.77 0.11 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.148 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.613 ' HA2' ' SG ' ' A' ' 990' ' ' CYS . . . -83.01 -161.11 30.23 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.858 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 45.4 ttm -159.17 114.55 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.629 ' CG2' HD12 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.9 144.22 9.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.284 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -119.75 91.72 3.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.148 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.674 ' HA ' HG22 ' A' ' 986' ' ' ILE . 64.0 t -66.47 103.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.179 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.2 mt -84.14 -92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 41.2 p -84.14 62.84 7.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 111.819 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.92 -153.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.706 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.47 HG22 ' HH2' ' A' 1013 ' ' TRP . 21.5 pt -155.81 26.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.945 0.403 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.629 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 22.6 pt20 -87.34 28.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.061 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 70.8 t 100.43 142.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 111.34 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 70.71 -7.46 5.2 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.234 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 34.9 m -68.33 160.05 30.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.273 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 985' ' ' ARG . 55.9 ttp85 -143.13 109.4 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.227 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 976' ' ' VAL . 27.2 pt -96.77 -174.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 65.9 p -149.43 131.3 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.709 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.4 m-85 -96.23 165.08 12.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.0 p -149.75 -40.56 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 111.408 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.613 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 12.8 t 71.26 177.99 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.893 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 971' ' ' ASN . 22.2 p -62.98 -161.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.321 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 993' ' ' GLY . 11.8 t -94.7 -44.94 7.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.145 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 992' ' ' THR . . . -94.62 39.05 2.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.411 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.66 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 45.3 m80 -149.08 132.76 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.952 0.376 . . . . 0.0 110.681 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' 1021 ' ' GLN . 79.1 ttt180 -82.01 123.4 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 997' ' ' ILE . 8.4 tp -71.25 132.16 44.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.712 HG13 ' HG2' ' A' 1021 ' ' GLN . 17.6 mm -132.13 62.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.628 0.728 . . . . 0.0 110.792 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . -154.27 33.51 0.71 Allowed Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.122 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 59.11 4.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 81.7 p 43.65 31.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.07 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.413 ' O ' HG21 ' A' 1015 ' ' THR . 83.2 p -162.23 151.12 15.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.528 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -158.04 128.94 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.335 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.81 127.22 47.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.812 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -77.48 82.29 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.611 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' 1014 ' ' SER . 46.3 pt -87.21 -152.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.535 ' C ' HD13 ' A' 1006 ' ' LEU . 3.0 tm? -141.9 121.12 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.588 ' HB2' ' HD2' ' A' 1012 ' ' HIS . 45.5 m -93.42 -39.14 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.486 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.522 ' O ' HD11 ' A' 1006 ' ' LEU . . . -169.05 -126.27 0.84 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.084 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -68.38 8.2 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.224 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' 1008 ' ' GLY . 99.3 m -151.87 145.28 24.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 963' ' ' CYS . . . -75.31 147.95 39.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.588 ' HD2' ' HB2' ' A' 1007 ' ' SER . 92.3 m-70 -149.43 149.92 31.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 111.539 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.47 ' HH2' HG22 ' A' ' 980' ' ' ILE . 60.8 m95 -81.11 117.25 21.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.197 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.61 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.1 p -53.35 -25.52 15.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.413 HG21 ' O ' ' A' 1001 ' ' SER . 82.2 p -86.93 141.81 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -65.72 150.1 96.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.371 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.31 115.32 2.11 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.124 1.883 . . . . 0.0 111.883 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.61 ' HG2' ' CE2' ' A' ' 988' ' ' TYR . 31.1 Cg_exo -61.12 140.5 89.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.913 2.409 . . . . 0.0 112.873 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.878 HG13 HG21 ' A' ' 970' ' ' VAL . 5.2 tt -129.78 136.48 58.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.725 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 64.6 m -97.25 126.08 42.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.541 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.712 ' HG2' HG13 ' A' ' 997' ' ' ILE . 99.1 mm-40 -75.77 124.34 27.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.62 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.81 -12.49 59.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' 1080 ' ' GLN . 53.5 mt 56.28 70.82 1.34 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 109.939 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' 1045 ' ' HIS . 9.4 Cg_endo -51.44 132.47 40.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.117 2.545 . . . . 0.0 113.519 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.705 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 3.0 m -86.43 -146.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . 0.526 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -153.24 -155.44 7.15 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.19 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' 1028 ' ' PRO . 75.4 mt -68.36 143.88 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.714 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.447 ' CG ' HG21 ' A' 1050 ' ' VAL . 20.5 Cg_exo -64.72 147.55 89.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 111.472 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.876 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 83.7 Cg_exo -47.34 113.38 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 112.213 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 68.5 p -77.6 140.45 39.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.495 HD13 ' HB1' ' A' 1088 ' ' ALA . 29.2 pt -151.32 31.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.559 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 52.04 117.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.376 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 1032 ' ' ALA . 75.6 m-20 74.74 -25.97 0.2 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.362 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' 1032 ' ' ALA . . . -70.7 68.77 0.76 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.702 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' 1036 ' ' PHE . 1.5 m-20 -68.75 -150.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.133 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.806 ' HB3' HG13 ' A' 1050 ' ' VAL . 12.3 p90 -155.99 141.6 17.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.559 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' 1037 ' ' ILE . 42.6 mm -92.62 63.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 69.2 m -159.98 -159.13 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 111.707 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 64.9 m -83.59 -92.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.553 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.61 ' OD1' ' HB3' ' A' 1048 ' ' SER . 73.3 m-80 54.06 -138.89 1.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 61.88 109.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' 1043 ' ' ASN . 16.6 pt-20 38.42 41.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.842 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' 1042 ' ' GLU . 72.3 m-80 -167.74 116.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.481 ' CE1' ' HA2' ' A' 1026 ' ' GLY . 0.8 OUTLIER -163.39 143.66 8.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' 1024 ' ' PRO . 16.9 m-70 -140.82 -58.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.449 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.715 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 48.3 t80 175.22 47.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.43 -25.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.032 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.61 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 63.3 m -47.62 147.69 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.262 0.554 . . . . 0.0 111.962 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.932 HG22 ' HB3' ' A' 1073 ' ' TYR . 69.2 t -137.62 145.98 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.124 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.806 HG13 ' HB3' ' A' 1036 ' ' PHE . 3.4 t -133.38 120.38 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.026 0.441 . . . . 0.0 112.183 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 76.7 m -100.23 119.44 38.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.196 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.559 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 26.5 m-85 -74.5 145.54 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.442 0.639 . . . . 0.0 112.431 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -150.99 -30.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.03 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . . . . . . . . . 9.6 t 70.31 142.68 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.115 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.442 ' O ' ' HE2' ' A' 1064 ' ' PHE . 12.6 t-20 -65.06 129.02 38.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.855 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.53 HD13 ' CZ ' ' A' 1064 ' ' PHE . 1.8 mm? -73.48 43.26 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.835 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 56.27 48.17 76.87 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' 1059 ' ' ARG . 45.6 t 58.02 39.23 26.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' 1058 ' ' SER . 23.9 mmm180 -157.54 -128.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.871 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -149.76 -26.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -57.74 147.6 27.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -65.2 133.02 50.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.973 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' 1063 ' ' VAL . 10.8 p -155.07 27.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.446 0.641 . . . . 0.0 111.137 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.53 ' CZ ' HD13 ' A' 1056 ' ' LEU . 0.4 OUTLIER -168.77 -175.3 2.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.672 -179.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . 0.553 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 72.4 mt-10 -150.11 122.39 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 110.592 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.676 HD21 ' HB3' ' A' 1070 ' ' PRO . 53.7 tp -68.56 119.67 13.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.698 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 85.0 t -101.62 86.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 62.1 -163.08 26.38 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.961 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' 1089 ' ' PRO . 29.9 tp10 30.25 58.43 0.89 Allowed Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.491 0.716 . . . . 0.0 112.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.676 ' HB3' HD21 ' A' 1066 ' ' LEU . 83.4 Cg_endo -80.75 2.76 8.3 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.473 2.115 . . . . 0.0 113.186 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 51.1 m -156.27 144.69 19.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' 1050 ' ' VAL . 19.5 pt -146.39 157.25 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.932 ' HB3' HG22 ' A' 1049 ' ' VAL . 0.3 OUTLIER -160.1 147.91 16.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.715 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 50.8 t -62.18 133.17 54.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.083 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 8.2 t -144.51 -20.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' 1079 ' ' ASP . 57.9 m 58.82 59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.469 HD22 ' N ' ' A' 1077 ' ' ASN . 0.0 OUTLIER -72.96 31.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.708 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' 1076 ' ' SER . 64.3 t0 179.43 53.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' 1076 ' ' SER . 59.3 m-20 62.15 -127.65 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.196 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.741 ' OE1' HG23 ' A' 1081 ' ' VAL . 0.0 OUTLIER -66.19 -140.17 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 121.369 -0.133 . . . . 0.0 111.194 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.741 HG23 ' OE1' ' A' 1080 ' ' GLN . 33.4 t 75.74 -44.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.705 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 78.26 46.86 8.71 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.762 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.458 ' HB ' ' ND2' ' A' 1077 ' ' ASN . 69.1 mt -82.0 130.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.829 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.412 ' HB3' ' H ' ' A' 1085 ' ' SER . 15.3 m95 -72.87 -150.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.412 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -74.19 -41.68 61.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -178.06 153.24 12.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.506 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' 1069 ' ' GLU . 89.2 Cg_exo -46.41 153.82 1.05 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.876 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . -62.54 143.61 96.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.872 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.559 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 51.9 Cg_endo -67.72 -143.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.96 2.44 . . . . 0.0 112.181 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.698 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.5 mm100 -135.46 125.0 25.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.975 0.417 . . . . 0.0 111.74 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 43.0 t -85.78 66.91 9.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.593 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.553 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 34.6 pt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.559 0.218 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER 61.88 145.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 50.3 m -153.74 132.48 12.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.054 0.454 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.439 ' HB3' ' C ' ' A' 1011 ' ' ALA . 14.5 p -79.89 140.54 36.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.677 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 1.1 tpmt? -63.73 146.29 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.267 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.619 ' H ' ' HE2' ' A' ' 964' ' ' LYS . 93.0 m -46.39 128.31 7.86 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.348 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.533 ' HD3' ' CZ2' ' A' 1013 ' ' TRP . 38.7 Cg_endo -66.65 130.94 24.64 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.18 1.92 . . . . 0.0 111.601 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.47 124.63 12.35 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.977 1.785 . . . . 0.0 111.428 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 32.2 m-20 -47.32 122.95 8.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.691 ' HB3' ' HB2' ' A' 1018 ' ' PRO . 6.6 Cg_endo -50.43 153.46 7.39 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 112.22 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.764 ' HB ' ' H ' ' A' 1020 ' ' CYS . 23.3 t -41.96 117.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.633 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.562 ' ND2' HG12 ' A' ' 970' ' ' VAL . 23.8 p30 41.91 46.3 3.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.938 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.611 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -159.11 133.7 3.48 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.736 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 22.3 ptp -97.66 150.37 21.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.977 0.418 . . . . 0.0 111.849 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 19.3 m -92.88 -157.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.409 ' N ' HG23 ' A' ' 974' ' ' VAL . 97.9 m-70 -157.8 100.58 1.76 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.28 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 980' ' ' ILE . 70.6 t -69.89 111.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.032 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 987' ' ' THR . 35.5 mt -84.93 -81.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.06 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 23.6 p -67.98 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.912 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.643 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.4 m-20 -163.26 17.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.587 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 979' ' ' ASP . 20.1 pt 52.1 28.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.269 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.34 160.08 18.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.386 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' 1004 ' ' CYS . 86.3 t -44.44 142.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.174 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.96 -33.8 1.93 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.134 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.604 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 49.4 m -68.48 177.38 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.878 0.339 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' 1002 ' ' ALA . 48.2 ttp85 -156.78 132.2 9.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.118 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.513 HG21 HG22 ' A' ' 980' ' ' ILE . 36.6 pt -96.56 -159.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 977' ' ' ILE . 40.6 p -152.17 128.38 10.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.631 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.857 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.1 OUTLIER -93.92 167.01 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 52.7 p -145.46 -43.39 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.611 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 36.3 t 74.05 164.88 0.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.061 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 992' ' ' THR . 11.3 t -60.77 -141.22 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.406 0.622 . . . . 0.0 112.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.597 HG23 ' N ' ' A' ' 993' ' ' GLY . 13.4 t -61.24 -137.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.82 -178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.597 ' N ' HG23 ' A' ' 992' ' ' THR . . . -70.6 30.39 0.48 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.573 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 17.1 m80 -83.34 129.14 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.473 0.637 . . . . 0.0 109.976 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.649 HH22 ' HB3' ' A' 1079 ' ' ASP . 33.1 ttm180 -81.9 91.59 6.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' A' 1000 ' ' SER . 2.4 pp -61.51 137.53 58.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.371 0.605 . . . . 0.0 110.71 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 998' ' ' GLY . 41.2 mm -100.13 160.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.785 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.4 12.49 81.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.709 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 84.3 m-70 71.02 138.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.884 ' HB3' HD21 ' A' ' 996' ' ' LEU . 83.5 p -80.53 41.15 0.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.808 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 13.1 t -162.13 159.67 26.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.19 132.51 3.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.602 ' HG3' HG23 ' A' 1005 ' ' ILE . 16.7 pt-20 -100.05 126.24 46.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.656 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 49.9 t -74.84 81.66 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.602 HG23 ' HG3' ' A' 1003 ' ' GLU . 46.1 pt -87.3 -157.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' 1009 ' ' ASN . 5.4 tt -158.43 124.36 4.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.481 ' N ' HD23 ' A' 1006 ' ' LEU . 50.1 m -77.56 -54.1 6.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.218 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.43 ' N ' HD23 ' A' 1006 ' ' LEU . . . 167.84 43.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.652 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.538 ' H ' HD21 ' A' 1006 ' ' LEU . 48.6 t30 -177.86 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 59.1 m -151.22 154.59 37.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.201 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.479 ' HB2' HG22 ' A' ' 982' ' ' VAL . . . -74.42 135.81 42.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.253 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.41 146.39 27.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.538 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 21.7 m95 -76.17 118.03 18.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.787 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.567 ' HB3' HD13 ' A' 1005 ' ' ILE . 90.4 p -52.95 -21.35 4.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.126 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 37.9 p -86.93 134.29 33.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.046 0.45 . . . . 0.0 111.771 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.19 152.36 88.32 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.3 125.56 7.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.691 ' HB2' ' HB3' ' A' ' 969' ' ' PRO . 96.7 Cg_endo -77.33 149.87 28.2 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.012 2.474 . . . . 0.0 113.459 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.621 HG22 HG23 ' A' ' 970' ' ' VAL . 32.7 pt -148.79 121.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.863 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.853 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 82.9 m -81.8 127.15 32.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.304 0.573 . . . . 0.0 112.196 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -84.33 129.48 34.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.145 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.686 ' NH1' ' HB3' ' A' 1046 ' ' TYR . 21.3 tpt85 -67.65 -10.29 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.582 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.656 HG23 ' NE2' ' A' 1080 ' ' GLN . 56.6 mt 51.74 64.59 7.56 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.607 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' 1045 ' ' HIS . 52.0 Cg_exo -53.72 124.12 15.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.542 2.161 . . . . 0.0 112.81 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.87 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 33.0 m -88.47 153.41 21.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.14 140.47 25.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.46 ' HA ' ' HZ ' ' A' 1044 ' ' PHE . 68.5 mt -41.57 142.01 1.09 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.977 0.389 . . . . 0.0 111.243 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.461 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 17.9 Cg_endo -57.68 140.21 92.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.083 1.855 . . . . 0.0 110.455 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.457 ' HD2' HD12 ' A' 1072 ' ' ILE . 99.5 Cg_exo -38.03 127.95 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.142 1.895 . . . . 0.0 111.493 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 70.2 p -76.62 137.35 39.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' 1091 ' ' CYS . 5.8 tt -147.46 107.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.574 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -64.43 143.41 57.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.173 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.651 ' HA ' ' ND2' ' A' 1055 ' ' ASN . 4.7 m120 76.76 -40.92 0.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.394 0.434 . . . . 0.0 111.264 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -74.76 72.64 1.52 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.672 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -68.81 133.44 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 111.076 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.595 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 22.4 p90 -84.01 150.68 25.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.246 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' 1037 ' ' ILE . 33.4 mm -110.32 58.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.513 ' H ' ' HD1' ' A' 1036 ' ' PHE . 68.6 m -162.89 -154.54 0.3 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.082 0.467 . . . . 0.0 111.869 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' 1038 ' ' SER . 41.7 p -86.1 -129.85 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.192 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.48 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 4.7 m120 59.65 44.91 13.76 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' 1041 ' ' ARG . 62.2 mtt-85 -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.543 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 63.29 37.28 11.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.588 HD22 ' N ' ' A' 1043 ' ' ASN . 0.0 OUTLIER -179.5 128.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.923 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' 1025 ' ' CYS . 5.5 p90 -163.27 -41.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.625 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' 1046 ' ' TYR . 90.1 m-70 72.65 -36.58 0.36 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.686 ' HB3' ' NH1' ' A' 1022 ' ' ARG . 25.1 t80 170.63 148.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.422 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.59 94.36 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.827 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.438 ' HB3' ' ND2' ' A' 1040 ' ' ASN . 29.2 m 178.0 143.56 0.1 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.938 0.495 . . . . 0.0 109.966 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' 1073 ' ' TYR . 12.3 p -138.21 161.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.289 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' 1036 ' ' PHE . 29.5 m -146.42 137.08 18.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 34.9 m -102.21 120.24 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.977 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.576 ' CE2' HG21 ' A' 1031 ' ' ILE . 2.9 m-85 -72.83 156.23 39.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' 1054 ' ' CYS . 78.4 ttt180 -154.53 -30.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.59 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.622 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 54.4 m 68.59 146.35 0.05 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.077 0.465 . . . . 0.0 111.046 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.7 ' O ' ' HG ' ' A' 1056 ' ' LEU . 75.9 m-20 -54.7 162.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.983 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' 1055 ' ' ASN . 3.3 mt -154.98 162.32 41.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.82 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.587 ' H ' ' HB3' ' A' 1061 ' ' ARG . . . -82.09 41.79 2.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.562 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 12.8 t 57.27 18.96 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -167.66 46.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.281 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.556 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 53.39 33.56 46.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.317 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.587 ' HB3' ' H ' ' A' 1057 ' ' GLY . 78.4 ttt180 -71.41 142.2 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 110.978 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.33 102.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.042 0.449 . . . . 0.0 110.413 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.69 HG22 ' HD1' ' A' 1064 ' ' PHE . 3.4 p -155.7 87.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.806 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.69 ' HD1' HG22 ' A' 1063 ' ' VAL . 80.5 m-85 70.84 139.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.757 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -134.26 134.91 42.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.883 0.373 . . . . 0.0 111.659 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.714 HD21 ' HA ' ' A' 1070 ' ' PRO . 17.0 tp -68.54 149.55 49.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 60.0 t -150.19 147.24 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.27 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 90.43 -50.13 3.25 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' 1089 ' ' PRO . 22.0 pt-20 -167.89 130.94 1.35 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 117.72 0.76 . . . . 0.0 112.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.714 ' HA ' HD21 ' A' 1066 ' ' LEU . 94.9 Cg_endo -98.53 8.83 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.512 2.808 . . . . 0.0 113.698 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 60.3 m -156.9 142.75 17.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' 1049 ' ' VAL . 19.6 pt -149.37 147.13 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.996 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' 1049 ' ' VAL . 1.9 p90 -153.47 149.32 27.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.5 t -65.06 150.7 47.65 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.0 t -140.1 -25.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.529 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 43.5 t 59.06 51.13 7.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.738 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.803 ' ND2' ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -67.32 -59.05 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.473 -179.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.803 ' H ' ' ND2' ' A' 1077 ' ' ASN . 1.6 m-20 -81.52 58.8 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 111.087 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.649 ' HB3' HH22 ' A' ' 995' ' ' ARG . 1.5 m-20 63.85 -132.07 0.38 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.071 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.656 ' NE2' HG23 ' A' 1023 ' ' ILE . 3.0 mm100 -64.33 -144.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.561 0.22 . . . . 0.0 110.525 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 21.8 t 72.59 -36.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.87 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 66.28 55.42 18.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.758 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.78 ' HB ' HD21 ' A' 1077 ' ' ASN . 74.4 mt -81.95 132.93 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.48 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 10.0 m95 -84.17 165.31 18.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.19 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 86.9 p -53.77 -31.72 49.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.526 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.65 148.97 14.15 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.3 -154.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.742 2.295 . . . . 0.0 112.689 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' 1089 ' ' PRO . . . -77.03 136.83 65.79 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.142 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.533 ' HG3' ' HG3' ' A' 1069 ' ' GLU . 3.1 Cg_exo -74.99 -134.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.237 2.624 . . . . 0.0 111.205 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.675 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -145.12 115.9 7.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.827 ' HB2' HD11 ' A' 1031 ' ' ILE . 22.0 t -97.37 63.98 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.099 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.299 -179.083 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.736 0.303 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 66.36 131.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.746 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.81 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 79.6 p -157.96 141.4 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.758 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.478 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 85.3 m -80.2 32.31 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.6 tptt 60.95 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.304 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.9 m -56.73 130.32 77.72 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.293 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.567 ' HB2' HG11 ' A' ' 974' ' ' VAL . 31.9 Cg_exo -58.57 120.88 9.04 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.4 Cg_endo -76.69 66.75 7.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.838 2.359 . . . . 0.0 111.949 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 967' ' ' PRO . 17.6 m-20 22.38 83.33 0.12 Allowed Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.675 0.609 . . . . 0.0 111.56 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.586 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 83.6 Cg_exo -42.69 148.67 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.139 2.56 . . . . 0.0 112.761 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 76.8 t -46.98 122.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.226 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.851 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 2.2 m120 71.92 -70.51 0.16 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.736 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 989' ' ' SER . . . -75.65 128.73 9.87 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.798 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 973' ' ' MET . 1.8 mpt? -84.35 155.7 22.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.645 0.26 . . . . 0.0 110.332 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.6 ' CG2' HD12 ' A' ' 986' ' ' ILE . 1.3 p -89.93 148.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.721 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 19.6 m170 -117.49 96.55 5.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.493 HG13 HG23 ' A' ' 980' ' ' ILE . 60.8 t -71.17 81.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.339 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.29 -78.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.371 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.7 p -68.41 -77.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.45 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 52.2 m-20 -165.7 149.57 8.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.072 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.532 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 16.8 pt -84.11 -20.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.176 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.81 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 26.3 mt-30 -72.46 157.91 36.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.459 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' 1006 ' ' LEU . 9.0 p -44.24 144.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.191 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.84 43.97 21.12 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.166 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 66.9 m -168.36 129.73 1.34 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 32.0 ttm-85 -101.61 128.38 47.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.897 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.6 HD12 ' CG2' ' A' ' 974' ' ' VAL . 29.3 pt -97.15 -164.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.229 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 66.7 p -150.29 127.96 11.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.569 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.586 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 2.8 m-85 -99.49 163.14 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.538 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.613 ' O ' ' HA3' ' A' ' 972' ' ' GLY . 22.7 t -145.53 -156.92 0.75 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.004 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 23.4 m -158.06 157.89 33.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.592 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 992' ' ' THR . 17.9 p -68.64 -151.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.772 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.443 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.0 t -85.4 132.58 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.07 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.78 91.62 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.765 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.591 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 13.8 m80 -142.12 129.46 21.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 111.508 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.511 ' NH1' HD13 ' A' ' 997' ' ' ILE . 6.6 ptm180 -95.91 135.86 37.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.407 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' 1018 ' ' PRO . 4.6 tt -76.18 132.18 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.936 0.398 . . . . 0.0 111.653 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.886 ' HB ' HG13 ' A' 1019 ' ' ILE . 44.2 mm -97.85 144.04 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.331 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.79 43.81 Favored Glycine 0 C--N 1.328 0.116 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.1 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.13 132.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.611 ' CB ' HD13 ' A' ' 996' ' ' LEU . 79.6 p -90.85 38.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.0 p -162.15 145.7 11.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -158.41 130.98 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.182 0.515 . . . . 0.0 111.396 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 86.8 tt0 -105.0 132.49 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.528 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -70.93 127.08 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.103 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.81 152.24 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' 1007 ' ' SER . 0.2 OUTLIER -85.62 141.04 30.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.431 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.636 ' N ' HD13 ' A' 1006 ' ' LEU . 48.0 t -155.17 131.54 10.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 65.66 -82.4 0.08 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.316 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -157.77 16.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.004 0.43 . . . . 0.0 110.331 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.5 m -151.84 142.37 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.095 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.478 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.22 141.86 43.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.449 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.0 m-70 -149.57 141.63 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.573 ' HB2' ' HA ' ' A' 1016 ' ' LYS . 89.5 m95 -66.65 132.65 48.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.3 t -52.48 -21.53 3.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 71.7 p -131.47 -14.19 3.31 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.514 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.621 ' HZ3' ' HD2' ' A' 1017 ' ' PRO . 2.0 mmmp? 66.69 148.33 0.11 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.632 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.621 ' HD2' ' HZ3' ' A' 1016 ' ' LYS . 79.7 Cg_exo -45.21 104.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.56 2.173 . . . . 0.0 112.283 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.631 ' HB2' HD21 ' A' ' 996' ' ' LEU . 12.6 Cg_exo -71.34 -144.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.127 2.551 . . . . 0.0 112.957 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.886 HG13 ' HB ' ' A' ' 997' ' ' ILE . 21.4 pt -149.75 -159.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.201 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.851 ' HB3' ' HB2' ' A' ' 971' ' ' ASN . 8.6 t -153.59 111.7 3.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.979 0.418 . . . . 0.0 110.465 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.428 ' HB2' ' CG1' ' A' ' 997' ' ' ILE . 3.1 tp-100 -81.62 132.93 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.152 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.8 ' HE ' ' HB3' ' A' 1045 ' ' HIS . 17.1 ttp-105 -66.84 128.48 36.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.331 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' 1046 ' ' TYR . 33.1 mm -53.76 107.71 0.93 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.31 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' 1045 ' ' HIS . 86.4 Cg_endo -86.93 126.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.733 2.289 . . . . 0.0 113.953 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' 1044 ' ' PHE . 26.2 p -108.17 127.85 54.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.922 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.36 -154.77 7.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.44 155.27 68.46 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 122.245 0.218 . . . . 0.0 111.139 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 9.2 Cg_endo -50.35 140.8 33.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.683 2.255 . . . . 0.0 111.627 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' 1030 ' ' THR . 33.8 Cg_exo -57.73 -9.1 5.05 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.606 2.204 . . . . 0.0 112.86 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . 0.49 HG22 ' O ' ' A' 1029 ' ' PRO . 13.5 t 47.08 176.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' 1090 ' ' GLN . 28.3 pt -152.08 30.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.605 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 54.64 123.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.403 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-80 74.87 -36.84 0.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -76.09 121.05 6.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.38 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.543 ' CG ' ' HA ' ' A' 1055 ' ' ASN . 61.0 m-20 -75.4 -159.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.582 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.869 ' HB2' HG21 ' A' 1050 ' ' VAL . 21.4 p90 -156.03 142.13 18.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.358 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 43.4 mm -123.68 109.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.691 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.69 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 97.6 p -171.07 151.5 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 88.4 m -60.58 -39.41 87.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.656 HD22 ' HE2' ' A' 1044 ' ' PHE . 1.9 p-10 -61.54 143.56 55.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.348 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.36 -36.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.01 -44.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.031 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -73.39 59.11 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.656 ' HE2' HD22 ' A' 1040 ' ' ASN . 64.1 m-85 -76.66 -57.11 4.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.747 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.8 ' HB3' ' HE ' ' A' 1022 ' ' ARG . 64.4 m170 66.9 -67.66 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.885 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' 1045 ' ' HIS . 33.8 t80 173.96 35.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.536 0.684 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' 1048 ' ' SER . . . -160.48 98.81 0.17 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.135 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 26.2 m 177.35 153.39 0.25 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.366 0.603 . . . . 0.0 111.054 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.835 HG22 ' HB3' ' A' 1073 ' ' TYR . 76.5 t -137.82 144.12 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.166 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.869 HG21 ' HB2' ' A' 1036 ' ' PHE . 15.0 p -135.86 147.87 28.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' 1070 ' ' PRO . 88.2 m -118.54 125.88 50.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.757 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.45 149.37 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' 1053 ' ' ARG . 35.7 ttt85 -152.9 25.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.56 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 64.6 m 57.69 153.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.543 ' HA ' ' CG ' ' A' 1035 ' ' ASP . 28.3 t-20 -65.91 -57.27 8.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.41 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.974 HD22 ' HA2' ' A' 1060 ' ' GLY . 2.9 mt 66.17 159.61 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.493 ' HA3' ' NH2' ' A' 1061 ' ' ARG . . . -81.92 -33.9 25.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.175 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.7 p -153.86 62.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.745 0.272 . . . . 0.0 111.171 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.593 ' O ' HD13 ' A' 1056 ' ' LEU . 35.1 mmt180 77.83 -40.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.819 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.974 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 178.62 127.82 1.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.731 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.493 ' NH2' ' HA3' ' A' 1057 ' ' GLY . 40.3 ptt180 -172.74 41.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 0.0 110.634 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt 44.32 71.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.56 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.776 HG23 ' HD2' ' A' 1064 ' ' PHE . 23.9 m -142.68 -7.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.78 0.8 . . . . 0.0 110.116 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.776 ' HD2' HG23 ' A' 1063 ' ' VAL . 70.6 m-85 -155.73 140.79 17.38 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.682 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -143.33 121.22 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 0.0 111.291 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.612 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 36.3 tp -71.86 153.96 41.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.808 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' 1089 ' ' PRO . 85.2 t -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.237 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 83.17 -157.7 35.41 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.723 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.565 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.9 pt-20 -64.41 118.77 50.48 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-O 120.769 0.318 . . . . 0.0 111.474 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.612 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 56.8 Cg_endo -96.26 27.21 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.092 2.528 . . . . 0.0 113.564 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' 1050 ' ' VAL . 58.6 m -156.18 142.06 18.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 112.036 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' 1049 ' ' VAL . 31.2 pt -144.93 174.78 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.766 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.835 ' HB3' HG22 ' A' 1049 ' ' VAL . 6.2 p90 -155.27 148.0 24.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.996 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 60.4 m -63.26 125.25 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.347 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' 1085 ' ' SER . 11.4 t -157.84 145.78 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.516 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 79.3 p -74.6 149.13 40.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.35 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.83 HD21 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -164.55 -42.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.751 ' H ' HD22 ' A' 1077 ' ' ASN . 38.1 t70 -83.05 -80.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.978 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.12 -130.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.311 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -59.58 -34.44 72.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 110.808 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' 1081 ' ' VAL . 2.6 t -59.02 -53.2 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.15 0.5 . . . . 0.0 110.989 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.51 ' O ' HG12 ' A' 1083 ' ' ILE . . . 77.55 -44.51 2.25 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.63 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.83 HG12 HD21 ' A' 1077 ' ' ASN . 17.1 pt 46.28 -163.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.445 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 36.2 m95 -85.26 -163.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.908 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.423 ' HA ' ' CG2' ' A' 1075 ' ' THR . 76.7 p -67.48 -65.1 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.984 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . 178.21 131.84 1.62 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.596 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 16.5 Cg_exo -68.52 143.05 55.81 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.729 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -168.02 -49.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.729 ' HD2' ' H ' ' A' 1088 ' ' ALA . 11.9 Cg_endo -55.65 148.91 51.82 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.333 2.022 . . . . 0.0 112.149 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.632 ' HA ' HD12 ' A' 1031 ' ' ILE . 37.7 tt0 -152.36 133.47 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 41.5 t -92.63 141.3 28.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.104 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.614 ' HD2' HD21 ' A' 1006 ' ' LEU . 28.5 mttm -77.6 142.09 39.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 77.9 p -157.28 141.07 15.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.059 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 71.4 m -79.93 134.02 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.594 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.75 140.57 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 97.4 m -53.52 120.31 21.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.143 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 42.9 Cg_exo -57.94 112.6 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.342 2.028 . . . . 0.0 112.656 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.68 134.38 32.55 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.575 2.183 . . . . 0.0 111.013 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -48.48 106.81 0.65 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.903 0.382 . . . . 0.0 111.216 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 72.9 Cg_endo -75.33 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.591 2.194 . . . . 0.0 112.295 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' 1020 ' ' CYS . 95.6 t -49.01 85.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 969' ' ' PRO . 71.2 m-80 44.68 63.8 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.896 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.851 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -157.04 124.97 1.5 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.783 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 37.8 ttp -97.75 134.49 40.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.698 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.723 HG21 HD12 ' A' ' 986' ' ' ILE . 3.9 p -93.69 151.32 3.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -116.79 106.82 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.376 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 986' ' ' ILE . 22.0 t -65.44 113.3 2.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 986' ' ' ILE . 46.5 mm -80.38 -91.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.312 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 41.3 p -80.68 -58.63 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.834 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' A' ' 984' ' ' SER . 30.0 m-20 -164.58 -154.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.751 HG22 ' HH2' ' A' 1013 ' ' TRP . 14.2 pt -155.89 25.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.737 0.303 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 962' ' ' SER . 87.1 mt-30 -87.33 -56.26 3.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.351 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 981' ' ' GLN . 21.6 t -173.1 141.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.24 1.016 . . . . 0.0 109.412 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.42 -34.82 0.97 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.573 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 979' ' ' ASP . 50.3 m -68.41 126.85 30.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.416 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -101.39 -179.63 4.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.391 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.723 HD12 HG21 ' A' ' 974' ' ' VAL . 20.3 pt -154.01 171.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.616 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' 1001 ' ' SER . 77.8 p -141.71 129.56 21.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.317 . . . . 0.0 111.47 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.706 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.4 m-85 -83.27 -164.46 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 75.5 p -153.83 -46.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.397 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.851 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 42.7 t 71.96 150.76 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.868 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -62.42 152.0 35.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.811 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 54.4 m -58.06 137.51 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.482 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 75.63 35.5 46.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.267 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.602 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 30.6 m80 -147.0 132.49 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.65 ' NH1' HG12 ' A' ' 997' ' ' ILE . 50.8 ttt-85 -81.58 117.47 21.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.43 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 988' ' ' TYR . 5.7 tt -76.05 111.83 11.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.457 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.736 ' HB ' HG13 ' A' 1019 ' ' ILE . 18.3 mt -99.47 59.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.528 0.68 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . -154.32 20.3 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.787 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 57.07 17.58 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.604 0.24 . . . . 0.0 111.122 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.613 ' H ' HD22 ' A' ' 996' ' ' LEU . 83.2 p 36.99 39.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 18.0 t -162.14 161.86 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.637 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.28 126.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' 1013 ' ' TRP . 43.5 tt0 -105.0 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.1 t -73.19 81.3 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' 1014 ' ' SER . 44.3 pt -86.87 -172.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.359 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.614 HD21 ' HD2' ' A' ' 961' ' ' LYS . 10.8 tp -158.36 124.42 4.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.47 . . . . 0.0 111.919 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.435 ' N ' HD12 ' A' 1006 ' ' LEU . 45.7 t -83.67 -45.56 13.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.153 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.77 -45.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.752 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.23 -52.41 10.09 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.433 ' C ' HD13 ' A' 1006 ' ' LEU . 86.9 m -151.26 149.16 29.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -74.72 140.75 44.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.1 p80 -153.08 151.91 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.751 ' HH2' HG22 ' A' ' 980' ' ' ILE . 53.4 m95 -72.08 120.04 17.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.958 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.593 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.1 p -52.5 -25.32 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 44.6 p -86.9 133.8 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 111.954 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 25.3 pttm -62.7 152.42 81.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.681 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 74.9 Cg_exo -47.55 118.09 2.75 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.323 2.015 . . . . 0.0 111.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.719 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 15.9 Cg_exo -69.43 139.94 42.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.015 2.477 . . . . 0.0 112.987 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.736 HG13 ' HB ' ' A' ' 997' ' ' ILE . 16.7 pt -134.28 126.26 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.921 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 92.5 m -86.43 95.67 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 111.211 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -77.02 138.43 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.191 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.475 ' HE ' ' HD2' ' A' 1045 ' ' HIS . 39.3 ttt85 -54.76 127.61 29.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.698 ' O ' ' HB2' ' A' 1046 ' ' TYR . 47.1 mm -56.02 110.38 2.27 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' 1080 ' ' GLN . 93.6 Cg_endo -81.17 133.09 8.61 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.511 2.141 . . . . 0.0 113.374 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 8.1 p -113.02 143.81 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.896 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.06 -148.63 2.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.095 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' 1027 ' ' LEU . 10.1 mt -70.02 148.82 96.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' 1029 ' ' PRO . 16.4 Cg_exo -66.5 137.07 45.28 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 110.499 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' 1028 ' ' PRO . 49.9 Cg_exo -34.11 135.28 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.667 2.244 . . . . 0.0 111.782 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 77.2 p -76.54 139.39 40.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.755 HG23 ' HA3' ' A' 1034 ' ' GLY . 7.8 tt -142.67 117.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.321 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -44.7 131.42 6.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.529 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' 1091 ' ' CYS . 22.5 p30 42.58 30.12 0.2 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.482 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.755 ' HA3' HG23 ' A' 1031 ' ' ILE . . . -79.16 160.8 46.59 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.526 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.724 ' HB2' ' HA ' ' A' 1055 ' ' ASN . 31.3 t0 -156.56 156.62 33.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.704 ' HA ' ' O ' ' A' 1051 ' ' THR . 23.4 p90 -155.88 145.37 20.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 111.91 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.448 HG13 HH11 ' A' 1053 ' ' ARG . 29.5 mt -109.23 111.27 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.775 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' 1039 ' ' THR . 57.1 m -171.12 -140.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.441 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.448 ' H ' ' HB3' ' A' 1038 ' ' SER . 11.6 t -117.79 -27.87 6.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -45.56 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.951 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.426 ' H ' ' HE1' ' A' 1036 ' ' PHE . 38.9 mmt180 54.39 -126.69 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -77.03 -40.73 45.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.136 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -67.5 148.45 51.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.31 152.91 15.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.307 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' 1046 ' ' TYR . 15.7 p-80 -155.08 -62.07 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.809 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.698 ' HB2' ' O ' ' A' 1023 ' ' ILE . 6.2 t80 169.11 40.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.594 0.235 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.46 -43.87 0.02 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.568 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 66.7 m -47.58 128.51 12.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 112.001 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' 1050 ' ' VAL . 7.7 p -97.17 175.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.558 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' 1049 ' ' VAL . 30.9 m -151.41 131.77 4.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.172 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.704 ' O ' ' HA ' ' A' 1036 ' ' PHE . 42.4 m -104.33 102.64 12.32 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.433 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' 1035 ' ' ASP . 2.5 m-85 -70.57 135.08 48.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 111.254 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.532 HH22 HG21 ' A' 1051 ' ' THR . 3.1 ptp85 -159.63 34.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.388 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.811 ' HB2' HG12 ' A' 1063 ' ' VAL . 77.5 m 62.03 149.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.188 0.518 . . . . 0.0 111.809 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.724 ' HA ' ' HB2' ' A' 1035 ' ' ASP . 47.3 t30 -63.45 -35.38 80.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.279 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 1.003 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 21.7 mt -70.31 -157.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 58.68 39.8 93.96 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.607 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 11.6 p -175.04 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 110.552 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -155.88 45.58 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.839 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.792 ' HA3' HD23 ' A' 1056 ' ' LEU . . . -172.19 -41.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.834 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' 1062 ' ' LYS . 20.8 tpp180 67.6 158.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.461 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' A' 1061 ' ' ARG . 20.2 tptm 94.97 -35.97 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.014 0.821 . . . . 0.0 110.077 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 1.003 ' HA ' ' HB2' ' A' 1056 ' ' LEU . 0.1 OUTLIER 43.1 32.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.537 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' 1091 ' ' CYS . 0.1 OUTLIER 36.93 -135.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' 1092 ' ' ILE . 98.7 mt-10 -150.14 105.71 3.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.205 0.526 . . . . 0.0 110.814 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' 1070 ' ' PRO . 43.6 tp -70.51 149.73 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.112 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' 1089 ' ' PRO . 97.2 t -139.18 137.51 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.325 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.13 -158.79 35.0 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.561 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' 1089 ' ' PRO . 18.6 pt-20 -69.03 125.97 92.4 Favored Pre-proline 0 C--O 1.227 -0.117 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.76 ' HB3' HD21 ' A' 1066 ' ' LEU . 84.7 Cg_endo -96.16 26.15 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.114 2.542 . . . . 0.0 112.869 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 78.8 p -157.4 143.59 17.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.503 HD11 ' OH ' ' A' 1052 ' ' TYR . 13.4 pt -155.19 171.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.881 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.8 p90 -137.46 144.07 42.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 0.0 111.315 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.579 ' HA ' ' CE2' ' A' 1084 ' ' TRP . 0.9 OUTLIER -62.19 121.37 12.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.55 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' 1084 ' ' TRP . 11.8 t -157.72 140.68 15.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.719 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' 1082 ' ' GLY . 69.7 m -89.77 -154.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.955 HD21 HD13 ' A' 1083 ' ' ILE . 0.0 OUTLIER 179.22 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.409 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.749 ' H ' HD22 ' A' 1077 ' ' ASN . 29.5 m-20 -80.67 -54.92 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -163.24 -46.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.009 0.433 . . . . 0.0 111.635 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.688 ' HB2' ' HG2' ' A' 1024 ' ' PRO . 17.0 pt20 -175.3 32.81 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.74 HG13 ' H ' ' A' 1082 ' ' GLY . 2.5 p -88.93 -104.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.612 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.74 ' H ' HG13 ' A' 1081 ' ' VAL . . . -153.24 -115.15 0.58 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.955 HD13 HD21 ' A' 1077 ' ' ASN . 4.2 mp 56.02 82.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.579 ' CE2' ' HA ' ' A' 1074 ' ' CYS . 15.4 m0 -70.66 -153.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.707 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' 1084 ' ' TRP . 47.9 t -56.42 -57.01 14.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 131.8 1.63 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.478 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.5 130.67 9.05 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 111.184 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.785 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -169.92 -46.74 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.785 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.7 Cg_endo -52.02 132.82 44.4 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.195 1.93 . . . . 0.0 112.54 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.499 HE22 HG12 ' A' 1092 ' ' ILE . 0.0 OUTLIER -153.21 138.51 17.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.427 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.596 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 74.5 m -103.04 135.32 44.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' 1065 ' ' GLU . 13.5 pt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.381 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.85 0.357 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.758 ' HD2' ' H ' ' A' 1011 ' ' ALA . 4.4 tppp? -77.46 140.85 39.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.823 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 67.2 p -157.99 144.84 17.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.545 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 76.8 m -79.9 31.7 0.26 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.838 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 59.47 142.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.841 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 966' ' ' PRO . 54.8 m -52.15 122.13 22.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.6 ' HG2' HG11 ' A' ' 974' ' ' VAL . 10.1 Cg_endo -53.53 115.52 2.36 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.495 2.13 . . . . 0.0 112.168 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 22.8 Cg_exo -64.51 127.71 19.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.502 2.134 . . . . 0.0 111.559 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.18 109.74 2.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.864 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.669 ' HG3' ' HG2' ' A' 1018 ' ' PRO . 26.4 Cg_exo -61.94 147.25 95.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 111.571 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 970' ' ' VAL . 35.9 m -47.43 127.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 990' ' ' CYS . 75.4 m-20 51.23 46.35 26.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.718 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -171.53 124.1 1.08 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.198 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.73 144.53 27.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.696 0.284 . . . . 0.0 111.53 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' ' 966' ' ' PRO . 1.4 p -89.57 147.13 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.041 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.462 ' O ' HG13 ' A' ' 977' ' ' ILE . 17.7 m170 -115.43 95.27 5.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 979' ' ' ASP . 73.7 t -67.56 89.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.643 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 975' ' ' HIS . 42.5 mt -75.13 -90.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.512 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.8 p -59.65 -63.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.378 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 976' ' ' VAL . 25.4 m-20 -165.68 -137.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.24 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.477 HG23 HG13 ' A' ' 976' ' ' VAL . 8.3 pt -152.51 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.518 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.823 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 22.4 mt-30 -72.35 164.42 26.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.595 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' 1004 ' ' CYS . 3.5 p -43.99 135.84 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.887 0.375 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.19 54.74 4.29 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.795 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.421 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 94.4 p -164.52 130.37 2.87 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.625 ' NE ' ' HB2' ' A' 1003 ' ' GLU . 35.9 mmt180 -94.11 149.63 21.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.586 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' 1001 ' ' SER . 48.7 pt -142.83 141.38 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -106.37 123.97 48.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.372 . . . . 0.0 111.951 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.578 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 1.3 m-85 -86.66 172.04 10.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.7 t -145.47 -174.24 4.34 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.081 0.467 . . . . 0.0 111.852 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.568 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 92.2 m -158.12 159.67 36.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 992' ' ' THR . 41.3 p -67.72 -160.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 111.378 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' A' ' 991' ' ' THR . 43.7 m -82.53 130.26 35.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.694 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' 1023 ' ' ILE . . . 68.44 45.39 68.69 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.538 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -148.08 123.13 10.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.507 ' HG3' HE22 ' A' 1080 ' ' GLN . 78.7 ttt180 -84.98 129.05 34.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.354 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' 1000 ' ' SER . 3.7 tt -74.66 130.79 40.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.562 ' N ' HD23 ' A' ' 996' ' ' LEU . 49.6 mm -99.87 144.61 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.878 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.451 ' HA3' ' HE3' ' A' 1016 ' ' LYS . . . 77.26 36.23 35.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.872 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 59.4 131.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.63 ' HB3' HD13 ' A' ' 996' ' ' LEU . 79.1 p -84.59 36.4 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.527 ' O ' HG21 ' A' 1015 ' ' THR . 80.9 p -162.09 145.89 12.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.07 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.448 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -161.07 141.51 11.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.145 0.497 . . . . 0.0 112.162 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.625 ' HB2' ' NE ' ' A' ' 985' ' ' ARG . 89.0 tt0 -104.78 134.43 47.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.953 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 54.0 t -74.62 98.2 3.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 26.7 pt -90.73 -166.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.073 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' 1011 ' ' ALA . 0.4 OUTLIER -141.08 121.78 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.147 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.404 ' N ' HD13 ' A' 1006 ' ' LEU . 37.8 t -90.38 41.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.496 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 50.92 39.84 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.599 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.65 -46.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.094 0.474 . . . . 0.0 110.571 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 67.8 m -151.24 147.85 27.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.758 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.19 134.78 41.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.522 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 88.9 m-70 -149.46 141.71 24.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.473 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 78.3 m95 -68.9 125.56 27.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.351 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 32.7 m -52.62 -25.36 10.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.899 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.527 HG21 ' O ' ' A' 1001 ' ' SER . 72.9 p -87.95 143.11 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' 1017 ' ' PRO . 0.0 OUTLIER -68.3 162.13 63.55 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.089 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.494 ' O ' ' HD2' ' A' 1016 ' ' LYS . 99.2 Cg_exo -43.18 116.57 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.519 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.669 ' HG2' ' HG3' ' A' ' 969' ' ' PRO . 56.1 Cg_endo -69.49 138.22 38.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.881 2.387 . . . . 0.0 112.728 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 997' ' ' ILE . 12.1 tt -148.81 133.27 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 79.2 m -86.38 113.33 22.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 111.575 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -78.79 129.05 34.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.926 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -71.16 122.4 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.893 HG21 ' HB2' ' A' 1077 ' ' ASN . 37.7 mt -52.55 121.62 22.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.427 ' O ' ' HA3' ' A' 1082 ' ' GLY . 84.9 Cg_endo -81.64 125.25 4.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.872 2.382 . . . . 0.0 111.03 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.699 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 0.5 OUTLIER -97.06 25.29 5.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 36.67 -143.96 0.13 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.328 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' 1044 ' ' PHE . 22.3 mt -93.27 141.84 24.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.592 0.235 . . . . 0.0 111.225 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.761 ' HG3' HD21 ' A' 1040 ' ' ASN . 56.6 Cg_endo -68.8 156.93 63.84 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.493 2.129 . . . . 0.0 111.307 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.545 ' HD2' HD11 ' A' 1072 ' ' ILE . 82.8 Cg_exo -42.7 126.29 4.17 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.526 2.151 . . . . 0.0 112.273 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 66.6 p -77.41 98.27 5.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' 1031 ' ' ILE . 7.4 tt -86.41 106.73 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.563 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -76.22 148.01 37.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.968 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.8 m120 73.7 28.35 1.64 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.524 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.656 ' HA2' ' N ' ' A' 1055 ' ' ASN . . . -160.86 -46.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.78 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' 1034 ' ' GLY . 57.8 m-20 71.44 147.38 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.611 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.519 ' HB2' HG21 ' A' 1050 ' ' VAL . 14.4 p90 -84.0 145.59 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.098 0.475 . . . . 0.0 112.017 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' 1053 ' ' ARG . 58.8 mt -90.72 164.01 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.56 ' N ' HG22 ' A' 1037 ' ' ILE . 75.1 m 72.57 166.43 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.598 0.237 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' 1040 ' ' ASN . 57.5 p -49.54 -64.93 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.761 HD21 ' HG3' ' A' 1028 ' ' PRO . 18.7 t-20 33.46 49.09 0.21 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.031 0.444 . . . . 0.0 110.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -86.4 -60.71 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -147.5 -42.76 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 1.1 m120 -71.48 123.29 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.581 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.512 ' CE2' HD23 ' A' 1027 ' ' LEU . 86.3 m-85 -148.56 -46.88 0.15 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.624 ' C ' ' H ' ' A' 1047 ' ' GLY . 23.8 m80 58.1 -111.66 0.59 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' 1074 ' ' CYS . 10.0 t80 -64.31 27.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.059 0.456 . . . . 0.0 110.556 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' 1045 ' ' HIS . . . 76.51 -84.85 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.519 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' 1047 ' ' GLY . 34.2 t 115.72 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.885 0.874 . . . . 0.0 109.669 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' 1072 ' ' ILE . 13.2 p -156.4 153.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.434 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.567 ' HB ' HD22 ' A' 1040 ' ' ASN . 5.0 p -153.81 129.08 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.945 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 71.7 m -86.74 120.62 28.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.128 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.492 ' CE1' HG12 ' A' 1072 ' ' ILE . 3.1 m-85 -80.28 139.44 36.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.592 ' HB2' HD11 ' A' 1037 ' ' ILE . 33.7 ttp180 -147.63 142.84 27.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.552 ' O ' HD12 ' A' 1056 ' ' LEU . 40.9 m -77.97 149.93 34.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.525 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.656 ' N ' ' HA2' ' A' 1034 ' ' GLY . 44.5 t30 -56.31 -51.74 67.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.861 ' HA ' HG13 ' A' 1063 ' ' VAL . 1.7 mt 49.47 34.79 7.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.718 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.16 0.37 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.307 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' 1059 ' ' ARG . 85.8 p -68.35 -54.14 19.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 1058 ' ' SER . 24.9 mmm180 -159.52 -47.02 0.05 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.697 0.284 . . . . 0.0 111.278 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.672 ' HA2' HD22 ' A' 1056 ' ' LEU . . . -167.14 50.58 0.25 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.43 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' 1062 ' ' LYS . 0.0 OUTLIER -77.06 47.7 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.403 0.281 . . . . 0.0 110.491 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' 1062 ' ' LYS . 61.9 tttp 38.45 61.98 1.07 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' 1056 ' ' LEU . 3.3 p -147.26 87.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.207 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.74 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 1.5 m-30 88.26 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.189 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -147.94 145.61 28.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.458 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' 1067 ' ' VAL . 3.8 tt -68.58 142.1 55.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.391 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.795 ' N ' HD23 ' A' 1066 ' ' LEU . 56.3 t -133.48 111.37 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.475 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' 1089 ' ' PRO . . . 77.03 133.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.355 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.723 ' O ' ' HG3' ' A' 1089 ' ' PRO . 5.2 tp10 46.0 107.94 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 111.833 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.558 ' HA ' ' CD1' ' A' 1066 ' ' LEU . 68.8 Cg_endo -87.18 -28.15 0.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.48 2.12 . . . . 0.0 113.106 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 87.6 p -151.2 129.97 12.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' 1049 ' ' VAL . 45.6 pt -106.86 175.84 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.436 0.636 . . . . 0.0 112.514 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.13 144.62 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.04 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 34.9 t -67.43 125.31 25.73 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.736 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.3 t -92.05 -40.98 10.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 10.9 p -166.49 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 0.0 111.421 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.893 ' HB2' HG21 ' A' 1023 ' ' ILE . 0.8 OUTLIER -170.97 143.33 1.98 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.385 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.717 ' H ' HD22 ' A' 1077 ' ' ASN . 61.7 t0 -57.52 -48.37 79.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.929 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -150.4 -55.65 0.16 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.507 HE22 ' HG3' ' A' ' 995' ' ' ARG . 13.3 mm-40 -148.21 -26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' 1023 ' ' ILE . 21.8 t -68.89 -110.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . -165.81 136.13 4.03 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.068 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.729 HG22 ' HA ' ' A' 1077 ' ' ASN . 8.1 tp -145.91 132.94 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.744 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 20.8 m95 -83.98 -155.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 67.2 m -79.75 -57.5 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.701 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.59 134.11 2.04 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.047 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.417 ' HB3' ' CG ' ' A' 1029 ' ' PRO . 87.8 Cg_endo -79.71 48.93 3.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.858 2.372 . . . . 0.0 112.017 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -69.92 -41.0 14.18 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.723 ' HG3' ' O ' ' A' 1069 ' ' GLU . 78.3 Cg_exo -48.96 120.42 5.43 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.759 1.639 . . . . 0.0 112.552 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.557 HE21 HG23 ' A' 1092 ' ' ILE . 58.6 tp60 -134.04 116.38 15.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.106 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 49.9 t -87.26 117.02 25.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.128 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.557 HG23 HE21 ' A' 1090 ' ' GLN . 10.2 pt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.213 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.961 0.41 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 962' ' ' SER . 45.4 mmtm -77.6 -127.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.746 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.978 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 47.3 t 74.19 139.76 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.224 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.569 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 79.0 m -79.98 37.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.008 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 61.27 134.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.34 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 95.1 m -59.69 114.34 9.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 24.1 Cg_exo -63.82 118.49 5.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.372 2.048 . . . . 0.0 112.08 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.56 132.37 15.96 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.396 2.064 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 30.4 m-20 -55.65 110.02 2.0 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.771 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.466 ' HD2' ' HA3' ' A' ' 972' ' ' GLY . 5.5 Cg_exo -79.84 -146.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.053 2.502 . . . . 0.0 111.923 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.672 HG11 HG23 ' A' 1019 ' ' ILE . 1.6 p -48.95 93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.647 ' O ' HG23 ' A' ' 991' ' ' THR . 76.6 m-20 49.28 22.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.393 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -83.05 159.31 37.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.6 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.542 ' N ' ' HA ' ' A' ' 990' ' ' CYS . 11.4 tpt -157.45 110.67 2.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.954 HG21 HD12 ' A' ' 986' ' ' ILE . 9.0 p -87.98 145.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.993 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.4 ' N ' ' CD2' ' A' ' 975' ' ' HIS . 11.8 m170 -106.58 97.45 7.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.823 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.704 HG13 HG23 ' A' ' 980' ' ' ILE . 16.3 t -65.29 96.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.427 HD11 ' OG1' ' A' ' 987' ' ' THR . 37.4 mt -75.24 -92.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.264 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.0 p -68.84 -73.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 110.359 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 984' ' ' SER . 3.9 m-20 -161.2 151.04 17.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 976' ' ' VAL . 11.5 pt -84.18 3.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.363 0.601 . . . . 0.0 109.793 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.978 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 88.6 mt-30 -82.03 157.08 24.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.945 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' 1005 ' ' ILE . 7.2 p -44.35 150.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.644 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 81.02 -44.19 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.712 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.511 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 54.4 m -74.14 -170.1 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.83 0.315 . . . . 0.0 111.035 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' 1003 ' ' GLU . 79.6 mtp180 -151.51 169.53 21.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.295 0.569 . . . . 0.0 111.991 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.954 HD12 HG21 ' A' ' 974' ' ' VAL . 37.6 pt -150.01 139.05 15.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.499 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' 1001 ' ' SER . 48.7 p -107.36 122.67 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 5.4 m-85 -83.28 160.1 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.995 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.458 ' HA ' HD12 ' A' ' 996' ' ' LEU . 75.1 m -161.5 -6.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.752 ' SG ' ' HG ' ' A' ' 996' ' ' LEU . 65.8 m 62.29 -158.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.07 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 971' ' ' ASN . 34.2 p -75.08 -142.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.604 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 993' ' ' GLY . 9.8 t -62.4 -127.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.537 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 992' ' ' THR . . . -72.57 43.75 0.93 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 114.501 0.56 . . . . 0.0 114.501 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -93.96 139.6 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.201 0.5 . . . . 0.0 110.646 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -81.99 117.22 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.738 0.304 . . . . 0.0 110.553 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.752 ' HG ' ' SG ' ' A' ' 990' ' ' CYS . 1.7 tt -76.16 133.28 40.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.647 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.969 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -105.16 155.1 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.406 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 79.41 -75.81 2.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.818 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -165.28 139.13 4.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.545 ' HA ' HD13 ' A' ' 996' ' ' LEU . 21.7 m -100.15 22.04 11.98 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 83.8 p -162.27 148.16 13.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.903 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.409 ' HB3' ' HE1' ' A' ' 988' ' ' TYR . . . -154.49 134.4 13.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 111.547 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 985' ' ' ARG . 87.7 tt0 -101.62 128.78 47.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.05 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -79.38 125.69 29.86 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' 1012 ' ' HIS . 0.2 OUTLIER -138.26 153.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 0.0 110.286 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' 1007 ' ' SER . 0.6 OUTLIER -81.58 124.2 29.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.473 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.536 ' N ' HD13 ' A' 1006 ' ' LEU . 81.2 p -86.63 -125.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.09 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -65.08 -54.89 24.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.154 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -153.35 20.79 0.56 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 95.4 m -151.37 147.45 26.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.569 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.3 136.39 40.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.591 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.655 ' O ' HD13 ' A' 1005 ' ' ILE . 82.9 m-70 -149.14 142.78 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.733 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.516 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 83.2 m95 -71.66 136.2 47.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.985 0.421 . . . . 0.0 111.428 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 74.8 p -52.44 -24.46 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.839 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 25.2 p -132.38 130.57 40.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.45 . . . . 0.0 111.858 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -57.95 158.9 11.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.629 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 97.9 Cg_exo -41.56 126.49 3.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.123 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.534 ' HB2' HD21 ' A' ' 996' ' ' LEU . 64.2 Cg_endo -72.57 -156.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.511 2.141 . . . . 0.0 112.217 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.969 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 11.3 mt -143.04 -179.26 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.866 ' H ' HG22 ' A' 1019 ' ' ILE . 21.1 m -145.81 79.06 1.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.377 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.784 ' H ' HD13 ' A' ' 997' ' ' ILE . 3.0 tp-100 -71.6 138.57 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.008 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.664 ' HB3' ' HB3' ' A' 1046 ' ' TYR . 9.5 mpt_? -72.33 126.61 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.998 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.2 mt -67.32 113.25 12.88 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.638 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' 1045 ' ' HIS . 30.1 Cg_endo -63.69 114.37 2.54 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.758 2.305 . . . . 0.0 113.679 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.586 ' O ' ' HB2' ' A' 1044 ' ' PHE . 9.1 p -95.67 135.97 36.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.208 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.13 -150.59 3.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.104 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.485 HD11 ' OE1' ' A' 1042 ' ' GLU . 1.5 mm? -62.87 139.03 97.26 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.12 168.33 19.4 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.024 2.483 . . . . 0.0 111.291 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.781 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 65.5 Cg_exo -50.86 110.3 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.873 1.716 . . . . 0.0 111.529 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.6 p -77.42 141.02 39.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.269 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.567 HG13 ' HA3' ' A' 1034 ' ' GLY . 24.1 pt -149.68 124.33 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.446 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.96 139.38 10.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-20 75.1 -28.41 0.19 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.344 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.567 ' HA3' HG13 ' A' 1031 ' ' ILE . . . -64.62 160.07 41.39 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' 1034 ' ' GLY . 71.5 m-20 -153.78 -156.53 0.69 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.741 ' HB2' HG23 ' A' 1050 ' ' VAL . 36.7 p90 -155.95 142.33 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 112.298 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' 1037 ' ' ILE . 53.9 mt -111.26 57.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.054 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.413 ' H ' ' HD1' ' A' 1036 ' ' PHE . 60.1 m -157.76 -163.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.488 HG22 ' O ' ' A' 1039 ' ' THR . 22.6 m -96.91 49.15 1.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.265 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.639 HD21 ' HB ' ' A' 1050 ' ' VAL . 5.3 m120 -62.93 -52.26 63.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.765 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 56.81 -137.27 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.485 ' OE1' HD11 ' A' 1027 ' ' LEU . 67.3 mm-40 -149.23 50.38 0.96 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.354 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -168.42 60.99 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.164 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.586 ' HB2' ' O ' ' A' 1025 ' ' CYS . 5.3 m-85 -76.77 129.99 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.744 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.583 ' O ' ' HA ' ' A' 1024 ' ' PRO . 20.8 m80 -98.42 -58.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.664 ' HB3' ' HB3' ' A' 1022 ' ' ARG . 42.3 t80 172.17 31.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.71 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.46 98.09 0.16 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.79 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.8 p 175.72 134.41 0.05 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.535 0.683 . . . . 0.0 111.391 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' 1072 ' ' ILE . 12.7 p -102.17 155.52 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.448 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.741 HG23 ' HB2' ' A' 1036 ' ' PHE . 6.4 p -133.47 126.47 52.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.012 0.435 . . . . 0.0 111.05 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 33.2 m -106.69 109.84 21.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.545 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 10.3 m-85 -71.92 147.65 46.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.726 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' 1054 ' ' CYS . 14.0 ptm180 -142.8 -14.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.201 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' 1053 ' ' ARG . 66.1 m 71.29 146.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.104 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' 1033 ' ' ASN . 28.7 t30 -62.64 -133.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 111.665 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.583 HD13 ' HA2' ' A' 1060 ' ' GLY . 8.6 mt -155.04 133.57 11.93 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.96 31.43 3.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.184 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.631 ' O ' ' HG2' ' A' 1059 ' ' ARG . 68.0 m -169.36 -70.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.783 0.292 . . . . 0.0 111.615 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' 1058 ' ' SER . 31.8 mmt-85 -167.21 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.65 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.583 ' HA2' HD13 ' A' 1056 ' ' LEU . . . -153.29 -32.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.444 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' 1061 ' ' ARG . 41.4 ttt85 -55.43 120.53 7.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.93 133.73 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 32.5 m -147.0 -29.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 111.302 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.533 ' HD2' ' HB3' ' A' 1091 ' ' CYS . 15.6 m-85 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' 1092 ' ' ILE . 34.6 mt-10 -98.52 126.43 44.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.718 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.932 HD23 ' N ' ' A' 1067 ' ' VAL . 3.6 tt -68.81 143.47 54.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.517 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.932 ' N ' HD23 ' A' 1066 ' ' LEU . 96.2 t -135.1 117.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 88.77 -142.82 17.28 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.658 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' 1089 ' ' PRO . 20.8 pt-20 -62.52 122.87 76.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.018 0.437 . . . . 0.0 112.17 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.6 ' HA ' HD11 ' A' 1066 ' ' LEU . 87.0 Cg_endo -85.33 -17.46 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.812 2.341 . . . . 0.0 112.175 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 77.9 p -156.37 155.66 32.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.502 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' 1049 ' ' VAL . 34.8 pt -150.29 -162.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.656 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -160.28 150.06 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 2.4 t -62.39 141.03 58.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.698 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 12.8 t -145.73 -146.89 0.2 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' 1082 ' ' GLY . 46.9 t -165.46 147.92 7.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.886 0.374 . . . . 0.0 111.46 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.726 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -163.97 -33.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.726 ' H ' HD22 ' A' 1077 ' ' ASN . 5.0 t0 -73.78 -139.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.49 -39.87 11.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -162.91 -16.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 50.5 t -58.74 -28.9 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.501 . . . . 0.0 110.776 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 81.13 -63.06 4.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.901 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.574 ' HB ' HD21 ' A' 1077 ' ' ASN . 75.4 mt 60.69 130.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.106 0.479 . . . . 0.0 111.847 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 18.1 m95 -80.19 138.2 36.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.587 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 71.5 p -55.47 -61.73 2.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.522 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -71.38 121.85 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.643 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.39 39.87 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.087 2.525 . . . . 0.0 112.012 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.781 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 61.98 135.02 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.504 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.545 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 36.3 Cg_endo -64.9 -138.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.657 2.238 . . . . 0.0 112.399 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.787 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -151.84 128.09 10.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' 1064 ' ' PHE . 98.8 m -102.74 104.06 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.361 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' 1065 ' ' GLU . 17.8 pt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.304 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.995 0.426 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' A' 1011 ' ' ALA . 0.0 OUTLIER 64.39 143.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 81.2 p -157.99 146.73 19.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.97 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.02 152.23 29.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 0.0 OUTLIER -63.87 133.57 53.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.598 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.433 ' HB ' ' CD1' ' A' ' 980' ' ' ILE . 6.5 t -73.73 125.73 90.2 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.857 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.637 ' HG2' HG11 ' A' ' 974' ' ' VAL . 93.5 Cg_endo -79.73 113.14 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.296 1.997 . . . . 0.0 111.219 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 95.5 Cg_exo -42.2 -48.96 6.25 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.435 2.09 . . . . 0.0 112.051 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 174.5 126.95 0.11 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.339 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.667 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 50.2 Cg_exo -54.04 150.91 29.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.69 HG21 HG13 ' A' 1019 ' ' ILE . 93.6 t -46.65 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.496 ' ND2' HG12 ' A' ' 970' ' ' VAL . 73.4 m-20 75.28 -43.42 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.829 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -69.13 -145.09 0.17 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.094 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.667 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 25.8 ptm -159.22 139.83 12.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.738 0.304 . . . . 0.0 110.668 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.637 HG11 ' HG2' ' A' ' 966' ' ' PRO . 9.9 p -92.08 142.68 12.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.225 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -106.88 93.97 4.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.746 HG13 HG23 ' A' ' 980' ' ' ILE . 84.3 t -65.35 -44.73 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.393 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.0 mt 61.06 -100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.4 p -67.35 -60.4 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.5 t0 -172.53 -141.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.746 HG23 HG13 ' A' ' 976' ' ' VAL . 9.0 pt -152.83 20.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 110.815 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 70.5 mt-30 -87.32 -157.59 0.4 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.517 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 94.2 t -46.57 140.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.751 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 984' ' ' SER . . . 74.11 -79.46 0.89 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.06 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' 1003 ' ' GLU . 95.8 p 21.15 106.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.391 0.676 . . . . 0.0 112.802 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -98.77 77.16 2.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 976' ' ' VAL . 41.0 pt -80.37 137.45 21.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.509 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -108.62 130.51 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.493 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 6.6 m-85 -98.21 147.21 24.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.514 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.5 p -152.48 128.26 10.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.8 t -86.87 -133.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.41 163.82 15.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.415 0.626 . . . . 0.0 111.593 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 25.4 m -53.8 123.57 12.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 131.87 -31.53 3.05 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.232 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -139.73 142.2 36.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.094 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -82.03 121.1 26.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' 1018 ' ' PRO . 4.4 tp -67.63 123.6 20.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.579 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 996' ' ' LEU . 43.3 mm -94.65 149.55 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.193 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 75.91 177.67 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.222 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' A' 1001 ' ' SER . 95.6 m-70 -74.98 131.68 40.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 0.0 111.006 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 10.0 m -75.21 28.82 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.992 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 999' ' ' HIS . 82.2 p -162.13 151.19 15.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -154.11 122.74 6.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 111.847 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 984' ' ' SER . 10.4 pt-20 -107.07 135.86 47.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.231 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.408 ' SG ' ' CZ3' ' A' 1013 ' ' TRP . 19.3 m -70.55 126.78 30.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.085 0.469 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' 1012 ' ' HIS . 0.2 OUTLIER -136.74 147.47 27.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.523 178.472 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' 1007 ' ' SER . 0.2 OUTLIER -86.55 127.02 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.613 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 46.4 t -90.09 -42.03 11.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -163.34 -36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.321 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 961' ' ' LYS . 77.0 m-20 -150.61 -49.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 111.175 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 89.4 m -97.49 137.82 35.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 111.626 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.572 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.21 140.26 43.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.752 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.671 ' O ' HD13 ' A' 1005 ' ' ILE . 9.3 p80 -149.52 153.29 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.492 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 74.8 m95 -67.95 131.61 45.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.432 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -52.43 -22.28 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.235 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.435 HG21 ' CD2' ' A' ' 999' ' ' HIS . 81.7 p -136.64 142.09 43.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.021 0.439 . . . . 0.0 112.148 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -54.94 148.66 26.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.789 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.86 120.42 7.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.447 2.098 . . . . 0.0 112.462 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.788 ' HB3' HD11 ' A' ' 996' ' ' LEU . 50.6 Cg_exo -54.95 152.21 30.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.69 HG13 HG21 ' A' ' 970' ' ' VAL . 3.6 tt -143.08 131.7 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.586 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.503 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 49.7 m -86.39 113.11 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 111.267 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -84.55 129.15 34.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.928 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.495 ' HD2' ' CD2' ' A' 1045 ' ' HIS . 20.0 ptt-85 -72.8 134.78 45.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.525 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 63.7 mt -100.72 131.07 24.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.315 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.0 115.06 4.19 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.2 1.933 . . . . 0.0 111.715 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.612 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 44.0 t -89.75 148.96 22.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.347 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 149.64 37.88 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.738 ' H ' HD23 ' A' 1027 ' ' LEU . 0.1 OUTLIER -52.52 141.4 34.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 117.048 0.424 . . . . 0.0 111.417 -179.159 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.409 ' HB2' HD11 ' A' 1072 ' ' ILE . 18.2 Cg_endo -59.11 145.01 99.13 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.547 2.164 . . . . 0.0 111.229 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.95 134.24 14.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.314 2.009 . . . . 0.0 112.128 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 73.3 p -77.5 126.17 30.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' 1034 ' ' GLY . 6.0 tt -89.56 113.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.445 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -60.86 141.17 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.932 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.6 m-20 57.55 35.37 25.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.966 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' 1031 ' ' ILE . . . -168.33 131.8 2.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.62 ' HB2' ' HD3' ' A' 1053 ' ' ARG . 35.8 m-20 -76.57 -148.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 110.82 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -155.88 141.22 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.614 HD12 ' HB ' ' A' 1051 ' ' THR . 59.5 mt -87.99 154.98 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.406 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' 1037 ' ' ILE . 73.6 m 73.79 138.33 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.265 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' 1040 ' ' ASN . 70.7 p -50.27 -61.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.978 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' 1039 ' ' THR . 55.1 t30 33.1 44.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.099 0.476 . . . . 0.0 111.091 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' 1041 ' ' ARG . 21.0 mmt85 -76.26 -161.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.956 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.08 67.86 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.672 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.2 p30 -169.72 23.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.862 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.571 ' O ' ' HD1' ' A' 1044 ' ' PHE . 0.1 OUTLIER -92.44 132.26 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.511 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' 1047 ' ' GLY . 5.6 m80 -84.26 -114.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -56.41 71.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.963 0.347 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.857 ' HA3' ' HB3' ' A' 1074 ' ' CYS . . . 43.5 -107.31 0.12 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.686 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' 1047 ' ' GLY . 95.6 p 135.06 -142.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.371 1.068 . . . . 0.0 109.806 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.846 HG22 ' HB3' ' A' 1073 ' ' TYR . 71.8 t -148.96 141.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.701 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 30.2 m -140.84 137.21 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.614 ' HB ' HD12 ' A' 1037 ' ' ILE . 72.6 m -92.5 125.41 37.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.077 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.715 ' OH ' HD13 ' A' 1072 ' ' ILE . 4.0 m-85 -72.0 156.33 39.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.62 ' HD3' ' HB2' ' A' 1035 ' ' ASP . 7.4 ptm180 -145.6 -145.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.112 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 62.0 m -155.1 145.54 22.08 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.95 0.405 . . . . 0.0 111.707 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -55.16 150.64 10.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.373 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' 1056 ' ' LEU . 1.6 mm? -70.4 -149.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -143.6 -29.28 0.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 54.8 m -144.58 -31.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' 1059 ' ' ARG . 31.9 tpt85 -167.66 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.586 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -165.68 39.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.828 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.749 ' HG2' ' H ' ' A' 1062 ' ' LYS . 27.0 ttm180 -81.26 -147.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.749 ' H ' ' HG2' ' A' 1061 ' ' ARG . 87.5 tttt -173.49 67.42 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 18.2 m -84.92 -38.37 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.223 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.687 ' HB2' ' HB3' ' A' 1054 ' ' CYS . 56.3 m-85 -72.71 147.54 45.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.114 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.98 120.48 32.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.662 HD21 ' HA ' ' A' 1070 ' ' PRO . 53.3 tp -68.46 144.26 54.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' 1089 ' ' PRO . 57.9 t -138.3 123.87 24.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 71.57 156.94 2.65 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.779 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' 1069 ' ' GLU . 41.4 tt0 30.32 65.81 0.85 Allowed Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.662 ' HA ' HD21 ' A' 1066 ' ' LEU . 88.1 Cg_endo -79.99 7.01 4.88 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.072 1.848 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 40.1 t -156.47 149.73 24.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.715 HD13 ' OH ' ' A' 1052 ' ' TYR . 25.2 pt -140.91 165.22 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.275 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.846 ' HB3' HG22 ' A' 1049 ' ' VAL . 9.9 p90 -151.58 138.72 19.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.386 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.857 ' HB3' ' HA3' ' A' 1047 ' ' GLY . 41.2 t -76.84 133.43 39.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 5.2 t -90.01 -35.05 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 73.4 m 61.84 135.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.82 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.699 HD21 HD11 ' A' 1083 ' ' ILE . 0.1 OUTLIER -175.25 -137.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.298 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' 1079 ' ' ASP . 27.6 t70 53.1 -138.53 1.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . 0.453 ' H ' ' CG ' ' A' 1078 ' ' ASP . 1.6 m-20 -92.44 -49.22 6.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.983 0.42 . . . . 0.0 110.446 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -179.86 31.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.432 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 41.3 t -87.21 -45.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 67.51 124.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.217 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.699 HD11 HD21 ' A' 1077 ' ' ASN . 0.2 OUTLIER -153.96 137.32 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.0 m95 -70.68 126.94 30.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.8 t -70.96 -39.56 72.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -62.28 122.77 29.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.166 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 17.9 Cg_exo -67.15 -121.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.298 2.665 . . . . 0.0 112.093 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' 1087 ' ' PRO . . . -160.85 129.34 2.97 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.594 ' HB2' ' O ' ' A' 1067 ' ' VAL . 73.3 Cg_endo -74.76 -141.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.885 2.39 . . . . 0.0 113.486 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.651 HE21 HG23 ' A' 1092 ' ' ILE . 57.1 tp60 -152.39 127.28 9.61 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.439 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 44.6 t -103.11 123.49 46.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.651 HG23 HE21 ' A' 1090 ' ' GLN . 11.8 pt . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.791 ' HG3' ' HB2' ' A' 1011 ' ' ALA . 0.4 OUTLIER 61.32 125.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.398 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.3 p -157.97 135.21 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.521 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 980' ' ' ILE . 2.9 p -84.71 148.65 26.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.171 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -63.64 140.16 58.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 -179.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 73.9 m -60.72 126.07 84.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.378 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 19.7 Cg_exo -66.87 121.5 8.71 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.47 2.113 . . . . 0.0 112.329 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 133.92 26.84 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.412 2.075 . . . . 0.0 111.676 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.26 109.4 1.41 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.769 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 971' ' ' ASN . 68.7 Cg_endo -87.83 -153.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 112.605 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' 1021 ' ' GLN . 2.2 p -49.42 88.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.32 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 969' ' ' PRO . 74.3 m-20 45.28 34.21 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.157 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.746 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -76.3 -56.88 4.15 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.786 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.631 ' HB2' ' HB2' ' A' ' 989' ' ' SER . 60.8 mtt 61.04 96.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.751 HG21 HD12 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.99 143.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.374 179.278 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.4 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 26.0 m170 -122.07 111.61 17.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.442 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.885 ' HA ' HG22 ' A' ' 986' ' ' ILE . 69.6 t -67.45 99.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.94 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 986' ' ' ILE . 41.8 mm -75.23 -90.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.685 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.0 p -65.59 -60.43 2.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.211 0.529 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.604 ' O ' HG13 ' A' ' 976' ' ' VAL . 7.5 t0 -167.49 -128.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.982 178.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.469 ' O ' ' SG ' ' A' ' 963' ' ' CYS . 5.2 pt -154.76 -21.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.742 0.306 . . . . 0.0 110.313 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' 1004 ' ' CYS . 23.5 pt20 -72.43 -164.29 0.14 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.684 HG22 HD21 ' A' 1006 ' ' LEU . 40.4 t -47.27 137.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 64.81 12.41 53.58 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.416 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' 1003 ' ' GLU . 87.7 p -77.0 171.06 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.199 0.5 . . . . 0.0 110.684 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.746 ' HD3' ' N ' ' A' ' 986' ' ' ILE . 0.0 OUTLIER -151.14 138.23 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.967 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.885 HG22 ' HA ' ' A' ' 976' ' ' VAL . 28.2 pt -142.7 173.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 111.538 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' 1000 ' ' SER . 69.6 p -136.98 124.8 22.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.61 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.6 m-85 -87.17 47.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.922 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 66.9 m 30.03 -77.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.685 ' SG ' HD13 ' A' ' 996' ' ' LEU . 33.8 m 67.02 70.65 0.38 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 1.2 t -60.16 154.54 19.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 11.0 t 38.94 -156.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 113.626 -1.625 . . . . 0.0 113.39 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -80.29 50.23 3.95 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.199 -0.455 . . . . 0.0 113.829 -178.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -82.67 149.8 27.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.85 0.325 . . . . 0.0 110.907 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.765 ' HB2' HG12 ' A' 1023 ' ' ILE . 79.5 ttt180 -80.26 93.2 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.874 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 997' ' ' ILE . 4.7 tp -76.05 124.6 27.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 996' ' ' LEU . 1.8 mp -98.15 137.55 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.128 178.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.46 ' O ' ' CD2' ' A' ' 999' ' ' HIS . . . 76.76 -118.66 5.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.481 -178.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.493 ' HB2' ' HB ' ' A' 1015 ' ' THR . 19.0 m170 -149.36 130.95 14.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.085 0.443 . . . . 0.0 111.278 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.61 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 88.1 p -79.95 34.0 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.351 0.596 . . . . 0.0 109.817 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.587 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 79.6 p -162.2 138.56 7.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.888 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.638 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -160.45 141.63 12.14 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 984' ' ' SER . 21.5 pt-20 -105.06 132.86 50.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.599 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 8.3 t -71.3 84.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -179.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' 1014 ' ' SER . 18.8 pt -87.27 158.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.684 HD21 HG22 ' A' ' 982' ' ' VAL . 3.3 mm? -95.31 136.18 35.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.67 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.609 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -162.43 131.02 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.18 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 58.44 39.02 92.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.86 36.31 27.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.676 0.274 . . . . 0.0 111.464 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.1 m -151.25 129.83 12.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.578 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.791 ' HB2' ' HG3' ' A' ' 961' ' ' LYS . . . -75.64 136.79 40.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.098 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.609 ' NE2' ' HB3' ' A' 1007 ' ' SER . 7.6 p80 -163.06 156.51 19.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.942 0.401 . . . . 0.0 111.105 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.577 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 29.6 m95 -74.35 118.28 17.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.517 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.517 ' HB3' HD13 ' A' 1005 ' ' ILE . 79.7 p -52.41 -22.37 4.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.239 -178.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.638 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 53.7 p -105.05 20.92 18.0 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' 1015 ' ' THR . 21.7 ptmt 47.49 165.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.46 107.15 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.121 1.88 . . . . 0.0 111.903 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' 1016 ' ' LYS . 90.5 Cg_endo -82.37 168.14 14.99 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.786 2.324 . . . . 0.0 112.352 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.677 HG13 ' HB ' ' A' ' 997' ' ' ILE . 18.1 pt -148.85 118.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.408 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.746 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 1.9 m -86.39 73.24 10.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.734 ' HA ' HG21 ' A' ' 970' ' ' VAL . 3.5 pt20 -71.73 -166.91 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.691 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' 1024 ' ' PRO . 38.4 ptt180 -96.94 136.18 37.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.765 HG12 ' HB2' ' A' ' 995' ' ' ARG . 53.6 mt -79.19 106.32 4.34 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.502 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' 1045 ' ' HIS . 45.6 Cg_endo -67.43 135.48 36.64 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.825 179.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.772 ' HB3' ' H ' ' A' 1075 ' ' THR . 3.4 p -87.62 144.03 26.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.739 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.15 174.32 53.34 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.074 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.406 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 14.4 mt -53.49 150.03 13.53 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.906 0.353 . . . . 0.0 111.142 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.439 ' CB ' ' HD2' ' A' 1029 ' ' PRO . 19.0 Cg_endo -59.74 174.75 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.987 ' HD3' ' HA ' ' A' 1085 ' ' SER . 56.6 Cg_endo -68.56 -0.78 6.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.933 2.422 . . . . 0.0 112.62 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' 1029 ' ' PRO . 70.8 p 55.71 145.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.946 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.65 HD12 ' HB1' ' A' 1088 ' ' ALA . 13.8 tt -151.1 112.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.364 0.602 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -66.88 155.73 37.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.76 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' 1032 ' ' ALA . 69.1 m-20 75.53 -40.57 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.685 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.516 ' HA2' ' CA ' ' A' 1054 ' ' CYS . . . -70.69 -157.13 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.953 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' 1053 ' ' ARG . 55.3 m-20 -160.01 135.91 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.465 ' HE1' ' O ' ' A' 1038 ' ' SER . 0.1 OUTLIER -84.03 148.36 26.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.435 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' 1051 ' ' THR . 67.7 mt -121.78 148.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.36 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.465 ' O ' ' HE1' ' A' 1036 ' ' PHE . 11.7 t 75.93 -136.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.727 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . . . . . . . . . 45.7 p -100.82 130.79 46.89 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.495 HD22 ' HB ' ' A' 1050 ' ' VAL . 22.2 t-20 -179.71 68.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.249 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' HE1' ' A' 1044 ' ' PHE . 32.0 ptt180 -170.38 105.6 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' 1041 ' ' ARG . 56.8 mt-10 69.24 -51.86 0.6 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' 1043 ' ' ASN . 0.0 OUTLIER -71.48 52.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.043 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.483 ' HE1' ' N ' ' A' 1041 ' ' ARG . 6.6 m-85 -88.5 148.93 23.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.732 0.777 . . . . 0.0 112.692 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.582 ' O ' ' SG ' ' A' 1074 ' ' CYS . 14.3 p-80 -166.88 179.03 5.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.264 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.839 ' HE1' HG11 ' A' 1081 ' ' VAL . 4.1 t80 -65.44 31.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' 1045 ' ' HIS . . . -161.19 104.4 0.24 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.379 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' 1074 ' ' CYS . 79.7 p 177.48 145.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.552 0.691 . . . . 0.0 111.585 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' 1072 ' ' ILE . 6.6 p -137.79 146.23 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' 1040 ' ' ASN . 7.6 p -137.71 133.5 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.968 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 91.3 m -102.48 134.22 46.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.401 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.47 ' HD2' HD13 ' A' 1031 ' ' ILE . 0.4 OUTLIER -70.56 -167.15 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.174 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.601 ' HB3' ' HB2' ' A' 1035 ' ' ASP . 6.0 tpm_? -159.62 -41.39 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.516 ' CA ' ' HA2' ' A' 1034 ' ' GLY . 88.2 m 68.4 121.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.815 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.629 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 19.0 t-20 21.66 -118.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.615 0.572 . . . . 0.0 112.068 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.692 ' HA ' HG23 ' A' 1063 ' ' VAL . 93.4 mt 62.18 117.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.106 0.479 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -100.66 129.56 9.94 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.572 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 15.7 t 72.73 -47.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.428 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.679 ' O ' ' HB3' ' A' 1056 ' ' LEU . 8.6 ttt85 -162.61 -135.51 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.244 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.494 ' H ' ' HG2' ' A' 1059 ' ' ARG . . . -88.62 46.6 3.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.202 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' 1061 ' ' ARG . 17.9 mmt85 -62.24 157.41 19.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.621 0.248 . . . . 0.0 111.197 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.57 71.7 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.994 0.426 . . . . 0.0 110.847 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' 1056 ' ' LEU . 4.0 m -154.51 86.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' 1055 ' ' ASN . 0.4 OUTLIER 70.1 143.42 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.69 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . 0.442 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 49.4 mt-10 -141.98 139.53 32.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' 1067 ' ' VAL . 2.2 tt -68.38 133.06 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.064 0.459 . . . . 0.0 111.397 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.884 ' N ' HD23 ' A' 1066 ' ' LEU . 47.1 t -138.24 129.73 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 93.89 -133.06 11.47 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.681 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.742 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 37.0 tt0 -57.11 106.06 0.62 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 117.153 0.476 . . . . 0.0 111.131 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.743 ' HA ' HD11 ' A' 1066 ' ' LEU . 81.7 Cg_endo -96.24 -12.19 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.098 2.532 . . . . 0.0 113.968 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 52.8 m -156.16 167.45 30.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.412 0.625 . . . . 0.0 112.268 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' 1049 ' ' VAL . 18.4 pt -141.22 157.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.637 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -117.7 149.71 40.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' 1045 ' ' HIS . 37.2 t -61.61 159.19 13.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.188 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.899 HG21 ' H ' ' A' 1084 ' ' TRP . 15.0 t -157.59 -150.61 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . 1.14 ' HB2' ' HB ' ' A' 1081 ' ' VAL . 47.2 t -89.79 -107.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 112.339 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.771 HD22 ' N ' ' A' 1077 ' ' ASN . 0.0 OUTLIER -174.62 -30.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.317 -177.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.765 ' H ' HD22 ' A' 1077 ' ' ASN . 54.4 t0 177.47 -9.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.353 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.92 -141.05 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.951 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.7 -52.47 51.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 1.14 ' HB ' ' HB2' ' A' 1076 ' ' SER . 19.7 t -56.98 -24.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.731 ' C ' HD13 ' A' 1083 ' ' ILE . . . 80.75 -140.19 21.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.215 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.731 HD13 ' C ' ' A' 1082 ' ' GLY . 0.0 OUTLIER -149.75 138.16 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.472 0.653 . . . . 0.0 112.639 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.899 ' H ' HG21 ' A' 1075 ' ' THR . 0.2 OUTLIER -77.38 -114.76 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.567 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . 0.987 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 30.6 t 69.52 59.14 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' 1088 ' ' ALA . . . -59.22 124.36 36.34 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.688 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' 1088 ' ' ALA . 23.9 Cg_exo -64.54 22.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.329 2.019 . . . . 0.0 113.749 -178.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' 1031 ' ' ILE . . . 53.88 139.22 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 113.112 178.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 84.7 Cg_endo -76.11 -122.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.762 2.308 . . . . 0.0 110.725 178.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.884 HE21 ' HB ' ' A' 1067 ' ' VAL . 1.8 pm0 -152.41 143.48 23.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.939 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 3.6 m -103.13 133.91 47.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.442 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 23.4 pt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.112 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.677 0.275 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.803 ' HG2' HD11 ' A' 1006 ' ' LEU . 55.3 tptt -77.61 150.01 34.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.396 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.53 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 64.1 p -157.42 154.74 29.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.494 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 90.0 m -79.31 159.6 27.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.094 179.446 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -63.88 132.96 52.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 0.0 111.039 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 59.9 m -73.14 112.87 17.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.038 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.506 ' HG2' HG21 ' A' ' 974' ' ' VAL . 30.8 Cg_exo -61.84 123.46 12.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.242 1.961 . . . . 0.0 111.963 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.83 -50.78 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.263 1.975 . . . . 0.0 111.497 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 179.26 115.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.679 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 32.2 Cg_endo -66.03 144.73 77.1 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.462 2.108 . . . . 0.0 111.969 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.847 HG11 HG13 ' A' 1019 ' ' ILE . 0.2 OUTLIER -44.97 116.92 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.888 179.879 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.577 HD22 ' HB3' ' A' 1020 ' ' CYS . 14.8 t30 70.94 -50.31 0.68 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -77.93 -152.53 5.71 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.392 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 24.0 ptm -159.2 133.36 7.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.506 HG21 ' HG2' ' A' ' 966' ' ' PRO . 3.3 p -81.91 146.76 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.454 ' O ' ' HB ' ' A' ' 986' ' ' ILE . 22.2 m170 -123.54 105.24 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 1.057 HG13 HG23 ' A' ' 980' ' ' ILE . 52.1 t -65.31 -65.74 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 47.9 mt 75.31 -51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.255 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 45.6 p -86.62 -80.91 0.23 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.002 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.614 ' O ' HG12 ' A' ' 980' ' ' ILE . 9.2 t70 -173.35 -18.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.404 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 1.057 HG23 HG13 ' A' ' 976' ' ' VAL . 28.6 pt 54.97 72.46 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.21 0.604 . . . . 0.0 111.419 -178.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 24.3 mt-30 -152.63 38.89 0.54 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.667 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 76.6 t 101.06 133.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.924 0.889 . . . . 0.0 112.096 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 71.79 -29.93 0.62 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.361 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.598 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 79.9 p -68.45 124.01 22.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.437 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 5.1 tmm_? -101.64 118.85 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.558 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 975' ' ' HIS . 28.7 pt -95.42 -169.0 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.312 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' 1001 ' ' SER . 35.2 p -153.01 128.71 10.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.544 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.0 m-85 -93.95 149.8 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.024 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.0 m -157.35 133.43 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.688 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 9.1 m -82.02 -131.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 110.693 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.417 ' O ' ' ND1' ' A' ' 994' ' ' HIS . 1.2 t -165.02 159.24 17.74 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.796 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 992' ' ' THR . 50.8 m 37.66 54.12 1.47 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.972 0.891 . . . . 0.0 110.266 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 994' ' ' HIS . . . 78.85 -99.53 1.66 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.957 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.578 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 24.9 m80 54.85 140.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.892 0.477 . . . . 0.0 111.53 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -89.86 106.5 18.51 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.229 -0.294 . . . . 0.0 111.018 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' 1000 ' ' SER . 1.7 tt -76.15 121.23 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.8 ' HB ' HG23 ' A' 1019 ' ' ILE . 38.6 mm -89.16 153.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.832 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.77 -112.54 3.53 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.732 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' 1001 ' ' SER . 92.1 m-70 -149.72 133.75 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 111.402 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 996' ' ' LEU . 81.2 p -80.61 30.25 0.3 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 61.3 m -162.14 151.24 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -157.59 127.49 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.577 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 44.7 tt0 -103.57 126.8 50.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.598 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.584 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 41.9 t -73.56 126.52 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.537 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 20.8 pt -147.41 155.32 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.803 HD11 ' HG2' ' A' ' 961' ' ' LYS . 3.8 mm? -92.36 146.33 23.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.292 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.531 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 44.7 t -162.44 -58.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -94.2 47.4 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.129 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.43 ' N ' HD22 ' A' 1009 ' ' ASN . 2.6 m120 60.49 13.84 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.037 0.446 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.784 ' HA ' ' HE2' ' A' ' 961' ' ' LYS . 89.2 m -151.25 146.21 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.584 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.29 134.14 41.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.96 0.409 . . . . 0.0 110.714 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' 1007 ' ' SER . 8.1 p80 -152.18 146.34 25.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.402 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.747 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 57.0 m95 -70.13 124.85 25.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.7 t -52.52 -25.44 10.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 77.1 p -92.2 137.82 32.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.065 0.459 . . . . 0.0 112.046 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.64 ' NZ ' ' HB3' ' A' 1016 ' ' LYS . 0.2 OUTLIER -62.19 152.5 78.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.272 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -43.9 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.54 147.77 92.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.052 2.502 . . . . 0.0 112.413 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.847 HG13 HG11 ' A' ' 970' ' ' VAL . 5.5 tt -148.01 122.8 2.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 994' ' ' HIS . 4.4 t -86.36 113.66 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.121 0.486 . . . . 0.0 111.411 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -84.75 130.1 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.971 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -82.07 124.25 29.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.319 179.319 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.1 mt -71.8 112.71 15.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.412 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.545 ' HG3' HH12 ' A' 1022 ' ' ARG . 34.4 Cg_exo -61.6 133.21 44.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.831 2.354 . . . . 0.0 113.063 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.742 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 92.4 m -98.39 -150.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.451 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -163.84 156.23 27.98 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.522 HD12 ' H ' ' A' 1027 ' ' LEU . 8.7 mp -40.3 132.17 1.63 Allowed Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.161 0.481 . . . . 0.0 111.459 -179.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.55 ' HB2' HD11 ' A' 1072 ' ' ILE . 54.4 Cg_endo -69.8 155.44 65.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.0 102.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.088 1.859 . . . . 0.0 111.363 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.3 p -77.39 118.35 19.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.661 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.78 HD13 ' HB2' ' A' 1089 ' ' PRO . 10.4 pt -93.63 116.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.474 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -49.54 141.0 9.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.722 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' 1054 ' ' CYS . 5.1 m120 74.91 -13.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.58 -140.62 0.02 OUTLIER Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.273 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' 1053 ' ' ARG . 30.4 t70 -168.9 -168.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.561 -0.376 . . . . 0.0 110.842 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.817 ' HD1' HG23 ' A' 1050 ' ' VAL . 1.2 t80 -155.99 127.52 7.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.882 HD12 ' HD2' ' A' 1053 ' ' ARG . 52.5 mt -147.78 77.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.791 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . . . . . . . . . 68.8 m -160.32 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.003 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.414 HG22 ' O ' ' A' 1039 ' ' THR . 7.0 m -136.99 41.67 2.47 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.599 ' ND2' ' HB ' ' A' 1050 ' ' VAL . 5.0 m120 -72.01 -99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.762 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 60.85 48.46 6.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.63 ' HG2' ' H ' ' A' 1043 ' ' ASN . 66.9 tt0 62.95 -136.37 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.63 ' H ' ' HG2' ' A' 1042 ' ' GLU . 23.2 p30 34.23 44.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' 1042 ' ' GLU . 88.4 m-85 -77.48 147.88 35.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.401 . . . . 0.0 111.533 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' 1046 ' ' TYR . 79.3 m-70 -147.13 -49.79 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.48 179.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.647 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 53.9 t80 171.87 149.03 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.303 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 78.71 -17.63 6.64 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.888 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 58.8 m -47.72 144.55 3.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.85 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' 1072 ' ' ILE . 12.8 p -137.79 148.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.273 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.817 HG23 ' HD1' ' A' 1036 ' ' PHE . 2.5 p -143.13 136.11 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.253 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . . . . . . . . . 87.8 m -106.54 111.97 24.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.449 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.554 ' HE1' HG12 ' A' 1072 ' ' ILE . 11.4 m-85 -85.25 142.18 29.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.882 ' HD2' HD12 ' A' 1037 ' ' ILE . 99.9 mtt180 -156.44 30.76 0.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.795 ' O ' HD22 ' A' 1056 ' ' LEU . 71.3 m 59.13 143.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 0.0 111.739 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 8.9 m120 -65.86 97.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.795 HD22 ' O ' ' A' 1054 ' ' CYS . 3.2 mm? -70.37 177.23 3.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.593 178.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' 1063 ' ' VAL . . . -82.74 -28.49 38.38 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 179.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 52.5 m -160.07 -29.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.69 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 33.9 tpt85 -163.83 -45.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.526 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.544 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . 178.61 43.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.775 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -77.3 46.76 0.52 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.633 0.254 . . . . 0.0 111.625 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.7 tttt 44.61 81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.173 0.511 . . . . 0.0 111.703 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' 1056 ' ' LEU . 3.3 m -155.13 95.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.465 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.701 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 65.8 m-85 72.82 136.44 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.437 -178.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -141.09 130.04 23.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.308 0.575 . . . . 0.0 111.693 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.828 HD21 ' HA ' ' A' 1070 ' ' PRO . 35.5 tp -68.47 158.87 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.839 HG21 HD11 ' A' 1092 ' ' ILE . 75.4 t -139.39 143.82 30.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.527 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.72 -144.56 26.66 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.12 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' 1089 ' ' PRO . 79.4 tt0 -60.41 127.81 87.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.817 0.309 . . . . 0.0 110.623 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.828 ' HA ' HD21 ' A' 1066 ' ' LEU . 26.0 Cg_endo -92.3 -54.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.813 2.342 . . . . 0.0 112.802 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . . . . . . . . . 41.7 t -98.85 152.86 19.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.579 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.663 ' O ' HG23 ' A' 1049 ' ' VAL . 31.5 pt -141.42 162.06 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.258 179.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 6.3 p90 -151.02 141.14 22.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.417 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 46.9 t -65.11 152.41 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.233 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . 0.443 ' C ' ' HE1' ' A' 1046 ' ' TYR . 13.1 t -140.09 -147.41 0.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.021 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.6 t -153.28 145.79 24.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.972 0.415 . . . . 0.0 111.537 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.693 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -162.7 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.064 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.693 ' H ' HD22 ' A' 1077 ' ' ASN . 1.2 m-20 -77.22 -147.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.568 0.223 . . . . 0.0 110.626 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -83.61 -45.38 13.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.286 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -178.22 30.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.737 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.495 ' HB ' ' CD1' ' A' 1083 ' ' ILE . 43.7 t -77.25 -34.84 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 85.37 61.37 1.73 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.994 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' 1083 ' ' ILE . 2.1 mp -81.99 135.11 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.93 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 14.4 m95 -72.57 -173.93 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.978 0.418 . . . . 0.0 112.003 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.3 t -59.51 -71.24 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.149 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 137.43 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.308 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.93 136.23 34.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.735 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -167.6 -44.99 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.78 ' HB2' HD13 ' A' 1031 ' ' ILE . 63.3 Cg_exo -48.23 137.98 23.38 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.122 1.881 . . . . 0.0 112.138 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.441 HE21 ' HB2' ' A' 1090 ' ' GLN . 0.3 OUTLIER -149.7 134.57 17.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 0.0 111.619 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 29.1 t -90.67 132.54 35.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.839 HD11 HG21 ' A' 1067 ' ' VAL . 39.2 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.074 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.933 0.397 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.918 ' HD2' ' H ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -79.18 132.02 36.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.878 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -92.44 135.57 33.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.728 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 80.9 m -81.1 26.42 0.44 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.037 0.446 . . . . 0.0 110.652 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 962' ' ' SER . 59.6 tttm 61.12 136.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.573 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.854 ' HA ' HG21 ' A' ' 980' ' ' ILE . 4.7 t -58.06 129.11 82.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.148 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 1.013 ' HG2' HG11 ' A' ' 974' ' ' VAL . 55.7 Cg_endo -69.72 107.2 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.115 1.877 . . . . 0.0 112.197 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 10.4 Cg_endo -53.47 143.68 54.26 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.546 2.164 . . . . 0.0 111.078 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -40.4 113.33 0.95 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.171 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.809 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 24.2 Cg_exo -64.03 148.24 91.54 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.044 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 971' ' ' ASN . 0.2 OUTLIER -43.92 114.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.458 179.853 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.539 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 7.7 t30 71.01 -57.45 0.6 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.096 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 990' ' ' CYS . . . -70.06 -162.47 3.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.978 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.809 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 88.5 mtp -158.15 140.12 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 1.013 HG11 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -83.66 148.85 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.592 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -109.81 87.15 2.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.997 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.519 ' HA ' HG22 ' A' ' 986' ' ' ILE . 58.4 t -65.45 109.85 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 29.3 mm -75.14 -83.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.909 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.4 p -81.42 -61.04 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.266 0.555 . . . . 0.0 109.979 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 976' ' ' VAL . 4.3 p-10 -165.94 -130.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.558 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.854 HG21 ' HA ' ' A' ' 965' ' ' THR . 0.2 OUTLIER -144.97 10.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 111.109 178.871 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.771 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 26.0 mt-30 -85.68 171.76 11.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.988 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.1 t -44.31 143.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.2 -31.25 1.83 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.276 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 36.2 m -68.4 124.02 22.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.028 0.414 . . . . 0.0 110.928 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.788 ' HD2' ' N ' ' A' ' 986' ' ' ILE . 5.5 tmm_? -101.63 152.2 21.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.562 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.788 ' N ' ' HD2' ' A' ' 985' ' ' ARG . 38.3 pt -142.25 138.41 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 80.8 p -107.53 125.68 51.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.682 ' HB2' ' HA ' ' A' 1000 ' ' SER . 5.2 m-85 -92.08 149.24 21.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.761 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.9 m -159.93 121.3 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.075 0.464 . . . . 0.0 111.335 179.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.6 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 85.0 m -99.91 155.15 17.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 35.9 p -61.6 161.16 10.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.089 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.1 m -57.45 145.68 32.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.695 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.59 -45.62 1.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.184 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.58 ' CD2' ' HA ' ' A' 1022 ' ' ARG . 7.5 m80 -82.45 136.06 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.758 0.313 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.582 ' HB2' HD11 ' A' 1023 ' ' ILE . 44.0 ttm-85 -82.03 130.47 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.619 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.703 ' HA ' ' SG ' ' A' 1020 ' ' CYS . 0.9 OUTLIER -76.11 126.91 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.058 0.456 . . . . 0.0 111.59 -179.474 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.591 ' HB ' HG13 ' A' 1019 ' ' ILE . 1.7 mp -107.14 148.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.443 178.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.44 -119.35 4.84 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.021 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.42 ' C ' ' H ' ' A' 1001 ' ' SER . 92.0 m-70 -149.67 133.53 16.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.132 0.466 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.682 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.2 p -78.44 30.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.2 p -162.19 140.07 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.356 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -164.13 131.12 3.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.603 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -104.94 137.52 42.57 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.502 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 53.4 t -71.1 131.69 43.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' 1011 ' ' ALA . 45.9 pt -148.04 -165.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 111.285 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.616 HD21 ' HD3' ' A' ' 961' ' ' LYS . 3.9 mm? -99.04 163.42 12.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.648 ' HB3' ' HD2' ' A' 1012 ' ' HIS . 47.4 t -162.51 -116.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -49.96 -43.86 40.58 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.779 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.9 t30 -167.73 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 110.981 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 7.7 t -96.48 -162.52 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.227 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.728 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -80.05 139.11 37.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.996 0.426 . . . . 0.0 110.925 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.648 ' HD2' ' HB3' ' A' 1007 ' ' SER . 94.5 m-70 -149.4 140.03 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 89.3 m95 -66.71 133.6 50.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.069 0.461 . . . . 0.0 110.956 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.7 p -52.33 -23.97 6.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.883 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.0 p -121.4 140.37 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 111.695 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -54.26 151.73 12.84 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.083 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.02 105.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.321 2.014 . . . . 0.0 112.028 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.15 143.72 96.35 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.603 2.202 . . . . 0.0 111.942 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.591 HG13 ' HB ' ' A' ' 997' ' ' ILE . 36.5 pt -138.67 -171.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 89.9 m -153.78 131.4 11.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.506 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.512 ' HG2' HD11 ' A' ' 997' ' ' ILE . 98.2 mm-40 -80.32 132.31 35.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 994' ' ' HIS . 15.7 ptp180 -67.98 -25.17 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.86 ' HA ' HE22 ' A' 1080 ' ' GLN . 46.4 mt 59.96 73.11 0.68 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.833 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.706 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 78.1 Cg_exo -49.8 126.98 17.78 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.362 2.041 . . . . 0.0 112.447 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 23.8 t -88.49 147.18 24.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.661 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.07 142.66 28.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.64 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' 1028 ' ' PRO . 28.4 tp -54.73 131.41 65.37 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 1.012 ' HB3' HD11 ' A' 1072 ' ' ILE . 67.0 Cg_exo -52.6 153.77 13.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.195 2.597 . . . . 0.0 112.821 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 37.4 Cg_exo -58.98 127.83 25.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.353 2.035 . . . . 0.0 111.664 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.5 p -77.47 142.24 39.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.206 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' 1031 ' ' ILE . 29.7 pt -140.37 123.07 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.417 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.42 141.74 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.278 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 75.63 -37.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.765 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -65.04 121.13 20.77 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.4 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.542 ' HB3' ' HG2' ' A' 1053 ' ' ARG . 35.5 t0 -82.23 -158.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.841 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -157.18 142.67 17.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 111.339 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.895 HD11 ' HD3' ' A' 1053 ' ' ARG . 6.9 mt -149.69 -138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.851 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.677 ' H ' HG22 ' A' 1037 ' ' ILE . 58.2 m 71.81 -163.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.499 HG23 ' N ' ' A' 1040 ' ' ASN . 7.9 t -73.66 -46.63 45.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.689 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.564 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 73.0 m-80 -54.06 151.13 7.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.18 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.841 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 83.1 mtm180 -143.02 -48.57 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.256 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.1 OUTLIER -162.94 145.24 10.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.48 179.656 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' 1042 ' ' GLU . 2.7 m120 82.13 -46.59 0.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.517 ' HD2' ' HZ2' ' A' 1084 ' ' TRP . 1.1 m-85 54.82 57.07 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.738 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.706 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 50.6 m170 -52.52 -44.65 65.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.454 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.6 ' HB2' ' O ' ' A' 1045 ' ' HIS . 9.7 t80 166.89 70.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.999 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -77.59 -77.02 0.85 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.935 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 4.3 m 167.71 -53.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' 1073 ' ' TYR . 20.4 t -147.56 153.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.658 HG11 ' HG2' ' A' 1028 ' ' PRO . 10.4 p -135.65 120.22 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.3 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' A' 1071 ' ' SER . 91.4 m -93.85 126.37 39.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.391 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' 1053 ' ' ARG . 13.2 m-85 -82.42 -41.29 20.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.895 ' HD3' HD11 ' A' 1037 ' ' ILE . 17.2 ptt180 66.5 -34.04 0.2 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.165 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.665 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 83.9 m 66.95 135.53 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.723 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 2.2 m120 21.58 -105.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' 1061 ' ' ARG . 0.2 OUTLIER -154.9 139.36 16.83 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.96 0.409 . . . . 0.0 111.032 -179.225 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.542 ' O ' ' HG2' ' A' 1061 ' ' ARG . . . -88.92 -48.44 3.86 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.205 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . . . . . . . . . 66.7 m -102.3 -57.39 2.07 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.464 ' O ' HD22 ' A' 1056 ' ' LEU . 27.2 mtt85 -76.98 117.41 18.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.405 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 74.49 -37.7 1.01 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.77 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' 1056 ' ' LEU . 0.0 OUTLIER 62.3 -139.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.483 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.522 ' H ' ' CD ' ' A' 1061 ' ' ARG . 59.6 tttm 69.02 25.2 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.514 0.673 . . . . 0.0 110.053 -178.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' 1055 ' ' ASN . 11.7 p -84.86 23.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.787 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' 1064 ' ' PHE . 0.2 OUTLIER 39.24 -131.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.086 0.47 . . . . 0.0 109.932 179.459 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -132.1 123.79 27.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.919 178.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.611 HD21 ' CA ' ' A' 1070 ' ' PRO . 48.3 tp -68.85 129.04 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 111.678 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' 1090 ' ' GLN . 62.0 t -106.35 121.45 58.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.986 179.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.42 -147.58 34.48 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.548 179.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' 1069 ' ' GLU . 0.3 OUTLIER -69.01 131.3 90.89 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.611 ' CA ' HD21 ' A' 1066 ' ' LEU . 54.1 Cg_endo -70.77 -32.84 13.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 111.777 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' 1051 ' ' THR . 80.4 p -142.58 132.01 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.363 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 1.012 HD11 ' HB3' ' A' 1028 ' ' PRO . 18.4 pt -87.81 -167.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.167 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.85 ' HB3' HG22 ' A' 1049 ' ' VAL . 7.9 p90 -158.89 137.37 10.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 0.0 112.072 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 49.0 t -76.7 164.0 26.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.915 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 6.5 t -155.04 -33.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 89.8 p 58.97 148.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.303 0.377 . . . . 0.0 110.904 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.74 ' ND2' HD11 ' A' 1083 ' ' ILE . 0.0 OUTLIER -164.81 -30.1 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.716 ' H ' HD22 ' A' 1077 ' ' ASN . 62.2 t0 -55.42 -87.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.708 0.29 . . . . 0.0 111.14 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -163.2 -38.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.86 HE22 ' HA ' ' A' 1023 ' ' ILE . 72.2 tp60 -166.22 51.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.701 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 15.6 t -130.38 -48.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.568 -178.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 66.28 125.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.989 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . 0.74 HD11 ' ND2' ' A' 1077 ' ' ASN . 0.2 OUTLIER -150.42 137.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.025 0.44 . . . . 0.0 111.141 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.564 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 18.4 m95 -70.53 135.83 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.196 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 46.8 t -65.93 -50.93 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' 1072 ' ' ILE . . . -65.99 125.88 28.21 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.705 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.96 41.52 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.6 2.2 . . . . 0.0 112.817 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 58.71 138.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.319 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' 1090 ' ' GLN . 84.6 Cg_endo -80.39 -150.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.748 2.299 . . . . 0.0 112.237 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.774 ' HG2' HG12 ' A' 1092 ' ' ILE . 35.0 tt0 -152.36 134.07 14.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.272 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 37.0 m -91.96 78.6 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.795 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . 0.774 HG12 ' HG2' ' A' 1090 ' ' GLN . 46.0 pt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.442 179.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.064 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 4.3 mptp? 61.63 159.07 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.407 0.623 . . . . 0.0 112.153 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.439 ' C ' ' HB3' ' A' 1011 ' ' ALA . 49.6 m -157.94 138.96 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.678 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.587 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -79.93 38.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 111.608 -179.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 55.6 tptt 63.68 130.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.564 ' HA ' HD12 ' A' ' 980' ' ' ILE . 88.8 m -74.43 130.04 82.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.733 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.712 ' HG2' HG11 ' A' ' 974' ' ' VAL . 68.8 Cg_endo -101.34 72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.912 3.075 . . . . 0.0 113.38 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 968' ' ' ASP . 57.1 Cg_endo -70.02 125.9 12.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.985 1.79 . . . . 0.0 111.731 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 967' ' ' PRO . 59.0 m-20 16.5 62.8 0.18 Allowed Pre-proline 0 N--CA 1.467 0.378 0 O-C-N 123.759 0.662 . . . . 0.0 112.167 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.634 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 39.2 Cg_exo -58.83 -143.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.002 2.468 . . . . 0.0 113.185 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' 1019 ' ' ILE . 4.0 p -49.05 85.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.819 -179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 969' ' ' PRO . 6.7 p-10 38.95 48.73 1.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.979 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.634 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -162.44 128.57 1.9 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.805 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 22.2 ptm -88.77 135.92 33.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 111.548 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.81 HG21 HD12 ' A' ' 986' ' ' ILE . 4.1 p -91.56 146.85 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -107.59 96.71 6.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.24 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.781 ' HA ' HG22 ' A' ' 986' ' ' ILE . 14.0 m -65.37 113.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.298 0.57 . . . . 0.0 110.801 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 987' ' ' THR . 38.8 mt -79.92 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.315 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.1 p -149.33 54.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.572 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 980' ' ' ILE . 1.6 m-20 59.57 -154.32 0.37 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.942 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.629 HG22 ' HH2' ' A' 1013 ' ' TRP . 6.1 pt -155.91 95.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.117 0.484 . . . . 0.0 111.463 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 24.0 mt-30 -152.62 28.98 0.54 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.55 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 66.0 t 102.13 135.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 124.239 0.962 . . . . 0.0 111.099 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.34 -29.75 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.862 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 982' ' ' VAL . 49.7 m -68.4 132.93 47.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 111.058 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 38.2 ttm180 -101.71 147.42 26.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.81 HD12 HG21 ' A' ' 974' ' ' VAL . 39.7 pt -143.14 134.08 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.17 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.738 ' HA ' ' HA ' ' A' 1001 ' ' SER . 80.3 p -100.72 122.96 44.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.597 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.8 m-85 -88.36 120.47 29.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 80.9 p -88.82 -54.09 4.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.609 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 13.0 t 69.54 142.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -178.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.1 p -60.25 146.75 42.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.284 0.564 . . . . 0.0 111.849 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.1 t -52.99 -26.65 15.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.38 41.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.52 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -139.87 139.99 36.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.245 0.522 . . . . 0.0 111.413 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' 1080 ' ' GLN . 57.0 ttt-85 -81.97 125.62 30.98 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.029 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' 1018 ' ' PRO . 0.7 OUTLIER -72.78 140.37 47.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.226 0.536 . . . . 0.0 111.605 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' 1019 ' ' ILE . 45.6 mm -107.92 148.53 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.1 41.49 21.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.674 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.46 136.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 112.122 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 82.7 p -79.16 36.36 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.439 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 46.2 m -158.58 160.61 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.471 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -159.81 128.8 5.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.392 . . . . 0.0 111.892 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -104.99 125.16 50.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.116 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 31.1 t -68.8 129.3 39.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.731 0.3 . . . . 0.0 110.753 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.727 HD13 ' HB2' ' A' 1014 ' ' SER . 15.0 pt -138.51 152.52 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' 1007 ' ' SER . 0.3 OUTLIER -95.47 120.38 35.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.405 ' N ' HD13 ' A' 1006 ' ' LEU . 47.0 t -80.9 -45.17 17.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.363 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -166.09 -34.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.079 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -148.84 -49.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.15 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 86.8 m -99.75 135.87 40.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 179.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.587 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.36 143.05 43.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.268 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.417 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 90.7 m-70 -149.45 142.94 25.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.629 ' HH2' HG22 ' A' ' 980' ' ' ILE . 79.3 m95 -68.14 116.71 9.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.105 0.478 . . . . 0.0 110.642 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.727 ' HB2' HD13 ' A' 1005 ' ' ILE . 47.2 t -52.42 -22.35 4.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.243 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.1 p -90.1 16.34 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.821 ' HA ' ' HE3' ' A' 1016 ' ' LYS . 0.0 OUTLIER 58.58 159.27 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.275 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.39 127.31 25.45 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.25 1.967 . . . . 0.0 112.104 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.626 ' HB2' HD21 ' A' ' 996' ' ' LEU . 67.2 Cg_endo -73.09 148.55 44.84 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.797 2.332 . . . . 0.0 112.371 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.965 ' HA ' HG11 ' A' ' 970' ' ' VAL . 6.4 tt -148.81 125.31 2.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.592 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 61.7 m -85.45 101.28 12.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.493 . . . . 0.0 112.006 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.453 ' HB3' HD11 ' A' ' 997' ' ' ILE . 7.6 tt0 -79.7 140.06 37.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.112 178.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.5 tpt180 -50.03 135.8 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.377 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' 1046 ' ' TYR . 26.6 mm -55.59 119.29 23.82 Favored Pre-proline 0 C--O 1.226 -0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.368 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' 1045 ' ' HIS . 67.4 Cg_endo -92.37 138.5 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.184 2.589 . . . . 0.0 112.877 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1025 ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 71.8 m -112.93 30.08 7.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.752 0.311 . . . . 0.0 111.622 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 42.84 -138.03 3.26 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.776 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1027 ' ' LEU . . . . . 0.532 ' HB3' ' HD2' ' A' 1028 ' ' PRO . 19.9 mt -108.74 164.96 13.56 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1028 ' ' PRO . . . . . 0.618 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 37.9 Cg_endo -66.0 152.22 81.91 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.72 2.28 . . . . 0.0 112.3 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1029 ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' A' 1030 ' ' THR . 86.1 Cg_exo -47.44 -29.2 9.69 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.626 2.217 . . . . 0.0 112.935 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1030 ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' 1029 ' ' PRO . 20.1 m 64.71 147.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1031 ' ' ILE . . . . . 0.536 ' HB ' ' HB1' ' A' 1088 ' ' ALA . 13.2 tt -152.47 125.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1032 ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -65.75 135.62 55.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.518 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1033 ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' 1032 ' ' ALA . 4.4 m120 74.81 -38.19 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.574 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1034 ' ' GLY . . . . . 0.811 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.66 121.6 22.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.699 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1035 ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' 1036 ' ' PHE . 9.6 t70 -74.46 163.34 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1036 ' ' PHE . . . . . 0.487 ' HB2' ' CG2' ' A' 1050 ' ' VAL . 29.9 p90 -144.31 136.35 26.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.204 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1037 ' ' ILE . . . . . 0.917 HG22 ' H ' ' A' 1038 ' ' SER . 5.7 mt -87.91 -160.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1038 ' ' SER . . . . . 0.917 ' H ' HG22 ' A' 1037 ' ' ILE . 57.0 m 55.26 -133.04 1.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1039 ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' 1041 ' ' ARG . 41.1 p -152.96 70.1 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1040 ' ' ASN . . . . . 0.637 HD21 ' HB ' ' A' 1050 ' ' VAL . 5.8 m120 -78.29 44.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.499 0.666 . . . . 0.0 109.69 178.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1041 ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' 1039 ' ' THR . 32.6 ptt180 -82.5 -43.93 16.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.209 -178.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1042 ' ' GLU . . . . . 0.455 ' HG2' ' H ' ' A' 1043 ' ' ASN . 74.3 tt0 -162.92 -126.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.922 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1043 ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' 1044 ' ' PHE . 3.1 m120 37.48 -125.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.212 0.205 . . . . 0.0 111.136 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1044 ' ' PHE . . . . . 0.618 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 5.3 m-30 69.52 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.969 0.414 . . . . 0.0 111.589 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1045 ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' 1023 ' ' ILE . 70.6 m-70 -149.42 -49.48 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.704 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1046 ' ' TYR . . . . . 0.665 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.5 t80 176.32 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.743 0.782 . . . . 0.0 110.343 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.48 -18.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.049 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1048 ' ' SER . . . . . . . . . . . . . 70.0 p -47.6 145.53 2.61 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.877 -0.662 . . . . 0.0 112.78 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1049 ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -145.59 155.26 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.457 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1050 ' ' VAL . . . . . 0.637 ' HB ' HD21 ' A' 1040 ' ' ASN . 5.9 p -153.97 130.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.981 0.419 . . . . 0.0 112.041 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1051 ' ' THR . . . . . 0.585 ' HB ' HD12 ' A' 1037 ' ' ILE . 85.8 m -103.43 116.55 32.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1052 ' ' TYR . . . . . 0.582 ' HE1' HG12 ' A' 1072 ' ' ILE . 7.4 m-85 -74.92 151.37 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1053 ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' 1053 ' ' ARG . 50.1 ttt-85 -142.75 -13.89 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.948 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1054 ' ' CYS . . . . . 0.811 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 91.9 m 69.88 152.19 0.1 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.895 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1055 ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' 1033 ' ' ASN . 27.9 t-20 -50.34 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.577 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1056 ' ' LEU . . . . . 0.811 HD23 HG23 ' A' 1063 ' ' VAL . 15.8 mt 61.02 -148.27 0.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.591 0.71 . . . . 0.0 111.393 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1057 ' ' GLY . . . . . 0.464 ' C ' ' N ' ' A' 1059 ' ' ARG . . . 71.84 -34.49 0.61 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.903 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1058 ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' 1059 ' ' ARG . 53.2 m -47.67 -26.99 1.71 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1059 ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' 1057 ' ' GLY . 39.3 mmm-85 -157.07 -1.24 0.11 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.488 -1.687 . . . . 0.0 108.656 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1060 ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' 1061 ' ' ARG . . . 48.31 30.46 7.97 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1061 ' ' ARG . . . . . 0.603 ' HD2' ' N ' ' A' 1062 ' ' LYS . 4.8 tmm_? 178.65 134.98 0.08 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.064 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1062 ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' 1061 ' ' ARG . 39.5 ttpt 54.64 42.34 31.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.904 0.859 . . . . 0.0 109.37 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1063 ' ' VAL . . . . . 0.811 HG23 HD23 ' A' 1056 ' ' LEU . 14.8 m -140.59 57.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.466 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1064 ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 71.3 m-85 83.9 95.59 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.081 -178.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -89.85 151.15 21.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.185 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1066 ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' 1070 ' ' PRO . 27.6 tp -68.56 142.67 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.484 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1067 ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 58.9 t -139.0 133.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.29 -139.12 21.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.956 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1069 ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' 1069 ' ' GLU . 1.1 pm0 -66.4 125.6 90.66 Favored Pre-proline 0 N--CA 1.453 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 111.837 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1070 ' ' PRO . . . . . 0.523 ' HB3' HD21 ' A' 1066 ' ' LEU . 3.3 Cg_endo -83.8 -26.94 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.142 2.562 . . . . 0.0 112.134 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1071 ' ' SER . . . . . 0.442 ' OG ' HG23 ' A' 1051 ' ' THR . 49.1 m -144.09 147.84 34.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1072 ' ' ILE . . . . . 0.582 HG12 ' HE1' ' A' 1052 ' ' TYR . 26.6 pt -143.61 160.65 16.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.336 0.588 . . . . 0.0 111.761 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1073 ' ' TYR . . . . . 0.53 ' HB3' HG23 ' A' 1049 ' ' VAL . 0.6 OUTLIER -160.19 148.61 16.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.504 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A 1074 ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 48.3 t -65.66 145.33 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1075 ' ' THR . . . . . . . . . . . . . 9.9 t -157.7 23.13 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.767 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1076 ' ' SER . . . . . . . . . . . . . 99.2 p 52.59 176.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.575 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1077 ' ' ASN . . . . . 0.707 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -174.1 -40.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.508 179.903 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A 1078 ' ' ASP . . . . . 0.707 ' H ' HD22 ' A' 1077 ' ' ASN . 7.9 t70 -84.04 -75.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.841 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.14 -41.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1080 ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 995' ' ' ARG . 3.0 pm0 -162.87 29.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1081 ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' 1078 ' ' ASP . 21.9 t -83.92 -37.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1082 ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 78.85 45.82 8.93 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.165 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 67.7 mt -81.98 136.04 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.008 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1084 ' ' TRP . . . . . 0.616 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.4 m95 -70.54 146.76 49.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.862 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1085 ' ' SER . . . . . . . . . . . . . 85.2 p -44.93 -37.25 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.885 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1086 ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.63 141.07 6.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.907 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 34.0 Cg_exo -57.79 177.29 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.928 2.419 . . . . 0.0 112.758 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1088 ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' 1031 ' ' ILE . . . -63.63 141.34 97.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.618 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1089 ' ' PRO . . . . . 0.488 ' HB2' ' H ' ' A' 1090 ' ' GLN . 37.6 Cg_endo -66.72 -141.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.916 2.411 . . . . 0.0 112.586 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1090 ' ' GLN . . . . . 0.671 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -145.37 132.65 20.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.019 0.437 . . . . 0.0 111.206 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1091 ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 95.9 m -99.53 72.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.197 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 35.9 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.044 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.638 0.256 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.44 -46.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -172.22 123.76 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.824 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -172.75 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.369 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.46 126.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.453 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -99.49 141.84 31.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.161 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.664 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 93.7 m -80.0 33.02 0.27 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.792 0.33 . . . . 0.0 110.809 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 962' ' ' SER . 60.5 tttp 60.8 136.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.546 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 42.8 m -63.94 124.55 85.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.167 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.671 ' HG2' HG11 ' A' ' 974' ' ' VAL . 37.0 Cg_endo -66.06 109.73 1.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.217 1.945 . . . . 0.0 111.958 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 9.0 Cg_exo -71.41 129.93 16.6 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.642 2.228 . . . . 0.0 111.805 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -51.33 104.9 0.46 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 2.6 Cg_exo -76.6 -152.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.734 2.289 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 970' ' ' VAL . 2.2 p -50.47 83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.156 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 991' ' ' THR . 3.4 t30 68.68 -34.9 0.28 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.622 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.4 116.4 7.48 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.253 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.27 140.17 31.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.584 0.23 . . . . 0.0 111.162 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.671 HG11 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -89.94 147.69 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.208 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 977' ' ' ILE . 18.8 m170 -111.94 82.53 1.64 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 976' ' ' VAL . 4.3 p -69.04 85.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 975' ' ' HIS . 50.5 mt -75.37 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.25 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.9 p -55.9 -72.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.671 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 3.4 m-20 -157.42 -133.33 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 979' ' ' ASP . 1.5 pt -155.87 -21.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 25.3 mt-30 -72.52 176.42 5.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.447 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' 1004 ' ' CYS . 71.4 t -44.35 144.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.938 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.66 -30.43 1.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.439 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.671 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 34.6 m -68.47 153.53 43.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' 1002 ' ' ALA . 53.0 ttt-85 -138.32 150.02 46.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.906 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.484 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 36.4 pt -142.8 -169.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 68.3 p -148.49 130.63 15.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.486 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.5 OUTLIER -98.31 154.95 17.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.076 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 94.1 p -161.23 128.1 4.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 111.851 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.612 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 85.1 m -82.92 51.15 1.86 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.944 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.531 HG22 HD21 ' A' ' 971' ' ' ASN . 14.9 t 38.22 -149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.262 0.553 . . . . 0.0 111.907 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 19.4 m -95.65 141.21 29.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.46 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.47 82.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.161 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.534 ' HB2' ' O ' ' A' ' 990' ' ' CYS . 50.4 m80 -152.83 135.03 14.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.92 0.36 . . . . 0.0 110.846 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.428 ' HG3' HH11 ' A' ' 995' ' ' ARG . 38.4 ttt85 -81.94 121.45 26.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 997' ' ' ILE . 2.9 tt -76.2 128.86 35.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.456 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.679 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -102.22 146.87 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.13 -118.86 4.71 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.503 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -149.65 129.54 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.164 0.482 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.0 p -69.9 -43.99 70.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 95.7 p -77.85 136.08 38.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.64 149.62 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.454 . . . . 0.0 111.433 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -134.0 131.63 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 50.3 t -70.43 96.88 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' 1012 ' ' HIS . 27.5 pt -90.43 -175.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' 1011 ' ' ALA . 9.6 tp -158.42 120.41 3.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 43.8 m -81.77 -48.65 11.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.495 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.88 -48.21 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.96 -49.83 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 91.6 m -151.19 149.95 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.304 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.664 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.16 140.48 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.553 ' O ' HG12 ' A' 1005 ' ' ILE . 90.5 m-70 -149.39 145.88 27.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 71.7 m95 -71.27 132.66 45.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.735 0.303 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.8 p -52.46 -29.07 22.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 72.9 p -87.76 -134.62 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -166.95 150.13 6.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.731 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -40.62 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.17 . . . . 0.0 112.503 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 29.8 Cg_exo -63.1 135.64 52.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.907 2.405 . . . . 0.0 112.028 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.917 HG22 ' H ' ' A' 1020 ' ' CYS . 5.0 mt -95.75 -170.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.006 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.917 ' H ' HG22 ' A' 1019 ' ' ILE . 67.6 m -152.31 98.02 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.473 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.597 ' H ' HD13 ' A' ' 997' ' ' ILE . 3.4 tp-100 -82.53 131.51 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.684 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.8 tpt180 -65.9 127.93 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.61 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.3 mm -63.25 106.63 0.94 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.504 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' 1045 ' ' HIS . 3.5 Cg_exo -76.12 136.37 18.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.7 2.267 . . . . 0.0 112.881 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.78 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 29.8 p -124.73 133.94 53.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.03 -154.45 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.733 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.54 147.97 87.54 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 120.66 0.266 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.712 ' HD3' ' HE2' ' A' 1044 ' ' PHE . 78.6 Cg_endo -75.86 142.97 25.94 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.533 2.155 . . . . 0.0 111.6 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.752 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.0 Cg_exo -51.67 106.29 0.13 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 121.997 1.798 . . . . 0.0 111.508 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 90.3 m -77.46 126.81 31.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.665 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.936 HD13 ' HB2' ' A' 1089 ' ' PRO . 18.0 pt -90.41 136.53 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.893 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -52.0 138.38 25.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.774 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.559 ' HA ' ' ND2' ' A' 1055 ' ' ASN . 4.4 m120 75.14 -36.18 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.282 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.799 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -72.23 132.86 19.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.814 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -81.64 -159.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.148 0.499 . . . . 0.0 111.335 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.638 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -155.99 133.18 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.587 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' 1050 ' ' VAL . 39.4 pt -142.04 -148.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.963 0.411 . . . . 0.0 111.484 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.486 ' HB2' ' H ' ' A' 1051 ' ' THR . 8.2 t 78.21 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.861 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 28.7 p -66.46 -43.3 85.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.755 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' 1044 ' ' PHE . 4.5 m120 -52.21 140.18 21.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.254 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.638 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 86.3 mtm180 -155.16 -47.17 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.402 ' C ' ' HD1' ' A' 1044 ' ' PHE . 23.4 pt-20 -162.99 -43.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -71.67 58.26 0.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.461 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.712 ' HE2' ' HD3' ' A' 1028 ' ' PRO . 2.3 m-85 -76.68 132.21 39.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' 1046 ' ' TYR . 55.4 m170 -130.71 -56.29 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.16 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' 1023 ' ' ILE . 78.0 t80 170.79 150.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.443 0.464 . . . . 0.0 110.386 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.577 ' N ' ' HB2' ' A' 1074 ' ' CYS . . . 76.46 -31.12 1.42 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.681 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.427 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 49.4 m -45.85 131.26 9.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' 1072 ' ' ILE . 6.8 p -102.2 146.45 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' 1037 ' ' ILE . 7.3 p -133.39 135.15 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.504 ' HB ' HG13 ' A' 1037 ' ' ILE . 44.1 m -98.63 122.57 42.01 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.53 ' OH ' ' HB2' ' A' 1028 ' ' PRO . 3.6 m-85 -85.64 167.11 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.508 ' HG3' HH11 ' A' 1053 ' ' ARG . 28.9 mtt85 -159.59 -149.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.972 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.799 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 8.5 t -163.57 157.68 19.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 110.531 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.699 ' O ' ' HG ' ' A' 1056 ' ' LEU . 77.2 m-20 -55.13 153.47 6.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.513 . . . . 0.0 112.316 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' 1055 ' ' ASN . 1.4 mt -154.97 43.25 0.47 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.937 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' 1058 ' ' SER . . . 72.48 -59.48 1.59 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.387 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' 1057 ' ' GLY . 43.3 t 174.38 -18.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 0.0 110.681 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -155.27 55.47 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.28 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . 72.49 129.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.285 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.501 ' O ' HD23 ' A' 1056 ' ' LEU . 39.6 ttm180 -178.15 145.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.577 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -65.25 81.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' 1056 ' ' LEU . 9.6 m -151.82 88.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.516 0.674 . . . . 0.0 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.905 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 72.5 m-85 70.79 141.86 0.05 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.511 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.7 mt-10 -142.39 142.33 32.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 111.103 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' 1067 ' ' VAL . 1.4 tt -68.57 137.71 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.295 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.825 ' N ' HD23 ' A' 1066 ' ' LEU . 7.3 p -139.49 127.43 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.663 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.55 138.56 1.4 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.395 -0.821 . . . . 0.0 114.056 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.807 ' O ' ' HG3' ' A' 1089 ' ' PRO . 32.9 tt0 36.75 59.21 3.64 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.193 0.597 . . . . 0.0 112.457 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.21 6.58 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.231 1.954 . . . . 0.0 112.612 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' 1069 ' ' GLU . 81.0 p -156.17 147.12 22.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.308 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' 1028 ' ' PRO . 44.7 pt -142.22 179.73 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -160.06 154.68 24.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.447 . . . . 0.0 111.828 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.577 ' HB2' ' N ' ' A' 1047 ' ' GLY . 65.8 m -62.6 146.23 52.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.907 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.0 t -155.76 -158.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.055 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.6 p -151.48 143.37 23.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' 1077 ' ' ASN . 0.0 OUTLIER -164.82 29.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.6 t70 176.38 52.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.258 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.25 -129.08 0.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.503 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.684 ' HG2' ' H ' ' A' 1081 ' ' VAL . 6.7 tt0 -67.59 -139.85 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.684 ' H ' ' HG2' ' A' 1080 ' ' GLN . 27.2 t 72.99 -43.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 122.541 0.336 . . . . 0.0 111.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.78 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 67.85 64.51 3.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.658 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' 1083 ' ' ILE . 3.4 mp -81.89 135.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 110.555 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 26.0 m95 -78.14 -160.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 77.6 p -81.58 -65.03 1.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 144.14 5.53 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.696 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.752 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 98.5 Cg_endo -83.71 49.9 3.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.097 2.531 . . . . 0.0 112.034 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.495 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -64.33 -41.62 61.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.936 ' HB2' HD13 ' A' 1031 ' ' ILE . 86.6 Cg_exo -45.78 137.78 12.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.507 2.138 . . . . 0.0 113.051 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.802 ' O ' HG12 ' A' 1067 ' ' VAL . 38.3 tt0 -150.32 143.08 24.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.905 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 73.9 m -84.32 137.18 33.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.458 ' H ' ' H ' ' A' 1065 ' ' GLU . 31.0 pt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -171.61 -44.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.82 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 63.78 123.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.796 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 43.39 38.23 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.851 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.542 ' HG3' HD11 ' A' 1006 ' ' LEU . 46.6 mmtm 62.1 145.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.987 0.423 . . . . 0.0 111.422 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 82.1 p -157.97 136.01 10.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.5 m -79.95 164.45 23.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.317 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.84 126.77 28.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 965' ' ' THR . 4.2 t -76.77 114.09 35.81 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.855 ' HG2' HG11 ' A' ' 974' ' ' VAL . 86.5 Cg_endo -85.48 111.06 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.485 2.123 . . . . 0.0 112.142 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 19.6 Cg_endo -58.88 -39.55 80.24 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.282 1.988 . . . . 0.0 110.951 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 62.9 t0 179.25 119.14 0.21 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.443 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 974' ' ' VAL . 35.5 Cg_endo -64.84 -150.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 112.613 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.786 HG11 ' H ' ' A' 1020 ' ' CYS . 9.6 p -53.13 -136.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.559 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.751 ' H ' HG22 ' A' ' 970' ' ' VAL . 4.7 m120 -65.33 -33.39 75.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.066 0.46 . . . . 0.0 110.583 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.439 ' H ' HG13 ' A' ' 970' ' ' VAL . . . -69.08 -147.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.803 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 85.5 mtp -156.35 142.51 18.2 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.327 0.251 . . . . 0.0 110.408 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.855 HG11 ' HG2' ' A' ' 966' ' ' PRO . 1.1 p -92.18 144.94 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.004 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.405 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 23.1 m170 -121.22 112.38 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 980' ' ' ILE . 90.5 t -64.72 -41.49 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.773 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 978' ' ' THR . 20.2 mt 64.88 -98.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.144 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 977' ' ' ILE . 12.6 p -80.73 -52.85 7.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.528 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 980' ' ' ILE . 21.1 m-20 -169.3 -157.69 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.235 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 976' ' ' VAL . 20.1 pt -155.91 10.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.837 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 74.3 mt-30 -73.2 -45.72 54.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.624 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 7.5 p 167.38 151.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 79.43 -40.32 2.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.361 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 14.4 t -69.83 141.99 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.39 . . . . 0.0 111.049 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 37.3 ttm180 -110.96 118.29 35.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.118 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.615 HD12 ' CG2' ' A' ' 974' ' ' VAL . 36.7 pt -91.28 138.46 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.203 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 82.6 p -103.51 132.18 49.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 4.7 m-85 -101.41 152.62 20.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.7 m -154.21 126.05 7.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.594 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 991' ' ' THR . 37.3 t -98.64 178.68 4.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.422 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 61.2 p -65.11 -158.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.216 0.532 . . . . 0.0 111.84 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 46.0 m -86.04 -68.02 0.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.001 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' 1046 ' ' TYR . . . -81.02 42.29 2.7 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.424 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.6 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 41.6 m80 -149.48 125.35 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 0.0 110.726 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.58 ' HB3' ' NE2' ' A' 1080 ' ' GLN . 52.2 ttt-85 -95.14 121.63 36.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.745 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 1.4 tt -76.21 137.34 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.66 ' HB ' HG23 ' A' 1019 ' ' ILE . 1.8 mp -101.29 149.81 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.017 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.79 34.68 38.01 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.691 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 58.96 130.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.223 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 988' ' ' TYR . 49.8 m -83.05 41.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.62 ' O ' HG21 ' A' 1015 ' ' THR . 68.8 m -162.18 148.39 13.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -159.22 128.06 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.5 tt0 -103.25 125.67 50.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.527 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 44.6 t -68.4 84.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' 1014 ' ' SER . 49.7 pt -87.3 -162.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.737 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' 1007 ' ' SER . 5.2 tt -158.36 125.81 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.346 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.544 ' N ' HD23 ' A' 1006 ' ' LEU . 45.3 m -78.39 -55.88 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.413 ' N ' HD23 ' A' 1006 ' ' LEU . . . 169.55 42.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.727 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.521 ' H ' HD21 ' A' 1006 ' ' LEU . 21.7 p30 -177.9 -36.95 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 111.578 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.26 149.58 29.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.527 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.26 132.95 41.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.129 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -149.43 145.81 27.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.501 ' HH2' HG22 ' A' ' 980' ' ' ILE . 52.3 m95 -70.82 122.83 20.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.328 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.6 p -52.48 -25.69 10.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.708 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.62 HG21 ' O ' ' A' 1001 ' ' SER . 50.5 p -87.72 -144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' 1016 ' ' LYS . 10.7 mtmp? -151.57 161.27 30.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.281 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 78.6 Cg_exo -40.95 124.69 2.08 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.61 2.206 . . . . 0.0 112.692 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.647 ' HB2' HD21 ' A' ' 996' ' ' LEU . 90.7 Cg_endo -80.67 145.59 16.32 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.143 2.562 . . . . 0.0 113.376 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 997' ' ' ILE . 7.2 tt -148.84 113.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.99 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.786 ' H ' HG11 ' A' ' 970' ' ' VAL . 9.7 t -86.44 121.16 28.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.124 0.488 . . . . 0.0 111.382 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -85.55 136.61 33.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.616 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' 1024 ' ' PRO . 57.8 mtt85 -75.93 127.75 33.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.177 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.775 HG12 ' HG3' ' A' 1080 ' ' GLN . 84.9 mt -76.73 108.54 6.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.282 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.912 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 66.7 Cg_endo -74.0 121.54 7.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.384 2.056 . . . . 0.0 111.384 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.529 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 16.8 m -89.16 28.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' A' 1044 ' ' PHE . . . 37.22 -158.83 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.668 -0.697 . . . . 0.0 114.273 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' 1027 ' ' LEU . 7.7 mp -74.01 145.78 84.09 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 122.599 0.36 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.843 ' HB3' HD11 ' A' 1072 ' ' ILE . 23.1 Cg_exo -63.43 144.8 91.57 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.731 2.287 . . . . 0.0 111.375 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' 1072 ' ' ILE . 5.9 Cg_endo -47.86 113.9 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.243 1.962 . . . . 0.0 111.396 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 64.0 p -77.78 141.36 39.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.304 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.501 HD13 ' HB1' ' A' 1088 ' ' ALA . 25.6 pt -147.82 121.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.64 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.08 135.63 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.123 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' 1032 ' ' ALA . 76.4 m-20 75.01 -38.36 0.38 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.516 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -69.98 76.97 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.81 126.26 29.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' 1038 ' ' SER . 17.8 p90 -93.26 147.3 23.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.98 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' 1038 ' ' SER . 49.8 mm -87.37 159.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.822 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.484 ' N ' HG22 ' A' 1037 ' ' ILE . 23.1 t 75.39 144.65 0.08 Allowed 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' 1041 ' ' ARG . 17.0 p -66.13 -57.02 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.486 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 61.28 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' 1039 ' ' THR . 49.8 mtt85 40.27 -128.36 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.29 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' 1043 ' ' ASN . 8.2 pt-20 -77.15 -145.75 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' 1042 ' ' GLU . 62.9 m-20 34.85 36.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.212 0.529 . . . . 0.0 110.61 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.474 ' CZ ' ' HA2' ' A' 1026 ' ' GLY . 1.2 p90 -89.02 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.048 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.912 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 21.0 p-80 -165.36 -164.59 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.174 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.512 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 22.1 t80 -59.24 153.76 17.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 111.56 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' 1049 ' ' VAL . . . 68.77 10.52 61.24 Favored Glycine 0 C--N 1.33 0.222 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.296 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' A' 1025 ' ' CYS . 74.4 p -48.39 134.32 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.179 0.49 . . . . 0.0 109.929 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.766 HG22 ' HA ' ' A' 1073 ' ' TYR . 38.3 t -146.72 142.86 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 28.4 m -152.64 134.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.192 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.419 HG23 ' OG ' ' A' 1071 ' ' SER . 91.2 m -92.9 124.72 37.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.695 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.583 ' OH ' HD13 ' A' 1072 ' ' ILE . 8.2 m-85 -73.72 154.67 39.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.473 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.458 ' HG3' HH11 ' A' 1053 ' ' ARG . 38.0 ttt85 -148.3 0.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.959 ' HB2' HG12 ' A' 1063 ' ' VAL . 59.0 m 64.12 152.27 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 111.079 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' 1057 ' ' GLY . 48.5 t30 -62.62 -49.19 76.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' 1060 ' ' GLY . 0.4 OUTLIER -71.31 39.23 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' 1055 ' ' ASN . . . -89.02 -24.17 32.93 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.1 p -151.91 121.14 6.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.324 -0.938 . . . . 0.0 109.52 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' 1058 ' ' SER . 38.5 mmt180 81.71 44.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.32 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.806 ' C ' HD23 ' A' 1056 ' ' LEU . . . 179.99 -44.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' 1062 ' ' LYS . 51.4 mmt-85 64.5 177.59 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 122.499 0.32 . . . . 0.0 111.826 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' 1061 ' ' ARG . 16.0 tptm 75.85 -41.7 0.44 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.367 0.603 . . . . 0.0 109.619 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.959 HG12 ' HB2' ' A' 1054 ' ' CYS . 0.0 OUTLIER 47.64 40.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.346 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.569 ' HE1' ' H ' ' A' 1056 ' ' LEU . 0.1 OUTLIER 42.84 -138.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -150.19 121.07 7.62 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.342 0.591 . . . . 0.0 110.47 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' 1070 ' ' PRO . 55.0 tp -68.5 145.58 53.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.167 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 65.1 t -138.2 131.75 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.889 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.38 -143.67 22.91 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.429 ' OE2' HG22 ' A' 1072 ' ' ILE . 22.5 pt-20 -68.49 126.94 93.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.436 ' HB3' HD21 ' A' 1066 ' ' LEU . 2.7 Cg_endo -83.3 -10.21 10.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.104 2.536 . . . . 0.0 111.759 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.419 ' OG ' HG23 ' A' 1051 ' ' THR . 49.4 m -153.5 127.41 8.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.093 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' 1028 ' ' PRO . 19.4 pt -89.5 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.3 0.572 . . . . 0.0 111.905 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.766 ' HA ' HG22 ' A' 1049 ' ' VAL . 24.8 p90 -145.06 128.94 17.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 13.5 t -63.68 164.15 10.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.113 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.0 t -155.78 -27.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.484 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 56.1 m 65.48 146.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.921 0.391 . . . . 0.0 111.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.725 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -164.98 -34.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.725 ' H ' HD22 ' A' 1077 ' ' ASN . 9.5 t70 -60.28 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.62 0.248 . . . . 0.0 110.863 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -162.95 -42.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.761 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.775 ' HG3' HG12 ' A' 1023 ' ' ILE . 52.4 tt0 -175.0 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.23 0.538 . . . . 0.0 110.321 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' 1082 ' ' GLY . 20.5 t -83.33 -117.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.678 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . -165.78 50.85 0.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.776 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' 1083 ' ' ILE . 2.0 mp -81.95 126.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.697 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.8 m95 -85.37 -151.23 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' 1073 ' ' TYR . 80.2 p -95.39 -27.63 15.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.111 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.43 152.66 21.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.612 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 10.7 Cg_exo -73.48 47.35 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 112.883 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' 1031 ' ' ILE . . . 65.36 141.89 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.859 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.504 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 58.6 Cg_endo -69.89 -146.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.726 2.284 . . . . 0.0 112.113 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.472 ' H ' ' HB2' ' A' 1089 ' ' PRO . 3.3 mm100 -150.65 128.71 11.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 91.9 m -96.69 70.54 2.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.459 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.25 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.64 0.257 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.14 132.56 52.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.027 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 86.5 tt0 53.96 45.13 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 110.412 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -78.46 38.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.262 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 0.8 OUTLIER 61.63 122.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.628 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 31.0 t -157.95 131.96 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.934 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 2.9 p -79.84 142.22 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.68 126.36 27.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 0.0 110.665 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.775 ' HB ' HD13 ' A' ' 980' ' ' ILE . 9.1 t -67.89 131.91 92.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.111 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.65 ' HG2' HG21 ' A' ' 974' ' ' VAL . 22.7 Cg_exo -64.74 108.83 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.349 2.033 . . . . 0.0 111.649 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 965' ' ' THR . 88.9 Cg_exo -48.02 -46.76 21.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.537 2.158 . . . . 0.0 111.644 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 968' ' ' ASP . 2.1 p30 179.28 111.73 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.223 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.55 152.9 74.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.668 2.245 . . . . 0.0 111.971 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.509 ' HB ' HG13 ' A' 1019 ' ' ILE . 60.0 t -48.02 100.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 75.3 m-20 74.44 -50.74 0.68 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.597 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -73.44 141.34 29.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.908 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.4 mtp -89.28 138.12 31.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 966' ' ' PRO . 4.9 p -83.5 151.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.397 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 987' ' ' THR . 21.8 m170 -119.07 76.17 1.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.812 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.535 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 48.5 t -75.21 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.27 -75.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.825 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 33.2 p -56.42 -88.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.567 ' OD1' ' HB2' ' A' ' 981' ' ' GLN . 2.8 p30 -168.7 151.42 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 965' ' ' THR . 5.1 pt -83.93 27.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.337 0.589 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.567 ' HB2' ' OD1' ' A' ' 979' ' ' ASP . 27.2 mt-30 -90.37 151.73 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.07 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' 1004 ' ' CYS . 74.8 t -44.26 146.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.734 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 83.26 -39.85 2.8 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 114.258 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.2 m -68.45 175.72 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.612 0.706 . . . . 0.0 111.143 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.455 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 4.7 tmm_? -156.6 128.72 7.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.194 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.535 ' CG2' ' HA ' ' A' ' 976' ' ' VAL . 34.3 pt -97.28 -163.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 975' ' ' HIS . 54.7 p -149.23 130.13 14.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.937 0.398 . . . . 0.0 112.028 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.1 m-85 -99.18 147.82 24.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.376 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -151.13 132.15 14.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.547 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 85.8 m -81.93 -125.93 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 992' ' ' THR . 1.8 t -165.01 176.15 8.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.306 0.574 . . . . 0.0 111.375 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.474 ' N ' ' OG1' ' A' ' 991' ' ' THR . 22.1 m -48.54 131.02 17.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.643 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.19 84.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.459 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.01 122.44 7.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.943 0.371 . . . . 0.0 110.706 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' 1080 ' ' GLN . 38.0 ttm180 -82.24 114.54 20.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 997' ' ' ILE . 7.6 tp -76.27 127.81 33.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.24 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.8 mp -98.75 140.78 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.482 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.2 174.34 40.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.068 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' 1001 ' ' SER . 86.6 m-70 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 0.0 111.357 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.3 p -75.4 31.3 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.838 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 999' ' ' HIS . 63.0 m -162.12 152.18 16.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.048 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.846 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -150.8 129.03 11.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.63 122.96 33.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.097 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 14.9 t -70.13 80.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.088 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 40.7 pt -87.33 -142.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.526 ' HG ' ' C ' ' A' 1010 ' ' THR . 5.1 tt -158.39 121.62 3.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.878 0.37 . . . . 0.0 110.566 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 53.0 m -92.03 47.03 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.811 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.48 ' N ' HD23 ' A' 1006 ' ' LEU . . . 75.35 -57.63 2.85 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.092 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -66.18 -60.08 3.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.855 0.327 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.526 ' C ' ' HG ' ' A' 1006 ' ' LEU . 15.2 t -151.27 -172.51 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.611 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -75.26 136.89 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 111.003 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -149.44 151.72 34.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.836 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.846 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 61.2 m95 -72.41 127.45 32.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.9 t -52.46 -27.7 17.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.972 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 82.5 p -105.8 142.28 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 111.95 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -57.08 149.2 47.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.276 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.84 108.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.247 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.442 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 34.1 Cg_exo -59.3 148.73 85.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.897 2.398 . . . . 0.0 112.163 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.693 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 9.1 tt -148.82 135.71 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.433 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 50.1 m -86.49 159.42 19.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.912 0.387 . . . . 0.0 110.64 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.444 ' HB3' HD11 ' A' ' 997' ' ' ILE . 7.0 tt0 -153.5 117.69 4.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.666 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -64.21 127.66 32.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.194 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' 1045 ' ' HIS . 76.0 mt -71.05 126.69 92.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 26.0 Cg_endo -61.39 126.49 19.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.563 2.175 . . . . 0.0 112.776 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.734 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 71.6 m -97.21 135.05 39.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -84.74 151.72 26.65 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.49 ' HA ' ' CZ ' ' A' 1044 ' ' PHE . 1.4 mm? -39.44 137.15 1.06 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 117.168 0.484 . . . . 0.0 111.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.557 ' HG3' HG11 ' A' 1050 ' ' VAL . 29.7 Cg_endo -63.68 145.24 91.04 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.677 2.251 . . . . 0.0 112.12 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.629 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 51.4 Cg_exo -54.61 91.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.295 1.997 . . . . 0.0 111.376 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . 0.503 HG23 ' O ' ' A' 1028 ' ' PRO . 53.2 p -77.47 118.78 20.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.66 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' 1089 ' ' PRO . 18.4 pt -84.95 119.89 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.46 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -43.55 141.53 1.41 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 78.08 -38.78 0.26 Allowed 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.506 0.504 . . . . 0.0 111.001 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -69.78 120.11 9.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.428 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' 1052 ' ' TYR . 1.4 m-20 -83.06 173.46 11.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.682 ' HA ' ' O ' ' A' 1051 ' ' THR . 43.9 p90 -151.43 133.64 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.169 0.509 . . . . 0.0 111.728 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.719 HD11 ' HD2' ' A' 1053 ' ' ARG . 29.5 mt -108.54 45.34 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.713 ' HB3' HG12 ' A' 1050 ' ' VAL . 81.6 p -71.2 -140.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.701 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' 1041 ' ' ARG . 88.7 m -161.16 -29.53 0.05 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.601 ' HB3' ' OG ' ' A' 1048 ' ' SER . 21.8 p30 -53.35 -39.05 63.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' 1039 ' ' THR . 37.9 mmt180 59.02 -111.43 0.55 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.231 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.12 -131.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.51 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.1 p30 -56.26 145.6 26.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' 1027 ' ' LEU . 29.6 p90 -159.79 129.23 5.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.75 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.496 ' O ' ' O ' ' A' 1023 ' ' ILE . 48.9 m-70 -76.6 -41.54 45.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' 1045 ' ' HIS . 60.1 t80 176.03 157.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.551 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' 1048 ' ' SER . . . 76.54 96.67 0.17 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.284 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.601 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 45.7 t 174.26 153.68 0.11 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 1.001 HG12 ' HB3' ' A' 1073 ' ' TYR . 3.6 m -137.81 159.42 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.258 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' 1038 ' ' SER . 18.1 m -133.37 134.67 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' 1036 ' ' PHE . 86.7 m -104.77 119.05 38.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' 1035 ' ' ASP . 7.7 m-85 -80.56 160.07 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.719 ' HD2' HD11 ' A' 1037 ' ' ILE . 79.6 mtp180 -142.71 -41.6 0.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.777 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 40.1 t 70.73 122.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.818 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' 1064 ' ' PHE . 3.5 m120 17.57 -123.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.785 ' HA ' HG23 ' A' 1063 ' ' VAL . 79.6 mt 69.5 123.49 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.69 -62.79 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.612 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.474 ' C ' ' HD2' ' A' 1059 ' ' ARG . 38.2 t -90.06 44.02 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.554 ' HD2' ' N ' ' A' 1059 ' ' ARG . 0.0 OUTLIER 39.45 44.98 1.21 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.071 -179.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.59 -29.13 0.12 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.098 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -45.75 146.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.605 0.241 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.561 ' HB3' ' NZ ' ' A' 1062 ' ' LYS . 6.3 ttpm? -65.37 80.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.986 0.422 . . . . 0.0 111.59 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' 1056 ' ' LEU . 3.2 m -155.17 90.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' 1055 ' ' ASN . 0.5 OUTLIER 68.75 144.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.566 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -146.18 143.36 29.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 112.338 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' 1070 ' ' PRO . 34.6 tp -68.55 151.7 46.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.969 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.878 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 76.9 t -138.22 136.25 44.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.061 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 78.1 -148.09 32.6 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.131 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.1 pt-20 -63.45 128.6 92.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.574 ' HB3' HD21 ' A' 1066 ' ' LEU . 79.4 Cg_endo -94.74 11.16 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.974 2.449 . . . . 0.0 113.23 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' 1050 ' ' VAL . 80.2 p -157.02 145.86 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . . . . . . . . . 42.9 pt -140.95 174.29 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.631 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 1.001 ' HB3' HG12 ' A' 1049 ' ' VAL . 1.6 p90 -160.04 148.13 16.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.486 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.895 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 44.6 t -65.37 137.37 57.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.409 ' O ' ' O ' ' A' 1076 ' ' SER . 8.0 t -154.98 11.05 0.35 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' 1075 ' ' THR . 99.7 p 55.74 151.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.614 ' ND2' ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -168.34 40.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.508 ' HB3' ' CG2' ' A' 1081 ' ' VAL . 54.3 t0 -178.57 -18.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' 1080 ' ' GLN . 33.1 m-20 70.42 134.63 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.604 ' HA ' ' NH2' ' A' ' 995' ' ' ARG . 72.7 mt-30 76.2 21.96 1.4 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.516 0.674 . . . . 0.0 109.211 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' 1080 ' ' GLN . 2.6 m -163.3 109.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.075 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.734 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . -74.31 63.89 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.581 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.614 ' HB ' ' ND2' ' A' 1077 ' ' ASN . 64.4 mt -81.92 138.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.895 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.5 m95 -70.98 -153.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.002 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.0 t -80.61 -65.75 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.999 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.6 145.44 6.08 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.343 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 92.3 Cg_endo -81.71 51.12 3.73 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.116 2.544 . . . . 0.0 112.787 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.486 ' HB3' ' CG ' ' A' 1069 ' ' GLU . . . -66.28 -43.94 56.29 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.602 ' HG3' ' O ' ' A' 1069 ' ' GLU . 87.1 Cg_exo -43.56 137.74 5.75 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.438 2.092 . . . . 0.0 112.699 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.878 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.4 mm100 -129.77 127.96 41.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 36.5 t -93.45 72.41 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.266 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 957' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.265 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 59.03 -138.78 0.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -171.37 47.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.938 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.12 51.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.593 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -77.62 146.86 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.545 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 80.4 p -157.98 143.29 16.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.524 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 95.5 m -80.01 146.83 31.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.256 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.83 139.43 58.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 111.337 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 62.9 m -68.28 128.12 93.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.981 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.515 ' HG2' HG21 ' A' ' 974' ' ' VAL . 11.0 Cg_exo -70.05 127.38 14.29 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 111.211 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.08 -60.09 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.114 1.876 . . . . 0.0 111.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 175.73 115.18 0.12 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.782 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 18.3 Cg_exo -66.22 134.92 38.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.489 2.126 . . . . 0.0 111.727 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.762 HG22 ' ND2' ' A' ' 971' ' ' ASN . 0.8 OUTLIER -49.11 125.47 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.039 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.762 ' ND2' HG22 ' A' ' 970' ' ' VAL . 73.4 m-20 75.29 -58.32 0.57 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.225 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -80.04 -161.54 23.89 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.782 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 40.6 tpp -160.47 135.16 7.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.613 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.569 ' CG2' HD12 ' A' ' 986' ' ' ILE . 2.8 p -81.76 150.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.321 . . . . 0.0 110.779 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 20.2 m170 -117.31 99.5 7.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.498 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.636 HG23 HG23 ' A' ' 980' ' ' ILE . 7.2 p -75.03 86.19 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.704 0.764 . . . . 0.0 109.693 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.22 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.505 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 984' ' ' SER . 41.2 p -79.86 79.27 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 111.044 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 980' ' ' ILE . 1.5 m-20 52.1 -142.38 0.75 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.054 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.636 HG23 HG23 ' A' ' 976' ' ' VAL . 3.6 pt -155.84 23.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 75.5 mt-30 -85.6 169.97 13.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.675 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' 1004 ' ' CYS . 92.3 t -44.33 145.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.368 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.51 ' HA2' ' OE2' ' A' 1003 ' ' GLU . . . 78.97 -44.45 2.59 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.927 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 978' ' ' THR . 92.8 p -68.36 123.64 21.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.463 0.631 . . . . 0.0 111.047 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.758 ' HD3' ' HB2' ' A' 1001 ' ' SER . 33.8 ttm180 -102.71 135.82 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.846 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.569 HD12 ' CG2' ' A' ' 974' ' ' VAL . 16.3 pt -95.52 -170.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.954 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 55.7 p -148.29 123.9 10.44 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.585 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 4.9 m-85 -97.24 154.15 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.539 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 20.8 m -157.64 126.29 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.668 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 85.0 m -85.16 147.83 26.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.518 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 991' ' ' THR . 0.0 OUTLIER -60.37 163.36 5.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.587 0.708 . . . . 0.0 112.154 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.4 m -55.79 138.25 48.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.476 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 71.52 40.1 60.06 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.836 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -151.07 138.53 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.494 0.188 . . . . 0.0 110.545 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 995' ' ' ARG . 37.3 ttt85 -82.02 127.13 32.77 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.218 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.668 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 3.5 tt -76.22 118.72 19.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 111.38 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' 1021 ' ' GLN . 30.4 mm -94.2 140.87 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.571 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.93 177.19 32.09 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.105 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.544 ' O ' ' HG3' ' A' 1018 ' ' PRO . 22.7 m170 -75.03 127.27 32.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.299 . . . . 0.0 111.172 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 83.4 p -79.02 26.36 0.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.044 0.45 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.758 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.1 p -162.16 140.44 8.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.401 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -156.09 128.45 7.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.51 ' OE2' ' HA2' ' A' ' 983' ' ' GLY . 85.6 tt0 -89.99 130.83 36.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.443 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.56 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 51.3 t -67.16 128.54 36.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' 1011 ' ' ALA . 31.2 pt -134.8 -142.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.34 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' 1010 ' ' THR . 0.3 OUTLIER -144.08 120.45 10.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 -179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.489 ' HB3' ' HD2' ' A' 1012 ' ' HIS . 46.0 t -85.93 -47.89 9.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.414 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 177.28 -50.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.111 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 42.3 t30 -79.79 -51.41 9.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.737 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.404 ' C ' HD22 ' A' 1006 ' ' LEU . 11.8 t -151.28 -161.95 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.56 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.31 140.78 43.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.489 ' HD2' ' HB3' ' A' 1007 ' ' SER . 90.2 m-70 -149.49 144.58 26.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.475 ' HH2' HG22 ' A' ' 980' ' ' ILE . 68.6 m95 -67.0 135.21 53.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.883 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 82.4 p -52.49 -22.2 4.58 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.675 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.509 HG21 ' ND1' ' A' ' 999' ' ' HIS . 70.8 p -131.44 139.86 49.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.876 0.369 . . . . 0.0 111.918 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -52.16 145.47 18.45 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.826 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 5.8 Cg_endo -48.57 103.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.396 2.064 . . . . 0.0 111.806 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.585 ' HG2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_endo -62.42 150.79 86.09 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 111.998 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.653 HG13 ' HB ' ' A' ' 997' ' ' ILE . 41.3 pt -125.77 -148.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.572 ' HB2' HD22 ' A' ' 971' ' ' ASN . 22.0 m -146.75 121.32 9.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.789 ' HB2' HD11 ' A' ' 997' ' ' ILE . 64.8 tp60 -83.48 128.36 34.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' 1022 ' ' ARG . 40.4 ttt85 -81.55 117.89 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.121 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' 1076 ' ' SER . 75.7 mt -70.94 112.4 13.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.82 127.1 8.46 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.543 2.162 . . . . 0.0 112.139 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.614 ' HB2' ' O ' ' A' 1044 ' ' PHE . 62.8 m -88.43 -145.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 0.0 111.564 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' 1044 ' ' PHE . . . -161.08 154.81 25.87 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.629 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.571 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 45.8 mt -42.51 137.93 2.22 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-O 120.81 0.338 . . . . 0.0 111.529 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.588 ' HD3' ' ND2' ' A' 1040 ' ' ASN . 13.1 Cg_endo -56.31 146.68 71.26 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.777 2.318 . . . . 0.0 111.743 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.41 108.66 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.155 1.903 . . . . 0.0 111.606 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 82.1 p -77.59 116.54 18.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.877 HG21 ' HD2' ' A' 1089 ' ' PRO . 11.6 pt -100.28 29.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.449 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 55.2 120.95 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.415 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 61.7 m-80 69.64 12.41 8.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.745 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.62 134.51 38.34 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.998 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.81 -37.25 79.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.676 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.721 ' HD1' HG23 ' A' 1050 ' ' VAL . 0.8 OUTLIER 61.34 108.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.831 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.85 HG22 ' H ' ' A' 1038 ' ' SER . 7.9 mt -111.34 -176.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.715 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.85 ' H ' HG22 ' A' 1037 ' ' ILE . 15.7 t 69.71 -129.51 0.08 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.168 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 25.3 p -145.03 140.26 28.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 111.739 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.588 ' ND2' ' HD3' ' A' 1028 ' ' PRO . 23.9 t-20 -169.79 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' 1041 ' ' ARG . 42.1 mtp85 52.03 -142.18 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.7 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -79.06 -45.2 20.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.0 p30 -65.93 141.56 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' 1025 ' ' CYS . 0.5 OUTLIER -163.21 40.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.837 0.351 . . . . 0.0 111.212 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' 1046 ' ' TYR . 23.9 m80 -53.49 -40.27 65.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' 1045 ' ' HIS . 43.9 t80 173.61 159.79 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.695 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.99 -24.99 3.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.136 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 69.1 m -47.61 139.78 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' 1072 ' ' ILE . 14.4 p -138.19 157.65 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.721 HG23 ' HD1' ' A' 1036 ' ' PHE . 3.3 p -154.02 135.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.742 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 92.3 m -100.96 123.65 45.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.708 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.739 ' HD2' HD13 ' A' 1031 ' ' ILE . 3.7 m-85 -83.7 144.52 29.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.008 0.433 . . . . 0.0 111.355 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.532 ' HA ' ' HB2' ' A' 1066 ' ' LEU . 42.8 ttm-85 -157.42 -25.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.791 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 16.2 m 64.86 145.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.059 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 3.4 m120 -62.85 129.77 41.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.288 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.807 ' HG ' ' HA2' ' A' 1060 ' ' GLY . 1.9 mm? -70.33 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.639 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' 1056 ' ' LEU . . . -152.05 29.41 0.9 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 23.8 p 177.44 -51.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.74 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' 1059 ' ' ARG . 19.3 tpt85 -169.61 -49.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.807 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -172.72 29.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.985 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' 1056 ' ' LEU . 40.1 mtp85 -80.35 169.5 17.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.752 0.31 . . . . 0.0 111.09 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.32 83.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' 1064 ' ' PHE . 3.3 m -155.05 99.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.506 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.9 m-30 79.49 62.49 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.088 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -86.56 130.01 34.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.61 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' 1069 ' ' GLU . 3.2 tm? -68.53 138.66 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.266 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.583 ' H ' HD22 ' A' 1066 ' ' LEU . 11.6 t -151.91 156.68 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' 1067 ' ' VAL . . . 79.79 -27.76 2.56 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.989 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.706 ' O ' HD11 ' A' 1066 ' ' LEU . 16.5 tp10 -167.82 103.7 0.57 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.994 0.397 . . . . 0.0 111.323 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.431 ' HA ' ' CD1' ' A' 1066 ' ' LEU . 95.7 Cg_endo -87.5 -28.94 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.0 2.467 . . . . 0.0 114.642 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 48.9 m -152.95 137.19 16.52 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.604 HD11 ' OH ' ' A' 1052 ' ' TYR . 28.6 pt -140.94 166.23 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.641 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.536 ' HB3' HG23 ' A' 1049 ' ' VAL . 2.9 p90 -157.17 145.73 19.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.963 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 52.3 t -63.84 148.54 49.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.497 . . . . 0.0 111.413 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.7 t -140.89 150.56 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.114 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' 1023 ' ' ILE . 54.5 m -74.54 123.34 24.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.527 ' ND2' HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER 179.31 -165.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.742 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' 1081 ' ' VAL . 8.3 t0 44.35 46.64 7.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' 1080 ' ' GLN . 9.9 t0 72.97 -59.4 0.57 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.178 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.449 ' HG2' ' OD1' ' A' 1079 ' ' ASP . 18.0 pt20 179.61 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' 1078 ' ' ASP . 42.6 t -86.32 -38.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 82.58 55.41 3.02 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.484 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.527 HG12 ' ND2' ' A' 1077 ' ' ASN . 33.8 pt -81.96 137.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.688 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.499 ' HZ3' HG12 ' A' 1050 ' ' VAL . 11.9 m95 -70.58 146.52 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.641 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 80.1 p -56.54 -9.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.423 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.43 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.42 135.94 3.92 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.36 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.43 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 15.0 Cg_exo -69.44 -153.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.057 2.504 . . . . 0.0 113.038 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.812 ' HB1' HG22 ' A' 1031 ' ' ILE . . . -77.16 138.5 64.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.432 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.877 ' HD2' HG21 ' A' 1031 ' ' ILE . 2.3 Cg_endo -80.47 -136.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.491 2.794 . . . . 0.0 111.898 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.622 HE21 HG23 ' A' 1092 ' ' ILE . 62.5 tp60 -152.41 119.84 5.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.757 0.313 . . . . 0.0 110.889 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 88.8 m -103.11 128.75 49.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.523 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.622 HG23 HE21 ' A' 1090 ' ' GLN . 6.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.367 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.828 0.347 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 56.4 45.47 22.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.535 ' HG3' ' HZ3' ' A' ' 961' ' ' LYS . 39.4 tt0 55.91 47.34 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.516 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -68.0 -48.86 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.535 ' HZ3' ' HG3' ' A' ' 959' ' ' GLU . 47.6 mmtm 63.26 138.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 56.9 p -157.96 140.51 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 98.6 m -79.85 134.05 36.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -64.96 142.02 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.004 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.7 m -50.8 121.09 14.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' 1013 ' ' TRP . 50.6 Cg_exo -55.69 132.31 51.36 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.392 2.062 . . . . 0.0 112.416 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.72 140.64 62.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.425 2.083 . . . . 0.0 111.355 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.6 m-20 -48.57 117.65 6.24 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 110.719 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.582 ' HG2' ' N ' ' A' ' 973' ' ' MET . 18.8 Cg_endo -58.9 149.2 80.24 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.801 2.334 . . . . 0.0 112.524 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' 1020 ' ' CYS . 79.4 t -42.8 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.426 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 78.1 m-20 73.42 -42.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.727 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.607 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -69.1 -156.34 1.09 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.079 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.582 ' N ' ' HG2' ' A' ' 969' ' ' PRO . 22.5 ptp -159.25 138.89 11.61 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.631 0.253 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.953 ' HA ' ' HB3' ' A' ' 988' ' ' TYR . 0.7 OUTLIER -87.33 145.53 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.398 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -119.13 106.78 12.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 68.9 t -69.71 94.38 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.542 HD11 ' OG1' ' A' ' 987' ' ' THR . 39.3 mt -75.24 -90.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.367 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 37.2 p -62.11 -68.62 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 27.4 t70 -166.89 -138.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.064 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.466 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 10.9 pt -155.81 53.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 961' ' ' LYS . 8.4 tt0 -152.65 158.04 41.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.719 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' 1004 ' ' CYS . 56.5 t -28.29 123.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.31 0.381 . . . . 0.0 111.334 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.58 2.6 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.682 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 88.0 p -157.1 127.23 6.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.818 0.342 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 58.6 mtt85 -101.54 149.57 23.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.7 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.601 HD11 ' HB3' ' A' 1002 ' ' ALA . 38.9 pt -142.78 168.85 13.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.075 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.542 ' OG1' HD11 ' A' ' 977' ' ' ILE . 66.5 p -146.12 147.38 31.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.834 0.349 . . . . 0.0 111.867 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.953 ' HB3' ' HA ' ' A' ' 974' ' ' VAL . 6.5 p90 -145.9 159.29 43.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.8 p -155.23 143.48 20.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.931 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.628 ' H ' HD12 ' A' ' 996' ' ' LEU . 36.8 t -82.01 -179.56 7.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.452 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 38.1 p -60.24 155.06 18.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 112.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 52.2 m -54.82 139.59 39.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.476 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.437 ' O ' HD12 ' A' 1023 ' ' ILE . . . 82.93 -32.41 2.97 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.204 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -82.43 148.67 28.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.812 ' HG2' ' H ' ' A' ' 996' ' ' LEU . 49.2 ttt-85 -81.97 -172.25 3.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.024 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.812 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 5.5 tt -161.77 128.07 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.887 ' HB ' HG12 ' A' 1019 ' ' ILE . 1.7 mp -86.62 144.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.967 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.6 165.18 36.38 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' 1001 ' ' SER . 89.5 m-70 -71.38 137.03 48.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.625 0.213 . . . . 0.0 110.762 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 78.7 p -72.14 39.47 0.07 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.948 0.404 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.474 ' O ' HG21 ' A' 1015 ' ' THR . 36.4 t -160.06 171.44 19.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.98 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.27 134.02 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.4 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -114.05 128.25 56.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.434 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 48.9 t -73.2 85.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.093 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' 1014 ' ' SER . 14.7 pt -91.52 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.168 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' 1007 ' ' SER . 0.5 OUTLIER -92.46 128.34 38.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.709 0.29 . . . . 0.0 110.544 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.657 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 46.5 t -162.52 136.75 6.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 66.0 40.37 95.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.381 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.16 21.64 6.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.622 0.249 . . . . 0.0 111.564 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 87.9 m -152.36 133.59 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.818 0.342 . . . . 0.0 111.181 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.551 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.32 134.1 41.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.657 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.1 p80 -153.8 150.86 28.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.765 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.64 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 31.8 m95 -68.14 120.59 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.776 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.537 ' HB2' HD13 ' A' 1005 ' ' ILE . 44.8 t -52.38 -22.58 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.707 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.474 HG21 ' O ' ' A' 1001 ' ' SER . 46.6 p -87.0 132.43 33.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.644 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -66.05 156.43 84.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.62 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -46.82 118.32 2.62 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.236 1.958 . . . . 0.0 112.019 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.487 ' HG3' ' CZ ' ' A' ' 988' ' ' TYR . 64.4 Cg_endo -84.62 160.42 12.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.162 2.574 . . . . 0.0 113.169 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.887 HG12 ' HB ' ' A' ' 997' ' ' ILE . 35.2 pt -144.53 -157.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 49.4 t -143.36 171.18 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.309 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.459 ' HA ' ' OE1' ' A' 1021 ' ' GLN . 1.0 OUTLIER -153.51 130.76 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.036 0.446 . . . . 0.0 111.113 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' 1045 ' ' HIS . 77.7 ttt180 -64.37 -17.54 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.527 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 995' ' ' ARG . 61.4 mt 64.21 89.33 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.934 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.62 126.26 21.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.611 2.207 . . . . 0.0 112.931 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 56.1 m -88.43 -145.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.055 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -163.91 155.57 27.01 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.432 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' 1044 ' ' PHE . 8.8 mp -40.92 139.41 1.21 Allowed Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.599 ' HD3' HD21 ' A' 1040 ' ' ASN . 59.6 Cg_endo -71.67 145.37 46.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.882 2.388 . . . . 0.0 112.054 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.507 ' HB2' ' HG3' ' A' 1087 ' ' PRO . 24.0 Cg_endo -61.47 117.19 3.98 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.206 1.938 . . . . 0.0 111.933 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 83.5 m -82.47 121.05 26.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . . . . . . . . . 24.8 pt -86.66 135.55 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.352 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -51.79 138.61 23.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.482 ' HB3' ' HE2' ' A' 1064 ' ' PHE . 75.3 m-80 75.03 -40.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.172 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -79.16 116.71 4.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' 1053 ' ' ARG . 57.4 m-20 -68.81 -150.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 110.685 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 137.15 13.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.285 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' 1050 ' ' VAL . 34.5 pt -128.87 -161.07 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.566 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 66.4 m 63.66 159.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.857 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 99.9 m -56.48 130.55 45.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.306 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.599 HD21 ' HD3' ' A' 1028 ' ' PRO . 17.0 t-20 -177.18 -121.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' 1040 ' ' ASN . 21.9 mmt85 75.35 -49.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.606 0.362 . . . . 0.0 111.211 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' 1043 ' ' ASN . 13.5 pt-20 -162.95 -141.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.411 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.422 HD22 ' H ' ' A' 1043 ' ' ASN . 2.9 m120 33.56 43.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.193 0.52 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.562 ' CD2' HD12 ' A' 1027 ' ' LEU . 0.3 OUTLIER -77.89 43.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.882 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.607 ' HB3' ' HD3' ' A' 1022 ' ' ARG . 58.3 m-70 -53.3 -52.49 58.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.565 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 32.2 t80 171.9 160.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.392 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 77.51 -20.97 3.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.061 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' 1046 ' ' TYR . 55.3 m -47.66 142.2 4.74 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.896 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' 1072 ' ' ILE . 11.3 p -137.79 155.43 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.338 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' 1037 ' ' ILE . 9.4 p -149.03 139.27 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.334 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.533 ' O ' HG12 ' A' 1037 ' ' ILE . 96.6 m -102.55 128.99 48.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -73.5 139.95 46.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.526 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' 1035 ' ' ASP . 79.3 ttt180 -146.54 133.07 19.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.03 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.57 ' O ' HD23 ' A' 1056 ' ' LEU . 75.5 m -76.45 158.1 31.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 111.834 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.515 ' HA ' ' OD2' ' A' 1035 ' ' ASP . 24.4 t-20 -65.6 -22.92 66.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.957 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.609 HD13 ' H ' ' A' 1064 ' ' PHE . 4.1 mm? 46.21 43.77 11.53 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-O 120.786 0.326 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 72.81 -53.94 1.68 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 36.3 t -178.83 126.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' 1059 ' ' ARG . 3.0 mmp_? 72.37 -60.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.124 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 170.44 29.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.086 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.602 ' O ' ' HB3' ' A' 1056 ' ' LEU . 42.1 ttt85 -66.17 132.13 47.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -65.24 109.28 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.515 0.674 . . . . 0.0 111.992 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.591 HG13 ' HD1' ' A' 1064 ' ' PHE . 3.0 p -157.47 -45.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.156 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.609 ' H ' HD13 ' A' 1056 ' ' LEU . 3.1 m-85 -86.11 155.57 20.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.344 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -146.28 121.34 10.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' 1070 ' ' PRO . 30.9 tp -71.9 142.97 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.466 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' 1089 ' ' PRO . 63.7 t -138.33 138.16 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.1 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.8 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -62.42 110.41 3.32 Favored Pre-proline 0 C--O 1.225 -0.186 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.545 ' HB3' HD21 ' A' 1066 ' ' LEU . 74.3 Cg_endo -87.8 -45.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.547 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 83.4 p -94.54 146.86 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 112.009 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.804 HG13 ' HB2' ' A' 1085 ' ' SER . 7.0 tt -149.67 158.39 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.688 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' 1072 ' ' ILE . 0.1 OUTLIER -159.7 171.97 18.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.688 0.28 . . . . 0.0 111.19 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 43.4 t -62.16 -44.22 97.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.243 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 12.4 t 44.16 21.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.668 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.624 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 99.5 p 55.63 141.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.342 0.591 . . . . 0.0 112.483 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 1.012 ' HA ' HG12 ' A' 1083 ' ' ILE . 0.7 OUTLIER -67.05 -98.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.782 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.61 3.03 0.08 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.277 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 7.3 t0 -163.14 -51.01 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.509 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' 1080 ' ' GLN . 1.8 pm0 -174.84 50.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.442 ' HB ' ' CB ' ' A' 1077 ' ' ASN . 45.9 t -134.31 -37.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.954 -0.466 . . . . 0.0 111.867 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' 1076 ' ' SER . . . 73.8 64.79 2.37 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 1.012 HG12 ' HA ' ' A' 1077 ' ' ASN . 20.2 pt -81.98 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.57 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 11.1 m95 -72.43 162.91 28.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.218 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.804 ' HB2' HG13 ' A' 1072 ' ' ILE . 57.6 m -43.58 -41.76 4.73 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.444 ' H ' HD11 ' A' 1072 ' ' ILE . . . 107.43 145.94 12.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.664 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' 1029 ' ' PRO . 68.5 Cg_exo -50.77 149.28 14.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.152 2.568 . . . . 0.0 112.845 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.764 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -171.77 -47.57 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.3 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.764 ' HD2' ' H ' ' A' 1088 ' ' ALA . 20.1 Cg_endo -59.65 149.88 79.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.634 2.223 . . . . 0.0 112.725 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -147.7 149.85 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.757 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 56.4 m -93.73 142.3 27.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.092 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 33.4 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.943 179.582 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -61.27 135.95 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -171.0 143.13 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.651 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . 0.632 ' C ' ' HD2' ' A' ' 961' ' ' LYS . . . 55.92 -109.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.632 ' HD2' ' C ' ' A' ' 960' ' ' ALA . 3.1 mptp? -146.55 155.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 98.6 p -152.99 129.12 10.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.39 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 964' ' ' LYS . 1.6 p -79.92 30.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.254 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 964' ' ' LYS . 10.0 mmpt? 54.5 138.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.478 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 6.9 t -63.14 121.46 69.35 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.45 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 17.3 Cg_exo -67.25 107.25 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.475 2.117 . . . . 0.0 112.307 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 965' ' ' THR . 28.7 Cg_endo -63.39 136.2 53.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.211 1.941 . . . . 0.0 110.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.8 107.97 0.82 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.765 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 970' ' ' VAL . 73.2 Cg_endo -73.11 -133.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.936 2.424 . . . . 0.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.9 HG22 ' H ' ' A' ' 971' ' ' ASN . 8.5 p -51.95 -148.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.914 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.9 ' H ' HG22 ' A' ' 970' ' ' VAL . 5.1 m120 -65.46 -28.44 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.767 -0.583 . . . . 0.0 110.469 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 970' ' ' VAL . . . -72.33 126.6 11.59 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.234 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 988' ' ' TYR . 65.9 mtt -94.42 143.95 25.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.558 HG21 HD12 ' A' ' 986' ' ' ILE . 4.5 p -92.88 148.36 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 O-C-N 123.361 0.413 . . . . 0.0 111.6 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.16 109.12 16.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.022 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.759 HG13 HG23 ' A' ' 980' ' ' ILE . 72.6 t -65.38 -48.01 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 22.9 mt 64.69 -98.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.602 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.7 p -62.25 -65.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.526 ' O ' HG13 ' A' ' 976' ' ' VAL . 51.7 p-10 -173.33 -148.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.568 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.759 HG23 HG13 ' A' ' 976' ' ' VAL . 21.1 pt -155.95 25.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.2 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 962' ' ' SER . 85.7 mt-30 -78.81 -57.62 3.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.942 0.401 . . . . 0.0 111.272 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.642 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 7.7 p 167.77 156.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 982' ' ' VAL . . . 79.06 -35.87 1.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.669 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.458 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 80.7 p -68.5 -160.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.12 0.486 . . . . 0.0 111.444 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 986' ' ' ILE . 45.4 ttm-85 -156.66 160.64 39.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.085 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.558 HD12 HG21 ' A' ' 974' ' ' VAL . 47.0 pt -142.75 155.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.117 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' 1001 ' ' SER . 82.2 p -142.25 134.32 27.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' 1000 ' ' SER . 4.0 m-85 -83.23 -161.87 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 73.6 m -148.18 -40.47 0.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.77 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 29.1 t 69.42 137.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.835 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -60.27 145.84 45.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.735 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 74.9 m -51.58 134.64 29.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.361 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 74.03 37.54 49.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.247 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.613 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 33.4 m80 -146.96 125.29 12.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.36 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.671 ' HB2' HD11 ' A' 1023 ' ' ILE . 38.2 ttt85 -82.0 96.82 7.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' 1000 ' ' SER . 3.6 pp -63.62 140.42 58.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.643 ' HB ' HG13 ' A' 1019 ' ' ILE . 50.4 mm -107.96 154.69 9.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.22 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.92 14.63 82.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.071 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 63.68 134.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.688 ' HB3' HD22 ' A' ' 996' ' ' LEU . 77.8 p -87.76 46.78 1.42 Allowed 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -162.14 146.8 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.711 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.685 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -165.19 125.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.717 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.412 ' HB2' ' NH1' ' A' ' 985' ' ' ARG . 89.2 tt0 -87.65 130.96 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 43.4 t -74.13 86.57 1.88 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.888 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.496 ' HB ' ' H ' ' A' 1006 ' ' LEU . 2.4 pp -87.28 -146.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' 1010 ' ' THR . 4.6 tt -158.46 129.37 6.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.519 ' N ' HD23 ' A' 1006 ' ' LEU . 47.1 t -80.25 -59.63 2.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.306 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.27 42.8 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.508 ' H ' HD21 ' A' 1006 ' ' LEU . 16.5 p-10 -176.25 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.377 . . . . 0.0 110.395 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.581 ' O ' ' HG ' ' A' 1006 ' ' LEU . 11.8 t -151.29 175.99 11.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.56 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -74.8 145.71 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.125 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -149.44 145.61 27.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.438 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.427 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 92.9 m95 -76.42 125.41 29.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.362 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.2 p -53.69 -19.91 4.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.092 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.685 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 30.3 p -131.26 135.84 47.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 112.265 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' 1017 ' ' PRO . 14.7 mmmm -69.81 161.96 71.29 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.891 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' 1016 ' ' LYS . 80.2 Cg_exo -45.43 132.31 12.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.735 2.29 . . . . 0.0 112.686 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 88.9 Cg_endo -80.51 170.56 15.74 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.997 2.465 . . . . 0.0 113.143 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.643 HG13 ' HB ' ' A' ' 997' ' ' ILE . 25.4 pt -148.83 121.53 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.811 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.764 ' H ' HG11 ' A' ' 970' ' ' VAL . 88.9 m -86.16 118.26 25.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 112.118 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -82.41 126.01 31.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.915 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' 1046 ' ' TYR . 40.9 ttt85 -67.2 -9.37 39.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.256 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.671 HD11 ' HB2' ' A' ' 995' ' ' ARG . 45.9 mt 54.01 56.77 12.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.428 . . . . 0.0 110.445 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.518 ' CB ' ' HA ' ' A' 1045 ' ' HIS . 58.0 Cg_endo -71.6 138.28 31.89 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.273 . . . . 0.0 113.019 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 3.8 p -88.42 -136.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.317 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' 1044 ' ' PHE . . . -148.4 -151.35 5.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.809 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' 1044 ' ' PHE . 70.6 mt -64.73 132.84 95.55 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-O 120.711 0.291 . . . . 0.0 111.567 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.58 149.81 88.18 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 111.092 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.596 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 95.9 Cg_exo -45.47 119.59 2.74 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.287 1.992 . . . . 0.0 112.283 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 81.3 p -81.81 139.9 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.958 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' 1031 ' ' ILE . 45.6 pt -148.45 120.6 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.433 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -73.56 14.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.111 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' 1031 ' ' ILE . 3.5 m120 -80.36 -31.83 37.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.22 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.659 ' HA2' ' ND2' ' A' 1055 ' ' ASN . . . -163.14 -125.2 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.302 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' 1036 ' ' PHE . 53.3 m-20 -156.66 -151.7 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.597 ' HB2' HG13 ' A' 1050 ' ' VAL . 45.9 p90 -155.96 129.65 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 111.945 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.28 78.2 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.986 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 39.6 t -167.39 154.0 8.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 111.492 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.554 ' O ' ' HG3' ' A' 1041 ' ' ARG . 60.7 m -55.8 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' 1041 ' ' ARG . 7.0 m120 52.91 -125.1 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' 1039 ' ' THR . 76.0 mtp180 74.92 -47.34 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.662 0.385 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' 1044 ' ' PHE . 3.9 tm-20 -162.89 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.68 0.276 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -71.63 38.09 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.665 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.596 ' HD1' ' H ' ' A' 1045 ' ' HIS . 0.3 OUTLIER -76.7 -46.82 24.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.596 ' H ' ' HD1' ' A' 1044 ' ' PHE . 24.2 m-70 40.62 -147.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.18 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.722 ' O ' ' HB3' ' A' 1074 ' ' CYS . 14.8 t80 -63.45 -49.18 74.68 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -96.1 121.6 7.01 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.891 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 47.2 t 178.6 122.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.64 0.734 . . . . 0.0 111.344 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' 1072 ' ' ILE . 11.2 p -102.3 157.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.546 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.597 HG13 ' HB2' ' A' 1036 ' ' PHE . 87.4 t -146.81 117.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.951 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' 1036 ' ' PHE . 96.2 m -99.55 109.94 22.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.909 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.475 ' O ' HD22 ' A' 1066 ' ' LEU . 31.4 m-85 -80.98 124.66 29.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.976 0.417 . . . . 0.0 111.684 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' 1054 ' ' CYS . 18.2 tpt85 -97.07 -137.02 0.26 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.643 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.483 ' H ' ' HG3' ' A' 1053 ' ' ARG . 99.1 m -161.43 156.23 23.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 110.512 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.659 ' ND2' ' HA2' ' A' 1034 ' ' GLY . 5.2 m120 -65.85 62.1 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.629 ' HB3' ' HA2' ' A' 1060 ' ' GLY . 3.6 mm? -70.33 135.72 49.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 110.731 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' 1058 ' ' SER . . . -82.74 131.75 10.6 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.864 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' 1057 ' ' GLY . 55.1 m 74.91 -49.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.502 0.321 . . . . 0.0 111.731 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -167.75 -51.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.863 0.363 . . . . 0.0 111.543 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . -172.62 37.8 0.15 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.298 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -66.17 165.82 13.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.38 78.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.277 0.561 . . . . 0.0 111.025 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1064 ' ' PHE . 7.9 m -155.08 95.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.559 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' 1063 ' ' VAL . 1.1 m-85 75.77 139.58 0.07 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.026 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 143.63 31.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.66 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' 1070 ' ' PRO . 47.5 tp -68.47 142.36 55.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' 1089 ' ' PRO . 77.7 t -149.05 132.5 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.867 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 77.42 145.31 2.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.373 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' 1089 ' ' PRO . 16.3 pt-20 18.12 67.83 0.22 Allowed Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 112.689 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.596 ' HA ' HD21 ' A' 1066 ' ' LEU . 13.9 Cg_endo -56.18 -11.56 6.15 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.539 2.159 . . . . 0.0 111.907 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' 1050 ' ' VAL . 79.6 p -156.23 152.05 27.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' 1049 ' ' VAL . 26.3 pt -140.96 -166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.821 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' 1085 ' ' SER . 0.6 OUTLIER -160.09 158.14 29.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.958 0.409 . . . . 0.0 111.359 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.722 ' HB3' ' O ' ' A' 1046 ' ' TYR . 51.5 t -64.63 -42.6 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.97 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.547 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 14.7 t 45.95 -161.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.231 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.836 ' HA ' ' HA2' ' A' 1082 ' ' GLY . 81.2 p -165.38 139.49 4.76 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.579 0.228 . . . . 0.0 111.381 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.921 HD21 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -177.01 -39.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.784 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.721 ' H ' HD22 ' A' 1077 ' ' ASN . 38.7 t70 -82.97 47.22 1.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.196 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.34 -130.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.52 ' HA ' HG23 ' A' 1023 ' ' ILE . 12.0 mp0 -76.96 49.92 0.69 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.648 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 18.4 t -145.9 -46.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.836 ' HA2' ' HA ' ' A' 1076 ' ' SER . . . 77.67 -45.84 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.24 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.921 HG12 HD21 ' A' 1077 ' ' ASN . 6.6 pt 52.58 135.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.449 0.642 . . . . 0.0 111.752 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.443 ' HH2' HD21 ' A' 1040 ' ' ASN . 42.0 m95 -71.92 147.21 47.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.46 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' 1073 ' ' TYR . 80.2 p -48.02 -23.88 0.93 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.795 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.49 140.52 6.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.783 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 12.8 Cg_exo -72.44 47.85 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.528 2.818 . . . . 0.0 113.079 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 64.44 138.99 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.023 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.755 ' HB3' ' HG2' ' A' 1069 ' ' GLU . 97.4 Cg_endo -81.73 -140.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.963 2.442 . . . . 0.0 112.2 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.736 HE21 HD13 ' A' 1092 ' ' ILE . 39.8 tt0 -152.46 153.59 33.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.869 ' O ' HG12 ' A' 1092 ' ' ILE . 90.4 m -80.76 -146.82 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.869 HG12 ' O ' ' A' 1091 ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.777 0.322 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.17 -141.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.279 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -170.46 132.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.529 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 53.44 -92.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? 65.51 151.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 78.3 p -149.78 149.82 31.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.928 0.394 . . . . 0.0 111.497 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 89.1 m -79.93 147.61 31.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.335 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -63.75 138.2 58.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.898 0.38 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 62.2 m -51.94 125.19 30.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.065 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.691 ' HG2' HG11 ' A' ' 974' ' ' VAL . 56.6 Cg_endo -70.86 127.53 13.84 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.325 2.016 . . . . 0.0 111.824 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.85 139.01 50.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.289 1.992 . . . . 0.0 111.564 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -43.81 115.3 2.01 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 110.847 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.625 ' HG3' ' HD2' ' A' ' 988' ' ' TYR . 45.7 Cg_endo -67.45 149.5 80.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.792 2.328 . . . . 0.0 112.301 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.696 HG13 ' H ' ' A' 1020 ' ' CYS . 0.6 OUTLIER -44.86 102.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.206 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 4.8 m120 74.2 -37.28 0.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.86 -172.82 8.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.57 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 64.6 mtm -154.56 135.12 13.46 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 110.916 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.691 HG11 ' HG2' ' A' ' 966' ' ' PRO . 6.3 p -92.93 149.55 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.418 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 15.4 m170 -119.09 113.76 21.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.99 HG13 HG23 ' A' ' 980' ' ' ILE . 78.5 t -60.89 -51.64 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.152 0.501 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 33.6 mt 74.93 -33.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.195 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.5 p -138.0 -64.95 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.538 ' HB3' HE21 ' A' ' 981' ' ' GLN . 38.7 t70 -172.47 2.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.99 HG23 HG13 ' A' ' 976' ' ' VAL . 49.8 pt 52.81 72.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.431 0.634 . . . . 0.0 110.893 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' 1004 ' ' CYS . 22.6 pt20 -152.34 174.74 13.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.128 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' 1004 ' ' CYS . 48.4 t -43.38 138.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.337 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 80.54 -44.87 2.99 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.998 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.577 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 53.4 m -68.43 123.21 20.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.976 0.388 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.683 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 74.9 ttt180 -101.43 121.12 41.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.871 HG21 HG22 ' A' ' 980' ' ' ILE . 31.7 pt -93.46 160.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 78.0 p -143.99 132.38 22.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 111.911 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.625 ' HD2' ' HG3' ' A' ' 969' ' ' PRO . 3.7 m-85 -84.85 -168.11 2.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 11.1 t -161.59 -47.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.469 -0.493 . . . . 0.0 112.195 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.832 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 3.2 t 70.05 -137.64 0.06 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.33 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 158.28 4.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.641 0.734 . . . . 0.0 112.43 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 28.5 m -53.99 114.77 1.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.755 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 147.24 -28.15 1.53 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.591 ' HA ' HG12 ' A' 1023 ' ' ILE . 7.2 m80 -139.07 143.0 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.522 ' CZ ' ' HB2' ' A' 1021 ' ' GLN . 22.8 ptt-85 -80.02 127.34 32.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.143 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 997' ' ' ILE . 3.3 tt -76.13 129.86 37.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' 1019 ' ' ILE . 1.7 mp -104.33 146.68 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.119 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 74.75 169.9 24.28 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.78 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.417 ' ND1' HG21 ' A' 1015 ' ' THR . 24.4 m170 -75.01 125.71 29.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.458 ' O ' ' HD1' ' A' ' 988' ' ' TYR . 79.3 p -64.88 -44.05 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.459 ' HB3' ' NE ' ' A' ' 985' ' ' ARG . 50.5 m -82.72 142.95 31.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.409 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.427 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -161.66 116.4 1.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 37.5 tt0 -85.93 132.51 34.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 43.0 t -69.71 93.52 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.32 -178.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' 1007 ' ' SER . 9.9 tp -158.44 125.5 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.469 ' N ' HD12 ' A' 1006 ' ' LEU . 47.5 t -85.42 -48.91 8.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.278 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 171.84 -48.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.659 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.6 t30 -70.99 -55.19 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.817 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.403 ' C ' HD13 ' A' 1006 ' ' LEU . 87.9 m -151.21 149.05 28.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.492 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.432 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.28 143.96 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -150.71 149.98 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.464 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.428 ' CH2' HD13 ' A' ' 986' ' ' ILE . 52.1 m95 -68.78 132.53 46.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.713 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 78.5 p -52.36 -24.74 8.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.976 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.427 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 75.3 p -131.43 141.17 49.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -56.88 155.45 15.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 17.0 Cg_endo -57.71 118.11 4.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.36 2.04 . . . . 0.0 112.037 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.488 ' HB2' HD21 ' A' ' 996' ' ' LEU . 21.6 Cg_endo -61.48 159.15 32.96 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.545 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 26.4 pt -143.9 127.97 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.622 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.696 ' H ' HG13 ' A' ' 970' ' ' VAL . 50.5 m -88.0 112.79 22.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.052 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.566 ' HG2' HD13 ' A' ' 997' ' ' ILE . 93.0 mm-40 -86.38 145.02 27.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.955 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.587 ' NH2' ' HB3' ' A' 1046 ' ' TYR . 25.8 tpt85 -63.92 128.12 34.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.237 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 994' ' ' HIS . 48.5 mm -65.34 128.25 93.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 72.6 Cg_endo -96.97 139.3 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.738 2.959 . . . . 0.0 113.488 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.761 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 98.0 m -112.94 135.14 54.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.208 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.95 -152.35 4.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.789 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 48.8 mt -83.08 146.17 51.0 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.619 0.247 . . . . 0.0 111.059 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.16 149.8 90.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.324 2.016 . . . . 0.0 111.127 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.726 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 2.5 Cg_endo -46.18 119.66 3.16 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.573 2.182 . . . . 0.0 111.862 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 71.8 p -77.43 145.22 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.44 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' 1031 ' ' ILE . 10.3 tt -149.89 114.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.801 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -56.59 144.57 31.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.531 ' HB3' HD22 ' A' 1055 ' ' ASN . 5.0 m120 75.21 -35.95 0.3 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.501 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.62 178.12 8.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.532 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -156.58 127.32 6.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.79 ' HB2' HG23 ' A' 1050 ' ' VAL . 3.7 p90 -84.34 144.57 28.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 0.0 110.664 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' 1036 ' ' PHE . 42.2 mm -133.66 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.655 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 11.3 t -167.8 -161.18 0.37 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.974 0.416 . . . . 0.0 111.289 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 68.9 p -75.16 -13.4 60.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.279 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.541 ' OD1' ' HB ' ' A' 1050 ' ' VAL . 3.7 m120 -47.42 136.39 9.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.415 ' HB3' ' OE1' ' A' 1042 ' ' GLU . 25.3 mmm180 -154.18 -82.73 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.611 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.5 OUTLIER -163.01 145.16 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' 1042 ' ' GLU . 3.5 m120 70.27 58.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.893 0.377 . . . . 0.0 110.419 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' 1025 ' ' CYS . 2.5 m-85 -76.73 132.46 39.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' 1046 ' ' TYR . 20.4 m80 -90.32 -65.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.619 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.685 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.0 t80 171.91 44.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.548 0.69 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.45 89.2 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.73 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' 1047 ' ' GLY . 77.6 p 172.38 141.66 0.03 OUTLIER 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 111.515 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.967 HG12 ' HB3' ' A' 1073 ' ' TYR . 12.3 m -107.2 -173.53 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.431 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' 1036 ' ' PHE . 7.3 p -153.93 129.57 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.981 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 50.1 m -116.83 110.66 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.473 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 2.2 m-85 -70.58 158.03 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -149.75 -13.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.869 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 65.1 m 66.16 166.02 0.2 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' 1033 ' ' ASN . 19.1 p30 -55.68 -44.64 77.52 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.617 HD12 ' HA2' ' A' 1060 ' ' GLY . 2.8 mm? 38.69 33.32 0.07 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 68.89 -52.63 0.53 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.906 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.566 ' C ' ' HD2' ' A' 1059 ' ' ARG . 70.8 m -161.53 -28.62 0.05 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.321 0.56 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.566 ' HD2' ' C ' ' A' 1058 ' ' SER . 5.6 mpt_? -150.06 -50.58 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.526 0.203 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' 1056 ' ' LEU . . . -174.75 37.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.892 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -70.96 163.15 28.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' 1062 ' ' LYS . 39.9 ttpt -67.85 70.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.17 0.51 . . . . 0.0 110.934 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' 1063 ' ' VAL . 6.7 m -155.07 89.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.747 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' 1063 ' ' VAL . 77.4 m-85 75.55 145.5 0.08 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.951 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -145.09 143.7 30.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.649 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' 1070 ' ' PRO . 61.7 tp -68.57 135.54 51.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.0 111.314 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' 1089 ' ' PRO . 61.5 t -138.25 123.03 22.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.114 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1069 ' ' GLU . . . 71.82 161.3 4.9 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.285 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.609 ' OE2' HD13 ' A' 1072 ' ' ILE . 83.4 tt0 30.37 62.47 0.95 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.916 ' HA ' HD21 ' A' 1066 ' ' LEU . 57.3 Cg_endo -72.68 -24.59 18.25 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.993 1.795 . . . . 0.0 112.302 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' 1050 ' ' VAL . 42.7 m -156.25 137.67 13.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 111.567 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.609 HD13 ' OE2' ' A' 1069 ' ' GLU . 44.6 pt -145.43 -169.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.967 ' HB3' HG12 ' A' 1049 ' ' VAL . 0.6 OUTLIER -162.14 156.89 22.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.051 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.7 t -62.24 148.31 45.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.384 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.42 ' HA ' ' HE1' ' A' 1046 ' ' TYR . 6.5 t -146.04 -7.89 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.743 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.51 ' HB3' ' HA2' ' A' 1082 ' ' GLY . 89.3 p 47.81 54.74 9.49 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.773 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.692 HD21 ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -55.14 -46.23 75.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.86 ' HB2' HG21 ' A' 1081 ' ' VAL . 22.9 m-20 -75.71 -3.1 32.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.301 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.626 ' OD1' ' HG3' ' A' 1080 ' ' GLN . 9.8 t70 65.4 134.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.376 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.626 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 27.6 mt-30 56.87 43.3 25.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.86 HG21 ' HB2' ' A' 1078 ' ' ASP . 24.5 m -148.6 -35.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.253 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.761 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 63.98 41.15 98.73 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.084 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.692 ' HB ' HD21 ' A' 1077 ' ' ASN . 73.7 mt -85.73 136.5 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.837 0.351 . . . . 0.0 111.345 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' 1084 ' ' TRP . 8.1 m95 -76.15 141.12 41.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.704 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 78.9 p -59.78 -61.73 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.898 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.631 ' O ' ' HG3' ' A' 1029 ' ' PRO . . . -71.09 126.67 13.72 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.843 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -88.9 46.34 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.945 2.43 . . . . 0.0 112.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 62.37 130.89 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.519 ' HB2' ' O ' ' A' 1067 ' ' VAL . 86.3 Cg_endo -78.43 -137.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.821 2.347 . . . . 0.0 112.85 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.517 ' H ' ' HB2' ' A' 1089 ' ' PRO . 40.3 tt0 -152.37 140.14 19.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.012 0.435 . . . . 0.0 111.587 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 66.8 m -100.75 130.72 46.82 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.772 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.417 ' CG2' HE21 ' A' 1090 ' ' GLN . 21.5 pt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.053 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.756 0.313 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -60.77 -44.87 96.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -172.2 131.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -67.01 99.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.115 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.656 ' HB3' HD23 ' A' 1006 ' ' LEU . 17.1 tppt? -84.9 132.62 34.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.987 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.9 p -82.08 133.31 35.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.016 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.748 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 98.9 m -80.52 36.26 0.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.022 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.7 tptt 63.38 133.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 56.5 m -70.9 116.99 51.87 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.321 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.805 ' HG2' HG11 ' A' ' 974' ' ' VAL . 61.2 Cg_endo -72.99 120.68 6.76 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.243 1.962 . . . . 0.0 112.168 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 23.5 Cg_exo -63.98 -61.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.232 1.955 . . . . 0.0 111.299 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 170.65 96.93 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.262 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.616 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 58.0 Cg_exo -53.79 179.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.759 2.306 . . . . 0.0 112.668 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 972' ' ' GLY . 92.9 t -48.92 90.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.796 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.842 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 75.0 m-20 71.22 -26.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.262 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.52 114.2 5.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.415 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.559 ' H ' ' HA ' ' A' ' 990' ' ' CYS . 77.3 mmm -80.84 124.06 28.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.805 HG11 ' HG2' ' A' ' 966' ' ' PRO . 0.3 OUTLIER -92.38 138.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.45 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.411 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 23.3 m170 -122.65 108.96 13.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 986' ' ' ILE . 62.0 t -66.4 98.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.097 0.475 . . . . 0.0 109.832 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.19 -93.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.197 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -68.96 -58.4 4.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 0.0 110.182 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.583 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 54.6 m-20 -164.62 -133.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.191 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.585 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 5.0 pt -155.63 -16.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.254 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.987 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 68.1 mt-30 -73.53 177.36 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.621 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 961' ' ' LYS . 99.9 t -44.28 144.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.25 -38.24 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.295 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 49.2 m -68.51 148.1 51.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.845 0.323 . . . . 0.0 110.373 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 1002 ' ' ALA . 5.3 tmm_? -138.44 127.6 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 111.336 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 976' ' ' VAL . 17.4 pt -96.97 -176.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.095 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' 1001 ' ' SER . 50.5 p -150.14 127.96 11.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.004 0.43 . . . . 0.0 111.605 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.654 ' HB2' ' HA ' ' A' 1000 ' ' SER . 1.4 m-85 -85.18 -176.58 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 69.2 m -161.47 -34.41 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.676 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.559 ' HA ' ' H ' ' A' ' 973' ' ' MET . 43.0 t 68.36 167.14 0.26 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 990' ' ' CYS . 81.1 p -60.15 -170.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 51.6 m -88.8 129.55 35.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.155 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 72.25 39.56 57.38 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.788 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' 1022 ' ' ARG . 25.8 m80 -146.87 133.24 19.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 995' ' ' ARG . 35.2 ttt85 -98.68 113.74 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.0 111.283 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 1.015 ' HA ' ' HA ' ' A' 1020 ' ' CYS . 4.1 pp -76.14 138.39 40.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.498 . . . . 0.0 111.467 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' 1018 ' ' PRO . 1.7 mp -95.6 153.18 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.632 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.37 23.45 58.63 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.354 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 80.2 m-70 65.58 141.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.679 ' HB3' HD21 ' A' ' 996' ' ' LEU . 86.9 p -86.26 50.3 1.96 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.726 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 23.0 t -161.81 165.96 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.484 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.2 129.56 2.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -104.94 124.6 49.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.031 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 49.1 t -74.6 123.7 25.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 13.0 pt -136.99 150.92 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.658 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.656 HD23 ' HB3' ' A' ' 961' ' ' LYS . 0.4 OUTLIER -98.89 121.82 41.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.009 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.495 ' N ' HD13 ' A' 1006 ' ' LEU . 50.7 m -78.54 -55.5 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.36 37.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.127 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.55 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 0.0 110.33 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 53.2 m -151.26 149.9 29.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.923 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.748 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.1 141.4 43.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.92 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.4 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.5 m-70 -149.45 140.19 22.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.585 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 66.9 m95 -71.81 127.13 31.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.794 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 80.0 p -52.49 -28.8 21.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.691 ' O ' ' HG2' ' A' 1016 ' ' LYS . 48.2 p -90.64 -24.85 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' 1015 ' ' THR . 15.0 pttp 59.9 152.62 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 123.657 0.598 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.29 105.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.481 2.121 . . . . 0.0 112.157 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.656 ' HB2' ' O ' ' A' ' 997' ' ' ILE . 94.3 Cg_endo -80.14 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.446 HG13 ' HB ' ' A' ' 997' ' ' ILE . 35.4 pt -148.94 -169.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.44 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 15.8 t -153.98 110.82 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.69 ' HG3' ' H ' ' A' 1023 ' ' ILE . 3.2 tp-100 -77.66 134.13 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.401 ' HA ' ' CD2' ' A' ' 994' ' ' HIS . 15.2 ptp180 -76.49 6.36 5.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.452 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.761 HG23 ' HA ' ' A' 1080 ' ' GLN . 57.2 mt 53.29 76.55 0.52 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.665 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' 1045 ' ' HIS . 31.3 Cg_exo -59.39 116.83 3.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.242 1.961 . . . . 0.0 111.759 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 10.0 p -91.11 34.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.829 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 43.97 -142.37 2.61 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.062 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 72.2 mt -106.49 136.35 19.39 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-O 120.619 0.247 . . . . 0.0 111.381 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.428 ' HB3' ' CZ3' ' A' 1084 ' ' TRP . 35.3 Cg_endo -64.34 143.32 82.55 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.588 2.192 . . . . 0.0 111.714 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.887 ' HG2' ' HA ' ' A' 1087 ' ' PRO . 49.4 Cg_exo -55.3 108.88 0.34 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.255 1.97 . . . . 0.0 112.046 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 54.9 m -93.4 124.68 37.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.583 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' 1034 ' ' GLY . 62.7 mt -85.26 139.32 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.369 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -56.53 -55.39 34.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.245 0.545 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -80.23 -36.45 34.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.933 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.867 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -72.78 121.83 8.04 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.614 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -83.4 -151.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.403 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.475 ' HB2' HG23 ' A' 1050 ' ' VAL . 9.3 p90 -155.93 138.97 15.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' 1053 ' ' ARG . 46.3 mt -122.5 67.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 74.5 m -157.18 -140.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.347 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.478 HG22 ' O ' ' A' 1039 ' ' THR . 11.1 m -119.58 38.63 3.83 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.731 HD21 ' HB ' ' A' 1050 ' ' VAL . 5.1 m120 -80.89 121.32 25.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -156.42 43.3 0.39 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' 1043 ' ' ASN . 37.7 tt0 62.94 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' 1042 ' ' GLU . 73.4 m-80 78.64 52.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' 1045 ' ' HIS . 5.1 m-85 -76.74 -56.75 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.137 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' 1024 ' ' PRO . 21.9 m80 72.62 -44.44 0.59 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.71 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 43.3 t80 171.73 148.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.958 0.409 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 73.6 97.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.754 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' 1047 ' ' GLY . 81.4 p 173.45 156.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 110.979 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' 1072 ' ' ILE . 3.5 p -137.78 155.44 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.967 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.731 ' HB ' HD21 ' A' 1040 ' ' ASN . 13.5 p -143.52 127.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.418 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 89.4 m -104.46 120.21 40.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.224 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.425 ' HD2' HD12 ' A' 1031 ' ' ILE . 13.1 m-85 -83.84 148.01 27.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.642 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.656 ' HD2' HD11 ' A' 1037 ' ' ILE . 44.9 ttt85 -142.77 -27.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.017 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.867 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 11.7 t 67.66 154.99 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -51.19 -93.45 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.601 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' 1064 ' ' PHE . 5.7 mt 61.71 -166.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.226 0.536 . . . . 0.0 111.843 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.544 ' N ' ' N ' ' A' 1061 ' ' ARG . . . 54.28 -121.38 19.52 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.206 -0.906 . . . . 0.0 114.136 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 75.1 p -45.59 -66.43 0.4 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.26 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -87.21 35.62 0.71 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' 1056 ' ' LEU . . . -174.68 -117.68 0.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.563 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.736 ' O ' HG13 ' A' 1063 ' ' VAL . 11.2 tpt180 85.32 108.22 0.05 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.547 0.739 . . . . 0.0 110.103 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' 1062 ' ' LYS . 63.9 tttp 44.65 36.16 1.67 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 122.093 0.949 . . . . 0.0 109.609 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' 1061 ' ' ARG . 31.1 m -104.37 -12.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.591 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.866 ' HB2' HD21 ' A' 1056 ' ' LEU . 70.3 m-85 -156.09 162.99 40.19 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.921 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' 1091 ' ' CYS . 44.7 mt-10 -142.4 131.27 22.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.016 0.436 . . . . 0.0 110.826 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.484 HD11 ' CG ' ' A' 1089 ' ' PRO . 31.0 tp -68.48 147.21 52.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.646 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . . . . . . . . . 58.4 t -138.34 135.46 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 82.21 -148.03 26.44 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.302 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' 1069 ' ' GLU . 7.0 pm0 -72.1 120.67 81.57 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.476 ' HA ' HD21 ' A' 1066 ' ' LEU . 62.7 Cg_endo -75.84 -25.73 10.31 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.747 2.298 . . . . 0.0 112.395 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 54.3 m -137.57 153.95 49.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.739 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' 1049 ' ' VAL . 36.1 pt -143.01 -169.07 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.098 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' 1085 ' ' SER . 0.4 OUTLIER -160.01 158.26 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.284 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.71 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 10.2 t -62.16 -51.92 65.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.458 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.459 ' HB ' ' CD1' ' A' 1073 ' ' TYR . 15.3 t 45.59 -172.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.974 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 80.3 p -165.47 143.73 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.681 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -162.82 -45.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.737 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.67 ' H ' ' ND2' ' A' 1077 ' ' ASN . 40.3 t0 -81.12 -146.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.49 ' H ' ' CG ' ' A' 1078 ' ' ASP . 36.3 m-20 -82.04 -137.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.761 ' HA ' HG23 ' A' 1023 ' ' ILE . 73.8 mt-30 -81.0 26.16 0.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' 1079 ' ' ASP . 17.7 t -77.58 -44.25 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.298 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 59.66 63.22 5.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.191 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.546 HG12 HD21 ' A' 1077 ' ' ASN . 34.4 pt -81.93 129.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.462 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.428 ' CZ3' ' HB3' ' A' 1028 ' ' PRO . 20.0 m95 -76.53 163.88 26.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.1 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.49 ' HB2' ' CE1' ' A' 1073 ' ' TYR . 43.8 t -48.62 -32.86 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.641 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.51 147.58 12.26 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.033 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.887 ' HA ' ' HG2' ' A' 1029 ' ' PRO . 73.9 Cg_endo -75.38 49.42 2.36 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.988 2.459 . . . . 0.0 112.78 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 63.73 133.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.742 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.484 ' CG ' HD11 ' A' 1066 ' ' LEU . 56.1 Cg_endo -71.65 -149.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.116 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.417 ' H ' ' HB2' ' A' 1089 ' ' PRO . 3.6 mm100 -151.93 117.93 5.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.724 0.297 . . . . 0.0 111.442 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1065 ' ' GLU . 28.1 p -103.11 88.39 3.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.248 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.408 ' HA ' ' HD1' ' A' 1064 ' ' PHE . 27.8 pt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.841 0.353 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.33 -40.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 51.6 42.93 30.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 45.32 34.83 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.735 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.732 ' HG3' HD11 ' A' 1006 ' ' LEU . 71.9 mmtt -79.38 148.78 31.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.1 p -157.86 127.25 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.253 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.86 142.69 34.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.755 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.82 141.07 58.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.386 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.432 ' OG1' HD13 ' A' ' 980' ' ' ILE . 62.4 m -64.8 130.49 94.82 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 31.5 Cg_exo -59.35 120.51 8.39 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.188 1.925 . . . . 0.0 111.634 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 46.1 Cg_exo -55.97 -50.24 12.98 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.167 1.911 . . . . 0.0 111.659 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 59.2 t0 174.03 106.96 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.92 155.16 19.09 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.366 2.044 . . . . 0.0 111.232 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.7 ' HB ' ' HA ' ' A' 1019 ' ' ILE . 80.4 t -46.55 106.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.79 0.329 . . . . 0.0 111.445 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.693 HD22 ' HB2' ' A' 1020 ' ' CYS . 73.7 m-20 74.72 -53.98 0.67 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.078 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -79.5 138.34 20.22 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.274 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 86.7 mmm -81.87 -156.65 0.16 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 110.812 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 988' ' ' TYR . 3.3 p -159.29 148.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.441 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.444 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 17.1 m170 -120.15 109.84 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 986' ' ' ILE . 43.3 t -65.33 105.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.624 HG13 HG23 ' A' ' 987' ' ' THR . 44.7 mm -75.23 -94.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.753 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.7 p -67.93 -65.99 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.492 ' OD1' HG12 ' A' ' 980' ' ' ILE . 46.7 t0 -165.71 -132.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.63 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.54 HG22 ' CH2' ' A' 1013 ' ' TRP . 1.6 pt -155.95 14.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.355 0.597 . . . . 0.0 110.33 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.4 171.24 10.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.353 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 61.9 t -47.51 141.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.646 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.38 -46.95 2.6 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.489 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 151.28 47.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.262 0.531 . . . . 0.0 110.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.878 ' HB3' ' HA ' ' A' 1003 ' ' GLU . 0.0 OUTLIER -138.43 -168.53 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 977' ' ' ILE . 23.6 pt -148.55 -160.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.97 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.624 HG23 HG13 ' A' ' 977' ' ' ILE . 68.5 p -142.03 124.55 15.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 112.028 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.473 ' HA ' HG23 ' A' ' 974' ' ' VAL . 1.3 m-85 -98.89 150.94 21.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.319 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 19.3 m -150.25 138.95 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.261 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.697 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 42.4 t -81.97 154.39 25.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.285 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 992' ' ' THR . 11.0 t -64.87 -139.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.392 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.557 HG23 ' N ' ' A' ' 993' ' ' GLY . 12.8 t -60.94 -142.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.045 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.557 ' N ' HG23 ' A' ' 992' ' ' THR . . . -63.42 75.35 0.04 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 113.971 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.645 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 37.6 m80 -145.94 140.81 27.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.508 HH22 ' HB3' ' A' 1079 ' ' ASP . 41.3 ttm-85 -81.96 118.98 23.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.996 0.427 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 990' ' ' CYS . 5.9 tp -76.2 126.09 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.964 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 996' ' ' LEU . 1.8 mp -107.83 150.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.794 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.58 54.58 4.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.677 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 56.56 -143.85 0.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.196 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m -160.81 27.27 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.031 0.443 . . . . 0.0 110.152 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 65.9 p -162.17 162.51 28.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.223 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.759 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -153.79 130.65 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.837 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.878 ' HA ' ' HB3' ' A' ' 985' ' ' ARG . 21.1 pt-20 -101.74 129.6 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.946 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.512 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 5.9 t -72.17 128.54 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.334 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.5 pt -145.55 169.36 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.103 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.732 HD11 ' HG3' ' A' ' 961' ' ' LYS . 4.0 mm? -81.57 146.43 30.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.938 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.631 ' HB2' ' HD2' ' A' 1012 ' ' HIS . 71.2 m -159.8 59.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 104.99 51.39 0.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.166 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 58.87 24.97 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.039 0.447 . . . . 0.0 110.399 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 71.4 m -151.32 139.21 19.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.679 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.512 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.33 136.7 40.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.959 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.631 ' HD2' ' HB2' ' A' 1007 ' ' SER . 92.1 m-70 -149.47 141.32 23.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.759 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 70.6 m95 -67.75 123.6 20.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.127 0.489 . . . . 0.0 110.854 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 20.7 m -52.39 -24.44 7.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.947 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 55.2 p -103.65 142.02 35.05 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 61.5 pttt -62.61 149.74 88.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.868 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 120.99 9.16 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.304 2.003 . . . . 0.0 111.7 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.672 ' HB3' HD11 ' A' ' 996' ' ' LEU . 32.7 Cg_exo -59.18 145.29 98.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.829 2.353 . . . . 0.0 112.903 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.7 ' HA ' ' HB ' ' A' ' 970' ' ' VAL . 40.3 pt -140.05 130.4 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.693 ' HB2' HD22 ' A' ' 971' ' ' ASN . 74.2 m -86.35 108.93 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.181 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.419 HE21 ' HA ' ' A' 1021 ' ' GLN . 2.7 tp-100 -81.62 130.49 35.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.524 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -71.65 120.14 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' 1079 ' ' ASP . 77.4 mt -67.24 110.97 6.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.741 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.06 125.22 17.51 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.898 2.399 . . . . 0.0 113.424 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.611 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 66.9 m -95.94 133.11 40.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.087 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -79.87 -154.0 8.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.394 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 138.99 94.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.788 0.328 . . . . 0.0 111.321 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.461 ' HB2' ' OH ' ' A' 1052 ' ' TYR . 51.1 Cg_endo -68.64 148.73 72.75 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.774 2.316 . . . . 0.0 112.048 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.759 ' HB2' ' HB3' ' A' 1087 ' ' PRO . 34.7 Cg_exo -59.15 111.18 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.081 1.854 . . . . 0.0 111.476 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 26.9 p -77.52 122.46 25.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.641 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' 1032 ' ' ALA . 18.4 pt -88.59 29.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.851 0.358 . . . . 0.0 111.855 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' 1031 ' ' ILE . . . 52.87 125.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.495 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' 1032 ' ' ALA . 77.1 m-20 71.43 -26.6 0.17 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.234 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -69.54 124.73 16.09 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.717 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' 1053 ' ' ARG . 1.5 m-20 -76.46 -159.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.657 0.265 . . . . 0.0 110.368 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' 1051 ' ' THR . 45.6 p90 -155.99 137.8 14.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.633 HD11 HH11 ' A' 1053 ' ' ARG . 20.3 mm -128.77 37.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.756 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 78.2 p -69.24 145.48 53.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.615 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 38.2 m -59.42 -38.37 80.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.694 HD22 ' HB3' ' A' 1048 ' ' SER . 23.4 p30 -72.19 -155.44 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.597 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' 1040 ' ' ASN . 18.3 mmt85 -162.2 -54.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.701 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' 1043 ' ' ASN . 42.0 tt0 -162.89 148.73 12.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' 1042 ' ' GLU . 75.4 m-20 78.12 65.2 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.59 134.92 39.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.308 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' 1046 ' ' TYR . 13.1 m80 -96.93 -51.52 4.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.555 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 69.7 t80 171.06 144.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.412 0.445 . . . . 0.0 110.55 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 76.5 -14.54 6.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.221 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.694 ' HB3' HD22 ' A' 1040 ' ' ASN . 65.5 m -47.36 136.15 9.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.033 0.444 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' 1038 ' ' SER . 88.7 t -102.19 146.88 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.224 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.756 ' HA ' ' HB3' ' A' 1038 ' ' SER . 30.8 m -142.57 126.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.398 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' 1036 ' ' PHE . 59.1 m -100.49 108.69 20.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.461 ' OH ' ' HB2' ' A' 1028 ' ' PRO . 21.0 m-85 -77.08 163.13 26.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.307 0.575 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.734 ' HB2' ' HB2' ' A' 1035 ' ' ASP . 75.6 mtp180 -142.76 -138.96 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.655 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.526 ' O ' HD23 ' A' 1056 ' ' LEU . 48.7 t -163.7 145.42 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 111.686 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.1 68.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.243 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.568 ' HA ' HG23 ' A' 1063 ' ' VAL . 3.7 mm? -72.22 41.91 0.09 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 53.37 -106.15 0.39 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.525 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.546 ' HB2' ' HD3' ' A' 1061 ' ' ARG . 66.8 m -67.37 -48.28 67.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' 1059 ' ' ARG . 11.6 tpt180 -165.83 -49.85 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.044 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.515 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -164.38 39.91 0.31 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.752 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.666 ' N ' ' HD2' ' A' 1061 ' ' ARG . 0.7 OUTLIER -83.14 172.76 12.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 110.769 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 58.5 tttm -65.48 79.91 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' 1056 ' ' LEU . 6.9 m -155.14 92.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.637 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.664 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 0.8 OUTLIER 74.27 141.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.695 -178.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' 1091 ' ' CYS . 49.8 mt-10 -137.27 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.064 0.459 . . . . 0.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.617 HD21 ' HB3' ' A' 1070 ' ' PRO . 38.7 tp -68.44 152.09 45.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.156 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' 1089 ' ' PRO . 65.1 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 77.51 -168.37 54.39 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' 1069 ' ' GLU . 15.2 pm0 -72.05 126.85 91.13 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.617 ' HB3' HD21 ' A' 1066 ' ' LEU . 96.8 Cg_endo -82.17 -36.95 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.38 2.053 . . . . 0.0 111.87 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.8 p -83.81 140.87 31.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.179 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' 1049 ' ' VAL . 36.3 pt -147.78 -171.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.899 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 3.3 p90 -162.26 143.87 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.699 0.285 . . . . 0.0 111.386 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.929 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 52.1 t -66.51 154.15 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.075 0.464 . . . . 0.0 111.0 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 10.2 t -147.59 -144.62 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.106 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.5 t -155.76 137.77 14.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.018 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.599 HD21 HD12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -166.58 31.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.757 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' 1077 ' ' ASN . 38.7 t70 175.84 50.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.255 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.544 ' O ' HD13 ' A' 1023 ' ' ILE . 1.5 m-20 61.88 -125.24 0.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.515 ' HA ' HG23 ' A' 1023 ' ' ILE . 25.3 pt20 -66.01 -140.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.51 0.195 . . . . 0.0 110.71 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' 1080 ' ' GLN . 25.9 t 74.22 -45.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.992 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 66.36 62.61 4.5 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.599 HD12 HD21 ' A' 1077 ' ' ASN . 74.3 mt -80.19 130.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.009 0.433 . . . . 0.0 110.972 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.929 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 26.1 m95 -72.6 177.09 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.0 t -55.52 -64.2 0.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.684 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.57 131.66 1.6 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.628 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.759 ' HB3' ' HB2' ' A' 1029 ' ' PRO . 93.7 Cg_endo -79.72 48.64 2.92 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.828 2.352 . . . . 0.0 111.698 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.689 ' N ' ' HD2' ' A' 1089 ' ' PRO . . . -62.57 -47.34 88.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.34 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' 1088 ' ' ALA . 4.9 Cg_endo -48.45 137.12 25.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.432 2.088 . . . . 0.0 112.112 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.89 132.99 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 15.2 t -102.49 137.79 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.415 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.353 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.602 0.239 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -176.2 -42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -170.48 52.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.121 0.486 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.95 41.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.424 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.592 ' O ' HG23 ' A' ' 982' ' ' VAL . 1.0 OUTLIER 55.86 47.11 20.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.439 . . . . 0.0 111.436 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 81.4 p -89.95 132.2 35.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.644 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 73.0 m -79.93 39.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.816 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.4 OUTLIER 60.58 116.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.595 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 51.0 m -59.84 112.81 5.89 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.081 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.497 ' HB2' HG21 ' A' ' 974' ' ' VAL . 27.2 Cg_exo -62.0 113.05 1.7 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.11 1.873 . . . . 0.0 111.761 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 26.5 Cg_endo -62.39 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.203 1.935 . . . . 0.0 111.277 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 967' ' ' PRO . 2.5 p30 176.19 119.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.823 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 37.4 Cg_endo -66.92 149.34 83.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.339 2.026 . . . . 0.0 111.267 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.539 HG12 ' ND2' ' A' ' 971' ' ' ASN . 98.6 t -40.65 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.826 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.567 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 75.6 m-20 75.27 -51.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.662 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.56 -172.37 7.33 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.88 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.823 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 67.3 mtm -156.7 136.29 12.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.675 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.876 ' HB ' HD12 ' A' ' 986' ' ' ILE . 2.6 m -85.27 149.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.475 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 32.8 m170 -114.93 104.0 11.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.75 ' HA ' HG22 ' A' ' 986' ' ' ILE . 59.5 t -70.43 92.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.043 0.449 . . . . 0.0 110.333 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.18 -91.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.881 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 38.0 p -71.53 -68.83 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.343 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 18.6 t70 -165.67 -153.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.353 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.651 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.4 pt -155.94 11.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.618 0.247 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.648 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 25.7 mt-30 -87.22 30.81 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 67.4 t 100.61 143.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.553 0.741 . . . . 0.0 111.762 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.87 -46.22 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.626 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.488 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 57.9 m -68.41 150.79 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.569 ' HD2' ' H ' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -138.4 135.87 35.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.228 0.537 . . . . 0.0 111.113 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.876 HD12 ' HB ' ' A' ' 974' ' ' VAL . 20.1 pt -91.06 -163.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.226 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 45.5 p -146.38 123.72 11.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.004 0.43 . . . . 0.0 111.561 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.647 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.6 OUTLIER -91.86 151.12 20.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.565 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.8 p -155.18 125.7 6.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 61.3 m -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 994' ' ' HIS . 62.5 p 27.94 -143.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.054 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 7.3 t -117.32 -24.72 7.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.396 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -135.5 45.49 1.1 Allowed Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.111 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.402 ' HB2' ' OG1' ' A' ' 991' ' ' THR . 27.5 m80 -139.91 144.92 37.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.693 0.283 . . . . 0.0 110.589 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' 1079 ' ' ASP . 43.7 ttm-85 -81.97 125.97 31.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.671 HD13 ' OG ' ' A' 1000 ' ' SER . 7.0 tt -76.24 123.14 25.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.695 ' HB ' HG13 ' A' 1019 ' ' ILE . 51.7 mm -86.64 148.42 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.402 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.79 -107.04 2.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.832 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' 1001 ' ' SER . 91.2 m-70 -149.76 133.02 16.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 996' ' ' LEU . 15.6 m -78.43 27.41 0.2 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.522 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 999' ' ' HIS . 81.4 p -162.22 145.77 11.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.451 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.98 132.27 10.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.411 . . . . 0.0 111.435 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -104.95 133.53 49.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.197 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 53.1 t -73.46 129.39 37.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' 1012 ' ' HIS . 38.1 pt -130.49 -167.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.802 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.573 HD13 ' N ' ' A' 1007 ' ' SER . 0.4 OUTLIER -142.95 127.06 17.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.895 0.379 . . . . 0.0 110.79 -179.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.573 ' N ' HD13 ' A' 1006 ' ' LEU . 56.5 p -81.75 -59.4 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.856 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.52 35.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -37.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 110.361 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 27.6 m -149.98 142.73 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.644 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.31 141.18 43.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.226 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.9 p80 -149.68 147.19 27.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.3 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.651 ' HH2' HG22 ' A' ' 980' ' ' ILE . 84.2 m95 -67.19 129.61 40.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 111.021 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.4 p -52.37 -27.16 14.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.865 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 75.9 p -107.99 138.35 44.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -58.23 152.38 42.3 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.5 103.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.381 2.054 . . . . 0.0 112.532 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.1 154.35 72.7 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.993 2.462 . . . . 0.0 111.767 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 997' ' ' ILE . 37.1 pt -135.84 -147.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.403 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 971' ' ' ASN . 23.0 m -143.06 -178.78 6.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -166.86 126.54 1.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -74.3 120.71 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.35 119.51 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.213 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.06 122.45 7.64 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.188 1.926 . . . . 0.0 111.758 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 28.8 m -88.41 134.93 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.591 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 161.79 52.24 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.051 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.567 ' HG ' ' HE2' ' A' 1044 ' ' PHE . 10.4 mt -49.75 138.83 17.01 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 117.018 0.409 . . . . 0.0 111.895 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.497 ' HB3' ' CD2' ' A' 1084 ' ' TRP . 59.2 Cg_endo -70.85 150.31 61.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.893 2.396 . . . . 0.0 111.516 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 83.4 Cg_exo -47.01 126.12 10.89 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.415 2.077 . . . . 0.0 111.985 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.0 p -77.53 126.56 31.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' 1034 ' ' GLY . 6.7 tt -88.59 111.29 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -67.11 141.77 57.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.4 m-20 68.84 26.93 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.308 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.779 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -175.34 135.06 2.9 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.28 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -74.17 -155.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.572 ' HB2' ' CG1' ' A' 1050 ' ' VAL . 49.0 p90 -156.0 131.89 9.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 111.251 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.546 HG13 ' CZ ' ' A' 1053 ' ' ARG . 47.9 mm -91.3 99.97 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.822 ' HB2' ' HA ' ' A' 1050 ' ' VAL . 44.3 t -171.12 146.58 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.911 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 90.9 m -58.94 -33.61 70.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 44.7 t30 -56.53 128.39 35.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -151.69 -31.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.635 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -147.16 -51.73 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.163 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -71.57 135.71 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.567 ' HE2' ' HG ' ' A' 1027 ' ' LEU . 0.1 OUTLIER -162.21 55.09 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' 1046 ' ' TYR . 12.2 m80 -63.5 -47.9 79.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.196 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' 1045 ' ' HIS . 74.0 t80 172.37 161.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.53 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 79.9 -24.11 3.47 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 49.7 m -47.59 143.87 3.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 110.92 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -142.47 123.53 11.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.782 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.822 ' HA ' ' HB2' ' A' 1038 ' ' SER . 98.1 t -106.55 129.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.042 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.7 m -99.43 125.05 45.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.632 ' HB2' HD11 ' A' 1066 ' ' LEU . 4.6 m-85 -72.24 146.79 47.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.546 ' CZ ' HG13 ' A' 1037 ' ' ILE . 38.3 ttm180 -146.11 -29.24 0.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.779 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 47.7 t 65.44 160.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.483 ' N ' ' HA2' ' A' 1034 ' ' GLY . 75.1 m-20 -62.13 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.584 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.763 ' HB3' ' HA2' ' A' 1060 ' ' GLY . 23.0 mt -154.94 27.0 0.43 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.285 0.564 . . . . 0.0 110.65 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' 1063 ' ' VAL . . . 53.71 -113.15 2.89 Favored Glycine 0 C--N 1.317 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.859 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 49.3 m -51.44 -50.48 59.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -167.7 -53.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.352 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.763 ' HA2' ' HB3' ' A' 1056 ' ' LEU . . . -176.89 38.2 0.09 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.942 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' 1061 ' ' ARG . 34.6 ttm180 -93.86 33.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' 1062 ' ' LYS . 26.2 ttpp 41.09 52.19 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.172 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.722 HG23 ' HD1' ' A' 1064 ' ' PHE . 16.1 m -85.02 -39.27 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.253 0.549 . . . . 0.0 110.728 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.722 ' HD1' HG23 ' A' 1063 ' ' VAL . 2.9 m-85 -85.96 147.76 26.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.066 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -134.44 128.91 34.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 111.658 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' 1067 ' ' VAL . 4.5 tt -68.6 140.31 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.309 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.875 ' N ' HD23 ' A' 1066 ' ' LEU . 78.5 t -135.49 109.51 10.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 111.142 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . 0.558 ' O ' ' HG3' ' A' 1089 ' ' PRO . . . 76.98 156.55 7.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.754 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 38.2 tt0 30.37 77.39 0.32 Allowed Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' 1066 ' ' LEU . 90.0 Cg_endo -86.66 7.39 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.588 2.192 . . . . 0.0 112.473 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 53.1 m -156.23 150.01 24.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.387 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' 1049 ' ' VAL . 15.5 pt -148.0 150.15 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.635 ' HB3' HG23 ' A' 1049 ' ' VAL . 2.8 p90 -160.12 145.67 15.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.601 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.919 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 42.0 t -66.28 144.12 56.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.7 t -144.07 -7.55 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.296 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' 1082 ' ' GLY . 57.8 m 66.11 136.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.308 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.518 HD21 ' HB ' ' A' 1083 ' ' ILE . 0.0 OUTLIER -172.18 43.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.867 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -170.07 -122.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.453 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' 1081 ' ' VAL . 9.5 t70 -163.09 121.48 2.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.771 0.319 . . . . 0.0 110.757 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.467 ' HG3' ' OD1' ' A' 1079 ' ' ASP . 86.7 mt-30 55.88 42.35 28.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' 1079 ' ' ASP . 21.1 t -147.59 -38.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 110.46 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 76.73 -68.96 2.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.753 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.518 ' HB ' HD21 ' A' 1077 ' ' ASN . 75.5 mt 60.57 130.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.981 0.419 . . . . 0.0 111.202 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.919 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.6 m95 -74.58 -153.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -62.96 -46.84 85.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.501 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . 178.66 -149.05 8.69 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.906 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' 1029 ' ' PRO . 10.4 Cg_exo -71.57 -127.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.387 2.725 . . . . 0.0 112.74 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . -159.33 138.84 8.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 58.5 Cg_endo -68.36 -138.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.505 2.803 . . . . 0.0 113.105 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.452 ' H ' ' HB2' ' A' 1089 ' ' PRO . 40.5 tt0 -152.4 143.51 23.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.177 0.513 . . . . 0.0 111.734 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 42.6 t -103.13 139.38 38.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.573 HD11 HG21 ' A' 1067 ' ' VAL . 11.9 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.127 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -77.42 43.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.551 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.4 mm-40 -68.98 -159.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -80.06 55.36 2.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.551 ' NZ ' ' HB2' ' A' ' 959' ' ' GLU . 47.9 mmtm -77.51 140.97 39.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 83.6 p -155.41 139.85 16.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.464 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.0 m -80.0 140.85 36.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.268 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.93 148.66 49.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.008 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 41.8 m -39.71 119.66 1.37 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.537 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.78 ' HG2' HG11 ' A' ' 974' ' ' VAL . 11.2 Cg_endo -55.03 127.2 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.358 2.039 . . . . 0.0 111.725 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.14 125.14 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.038 1.825 . . . . 0.0 111.37 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.06 120.03 11.17 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.457 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.554 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 77.2 Cg_exo -50.51 140.34 35.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.479 2.119 . . . . 0.0 112.247 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.657 ' HB ' ' H ' ' A' 1020 ' ' CYS . 66.9 t -47.03 110.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.508 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.2 m-20 75.66 -45.91 0.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.581 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -72.62 -156.02 3.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.896 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.554 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 94.9 mmm -158.85 143.3 15.69 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.51 0.324 . . . . 0.0 110.418 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.78 HG11 ' HG2' ' A' ' 966' ' ' PRO . 0.5 OUTLIER -91.61 144.73 8.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.387 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -117.06 107.96 15.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.736 0.303 . . . . 0.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.766 ' HA ' HG22 ' A' ' 986' ' ' ILE . 57.3 t -66.42 119.59 11.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.943 HD11 HG23 ' A' ' 987' ' ' THR . 31.3 mt -84.43 -89.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.802 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 30.9 p -75.25 -69.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.54 ' H ' ' HB2' ' A' ' 984' ' ' SER . 2.6 m-20 -153.13 -147.57 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.95 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.434 HG22 ' CH2' ' A' 1013 ' ' TRP . 12.1 pt -155.95 25.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.705 0.288 . . . . 0.0 111.21 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 71.3 mt-30 -87.26 -55.75 3.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.474 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 981' ' ' GLN . 13.1 t -173.42 140.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 124.142 0.901 . . . . 0.0 109.469 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.24 -20.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.888 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.54 ' HB2' ' H ' ' A' ' 979' ' ' ASP . 81.1 p -68.34 129.15 39.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 48.3 ttm-85 -97.47 156.74 16.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 976' ' ' VAL . 28.2 pt -143.16 136.22 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.943 HG23 HD11 ' A' ' 977' ' ' ILE . 59.4 p -91.0 126.24 36.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.06 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.917 ' HB2' ' HA ' ' A' 1000 ' ' SER . 2.4 m-85 -96.48 146.93 24.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 15.3 t -145.53 169.34 18.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.973 ' HB2' HD12 ' A' ' 996' ' ' LEU . 4.7 t -158.11 107.07 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 992' ' ' THR . 35.6 p 34.73 -150.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.971 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.413 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.4 t -117.91 -37.09 3.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.819 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' 1046 ' ' TYR . . . -118.05 48.9 0.9 Allowed Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.275 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -144.71 131.81 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.639 HH21 ' HA ' ' A' 1079 ' ' ASP . 39.1 ttm-85 -82.04 109.88 16.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.703 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.973 HD12 ' HB2' ' A' ' 990' ' ' CYS . 6.6 tt -76.44 113.69 14.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.564 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' 1019 ' ' ILE . 2.0 mp -90.11 91.41 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.922 0.868 . . . . 0.0 110.663 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -161.05 -113.71 0.32 Allowed Glycine 0 C--N 1.315 -0.621 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.023 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' 1000 ' ' SER . 92.8 m-70 -154.19 -10.43 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.917 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 19.4 m 57.58 18.52 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.432 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.603 ' O ' HG21 ' A' 1015 ' ' THR . 79.6 p -162.18 144.39 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.433 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -162.97 153.67 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.779 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' 1003 ' ' GLU . 11.2 pm0 -135.04 135.46 41.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.724 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.421 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 31.6 t -71.41 88.65 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.304 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.411 HG23 ' HG2' ' A' 1003 ' ' GLU . 37.8 pt -87.33 -167.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' 1008 ' ' GLY . 4.0 tt -158.38 121.89 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.417 ' N ' HD23 ' A' 1006 ' ' LEU . 44.3 t -77.51 -48.04 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.74 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.439 ' N ' HD23 ' A' 1006 ' ' LEU . . . 175.83 -45.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.793 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.32 -48.86 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 47.3 m -151.2 153.3 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.924 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.421 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.32 141.33 43.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.1 p80 -154.92 147.87 24.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.698 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.434 ' CH2' HG22 ' A' ' 980' ' ' ILE . 41.2 m95 -70.76 126.87 30.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 110.531 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 t -52.43 -25.54 10.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.788 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.603 HG21 ' O ' ' A' 1001 ' ' SER . 30.9 p -95.5 138.81 32.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.59 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 24.0 pttm -79.16 163.8 57.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.354 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 11.2 Cg_endo -54.28 120.0 7.28 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.086 1.858 . . . . 0.0 111.405 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.507 ' HB2' HD21 ' A' ' 996' ' ' LEU . 72.3 Cg_endo -76.66 136.22 16.92 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.769 2.313 . . . . 0.0 113.521 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.674 ' O ' ' HB ' ' A' ' 997' ' ' ILE . 30.0 pt -116.37 124.07 72.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.657 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 84.6 m -91.12 121.46 32.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.575 ' HG2' HD13 ' A' ' 997' ' ' ILE . 96.9 mm-40 -86.52 129.92 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.166 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.616 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.01 129.68 40.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.677 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' 1046 ' ' TYR . 44.1 mm -73.93 107.64 3.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.21 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 92.4 Cg_endo -81.4 123.57 4.43 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.297 1.998 . . . . 0.0 112.477 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' 1044 ' ' PHE . 73.3 m -88.64 132.97 34.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.202 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -82.93 -154.61 16.4 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.064 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' 1027 ' ' LEU . 1.7 mm? -72.75 144.9 86.34 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 120.711 0.291 . . . . 0.0 111.519 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.702 ' HG3' HD21 ' A' 1040 ' ' ASN . 27.1 Cg_endo -61.45 166.65 11.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.879 2.386 . . . . 0.0 112.284 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' 1086 ' ' GLY . 81.9 Cg_exo -47.98 -24.35 5.2 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.757 2.305 . . . . 0.0 112.449 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . 0.593 HG23 ' O ' ' A' 1028 ' ' PRO . 46.4 p 56.91 144.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.733 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.78 HD13 ' HB1' ' A' 1088 ' ' ALA . 2.9 pt -152.88 117.97 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -70.11 67.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.148 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' 1034 ' ' GLY . 15.0 p30 -174.25 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.609 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -79.25 -177.18 49.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.367 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' 1053 ' ' ARG . 3.2 m-20 -156.47 132.65 9.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 5.1 p90 -84.02 152.71 24.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.425 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.508 HD13 ' O ' ' A' 1036 ' ' PHE . 39.1 mm -127.71 66.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' 1050 ' ' VAL . 9.6 t -171.08 -141.52 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' 1040 ' ' ASN . 39.7 m -67.57 -103.92 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.72 ' HB2' HG11 ' A' 1050 ' ' VAL . 24.2 t-20 50.1 118.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' 1040 ' ' ASN . 22.0 mmt180 -164.57 -69.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.242 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -156.62 -51.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.188 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' 1043 ' ' ASN . 2.5 m120 -72.87 61.58 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.75 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' 1025 ' ' CYS . 73.1 m-85 -76.72 -58.08 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.314 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.74 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 7.2 m80 55.54 -172.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.53 ' CZ ' ' HA3' ' A' ' 993' ' ' GLY . 34.4 t80 -56.9 142.78 40.11 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.48 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.433 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.47 124.34 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' 1073 ' ' TYR . 38.2 m 178.37 144.55 0.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.374 0.67 . . . . 0.0 110.041 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' 1072 ' ' ILE . 11.2 p -155.83 145.32 12.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' 1040 ' ' ASN . 27.3 m -149.54 141.88 17.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.638 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 60.5 m -88.68 124.46 34.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.327 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' A' 1070 ' ' PRO . 11.3 m-85 -85.26 147.95 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.722 0.772 . . . . 0.0 112.789 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' 1035 ' ' ASP . 43.1 ttt85 -148.71 129.75 14.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.29 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 12.8 t -76.44 153.54 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.675 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -49.19 -70.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.02 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.817 HD22 ' HA2' ' A' 1060 ' ' GLY . 4.3 mt 62.37 164.99 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.403 ' C ' ' HG ' ' A' 1058 ' ' SER . . . -82.8 42.25 2.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.394 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' 1059 ' ' ARG . 84.0 p 49.73 29.12 2.99 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.349 . . . . 0.0 111.391 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' 1058 ' ' SER . 0.7 OUTLIER -152.77 -37.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.817 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 98.08 46.36 2.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.702 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' 1061 ' ' ARG . 13.5 tpp85 -76.93 40.2 0.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' 1062 ' ' LYS . 24.7 ttmm 44.17 35.04 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.528 0.68 . . . . 0.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.755 HG23 ' HD1' ' A' 1064 ' ' PHE . 11.3 m -95.9 -10.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.755 ' HD1' HG23 ' A' 1063 ' ' VAL . 88.3 m-85 -153.93 141.48 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.606 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -142.16 119.14 11.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.01 0.433 . . . . 0.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' 1067 ' ' VAL . 5.5 tt -73.42 130.16 39.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.64 ' N ' HD23 ' A' 1066 ' ' LEU . 7.5 p -156.64 73.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.038 0.923 . . . . 0.0 110.88 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . 0.837 ' HA3' ' HA ' ' A' 1089 ' ' PRO . . . -172.64 23.05 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.218 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.729 ' HB3' ' O ' ' A' 1068 ' ' GLY . 7.8 tt0 81.99 104.4 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.629 ' HA ' ' HB2' ' A' 1052 ' ' TYR . 89.0 Cg_endo -82.96 31.64 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.912 2.408 . . . . 0.0 113.229 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.9 p -158.86 134.65 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.561 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' 1049 ' ' VAL . 42.2 pt -140.89 152.31 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.06 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' 1048 ' ' SER . 9.9 p90 -146.77 137.08 23.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.421 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 41.7 t -75.18 148.01 39.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.229 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' 1082 ' ' GLY . 5.2 t -155.07 130.32 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.631 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' 1023 ' ' ILE . 80.9 p -75.66 153.72 37.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.327 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.661 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -165.34 -22.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.661 ' H ' HD22 ' A' 1077 ' ' ASN . 57.9 m-20 -116.46 -128.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.216 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.639 ' HA ' HH21 ' A' ' 995' ' ' ARG . 54.5 m-20 -76.78 -150.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -85.53 29.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.044 0.45 . . . . 0.0 110.495 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 32.4 t -79.97 -35.45 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.489 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.65 ' C ' HD13 ' A' 1083 ' ' ILE . . . 85.09 -48.98 4.15 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.729 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.65 HD13 ' C ' ' A' 1082 ' ' GLY . 0.1 OUTLIER 39.38 118.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.643 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 22.2 m95 -72.23 138.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.507 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 79.8 p -64.46 -54.31 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -72.07 125.51 11.02 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.285 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.13 41.13 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.579 2.186 . . . . 0.0 112.953 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.78 ' HB1' HD13 ' A' 1031 ' ' ILE . . . 60.46 134.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.489 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.837 ' HA ' ' HA3' ' A' 1068 ' ' GLY . 40.4 Cg_endo -68.13 156.74 64.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.226 2.617 . . . . 0.0 113.71 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.637 HE21 HG23 ' A' 1092 ' ' ILE . 60.9 tp60 -104.69 114.73 29.12 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.797 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 48.1 t -97.29 132.15 43.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.327 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.637 HG23 HE21 ' A' 1090 ' ' GLN . 7.0 pt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.422 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -173.06 135.31 0.59 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.988 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 959' ' ' GLU . 17.3 tp10 56.87 52.68 9.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . 0.442 ' H ' ' HD3' ' A' ' 961' ' ' LYS . . . -167.78 45.09 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.066 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.561 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 2.6 mppt? -77.63 137.35 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.94 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 86.5 p -82.09 136.29 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.598 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 87.8 m -79.96 34.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 962' ' ' SER . 86.3 tttt 62.73 139.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.71 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.4 m -61.61 124.75 82.55 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.336 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.413 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 17.0 Cg_exo -68.05 118.29 5.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.6 2.2 . . . . 0.0 112.561 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 135.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 111.271 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -48.39 104.28 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.19 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 54.7 Cg_endo -69.15 -151.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.607 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' 1019 ' ' ILE . 45.5 t -52.76 73.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.812 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 969' ' ' PRO . 75.5 m-20 72.57 -35.85 0.34 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -68.44 130.35 26.18 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.923 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 84.1 mtp -92.27 145.5 24.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.621 ' CG2' HD12 ' A' ' 986' ' ' ILE . 3.1 p -84.88 151.15 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -114.02 99.33 7.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 980' ' ' ILE . 39.2 t -75.31 85.65 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 46.1 mt -74.75 -92.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.778 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 23.3 p -61.84 -65.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -159.16 -136.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.578 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.559 HG23 HG13 ' A' ' 976' ' ' VAL . 6.5 pt -154.31 -19.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.06 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.94 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 25.2 mt-30 -73.01 175.8 6.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.654 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' 1004 ' ' CYS . 64.2 t -44.29 147.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.832 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.86 -36.82 1.89 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.354 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 43.1 t -68.38 158.86 32.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 0.0 111.092 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.699 ' HE ' ' HB2' ' A' 1003 ' ' GLU . 39.4 ttm180 -145.16 120.75 10.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.8 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.621 HD12 ' CG2' ' A' ' 974' ' ' VAL . 18.8 pt -97.16 -168.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.351 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 73.7 p -153.09 124.09 7.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' 1000 ' ' SER . 2.0 m-85 -94.76 154.47 17.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.184 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 72.5 p -152.91 127.47 9.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.111 0.482 . . . . 0.0 111.13 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 73.3 m -82.94 148.13 27.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.052 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 26.1 p -62.06 157.65 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.182 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 60.7 m -48.68 138.29 11.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.583 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.543 ' O ' HD12 ' A' 1023 ' ' ILE . . . 95.9 -41.86 2.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.572 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -82.41 133.46 35.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.979 0.389 . . . . 0.0 111.286 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.727 ' HB2' HD11 ' A' 1023 ' ' ILE . 40.5 ttt85 -82.25 120.65 25.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.851 HD21 ' HB3' ' A' 1000 ' ' SER . 7.3 tp -65.97 124.47 22.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.177 0.513 . . . . 0.0 111.804 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' 1019 ' ' ILE . 46.7 mm -107.83 145.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.919 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 76.45 169.92 30.29 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.458 ' O ' ' HG3' ' A' 1018 ' ' PRO . 88.5 m-70 -74.98 125.56 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 0.0 111.587 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.851 ' HB3' HD21 ' A' ' 996' ' ' LEU . 81.6 p -68.18 -46.8 69.69 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.066 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.6 p -77.93 139.77 39.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.64 127.62 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.282 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.699 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 43.4 tt0 -98.02 132.09 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.709 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 52.9 t -66.7 94.54 0.3 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 22.2 pt -90.07 -155.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.872 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' 1008 ' ' GLY . 2.0 tm? -149.96 124.21 9.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.599 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.467 ' N ' HD13 ' A' 1006 ' ' LEU . 46.1 t -80.53 -48.4 12.82 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.509 ' N ' HD13 ' A' 1006 ' ' LEU . . . -161.44 -54.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.305 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.4 m120 -123.53 -52.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.1 m -88.9 144.34 26.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.29 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.598 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.24 145.02 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.044 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.478 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 93.3 m-70 -149.17 140.69 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.456 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 82.5 m95 -68.12 135.68 52.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.619 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 m -52.34 -24.68 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.184 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 53.4 p -132.94 137.59 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 111.817 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -56.51 150.1 36.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.06 117.99 2.16 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.342 2.028 . . . . 0.0 112.521 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.502 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 72.5 Cg_exo -51.06 138.35 43.91 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.693 2.262 . . . . 0.0 112.063 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 997' ' ' ILE . 0.0 OUTLIER -110.08 139.7 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.41 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.686 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 63.0 m -97.68 128.91 44.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.816 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 995' ' ' ARG . 3.1 tp-100 -82.17 125.52 31.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.314 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.4 tpt180 -67.71 -26.36 66.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.486 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.727 HD11 ' HB2' ' A' ' 995' ' ' ARG . 49.7 mt 58.24 61.53 5.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.245 0.545 . . . . 0.0 109.678 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.652 ' HA ' ' N ' ' A' 1046 ' ' TYR . 38.1 Cg_endo -65.68 138.49 54.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.13 2.553 . . . . 0.0 114.008 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.491 ' HA ' ' CA ' ' A' 1082 ' ' GLY . 38.5 m -88.43 141.23 28.71 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.744 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.19 -153.36 4.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.143 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.95 155.51 91.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.113 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.657 ' O ' HG23 ' A' 1030 ' ' THR . 31.2 Cg_exo -58.01 154.48 38.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.265 . . . . 0.0 111.879 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.547 ' HD2' ' OH ' ' A' 1052 ' ' TYR . 55.3 Cg_exo -51.13 -17.3 3.55 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.435 2.09 . . . . 0.0 112.274 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . 0.657 HG23 ' O ' ' A' 1028 ' ' PRO . 73.8 p 49.08 94.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.663 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' 1031 ' ' ILE . 29.5 pt -84.1 104.3 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . 43.03 -139.36 0.21 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -79.64 41.74 0.5 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.44 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.68 -141.43 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.361 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' 1036 ' ' PHE . 19.6 t70 -168.03 -159.86 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.32 . . . . 0.0 110.795 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.73 ' CD1' HG23 ' A' 1050 ' ' VAL . 1.4 t80 -156.0 125.82 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.221 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' 1036 ' ' PHE . 4.3 mp -143.98 70.46 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.148 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 40.4 t -159.63 -119.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' 1040 ' ' ASN . 65.3 p -140.5 111.73 7.19 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.832 0.348 . . . . 0.0 111.917 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.503 ' HB2' ' CE2' ' A' 1044 ' ' PHE . 19.7 p30 165.31 130.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.062 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' 1043 ' ' ASN . 84.0 mtm180 -153.17 117.25 4.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.745 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.564 ' N ' ' HE1' ' A' 1044 ' ' PHE . 0.5 OUTLIER 53.1 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.551 179.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' 1041 ' ' ARG . 72.1 m-20 -70.37 65.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.13 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.643 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 1.9 m-85 -76.79 135.69 38.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.335 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.525 ' HA ' ' CB ' ' A' 1024 ' ' PRO . 52.0 m-70 -141.91 -165.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.553 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.652 ' N ' ' HA ' ' A' 1024 ' ' PRO . 10.5 t80 -58.02 139.25 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.414 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 64.87 111.18 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.453 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' 1073 ' ' TYR . 79.6 p 176.54 128.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.265 0.555 . . . . 0.0 110.521 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' 1073 ' ' TYR . 97.4 t -102.16 147.04 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.965 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.73 HG23 ' CD1' ' A' 1036 ' ' PHE . 12.3 p -138.46 126.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.927 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' 1037 ' ' ILE . 87.9 m -101.04 117.32 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 111.559 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.547 ' OH ' ' HD2' ' A' 1029 ' ' PRO . 4.8 m-85 -83.94 134.71 34.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.186 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.464 ' O ' ' HE2' ' A' 1062 ' ' LYS . 50.9 mtp85 -148.19 25.02 1.02 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.812 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.57 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 57.9 m 58.78 150.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' 1056 ' ' LEU . 13.5 t-20 -68.29 39.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.576 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.585 ' HA ' ' HA ' ' A' 1062 ' ' LYS . 0.4 OUTLIER 27.59 50.56 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.681 ' HA2' ' HE1' ' A' 1064 ' ' PHE . . . 73.7 -40.02 0.95 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.269 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 47.0 t -169.87 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.906 0.353 . . . . 0.0 111.274 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.643 ' N ' ' HD3' ' A' 1059 ' ' ARG . 0.0 OUTLIER -163.0 -28.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.451 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' 1056 ' ' LEU . . . -151.02 149.39 21.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.837 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' 1056 ' ' LEU . 44.5 ttm-85 71.61 116.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' 1056 ' ' LEU . 40.1 ttmt -72.99 146.0 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 28.5 m -143.87 -22.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 4.7 m-85 -73.82 -26.36 60.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.72 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' 1062 ' ' LYS . 58.5 mm-40 61.39 111.66 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.751 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.781 HD22 ' H ' ' A' 1067 ' ' VAL . 3.2 tm? -71.23 149.48 46.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.323 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.781 ' H ' HD22 ' A' 1066 ' ' LEU . 21.3 t -129.56 138.57 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.95 -153.94 42.55 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.536 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.545 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.0 pt-20 -72.11 113.46 20.69 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-O 120.504 0.192 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' A' 1051 ' ' THR . 93.2 Cg_endo -84.67 24.41 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.274 1.982 . . . . 0.0 112.929 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' 1050 ' ' VAL . 40.4 t -158.87 142.11 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 111.678 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.503 HG12 ' HE1' ' A' 1052 ' ' TYR . 42.2 pt -141.92 -177.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.482 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.799 ' HB3' HG22 ' A' 1049 ' ' VAL . 2.3 p90 -160.21 151.09 18.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 32.3 t -62.14 149.13 42.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.611 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 -27.44 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.646 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 58.3 m 58.78 54.3 5.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.702 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -63.84 -43.04 97.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.173 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.702 ' H ' HD22 ' A' 1077 ' ' ASN . 33.2 m-20 -74.15 -82.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.775 0.322 . . . . 0.0 111.395 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' 1081 ' ' VAL . 2.2 p30 -163.18 -135.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.026 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.529 ' HA ' HG23 ' A' 1023 ' ' ILE . 64.5 mt-30 -68.34 12.17 0.14 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' 1079 ' ' ASP . 14.0 t -68.04 -43.56 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.311 0.577 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' 1025 ' ' CYS . . . 82.57 42.06 8.65 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.471 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 62.7 mt -82.02 142.3 13.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.668 0.271 . . . . 0.0 110.295 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.47 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 28.4 m95 -70.5 -163.97 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.358 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.458 ' OG ' ' HB ' ' A' 1072 ' ' ILE . 81.6 p -65.02 -63.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 177.86 127.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.224 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.41 140.62 70.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.518 2.145 . . . . 0.0 111.537 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.709 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -165.69 -50.88 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.611 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.709 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.4 Cg_endo -52.36 145.55 35.71 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.395 2.063 . . . . 0.0 111.76 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -152.37 136.8 16.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.662 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 94.7 m -91.9 123.15 35.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.015 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.662 -179.308 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.675 0.274 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -177.23 -135.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -169.16 50.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.045 0.45 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -76.94 52.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.674 ' HA ' ' HE3' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -77.58 134.01 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.113 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 25.1 m -154.4 135.0 13.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 92.8 m -79.92 136.62 36.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -63.78 138.68 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.458 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 7.1 t -57.44 122.65 56.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.842 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.871 ' HG2' HG11 ' A' ' 974' ' ' VAL . 42.4 Cg_endo -66.95 107.62 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.384 2.056 . . . . 0.0 111.98 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 965' ' ' THR . 26.4 Cg_exo -61.69 134.6 51.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.549 2.166 . . . . 0.0 111.694 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -53.26 106.97 0.73 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.777 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 97.4 Cg_endo -82.34 -150.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.534 2.156 . . . . 0.0 112.903 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 970' ' ' VAL . 1.4 p -48.94 83.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.52 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 969' ' ' PRO . 76.6 m-20 69.83 -28.37 0.17 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.73 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -68.4 147.27 46.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.444 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 63.4 mtm -143.19 131.8 22.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 110.413 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.991 HG21 HD12 ' A' ' 986' ' ' ILE . 3.3 p -87.4 154.03 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.366 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -114.7 100.02 7.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.774 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 986' ' ' ILE . 35.6 t -65.73 106.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.6 mt -75.27 -94.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 22.0 p -72.44 -56.35 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 0.0 110.144 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 976' ' ' VAL . 5.7 p-10 -165.75 -131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.563 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.517 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 1.8 pt -153.59 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.017 0.437 . . . . 0.0 111.113 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 19.8 mt-30 -87.33 -176.44 5.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.69 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 97.8 t -48.57 139.99 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.251 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.17 1.55 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 92.1 p -67.92 130.31 42.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.899 0.849 . . . . 0.0 111.127 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.716 ' HG2' ' HB3' ' A' 1003 ' ' GLU . 99.1 mtt180 -101.58 163.63 12.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.991 HD12 HG21 ' A' ' 974' ' ' VAL . 26.0 pt -150.68 139.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.083 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' 1000 ' ' SER . 81.1 p -102.95 122.25 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -92.33 155.51 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.263 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 996' ' ' LEU . 16.6 m -160.3 122.6 3.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.38 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.73 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 94.4 m -82.25 68.16 8.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 992' ' ' THR . 33.7 p 45.95 -155.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.479 . . . . 0.0 111.864 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 993' ' ' GLY . 13.6 t -97.4 -45.39 6.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.211 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 992' ' ' THR . . . -93.17 43.73 2.53 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.419 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' 1022 ' ' ARG . 56.1 m-70 -157.53 135.21 10.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.651 ' HG3' ' HG3' ' A' 1080 ' ' GLN . 77.7 ttt180 -82.19 129.68 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.7 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 4.0 tt -75.01 100.18 4.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.443 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.684 ' HB ' HG23 ' A' 1019 ' ' ILE . 26.6 mm -87.35 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.126 0.965 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . -156.52 -118.55 0.58 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.291 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -153.08 109.92 3.45 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 987' ' ' THR . 78.8 p -57.2 -54.64 44.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 110.174 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.5 p -77.86 137.23 38.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.475 ' HB3' ' HE1' ' A' ' 988' ' ' TYR . . . -157.94 150.06 22.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.716 ' HB3' ' HG2' ' A' ' 985' ' ' ARG . 10.1 pt-20 -135.11 132.02 37.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.601 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 44.2 t -66.68 93.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.33 -168.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 11.0 tp -158.36 120.94 3.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 25.4 m -81.51 -55.17 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.085 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 164.57 47.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -175.61 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.08 0.467 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 82.3 m -151.35 146.7 26.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.018 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.601 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -72.94 135.92 45.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.437 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.45 145.05 26.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.703 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.517 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 58.9 m95 -69.68 128.2 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -52.47 -26.2 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 64.2 p -86.93 130.87 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.776 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.72 155.63 81.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.874 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 81.3 Cg_exo -41.42 112.44 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.154 1.902 . . . . 0.0 111.905 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.458 ' HG3' ' CD2' ' A' ' 988' ' ' TYR . 51.0 Cg_endo -69.9 129.1 16.88 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.928 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.684 HG23 ' HB ' ' A' ' 997' ' ' ILE . 8.1 tt -116.62 147.24 20.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.558 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.559 ' HB2' HG22 ' A' ' 970' ' ' VAL . 72.1 m -106.88 156.83 18.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.15 124.1 6.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.985 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.722 ' HD3' ' HB3' ' A' 1046 ' ' TYR . 40.6 ttm180 -59.43 132.71 54.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.839 HD13 ' HA ' ' A' 1080 ' ' GLN . 68.1 mt -73.15 122.4 87.54 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.426 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' 1045 ' ' HIS . 96.2 Cg_endo -84.95 130.79 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.861 2.374 . . . . 0.0 112.532 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.512 ' HB3' ' NE1' ' A' 1084 ' ' TRP . 22.5 m -88.39 32.33 0.78 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.525 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' 1044 ' ' PHE . . . 40.18 -130.69 2.77 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.287 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.921 HD12 ' HD2' ' A' 1028 ' ' PRO . 24.1 tp -121.94 126.56 26.3 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.921 ' HD2' HD12 ' A' 1027 ' ' LEU . 26.2 Cg_endo -61.42 156.26 47.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.824 2.349 . . . . 0.0 112.42 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.833 ' HG3' ' HA ' ' A' 1087 ' ' PRO . 19.2 Cg_endo -58.67 126.1 20.25 Favored 'Trans proline' 0 CA--C 1.518 -0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 112.036 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 17.9 m -93.27 151.19 19.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.016 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' 1034 ' ' GLY . 11.1 pt -142.57 134.58 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.261 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -67.86 163.99 20.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.514 ' HB3' ' SG ' ' A' 1054 ' ' CYS . 6.6 m120 76.8 -41.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.452 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' 1054 ' ' CYS . . . -168.28 136.54 4.14 Favored Glycine 0 CA--C 1.507 -0.455 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.444 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.488 ' HB3' HG13 ' A' 1031 ' ' ILE . 2.8 p30 -171.17 142.71 1.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.069 0.462 . . . . 0.0 112.034 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 12.3 t80 60.4 115.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.349 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.625 HD12 ' HD3' ' A' 1053 ' ' ARG . 38.2 mt -152.09 60.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.143 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.767 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 22.9 t -163.78 -137.09 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.032 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' 1040 ' ' ASN . 85.9 m -111.64 128.09 55.95 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' 1039 ' ' THR . 26.4 t-20 174.87 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.451 ' HG3' HH11 ' A' 1041 ' ' ARG . 52.7 mtt85 58.84 67.67 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.239 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.701 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 47.9 mt-10 58.87 -169.85 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' 1042 ' ' GLU . 2.6 m120 76.62 -70.3 0.14 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.969 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.701 ' CE2' ' HA ' ' A' 1042 ' ' GLU . 7.6 m-85 52.66 47.27 25.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.97 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' 1024 ' ' PRO . 27.3 m80 -62.63 -51.5 67.05 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.039 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.787 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 62.4 t80 173.24 139.07 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' 1048 ' ' SER . . . 72.29 92.93 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.414 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.4 p 172.15 130.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' 1050 ' ' VAL . 11.3 p -102.25 156.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.997 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.767 ' HA ' ' HB3' ' A' 1038 ' ' SER . 18.8 m -149.15 130.13 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 40.2 m -89.93 110.42 21.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.437 ' CE1' HD11 ' A' 1072 ' ' ILE . 15.8 m-85 -85.22 135.79 33.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.453 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 1.01 ' HA ' HD22 ' A' 1066 ' ' LEU . 41.2 mtp85 -146.28 -143.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.235 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.931 ' HA ' ' HA3' ' A' 1034 ' ' GLY . 32.6 t -163.66 135.3 4.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -65.81 97.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.483 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.734 ' HG ' ' HA2' ' A' 1060 ' ' GLY . 0.0 OUTLIER -80.76 43.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.784 179.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.506 ' N ' ' HB ' ' A' 1063 ' ' VAL . . . 79.1 -62.48 4.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.296 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' 1059 ' ' ARG . 69.2 m -167.29 93.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.242 0.521 . . . . 0.0 111.686 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' 1059 ' ' ARG . 39.5 mmt-85 72.54 -42.24 0.53 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.734 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . 174.57 39.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.531 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' 1061 ' ' ARG . 35.9 ttm180 -83.96 32.4 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 42.47 83.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.607 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' 1056 ' ' LEU . 6.0 t -149.99 89.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.629 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 29.8 m-85 71.21 90.35 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -90.74 136.26 33.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 1.01 HD22 ' HA ' ' A' 1053 ' ' ARG . 47.5 tp -68.35 155.96 38.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.607 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' 1089 ' ' PRO . 72.5 t -142.62 139.82 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.926 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 86.0 -158.91 32.26 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.417 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' 1089 ' ' PRO . 10.7 pt-20 -64.08 111.15 4.84 Favored Pre-proline 0 CA--C 1.528 0.107 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.587 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 94.8 Cg_endo -90.79 23.07 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.885 2.39 . . . . 0.0 113.152 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 79.4 p -157.64 143.79 17.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.437 HD11 ' CE1' ' A' 1052 ' ' TYR . 44.2 pt -148.16 171.12 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.137 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.5 p90 -161.67 145.3 12.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.787 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 4.2 t -66.04 144.98 56.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.907 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 11.4 t -144.41 -151.41 0.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.231 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.408 ' OG ' HD12 ' A' 1023 ' ' ILE . 44.9 t -161.29 131.34 4.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.016 0.436 . . . . 0.0 111.563 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.582 HD21 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER 178.96 -146.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.115 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . . . . . . . . . 63.3 t0 52.48 -87.63 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' 1077 ' ' ASN . 11.6 p-10 -163.13 51.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.151 0.501 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.839 ' HA ' HD13 ' A' 1023 ' ' ILE . 3.5 mm100 65.42 41.24 4.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 25.4 t -94.05 -40.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' 1025 ' ' CYS . . . 86.28 47.15 5.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.238 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.582 HG12 HD21 ' A' 1077 ' ' ASN . 35.6 pt -81.97 135.1 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.578 ' HZ2' ' HB3' ' A' 1044 ' ' PHE . 26.3 m95 -70.64 147.27 49.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.1 t -40.36 -36.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.581 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.94 150.05 16.43 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.442 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.833 ' HA ' ' HG3' ' A' 1029 ' ' PRO . 31.5 Cg_endo -63.01 157.54 48.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.884 2.389 . . . . 0.0 112.336 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.431 ' H ' ' CG ' ' A' 1029 ' ' PRO . . . -62.62 144.91 95.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.109 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.568 ' HB2' ' O ' ' A' 1067 ' ' VAL . 56.5 Cg_endo -68.0 -144.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.784 2.322 . . . . 0.0 112.271 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.455 HE21 ' HB2' ' A' 1090 ' ' GLN . 0.1 OUTLIER -152.41 136.33 16.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.064 0.459 . . . . 0.0 111.702 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 50.7 t -98.37 132.97 43.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 26.2 pt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.117 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . 0.438 ' N ' ' OE1' ' A' ' 957' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.784 0.326 . . . . 0.0 111.174 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 57.41 44.68 21.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -68.03 136.13 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -79.37 46.9 0.77 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.431 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' A' 1011 ' ' ALA . 15.3 tppt? 66.3 149.19 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 80.5 p -156.44 129.8 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.285 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' 1011 ' ' ALA . 2.0 p -84.63 35.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.893 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 963' ' ' CYS . 58.0 tptt 56.63 129.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.709 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 85.6 m -61.56 122.4 70.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.409 ' HB2' HG21 ' A' ' 974' ' ' VAL . 38.1 Cg_exo -57.73 110.24 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.287 1.991 . . . . 0.0 112.519 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.85 139.55 24.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.559 2.173 . . . . 0.0 111.47 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 11.7 p-10 -49.42 107.25 0.74 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 971' ' ' ASN . 6.3 Cg_exo -78.87 -146.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.064 2.509 . . . . 0.0 111.938 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.878 HG21 HG13 ' A' 1019 ' ' ILE . 64.4 t -49.1 81.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.434 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 991' ' ' THR . 22.0 p30 42.72 27.77 0.11 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.148 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.613 ' HA2' ' SG ' ' A' ' 990' ' ' CYS . . . -83.01 -161.11 30.23 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.858 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 45.4 ttm -159.17 114.55 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.629 ' CG2' HD12 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.9 144.22 9.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.284 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -119.75 91.72 3.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.148 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.674 ' HA ' HG22 ' A' ' 986' ' ' ILE . 64.0 t -66.47 103.86 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.179 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 47.2 mt -84.14 -92.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 41.2 p -84.14 62.84 7.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 111.819 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.92 -153.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.706 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.47 HG22 ' HH2' ' A' 1013 ' ' TRP . 21.5 pt -155.81 26.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.945 0.403 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.629 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 22.6 pt20 -87.34 28.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.061 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 70.8 t 100.43 142.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 111.34 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 70.71 -7.46 5.2 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.234 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 34.9 m -68.33 160.05 30.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.273 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 985' ' ' ARG . 55.9 ttp85 -143.13 109.4 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.227 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 976' ' ' VAL . 27.2 pt -96.77 -174.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 65.9 p -149.43 131.3 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.709 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.4 m-85 -96.23 165.08 12.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.0 p -149.75 -40.56 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 111.408 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.613 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 12.8 t 71.26 177.99 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.893 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 971' ' ' ASN . 22.2 p -62.98 -161.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.321 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 993' ' ' GLY . 11.8 t -94.7 -44.94 7.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.145 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 992' ' ' THR . . . -94.62 39.05 2.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.411 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.66 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 45.3 m80 -149.08 132.76 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.952 0.376 . . . . 0.0 110.681 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' 1021 ' ' GLN . 79.1 ttt180 -82.01 123.4 28.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 997' ' ' ILE . 8.4 tp -71.25 132.16 44.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.712 HG13 ' HG2' ' A' 1021 ' ' GLN . 17.6 mm -132.13 62.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.628 0.728 . . . . 0.0 110.792 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . -154.27 33.51 0.71 Allowed Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.122 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 59.11 4.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 81.7 p 43.65 31.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.07 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.413 ' O ' HG21 ' A' 1015 ' ' THR . 83.2 p -162.23 151.12 15.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.528 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -158.04 128.94 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.335 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.81 127.22 47.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.812 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -77.48 82.29 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.611 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' 1014 ' ' SER . 46.3 pt -87.21 -152.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.535 ' C ' HD13 ' A' 1006 ' ' LEU . 3.0 tm? -141.9 121.12 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.588 ' HB2' ' HD2' ' A' 1012 ' ' HIS . 45.5 m -93.42 -39.14 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.486 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.522 ' O ' HD11 ' A' 1006 ' ' LEU . . . -169.05 -126.27 0.84 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.084 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -68.38 8.2 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.224 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' 1008 ' ' GLY . 99.3 m -151.87 145.28 24.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 963' ' ' CYS . . . -75.31 147.95 39.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.588 ' HD2' ' HB2' ' A' 1007 ' ' SER . 92.3 m-70 -149.43 149.92 31.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 111.539 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.47 ' HH2' HG22 ' A' ' 980' ' ' ILE . 60.8 m95 -81.11 117.25 21.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.197 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.61 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.1 p -53.35 -25.52 15.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.413 HG21 ' O ' ' A' 1001 ' ' SER . 82.2 p -86.93 141.81 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -65.72 150.1 96.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.371 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.31 115.32 2.11 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.124 1.883 . . . . 0.0 111.883 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.61 ' HG2' ' CE2' ' A' ' 988' ' ' TYR . 31.1 Cg_exo -61.12 140.5 89.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.913 2.409 . . . . 0.0 112.873 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.878 HG13 HG21 ' A' ' 970' ' ' VAL . 5.2 tt -129.78 136.48 58.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.725 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 64.6 m -97.25 126.08 42.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.541 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.712 ' HG2' HG13 ' A' ' 997' ' ' ILE . 99.1 mm-40 -75.77 124.34 27.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.62 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -66.81 -12.49 59.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' 1080 ' ' GLN . 53.5 mt 56.28 70.82 1.34 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 109.939 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' 1045 ' ' HIS . 9.4 Cg_endo -51.44 132.47 40.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.117 2.545 . . . . 0.0 113.519 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.705 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 3.0 m -86.43 -146.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . 0.526 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -153.24 -155.44 7.15 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.19 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' 1028 ' ' PRO . 75.4 mt -68.36 143.88 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.714 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.447 ' CG ' HG21 ' A' 1050 ' ' VAL . 20.5 Cg_exo -64.72 147.55 89.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 111.472 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.876 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 83.7 Cg_exo -47.34 113.38 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 112.213 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 68.5 p -77.6 140.45 39.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.495 HD13 ' HB1' ' A' 1088 ' ' ALA . 29.2 pt -151.32 31.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.559 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 52.04 117.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.376 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 1032 ' ' ALA . 75.6 m-20 74.74 -25.97 0.2 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.362 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' 1032 ' ' ALA . . . -70.7 68.77 0.76 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.702 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' 1036 ' ' PHE . 1.5 m-20 -68.75 -150.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.991 0.424 . . . . 0.0 111.133 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.806 ' HB3' HG13 ' A' 1050 ' ' VAL . 12.3 p90 -155.99 141.6 17.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.559 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' 1037 ' ' ILE . 42.6 mm -92.62 63.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 69.2 m -159.98 -159.13 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 111.707 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 64.9 m -83.59 -92.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.553 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.61 ' OD1' ' HB3' ' A' 1048 ' ' SER . 73.3 m-80 54.06 -138.89 1.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 61.88 109.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' 1043 ' ' ASN . 16.6 pt-20 38.42 41.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.842 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' 1042 ' ' GLU . 72.3 m-80 -167.74 116.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.481 ' CE1' ' HA2' ' A' 1026 ' ' GLY . 0.8 OUTLIER -163.39 143.66 8.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' 1024 ' ' PRO . 16.9 m-70 -140.82 -58.31 0.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.449 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.715 ' HA ' ' SG ' ' A' 1074 ' ' CYS . 48.3 t80 175.22 47.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.43 -25.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.032 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.61 ' HB3' ' OD1' ' A' 1040 ' ' ASN . 63.3 m -47.62 147.69 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.262 0.554 . . . . 0.0 111.962 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.932 HG22 ' HB3' ' A' 1073 ' ' TYR . 69.2 t -137.62 145.98 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.124 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.806 HG13 ' HB3' ' A' 1036 ' ' PHE . 3.4 t -133.38 120.38 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.026 0.441 . . . . 0.0 112.183 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 76.7 m -100.23 119.44 38.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.196 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.559 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 26.5 m-85 -74.5 145.54 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.442 0.639 . . . . 0.0 112.431 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -150.99 -30.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.03 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . . . . . . . . . 9.6 t 70.31 142.68 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.115 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.442 ' O ' ' HE2' ' A' 1064 ' ' PHE . 12.6 t-20 -65.06 129.02 38.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.855 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.53 HD13 ' CZ ' ' A' 1064 ' ' PHE . 1.8 mm? -73.48 43.26 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.835 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 56.27 48.17 76.87 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' 1059 ' ' ARG . 45.6 t 58.02 39.23 26.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' 1058 ' ' SER . 23.9 mmm180 -157.54 -128.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.871 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . -149.76 -26.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -57.74 147.6 27.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -65.2 133.02 50.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.973 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' 1063 ' ' VAL . 10.8 p -155.07 27.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.446 0.641 . . . . 0.0 111.137 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.53 ' CZ ' HD13 ' A' 1056 ' ' LEU . 0.4 OUTLIER -168.77 -175.3 2.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.672 -179.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . 0.553 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 72.4 mt-10 -150.11 122.39 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 110.592 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.676 HD21 ' HB3' ' A' 1070 ' ' PRO . 53.7 tp -68.56 119.67 13.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.698 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 85.0 t -101.62 86.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 62.1 -163.08 26.38 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.961 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' 1089 ' ' PRO . 29.9 tp10 30.25 58.43 0.89 Allowed Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.491 0.716 . . . . 0.0 112.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.676 ' HB3' HD21 ' A' 1066 ' ' LEU . 83.4 Cg_endo -80.75 2.76 8.3 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.473 2.115 . . . . 0.0 113.186 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 51.1 m -156.27 144.69 19.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' 1050 ' ' VAL . 19.5 pt -146.39 157.25 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.932 ' HB3' HG22 ' A' 1049 ' ' VAL . 0.3 OUTLIER -160.1 147.91 16.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.715 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 50.8 t -62.18 133.17 54.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.083 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 8.2 t -144.51 -20.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' 1079 ' ' ASP . 57.9 m 58.82 59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.469 HD22 ' N ' ' A' 1077 ' ' ASN . 0.0 OUTLIER -72.96 31.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.708 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' 1076 ' ' SER . 64.3 t0 179.43 53.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' 1076 ' ' SER . 59.3 m-20 62.15 -127.65 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.196 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.741 ' OE1' HG23 ' A' 1081 ' ' VAL . 0.0 OUTLIER -66.19 -140.17 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 121.369 -0.133 . . . . 0.0 111.194 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.741 HG23 ' OE1' ' A' 1080 ' ' GLN . 33.4 t 75.74 -44.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.705 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 78.26 46.86 8.71 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.762 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.458 ' HB ' ' ND2' ' A' 1077 ' ' ASN . 69.1 mt -82.0 130.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.829 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.412 ' HB3' ' H ' ' A' 1085 ' ' SER . 15.3 m95 -72.87 -150.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.412 ' H ' ' HB3' ' A' 1084 ' ' TRP . 48.2 t -74.19 -41.68 61.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -178.06 153.24 12.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.506 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' 1069 ' ' GLU . 89.2 Cg_exo -46.41 153.82 1.05 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.876 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . -62.54 143.61 96.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.872 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.559 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 51.9 Cg_endo -67.72 -143.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.96 2.44 . . . . 0.0 112.181 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.698 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.5 mm100 -135.46 125.0 25.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.975 0.417 . . . . 0.0 111.74 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 43.0 t -85.78 66.91 9.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.593 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.553 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 34.6 pt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -175.36 -147.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.57 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 961' ' ' LYS . 38.6 tt0 -69.6 137.51 52.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.566 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -75.77 35.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER 61.88 145.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 50.3 m -153.74 132.48 12.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.054 0.454 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.439 ' HB3' ' C ' ' A' 1011 ' ' ALA . 14.5 p -79.89 140.54 36.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.677 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 1.1 tpmt? -63.73 146.29 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.267 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.619 ' H ' ' HE2' ' A' ' 964' ' ' LYS . 93.0 m -46.39 128.31 7.86 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.348 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.533 ' HD3' ' CZ2' ' A' 1013 ' ' TRP . 38.7 Cg_endo -66.65 130.94 24.64 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.18 1.92 . . . . 0.0 111.601 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.47 124.63 12.35 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.977 1.785 . . . . 0.0 111.428 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 32.2 m-20 -47.32 122.95 8.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.691 ' HB3' ' HB2' ' A' 1018 ' ' PRO . 6.6 Cg_endo -50.43 153.46 7.39 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 112.22 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.764 ' HB ' ' H ' ' A' 1020 ' ' CYS . 23.3 t -41.96 117.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.633 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.562 ' ND2' HG12 ' A' ' 970' ' ' VAL . 23.8 p30 41.91 46.3 3.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.938 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.611 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -159.11 133.7 3.48 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.736 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 22.3 ptp -97.66 150.37 21.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.977 0.418 . . . . 0.0 111.849 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 19.3 m -92.88 -157.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.409 ' N ' HG23 ' A' ' 974' ' ' VAL . 97.9 m-70 -157.8 100.58 1.76 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.28 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 980' ' ' ILE . 70.6 t -69.89 111.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.032 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 987' ' ' THR . 35.5 mt -84.93 -81.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.06 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 23.6 p -67.98 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.912 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.643 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.4 m-20 -163.26 17.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.587 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 979' ' ' ASP . 20.1 pt 52.1 28.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.269 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.34 160.08 18.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.386 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' 1004 ' ' CYS . 86.3 t -44.44 142.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.174 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.96 -33.8 1.93 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.134 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.604 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 49.4 m -68.48 177.38 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.878 0.339 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' 1002 ' ' ALA . 48.2 ttp85 -156.78 132.2 9.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.118 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.513 HG21 HG22 ' A' ' 980' ' ' ILE . 36.6 pt -96.56 -159.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 977' ' ' ILE . 40.6 p -152.17 128.38 10.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.631 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.857 ' HB2' ' HA ' ' A' 1000 ' ' SER . 0.1 OUTLIER -93.92 167.01 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 52.7 p -145.46 -43.39 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.611 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 36.3 t 74.05 164.88 0.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.061 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 992' ' ' THR . 11.3 t -60.77 -141.22 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.406 0.622 . . . . 0.0 112.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.597 HG23 ' N ' ' A' ' 993' ' ' GLY . 13.4 t -61.24 -137.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.82 -178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.597 ' N ' HG23 ' A' ' 992' ' ' THR . . . -70.6 30.39 0.48 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.573 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 17.1 m80 -83.34 129.14 34.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.473 0.637 . . . . 0.0 109.976 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.649 HH22 ' HB3' ' A' 1079 ' ' ASP . 33.1 ttm180 -81.9 91.59 6.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' A' 1000 ' ' SER . 2.4 pp -61.51 137.53 58.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.371 0.605 . . . . 0.0 110.71 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 998' ' ' GLY . 41.2 mm -100.13 160.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.785 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 999' ' ' HIS . . . 81.4 12.49 81.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.709 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 998' ' ' GLY . 84.3 m-70 71.02 138.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.884 ' HB3' HD21 ' A' ' 996' ' ' LEU . 83.5 p -80.53 41.15 0.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.808 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 13.1 t -162.13 159.67 26.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.19 132.51 3.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.602 ' HG3' HG23 ' A' 1005 ' ' ILE . 16.7 pt-20 -100.05 126.24 46.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.656 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 49.9 t -74.84 81.66 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.602 HG23 ' HG3' ' A' 1003 ' ' GLU . 46.1 pt -87.3 -157.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' 1009 ' ' ASN . 5.4 tt -158.43 124.36 4.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.481 ' N ' HD23 ' A' 1006 ' ' LEU . 50.1 m -77.56 -54.1 6.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.218 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.43 ' N ' HD23 ' A' 1006 ' ' LEU . . . 167.84 43.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.652 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.538 ' H ' HD21 ' A' 1006 ' ' LEU . 48.6 t30 -177.86 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 59.1 m -151.22 154.59 37.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.201 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.479 ' HB2' HG22 ' A' ' 982' ' ' VAL . . . -74.42 135.81 42.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.253 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -149.41 146.39 27.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.538 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 21.7 m95 -76.17 118.03 18.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.787 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.567 ' HB3' HD13 ' A' 1005 ' ' ILE . 90.4 p -52.95 -21.35 4.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.126 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 37.9 p -86.93 134.29 33.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.046 0.45 . . . . 0.0 111.771 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.19 152.36 88.32 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.3 125.56 7.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.691 ' HB2' ' HB3' ' A' ' 969' ' ' PRO . 96.7 Cg_endo -77.33 149.87 28.2 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.012 2.474 . . . . 0.0 113.459 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.621 HG22 HG23 ' A' ' 970' ' ' VAL . 32.7 pt -148.79 121.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.863 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.853 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 82.9 m -81.8 127.15 32.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.304 0.573 . . . . 0.0 112.196 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -84.33 129.48 34.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.145 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.686 ' NH1' ' HB3' ' A' 1046 ' ' TYR . 21.3 tpt85 -67.65 -10.29 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.582 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.656 HG23 ' NE2' ' A' 1080 ' ' GLN . 56.6 mt 51.74 64.59 7.56 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.607 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' 1045 ' ' HIS . 52.0 Cg_exo -53.72 124.12 15.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.542 2.161 . . . . 0.0 112.81 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.87 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 33.0 m -88.47 153.41 21.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.14 140.47 25.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.46 ' HA ' ' HZ ' ' A' 1044 ' ' PHE . 68.5 mt -41.57 142.01 1.09 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.977 0.389 . . . . 0.0 111.243 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.461 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 17.9 Cg_endo -57.68 140.21 92.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.083 1.855 . . . . 0.0 110.455 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.457 ' HD2' HD12 ' A' 1072 ' ' ILE . 99.5 Cg_exo -38.03 127.95 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.142 1.895 . . . . 0.0 111.493 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 70.2 p -76.62 137.35 39.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' 1091 ' ' CYS . 5.8 tt -147.46 107.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.574 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -64.43 143.41 57.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.173 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.651 ' HA ' ' ND2' ' A' 1055 ' ' ASN . 4.7 m120 76.76 -40.92 0.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.394 0.434 . . . . 0.0 111.264 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -74.76 72.64 1.52 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.672 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -68.81 133.44 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 111.076 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.595 ' HB2' ' HB ' ' A' 1050 ' ' VAL . 22.4 p90 -84.01 150.68 25.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.246 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' 1037 ' ' ILE . 33.4 mm -110.32 58.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.513 ' H ' ' HD1' ' A' 1036 ' ' PHE . 68.6 m -162.89 -154.54 0.3 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.082 0.467 . . . . 0.0 111.869 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' 1038 ' ' SER . 41.7 p -86.1 -129.85 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.192 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.48 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 4.7 m120 59.65 44.91 13.76 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' 1041 ' ' ARG . 62.2 mtt-85 -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.543 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 63.29 37.28 11.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.588 HD22 ' N ' ' A' 1043 ' ' ASN . 0.0 OUTLIER -179.5 128.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.923 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' 1025 ' ' CYS . 5.5 p90 -163.27 -41.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.625 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' 1046 ' ' TYR . 90.1 m-70 72.65 -36.58 0.36 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.686 ' HB3' ' NH1' ' A' 1022 ' ' ARG . 25.1 t80 170.63 148.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.422 ' O ' ' OG ' ' A' 1048 ' ' SER . . . 69.59 94.36 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.827 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.438 ' HB3' ' ND2' ' A' 1040 ' ' ASN . 29.2 m 178.0 143.56 0.1 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.938 0.495 . . . . 0.0 109.966 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' 1073 ' ' TYR . 12.3 p -138.21 161.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.289 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' 1036 ' ' PHE . 29.5 m -146.42 137.08 18.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 34.9 m -102.21 120.24 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.977 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.576 ' CE2' HG21 ' A' 1031 ' ' ILE . 2.9 m-85 -72.83 156.23 39.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.047 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' 1054 ' ' CYS . 78.4 ttt180 -154.53 -30.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.59 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.622 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 54.4 m 68.59 146.35 0.05 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.077 0.465 . . . . 0.0 111.046 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.7 ' O ' ' HG ' ' A' 1056 ' ' LEU . 75.9 m-20 -54.7 162.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.983 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' 1055 ' ' ASN . 3.3 mt -154.98 162.32 41.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.82 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.587 ' H ' ' HB3' ' A' 1061 ' ' ARG . . . -82.09 41.79 2.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.562 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 12.8 t 57.27 18.96 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -167.66 46.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.281 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.556 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 53.39 33.56 46.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.317 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.587 ' HB3' ' H ' ' A' 1057 ' ' GLY . 78.4 ttt180 -71.41 142.2 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 110.978 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.33 102.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.042 0.449 . . . . 0.0 110.413 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.69 HG22 ' HD1' ' A' 1064 ' ' PHE . 3.4 p -155.7 87.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.806 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.69 ' HD1' HG22 ' A' 1063 ' ' VAL . 80.5 m-85 70.84 139.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.757 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -134.26 134.91 42.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.883 0.373 . . . . 0.0 111.659 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.714 HD21 ' HA ' ' A' 1070 ' ' PRO . 17.0 tp -68.54 149.55 49.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 60.0 t -150.19 147.24 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.27 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 90.43 -50.13 3.25 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' 1089 ' ' PRO . 22.0 pt-20 -167.89 130.94 1.35 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 117.72 0.76 . . . . 0.0 112.44 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.714 ' HA ' HD21 ' A' 1066 ' ' LEU . 94.9 Cg_endo -98.53 8.83 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.512 2.808 . . . . 0.0 113.698 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 60.3 m -156.9 142.75 17.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' 1049 ' ' VAL . 19.6 pt -149.37 147.13 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.996 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' 1049 ' ' VAL . 1.9 p90 -153.47 149.32 27.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 44.5 t -65.06 150.7 47.65 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 4.0 t -140.1 -25.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.529 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 43.5 t 59.06 51.13 7.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.738 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.803 ' ND2' ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -67.32 -59.05 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.473 -179.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.803 ' H ' ' ND2' ' A' 1077 ' ' ASN . 1.6 m-20 -81.52 58.8 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 111.087 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.649 ' HB3' HH22 ' A' ' 995' ' ' ARG . 1.5 m-20 63.85 -132.07 0.38 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.071 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.656 ' NE2' HG23 ' A' 1023 ' ' ILE . 3.0 mm100 -64.33 -144.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.561 0.22 . . . . 0.0 110.525 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 21.8 t 72.59 -36.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.87 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 66.28 55.42 18.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.758 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.78 ' HB ' HD21 ' A' 1077 ' ' ASN . 74.4 mt -81.95 132.93 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.48 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 10.0 m95 -84.17 165.31 18.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.19 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 86.9 p -53.77 -31.72 49.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.526 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . -166.65 148.97 14.15 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.3 -154.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.742 2.295 . . . . 0.0 112.689 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' 1089 ' ' PRO . . . -77.03 136.83 65.79 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.142 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.533 ' HG3' ' HG3' ' A' 1069 ' ' GLU . 3.1 Cg_exo -74.99 -134.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.237 2.624 . . . . 0.0 111.205 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.675 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -145.12 115.9 7.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.827 ' HB2' HD11 ' A' 1031 ' ' ILE . 22.0 t -97.37 63.98 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.099 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.299 -179.083 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 957' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.89 0.376 . . . . 0.0 111.202 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 58.28 -135.51 0.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 959' ' ' GLU . 0.3 OUTLIER -67.74 139.18 56.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.071 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -78.64 50.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 66.36 131.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.746 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.81 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 79.6 p -157.96 141.4 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.758 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.478 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 85.3 m -80.2 32.31 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.6 tptt 60.95 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.304 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 88.9 m -56.73 130.32 77.72 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.293 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.567 ' HB2' HG11 ' A' ' 974' ' ' VAL . 31.9 Cg_exo -58.57 120.88 9.04 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.4 Cg_endo -76.69 66.75 7.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.838 2.359 . . . . 0.0 111.949 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 967' ' ' PRO . 17.6 m-20 22.38 83.33 0.12 Allowed Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.675 0.609 . . . . 0.0 111.56 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.586 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 83.6 Cg_exo -42.69 148.67 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.139 2.56 . . . . 0.0 112.761 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 76.8 t -46.98 122.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.226 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.851 ' HB2' ' HB3' ' A' 1020 ' ' CYS . 2.2 m120 71.92 -70.51 0.16 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.736 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 989' ' ' SER . . . -75.65 128.73 9.87 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.798 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 973' ' ' MET . 1.8 mpt? -84.35 155.7 22.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.645 0.26 . . . . 0.0 110.332 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.6 ' CG2' HD12 ' A' ' 986' ' ' ILE . 1.3 p -89.93 148.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.721 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 987' ' ' THR . 19.6 m170 -117.49 96.55 5.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.493 HG13 HG23 ' A' ' 980' ' ' ILE . 60.8 t -71.17 81.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.339 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.29 -78.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.371 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.7 p -68.41 -77.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.45 ' HB2' ' OG ' ' A' ' 984' ' ' SER . 52.2 m-20 -165.7 149.57 8.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.072 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.532 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 16.8 pt -84.11 -20.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.176 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.81 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 26.3 mt-30 -72.46 157.91 36.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.459 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' 1006 ' ' LEU . 9.0 p -44.24 144.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.191 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 75.84 43.97 21.12 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.166 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 979' ' ' ASP . 66.9 m -168.36 129.73 1.34 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 32.0 ttm-85 -101.61 128.38 47.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.897 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.6 HD12 ' CG2' ' A' ' 974' ' ' VAL . 29.3 pt -97.15 -164.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.229 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 975' ' ' HIS . 66.7 p -150.29 127.96 11.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.569 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.586 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 2.8 m-85 -99.49 163.14 12.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.538 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.613 ' O ' ' HA3' ' A' ' 972' ' ' GLY . 22.7 t -145.53 -156.92 0.75 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.004 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 23.4 m -158.06 157.89 33.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.592 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 992' ' ' THR . 17.9 p -68.64 -151.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.772 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.443 ' H ' ' HB ' ' A' ' 991' ' ' THR . 9.0 t -85.4 132.58 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.07 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.78 91.62 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.765 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.591 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 13.8 m80 -142.12 129.46 21.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 111.508 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.511 ' NH1' HD13 ' A' ' 997' ' ' ILE . 6.6 ptm180 -95.91 135.86 37.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.407 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' 1018 ' ' PRO . 4.6 tt -76.18 132.18 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.936 0.398 . . . . 0.0 111.653 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.886 ' HB ' HG13 ' A' 1019 ' ' ILE . 44.2 mm -97.85 144.04 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.331 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.79 43.81 Favored Glycine 0 C--N 1.328 0.116 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.1 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.13 132.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.611 ' CB ' HD13 ' A' ' 996' ' ' LEU . 79.6 p -90.85 38.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 80.0 p -162.15 145.7 11.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -158.41 130.98 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.182 0.515 . . . . 0.0 111.396 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 86.8 tt0 -105.0 132.49 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.528 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -70.93 127.08 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.103 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.81 152.24 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' 1007 ' ' SER . 0.2 OUTLIER -85.62 141.04 30.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.431 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.636 ' N ' HD13 ' A' 1006 ' ' LEU . 48.0 t -155.17 131.54 10.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 65.66 -82.4 0.08 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.316 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -157.77 16.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.004 0.43 . . . . 0.0 110.331 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 99.5 m -151.84 142.37 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.095 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.478 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.22 141.86 43.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.449 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 91.0 m-70 -149.57 141.63 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.573 ' HB2' ' HA ' ' A' 1016 ' ' LYS . 89.5 m95 -66.65 132.65 48.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.3 t -52.48 -21.53 3.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 71.7 p -131.47 -14.19 3.31 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.514 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.621 ' HZ3' ' HD2' ' A' 1017 ' ' PRO . 2.0 mmmp? 66.69 148.33 0.11 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.632 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.621 ' HD2' ' HZ3' ' A' 1016 ' ' LYS . 79.7 Cg_exo -45.21 104.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.56 2.173 . . . . 0.0 112.283 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.631 ' HB2' HD21 ' A' ' 996' ' ' LEU . 12.6 Cg_exo -71.34 -144.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.127 2.551 . . . . 0.0 112.957 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.886 HG13 ' HB ' ' A' ' 997' ' ' ILE . 21.4 pt -149.75 -159.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.201 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.851 ' HB3' ' HB2' ' A' ' 971' ' ' ASN . 8.6 t -153.59 111.7 3.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.979 0.418 . . . . 0.0 110.465 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.428 ' HB2' ' CG1' ' A' ' 997' ' ' ILE . 3.1 tp-100 -81.62 132.93 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.152 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.8 ' HE ' ' HB3' ' A' 1045 ' ' HIS . 17.1 ttp-105 -66.84 128.48 36.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.331 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' 1046 ' ' TYR . 33.1 mm -53.76 107.71 0.93 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.31 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' 1045 ' ' HIS . 86.4 Cg_endo -86.93 126.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.733 2.289 . . . . 0.0 113.953 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' 1044 ' ' PHE . 26.2 p -108.17 127.85 54.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.922 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -78.36 -154.77 7.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.44 155.27 68.46 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 122.245 0.218 . . . . 0.0 111.139 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 9.2 Cg_endo -50.35 140.8 33.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.683 2.255 . . . . 0.0 111.627 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' 1030 ' ' THR . 33.8 Cg_exo -57.73 -9.1 5.05 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.606 2.204 . . . . 0.0 112.86 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . 0.49 HG22 ' O ' ' A' 1029 ' ' PRO . 13.5 t 47.08 176.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' 1090 ' ' GLN . 28.3 pt -152.08 30.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.605 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . 54.64 123.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.403 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-80 74.87 -36.84 0.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.476 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -76.09 121.05 6.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.38 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.543 ' CG ' ' HA ' ' A' 1055 ' ' ASN . 61.0 m-20 -75.4 -159.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.582 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.869 ' HB2' HG21 ' A' 1050 ' ' VAL . 21.4 p90 -156.03 142.13 18.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.358 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . . . . . . . . . 43.4 mm -123.68 109.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.691 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.69 ' HB3' ' HA ' ' A' 1050 ' ' VAL . 97.6 p -171.07 151.5 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 88.4 m -60.58 -39.41 87.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.656 HD22 ' HE2' ' A' 1044 ' ' PHE . 1.9 p-10 -61.54 143.56 55.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.348 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.36 -36.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.01 -44.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.031 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -73.39 59.11 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.656 ' HE2' HD22 ' A' 1040 ' ' ASN . 64.1 m-85 -76.66 -57.11 4.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.747 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.8 ' HB3' ' HE ' ' A' 1022 ' ' ARG . 64.4 m170 66.9 -67.66 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.885 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' 1045 ' ' HIS . 33.8 t80 173.96 35.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.536 0.684 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' 1048 ' ' SER . . . -160.48 98.81 0.17 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.135 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' 1040 ' ' ASN . 26.2 m 177.35 153.39 0.25 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.366 0.603 . . . . 0.0 111.054 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.835 HG22 ' HB3' ' A' 1073 ' ' TYR . 76.5 t -137.82 144.12 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.166 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.869 HG21 ' HB2' ' A' 1036 ' ' PHE . 15.0 p -135.86 147.87 28.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' 1070 ' ' PRO . 88.2 m -118.54 125.88 50.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.757 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.45 149.37 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' 1053 ' ' ARG . 35.7 ttt85 -152.9 25.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.56 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 64.6 m 57.69 153.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.543 ' HA ' ' CG ' ' A' 1035 ' ' ASP . 28.3 t-20 -65.91 -57.27 8.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.41 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.974 HD22 ' HA2' ' A' 1060 ' ' GLY . 2.9 mt 66.17 159.61 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.493 ' HA3' ' NH2' ' A' 1061 ' ' ARG . . . -81.92 -33.9 25.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.175 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' 1059 ' ' ARG . 77.7 p -153.86 62.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.745 0.272 . . . . 0.0 111.171 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.593 ' O ' HD13 ' A' 1056 ' ' LEU . 35.1 mmt180 77.83 -40.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.819 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.974 ' HA2' HD22 ' A' 1056 ' ' LEU . . . 178.62 127.82 1.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.731 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.493 ' NH2' ' HA3' ' A' 1057 ' ' GLY . 40.3 ptt180 -172.74 41.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 0.0 110.634 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt 44.32 71.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.56 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.776 HG23 ' HD2' ' A' 1064 ' ' PHE . 23.9 m -142.68 -7.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.78 0.8 . . . . 0.0 110.116 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.776 ' HD2' HG23 ' A' 1063 ' ' VAL . 70.6 m-85 -155.73 140.79 17.38 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.682 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -143.33 121.22 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 0.0 111.291 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.612 ' CD2' ' HB3' ' A' 1070 ' ' PRO . 36.3 tp -71.86 153.96 41.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.808 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' 1089 ' ' PRO . 85.2 t -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.237 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 83.17 -157.7 35.41 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.723 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.565 ' HG3' ' HD3' ' A' 1089 ' ' PRO . 14.9 pt-20 -64.41 118.77 50.48 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-O 120.769 0.318 . . . . 0.0 111.474 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.612 ' HB3' ' CD2' ' A' 1066 ' ' LEU . 56.8 Cg_endo -96.26 27.21 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.092 2.528 . . . . 0.0 113.564 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' 1050 ' ' VAL . 58.6 m -156.18 142.06 18.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 112.036 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' 1049 ' ' VAL . 31.2 pt -144.93 174.78 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.766 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.835 ' HB3' HG22 ' A' 1049 ' ' VAL . 6.2 p90 -155.27 148.0 24.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.996 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . . . . . . . . . 60.4 m -63.26 125.25 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.347 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' 1085 ' ' SER . 11.4 t -157.84 145.78 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.516 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 79.3 p -74.6 149.13 40.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.35 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.83 HD21 HG12 ' A' 1083 ' ' ILE . 0.0 OUTLIER -164.55 -42.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.751 ' H ' HD22 ' A' 1077 ' ' ASN . 38.1 t70 -83.05 -80.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.978 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.12 -130.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.311 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -59.58 -34.44 72.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 110.808 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' 1081 ' ' VAL . 2.6 t -59.02 -53.2 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.15 0.5 . . . . 0.0 110.989 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.51 ' O ' HG12 ' A' 1083 ' ' ILE . . . 77.55 -44.51 2.25 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.63 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.83 HG12 HD21 ' A' 1077 ' ' ASN . 17.1 pt 46.28 -163.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.445 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 36.2 m95 -85.26 -163.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.908 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.423 ' HA ' ' CG2' ' A' 1075 ' ' THR . 76.7 p -67.48 -65.1 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.984 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . 178.21 131.84 1.62 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.596 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 16.5 Cg_exo -68.52 143.05 55.81 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.729 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -168.02 -49.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.729 ' HD2' ' H ' ' A' 1088 ' ' ALA . 11.9 Cg_endo -55.65 148.91 51.82 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.333 2.022 . . . . 0.0 112.149 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.632 ' HA ' HD12 ' A' 1031 ' ' ILE . 37.7 tt0 -152.36 133.47 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 41.5 t -92.63 141.3 28.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.104 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.15 136.45 57.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.201 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 40.2 tt0 58.05 45.82 17.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.652 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -79.6 40.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.914 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.614 ' HD2' HD21 ' A' 1006 ' ' LEU . 28.5 mttm -77.6 142.09 39.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 981' ' ' GLN . 77.9 p -157.28 141.07 15.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.059 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 71.4 m -79.93 134.02 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.594 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.75 140.57 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 97.4 m -53.52 120.31 21.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.143 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 42.9 Cg_exo -57.94 112.6 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.342 2.028 . . . . 0.0 112.656 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.68 134.38 32.55 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.575 2.183 . . . . 0.0 111.013 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -48.48 106.81 0.65 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.903 0.382 . . . . 0.0 111.216 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 72.9 Cg_endo -75.33 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.591 2.194 . . . . 0.0 112.295 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' 1020 ' ' CYS . 95.6 t -49.01 85.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 969' ' ' PRO . 71.2 m-80 44.68 63.8 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.896 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.851 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -157.04 124.97 1.5 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.783 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 37.8 ttp -97.75 134.49 40.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.698 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.723 HG21 HD12 ' A' ' 986' ' ' ILE . 3.9 p -93.69 151.32 3.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -116.79 106.82 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.376 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 986' ' ' ILE . 22.0 t -65.44 113.3 2.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 986' ' ' ILE . 46.5 mm -80.38 -91.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.312 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 41.3 p -80.68 -58.63 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.834 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' A' ' 984' ' ' SER . 30.0 m-20 -164.58 -154.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.751 HG22 ' HH2' ' A' 1013 ' ' TRP . 14.2 pt -155.89 25.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.737 0.303 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 962' ' ' SER . 87.1 mt-30 -87.33 -56.26 3.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.351 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 981' ' ' GLN . 21.6 t -173.1 141.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.24 1.016 . . . . 0.0 109.412 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.42 -34.82 0.97 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.573 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 979' ' ' ASP . 50.3 m -68.41 126.85 30.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.416 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 0.0 OUTLIER -101.39 -179.63 4.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.391 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.723 HD12 HG21 ' A' ' 974' ' ' VAL . 20.3 pt -154.01 171.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.616 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' 1001 ' ' SER . 77.8 p -141.71 129.56 21.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.317 . . . . 0.0 111.47 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.706 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.4 m-85 -83.27 -164.46 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 990' ' ' CYS . 75.5 p -153.83 -46.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.397 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.851 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 42.7 t 71.96 150.76 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.868 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 20.7 p -62.42 152.0 35.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.811 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 54.4 m -58.06 137.51 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.482 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 75.63 35.5 46.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.267 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.602 ' HB3' ' HB3' ' A' 1020 ' ' CYS . 30.6 m80 -147.0 132.49 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.65 ' NH1' HG12 ' A' ' 997' ' ' ILE . 50.8 ttt-85 -81.58 117.47 21.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.43 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 988' ' ' TYR . 5.7 tt -76.05 111.83 11.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.457 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.736 ' HB ' HG13 ' A' 1019 ' ' ILE . 18.3 mt -99.47 59.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.528 0.68 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . -154.32 20.3 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.787 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 57.07 17.58 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.604 0.24 . . . . 0.0 111.122 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.613 ' H ' HD22 ' A' ' 996' ' ' LEU . 83.2 p 36.99 39.21 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 18.0 t -162.14 161.86 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.637 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -165.28 126.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' 1013 ' ' TRP . 43.5 tt0 -105.0 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.1 t -73.19 81.3 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' 1014 ' ' SER . 44.3 pt -86.87 -172.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.359 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.614 HD21 ' HD2' ' A' ' 961' ' ' LYS . 10.8 tp -158.36 124.42 4.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.47 . . . . 0.0 111.919 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.435 ' N ' HD12 ' A' 1006 ' ' LEU . 45.7 t -83.67 -45.56 13.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.153 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.77 -45.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.752 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.23 -52.41 10.09 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.433 ' C ' HD13 ' A' 1006 ' ' LEU . 86.9 m -151.26 149.16 29.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -74.72 140.75 44.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.1 p80 -153.08 151.91 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.751 ' HH2' HG22 ' A' ' 980' ' ' ILE . 53.4 m95 -72.08 120.04 17.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.958 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.593 ' HB3' HD13 ' A' 1005 ' ' ILE . 80.1 p -52.5 -25.32 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 44.6 p -86.9 133.8 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 111.954 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 25.3 pttm -62.7 152.42 81.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.681 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 74.9 Cg_exo -47.55 118.09 2.75 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.323 2.015 . . . . 0.0 111.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.719 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 15.9 Cg_exo -69.43 139.94 42.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.015 2.477 . . . . 0.0 112.987 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.736 HG13 ' HB ' ' A' ' 997' ' ' ILE . 16.7 pt -134.28 126.26 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.921 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 994' ' ' HIS . 92.5 m -86.43 95.67 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 111.211 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -77.02 138.43 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.191 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.475 ' HE ' ' HD2' ' A' 1045 ' ' HIS . 39.3 ttt85 -54.76 127.61 29.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.499 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.698 ' O ' ' HB2' ' A' 1046 ' ' TYR . 47.1 mm -56.02 110.38 2.27 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' 1080 ' ' GLN . 93.6 Cg_endo -81.17 133.09 8.61 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.511 2.141 . . . . 0.0 113.374 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 8.1 p -113.02 143.81 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.896 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.06 -148.63 2.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.095 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' 1027 ' ' LEU . 10.1 mt -70.02 148.82 96.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' 1029 ' ' PRO . 16.4 Cg_exo -66.5 137.07 45.28 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 110.499 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' 1028 ' ' PRO . 49.9 Cg_exo -34.11 135.28 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.667 2.244 . . . . 0.0 111.782 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 77.2 p -76.54 139.39 40.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.755 HG23 ' HA3' ' A' 1034 ' ' GLY . 7.8 tt -142.67 117.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.321 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -44.7 131.42 6.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.529 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' 1091 ' ' CYS . 22.5 p30 42.58 30.12 0.2 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.482 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.755 ' HA3' HG23 ' A' 1031 ' ' ILE . . . -79.16 160.8 46.59 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.526 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.724 ' HB2' ' HA ' ' A' 1055 ' ' ASN . 31.3 t0 -156.56 156.62 33.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.704 ' HA ' ' O ' ' A' 1051 ' ' THR . 23.4 p90 -155.88 145.37 20.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 111.91 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.448 HG13 HH11 ' A' 1053 ' ' ARG . 29.5 mt -109.23 111.27 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.775 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' 1039 ' ' THR . 57.1 m -171.12 -140.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.441 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.448 ' H ' ' HB3' ' A' 1038 ' ' SER . 11.6 t -117.79 -27.87 6.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -45.56 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.951 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.426 ' H ' ' HE1' ' A' 1036 ' ' PHE . 38.9 mmt180 54.39 -126.69 2.31 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -77.03 -40.73 45.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.136 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -67.5 148.45 51.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.31 152.91 15.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.307 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' 1046 ' ' TYR . 15.7 p-80 -155.08 -62.07 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.809 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.698 ' HB2' ' O ' ' A' 1023 ' ' ILE . 6.2 t80 169.11 40.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.594 0.235 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.46 -43.87 0.02 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.568 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 66.7 m -47.58 128.51 12.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 112.001 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' 1050 ' ' VAL . 7.7 p -97.17 175.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.558 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' 1049 ' ' VAL . 30.9 m -151.41 131.77 4.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.172 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.704 ' O ' ' HA ' ' A' 1036 ' ' PHE . 42.4 m -104.33 102.64 12.32 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.433 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' 1035 ' ' ASP . 2.5 m-85 -70.57 135.08 48.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.0 111.254 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.532 HH22 HG21 ' A' 1051 ' ' THR . 3.1 ptp85 -159.63 34.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.388 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.811 ' HB2' HG12 ' A' 1063 ' ' VAL . 77.5 m 62.03 149.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.188 0.518 . . . . 0.0 111.809 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.724 ' HA ' ' HB2' ' A' 1035 ' ' ASP . 47.3 t30 -63.45 -35.38 80.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.279 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 1.003 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 21.7 mt -70.31 -157.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 58.68 39.8 93.96 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.607 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 11.6 p -175.04 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 110.552 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -155.88 45.58 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.839 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.792 ' HA3' HD23 ' A' 1056 ' ' LEU . . . -172.19 -41.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.834 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' 1062 ' ' LYS . 20.8 tpp180 67.6 158.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.461 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' A' 1061 ' ' ARG . 20.2 tptm 94.97 -35.97 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.014 0.821 . . . . 0.0 110.077 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 1.003 ' HA ' ' HB2' ' A' 1056 ' ' LEU . 0.1 OUTLIER 43.1 32.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.537 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' 1091 ' ' CYS . 0.1 OUTLIER 36.93 -135.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' 1092 ' ' ILE . 98.7 mt-10 -150.14 105.71 3.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.205 0.526 . . . . 0.0 110.814 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' 1070 ' ' PRO . 43.6 tp -70.51 149.73 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.112 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' 1089 ' ' PRO . 97.2 t -139.18 137.51 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.325 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 84.13 -158.79 35.0 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.561 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' 1089 ' ' PRO . 18.6 pt-20 -69.03 125.97 92.4 Favored Pre-proline 0 C--O 1.227 -0.117 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.76 ' HB3' HD21 ' A' 1066 ' ' LEU . 84.7 Cg_endo -96.16 26.15 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.114 2.542 . . . . 0.0 112.869 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 78.8 p -157.4 143.59 17.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.503 HD11 ' OH ' ' A' 1052 ' ' TYR . 13.4 pt -155.19 171.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.881 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 1.8 p90 -137.46 144.07 42.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 0.0 111.315 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.579 ' HA ' ' CE2' ' A' 1084 ' ' TRP . 0.9 OUTLIER -62.19 121.37 12.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.55 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' 1084 ' ' TRP . 11.8 t -157.72 140.68 15.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.719 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' 1082 ' ' GLY . 69.7 m -89.77 -154.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.955 HD21 HD13 ' A' 1083 ' ' ILE . 0.0 OUTLIER 179.22 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.409 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.749 ' H ' HD22 ' A' 1077 ' ' ASN . 29.5 m-20 -80.67 -54.92 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -163.24 -46.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.009 0.433 . . . . 0.0 111.635 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.688 ' HB2' ' HG2' ' A' 1024 ' ' PRO . 17.0 pt20 -175.3 32.81 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.74 HG13 ' H ' ' A' 1082 ' ' GLY . 2.5 p -88.93 -104.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.612 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.74 ' H ' HG13 ' A' 1081 ' ' VAL . . . -153.24 -115.15 0.58 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.955 HD13 HD21 ' A' 1077 ' ' ASN . 4.2 mp 56.02 82.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.579 ' CE2' ' HA ' ' A' 1074 ' ' CYS . 15.4 m0 -70.66 -153.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.707 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' 1084 ' ' TRP . 47.9 t -56.42 -57.01 14.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 131.8 1.63 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.478 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.5 130.67 9.05 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 111.184 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.785 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -169.92 -46.74 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.785 ' HD2' ' H ' ' A' 1088 ' ' ALA . 9.7 Cg_endo -52.02 132.82 44.4 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.195 1.93 . . . . 0.0 112.54 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.499 HE22 HG12 ' A' 1092 ' ' ILE . 0.0 OUTLIER -153.21 138.51 17.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.427 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.596 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 74.5 m -103.04 135.32 44.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' 1065 ' ' GLU . 13.5 pt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.381 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -78.77 43.36 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.31 46.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.008 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 48.44 40.63 15.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.469 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.758 ' HD2' ' H ' ' A' 1011 ' ' ALA . 4.4 tppp? -77.46 140.85 39.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.823 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 67.2 p -157.99 144.84 17.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.545 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 76.8 m -79.9 31.7 0.26 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.838 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 59.47 142.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.841 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 966' ' ' PRO . 54.8 m -52.15 122.13 22.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.6 ' HG2' HG11 ' A' ' 974' ' ' VAL . 10.1 Cg_endo -53.53 115.52 2.36 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.495 2.13 . . . . 0.0 112.168 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 22.8 Cg_exo -64.51 127.71 19.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.502 2.134 . . . . 0.0 111.559 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.18 109.74 2.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.864 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.669 ' HG3' ' HG2' ' A' 1018 ' ' PRO . 26.4 Cg_exo -61.94 147.25 95.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 111.571 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 970' ' ' VAL . 35.9 m -47.43 127.05 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 990' ' ' CYS . 75.4 m-20 51.23 46.35 26.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.718 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -171.53 124.1 1.08 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.198 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.73 144.53 27.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.696 0.284 . . . . 0.0 111.53 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' ' 966' ' ' PRO . 1.4 p -89.57 147.13 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.041 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.462 ' O ' HG13 ' A' ' 977' ' ' ILE . 17.7 m170 -115.43 95.27 5.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 979' ' ' ASP . 73.7 t -67.56 89.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.643 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 975' ' ' HIS . 42.5 mt -75.13 -90.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.512 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 38.8 p -59.65 -63.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.378 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 976' ' ' VAL . 25.4 m-20 -165.68 -137.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.24 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.477 HG23 HG13 ' A' ' 976' ' ' VAL . 8.3 pt -152.51 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.518 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.823 ' HG2' ' HB3' ' A' ' 962' ' ' SER . 22.4 mt-30 -72.35 164.42 26.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.595 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' 1004 ' ' CYS . 3.5 p -43.99 135.84 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.887 0.375 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.19 54.74 4.29 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.795 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.421 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 94.4 p -164.52 130.37 2.87 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.625 ' NE ' ' HB2' ' A' 1003 ' ' GLU . 35.9 mmt180 -94.11 149.63 21.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.586 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' 1001 ' ' SER . 48.7 pt -142.83 141.38 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -106.37 123.97 48.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.372 . . . . 0.0 111.951 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.578 ' CE2' ' HG3' ' A' 1018 ' ' PRO . 1.3 m-85 -86.66 172.04 10.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.7 t -145.47 -174.24 4.34 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.081 0.467 . . . . 0.0 111.852 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.568 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 92.2 m -158.12 159.67 36.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 992' ' ' THR . 41.3 p -67.72 -160.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 111.378 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' A' ' 991' ' ' THR . 43.7 m -82.53 130.26 35.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.694 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' 1023 ' ' ILE . . . 68.44 45.39 68.69 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.538 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -148.08 123.13 10.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.507 ' HG3' HE22 ' A' 1080 ' ' GLN . 78.7 ttt180 -84.98 129.05 34.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.354 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' 1000 ' ' SER . 3.7 tt -74.66 130.79 40.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.562 ' N ' HD23 ' A' ' 996' ' ' LEU . 49.6 mm -99.87 144.61 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.878 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.451 ' HA3' ' HE3' ' A' 1016 ' ' LYS . . . 77.26 36.23 35.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.872 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 59.4 131.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.63 ' HB3' HD13 ' A' ' 996' ' ' LEU . 79.1 p -84.59 36.4 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.527 ' O ' HG21 ' A' 1015 ' ' THR . 80.9 p -162.09 145.89 12.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.07 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.448 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -161.07 141.51 11.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.145 0.497 . . . . 0.0 112.162 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.625 ' HB2' ' NE ' ' A' ' 985' ' ' ARG . 89.0 tt0 -104.78 134.43 47.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.953 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 54.0 t -74.62 98.2 3.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 26.7 pt -90.73 -166.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.073 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' 1011 ' ' ALA . 0.4 OUTLIER -141.08 121.78 14.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.147 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.404 ' N ' HD13 ' A' 1006 ' ' LEU . 37.8 t -90.38 41.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.496 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 50.92 39.84 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.599 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.65 -46.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.094 0.474 . . . . 0.0 110.571 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 67.8 m -151.24 147.85 27.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.758 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.19 134.78 41.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.522 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 88.9 m-70 -149.46 141.71 24.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.473 ' HH2' ' HA ' ' A' ' 980' ' ' ILE . 78.3 m95 -68.9 125.56 27.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.351 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 32.7 m -52.62 -25.36 10.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.899 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.527 HG21 ' O ' ' A' 1001 ' ' SER . 72.9 p -87.95 143.11 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' 1017 ' ' PRO . 0.0 OUTLIER -68.3 162.13 63.55 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.089 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.494 ' O ' ' HD2' ' A' 1016 ' ' LYS . 99.2 Cg_exo -43.18 116.57 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.519 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.669 ' HG2' ' HG3' ' A' ' 969' ' ' PRO . 56.1 Cg_endo -69.49 138.22 38.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.881 2.387 . . . . 0.0 112.728 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 997' ' ' ILE . 12.1 tt -148.81 133.27 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 79.2 m -86.38 113.33 22.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 111.575 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -78.79 129.05 34.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.926 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -71.16 122.4 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.893 HG21 ' HB2' ' A' 1077 ' ' ASN . 37.7 mt -52.55 121.62 22.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.427 ' O ' ' HA3' ' A' 1082 ' ' GLY . 84.9 Cg_endo -81.64 125.25 4.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.872 2.382 . . . . 0.0 111.03 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.699 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 0.5 OUTLIER -97.06 25.29 5.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 36.67 -143.96 0.13 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.328 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' 1044 ' ' PHE . 22.3 mt -93.27 141.84 24.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.592 0.235 . . . . 0.0 111.225 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.761 ' HG3' HD21 ' A' 1040 ' ' ASN . 56.6 Cg_endo -68.8 156.93 63.84 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.493 2.129 . . . . 0.0 111.307 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.545 ' HD2' HD11 ' A' 1072 ' ' ILE . 82.8 Cg_exo -42.7 126.29 4.17 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.526 2.151 . . . . 0.0 112.273 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 66.6 p -77.41 98.27 5.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' 1031 ' ' ILE . 7.4 tt -86.41 106.73 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.563 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -76.22 148.01 37.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.968 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.8 m120 73.7 28.35 1.64 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.524 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.656 ' HA2' ' N ' ' A' 1055 ' ' ASN . . . -160.86 -46.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.78 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' 1034 ' ' GLY . 57.8 m-20 71.44 147.38 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.611 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.519 ' HB2' HG21 ' A' 1050 ' ' VAL . 14.4 p90 -84.0 145.59 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.098 0.475 . . . . 0.0 112.017 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' 1053 ' ' ARG . 58.8 mt -90.72 164.01 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.56 ' N ' HG22 ' A' 1037 ' ' ILE . 75.1 m 72.57 166.43 0.3 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.598 0.237 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' 1040 ' ' ASN . 57.5 p -49.54 -64.93 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.761 HD21 ' HG3' ' A' 1028 ' ' PRO . 18.7 t-20 33.46 49.09 0.21 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.031 0.444 . . . . 0.0 110.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -86.4 -60.71 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -147.5 -42.76 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 1.1 m120 -71.48 123.29 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.581 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.512 ' CE2' HD23 ' A' 1027 ' ' LEU . 86.3 m-85 -148.56 -46.88 0.15 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.624 ' C ' ' H ' ' A' 1047 ' ' GLY . 23.8 m80 58.1 -111.66 0.59 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' 1074 ' ' CYS . 10.0 t80 -64.31 27.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.059 0.456 . . . . 0.0 110.556 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' 1045 ' ' HIS . . . 76.51 -84.85 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.519 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' 1047 ' ' GLY . 34.2 t 115.72 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.885 0.874 . . . . 0.0 109.669 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' 1072 ' ' ILE . 13.2 p -156.4 153.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.434 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.567 ' HB ' HD22 ' A' 1040 ' ' ASN . 5.0 p -153.81 129.08 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.945 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 71.7 m -86.74 120.62 28.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.128 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.492 ' CE1' HG12 ' A' 1072 ' ' ILE . 3.1 m-85 -80.28 139.44 36.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.592 ' HB2' HD11 ' A' 1037 ' ' ILE . 33.7 ttp180 -147.63 142.84 27.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.552 ' O ' HD12 ' A' 1056 ' ' LEU . 40.9 m -77.97 149.93 34.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.525 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.656 ' N ' ' HA2' ' A' 1034 ' ' GLY . 44.5 t30 -56.31 -51.74 67.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.861 ' HA ' HG13 ' A' 1063 ' ' VAL . 1.7 mt 49.47 34.79 7.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.718 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.16 0.37 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.307 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' 1059 ' ' ARG . 85.8 p -68.35 -54.14 19.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 1058 ' ' SER . 24.9 mmm180 -159.52 -47.02 0.05 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.697 0.284 . . . . 0.0 111.278 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.672 ' HA2' HD22 ' A' 1056 ' ' LEU . . . -167.14 50.58 0.25 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.43 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' 1062 ' ' LYS . 0.0 OUTLIER -77.06 47.7 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.403 0.281 . . . . 0.0 110.491 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' 1062 ' ' LYS . 61.9 tttp 38.45 61.98 1.07 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' 1056 ' ' LEU . 3.3 p -147.26 87.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.207 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.74 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 1.5 m-30 88.26 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.189 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -147.94 145.61 28.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.458 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' 1067 ' ' VAL . 3.8 tt -68.58 142.1 55.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.391 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.795 ' N ' HD23 ' A' 1066 ' ' LEU . 56.3 t -133.48 111.37 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.475 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' 1089 ' ' PRO . . . 77.03 133.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.355 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.723 ' O ' ' HG3' ' A' 1089 ' ' PRO . 5.2 tp10 46.0 107.94 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 111.833 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.558 ' HA ' ' CD1' ' A' 1066 ' ' LEU . 68.8 Cg_endo -87.18 -28.15 0.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.48 2.12 . . . . 0.0 113.106 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 87.6 p -151.2 129.97 12.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' 1049 ' ' VAL . 45.6 pt -106.86 175.84 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.436 0.636 . . . . 0.0 112.514 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.13 144.62 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.04 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 34.9 t -67.43 125.31 25.73 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.736 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 3.3 t -92.05 -40.98 10.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 10.9 p -166.49 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 0.0 111.421 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.893 ' HB2' HG21 ' A' 1023 ' ' ILE . 0.8 OUTLIER -170.97 143.33 1.98 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.385 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.717 ' H ' HD22 ' A' 1077 ' ' ASN . 61.7 t0 -57.52 -48.37 79.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.929 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -150.4 -55.65 0.16 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.507 HE22 ' HG3' ' A' ' 995' ' ' ARG . 13.3 mm-40 -148.21 -26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' 1023 ' ' ILE . 21.8 t -68.89 -110.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . -165.81 136.13 4.03 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.068 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.729 HG22 ' HA ' ' A' 1077 ' ' ASN . 8.1 tp -145.91 132.94 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.744 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 20.8 m95 -83.98 -155.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 67.2 m -79.75 -57.5 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.701 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.59 134.11 2.04 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.047 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.417 ' HB3' ' CG ' ' A' 1029 ' ' PRO . 87.8 Cg_endo -79.71 48.93 3.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.858 2.372 . . . . 0.0 112.017 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' A' 1089 ' ' PRO . . . -69.92 -41.0 14.18 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.723 ' HG3' ' O ' ' A' 1069 ' ' GLU . 78.3 Cg_exo -48.96 120.42 5.43 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.759 1.639 . . . . 0.0 112.552 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.557 HE21 HG23 ' A' 1092 ' ' ILE . 58.6 tp60 -134.04 116.38 15.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.106 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 49.9 t -87.26 117.02 25.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.128 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.557 HG23 HE21 ' A' 1090 ' ' GLN . 10.2 pt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.213 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 958' ' ' ALA . 23.6 pt-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 957' ' ' GLU . . . -178.7 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 959' ' ' GLU . 88.9 tt0 -169.07 58.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.756 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -77.58 56.47 1.45 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 962' ' ' SER . 45.4 mmtm -77.6 -127.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.746 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.978 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 47.3 t 74.19 139.76 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.224 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.569 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 79.0 m -79.98 37.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.008 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 61.27 134.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.34 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 95.1 m -59.69 114.34 9.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' A' ' 986' ' ' ILE . 24.1 Cg_exo -63.82 118.49 5.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.372 2.048 . . . . 0.0 112.08 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.56 132.37 15.96 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.396 2.064 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 30.4 m-20 -55.65 110.02 2.0 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.771 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.466 ' HD2' ' HA3' ' A' ' 972' ' ' GLY . 5.5 Cg_exo -79.84 -146.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.053 2.502 . . . . 0.0 111.923 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.672 HG11 HG23 ' A' 1019 ' ' ILE . 1.6 p -48.95 93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.647 ' O ' HG23 ' A' ' 991' ' ' THR . 76.6 m-20 49.28 22.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.393 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -83.05 159.31 37.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.6 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.542 ' N ' ' HA ' ' A' ' 990' ' ' CYS . 11.4 tpt -157.45 110.67 2.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.954 HG21 HD12 ' A' ' 986' ' ' ILE . 9.0 p -87.98 145.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.993 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.4 ' N ' ' CD2' ' A' ' 975' ' ' HIS . 11.8 m170 -106.58 97.45 7.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.823 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.704 HG13 HG23 ' A' ' 980' ' ' ILE . 16.3 t -65.29 96.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.427 HD11 ' OG1' ' A' ' 987' ' ' THR . 37.4 mt -75.24 -92.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.264 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 984' ' ' SER . 40.0 p -68.84 -73.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 110.359 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 984' ' ' SER . 3.9 m-20 -161.2 151.04 17.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 976' ' ' VAL . 11.5 pt -84.18 3.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.363 0.601 . . . . 0.0 109.793 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.978 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 88.6 mt-30 -82.03 157.08 24.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.945 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' 1005 ' ' ILE . 7.2 p -44.35 150.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.644 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 81.02 -44.19 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.712 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.511 ' HB3' ' OG1' ' A' ' 978' ' ' THR . 54.4 m -74.14 -170.1 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.83 0.315 . . . . 0.0 111.035 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' 1003 ' ' GLU . 79.6 mtp180 -151.51 169.53 21.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.295 0.569 . . . . 0.0 111.991 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.954 HD12 HG21 ' A' ' 974' ' ' VAL . 37.6 pt -150.01 139.05 15.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.499 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' 1001 ' ' SER . 48.7 p -107.36 122.67 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 5.4 m-85 -83.28 160.1 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.995 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.458 ' HA ' HD12 ' A' ' 996' ' ' LEU . 75.1 m -161.5 -6.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.752 ' SG ' ' HG ' ' A' ' 996' ' ' LEU . 65.8 m 62.29 -158.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.07 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 971' ' ' ASN . 34.2 p -75.08 -142.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.604 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 993' ' ' GLY . 9.8 t -62.4 -127.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.537 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 992' ' ' THR . . . -72.57 43.75 0.93 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 114.501 0.56 . . . . 0.0 114.501 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -93.96 139.6 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.201 0.5 . . . . 0.0 110.646 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -81.99 117.22 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.738 0.304 . . . . 0.0 110.553 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.752 ' HG ' ' SG ' ' A' ' 990' ' ' CYS . 1.7 tt -76.16 133.28 40.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.647 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.969 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.7 mp -105.16 155.1 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.406 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 79.41 -75.81 2.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.818 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -165.28 139.13 4.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.545 ' HA ' HD13 ' A' ' 996' ' ' LEU . 21.7 m -100.15 22.04 11.98 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 83.8 p -162.27 148.16 13.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.903 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.409 ' HB3' ' HE1' ' A' ' 988' ' ' TYR . . . -154.49 134.4 13.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 111.547 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 985' ' ' ARG . 87.7 tt0 -101.62 128.78 47.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.05 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 47.7 t -79.38 125.69 29.86 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' 1012 ' ' HIS . 0.2 OUTLIER -138.26 153.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 0.0 110.286 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' 1007 ' ' SER . 0.6 OUTLIER -81.58 124.2 29.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.473 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.536 ' N ' HD13 ' A' 1006 ' ' LEU . 81.2 p -86.63 -125.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.09 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -65.08 -54.89 24.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.154 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 7.7 m120 -153.35 20.79 0.56 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 95.4 m -151.37 147.45 26.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.569 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.3 136.39 40.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.591 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.655 ' O ' HD13 ' A' 1005 ' ' ILE . 82.9 m-70 -149.14 142.78 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.733 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.516 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 83.2 m95 -71.66 136.2 47.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.985 0.421 . . . . 0.0 111.428 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 74.8 p -52.44 -24.46 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.839 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 25.2 p -132.38 130.57 40.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.45 . . . . 0.0 111.858 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -57.95 158.9 11.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.629 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 97.9 Cg_exo -41.56 126.49 3.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.123 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.534 ' HB2' HD21 ' A' ' 996' ' ' LEU . 64.2 Cg_endo -72.57 -156.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.511 2.141 . . . . 0.0 112.217 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.969 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 11.3 mt -143.04 -179.26 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.866 ' H ' HG22 ' A' 1019 ' ' ILE . 21.1 m -145.81 79.06 1.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.377 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.784 ' H ' HD13 ' A' ' 997' ' ' ILE . 3.0 tp-100 -71.6 138.57 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.008 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.664 ' HB3' ' HB3' ' A' 1046 ' ' TYR . 9.5 mpt_? -72.33 126.61 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.998 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.2 mt -67.32 113.25 12.88 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.638 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' 1045 ' ' HIS . 30.1 Cg_endo -63.69 114.37 2.54 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.758 2.305 . . . . 0.0 113.679 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.586 ' O ' ' HB2' ' A' 1044 ' ' PHE . 9.1 p -95.67 135.97 36.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.208 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.13 -150.59 3.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.104 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.485 HD11 ' OE1' ' A' 1042 ' ' GLU . 1.5 mm? -62.87 139.03 97.26 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.12 168.33 19.4 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.024 2.483 . . . . 0.0 111.291 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.781 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 65.5 Cg_exo -50.86 110.3 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.873 1.716 . . . . 0.0 111.529 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.6 p -77.42 141.02 39.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.269 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.567 HG13 ' HA3' ' A' 1034 ' ' GLY . 24.1 pt -149.68 124.33 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.446 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.96 139.38 10.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' 1055 ' ' ASN . 74.6 m-20 75.1 -28.41 0.19 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.344 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.567 ' HA3' HG13 ' A' 1031 ' ' ILE . . . -64.62 160.07 41.39 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' 1034 ' ' GLY . 71.5 m-20 -153.78 -156.53 0.69 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.741 ' HB2' HG23 ' A' 1050 ' ' VAL . 36.7 p90 -155.95 142.33 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 112.298 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' 1037 ' ' ILE . 53.9 mt -111.26 57.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.054 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.413 ' H ' ' HD1' ' A' 1036 ' ' PHE . 60.1 m -157.76 -163.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.488 HG22 ' O ' ' A' 1039 ' ' THR . 22.6 m -96.91 49.15 1.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.265 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.639 HD21 ' HB ' ' A' 1050 ' ' VAL . 5.3 m120 -62.93 -52.26 63.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.765 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 56.81 -137.27 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.485 ' OE1' HD11 ' A' 1027 ' ' LEU . 67.3 mm-40 -149.23 50.38 0.96 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.354 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -168.42 60.99 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.164 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.586 ' HB2' ' O ' ' A' 1025 ' ' CYS . 5.3 m-85 -76.77 129.99 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.744 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.583 ' O ' ' HA ' ' A' 1024 ' ' PRO . 20.8 m80 -98.42 -58.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.664 ' HB3' ' HB3' ' A' 1022 ' ' ARG . 42.3 t80 172.17 31.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.71 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' 1048 ' ' SER . . . -160.46 98.09 0.16 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.79 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' 1047 ' ' GLY . 78.8 p 175.72 134.41 0.05 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.535 0.683 . . . . 0.0 111.391 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' 1072 ' ' ILE . 12.7 p -102.17 155.52 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.448 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.741 HG23 ' HB2' ' A' 1036 ' ' PHE . 6.4 p -133.47 126.47 52.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.012 0.435 . . . . 0.0 111.05 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 33.2 m -106.69 109.84 21.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.545 ' CE2' ' HD2' ' A' 1089 ' ' PRO . 10.3 m-85 -71.92 147.65 46.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.726 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' 1054 ' ' CYS . 14.0 ptm180 -142.8 -14.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.201 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' 1053 ' ' ARG . 66.1 m 71.29 146.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.104 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' 1033 ' ' ASN . 28.7 t30 -62.64 -133.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 111.665 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.583 HD13 ' HA2' ' A' 1060 ' ' GLY . 8.6 mt -155.04 133.57 11.93 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -82.96 31.43 3.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.184 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.631 ' O ' ' HG2' ' A' 1059 ' ' ARG . 68.0 m -169.36 -70.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.783 0.292 . . . . 0.0 111.615 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' 1058 ' ' SER . 31.8 mmt-85 -167.21 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.65 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.583 ' HA2' HD13 ' A' 1056 ' ' LEU . . . -153.29 -32.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.444 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' 1061 ' ' ARG . 41.4 ttt85 -55.43 120.53 7.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.93 133.73 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 32.5 m -147.0 -29.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 111.302 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.533 ' HD2' ' HB3' ' A' 1091 ' ' CYS . 15.6 m-85 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' 1092 ' ' ILE . 34.6 mt-10 -98.52 126.43 44.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.718 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.932 HD23 ' N ' ' A' 1067 ' ' VAL . 3.6 tt -68.81 143.47 54.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.517 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.932 ' N ' HD23 ' A' 1066 ' ' LEU . 96.2 t -135.1 117.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 88.77 -142.82 17.28 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.658 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' 1089 ' ' PRO . 20.8 pt-20 -62.52 122.87 76.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.018 0.437 . . . . 0.0 112.17 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.6 ' HA ' HD11 ' A' 1066 ' ' LEU . 87.0 Cg_endo -85.33 -17.46 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.812 2.341 . . . . 0.0 112.175 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 77.9 p -156.37 155.66 32.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.502 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' 1049 ' ' VAL . 34.8 pt -150.29 -162.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.656 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -160.28 150.06 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 2.4 t -62.39 141.03 58.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.698 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 12.8 t -145.73 -146.89 0.2 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' 1082 ' ' GLY . 46.9 t -165.46 147.92 7.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.886 0.374 . . . . 0.0 111.46 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.726 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -163.97 -33.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.726 ' H ' HD22 ' A' 1077 ' ' ASN . 5.0 t0 -73.78 -139.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.49 -39.87 11.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -162.91 -16.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 50.5 t -58.74 -28.9 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.501 . . . . 0.0 110.776 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' 1076 ' ' SER . . . 81.13 -63.06 4.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.901 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.574 ' HB ' HD21 ' A' 1077 ' ' ASN . 75.4 mt 60.69 130.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.106 0.479 . . . . 0.0 111.847 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . . . . . . . . . 18.1 m95 -80.19 138.2 36.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.587 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 71.5 p -55.47 -61.73 2.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.522 ' O ' ' HG2' ' A' 1029 ' ' PRO . . . -71.38 121.85 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.643 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.39 39.87 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.087 2.525 . . . . 0.0 112.012 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.781 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 61.98 135.02 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.504 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.545 ' HD2' ' CE2' ' A' 1052 ' ' TYR . 36.3 Cg_endo -64.9 -138.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.657 2.238 . . . . 0.0 112.399 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.787 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -151.84 128.09 10.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' 1064 ' ' PHE . 98.8 m -102.74 104.06 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.361 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' 1065 ' ' GLU . 17.8 pt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.304 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.748 0.309 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -174.62 48.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 959' ' ' GLU . 17.5 tp10 54.71 42.6 31.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.333 0.587 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -71.27 -43.32 67.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.111 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' A' 1011 ' ' ALA . 0.0 OUTLIER 64.39 143.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 81.2 p -157.99 146.73 19.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.97 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.02 152.23 29.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 0.0 OUTLIER -63.87 133.57 53.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.598 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.433 ' HB ' ' CD1' ' A' ' 980' ' ' ILE . 6.5 t -73.73 125.73 90.2 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.857 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.637 ' HG2' HG11 ' A' ' 974' ' ' VAL . 93.5 Cg_endo -79.73 113.14 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.296 1.997 . . . . 0.0 111.219 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 968' ' ' ASP . 95.5 Cg_exo -42.2 -48.96 6.25 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.435 2.09 . . . . 0.0 112.051 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 967' ' ' PRO . 9.4 t70 174.5 126.95 0.11 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.339 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.667 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 50.2 Cg_exo -54.04 150.91 29.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.69 HG21 HG13 ' A' 1019 ' ' ILE . 93.6 t -46.65 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.496 ' ND2' HG12 ' A' ' 970' ' ' VAL . 73.4 m-20 75.28 -43.42 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.829 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -69.13 -145.09 0.17 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.094 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.667 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 25.8 ptm -159.22 139.83 12.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.738 0.304 . . . . 0.0 110.668 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.637 HG11 ' HG2' ' A' ' 966' ' ' PRO . 9.9 p -92.08 142.68 12.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.225 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -106.88 93.97 4.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.746 HG13 HG23 ' A' ' 980' ' ' ILE . 84.3 t -65.35 -44.73 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.393 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 32.0 mt 61.06 -100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.4 p -67.35 -60.4 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.5 t0 -172.53 -141.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.746 HG23 HG13 ' A' ' 976' ' ' VAL . 9.0 pt -152.83 20.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 110.815 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 70.5 mt-30 -87.32 -157.59 0.4 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.517 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 94.2 t -46.57 140.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.751 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 984' ' ' SER . . . 74.11 -79.46 0.89 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.06 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' 1003 ' ' GLU . 95.8 p 21.15 106.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.391 0.676 . . . . 0.0 112.802 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -98.77 77.16 2.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 976' ' ' VAL . 41.0 pt -80.37 137.45 21.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.509 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 63.7 p -108.62 130.51 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.493 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 6.6 m-85 -98.21 147.21 24.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.514 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 95.5 p -152.48 128.26 10.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.8 t -86.87 -133.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.41 163.82 15.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.415 0.626 . . . . 0.0 111.593 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 25.4 m -53.8 123.57 12.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 131.87 -31.53 3.05 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.232 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -139.73 142.2 36.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.094 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -82.03 121.1 26.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' 1018 ' ' PRO . 4.4 tp -67.63 123.6 20.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.579 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 996' ' ' LEU . 43.3 mm -94.65 149.55 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.193 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 75.91 177.67 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.222 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' A' 1001 ' ' SER . 95.6 m-70 -74.98 131.68 40.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 0.0 111.006 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 10.0 m -75.21 28.82 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.992 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 999' ' ' HIS . 82.2 p -162.13 151.19 15.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -154.11 122.74 6.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 111.847 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 984' ' ' SER . 10.4 pt-20 -107.07 135.86 47.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.231 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.408 ' SG ' ' CZ3' ' A' 1013 ' ' TRP . 19.3 m -70.55 126.78 30.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.085 0.469 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' 1012 ' ' HIS . 0.2 OUTLIER -136.74 147.47 27.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.523 178.472 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' 1007 ' ' SER . 0.2 OUTLIER -86.55 127.02 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.613 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 46.4 t -90.09 -42.03 11.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -163.34 -36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.321 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 961' ' ' LYS . 77.0 m-20 -150.61 -49.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 111.175 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 89.4 m -97.49 137.82 35.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 111.626 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.572 ' H ' ' HD2' ' A' ' 961' ' ' LYS . . . -75.21 140.26 43.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.752 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.671 ' O ' HD13 ' A' 1005 ' ' ILE . 9.3 p80 -149.52 153.29 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.492 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 74.8 m95 -67.95 131.61 45.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.432 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -52.43 -22.28 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.235 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.435 HG21 ' CD2' ' A' ' 999' ' ' HIS . 81.7 p -136.64 142.09 43.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.021 0.439 . . . . 0.0 112.148 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -54.94 148.66 26.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.789 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.86 120.42 7.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.447 2.098 . . . . 0.0 112.462 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.788 ' HB3' HD11 ' A' ' 996' ' ' LEU . 50.6 Cg_exo -54.95 152.21 30.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.69 HG13 HG21 ' A' ' 970' ' ' VAL . 3.6 tt -143.08 131.7 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.586 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.503 ' H ' ' HB ' ' A' ' 970' ' ' VAL . 49.7 m -86.39 113.11 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 111.267 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -84.55 129.15 34.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.928 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.495 ' HD2' ' CD2' ' A' 1045 ' ' HIS . 20.0 ptt-85 -72.8 134.78 45.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.525 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 63.7 mt -100.72 131.07 24.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.315 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.0 115.06 4.19 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.2 1.933 . . . . 0.0 111.715 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.612 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 44.0 t -89.75 148.96 22.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.347 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.1 149.64 37.88 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.738 ' H ' HD23 ' A' 1027 ' ' LEU . 0.1 OUTLIER -52.52 141.4 34.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 117.048 0.424 . . . . 0.0 111.417 -179.159 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.409 ' HB2' HD11 ' A' 1072 ' ' ILE . 18.2 Cg_endo -59.11 145.01 99.13 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.547 2.164 . . . . 0.0 111.229 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.95 134.24 14.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.314 2.009 . . . . 0.0 112.128 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 73.3 p -77.5 126.17 30.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' 1034 ' ' GLY . 6.0 tt -89.56 113.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.445 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . . . . . . . . . . . -60.86 141.17 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.932 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . . . . . . . . . 74.6 m-20 57.55 35.37 25.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.966 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' 1031 ' ' ILE . . . -168.33 131.8 2.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.62 ' HB2' ' HD3' ' A' 1053 ' ' ARG . 35.8 m-20 -76.57 -148.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 110.82 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -155.88 141.22 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.614 HD12 ' HB ' ' A' 1051 ' ' THR . 59.5 mt -87.99 154.98 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.406 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' 1037 ' ' ILE . 73.6 m 73.79 138.33 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.265 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' 1040 ' ' ASN . 70.7 p -50.27 -61.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.978 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' 1039 ' ' THR . 55.1 t30 33.1 44.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.099 0.476 . . . . 0.0 111.091 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' 1041 ' ' ARG . 21.0 mmt85 -76.26 -161.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.956 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.08 67.86 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.672 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . . . . . . . . . 23.2 p30 -169.72 23.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.862 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.571 ' O ' ' HD1' ' A' 1044 ' ' PHE . 0.1 OUTLIER -92.44 132.26 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.511 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' 1047 ' ' GLY . 5.6 m80 -84.26 -114.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -56.41 71.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.963 0.347 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.857 ' HA3' ' HB3' ' A' 1074 ' ' CYS . . . 43.5 -107.31 0.12 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.686 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' 1047 ' ' GLY . 95.6 p 135.06 -142.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.371 1.068 . . . . 0.0 109.806 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.846 HG22 ' HB3' ' A' 1073 ' ' TYR . 71.8 t -148.96 141.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.701 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . . . . . . . . . 30.2 m -140.84 137.21 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.614 ' HB ' HD12 ' A' 1037 ' ' ILE . 72.6 m -92.5 125.41 37.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.077 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.715 ' OH ' HD13 ' A' 1072 ' ' ILE . 4.0 m-85 -72.0 156.33 39.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.235 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.62 ' HD3' ' HB2' ' A' 1035 ' ' ASP . 7.4 ptm180 -145.6 -145.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.112 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 62.0 m -155.1 145.54 22.08 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.95 0.405 . . . . 0.0 111.707 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -55.16 150.64 10.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.373 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' 1056 ' ' LEU . 1.6 mm? -70.4 -149.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -143.6 -29.28 0.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 54.8 m -144.58 -31.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' 1059 ' ' ARG . 31.9 tpt85 -167.66 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.586 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . -165.68 39.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.828 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.749 ' HG2' ' H ' ' A' 1062 ' ' LYS . 27.0 ttm180 -81.26 -147.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.749 ' H ' ' HG2' ' A' 1061 ' ' ARG . 87.5 tttt -173.49 67.42 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . . . . . . . . . 18.2 m -84.92 -38.37 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 111.223 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.687 ' HB2' ' HB3' ' A' 1054 ' ' CYS . 56.3 m-85 -72.71 147.54 45.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.114 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.98 120.48 32.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.662 HD21 ' HA ' ' A' 1070 ' ' PRO . 53.3 tp -68.46 144.26 54.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' 1089 ' ' PRO . 57.9 t -138.3 123.87 24.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 71.57 156.94 2.65 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.779 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' 1069 ' ' GLU . 41.4 tt0 30.32 65.81 0.85 Allowed Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.662 ' HA ' HD21 ' A' 1066 ' ' LEU . 88.1 Cg_endo -79.99 7.01 4.88 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.072 1.848 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 40.1 t -156.47 149.73 24.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.715 HD13 ' OH ' ' A' 1052 ' ' TYR . 25.2 pt -140.91 165.22 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.275 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.846 ' HB3' HG22 ' A' 1049 ' ' VAL . 9.9 p90 -151.58 138.72 19.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.386 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.857 ' HB3' ' HA3' ' A' 1047 ' ' GLY . 41.2 t -76.84 133.43 39.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 5.2 t -90.01 -35.05 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 73.4 m 61.84 135.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.82 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.699 HD21 HD11 ' A' 1083 ' ' ILE . 0.1 OUTLIER -175.25 -137.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.298 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' 1079 ' ' ASP . 27.6 t70 53.1 -138.53 1.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . 0.453 ' H ' ' CG ' ' A' 1078 ' ' ASP . 1.6 m-20 -92.44 -49.22 6.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.983 0.42 . . . . 0.0 110.446 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -179.86 31.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.432 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 41.3 t -87.21 -45.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 67.51 124.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.217 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.699 HD11 HD21 ' A' 1077 ' ' ASN . 0.2 OUTLIER -153.96 137.32 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 11.0 m95 -70.68 126.94 30.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 44.8 t -70.96 -39.56 72.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -62.28 122.77 29.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.166 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 17.9 Cg_exo -67.15 -121.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.298 2.665 . . . . 0.0 112.093 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' 1087 ' ' PRO . . . -160.85 129.34 2.97 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.594 ' HB2' ' O ' ' A' 1067 ' ' VAL . 73.3 Cg_endo -74.76 -141.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.885 2.39 . . . . 0.0 113.486 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.651 HE21 HG23 ' A' 1092 ' ' ILE . 57.1 tp60 -152.39 127.28 9.61 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.439 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 44.6 t -103.11 123.49 46.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.651 HG23 HE21 ' A' 1090 ' ' GLN . 11.8 pt . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -168.38 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 41.99 36.97 0.73 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.709 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 41.36 38.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.23 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.791 ' HG3' ' HB2' ' A' 1011 ' ' ALA . 0.4 OUTLIER 61.32 125.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.398 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.3 p -157.97 135.21 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.521 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 980' ' ' ILE . 2.9 p -84.71 148.65 26.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.171 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -63.64 140.16 58.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 -179.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 73.9 m -60.72 126.07 84.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.378 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 19.7 Cg_exo -66.87 121.5 8.71 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.47 2.113 . . . . 0.0 112.329 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 133.92 26.84 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.412 2.075 . . . . 0.0 111.676 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.26 109.4 1.41 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.769 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 971' ' ' ASN . 68.7 Cg_endo -87.83 -153.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.758 2.305 . . . . 0.0 112.605 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' 1021 ' ' GLN . 2.2 p -49.42 88.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.32 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 969' ' ' PRO . 74.3 m-20 45.28 34.21 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.157 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.746 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -76.3 -56.88 4.15 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.786 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.631 ' HB2' ' HB2' ' A' ' 989' ' ' SER . 60.8 mtt 61.04 96.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.751 HG21 HD12 ' A' ' 986' ' ' ILE . 0.3 OUTLIER -92.99 143.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.374 179.278 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.4 ' HD2' ' C ' ' A' ' 974' ' ' VAL . 26.0 m170 -122.07 111.61 17.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.442 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.885 ' HA ' HG22 ' A' ' 986' ' ' ILE . 69.6 t -67.45 99.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.94 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 986' ' ' ILE . 41.8 mm -75.23 -90.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.685 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 35.0 p -65.59 -60.43 2.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.211 0.529 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.604 ' O ' HG13 ' A' ' 976' ' ' VAL . 7.5 t0 -167.49 -128.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.982 178.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.469 ' O ' ' SG ' ' A' ' 963' ' ' CYS . 5.2 pt -154.76 -21.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.742 0.306 . . . . 0.0 110.313 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' 1004 ' ' CYS . 23.5 pt20 -72.43 -164.29 0.14 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.684 HG22 HD21 ' A' 1006 ' ' LEU . 40.4 t -47.27 137.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 64.81 12.41 53.58 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.416 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' 1003 ' ' GLU . 87.7 p -77.0 171.06 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.199 0.5 . . . . 0.0 110.684 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.746 ' HD3' ' N ' ' A' ' 986' ' ' ILE . 0.0 OUTLIER -151.14 138.23 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.967 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.885 HG22 ' HA ' ' A' ' 976' ' ' VAL . 28.2 pt -142.7 173.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 111.538 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' 1000 ' ' SER . 69.6 p -136.98 124.8 22.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.61 ' HB2' ' HA ' ' A' 1000 ' ' SER . 24.6 m-85 -87.17 47.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.922 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 66.9 m 30.03 -77.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.685 ' SG ' HD13 ' A' ' 996' ' ' LEU . 33.8 m 67.02 70.65 0.38 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 1.2 t -60.16 154.54 19.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 11.0 t 38.94 -156.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 113.626 -1.625 . . . . 0.0 113.39 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -80.29 50.23 3.95 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.199 -0.455 . . . . 0.0 113.829 -178.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -82.67 149.8 27.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.85 0.325 . . . . 0.0 110.907 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.765 ' HB2' HG12 ' A' 1023 ' ' ILE . 79.5 ttt180 -80.26 93.2 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.874 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 997' ' ' ILE . 4.7 tp -76.05 124.6 27.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 996' ' ' LEU . 1.8 mp -98.15 137.55 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.128 178.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.46 ' O ' ' CD2' ' A' ' 999' ' ' HIS . . . 76.76 -118.66 5.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.481 -178.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.493 ' HB2' ' HB ' ' A' 1015 ' ' THR . 19.0 m170 -149.36 130.95 14.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.085 0.443 . . . . 0.0 111.278 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.61 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 88.1 p -79.95 34.0 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.351 0.596 . . . . 0.0 109.817 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.587 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 79.6 p -162.2 138.56 7.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.888 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.638 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -160.45 141.63 12.14 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 984' ' ' SER . 21.5 pt-20 -105.06 132.86 50.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.599 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 8.3 t -71.3 84.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -179.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' 1014 ' ' SER . 18.8 pt -87.27 158.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.684 HD21 HG22 ' A' ' 982' ' ' VAL . 3.3 mm? -95.31 136.18 35.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.67 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.609 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -162.43 131.02 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.18 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 58.44 39.02 92.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.86 36.31 27.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.676 0.274 . . . . 0.0 111.464 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.1 m -151.25 129.83 12.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.578 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.791 ' HB2' ' HG3' ' A' ' 961' ' ' LYS . . . -75.64 136.79 40.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.098 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.609 ' NE2' ' HB3' ' A' 1007 ' ' SER . 7.6 p80 -163.06 156.51 19.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.942 0.401 . . . . 0.0 111.105 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.577 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 29.6 m95 -74.35 118.28 17.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.517 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.517 ' HB3' HD13 ' A' 1005 ' ' ILE . 79.7 p -52.41 -22.37 4.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.239 -178.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.638 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 53.7 p -105.05 20.92 18.0 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' 1015 ' ' THR . 21.7 ptmt 47.49 165.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.46 107.15 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.121 1.88 . . . . 0.0 111.903 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' 1016 ' ' LYS . 90.5 Cg_endo -82.37 168.14 14.99 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.786 2.324 . . . . 0.0 112.352 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.677 HG13 ' HB ' ' A' ' 997' ' ' ILE . 18.1 pt -148.85 118.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.408 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.746 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 1.9 m -86.39 73.24 10.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.734 ' HA ' HG21 ' A' ' 970' ' ' VAL . 3.5 pt20 -71.73 -166.91 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.691 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' 1024 ' ' PRO . 38.4 ptt180 -96.94 136.18 37.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.765 HG12 ' HB2' ' A' ' 995' ' ' ARG . 53.6 mt -79.19 106.32 4.34 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.502 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' 1045 ' ' HIS . 45.6 Cg_endo -67.43 135.48 36.64 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.825 179.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.772 ' HB3' ' H ' ' A' 1075 ' ' THR . 3.4 p -87.62 144.03 26.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.739 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.15 174.32 53.34 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.074 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.406 ' HA ' ' CE2' ' A' 1044 ' ' PHE . 14.4 mt -53.49 150.03 13.53 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.906 0.353 . . . . 0.0 111.142 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.439 ' CB ' ' HD2' ' A' 1029 ' ' PRO . 19.0 Cg_endo -59.74 174.75 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.987 ' HD3' ' HA ' ' A' 1085 ' ' SER . 56.6 Cg_endo -68.56 -0.78 6.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.933 2.422 . . . . 0.0 112.62 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' 1029 ' ' PRO . 70.8 p 55.71 145.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.946 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.65 HD12 ' HB1' ' A' 1088 ' ' ALA . 13.8 tt -151.1 112.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.364 0.602 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -66.88 155.73 37.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.76 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' 1032 ' ' ALA . 69.1 m-20 75.53 -40.57 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.685 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.516 ' HA2' ' CA ' ' A' 1054 ' ' CYS . . . -70.69 -157.13 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.953 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' 1053 ' ' ARG . 55.3 m-20 -160.01 135.91 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.465 ' HE1' ' O ' ' A' 1038 ' ' SER . 0.1 OUTLIER -84.03 148.36 26.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.435 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' 1051 ' ' THR . 67.7 mt -121.78 148.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.36 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.465 ' O ' ' HE1' ' A' 1036 ' ' PHE . 11.7 t 75.93 -136.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.727 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . . . . . . . . . 45.7 p -100.82 130.79 46.89 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.495 HD22 ' HB ' ' A' 1050 ' ' VAL . 22.2 t-20 -179.71 68.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.249 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.483 ' N ' ' HE1' ' A' 1044 ' ' PHE . 32.0 ptt180 -170.38 105.6 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' 1041 ' ' ARG . 56.8 mt-10 69.24 -51.86 0.6 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' 1043 ' ' ASN . 0.0 OUTLIER -71.48 52.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.043 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.483 ' HE1' ' N ' ' A' 1041 ' ' ARG . 6.6 m-85 -88.5 148.93 23.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.732 0.777 . . . . 0.0 112.692 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.582 ' O ' ' SG ' ' A' 1074 ' ' CYS . 14.3 p-80 -166.88 179.03 5.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.264 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.839 ' HE1' HG11 ' A' 1081 ' ' VAL . 4.1 t80 -65.44 31.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' 1045 ' ' HIS . . . -161.19 104.4 0.24 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.379 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' 1074 ' ' CYS . 79.7 p 177.48 145.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.552 0.691 . . . . 0.0 111.585 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' 1072 ' ' ILE . 6.6 p -137.79 146.23 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' 1040 ' ' ASN . 7.6 p -137.71 133.5 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.968 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' 1037 ' ' ILE . 91.3 m -102.48 134.22 46.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.401 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.47 ' HD2' HD13 ' A' 1031 ' ' ILE . 0.4 OUTLIER -70.56 -167.15 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.174 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.601 ' HB3' ' HB2' ' A' 1035 ' ' ASP . 6.0 tpm_? -159.62 -41.39 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.516 ' CA ' ' HA2' ' A' 1034 ' ' GLY . 88.2 m 68.4 121.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.815 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.629 ' HB3' ' HB2' ' A' 1064 ' ' PHE . 19.0 t-20 21.66 -118.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.615 0.572 . . . . 0.0 112.068 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.692 ' HA ' HG23 ' A' 1063 ' ' VAL . 93.4 mt 62.18 117.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.106 0.479 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . . . . . . . . . . . -100.66 129.56 9.94 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.572 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 15.7 t 72.73 -47.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.428 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.679 ' O ' ' HB3' ' A' 1056 ' ' LEU . 8.6 ttt85 -162.61 -135.51 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.244 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.494 ' H ' ' HG2' ' A' 1059 ' ' ARG . . . -88.62 46.6 3.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.202 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' 1061 ' ' ARG . 17.9 mmt85 -62.24 157.41 19.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.621 0.248 . . . . 0.0 111.197 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.57 71.7 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.994 0.426 . . . . 0.0 110.847 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' 1056 ' ' LEU . 4.0 m -154.51 86.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' 1055 ' ' ASN . 0.4 OUTLIER 70.1 143.42 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.69 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . 0.442 ' HB2' ' OXT' ' A' 1092 ' ' ILE . 49.4 mt-10 -141.98 139.53 32.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' 1067 ' ' VAL . 2.2 tt -68.38 133.06 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.064 0.459 . . . . 0.0 111.397 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.884 ' N ' HD23 ' A' 1066 ' ' LEU . 47.1 t -138.24 129.73 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 93.89 -133.06 11.47 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.681 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.742 ' HB3' ' HD3' ' A' 1089 ' ' PRO . 37.0 tt0 -57.11 106.06 0.62 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 117.153 0.476 . . . . 0.0 111.131 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.743 ' HA ' HD11 ' A' 1066 ' ' LEU . 81.7 Cg_endo -96.24 -12.19 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.098 2.532 . . . . 0.0 113.968 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 52.8 m -156.16 167.45 30.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.412 0.625 . . . . 0.0 112.268 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' 1049 ' ' VAL . 18.4 pt -141.22 157.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.637 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 4.4 p90 -117.7 149.71 40.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' 1045 ' ' HIS . 37.2 t -61.61 159.19 13.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.188 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.899 HG21 ' H ' ' A' 1084 ' ' TRP . 15.0 t -157.59 -150.61 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . 1.14 ' HB2' ' HB ' ' A' 1081 ' ' VAL . 47.2 t -89.79 -107.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 112.339 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.771 HD22 ' N ' ' A' 1077 ' ' ASN . 0.0 OUTLIER -174.62 -30.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.317 -177.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.765 ' H ' HD22 ' A' 1077 ' ' ASN . 54.4 t0 177.47 -9.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.353 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.92 -141.05 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.951 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.7 -52.47 51.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 1.14 ' HB ' ' HB2' ' A' 1076 ' ' SER . 19.7 t -56.98 -24.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.731 ' C ' HD13 ' A' 1083 ' ' ILE . . . 80.75 -140.19 21.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.215 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.731 HD13 ' C ' ' A' 1082 ' ' GLY . 0.0 OUTLIER -149.75 138.16 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.472 0.653 . . . . 0.0 112.639 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.899 ' H ' HG21 ' A' 1075 ' ' THR . 0.2 OUTLIER -77.38 -114.76 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.567 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . 0.987 ' HA ' ' HD3' ' A' 1029 ' ' PRO . 30.6 t 69.52 59.14 0.31 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' 1088 ' ' ALA . . . -59.22 124.36 36.34 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.688 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' 1088 ' ' ALA . 23.9 Cg_exo -64.54 22.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.329 2.019 . . . . 0.0 113.749 -178.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' 1031 ' ' ILE . . . 53.88 139.22 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 113.112 178.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' 1069 ' ' GLU . 84.7 Cg_endo -76.11 -122.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.762 2.308 . . . . 0.0 110.725 178.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.884 HE21 ' HB ' ' A' 1067 ' ' VAL . 1.8 pm0 -152.41 143.48 23.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.939 178.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 3.6 m -103.13 133.91 47.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.442 ' OXT' ' HB2' ' A' 1065 ' ' GLU . 23.4 pt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.112 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -171.78 -138.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.041 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -172.16 134.89 0.74 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.745 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -78.55 46.45 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.803 ' HG2' HD11 ' A' 1006 ' ' LEU . 55.3 tptt -77.61 150.01 34.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.396 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.53 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 64.1 p -157.42 154.74 29.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.494 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 90.0 m -79.31 159.6 27.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.094 179.446 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -63.88 132.96 52.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 0.0 111.039 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 59.9 m -73.14 112.87 17.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.038 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.506 ' HG2' HG21 ' A' ' 974' ' ' VAL . 30.8 Cg_exo -61.84 123.46 12.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.242 1.961 . . . . 0.0 111.963 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.83 -50.78 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.263 1.975 . . . . 0.0 111.497 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 179.26 115.32 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.679 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 32.2 Cg_endo -66.03 144.73 77.1 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.462 2.108 . . . . 0.0 111.969 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.847 HG11 HG13 ' A' 1019 ' ' ILE . 0.2 OUTLIER -44.97 116.92 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.888 179.879 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.577 HD22 ' HB3' ' A' 1020 ' ' CYS . 14.8 t30 70.94 -50.31 0.68 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -77.93 -152.53 5.71 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.392 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 24.0 ptm -159.2 133.36 7.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.506 HG21 ' HG2' ' A' ' 966' ' ' PRO . 3.3 p -81.91 146.76 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.454 ' O ' ' HB ' ' A' ' 986' ' ' ILE . 22.2 m170 -123.54 105.24 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 1.057 HG13 HG23 ' A' ' 980' ' ' ILE . 52.1 t -65.31 -65.74 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 976' ' ' VAL . 47.9 mt 75.31 -51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.255 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 984' ' ' SER . 45.6 p -86.62 -80.91 0.23 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.002 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.614 ' O ' HG12 ' A' ' 980' ' ' ILE . 9.2 t70 -173.35 -18.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.404 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 1.057 HG23 HG13 ' A' ' 976' ' ' VAL . 28.6 pt 54.97 72.46 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.21 0.604 . . . . 0.0 111.419 -178.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 24.3 mt-30 -152.63 38.89 0.54 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.667 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 76.6 t 101.06 133.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.924 0.889 . . . . 0.0 112.096 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 71.79 -29.93 0.62 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.361 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.598 ' HB2' ' OG1' ' A' ' 978' ' ' THR . 79.9 p -68.45 124.01 22.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.437 ' C ' ' HD2' ' A' ' 985' ' ' ARG . 5.1 tmm_? -101.64 118.85 37.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.558 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 975' ' ' HIS . 28.7 pt -95.42 -169.0 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.312 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' 1001 ' ' SER . 35.2 p -153.01 128.71 10.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.544 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.0 m-85 -93.95 149.8 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.024 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.0 m -157.35 133.43 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.688 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 9.1 m -82.02 -131.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 110.693 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.417 ' O ' ' ND1' ' A' ' 994' ' ' HIS . 1.2 t -165.02 159.24 17.74 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.796 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 992' ' ' THR . 50.8 m 37.66 54.12 1.47 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.972 0.891 . . . . 0.0 110.266 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 994' ' ' HIS . . . 78.85 -99.53 1.66 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.957 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.578 ' HB3' ' SG ' ' A' 1020 ' ' CYS . 24.9 m80 54.85 140.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.892 0.477 . . . . 0.0 111.53 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -89.86 106.5 18.51 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.229 -0.294 . . . . 0.0 111.018 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' 1000 ' ' SER . 1.7 tt -76.15 121.23 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.8 ' HB ' HG23 ' A' 1019 ' ' ILE . 38.6 mm -89.16 153.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.832 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.77 -112.54 3.53 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.732 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' 1001 ' ' SER . 92.1 m-70 -149.72 133.75 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 111.402 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 996' ' ' LEU . 81.2 p -80.61 30.25 0.3 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 61.3 m -162.14 151.24 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -157.59 127.49 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.577 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 44.7 tt0 -103.57 126.8 50.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.598 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.584 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 41.9 t -73.56 126.52 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.537 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 20.8 pt -147.41 155.32 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.803 HD11 ' HG2' ' A' ' 961' ' ' LYS . 3.8 mm? -92.36 146.33 23.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.292 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.531 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 44.7 t -162.44 -58.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -94.2 47.4 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.129 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.43 ' N ' HD22 ' A' 1009 ' ' ASN . 2.6 m120 60.49 13.84 4.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.037 0.446 . . . . 0.0 110.512 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.784 ' HA ' ' HE2' ' A' ' 961' ' ' LYS . 89.2 m -151.25 146.21 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.571 179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.584 ' HB1' ' SG ' ' A' 1004 ' ' CYS . . . -75.29 134.14 41.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.96 0.409 . . . . 0.0 110.714 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' 1007 ' ' SER . 8.1 p80 -152.18 146.34 25.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.402 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.747 ' HB3' ' HB1' ' A' 1002 ' ' ALA . 57.0 m95 -70.13 124.85 25.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.7 t -52.52 -25.44 10.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 77.1 p -92.2 137.82 32.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.065 0.459 . . . . 0.0 112.046 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.64 ' NZ ' ' HB3' ' A' 1016 ' ' LYS . 0.2 OUTLIER -62.19 152.5 78.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.272 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -43.9 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.54 147.77 92.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.052 2.502 . . . . 0.0 112.413 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.847 HG13 HG11 ' A' ' 970' ' ' VAL . 5.5 tt -148.01 122.8 2.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 994' ' ' HIS . 4.4 t -86.36 113.66 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.121 0.486 . . . . 0.0 111.411 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -84.75 130.1 34.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.971 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' 1022 ' ' ARG . 0.0 OUTLIER -82.07 124.25 29.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.319 179.319 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' 1045 ' ' HIS . 64.1 mt -71.8 112.71 15.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.412 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.545 ' HG3' HH12 ' A' 1022 ' ' ARG . 34.4 Cg_exo -61.6 133.21 44.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.831 2.354 . . . . 0.0 113.063 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.742 ' HA ' ' HA3' ' A' 1082 ' ' GLY . 92.4 m -98.39 -150.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.451 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' 1025 ' ' CYS . . . -163.84 156.23 27.98 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.522 HD12 ' H ' ' A' 1027 ' ' LEU . 8.7 mp -40.3 132.17 1.63 Allowed Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.161 0.481 . . . . 0.0 111.459 -179.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.55 ' HB2' HD11 ' A' 1072 ' ' ILE . 54.4 Cg_endo -69.8 155.44 65.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.0 102.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.088 1.859 . . . . 0.0 111.363 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 49.3 p -77.39 118.35 19.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.661 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.78 HD13 ' HB2' ' A' 1089 ' ' PRO . 10.4 pt -93.63 116.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.474 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -49.54 141.0 9.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.722 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' 1054 ' ' CYS . 5.1 m120 74.91 -13.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . . . . . . . . . . . -64.58 -140.62 0.02 OUTLIER Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.273 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' 1053 ' ' ARG . 30.4 t70 -168.9 -168.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.561 -0.376 . . . . 0.0 110.842 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.817 ' HD1' HG23 ' A' 1050 ' ' VAL . 1.2 t80 -155.99 127.52 7.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.882 HD12 ' HD2' ' A' 1053 ' ' ARG . 52.5 mt -147.78 77.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.791 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . . . . . . . . . 68.8 m -160.32 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.003 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.414 HG22 ' O ' ' A' 1039 ' ' THR . 7.0 m -136.99 41.67 2.47 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.599 ' ND2' ' HB ' ' A' 1050 ' ' VAL . 5.0 m120 -72.01 -99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.762 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 60.85 48.46 6.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.63 ' HG2' ' H ' ' A' 1043 ' ' ASN . 66.9 tt0 62.95 -136.37 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.63 ' H ' ' HG2' ' A' 1042 ' ' GLU . 23.2 p30 34.23 44.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' 1042 ' ' GLU . 88.4 m-85 -77.48 147.88 35.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.401 . . . . 0.0 111.533 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' 1046 ' ' TYR . 79.3 m-70 -147.13 -49.79 0.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.48 179.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.647 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 53.9 t80 171.87 149.03 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.303 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . 78.71 -17.63 6.64 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.888 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 58.8 m -47.72 144.55 3.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.85 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' 1072 ' ' ILE . 12.8 p -137.79 148.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.273 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.817 HG23 ' HD1' ' A' 1036 ' ' PHE . 2.5 p -143.13 136.11 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.253 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . . . . . . . . . 87.8 m -106.54 111.97 24.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.449 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.554 ' HE1' HG12 ' A' 1072 ' ' ILE . 11.4 m-85 -85.25 142.18 29.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.882 ' HD2' HD12 ' A' 1037 ' ' ILE . 99.9 mtt180 -156.44 30.76 0.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.795 ' O ' HD22 ' A' 1056 ' ' LEU . 71.3 m 59.13 143.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 0.0 111.739 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . . . . . . . . . 8.9 m120 -65.86 97.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.795 HD22 ' O ' ' A' 1054 ' ' CYS . 3.2 mm? -70.37 177.23 3.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.593 178.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' 1063 ' ' VAL . . . -82.74 -28.49 38.38 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 179.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 52.5 m -160.07 -29.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.69 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . . . . . . . . . 33.9 tpt85 -163.83 -45.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.526 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.544 ' HA2' ' HG ' ' A' 1056 ' ' LEU . . . 178.61 43.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.775 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -77.3 46.76 0.52 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.633 0.254 . . . . 0.0 111.625 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . . . . . . . . . 87.7 tttt 44.61 81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.173 0.511 . . . . 0.0 111.703 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' 1056 ' ' LEU . 3.3 m -155.13 95.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.465 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.701 ' HB3' ' SG ' ' A' 1091 ' ' CYS . 65.8 m-85 72.82 136.44 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.437 -178.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -141.09 130.04 23.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.308 0.575 . . . . 0.0 111.693 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.828 HD21 ' HA ' ' A' 1070 ' ' PRO . 35.5 tp -68.47 158.87 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.839 HG21 HD11 ' A' 1092 ' ' ILE . 75.4 t -139.39 143.82 30.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.527 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.72 -144.56 26.66 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.12 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' 1089 ' ' PRO . 79.4 tt0 -60.41 127.81 87.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.817 0.309 . . . . 0.0 110.623 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.828 ' HA ' HD21 ' A' 1066 ' ' LEU . 26.0 Cg_endo -92.3 -54.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.813 2.342 . . . . 0.0 112.802 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . . . . . . . . . 41.7 t -98.85 152.86 19.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.579 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.663 ' O ' HG23 ' A' 1049 ' ' VAL . 31.5 pt -141.42 162.06 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.258 179.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . . . . . . . . . 6.3 p90 -151.02 141.14 22.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.417 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 46.9 t -65.11 152.41 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.233 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . 0.443 ' C ' ' HE1' ' A' 1046 ' ' TYR . 13.1 t -140.09 -147.41 0.22 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.021 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 47.6 t -153.28 145.79 24.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.972 0.415 . . . . 0.0 111.537 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.693 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -162.7 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.064 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.693 ' H ' HD22 ' A' 1077 ' ' ASN . 1.2 m-20 -77.22 -147.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.568 0.223 . . . . 0.0 110.626 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -83.61 -45.38 13.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.286 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -178.22 30.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.737 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.495 ' HB ' ' CD1' ' A' 1083 ' ' ILE . 43.7 t -77.25 -34.84 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 85.37 61.37 1.73 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.994 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' 1083 ' ' ILE . 2.1 mp -81.99 135.11 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.93 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 14.4 m95 -72.57 -173.93 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.978 0.418 . . . . 0.0 112.003 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 47.3 t -59.51 -71.24 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.149 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . . . . . . . . . . . 178.63 137.43 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.308 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.93 136.23 34.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.735 ' H ' ' HD2' ' A' 1089 ' ' PRO . . . -167.6 -44.99 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.78 ' HB2' HD13 ' A' 1031 ' ' ILE . 63.3 Cg_exo -48.23 137.98 23.38 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.122 1.881 . . . . 0.0 112.138 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.441 HE21 ' HB2' ' A' 1090 ' ' GLN . 0.3 OUTLIER -149.7 134.57 17.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 0.0 111.619 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' 1064 ' ' PHE . 29.1 t -90.67 132.54 35.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.839 HD11 HG21 ' A' 1067 ' ' VAL . 39.2 pt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.074 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.675 0.274 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -175.3 -134.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.662 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 57.53 47.41 16.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.192 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . -164.2 39.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.918 ' HD2' ' H ' ' A' ' 961' ' ' LYS . 0.0 OUTLIER -79.18 132.02 36.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.878 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 80.7 p -92.44 135.57 33.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.728 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 80.9 m -81.1 26.42 0.44 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.037 0.446 . . . . 0.0 110.652 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 962' ' ' SER . 59.6 tttm 61.12 136.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.573 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.854 ' HA ' HG21 ' A' ' 980' ' ' ILE . 4.7 t -58.06 129.11 82.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.148 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 1.013 ' HG2' HG11 ' A' ' 974' ' ' VAL . 55.7 Cg_endo -69.72 107.2 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.115 1.877 . . . . 0.0 112.197 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' A' ' 966' ' ' PRO . 10.4 Cg_endo -53.47 143.68 54.26 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.546 2.164 . . . . 0.0 111.078 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -40.4 113.33 0.95 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.171 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.809 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 24.2 Cg_exo -64.03 148.24 91.54 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.044 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 971' ' ' ASN . 0.2 OUTLIER -43.92 114.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.458 179.853 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.539 ' HB3' ' O ' ' A' ' 970' ' ' VAL . 7.7 t30 71.01 -57.45 0.6 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.096 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 990' ' ' CYS . . . -70.06 -162.47 3.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.978 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.809 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 88.5 mtp -158.15 140.12 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 1.013 HG11 ' HG2' ' A' ' 966' ' ' PRO . 2.8 p -83.66 148.85 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.592 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -109.81 87.15 2.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.997 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.519 ' HA ' HG22 ' A' ' 986' ' ' ILE . 58.4 t -65.45 109.85 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 29.3 mm -75.14 -83.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.909 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 40.4 p -81.42 -61.04 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.266 0.555 . . . . 0.0 109.979 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 976' ' ' VAL . 4.3 p-10 -165.94 -130.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.558 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.854 HG21 ' HA ' ' A' ' 965' ' ' THR . 0.2 OUTLIER -144.97 10.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 111.109 178.871 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.771 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 26.0 mt-30 -85.68 171.76 11.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.988 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.1 t -44.31 143.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 78.2 -31.25 1.83 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.276 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 36.2 m -68.4 124.02 22.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.028 0.414 . . . . 0.0 110.928 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.788 ' HD2' ' N ' ' A' ' 986' ' ' ILE . 5.5 tmm_? -101.63 152.2 21.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.562 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.788 ' N ' ' HD2' ' A' ' 985' ' ' ARG . 38.3 pt -142.25 138.41 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 80.8 p -107.53 125.68 51.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.682 ' HB2' ' HA ' ' A' 1000 ' ' SER . 5.2 m-85 -92.08 149.24 21.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.761 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 50.9 m -159.93 121.3 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.075 0.464 . . . . 0.0 111.335 179.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.6 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 85.0 m -99.91 155.15 17.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 35.9 p -61.6 161.16 10.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.089 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 47.1 m -57.45 145.68 32.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.695 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.59 -45.62 1.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.184 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.58 ' CD2' ' HA ' ' A' 1022 ' ' ARG . 7.5 m80 -82.45 136.06 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.758 0.313 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.582 ' HB2' HD11 ' A' 1023 ' ' ILE . 44.0 ttm-85 -82.03 130.47 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.619 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.703 ' HA ' ' SG ' ' A' 1020 ' ' CYS . 0.9 OUTLIER -76.11 126.91 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.058 0.456 . . . . 0.0 111.59 -179.474 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.591 ' HB ' HG13 ' A' 1019 ' ' ILE . 1.7 mp -107.14 148.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.443 178.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 82.44 -119.35 4.84 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.021 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.42 ' C ' ' H ' ' A' 1001 ' ' SER . 92.0 m-70 -149.67 133.53 16.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.132 0.466 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.682 ' HA ' ' HB2' ' A' ' 988' ' ' TYR . 80.2 p -78.44 30.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.2 p -162.19 140.07 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.356 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -164.13 131.12 3.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.603 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -104.94 137.52 42.57 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.502 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 53.4 t -71.1 131.69 43.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' 1011 ' ' ALA . 45.9 pt -148.04 -165.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 111.285 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.616 HD21 ' HD3' ' A' ' 961' ' ' LYS . 3.9 mm? -99.04 163.42 12.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.648 ' HB3' ' HD2' ' A' 1012 ' ' HIS . 47.4 t -162.51 -116.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -49.96 -43.86 40.58 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.779 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 43.9 t30 -167.73 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 110.981 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 7.7 t -96.48 -162.52 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.227 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.728 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -80.05 139.11 37.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.996 0.426 . . . . 0.0 110.925 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.648 ' HD2' ' HB3' ' A' 1007 ' ' SER . 94.5 m-70 -149.4 140.03 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 89.3 m95 -66.71 133.6 50.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.069 0.461 . . . . 0.0 110.956 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 87.7 p -52.33 -23.97 6.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.883 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.0 p -121.4 140.37 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 111.695 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -54.26 151.73 12.84 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.083 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.02 105.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.321 2.014 . . . . 0.0 112.028 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.15 143.72 96.35 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.603 2.202 . . . . 0.0 111.942 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.591 HG13 ' HB ' ' A' ' 997' ' ' ILE . 36.5 pt -138.67 -171.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 89.9 m -153.78 131.4 11.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.506 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.512 ' HG2' HD11 ' A' ' 997' ' ' ILE . 98.2 mm-40 -80.32 132.31 35.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 994' ' ' HIS . 15.7 ptp180 -67.98 -25.17 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.86 ' HA ' HE22 ' A' 1080 ' ' GLN . 46.4 mt 59.96 73.11 0.68 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.833 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.706 ' HA ' ' HA ' ' A' 1045 ' ' HIS . 78.1 Cg_exo -49.8 126.98 17.78 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.362 2.041 . . . . 0.0 112.447 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . . . . . . . . . 23.8 t -88.49 147.18 24.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.661 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . -76.07 142.66 28.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.64 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' 1028 ' ' PRO . 28.4 tp -54.73 131.41 65.37 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 1.012 ' HB3' HD11 ' A' 1072 ' ' ILE . 67.0 Cg_exo -52.6 153.77 13.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.195 2.597 . . . . 0.0 112.821 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' 1088 ' ' ALA . 37.4 Cg_exo -58.98 127.83 25.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.353 2.035 . . . . 0.0 111.664 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . . . . . . . . . 24.5 p -77.47 142.24 39.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.206 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' 1031 ' ' ILE . 29.7 pt -140.37 123.07 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.417 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -48.42 141.74 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.278 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' 1032 ' ' ALA . 5.1 m120 75.63 -37.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.765 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -65.04 121.13 20.77 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.4 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.542 ' HB3' ' HG2' ' A' 1053 ' ' ARG . 35.5 t0 -82.23 -158.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.841 ' HZ ' ' HA ' ' A' 1041 ' ' ARG . 0.0 OUTLIER -157.18 142.67 17.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 111.339 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.895 HD11 ' HD3' ' A' 1053 ' ' ARG . 6.9 mt -149.69 -138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.851 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.677 ' H ' HG22 ' A' 1037 ' ' ILE . 58.2 m 71.81 -163.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.499 HG23 ' N ' ' A' 1040 ' ' ASN . 7.9 t -73.66 -46.63 45.37 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.689 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.564 ' ND2' ' HH2' ' A' 1084 ' ' TRP . 73.0 m-80 -54.06 151.13 7.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.18 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.841 ' HA ' ' HZ ' ' A' 1036 ' ' PHE . 83.1 mtm180 -143.02 -48.57 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.256 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' 1043 ' ' ASN . 0.1 OUTLIER -162.94 145.24 10.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.48 179.656 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' 1042 ' ' GLU . 2.7 m120 82.13 -46.59 0.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.517 ' HD2' ' HZ2' ' A' 1084 ' ' TRP . 1.1 m-85 54.82 57.07 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.738 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.706 ' HA ' ' HA ' ' A' 1024 ' ' PRO . 50.6 m170 -52.52 -44.65 65.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.454 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.6 ' HB2' ' O ' ' A' 1045 ' ' HIS . 9.7 t80 166.89 70.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.999 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -77.59 -77.02 0.85 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.935 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 4.3 m 167.71 -53.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' 1073 ' ' TYR . 20.4 t -147.56 153.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.658 HG11 ' HG2' ' A' 1028 ' ' PRO . 10.4 p -135.65 120.22 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.3 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' A' 1071 ' ' SER . 91.4 m -93.85 126.37 39.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.391 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' 1053 ' ' ARG . 13.2 m-85 -82.42 -41.29 20.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.895 ' HD3' HD11 ' A' 1037 ' ' ILE . 17.2 ptt180 66.5 -34.04 0.2 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.165 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.665 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 83.9 m 66.95 135.53 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.723 ' HB2' ' HA ' ' A' 1063 ' ' VAL . 2.2 m120 21.58 -105.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' 1061 ' ' ARG . 0.2 OUTLIER -154.9 139.36 16.83 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.96 0.409 . . . . 0.0 111.032 -179.225 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.542 ' O ' ' HG2' ' A' 1061 ' ' ARG . . . -88.92 -48.44 3.86 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.205 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . . . . . . . . . 66.7 m -102.3 -57.39 2.07 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.464 ' O ' HD22 ' A' 1056 ' ' LEU . 27.2 mtt85 -76.98 117.41 18.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.405 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . . . . . . . . . . . 74.49 -37.7 1.01 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.77 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' 1056 ' ' LEU . 0.0 OUTLIER 62.3 -139.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.483 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.522 ' H ' ' CD ' ' A' 1061 ' ' ARG . 59.6 tttm 69.02 25.2 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.514 0.673 . . . . 0.0 110.053 -178.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' 1055 ' ' ASN . 11.7 p -84.86 23.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.787 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' 1064 ' ' PHE . 0.2 OUTLIER 39.24 -131.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.086 0.47 . . . . 0.0 109.932 179.459 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -132.1 123.79 27.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.919 178.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.611 HD21 ' CA ' ' A' 1070 ' ' PRO . 48.3 tp -68.85 129.04 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 111.678 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' 1090 ' ' GLN . 62.0 t -106.35 121.45 58.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.986 179.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 76.42 -147.58 34.48 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.548 179.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' 1069 ' ' GLU . 0.3 OUTLIER -69.01 131.3 90.89 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.611 ' CA ' HD21 ' A' 1066 ' ' LEU . 54.1 Cg_endo -70.77 -32.84 13.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 111.777 178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' 1051 ' ' THR . 80.4 p -142.58 132.01 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.363 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 1.012 HD11 ' HB3' ' A' 1028 ' ' PRO . 18.4 pt -87.81 -167.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.167 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.85 ' HB3' HG22 ' A' 1049 ' ' VAL . 7.9 p90 -158.89 137.37 10.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 0.0 112.072 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 49.0 t -76.7 164.0 26.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.915 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 6.5 t -155.04 -33.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 89.8 p 58.97 148.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.303 0.377 . . . . 0.0 110.904 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.74 ' ND2' HD11 ' A' 1083 ' ' ILE . 0.0 OUTLIER -164.81 -30.1 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.716 ' H ' HD22 ' A' 1077 ' ' ASN . 62.2 t0 -55.42 -87.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.708 0.29 . . . . 0.0 111.14 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -163.2 -38.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.86 HE22 ' HA ' ' A' 1023 ' ' ILE . 72.2 tp60 -166.22 51.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.701 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . . . . . . . . . 15.6 t -130.38 -48.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.568 -178.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . . . . . . . . . . . 66.28 125.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.989 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . 0.74 HD11 ' ND2' ' A' 1077 ' ' ASN . 0.2 OUTLIER -150.42 137.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.025 0.44 . . . . 0.0 111.141 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.564 ' HH2' ' ND2' ' A' 1040 ' ' ASN . 18.4 m95 -70.53 135.83 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.196 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 46.8 t -65.93 -50.93 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' 1072 ' ' ILE . . . -65.99 125.88 28.21 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.705 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.96 41.52 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.6 2.2 . . . . 0.0 112.817 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' 1029 ' ' PRO . . . 58.71 138.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.319 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' 1090 ' ' GLN . 84.6 Cg_endo -80.39 -150.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.748 2.299 . . . . 0.0 112.237 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.774 ' HG2' HG12 ' A' 1092 ' ' ILE . 35.0 tt0 -152.36 134.07 14.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.272 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . . . . . . . . . 37.0 m -91.96 78.6 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.795 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . 0.774 HG12 ' HG2' ' A' 1090 ' ' GLN . 46.0 pt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.442 179.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 57.03 -141.45 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 959' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -172.25 143.81 1.52 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 960' ' ' ALA . . . . . . . . . . . . . . . 54.26 42.28 31.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.672 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 961' ' ' LYS . 4.3 mptp? 61.63 159.07 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.407 0.623 . . . . 0.0 112.153 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.439 ' C ' ' HB3' ' A' 1011 ' ' ALA . 49.6 m -157.94 138.96 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.678 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.587 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -79.93 38.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 111.608 -179.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 55.6 tptt 63.68 130.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.564 ' HA ' HD12 ' A' ' 980' ' ' ILE . 88.8 m -74.43 130.04 82.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.733 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.712 ' HG2' HG11 ' A' ' 974' ' ' VAL . 68.8 Cg_endo -101.34 72.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.912 3.075 . . . . 0.0 113.38 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 968' ' ' ASP . 57.1 Cg_endo -70.02 125.9 12.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.985 1.79 . . . . 0.0 111.731 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 967' ' ' PRO . 59.0 m-20 16.5 62.8 0.18 Allowed Pre-proline 0 N--CA 1.467 0.378 0 O-C-N 123.759 0.662 . . . . 0.0 112.167 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.634 ' HD2' ' O ' ' A' ' 972' ' ' GLY . 39.2 Cg_exo -58.83 -143.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.002 2.468 . . . . 0.0 113.185 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' 1019 ' ' ILE . 4.0 p -49.05 85.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.819 -179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 969' ' ' PRO . 6.7 p-10 38.95 48.73 1.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.979 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.634 ' O ' ' HD2' ' A' ' 969' ' ' PRO . . . -162.44 128.57 1.9 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.805 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 22.2 ptm -88.77 135.92 33.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 111.548 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.81 HG21 HD12 ' A' ' 986' ' ' ILE . 4.1 p -91.56 146.85 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -107.59 96.71 6.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.24 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.781 ' HA ' HG22 ' A' ' 986' ' ' ILE . 14.0 m -65.37 113.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.298 0.57 . . . . 0.0 110.801 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 987' ' ' THR . 38.8 mt -79.92 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.315 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 32.1 p -149.33 54.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.572 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 980' ' ' ILE . 1.6 m-20 59.57 -154.32 0.37 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.942 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.629 HG22 ' HH2' ' A' 1013 ' ' TRP . 6.1 pt -155.91 95.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.117 0.484 . . . . 0.0 111.463 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 982' ' ' VAL . 24.0 mt-30 -152.62 28.98 0.54 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.55 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 981' ' ' GLN . 66.0 t 102.13 135.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 124.239 0.962 . . . . 0.0 111.099 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 74.34 -29.75 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.862 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 982' ' ' VAL . 49.7 m -68.4 132.93 47.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 111.058 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 977' ' ' ILE . 38.2 ttm180 -101.71 147.42 26.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.81 HD12 HG21 ' A' ' 974' ' ' VAL . 39.7 pt -143.14 134.08 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.17 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.738 ' HA ' ' HA ' ' A' 1001 ' ' SER . 80.3 p -100.72 122.96 44.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.597 ' O ' ' HB2' ' A' 1000 ' ' SER . 3.8 m-85 -88.36 120.47 29.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 80.9 p -88.82 -54.09 4.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.609 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 13.0 t 69.54 142.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -178.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.1 p -60.25 146.75 42.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.284 0.564 . . . . 0.0 111.849 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.1 t -52.99 -26.65 15.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.38 41.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.52 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -139.87 139.99 36.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.245 0.522 . . . . 0.0 111.413 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' 1080 ' ' GLN . 57.0 ttt-85 -81.97 125.62 30.98 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.029 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' 1018 ' ' PRO . 0.7 OUTLIER -72.78 140.37 47.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.226 0.536 . . . . 0.0 111.605 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' 1019 ' ' ILE . 45.6 mm -107.92 148.53 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 77.1 41.49 21.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.674 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 62.46 136.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 112.122 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 988' ' ' TYR . 82.7 p -79.16 36.36 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.439 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 46.2 m -158.58 160.61 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.471 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' 1013 ' ' TRP . . . -159.81 128.8 5.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.392 . . . . 0.0 111.892 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -104.99 125.16 50.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.116 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 31.1 t -68.8 129.3 39.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.731 0.3 . . . . 0.0 110.753 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.727 HD13 ' HB2' ' A' 1014 ' ' SER . 15.0 pt -138.51 152.52 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' 1007 ' ' SER . 0.3 OUTLIER -95.47 120.38 35.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.405 ' N ' HD13 ' A' 1006 ' ' LEU . 47.0 t -80.9 -45.17 17.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.363 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -166.09 -34.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.079 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -148.84 -49.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.15 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 86.8 m -99.75 135.87 40.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 179.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.587 ' HB1' ' SG ' ' A' ' 963' ' ' CYS . . . -75.36 143.05 43.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.268 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.417 ' N ' ' SG ' ' A' ' 963' ' ' CYS . 90.7 m-70 -149.45 142.94 25.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.629 ' HH2' HG22 ' A' ' 980' ' ' ILE . 79.3 m95 -68.14 116.71 9.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.105 0.478 . . . . 0.0 110.642 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.727 ' HB2' HD13 ' A' 1005 ' ' ILE . 47.2 t -52.42 -22.35 4.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.243 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.1 p -90.1 16.34 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.821 ' HA ' ' HE3' ' A' 1016 ' ' LYS . 0.0 OUTLIER 58.58 159.27 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.275 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.39 127.31 25.45 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.25 1.967 . . . . 0.0 112.104 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.626 ' HB2' HD21 ' A' ' 996' ' ' LEU . 67.2 Cg_endo -73.09 148.55 44.84 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.797 2.332 . . . . 0.0 112.371 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.965 ' HA ' HG11 ' A' ' 970' ' ' VAL . 6.4 tt -148.81 125.31 2.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.592 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 996' ' ' LEU . 61.7 m -85.45 101.28 12.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.493 . . . . 0.0 112.006 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.453 ' HB3' HD11 ' A' ' 997' ' ' ILE . 7.6 tt0 -79.7 140.06 37.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.112 178.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' 1022 ' ' ARG . 11.5 tpt180 -50.03 135.8 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.377 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' 1046 ' ' TYR . 26.6 mm -55.59 119.29 23.82 Favored Pre-proline 0 C--O 1.226 -0.157 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.368 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' 1045 ' ' HIS . 67.4 Cg_endo -92.37 138.5 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.184 2.589 . . . . 0.0 112.877 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1025 ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' 1046 ' ' TYR . 71.8 m -112.93 30.08 7.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.752 0.311 . . . . 0.0 111.622 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1026 ' ' GLY . . . . . . . . . . . . . . . 42.84 -138.03 3.26 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.776 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1027 ' ' LEU . . . . . 0.532 ' HB3' ' HD2' ' A' 1028 ' ' PRO . 19.9 mt -108.74 164.96 13.56 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1028 ' ' PRO . . . . . 0.618 ' HD3' ' CE2' ' A' 1044 ' ' PHE . 37.9 Cg_endo -66.0 152.22 81.91 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.72 2.28 . . . . 0.0 112.3 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1029 ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' A' 1030 ' ' THR . 86.1 Cg_exo -47.44 -29.2 9.69 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.626 2.217 . . . . 0.0 112.935 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1030 ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' 1029 ' ' PRO . 20.1 m 64.71 147.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.95 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1031 ' ' ILE . . . . . 0.536 ' HB ' ' HB1' ' A' 1088 ' ' ALA . 13.2 tt -152.47 125.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1032 ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' 1033 ' ' ASN . . . -65.75 135.62 55.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.518 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1033 ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' 1032 ' ' ALA . 4.4 m120 74.81 -38.19 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.574 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1034 ' ' GLY . . . . . 0.811 ' HA2' ' HA ' ' A' 1054 ' ' CYS . . . -64.66 121.6 22.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.699 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1035 ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' 1036 ' ' PHE . 9.6 t70 -74.46 163.34 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1036 ' ' PHE . . . . . 0.487 ' HB2' ' CG2' ' A' 1050 ' ' VAL . 29.9 p90 -144.31 136.35 26.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.204 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1037 ' ' ILE . . . . . 0.917 HG22 ' H ' ' A' 1038 ' ' SER . 5.7 mt -87.91 -160.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1038 ' ' SER . . . . . 0.917 ' H ' HG22 ' A' 1037 ' ' ILE . 57.0 m 55.26 -133.04 1.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1039 ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' 1041 ' ' ARG . 41.1 p -152.96 70.1 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1040 ' ' ASN . . . . . 0.637 HD21 ' HB ' ' A' 1050 ' ' VAL . 5.8 m120 -78.29 44.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.499 0.666 . . . . 0.0 109.69 178.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1041 ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' 1039 ' ' THR . 32.6 ptt180 -82.5 -43.93 16.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.209 -178.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1042 ' ' GLU . . . . . 0.455 ' HG2' ' H ' ' A' 1043 ' ' ASN . 74.3 tt0 -162.92 -126.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.922 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1043 ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' 1044 ' ' PHE . 3.1 m120 37.48 -125.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.212 0.205 . . . . 0.0 111.136 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1044 ' ' PHE . . . . . 0.618 ' CE2' ' HD3' ' A' 1028 ' ' PRO . 5.3 m-30 69.52 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.969 0.414 . . . . 0.0 111.589 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1045 ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' 1023 ' ' ILE . 70.6 m-70 -149.42 -49.48 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.704 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1046 ' ' TYR . . . . . 0.665 ' HA ' ' SG ' ' A' 1025 ' ' CYS . 7.5 t80 176.32 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.743 0.782 . . . . 0.0 110.343 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1047 ' ' GLY . . . . . . . . . . . . . . . -160.48 -18.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.049 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1048 ' ' SER . . . . . . . . . . . . . 70.0 p -47.6 145.53 2.61 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.877 -0.662 . . . . 0.0 112.78 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1049 ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' 1073 ' ' TYR . 14.7 p -145.59 155.26 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.457 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1050 ' ' VAL . . . . . 0.637 ' HB ' HD21 ' A' 1040 ' ' ASN . 5.9 p -153.97 130.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.981 0.419 . . . . 0.0 112.041 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1051 ' ' THR . . . . . 0.585 ' HB ' HD12 ' A' 1037 ' ' ILE . 85.8 m -103.43 116.55 32.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1052 ' ' TYR . . . . . 0.582 ' HE1' HG12 ' A' 1072 ' ' ILE . 7.4 m-85 -74.92 151.37 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1053 ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' 1053 ' ' ARG . 50.1 ttt-85 -142.75 -13.89 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.948 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1054 ' ' CYS . . . . . 0.811 ' HA ' ' HA2' ' A' 1034 ' ' GLY . 91.9 m 69.88 152.19 0.1 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.895 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1055 ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' 1033 ' ' ASN . 27.9 t-20 -50.34 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.577 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1056 ' ' LEU . . . . . 0.811 HD23 HG23 ' A' 1063 ' ' VAL . 15.8 mt 61.02 -148.27 0.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.591 0.71 . . . . 0.0 111.393 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1057 ' ' GLY . . . . . 0.464 ' C ' ' N ' ' A' 1059 ' ' ARG . . . 71.84 -34.49 0.61 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.903 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1058 ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' 1059 ' ' ARG . 53.2 m -47.67 -26.99 1.71 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1059 ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' 1057 ' ' GLY . 39.3 mmm-85 -157.07 -1.24 0.11 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.488 -1.687 . . . . 0.0 108.656 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1060 ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' 1061 ' ' ARG . . . 48.31 30.46 7.97 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1061 ' ' ARG . . . . . 0.603 ' HD2' ' N ' ' A' 1062 ' ' LYS . 4.8 tmm_? 178.65 134.98 0.08 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.064 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1062 ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' 1061 ' ' ARG . 39.5 ttpt 54.64 42.34 31.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.904 0.859 . . . . 0.0 109.37 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1063 ' ' VAL . . . . . 0.811 HG23 HD23 ' A' 1056 ' ' LEU . 14.8 m -140.59 57.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.466 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1064 ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' 1091 ' ' CYS . 71.3 m-85 83.9 95.59 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.081 -178.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1065 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -89.85 151.15 21.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.185 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1066 ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' 1070 ' ' PRO . 27.6 tp -68.56 142.67 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.484 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1067 ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' 1090 ' ' GLN . 58.9 t -139.0 133.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1068 ' ' GLY . . . . . . . . . . . . . . . 79.29 -139.12 21.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.956 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1069 ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' 1069 ' ' GLU . 1.1 pm0 -66.4 125.6 90.66 Favored Pre-proline 0 N--CA 1.453 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 111.837 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1070 ' ' PRO . . . . . 0.523 ' HB3' HD21 ' A' 1066 ' ' LEU . 3.3 Cg_endo -83.8 -26.94 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.142 2.562 . . . . 0.0 112.134 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1071 ' ' SER . . . . . 0.442 ' OG ' HG23 ' A' 1051 ' ' THR . 49.1 m -144.09 147.84 34.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1072 ' ' ILE . . . . . 0.582 HG12 ' HE1' ' A' 1052 ' ' TYR . 26.6 pt -143.61 160.65 16.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.336 0.588 . . . . 0.0 111.761 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1073 ' ' TYR . . . . . 0.53 ' HB3' HG23 ' A' 1049 ' ' VAL . 0.6 OUTLIER -160.19 148.61 16.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.504 179.666 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A 1074 ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' 1084 ' ' TRP . 48.3 t -65.66 145.33 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1075 ' ' THR . . . . . . . . . . . . . 9.9 t -157.7 23.13 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.767 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1076 ' ' SER . . . . . . . . . . . . . 99.2 p 52.59 176.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.575 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1077 ' ' ASN . . . . . 0.707 HD22 ' H ' ' A' 1078 ' ' ASP . 0.0 OUTLIER -174.1 -40.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.508 179.903 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A 1078 ' ' ASP . . . . . 0.707 ' H ' HD22 ' A' 1077 ' ' ASN . 7.9 t70 -84.04 -75.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.841 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1079 ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.14 -41.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1080 ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 995' ' ' ARG . 3.0 pm0 -162.87 29.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1081 ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' 1078 ' ' ASP . 21.9 t -83.92 -37.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1082 ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' 1025 ' ' CYS . . . 78.85 45.82 8.93 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.165 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1083 ' ' ILE . . . . . . . . . . . . . 67.7 mt -81.98 136.04 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.008 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1084 ' ' TRP . . . . . 0.616 ' HA ' ' HA ' ' A' 1074 ' ' CYS . 12.4 m95 -70.54 146.76 49.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.862 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1085 ' ' SER . . . . . . . . . . . . . 85.2 p -44.93 -37.25 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.885 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1086 ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' 1087 ' ' PRO . . . -166.63 141.07 6.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.907 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' 1086 ' ' GLY . 34.0 Cg_exo -57.79 177.29 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.928 2.419 . . . . 0.0 112.758 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1088 ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' 1031 ' ' ILE . . . -63.63 141.34 97.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.618 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1089 ' ' PRO . . . . . 0.488 ' HB2' ' H ' ' A' 1090 ' ' GLN . 37.6 Cg_endo -66.72 -141.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.916 2.411 . . . . 0.0 112.586 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1090 ' ' GLN . . . . . 0.671 ' HB2' ' HB ' ' A' 1067 ' ' VAL . 3.2 mm100 -145.37 132.65 20.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.019 0.437 . . . . 0.0 111.206 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1091 ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' 1064 ' ' PHE . 95.9 m -99.53 72.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.197 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 35.9 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.044 -179.988 . . . . . . . . 0 0 . 1 stop_ save_